Citrus Sinensis ID: 046972
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 483 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | yes | no | 0.929 | 0.951 | 0.465 | 1e-113 | |
| Q3EBR4 | 453 | Putative receptor-like pr | no | no | 0.807 | 0.860 | 0.466 | 4e-94 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.641 | 0.709 | 0.528 | 2e-89 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.892 | 0.872 | 0.384 | 5e-85 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.908 | 0.907 | 0.395 | 3e-82 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.931 | 0.963 | 0.384 | 2e-81 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.590 | 0.274 | 0.416 | 6e-55 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.761 | 0.540 | 0.314 | 3e-54 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.590 | 0.275 | 0.406 | 4e-54 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.573 | 0.372 | 0.378 | 3e-53 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 409 bits (1050), Expect = e-113, Method: Compositional matrix adjust.
Identities = 223/479 (46%), Positives = 304/479 (63%), Gaps = 30/479 (6%)
Query: 5 LKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFR---LP 61
L +LSK TS FG+ LW++I L L LI IA+ L + + RRK A F +
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGIL--LGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIA 66
Query: 62 KNPISPK-NHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNR 120
PIS + + P S + EI++++ K + + +FSDR SSG S
Sbjct: 67 TPPISKEIKEIVPAQNQSVPA------------EIQVDIGKIEHRVVFSDRVSSGESRGT 114
Query: 121 CTRAQ-----ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL 175
+ ++ +GN VS + G +L+E++ T+G E+NVI G G+VYR +L
Sbjct: 115 ASASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILT 174
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D + AVK L++N E++F +VE IG+V+HKNLV+L GYCVEG R+LVY+++DNGN
Sbjct: 175 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGN 234
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L+QW+HG +G+ PLTWD RM II G AKGLAYLHE +EPK+VH ++KSSNILLD WN
Sbjct: 235 LEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNA 294
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
K+SD GLAKL G E S T+ + GY+A E + T + NEKSD+YSFGILIMEI++GR
Sbjct: 295 KVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDIYSFGILIMEIITGR 353
Query: 356 LPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIK 413
PVDYS+PQ L+DWLKSMV ++ V+DPK+PE PS K LKR++L+ALRCVDPD
Sbjct: 354 NPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDAN 413
Query: 414 HRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKTAVLCDADISTHDEENRAHE 472
RPKMG ++ MLE DLL R+E R R H ++ +TAV+ A + + +R H+
Sbjct: 414 KRPKMGHIIHMLEAEDLLYRDERRTTRD---HGSRERQETAVVA-AGSESGESGSRHHQ 468
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q3EBR4|Y2394_ARATH Putative receptor-like protein kinase At2g30940 OS=Arabidopsis thaliana GN=At2g30940 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 345 bits (885), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 203/435 (46%), Positives = 258/435 (59%), Gaps = 45/435 (10%)
Query: 2 SSSLKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFRLP 61
S +K KLS+HTSFFGI LWILI + L+ + I L FIFHRR+ S FRL
Sbjct: 36 SDLIKQKLSQHTSFFGIKLWILITASASIAFLLVLIISVLLCFIFHRRRCS--QEPFRLR 93
Query: 62 KNPISPKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSS-GTSTNR 120
P +H+ N +I N D++ S R S G S+ R
Sbjct: 94 SKLCLPLSHIPLTNK----------------QQIPYNRCGDDIE---SQRISQVGWSSAR 134
Query: 121 CTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRA 180
+ + + S + + EI VTD FA+ NVI GD+ VYR +L+ +
Sbjct: 135 LSYYTRSFSSTGSFGSFNV---FTFMEIKNVTDSFADDNVITKGDSSTVYRGILMGTVTV 191
Query: 181 AVK-LLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
AVK L SNS E++DFI K E I V+HKN+V+L GYC+EG R+LVYEY + G+L +W
Sbjct: 192 AVKRFLPSNSRYEDKDFITKAEMIANVRHKNVVRLLGYCIEGDERVLVYEYAEKGDLHEW 251
Query: 240 LHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299
LHGS G +PLTW RMKIIQG AKGLAY+HEDIEPKI H +++ S ILLD+ WNPKI D
Sbjct: 252 LHGSAGRNRPLTWRKRMKIIQGVAKGLAYIHEDIEPKITHQDIRPSKILLDYQWNPKILD 311
Query: 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
VG I + + +EK DVYSFG +IME+VSGR+ VD
Sbjct: 312 VGFIGHSDIPTLIPSPGNM-----------------DEKIDVYSFGNMIMELVSGRVSVD 354
Query: 360 YSQP--QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK 417
S P +V+L+DW+K MVA I VLDP LPE P+ KELKRI+LI+LRCVDP++K RPK
Sbjct: 355 QSSPHVRVYLVDWIKEMVANHMIVDVLDPSLPEFPTIKELKRIVLISLRCVDPELKERPK 414
Query: 418 MGDVLRMLEPRDLLL 432
MGDV+ ML+P DLLL
Sbjct: 415 MGDVIHMLQPHDLLL 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (846), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 167/316 (52%), Positives = 218/316 (68%), Gaps = 6/316 (1%)
Query: 126 ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLL 185
++G++ S M G SLK+++I T GF++ N+I G GVVYRA D AAVK L
Sbjct: 117 SSGDVGTS-EAMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNL 175
Query: 186 MSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILVYEYIDNGNLQQWLHGS 243
++N E++F +VEAIG+V+HKNLV L GYC + R+LVYEYIDNGNL+QWLHG
Sbjct: 176 LNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGD 235
Query: 244 LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303
+G PLTWD RMKI GTAKGLAYLHE +EPK+VH ++KSSNILLD WN K+SD GLA
Sbjct: 236 VGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLA 295
Query: 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
KL G E S T+ + GY++ E + T + NE SDVYSFG+L+MEI++GR PVDYS+P
Sbjct: 296 KLLGSETSYVTTRVMGTFGYVSPEYA-STGMLNECSDVYSFGVLLMEIITGRSPVDYSRP 354
Query: 364 --QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421
++ L+DW K MVA ++ V+DPK+ P + LKR +L+ LRC+D D RPKMG +
Sbjct: 355 PGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQI 414
Query: 422 LRMLEPRDLLLREEYR 437
+ MLE D R E+R
Sbjct: 415 IHMLEAEDFPFRPEHR 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (807), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 184/478 (38%), Positives = 280/478 (58%), Gaps = 47/478 (9%)
Query: 3 SSLKHKLSKHTSFFGIP---LWILIVTLTLLFLLIFIAILFLYI------------FIFH 47
SSL ++SK SFFG+ LW+ + + +F+++ + IL L+I F F+
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSKFPFN 64
Query: 48 R----------RKKSYINAH---FRLPKNPISPKNHVHPHNTFSTSSLDRRLLSCNTMSE 94
+ + + N H + N S + H + SS + L C++++
Sbjct: 65 QIPHVSKDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCSSVNH 124
Query: 95 IEMNLSKPDLQFMFSDRWSSGTSTNRCTRAQANGNIRRS-------VSGMRLGIRISLKE 147
E S + G++ R G + S +S + G +L++
Sbjct: 125 HERACSSHS-----GEEGGFGSAG----RQYGGGPVTASPLVGLPEISHLGWGHWFTLRD 175
Query: 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK 207
+++ T+ FA NV+ G GVVYR L++ AVK L++N E++F +VEAIG V+
Sbjct: 176 LELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 235
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
HKNLV+L GYC+EG +R+LVYEY+++GNL+QWLHG++ + LTW+ RMKII GTA+ LA
Sbjct: 236 HKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALA 295
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
YLHE IEPK+VH ++K+SNIL+D +N K+SD GLAKL S T+ + GY+A E
Sbjct: 296 YLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPE 355
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVAQQKIAYVLD 385
+ T + NEKSD+YSFG+L++E ++GR PVDY +P +V L++WLK MV ++ V+D
Sbjct: 356 YA-NTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 414
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRAAS 443
P+L PS+ LKR +L++LRCVDP+ + RP+M V RMLE + +E R KR+ +
Sbjct: 415 PRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSKT 472
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 187/473 (39%), Positives = 272/473 (57%), Gaps = 34/473 (7%)
Query: 1 MSSSLKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHF-- 58
M S L LS++ + G+ LW +IV ++ IF+ +L + +++ RRK S +++
Sbjct: 1 MGSGLNDTLSRN--YNGLELWEIIV---IVLSAIFVVVLAISLWLTFRRKTSRSSSNLIP 55
Query: 59 ---RLPK-----------NPISPKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDL 104
++P + +S N + + + S D+ +E E S
Sbjct: 56 VSRQIPPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEP-EKGIKAESENGDSSRSG 114
Query: 105 QFMFSDR--WSSGTSTNRCTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIA 162
F ++ SS +S N T + S + G +L+++ + T+ F+ N+I
Sbjct: 115 SFNHLEKKDGSSVSSANPLTAPSPLSGLPE-FSHLGWGHWFTLRDLQMATNQFSRDNIIG 173
Query: 163 SGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222
G GVVYR L++ AVK L++N ++DF +VEAIG V+HKNLV+L GYC+EG
Sbjct: 174 DGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGT 233
Query: 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNM 282
R+LVYEY++NGNL+QWL G + LTW+ R+KI+ GTAK LAYLHE IEPK+VH ++
Sbjct: 234 QRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDI 293
Query: 283 KSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVY 342
KSSNIL+D +N KISD GLAKL G + S T+ + GY+A E + + + NEKSDVY
Sbjct: 294 KSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYA-NSGLLNEKSDVY 352
Query: 343 SFGILIMEIVSGRLPVDYSQ--PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRI 400
SFG++++E ++GR PVDY++ P+V L++WLK MV Q++ V+DP L PS LKR
Sbjct: 353 SFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRT 412
Query: 401 ILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKT 453
+L ALRCVDP + RP+M V RMLE EEY I R Q T
Sbjct: 413 LLTALRCVDPMSEKRPRMSQVARMLE------SEEYPIAREDRRRRRSQNGTT 459
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 183/476 (38%), Positives = 275/476 (57%), Gaps = 26/476 (5%)
Query: 1 MSSSLKHKLSKHTSFFGI-PLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINA--- 56
M+S LK L+K +G+ LW +IV + FI IL L +++ R+K NA
Sbjct: 1 MTSQLKRTLTKR---YGVLELWEIIV---IALFAAFIVILVLSVWLSFRKKSKRSNATTL 54
Query: 57 ------HFRLPKNPISPKNHVHPHNTFSTSSLDRRLLS-CNTMSEIEMNLSKPDLQFMFS 109
F IS + +N S +LD + + + +L K L
Sbjct: 55 PVTQSPRFTEEIKEISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLV---- 110
Query: 110 DRWSSGTSTNRCTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVV 169
S + T A + VS + G +L+++ + T+ F+++++I G GVV
Sbjct: 111 --GSHLPPSTPSTTAPSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVV 168
Query: 170 YRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229
Y L + AVK L++N ++DF +VEAIG V+HKNLV+L GYCVEG +R+LVYE
Sbjct: 169 YHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYE 228
Query: 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL 289
Y++NGNL+QWLHG + LTW+ R+K++ GTAK LAYLHE IEPK+VH ++KSSNIL+
Sbjct: 229 YMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILM 288
Query: 290 DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIM 349
D +++ K+SD GLAKL G + + ++ + GY+A E + + + NEKSDVYS+G++++
Sbjct: 289 DDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAPEYA-NSGLLNEKSDVYSYGVVLL 347
Query: 350 EIVSGRLPVDYSQP--QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRC 407
E ++GR PVDY++P +V +++WLK MV Q++ V+D +L P+ ELKR +L ALRC
Sbjct: 348 EAITGRYPVDYARPKEEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRC 407
Query: 408 VDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKTAVLCDADIST 463
VDPD RPKM V RMLE + + +R + + + T D DI+T
Sbjct: 408 VDPDADKRPKMSQVARMLESDEYPVMPREERRRRRNQNAETHRESTDTNKDNDITT 463
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (548), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 120/288 (41%), Positives = 173/288 (60%), Gaps = 3/288 (1%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEA 202
+LK+I T+ F +N I G G VY+ VL D M AVK L S S +F+ ++
Sbjct: 657 FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGM 716
Query: 203 IGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262
I ++H NLVKL+G C+EG+ +LVYEY++N +L + L G+ + L W TR KI G
Sbjct: 717 ISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGI 776
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
AKGLAYLHE+ KIVH ++K++N+LLD N KISD GLAKL+ E + ++ G
Sbjct: 777 AKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIG 836
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLIDWLKSMVAQQKI 380
Y+A E + R +K+DVYSFG++ +EIVSG+ +Y + V+L+DW + Q +
Sbjct: 837 YMAPEYAMR-GYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSL 895
Query: 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428
++DP L S+KE R++ IAL C +P RP M V+ MLE +
Sbjct: 896 LELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGK 943
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 130/413 (31%), Positives = 217/413 (52%), Gaps = 45/413 (10%)
Query: 24 IVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFRLPKNPISPKNHVHPHNTFSTSSLD 83
IV + ++ L+F+++ + ++ +RK+ K+P + + P + +S+
Sbjct: 238 IVAIGVIVGLVFLSLFVMGVWFTRKRKR----------KDPGTFVGYTMPPSAYSSPQGS 287
Query: 84 RRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNRCTRAQANGNIRRSVSGMRLGIRI 143
+L + S S +M++ S S R
Sbjct: 288 DVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSW--------------------F 327
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAI 203
S E+ VT GF+E+N++ G G VY+ VL D AVK L E +F +VE I
Sbjct: 328 SYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEII 387
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKP-LTWDTRMKIIQGT 262
+V H++LV L GYC+ Q+R+LVY+Y+ N L LH +P +TW+TR+++ G
Sbjct: 388 SRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH---APGRPVMTWETRVRVAAGA 444
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR--- 319
A+G+AYLHED P+I+H ++KSSNILLD+ + ++D GLAK+ E ++T R
Sbjct: 445 ARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKI-AQELDLNTHVSTRVMG 503
Query: 320 NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVAQ 377
GY+A E + + +EK+DVYS+G++++E+++GR PVD SQP L++W + ++ Q
Sbjct: 504 TFGYMAPEYA-TSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQ 562
Query: 378 ----QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
++ ++DP+L + E+ R++ A CV RPKM V+R L+
Sbjct: 563 AIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 212 bits (540), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 117/288 (40%), Positives = 172/288 (59%), Gaps = 3/288 (1%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEA 202
+LK+I T+ F +N I G G VY+ VL D M AVK L S S +F+ ++
Sbjct: 655 FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGM 714
Query: 203 IGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262
I ++H NLVKL+G C+EG+ +LVYEY++N +L + L G+ + L W TR K+ G
Sbjct: 715 ISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGI 774
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
AKGLAYLHE+ KIVH ++K++N+LLD N KISD GLAKL E + ++ G
Sbjct: 775 AKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIG 834
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLIDWLKSMVAQQKI 380
Y+A E + R +K+DVYSFG++ +EIVSG+ +Y + ++L+DW + Q +
Sbjct: 835 YMAPEYAMR-GYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSL 893
Query: 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428
++DP L S+KE R++ IAL C +P RP M V+ ML+ +
Sbjct: 894 LELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGK 941
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (533), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 109/288 (37%), Positives = 179/288 (62%), Gaps = 11/288 (3%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEA 202
+L E++ TD F+ + V+ G G VY+ + D AVKLL ++ + + +FI +VE
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAEVEM 396
Query: 203 IGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262
+ ++ H+NLVKL G C+EG+ R L+YE + NG+++ LH L WD R+KI G
Sbjct: 397 LSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGT-----LDWDARLKIALGA 451
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS- 321
A+GLAYLHED P+++H + K+SN+LL+ + PK+SD GLA+ E S S + +
Sbjct: 452 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR-EATEGSQHISTRVMGTF 510
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVA-QQ 378
GY+A E + T KSDVYS+G++++E+++GR PVD SQP + L+ W + ++A ++
Sbjct: 511 GYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANRE 569
Query: 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ ++DP L + ++ ++ IA CV ++ HRP MG+V++ L+
Sbjct: 570 GLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 483 | ||||||
| 255541684 | 492 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.971 | 0.953 | 0.483 | 1e-114 | |
| 224130370 | 485 | predicted protein [Populus trichocarpa] | 0.948 | 0.944 | 0.472 | 1e-112 | |
| 255545180 | 449 | ATP binding protein, putative [Ricinus c | 0.871 | 0.937 | 0.492 | 1e-112 | |
| 359489654 | 492 | PREDICTED: probable serine/threonine-pro | 0.913 | 0.896 | 0.490 | 1e-111 | |
| 297848354 | 472 | kinase family protein [Arabidopsis lyrat | 0.929 | 0.951 | 0.465 | 1e-111 | |
| 15223428 | 472 | putative serine/threonine-protein kinase | 0.929 | 0.951 | 0.465 | 1e-111 | |
| 14194119 | 479 | At1g01540/F22L4_6 [Arabidopsis thaliana] | 0.929 | 0.937 | 0.465 | 1e-111 | |
| 224135263 | 295 | predicted protein [Populus trichocarpa] | 0.606 | 0.993 | 0.667 | 1e-111 | |
| 297814211 | 481 | predicted protein [Arabidopsis lyrata su | 0.925 | 0.929 | 0.443 | 1e-109 | |
| 240255713 | 479 | protein kinase family protein [Arabidops | 0.917 | 0.924 | 0.445 | 1e-107 |
| >gi|255541684|ref|XP_002511906.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223549086|gb|EEF50575.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1078), Expect = e-114, Method: Compositional matrix adjust.
Identities = 235/486 (48%), Positives = 306/486 (62%), Gaps = 17/486 (3%)
Query: 8 KLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFRLPKNPISP 67
+LSK TS FG+ LW++I L L LI +A+ L + I RRK PIS
Sbjct: 12 ELSKPTSIFGLRLWVVIGIL--LGSLIVLALFLLSLCITSRRKNKKTLKLTDTITPPISK 69
Query: 68 KNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTS---TNRCTRA 124
+ H F T + EI++ + K + + +FSDR SSG S + C A
Sbjct: 70 EIQEIVH--FPTQDNHHHHHHAVQVPEIQVEIGKTEHRVVFSDRPSSGESRGTASACETA 127
Query: 125 Q-ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVK 183
+G++ VS + G +L+E++ T+G E+NVI G G+VY VL D R AVK
Sbjct: 128 SFGSGSVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYSGVLSDGTRVAVK 187
Query: 184 LLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGS 243
L++N E++F +VE IG+V+HKNLV+L GYCVEG R+LVYEY+DNGNL QWLHG
Sbjct: 188 NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD 247
Query: 244 LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303
+G+ PLTWD RM II GTAKGLAYLHE +EPK+VH ++KSSNILLD WNPK+SD GLA
Sbjct: 248 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNPKVSDFGLA 307
Query: 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
KL E S T+ + GY+A E + T + NEKSD+YSFGILIME++SGR PVDYS+P
Sbjct: 308 KLLCSERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDIYSFGILIMELISGRSPVDYSRP 366
Query: 364 Q--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421
Q V L+DWLK+MV +K V+DPKLPEMP+ K LKR++L+ALRCVDPD RPKMG V
Sbjct: 367 QGEVNLVDWLKTMVGNRKSEEVVDPKLPEMPASKALKRVLLVALRCVDPDATRRPKMGHV 426
Query: 422 LRMLEPRDLLLREEYRIKRAA--SYHNYPQKN-KTAVLCD---ADISTHDEENRAHEPDH 475
+ MLE DLL R+E RI R + S H Y Q+N A L D + ++ E + H
Sbjct: 427 IHMLEADDLLFRDERRIGRESSNSRHEYEQENPAVAKLGDRQFGEGTSDTSEGDSSRNLH 486
Query: 476 ENPPWK 481
+ W+
Sbjct: 487 QQSRWR 492
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130370|ref|XP_002320820.1| predicted protein [Populus trichocarpa] gi|222861593|gb|EEE99135.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1059), Expect = e-112, Method: Compositional matrix adjust.
Identities = 226/478 (47%), Positives = 301/478 (62%), Gaps = 20/478 (4%)
Query: 8 KLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFRLPKNPISP 67
+LSK TS FG+ LW++I L L LI +A+ L + + RRK N F+L K +P
Sbjct: 12 ELSKPTSIFGLRLWVVIGIL--LGSLIVLALFLLSLCVTSRRK----NRQFKLTKTDTTP 65
Query: 68 KNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNRCTRAQAN 127
D + + EI++ + K + + +FS S GT++ T + +
Sbjct: 66 PISKEIQEIVHLPVQDHNHHAIQ-VPEIQVGIGKVEHRVVFSSGESRGTASGGETASFGS 124
Query: 128 GNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMS 187
G++ VS + G +L+E++ T G E+NVI G G+VYR VL D + AVK L++
Sbjct: 125 GSVGPEVSHLGWGRWYTLRELEAATGGLCEENVIGEGGYGIVYRGVLSDGTKVAVKNLLN 184
Query: 188 NSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEA 247
N E +F +VE IG+V+HKNLV+L GYCVEG R+LVYEY+DNGNL QWLHG +GE
Sbjct: 185 NRGQAEREFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGEV 244
Query: 248 KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
PLTWD R II GTAKGLAYLH+ +EPK+VH ++KSSNILLD WN K+SD GLAKL
Sbjct: 245 SPLTWDIRRNIILGTAKGLAYLHDGLEPKVVHRDVKSSNILLDRQWNSKVSDFGLAKLLH 304
Query: 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--V 365
E S T+ + GY+A E + T + NEKSDVYSFGILIMEI+SGR PVDYS+PQ V
Sbjct: 305 SERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIISGRSPVDYSRPQGEV 363
Query: 366 FLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
L++WLK+MV +K V+DPKLPEMP+ K LKR +L+AL+CVDPD RPKMG V+ ML
Sbjct: 364 NLVEWLKTMVGNRKSEEVVDPKLPEMPASKALKRALLVALKCVDPDATKRPKMGHVIHML 423
Query: 426 EPRDLLLREEYRIKRAASY--HNYPQKNKTAVL--------CDADISTHDEENRAHEP 473
E DLL R+E R+ R S+ H+Y Q+N A+ +D S + + H+P
Sbjct: 424 EADDLLFRDERRVGREPSHSQHDYEQENHAAMKFIDKQSGEGTSDTSEGESGRKHHQP 481
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545180|ref|XP_002513651.1| ATP binding protein, putative [Ricinus communis] gi|223547559|gb|EEF49054.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 411 bits (1057), Expect = e-112, Method: Compositional matrix adjust.
Identities = 234/475 (49%), Positives = 290/475 (61%), Gaps = 54/475 (11%)
Query: 3 SSLKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKS-YINAHFRLP 61
SSL LS HTSFFGI LWI++V LLF + + ++F+ I R+KKS HF LP
Sbjct: 7 SSLNKNLSTHTSFFGIRLWIILVAFVLLFTALILIVIFISIVYLCRQKKSKSFKPHFLLP 66
Query: 62 KNPISPKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNRC 121
N IS N+ N++S SSLDRRLLS + EIEMN++K D S GT T
Sbjct: 67 -NAISCSNNFR--NSYSASSLDRRLLS-QRIVEIEMNMAKLDHHTNLS-----GTIT--- 114
Query: 122 TRAQANGNIRRSVS-------GMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVL 174
T+ NG SV+ G R + +I+++TDGF+++N+I +GD GVVYR +L
Sbjct: 115 TQDNNNGADLESVARYFPVVFDAWRGNRFTYHDIEVMTDGFSDENLIGNGDRGVVYRGIL 174
Query: 175 LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234
LD R AVK L+S S EE F+++VE IG V+HKN+VKL G C EG RILV EY+DNG
Sbjct: 175 LDATRVAVKSLLSKSCQAEE-FVDEVEVIGHVRHKNIVKLLGCCTEGGYRILVNEYVDNG 233
Query: 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294
NL QWLHG E PLTW RM IIQG AKGLAYLHEDIEPKI+H +KS+NILLDH WN
Sbjct: 234 NLHQWLHGWTEEVSPLTWGIRMNIIQGVAKGLAYLHEDIEPKIIHQTLKSTNILLDHQWN 293
Query: 295 PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG 354
PKISD G+ KL GP +A L G + S ++
Sbjct: 294 PKISDFGIVKLCGP-----------GGNQMAARLMGTSGAMCLSSAKWNL---------- 332
Query: 355 RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKH 414
V+LIDWLKSMVA KI Y+ DPKLPE PS KELKR++L+ALRCVDPDIKH
Sbjct: 333 ----------VYLIDWLKSMVASHKIMYIADPKLPEFPSSKELKRVLLLALRCVDPDIKH 382
Query: 415 RPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKT--AVLCDADISTHDEE 467
RP M DV+ ML+PRDLLL +E R +R + H P K A ++D +TH+ E
Sbjct: 383 RPTMRDVIHMLQPRDLLLNDERRFRRDSPSHQSPSKESQIIAKAGESDFTTHERE 437
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489654|ref|XP_003633957.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] gi|297745343|emb|CBI40423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1052), Expect = e-111, Method: Compositional matrix adjust.
Identities = 223/455 (49%), Positives = 294/455 (64%), Gaps = 14/455 (3%)
Query: 5 LKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFRLPKNP 64
L +LSK TS FG+ LW++I +F+ I I+ + + ++ + +L
Sbjct: 9 LNSELSKPTSIFGLRLWVVIG----IFVGAVIVIILFLLSLCITSRRRRPPSSSKLGAGE 64
Query: 65 ISPKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTS----TNR 120
+P ++ D R + SEI++++ K + + +FSDR SS S
Sbjct: 65 FTPVVSKEIQEIVHEAAPDHRPV-LPPASEIQIDIGKSEHRVVFSDRLSSQASGESRATS 123
Query: 121 CTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRA 180
T + G VS + G +L+E++ T+G A++NVI G G+VYR VL DN R
Sbjct: 124 VTETASLGGGPPEVSHLGWGRWYTLRELEAATNGLADENVIGEGGYGIVYRGVLADNTRV 183
Query: 181 AVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL 240
AVK L++N E++F +VEAIG+V+HKNLV+L GYC EG R+LVYEY+DNGNL QWL
Sbjct: 184 AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAYRMLVYEYVDNGNLDQWL 243
Query: 241 HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300
HG +GE PLTWD R+ II GTAKGLAYLHE +EPK+VH ++KSSNILLD WN K+SD
Sbjct: 244 HGDVGEVSPLTWDIRINIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNSKVSDF 303
Query: 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY 360
GLAKL E S T+ + GY+A E + T + NEKSDVYSFGILIMEI+SGR PVDY
Sbjct: 304 GLAKLLCSEISYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIISGRNPVDY 362
Query: 361 SQP--QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM 418
SQ +V L+DWLK+MV +K V+DPKLPEMPS K LKR++L+ALRCVDPD RPKM
Sbjct: 363 SQAPGEVNLVDWLKTMVGNRKSEEVVDPKLPEMPSSKALKRVLLVALRCVDPDATKRPKM 422
Query: 419 GDVLRMLEPRDLLLREEYRIKRAA--SYHNYPQKN 451
G V+ MLE DLL R+E RI R + S+H+Y Q+N
Sbjct: 423 GHVIHMLEADDLLFRDERRIGRESSHSHHDYQQEN 457
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848354|ref|XP_002892058.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297337900|gb|EFH68317.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1050), Expect = e-111, Method: Compositional matrix adjust.
Identities = 223/479 (46%), Positives = 305/479 (63%), Gaps = 30/479 (6%)
Query: 5 LKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFR---LP 61
L +LSK TS FG+ LW++I L L LI IA+ L + + RRK A F +
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGIL--LGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIA 66
Query: 62 KNPISPK-NHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNR 120
PIS + + P T S + EI++++ K + + +FSDR SSG S
Sbjct: 67 TPPISKEIKEIVPAQTQSVPA------------EIQVDIGKIEHRVVFSDRVSSGESRGT 114
Query: 121 CTRAQ-----ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL 175
+ ++ +GN VS + G +L+E++ T+G E+NVI G G+VYR +L
Sbjct: 115 ASASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILT 174
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D + AVK L++N E++F +VE IG+V+HKNLV+L GYCVEG R+LVY+++DNGN
Sbjct: 175 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGN 234
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L+QW+HG +G+ PLTWD RM II G AKGLAYLHE +EPK+VH ++KSSNILLD WN
Sbjct: 235 LEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNA 294
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
K+SD GLAKL G E S T+ + GY+A E + T + NEKSD+YSFGILIMEI++GR
Sbjct: 295 KVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDIYSFGILIMEIITGR 353
Query: 356 LPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIK 413
PVDYS+PQ L+DWLKSMV ++ V+DPK+PE PS K LKR++L+ALRCVDPD
Sbjct: 354 NPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDAN 413
Query: 414 HRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKTAVLCDADISTHDEENRAHE 472
RPKMG ++ MLE D+L R+E R R H ++ +TAV+ A + + +R H+
Sbjct: 414 KRPKMGHIIHMLEAEDVLYRDERRTTRD---HGSRERQETAVVV-AGSESGESGSRHHQ 468
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223428|ref|NP_171661.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|158564340|sp|Q3EDL4.2|Y1154_ARATH RecName: Full=Probable serine/threonine-protein kinase At1g01540 gi|12083266|gb|AAG48792.1|AF332429_1 putative protein serine/threonine kinase [Arabidopsis thaliana] gi|2505874|emb|CAA73303.1| putative kinase [Arabidopsis thaliana] gi|332189181|gb|AEE27302.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1050), Expect = e-111, Method: Compositional matrix adjust.
Identities = 223/479 (46%), Positives = 304/479 (63%), Gaps = 30/479 (6%)
Query: 5 LKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFR---LP 61
L +LSK TS FG+ LW++I L L LI IA+ L + + RRK A F +
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGIL--LGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIA 66
Query: 62 KNPISPK-NHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNR 120
PIS + + P S + EI++++ K + + +FSDR SSG S
Sbjct: 67 TPPISKEIKEIVPAQNQSVPA------------EIQVDIGKIEHRVVFSDRVSSGESRGT 114
Query: 121 CTRAQ-----ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL 175
+ ++ +GN VS + G +L+E++ T+G E+NVI G G+VYR +L
Sbjct: 115 ASASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILT 174
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D + AVK L++N E++F +VE IG+V+HKNLV+L GYCVEG R+LVY+++DNGN
Sbjct: 175 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGN 234
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L+QW+HG +G+ PLTWD RM II G AKGLAYLHE +EPK+VH ++KSSNILLD WN
Sbjct: 235 LEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNA 294
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
K+SD GLAKL G E S T+ + GY+A E + T + NEKSD+YSFGILIMEI++GR
Sbjct: 295 KVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDIYSFGILIMEIITGR 353
Query: 356 LPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIK 413
PVDYS+PQ L+DWLKSMV ++ V+DPK+PE PS K LKR++L+ALRCVDPD
Sbjct: 354 NPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDAN 413
Query: 414 HRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKTAVLCDADISTHDEENRAHE 472
RPKMG ++ MLE DLL R+E R R H ++ +TAV+ A + + +R H+
Sbjct: 414 KRPKMGHIIHMLEAEDLLYRDERRTTRD---HGSRERQETAVVA-AGSESGESGSRHHQ 468
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14194119|gb|AAK56254.1|AF367265_1 At1g01540/F22L4_6 [Arabidopsis thaliana] gi|20334728|gb|AAM16225.1| At1g01540/F22L4_6 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1050), Expect = e-111, Method: Compositional matrix adjust.
Identities = 223/479 (46%), Positives = 304/479 (63%), Gaps = 30/479 (6%)
Query: 5 LKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKKSYINAHFR---LP 61
L +LSK TS FG+ LW++I L L LI IA+ L + + RRK A F +
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGIL--LGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIA 66
Query: 62 KNPISPK-NHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNR 120
PIS + + P S + EI++++ K + + +FSDR SSG S
Sbjct: 67 TPPISKEIKEIVPAQNQSVPA------------EIQVDIGKIEHRVVFSDRVSSGESRGT 114
Query: 121 CTRAQ-----ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL 175
+ ++ +GN VS + G +L+E++ T+G E+NVI G G+VYR +L
Sbjct: 115 ASASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILT 174
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D + AVK L++N E++F +VE IG+V+HKNLV+L GYCVEG R+LVY+++DNGN
Sbjct: 175 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGN 234
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L+QW+HG +G+ PLTWD RM II G AKGLAYLHE +EPK+VH ++KSSNILLD WN
Sbjct: 235 LEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNA 294
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
K+SD GLAKL G E S T+ + GY+A E + T + NEKSD+YSFGILIMEI++GR
Sbjct: 295 KVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDIYSFGILIMEIITGR 353
Query: 356 LPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIK 413
PVDYS+PQ L+DWLKSMV ++ V+DPK+PE PS K LKR++L+ALRCVDPD
Sbjct: 354 NPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDAN 413
Query: 414 HRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKTAVLCDADISTHDEENRAHE 472
RPKMG ++ MLE DLL R+E R R H ++ +TAV+ A + + +R H+
Sbjct: 414 KRPKMGHIIHMLEAEDLLYRDERRTTRD---HGSRERQETAVVA-AGSESGESGSRHHQ 468
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135263|ref|XP_002327605.1| predicted protein [Populus trichocarpa] gi|222836159|gb|EEE74580.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1048), Expect = e-111, Method: Compositional matrix adjust.
Identities = 197/295 (66%), Positives = 233/295 (78%), Gaps = 2/295 (0%)
Query: 140 GIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEK 199
G RI+LKEI++VTDGFA+ N+I SGD V YR VLLD R AVK L+SNS + EDFI +
Sbjct: 1 GNRIALKEIEVVTDGFADMNMIGSGDYSVAYRGVLLDTTRVAVKRLLSNS-CQAEDFIAE 59
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKII 259
E IG ++HKNLVKL GYC+E RILV EY+DNGNL QWL+G + PLTW RM II
Sbjct: 60 AEMIGHIRHKNLVKLLGYCMEEGYRILVSEYVDNGNLHQWLYGCPEQPSPLTWAIRMNII 119
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
QG AKGLAYLHEDIEPK +H N+KSSNILLDH WNPKISD G+AKL GP+W T+ +
Sbjct: 120 QGIAKGLAYLHEDIEPKFIHQNLKSSNILLDHQWNPKISDFGIAKLFGPQWIDITTLAME 179
Query: 320 NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379
SGYLA E T + +EKSDVYSFGILIMEI+ R PVD++QPQV+L+DWLKSMVA ++
Sbjct: 180 TSGYLAHE-HEYTGVLSEKSDVYSFGILIMEIICARAPVDHNQPQVYLVDWLKSMVANKQ 238
Query: 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLRE 434
I +V+DPKLPE+PS KELKRI+L+ALRCVD DIKHRP MGDV+ MLEPRDLLL +
Sbjct: 239 IMFVVDPKLPEIPSSKELKRILLLALRCVDRDIKHRPTMGDVIHMLEPRDLLLDD 293
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814211|ref|XP_002874989.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297320826|gb|EFH51248.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1029), Expect = e-109, Method: Compositional matrix adjust.
Identities = 218/491 (44%), Positives = 305/491 (62%), Gaps = 44/491 (8%)
Query: 4 SLKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKK------SYINAH 57
S+ ++LSK TS FG+ LW++I L L LI IA+ FL + + RR+ + +A
Sbjct: 10 SINNELSKQTSIFGLKLWVVIGIL--LGSLIVIALFFLSLCLTSRRRNRKPRHADFASAA 67
Query: 58 FRLPKNPIS----------PKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFM 107
P PIS ++H HP + +EI++++ K + + +
Sbjct: 68 VATP--PISKEIQEIVRSPAQDHYHPTQPVA--------------AEIQVDIGKIEHRVV 111
Query: 108 FSDRWSSGTSTNRCTRAQ-----ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIA 162
FSDR SSG S + ++ +G + VS + G +L+E++ T+G E+NVI
Sbjct: 112 FSDRVSSGESRGTVSASETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIG 171
Query: 163 SGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222
G G+VY +L D + AVK L++N E++F +VEAIG+V+HKNLV+L GYCVEG
Sbjct: 172 EGGYGIVYSGILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGA 231
Query: 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNM 282
R+LVY+Y+DNGNL+QW+HG +G+ PLTWD RM II AKGLAYLHE +EPK+VH ++
Sbjct: 232 YRMLVYDYVDNGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDI 291
Query: 283 KSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVY 342
KSSNILLD WN K+SD GLAKL E S T+ + GY+A E + T + EKSD+Y
Sbjct: 292 KSSNILLDRQWNAKVSDFGLAKLLFSESSYVTTRVMGTFGYVAPEYAC-TGMLTEKSDIY 350
Query: 343 SFGILIMEIVSGRLPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRI 400
SFGILIMEI++GR PVDYS+PQ V L++WLK+MV ++ V+DPK+PE P+ K LKR+
Sbjct: 351 SFGILIMEIITGRNPVDYSRPQGEVNLVEWLKTMVGNRRSEEVVDPKIPEPPTSKALKRV 410
Query: 401 ILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKR--AASYHNYPQKNKTAVLCD 458
+L+ALRCVDPD RPKMG ++ MLE DL R+E R R A+ +N PQ +A +
Sbjct: 411 LLVALRCVDPDANKRPKMGHIIHMLEAEDLFYRDERRATREHASRDYNQPQTEVSAAAAE 470
Query: 459 ADISTHDEENR 469
S ++ R
Sbjct: 471 TSESDSSKDRR 481
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240255713|ref|NP_192042.5| protein kinase family protein [Arabidopsis thaliana] gi|332656610|gb|AEE82010.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1015), Expect = e-107, Method: Compositional matrix adjust.
Identities = 215/483 (44%), Positives = 298/483 (61%), Gaps = 40/483 (8%)
Query: 4 SLKHKLSKHTSFFGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKK------SYINAH 57
S+ ++LSK TS FG+ LW++I L L LI IA+ FL + + RR+ + +A
Sbjct: 10 SINNELSKPTSIFGLKLWVVIGIL--LGSLIVIALFFLSLCLTSRRRNRKPRHADFASAA 67
Query: 58 FRLPKNPIS----------PKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFM 107
P PIS ++H HP + +EI++++ K + + +
Sbjct: 68 VATP--PISKEIQEIVRPPAQDHCHPTQPVA--------------AEIQVDIGKTEHRVV 111
Query: 108 FSDRWSSGTSTNRCTRA---QANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASG 164
FSDR SSG S + +G + VS + G +L+E++ T+G E+NVI G
Sbjct: 112 FSDRVSSGESRGTVSETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEG 171
Query: 165 DNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224
G+VY +L D + AVK L++N E++F +VEAIG+V+HKNLV+L GYCVEG R
Sbjct: 172 GYGIVYSGILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGAYR 231
Query: 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284
+LVY+Y+DNGNL+QW+HG +G+ PLTWD RM II AKGLAYLHE +EPK+VH ++KS
Sbjct: 232 MLVYDYVDNGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDIKS 291
Query: 285 SNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSF 344
SNILLD WN K+SD GLAKL E S T+ + GY+A E + T + EKSD+YSF
Sbjct: 292 SNILLDRQWNAKVSDFGLAKLLFSESSYVTTRVMGTFGYVAPEYAC-TGMLTEKSDIYSF 350
Query: 345 GILIMEIVSGRLPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIIL 402
GILIMEI++GR PVDYS+PQ V L++WLK+MV ++ V+DPK+PE P+ K LKR++L
Sbjct: 351 GILIMEIITGRNPVDYSRPQGEVNLVEWLKTMVGNRRSEEVVDPKIPEPPTSKALKRVLL 410
Query: 403 IALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRAASYHNYPQKNKTAVLCDADIS 462
+ALRCVDPD RPKMG ++ MLE DL R+E R R + ++ Q A+ S
Sbjct: 411 VALRCVDPDANKRPKMGHIIHMLEAEDLFYRDERRATREHASRDFNQPRTEISPAVAETS 470
Query: 463 THD 465
D
Sbjct: 471 ESD 473
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 483 | ||||||
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.776 | 0.794 | 0.503 | 4.5e-98 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.627 | 0.615 | 0.540 | 1.3e-86 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.654 | 0.723 | 0.521 | 1.5e-83 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.612 | 0.635 | 0.506 | 9.7e-80 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.635 | 0.599 | 0.487 | 7.9e-78 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.635 | 0.621 | 0.487 | 3.4e-77 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.718 | 0.716 | 0.461 | 9e-77 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.648 | 0.636 | 0.475 | 1.1e-76 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.677 | 0.700 | 0.461 | 1.9e-76 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.687 | 0.462 | 0.355 | 6.1e-54 |
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
Identities = 195/387 (50%), Positives = 266/387 (68%)
Query: 93 SEIEMNLSKPDLQFMFSDRWSSGTSTNRCTRAQA-----NGNIRRSVSGMRLGIRISLKE 147
+EI++++ K + + +FSDR SSG S + ++ +GN VS + G +L+E
Sbjct: 87 AEIQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHLGWGRWYTLRE 146
Query: 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK 207
++ T+G E+NVI G G+VYR +L D + AVK L++N E++F +VE IG+V+
Sbjct: 147 LEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR 206
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
HKNLV+L GYCVEG R+LVY+++DNGNL+QW+HG +G+ PLTWD RM II G AKGLA
Sbjct: 207 HKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLA 266
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
YLHE +EPK+VH ++KSSNILLD WN K+SD GLAKL G E S T+ + GY+A E
Sbjct: 267 YLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPE 326
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLIDWLKSMVAQQKIAYVLD 385
+ T + NEKSD+YSFGILIMEI++GR PVDYS+PQ L+DWLKSMV ++ V+D
Sbjct: 327 YAC-TGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVD 385
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRAASYH 445
PK+PE PS K LKR++L+ALRCVDPD RPKMG ++ MLE DLL R+E R R H
Sbjct: 386 PKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRD---H 442
Query: 446 NYPQKNKTAVLCDADISTHDEENRAHE 472
++ +TAV+ A + + +R H+
Sbjct: 443 GSRERQETAVVA-AGSESGESGSRHHQ 468
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 166/307 (54%), Positives = 226/307 (73%)
Query: 134 VSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE 193
VS + G +L+E+++ T+GFA++NVI G G+VYR VL D A+K L++N E
Sbjct: 141 VSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAE 200
Query: 194 EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGS-LGEAKPLTW 252
++F +VEAIG+V+HKNLV+L GYCVEG +R+LVYEY+DNGNL+QW+HG LG PLTW
Sbjct: 201 KEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTW 260
Query: 253 DTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312
+ RM I+ GTAKGL YLHE +EPK+VH ++KSSNILLD WN K+SD GLAKL G E S
Sbjct: 261 EIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSEMSY 320
Query: 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ-P-QVFLIDW 370
T+ + GY+A E + T + NE+SDVYSFG+L+MEI+SGR PVDYS+ P +V L++W
Sbjct: 321 VTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGVLVMEIISGRSPVDYSRAPGEVNLVEW 379
Query: 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430
LK +V + VLDP++ + PS + LKR +L+ALRCVDP+ + RPKMG ++ MLE DL
Sbjct: 380 LKRLVTNRDAEGVLDPRMVDKPSLRSLKRTLLVALRCVDPNAQKRPKMGHIIHMLEAEDL 439
Query: 431 LLREEYR 437
+ +++ R
Sbjct: 440 VSKDDRR 446
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
Identities = 168/322 (52%), Positives = 220/322 (68%)
Query: 126 ANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLL 185
++G++ S M G SLK+++I T GF++ N+I G GVVYRA D AAVK L
Sbjct: 117 SSGDVGTS-EAMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNL 175
Query: 186 MSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILVYEYIDNGNLQQWLHGS 243
++N E++F +VEAIG+V+HKNLV L GYC + R+LVYEYIDNGNL+QWLHG
Sbjct: 176 LNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGD 235
Query: 244 LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303
+G PLTWD RMKI GTAKGLAYLHE +EPK+VH ++KSSNILLD WN K+SD GLA
Sbjct: 236 VGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLA 295
Query: 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
KL G E S T+ + GY++ E + T + NE SDVYSFG+L+MEI++GR PVDYS+P
Sbjct: 296 KLLGSETSYVTTRVMGTFGYVSPEYAS-TGMLNECSDVYSFGVLLMEIITGRSPVDYSRP 354
Query: 364 --QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421
++ L+DW K MVA ++ V+DPK+ P + LKR +L+ LRC+D D RPKMG +
Sbjct: 355 PGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQI 414
Query: 422 LRMLEPRDLLLREEYRIKRAAS 443
+ MLE D R E+R + S
Sbjct: 415 IHMLEAEDFPFRPEHRSNQERS 436
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 9.7e-80, P = 9.7e-80
Identities = 152/300 (50%), Positives = 220/300 (73%)
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAI 203
+L++++I T+ F+++NVI G GVVYR L++ AVK ++++ E++F +V+AI
Sbjct: 146 TLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAI 205
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA 263
G V+HKNLV+L GYC+EG NRILVYEY++NGNL++WLHG++ LTW+ RMK++ GT+
Sbjct: 206 GHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTS 265
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY 323
K LAYLHE IEPK+VH ++KSSNIL+D +N KISD GLAKL G S T+ + GY
Sbjct: 266 KALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGY 325
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVAQQKIA 381
+A E + T + NEKSDVYSFG+L++E ++GR PVDY++P +V L++WLK MV +++
Sbjct: 326 VAPEYAN-TGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLE 384
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLL-REEYRIKR 440
V+DP + P+ + LKR++L ALRC+DPD + RPKM V+RMLE + + REE R++R
Sbjct: 385 EVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLESEEYPVPREERRVRR 444
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 783 (280.7 bits), Expect = 7.9e-78, P = 7.9e-78
Identities = 151/310 (48%), Positives = 220/310 (70%)
Query: 134 VSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE 193
+S + G +L+++ + T+ FA +NVI G GVVY+ L++ AVK L++N E
Sbjct: 169 ISHLGWGHWFTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAE 228
Query: 194 EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
++F +VEAIG V+HKNLV+L GYC+EG NR+LVYEY+++GNL+QWLHG++G+ LTW+
Sbjct: 229 KEFRVEVEAIGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWE 288
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313
RMKI+ GTA+ LAYLHE IEPK+VH ++K+SNIL+D +N K+SD GLAKL S
Sbjct: 289 ARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHI 348
Query: 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWL 371
T+ + GY+A E + T + NEKSD+YSFG+L++E ++GR PVDY +P +V L++WL
Sbjct: 349 TTRVMGTFGYVAPEYAN-TGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWL 407
Query: 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431
K MV ++ V+D ++ P+ + LKR +L+ALRCVDP+ + RPKM V+RMLE +
Sbjct: 408 KMMVGTRRAEEVVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDEHP 467
Query: 432 LREEYRIKRA 441
REE R +++
Sbjct: 468 FREERRNRKS 477
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
Identities = 151/310 (48%), Positives = 218/310 (70%)
Query: 134 VSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE 193
+S + G +L+++++ T+ FA NV+ G GVVYR L++ AVK L++N E
Sbjct: 162 ISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAE 221
Query: 194 EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
++F +VEAIG V+HKNLV+L GYC+EG +R+LVYEY+++GNL+QWLHG++ + LTW+
Sbjct: 222 KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWE 281
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313
RMKII GTA+ LAYLHE IEPK+VH ++K+SNIL+D +N K+SD GLAKL S
Sbjct: 282 ARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHI 341
Query: 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWL 371
T+ + GY+A E + T + NEKSD+YSFG+L++E ++GR PVDY +P +V L++WL
Sbjct: 342 TTRVMGTFGYVAPEYAN-TGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWL 400
Query: 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431
K MV ++ V+DP+L PS+ LKR +L++LRCVDP+ + RP+M V RMLE +
Sbjct: 401 KMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHP 460
Query: 432 LREEYRIKRA 441
+E R KR+
Sbjct: 461 FHKERRNKRS 470
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 166/360 (46%), Positives = 232/360 (64%)
Query: 113 SSGTSTNRCTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRA 172
SS +S N T + S + G +L+++ + T+ F+ N+I G GVVYR
Sbjct: 125 SSVSSANPLTAPSPLSGLPE-FSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRG 183
Query: 173 VLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232
L++ AVK L++N ++DF +VEAIG V+HKNLV+L GYC+EG R+LVYEY++
Sbjct: 184 NLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVN 243
Query: 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH 292
NGNL+QWL G + LTW+ R+KI+ GTAK LAYLHE IEPK+VH ++KSSNIL+D
Sbjct: 244 NGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDK 303
Query: 293 WNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV 352
+N KISD GLAKL G + S T+ + GY+A E + + + NEKSDVYSFG++++E +
Sbjct: 304 FNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAI 362
Query: 353 SGRLPVDYSQP--QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDP 410
+GR PVDY++P +V L++WLK MV Q++ V+DP L PS LKR +L ALRCVDP
Sbjct: 363 TGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDP 422
Query: 411 DIKHRPKMGDVLRMLEPRDL-LLREEYRIKRA---ASYHNYPQKNKTAVLCDADIST-HD 465
+ RP+M V RMLE + + RE+ R +R+ + + P +N T D D S HD
Sbjct: 423 MSEKRPRMSQVARMLESEEYPIAREDRRRRRSQNGTTRDSDPPRNST----DTDKSEYHD 478
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
Identities = 153/322 (47%), Positives = 219/322 (68%)
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAI 203
+L++++ T+ F+++NVI G GVVYR L++ AVK +++ E++F +V+AI
Sbjct: 168 TLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDAI 227
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA 263
G V+HKNLV+L GYC+EG +RILVYEY++NGNL+QWLHG++ + LTW+ RMK++ GT+
Sbjct: 228 GHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGTS 287
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY 323
K LAYLHE IEPK+VH ++KSSNIL++ +N K+SD GLAKL G S T+ + GY
Sbjct: 288 KALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 347
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVAQQKIA 381
+A E + + + NEKSDVYSFG++++E ++GR PVDY +P +V L+DWLK MV ++
Sbjct: 348 VAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGTRRSE 406
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRA 441
V+DP + P + LKR +L ALRCVDPD RPKM V+RMLE EEY I R
Sbjct: 407 EVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLES------EEYPIPRE 460
Query: 442 ASYHNYPQKNKTAVLCDADIST 463
+ ++ + D D+ST
Sbjct: 461 DRRRSRTREGSMEINSDTDMST 482
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 154/334 (46%), Positives = 228/334 (68%)
Query: 134 VSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE 193
VS + G +L+++ + T+ F+++++I G GVVY L + AVK L++N +
Sbjct: 133 VSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQAD 192
Query: 194 EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
+DF +VEAIG V+HKNLV+L GYCVEG +R+LVYEY++NGNL+QWLHG + LTW+
Sbjct: 193 KDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWE 252
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313
R+K++ GTAK LAYLHE IEPK+VH ++KSSNIL+D +++ K+SD GLAKL G + +
Sbjct: 253 ARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYV 312
Query: 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWL 371
++ + GY+A E + + + NEKSDVYS+G++++E ++GR PVDY++P +V +++WL
Sbjct: 313 STRVMGTFGYVAPEYAN-SGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEWL 371
Query: 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD-- 429
K MV Q++ V+D +L P+ ELKR +L ALRCVDPD RPKM V RMLE +
Sbjct: 372 KLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDEYP 431
Query: 430 LLLREEYRIKRAASYHNYPQKNKTAVLCDADIST 463
++ REE R +R + + + T D DI+T
Sbjct: 432 VMPREERRRRRNQNAETHRESTDTNK--DNDITT 463
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 6.1e-54, Sum P(2) = 6.1e-54
Identities = 123/346 (35%), Positives = 194/346 (56%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKV 200
I + +E+ +T+GF + V+ G G VY+ +L + A+K L S S +F +V
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEV 415
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
E I +V H++LV L GYC+ Q+R L+YE++ N L LHG L W R++I
Sbjct: 416 EIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGK--NLPVLEWSRRVRIAI 473
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELR 319
G AKGLAYLHED PKI+H ++KSSNILLD + +++D GLA+L+ S IST +
Sbjct: 474 GAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRV-MG 532
Query: 320 NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVAQ 377
GYLA E + + ++SDV+SFG++++E+++GR PVD SQP + L++W + + +
Sbjct: 533 TFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIE 591
Query: 378 --QK--IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL-- 431
+K I+ V+DP+L E+ ++I A CV RP+M V+R L+ RD L
Sbjct: 592 AIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDDLSD 651
Query: 432 LREEYRIKRAASYHNYPQKNKTAVLCDADISTHD-EENRAHEPDHE 476
L ++ ++ Y + N+ + A + D N + P +
Sbjct: 652 LTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGTNTGYYPSQD 697
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q3EDL4 | Y1154_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4655 | 0.9296 | 0.9512 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.1__79__AT1G01540.2 | annotation not avaliable (472 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 483 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 40/285 (14%)
Query: 159 NVIASGDNGVVYRAVLLDN----MRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVK 213
+ G G VY+ L AVK L ++ EE +DF+++ + ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEA-----KPLTWDTRMKIIQGTAKGLAY 268
L G C E + LV EY++ G+L +L S L+ + AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE----LRNSGYL 324
L K VH ++ + N L+ KISD GL++ + +R ++
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---WM 174
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
A E S + IF KSDV+SFG+L+ EI + G P Y + ++ + Y+
Sbjct: 175 APE-SLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YP-----------GLSNEEVLEYL 220
Query: 384 LDPKLPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
P EL ++ L C D + RP +++ LE
Sbjct: 221 RKGYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 160 VIASGDNGVVYRAVLLDN-----MRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVK 213
+ G G VY+ L + AVK L ++ ++ E+F+ + + ++ H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
L G C E + ++V EY+ G+L +L + K L+ + A+G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE---LRNSGYLAEELSG 330
+H ++ + N L+ + KISD GL++ + +R ++A E S
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR---WMAPE-SL 176
Query: 331 RTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389
+ F KSDV+SFG+L+ EI + G P Y M + + Y+
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP--YP-----------GMSNAEVLEYLKKGYRL 223
Query: 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
P + + L+C D + RP +++ +L
Sbjct: 224 PKPPNCP-PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 65/273 (23%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 160 VIASGDNGVVYRAVLLDN-----MRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVK 213
+ G G VY+ L + AVK L ++ ++ E+F+ + + ++ H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
L G C E + +V EY++ G+L +L + L+ + A+G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS 333
+H ++ + N L+ + KISD GL++ + ++A E S +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE-SLKEG 178
Query: 334 IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392
F KSDV+SFG+L+ EI + G P Y M ++ + Y+ + P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP--YPG-----------MSNEEVLEYLKNGYRLPQP 225
Query: 393 SRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
+ + L+C D + RP +++ +L
Sbjct: 226 PNCP-PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 57/194 (29%), Positives = 104/194 (53%), Gaps = 10/194 (5%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLM-SNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
+ G G VY A + A+K++ +S S E+ + ++E + ++ H N+VKL+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ + LV EY + G+L+ L L+ D ++I+ +GL YLH + I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 279 HHNMKSSNILLDH-HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNE 337
H ++K NILLD + K++D GL+KL + S+ + + Y+A E+ ++E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSE 173
Query: 338 KSDVYSFGILIMEI 351
KSD++S G+++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 45/282 (15%)
Query: 160 VIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVK 213
+ G G VY+ L + AVK L + EE E+F+E+ + ++ H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
L G C +G+ +V EY+ G+L +L LT +++ AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK- 121
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL-----AEEL 328
VH ++ + N L+ + KISD GL++ + R G L A E
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-DYYRK---RGGGKLPIKWMAPE- 174
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD-- 385
S + F KSDV+SFG+L+ EI + G P Y M ++ + + D
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--YPG-----------MSNEEVLELLEDGY 221
Query: 386 --PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
P+ P EL ++ L+C D + RP +++ L
Sbjct: 222 RLPRPENCP--DELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 31/272 (11%)
Query: 160 VIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEA--IGQVKHKNLVKLFG 216
+ SG G VY+A AVK+L S ++D + E + ++ H N+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ + LV EY + G+L +L PL+ D KI +GL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-GYLAEELSGRTSIF 335
I+H ++K NILLD + KI+D GLAK S S+ + Y+A E+ + +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 336 NEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM---- 391
K DV+S G+++ E+++G+ P F + + Q I +L P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP--------FSGENILDQ--LQLIRRILGPPLEFDEPKW 226
Query: 392 -PSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
+E K +I +C++ D RP ++L
Sbjct: 227 SSGSEEAKDLI---KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 31/272 (11%)
Query: 159 NVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFG 216
+ G G VY A A+K++ + ++ + I + ++ + ++KH N+V+L+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ LV EY + G+L L + L+ D ++ L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLA-EELSGRT 332
IVH ++K NILLD + K++D GLA+ P ++T G Y+A E L G+
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPEYMAPEVLLGKG 172
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392
+ + D++S G+++ E+++G+ P + L + K P ++
Sbjct: 173 --YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG------KPKPPFPPPEWDIS 224
Query: 393 SRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
E K +I + + D + R + L+
Sbjct: 225 --PEAKDLI---RKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRA-AVKL--LMSNSVSEEEDFIEKVEAIGQVKHKNL 211
F N I G GVV++ V + R A+K L + E E+ I++ + ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
++ + ++ +V EY +NG+L + L G +PL D + GLA+LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS 119
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR 331
KI+H ++KS N+ LD + N KI D+G+AKL + + + + YL+ EL
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELC-E 174
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391
+NEKSDV++ G+++ E +G+ P D + Q LI KI + P + +M
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFD-ANNQGALI---------LKIIRGVFPPVSQM 224
Query: 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
S +++ + +C+ D + RP +LR
Sbjct: 225 YS----QQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 24/275 (8%)
Query: 157 EQNVIASGDNGVVYRAVLLDN-MRAAVKLLM-SNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
E+NVI+ G G Y+ + N M+ VK + NS+ E + +G+++H N+VKL
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE-----IADMGKLQHPNIVKL 748
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
G C + L++EYI+ NL + L L+W+ R KI G AK L +LH
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCS 801
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI 334
P +V N+ I++D P + +L P + + +S Y+A E I
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 335 FNEKSDVYSFGILIMEIVSGRLPVDY-SQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
EKSD+Y FG++++E+++G+ P D +++W + + + +DP + S
Sbjct: 856 -TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 394 --RKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ E+ ++ +AL C D RP DVL+ LE
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 60/204 (29%), Positives = 115/204 (56%), Gaps = 8/204 (3%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
F + + SG G V+ + + +R A+K+L S+ + +++DF ++V+A+ +++HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
F C G+ ++ E ++ G+L +L E + L + + + A+G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI 334
+H ++ + NIL+ K++D GLA+L + +S+ ++ E S T
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 335 FNEKSDVYSFGILIMEIVS-GRLP 357
F+ KSDV+SFGIL+ E+ + G++P
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 48/292 (16%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEA 202
I+ KE+ I G+ G V + AVK L +S + + F+ +
Sbjct: 3 INSKELK-----LGAT--IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASV 53
Query: 203 IGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262
+ ++H NLV+L G ++G +V EY+ G+L +L S G A +T ++
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAV-ITLAQQLGFALDV 111
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
+G+ YL E VH ++ + N+L+ K+SD GLAK + + ++SG
Sbjct: 112 CEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSG 159
Query: 323 YL------AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMV 375
L E L R F+ KSDV+SFGIL+ EI S GR+P Y P++ LK +V
Sbjct: 160 KLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVP--Y--PRIP----LKDVV 209
Query: 376 AQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ Y ++ PE P + + C + D RP + L
Sbjct: 210 PHVEKGYRMEA--PEGCP-----PEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 66/264 (25%), Positives = 119/264 (45%), Gaps = 34/264 (12%)
Query: 160 VIASGDNGVVYRA-VLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
I G G VY+A A+K++ S ++E I +++ + + KH N+VK +G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
++ +V E+ G+L+ L + + LT + + KGL YLH + I+
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSGRTS 333
H ++K++NILL K+ D GL+ +S + RN+ ++A E+
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSA------QLSDTKA-RNTMVGTPYWMAPEVINGKP 173
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE-MP 392
++ K+D++S GI +E+ G+ P P +K++ KIA P L
Sbjct: 174 -YDYKADIWSLGITAIELAEGKPPYSELPP-------MKALF---KIATNGPPGLRNPEK 222
Query: 393 SRKELKRIILIALRCVDPDIKHRP 416
E K + +C+ + + RP
Sbjct: 223 WSDEFKDFL---KKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G G V+ + AVK L ++S E F+++ + + +++H LV+L+ C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V EY+ G+L +L GE K L + + A+G+AYL +H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 281 NMKSSNILLDHHWNPKISDVGLAKL---------HGPEWSIS-TSCELRNSGYLAEELSG 330
++ + NIL+ + KI+D GLA+L G ++ I T+ E N G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG-------- 179
Query: 331 RTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F KSDV+SFGIL+ EIV+ GR+P
Sbjct: 180 ---RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 5e-21
Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 36/280 (12%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEE--DFIEKVEAIGQVKHKNL 211
+ I G G VY D +K + +++SE+E D + +V+ + ++ H N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI-IQGTAKGLAYLH 270
+K + E +V EY D G+L Q + E KP + + +Q L YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-LCLALKYLH 120
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---YLA 325
KI+H ++K NI L + K+ D G++K +S++ +L + G YL+
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISK------VLSSTVDLAKTVVGTPYYLS 171
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD-YSQPQVFLIDWLKSMVAQQKIAYVL 384
EL +N KSD++S G ++ E+ + + P + + ++ KI
Sbjct: 172 PELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-----------LKILKGQ 219
Query: 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
P +P S EL+ ++ + D + RP + +L+
Sbjct: 220 YPPIPSQYS-SELRNLV---SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 40/278 (14%)
Query: 159 NVIASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEE-DFIEK-VEAIGQVKHKNLVKLF 215
++ G G VY A+ D AVK + + SEEE + +E+ + + ++H N+V+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 216 GYCV-EGQNRILVY-EYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
G E +N + ++ EY+ G+L L G L E + TR I++G LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQ-ILEG----LAYLHS 119
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEEL 328
+ IVH ++K +NIL+D K++D G AK G + G ++A E+
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG--DIETGEGTGSVRGTPYWMAPEV 174
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387
R + +D++S G ++E+ +G+ P + P L KI +P
Sbjct: 175 I-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY----------KIGSSGEP- 222
Query: 388 LPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLR 423
PE+P +E K + +C+ D K RP ++L+
Sbjct: 223 -PEIPEHLSEEAKDFL---RKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
I SG G+V+ L+ + A+K + ++SEE DFIE+ + + ++ H LV+L+G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
LV+E++++G L +L G+ + +T + + +G+AYL ++H
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 281 NMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++ + N L+ + K+SD G+ + +++ ST + E S S ++ KS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS--FSKYSSKS 182
Query: 340 DVYSFGILIMEIVS-GRLPVD 359
DV+SFG+L+ E+ S G+ P +
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 91.3 bits (225), Expect = 5e-20
Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 20/281 (7%)
Query: 154 GFAEQNVIASGDNGVVYRAVLLDNMRAAVKLL---MSNSVSEEEDFIEKVEAIGQVKH-K 209
+ + G G VY A D A+K+L + + E E F+ +++ + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
N+VKL+ + + + LV EY+D G+L+ L +G PL+ + I+ L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 270 HEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHGPEWSISTSCELRNS-----GY 323
H I+H ++K NILLD K+ D GLAKL S S+ L ++ GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 324 LAEELSGRTSI--FNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
+A E+ S+ + SD++S GI + E+++G P + + ++ +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELPTP 233
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
+ P P P K + + + D K+R L
Sbjct: 234 SLASPLSPSNPE-LISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 76/281 (27%), Positives = 141/281 (50%), Gaps = 33/281 (11%)
Query: 156 AEQNVIASGDNGVVYRAVLLDNMRA----AVKLLMSNSVSEE-EDFIEKVEAIGQVKHKN 210
+Q VI +G+ G V+R +L R A+K L ++ +DF+ + +GQ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+++L G + + +++ EY++NG L ++L GE + +++G A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGMKYLS 124
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL--HGPEWSISTSCELRNSGYLA-EE 327
+ VH ++ + NIL++ + K+SD GL+++ PE + +TS + A E
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVS-GRLPV-DYSQPQVFLIDWLKSMVAQQKIAYVLD 385
++ R F SDV+SFGI++ E++S G P D S +V +K++ ++ +D
Sbjct: 182 IAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-----MKAINDGFRLPAPMD 234
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
PS + + L+C D RP+ D++ +L+
Sbjct: 235 -----CPS-----AVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 34/266 (12%)
Query: 160 VIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFG- 216
V+ G +GVVY+ A+K + + E + + ++ + + +VK +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ EG+ I V EY+D G+L L + + I + KGL YLH
Sbjct: 68 FYKEGEISI-VLEYMDGGSL----ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--GYLA----EELSG 330
I+H ++K SN+L++ KI+D G++K + + + N+ G + E + G
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISK------VLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390
+ + +D++S G+ ++E G+ P + P + + M Q I P LP
Sbjct: 175 ESYSYA--ADIWSLGLTLLECALGKFP--FLPPGQ--PSFFELM---QAICDGPPPSLPA 225
Query: 391 MPSRKELKRIILIALRCVDPDIKHRP 416
E + I C+ D K RP
Sbjct: 226 EEFSPEFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 75/291 (25%), Positives = 126/291 (43%), Gaps = 58/291 (19%)
Query: 158 QNVIASGDNGVVYRAVLLDNMR----AAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLV 212
+ VI G+ G V R L + A+K L + S + DF+ + +GQ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+L G + + +++ EY++NG+L ++L + G+ T + +++G A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLS-- 123
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
E VH ++ + NIL++ + K+SD GL++ L +S G+
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSR------------RLEDSEATYTTKGGKI 170
Query: 333 SI------------FNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQK 379
I F SDV+SFGI++ E++S G P Y W M Q
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP--Y---------W--DMSNQDV 217
Query: 380 IAYVLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
I V D P + PS + + L C D RP ++ L+
Sbjct: 218 IKAVEDGYRLPPPMDCPS-----ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 68/261 (26%), Positives = 127/261 (48%), Gaps = 40/261 (15%)
Query: 181 AVKLLMSNSVSEEE---DFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQ 237
VK L +E +F +++ ++ HKN+V+L G C E + ++ EY D G+L+
Sbjct: 39 LVKAL--QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 238 QWLHGSLG-----EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH 292
Q+L + + PL+ ++ + A G+ +L + VH ++ + N L+
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ 153
Query: 293 WNPKISDVGLAK-LHGPEWSISTSCELRNS----GYLAEELSGRTSIFNEKSDVYSFGIL 347
K+S + L+K ++ E+ +LRN+ +LA E + + F+ KSDV+SFG+L
Sbjct: 154 REVKVSLLSLSKDVYNSEY-----YKLRNALIPLRWLAPE-AVQEDDFSTKSDVWSFGVL 207
Query: 348 IMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE-MPSRKELKRIILIAL 405
+ E+ + G LP Y + ++ + + A L+ +PE PSR L +++
Sbjct: 208 MWEVFTQGELPF-YGLSD-------EEVLNRLQ-AGKLELPVPEGCPSR--LYKLM---T 253
Query: 406 RCVDPDIKHRPKMGDVLRMLE 426
RC + K RP +++ L
Sbjct: 254 RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 26/207 (12%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G G V+ + + AVK L ++ + DF+ + + + +++H L++L+ C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V E + G+L ++L G G + L + + A G+AYL +H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127
Query: 281 NMKSSNILLDHHWNPKISDVGLAKL---------HGPEWSISTSCELRNSGYLAEELSGR 331
++ + N+L+ + K++D GLA++ G ++ I + A E +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK---------WTAPE-AAL 177
Query: 332 TSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ F+ KSDV+SFGIL+ EIV+ GR+P
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 8e-18
Identities = 55/201 (27%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ SG GVV+ + A+K++ ++SE+ DFIE+ + + ++ H NLV+L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V EY+ NG L +L G+ + + + + + YL + +H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GFIHR 124
Query: 281 NMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++ + N L+ K+SD GLA+ + +++ S + E S F+ KS
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD--YSRFSSKS 182
Query: 340 DVYSFGILIMEIVS-GRLPVD 359
DV+SFG+L+ E+ S G++P +
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 44/271 (16%)
Query: 158 QNVIASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEE--DFIEKVEAIGQVKHKNLVKL 214
++I G GVVY+ + L+ A+K + + EE +++++ + +KH N+VK
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
G + ++ EY +NG+L+Q + G E + +GLAYLHE
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE------SLVAVYVYQVLQGLAYLHEQ 118
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLA----KLHGPEWSISTSCELRNSGYLAEE- 327
++H ++K++NIL K++D G+A + + S+ + ++A E
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGT-----PYWMAPEV 170
Query: 328 --LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
+SG + SD++S G ++E+++G P Y L M A +I
Sbjct: 171 IEMSGAS----TASDIWSLGCTVIELLTGNPP--YYD--------LNPMAALFRIVQDDH 216
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
P LPE S ELK + ++C D RP
Sbjct: 217 PPLPEGIS-PELKDFL---MQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G+ G VY+ VL N AVK S + + F+++ E + Q H N+VKL G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK-IV 278
+ Q +V E + G+L +L LT +++ A G+ YL E K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYL----ESKNCI 115
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAEEL--SGRTSIF 335
H ++ + N L+ + KISD G+++ G +++S + + A E GR +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS- 174
Query: 336 NEKSDVYSFGILIMEIVSG 354
+SDV+S+GIL+ E S
Sbjct: 175 --ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G G V+ + + A+K L S+S E F+ + + Q++H LV+L+ V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ ++ EY++NG+L +L E LT + + + A+G+A++ +H
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 281 NMKSSNILLDHHWNPKISDVGLAKL---------HGPEWSIS-TSCELRNSGYLAEELSG 330
+++++NIL+ KI+D GLA+L G ++ I T+ E N G
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-------- 178
Query: 331 RTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F KSDV+SFGIL+ EIV+ GR+P
Sbjct: 179 ---TFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 67/267 (25%), Positives = 127/267 (47%), Gaps = 25/267 (9%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ SG GVV+ ++ A+K + ++SEE DFIE+ + + ++ H LV+L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V E+++NG L +L G+ D + + Q +G+ YL + +H
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 281 NMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSD 340
++ + N L+ K+SD G+ + + S+S + E+ S ++ KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF-NFSKYSSKSD 183
Query: 341 VYSFGILIMEIVS-GRLPVD-YSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELK 398
V+SFG+L+ E+ + G++P + S +V M+++ Y PKL M
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVV------EMISRGFRLY--RPKLASM------- 228
Query: 399 RIILIALRCVDPDIKHRPKMGDVLRML 425
+ + C + RP ++LR +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 159 NVIASGDNGVVYRA---VLLDNMRAAVKLLMSNSVSEEE---DFIEKVEAIGQVKHKNLV 212
+ G G V L DN V + N EE+ DF ++E + + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 213 KLFGYCVEGQNRI--LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
K G C + R L+ EY+ +G+L+ +L + + KG+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEE 327
+ +H ++ + NIL++ KISD GLAK+ + E S Y E
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL 367
L RTS F+ SDV+SFG+ + E+ + S P FL
Sbjct: 184 L--RTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFL 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 39/271 (14%)
Query: 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEED-FIEKVEAIGQVKHKNLVKLFG 216
+ +G++GVV + + AVK + + + +++ + + +V +G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ + EY+D G+L + L G + KI KGL YLHE K
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQG---RIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS---------GYLA-E 326
I+H ++K SNIL++ K+ D G+ S +L NS Y+A E
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGV------------SGQLVNSLAKTFVGTSSYMAPE 169
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386
+ G ++ KSD++S G+ ++E+ +GR P Y + + + Y+++
Sbjct: 170 RIQGND--YSVKSDIWSLGLSLIELATGRFP--YPPEN---DPPD--GIFEL-LQYIVNE 219
Query: 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPK 417
P +PS K C+ D + RP
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 158 QNVIASGDNGVVYRAVLLD-NMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLVKLF 215
VI G VVY A+ L N + A+K + + + ++ ++V+A+ Q H N+VK +
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 216 GYCVEGQNRILVYEYIDNGNL-----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
V G LV Y+ G+L + G L EA T +++ KGL YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------VLKEVLKGLEYLH 119
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGL-AKLHGPEWS--------ISTSCELRNS 321
+ +H ++K+ NILL + KI+D G+ A L + T C
Sbjct: 120 SN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC----- 171
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
++A E+ + ++ K+D++SFGI +E+ +G P
Sbjct: 172 -WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 34/287 (11%)
Query: 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDN-MRAAVKLLMSNSVSEEEDFIEKVEAIGQ 205
E + D E+ V+ G G+VY A L +R A+K + + E++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 206 VKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK- 264
+KH+N+V+ G E + E + G+L L G PL D II T +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIIFYTKQI 117
Query: 265 --GLAYLHEDIEPKIVHHNMKSSNILLDHHWNP-KISDVGLAK-LHGPEWSIST-SCELR 319
GL YLH++ +IVH ++K N+L++ + KISD G +K L G T + L+
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 320 NSGYLAEELSGR-TSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVAQ 377
Y+A E+ + + +D++S G I+E+ +G+ P ++ +PQ A
Sbjct: 175 ---YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----------AAM 221
Query: 378 QKIA-YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
K+ + + P++PE S E K I LRC +PD R D+L+
Sbjct: 222 FKVGMFKIHPEIPESLS-AEAKNFI---LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 192 EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL--VYEYIDNGNLQQWLHGSLGEAKP 249
E++ + +V + ++KH N+V+ + ++ N+ L V EY + G+L Q + E K
Sbjct: 42 EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY 101
Query: 250 LTWDTRMKIIQGTAKGLAYLH--EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+ + +I+ L H D ++H ++K +NI LD + N K+ D GLAK+ G
Sbjct: 102 IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161
Query: 308 PEWSISTSCELRNSG---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD-YSQP 363
+ S + + G Y++ E S ++EKSD++S G LI E+ + P +Q
Sbjct: 162 HDSSFAKTY----VGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
Q+ KI ++P S EL +I ++ D RP ++L+
Sbjct: 217 QL-----------ASKIKEGKFRRIPYRYS-SELNEVI---KSMLNVDPDKRPSTEELLQ 261
Query: 424 M 424
+
Sbjct: 262 L 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 43/208 (20%)
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D M AVK L S S +DF + E + ++H+++V+ +G C EG+ ++V+EY+ +G+
Sbjct: 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGD 93
Query: 236 LQQWLHGSLGEAK-----------PLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284
L ++L +AK LT + I A G+ YL VH ++ +
Sbjct: 94 LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLAT 150
Query: 285 SNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI---------- 334
N L+ KI D G+++ ++ ++ Y + GRT +
Sbjct: 151 RNCLVGQGLVVKIGDFGMSR------------DIYSTDYY--RVGGRTMLPIRWMPPESI 196
Query: 335 ----FNEKSDVYSFGILIMEIVS-GRLP 357
F +SD++SFG+++ EI + G+ P
Sbjct: 197 LYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 55/216 (25%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 160 VIASGDNGVVYRAV---LLDNMR--AAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLVK 213
V+ SG G VY+ V + ++ A+K+L + + ++ +++ + V H ++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLH---GSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L G C+ L+ + + G L ++ ++G L W ++ AKG++YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG------YL 324
E ++VH ++ + N+L+ + KI+D GLAKL + E G ++
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-----EYHAEGGKVPIKWM 178
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVD 359
A E S I+ KSDV+S+G+ + E+++ G P +
Sbjct: 179 ALE-SILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 158 QNVIASGDNGVVYRAVLLDN---MRAAVKLLMS-NSVSEEEDFIEKVEAIGQV-KHKNLV 212
++VI G+ G V RA++ + M AA+K+L S ++ DF ++E + ++ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 213 KLFGYCVEGQNRILVY---EYIDNGNLQQWLHGSL------------GEAKPLTWDTRMK 257
L G C +NR +Y EY GNL +L S G A LT ++
Sbjct: 67 NLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE 317
A G+ YL E + +H ++ + N+L+ + KI+D GL++ G E + +
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMG 178
Query: 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
++A E S S++ KSDV+SFG+L+ EIVS
Sbjct: 179 RLPVRWMAIE-SLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 69/249 (27%), Positives = 105/249 (42%), Gaps = 32/249 (12%)
Query: 183 KLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHG 242
K+L S+ F E + Q+ HK+LVKL+G CV +N I+V EY+ G L +LH
Sbjct: 36 KVLGSDHRDSLA-FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH- 92
Query: 243 SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302
L W ++ + + A L YL + K+VH N+ NIL+ + V
Sbjct: 93 REKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARY-GLNEGYVPF 146
Query: 303 AKLHGPEWSIS----TSCELRNSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVS-GRL 356
KL P I+ R ++A E + + +D +SFG ++EI S G
Sbjct: 147 IKLSDPGIPITVLSREERVER-IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
Query: 357 PVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
P L ++ + +K + D MP EL +I +C D RP
Sbjct: 206 P-------------LSTLSSSEKERFYQDQHRLPMPDCAELANLI---NQCWTYDPTKRP 249
Query: 417 KMGDVLRML 425
+LR L
Sbjct: 250 SFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 160 VIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLV 212
+ G G V+ D AVK L + ++ +DF + E + +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWL--HG--------SLGEAKPLTWDTRMKIIQGT 262
K +G C EG I+V+EY+++G+L ++L HG LT ++I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
A G+ YL VH ++ + N L+ + KI D G+++ + T+ R G
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRVGG 182
Query: 323 YL--------AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ E + R F +SDV+SFG+++ EI + G+ P
Sbjct: 183 HTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 159 NVIASGDNGVVYRAVLLDN---MRAAVKLLMS-NSVSEEEDFIEKVEAIGQV-KHKNLVK 213
+VI G+ G V +A + + M AA+K + S + DF ++E + ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 214 LFGYCVEGQNRILVY---EYIDNGNLQQWLHGSL------------GEAKPLTWDTRMKI 258
L G C ++R +Y EY +GNL +L S A L+ +
Sbjct: 61 LLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
A+G+ YL + + +H ++ + NIL+ ++ KI+D GL++ G E + +
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 172
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
++A E S S++ SDV+S+G+L+ EIVS
Sbjct: 173 LPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 29/200 (14%)
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D + AVK L S + +DF + E + ++H+++VK +G CVEG I+V+EY+ +G+
Sbjct: 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93
Query: 236 LQQWL--HGS----LGEAKP---LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286
L ++L HG + E LT + I Q A G+ YL VH ++ + N
Sbjct: 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRN 150
Query: 287 ILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL--------AEELSGRTSIFNEK 338
L+ + KI D G+++ + ++ R G+ E + R F +
Sbjct: 151 CLVGENLLVKIGDFGMSR------DVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTE 202
Query: 339 SDVYSFGILIMEIVS-GRLP 357
SDV+S G+++ EI + G+ P
Sbjct: 203 SDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 37/193 (19%)
Query: 181 AVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
AVK L + +++F+ + + Q+ H +V+L G C +G+ +LV E G L ++
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKY 85
Query: 240 L--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297
L + + ++ A G+AYL VH ++ + N+LL + KI
Sbjct: 86 LKKRREIPVSDLKELAHQV------AMGMAYLESK---HFVHRDLAARNVLLVNRHQAKI 136
Query: 298 SDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI------------FNEKSDVYSFG 345
SD G+++ G S Y +GR + F+ KSDV+S+G
Sbjct: 137 SDFGMSRALGA-----------GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYG 185
Query: 346 ILIMEIVS-GRLP 357
+ + E S G P
Sbjct: 186 VTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G GVV A+K++ S+SE+E FIE+ + + ++ H+ LV+L+G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V EY+ NG L +L K +++ + +G+AYL + +H
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 281 NMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++ + N L+D K+SD GL++ + E++ S + E L S F+ KS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL--LYSKFSSKS 182
Query: 340 DVYSFGILIMEIVS-GRLPVD 359
DV++FG+L+ E+ S G++P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 36/278 (12%)
Query: 154 GFAEQNVIASGDNGVVYRAV-LLDNMRAAVKL--LMSNSVSEEEDFIEKVEAIGQVKHKN 210
F + G G VY+ L DN A+K L S S E ED + ++ + V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
++ ++G +V EY G+L + + + K + +I +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS---ISTSCELRNSGYLAEE 327
E KI+H ++KS+NILL + KI D+G++K+ + I T Y+A E
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH------YMAPE 171
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY-VLDP 386
+ ++ KSD++S G L+ E+ + P + +SM Q + Y V
Sbjct: 172 VWKGRP-YSYKSDIWSLGCLLYEMATFAPPFE-----------ARSM---QDLRYKVQRG 216
Query: 387 KLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVL 422
K P +P ++L+ I + K RP +L
Sbjct: 217 KYPPIPPIYSQDLQNFI---RSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 35/281 (12%)
Query: 158 QNVIASGDNGVVYRAVLLDNMR----AAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLV 212
+ VI +G+ G V R L + A+K L S ++ DF+ + +GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
L G + + +++ E+++NG L +L + G+ + + +++G A G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS-- 123
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL-----HGPEWSISTSCELRNSGYLAEE 327
E VH ++ + NIL++ + K+SD GL++ P ++ S ++ E
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVS-GRLPV-DYSQPQVFLIDWLKSMVAQQKIAYVLD 385
++ R F SDV+S+GI++ E++S G P D S V + + Q Y L
Sbjct: 183 IAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------NAIEQD---YRLP 231
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
P + P+ + + L C D RPK G ++ L+
Sbjct: 232 PP-MDCPT-----ALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 158 QNVIASGDNGVV----YRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
I G+ G V YR + AVK + +++ ++ F+ + + Q++H NLV+
Sbjct: 11 LQTIGKGEFGDVMLGDYRGN-----KVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQ 63
Query: 214 LFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
L G VE + + +V EY+ G+L +L S G + L D +K + + YL +
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSV-LGGDCLLKFSLDVCEAMEYLEAN 121
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
VH ++ + N+L+ K+SD GL K S + +L E L R
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEAL--RE 173
Query: 333 SIFNEKSDVYSFGILIMEIVS-GRLP 357
F+ KSDV+SFGIL+ EI S GR+P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK-----VEAIGQVKHKNLVKL 214
I G GVVY+A L A+K + + E + I K ++ + ++ H N++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ LV+E++D +L + + + L + +GLA+ H
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI 334
I+H ++K N+L++ K++D GLA+ G T + Y A EL
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-YVVTRWYRAPELLLGDKG 175
Query: 335 FNEKSDVYSFGILIMEIVSGR--LPVDYSQPQVFLI 368
++ D++S G + E++S R P Q+F I
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G G V+ N + AVK L ++S E F+E+ + + +++H LV+L Y V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 221 GQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
+ I +V EY+ G+L +L GE + L + + A G+AY+ +H
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAEE-LSGRTSIFNE 337
+++S+NIL+ KI+D GLA+L E++ + E L GR +I
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI--- 182
Query: 338 KSDVYSFGILIMEIVS-GRLP 357
KSDV+SFGIL+ E+V+ GR+P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 164 GDNGVVYRA--VLLDNMRAAVKLLM-----SNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
G G VY+ + +A + + + +++F ++ E + ++H N+V L G
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKIIQGTAK 264
C + Q +++EY+ +G+L ++L G L + I A
Sbjct: 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGY 323
G+ YL VH ++ + N L+ KISD GL++ + ++ S L +
Sbjct: 136 GMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 324 LAEE--LSGRTSIFNEKSDVYSFGILIMEIVS 353
+ E L G+ F +SD++SFG+++ EI S
Sbjct: 193 MPPEAILYGK---FTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 181 AVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
AVK+L S + DF + + + H N+VKL G C G+ L++EY+ G+L ++
Sbjct: 39 AVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 98
Query: 240 L------------HGSLGEAK------PLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHN 281
L H + K PL+ ++ I + A G+AYL E K VH +
Sbjct: 99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155
Query: 282 MKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEK-- 338
+ + N L+ + KI+D GL+ ++ ++ + + + SIF +
Sbjct: 156 LATRNCLVGENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYT 210
Query: 339 --SDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396
SDV+++G+++ EI S + QP M ++ I YV D + P
Sbjct: 211 TESDVWAYGVVLWEIFSYGM-----QPYY-------GMAHEEVIYYVRDGNVLSCPDNCP 258
Query: 397 LKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
L+ L+ L C RP + R+L+
Sbjct: 259 LELYNLMRL-CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 159 NVIASGDNGVVYRAVLLD-------NMRAAVKLLMSNSVSEEE-DFIEKVEAIGQVKHKN 210
N + SG G VY D +R AVK L + +E+ +F+++ + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKP---LTWDTRMKIIQGTAKGLA 267
+VKL G C+ + + ++ E ++ G+L +L + E LT + I AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 268 YLHEDIEPKIVHHNMKSSNILL-----DHHWNPKISDVGLAK-LHGPEWSISTSCELRNS 321
YL E + +H ++ + N L+ D KI D GLA+ ++ ++ L
Sbjct: 121 YL-EQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
++A E S F +SDV+SFG+L+ EI++
Sbjct: 178 RWMAPE-SLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ G G V+ R A+K L ++S E F+++ + + +++H+ LV+L+ E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V EY+ G+L +L G +G K L + + A G+AY+ VH
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 281 NMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAE-ELSGRTSIFNEK 338
+++++NIL+ + K++D GLA+L E++ + E L GR +I K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI---K 183
Query: 339 SDVYSFGILIMEIVS-GRLP 357
SDV+SFGIL+ E+ + GR+P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 32/203 (15%)
Query: 176 DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
D M AVK L +++ +DF + E + ++H+++VK +G C +G I+V+EY+ +G+
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93
Query: 236 LQQWL--HGS----LGEAKPLTWDTRMKIIQ------GTAKGLAYLHEDIEPKIVHHNMK 283
L ++L HG L + +P + + Q A G+ YL VH ++
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 150
Query: 284 SSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL--------AEELSGRTSIF 335
+ N L+ + KI D G+++ + ++ R G+ E + R F
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR------DVYSTDYYRVGGHTMLPIRWMPPESIMYRK--F 202
Query: 336 NEKSDVYSFGILIMEIVS-GRLP 357
+SDV+SFG+++ EI + G+ P
Sbjct: 203 TTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 46/278 (16%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVK--LLMSNSVSEEE---DFIEKVEAIGQVKHKNLVKL 214
+ SG G VY + LD+ AVK L + + +E +++ + +++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
G E N + E + G+L + L +GS E P+ +I+ GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE--PVIRLYTRQIL----LGLEYLHDR 121
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY-LAEELSGR 331
VH ++K +NIL+D + K++D G+AK E+S + S + S Y +A E+ +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSF--KGSPYWMAPEVIAQ 175
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL----DPK 387
+ +D++S G ++E+ +G+ P +SQ + +A V +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP--WSQ--------------LEGVAAVFKIGRSKE 219
Query: 388 LPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLR 423
LP +P E K IL L+ DP RP ++L
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQ-RDP--SLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 55/293 (18%)
Query: 161 IASGDNGVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVK 213
+ G G+VY + R A+K + N S+ E +F+ + + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAK---PLTWDTRMKIIQGT---AKGLA 267
L G GQ ++V E + G+L+ +L EA+ L T K IQ A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG----- 322
YL K VH ++ + N ++ KI D G+ + I + R G
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRD------IYETDYYRKGGKGLLP 184
Query: 323 --YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDY---SQPQV--FLIDWLKSM 374
++A E S + +F KSDV+SFG+++ E+ + P Y S +V F+ID
Sbjct: 185 VRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMATLAEQP--YQGLSNEEVLKFVID----- 236
Query: 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427
LD LPE K L+ + C + K RP +++ L+
Sbjct: 237 ------GGHLD--LPENCPDKLLE----LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 159 NVIASGDNGVVYRAVLL----DN--MRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNL 211
+ G G VY + D ++ AVK L S S +E DF+ + + + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGS---LGEAKPLTWDTRMKIIQGTAKGLAY 268
V+L G E R ++ E + G+L+ +L + LT + + AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAK-LHGPEWSISTSCELRNSGY 323
L E+ +H ++ + N LL P KI+D G+A+ ++ + + +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 324 LAEE--LSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ E L G IF K+DV+SFG+L+ EI S G +P
Sbjct: 188 MPPEAFLDG---IFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 36/271 (13%)
Query: 164 GDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLF-GYCVEG 221
G G VY+A + AA K++ S E EDF+ +++ + + KH N+V L+ Y E
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75
Query: 222 QNRILVYEYIDNGNLQQWLHGSLGEA--KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
+ IL+ E+ D G L S+ + LT + + + L +LH K++H
Sbjct: 76 KLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 280 HNMKSSNILLDHHWNPKISDVGL-AKLHGPEWSISTSCELRNSGYLAEEL----SGRTSI 334
++K+ NILL + K++D G+ AK T + ++A E+ + + +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPEVVACETFKDNP 184
Query: 335 FNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394
++ K+D++S GI ++E+ P P L+ LKS +P + PS+
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-----------EPPTLDQPSK 233
Query: 395 --KELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ C+ D RP ++L+
Sbjct: 234 WSSSFNDFL---KSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDF--IEK-VEAIGQVKHKN 210
+ I SG G VY+A + A+K++ + +DF I++ + + + +H N
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPN 61
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+V FG + +V EY G+LQ + G PL+ + + T KGLAYLH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLH 118
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--------- 321
E +H ++K +NILL + K++D G++ ++ + R S
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQ------LTATIAKRKSFIGTPYWMA 169
Query: 322 -GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
A E G ++ K D+++ GI +E+ + P
Sbjct: 170 PEVAAVERKGG---YDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 144 SLKEIDIVTDG-----FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFI 197
DIV++G + I G +G VY+A A+K + ++E
Sbjct: 5 KAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN 64
Query: 198 EKVEAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTW-DTR 255
E + + KH N+V + + + +V EY+D G+L +T R
Sbjct: 65 E-ILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSL----------TDIITQNFVR 112
Query: 256 MK------IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309
M + + +GL YLH ++H ++KS NILL + K++D G A
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ---- 165
Query: 310 WSISTSCELRNS--G---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
++ RNS G ++A E+ R + K D++S GI+ +E+ G P
Sbjct: 166 --LTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 60/297 (20%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDN-MRAAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKN 210
+ E + + G G V + L + M A+K + ++ + ++ + ++E K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 211 LVKLFGYCVEGQNRIL--VYEYIDNGNLQQWLH------GSLGEAKPLTWDTRMKIIQGT 262
+VK +G ++ + + EY + G+L G +GE K L KI +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE-KVLG-----KIAESV 114
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
KGL+YLH KI+H ++K SNILL K+ D G+ S EL NS
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV------------SGELVNSL 159
Query: 323 ---------YLA-EELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDW 370
Y+A E + G+ SI SDV+S G+ ++E+ R P + I+
Sbjct: 160 AGTFTGTSFYMAPERIQGKPYSI---TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216
Query: 371 LKSMVAQQKIAYVLDPKLPEMPSR-----KELKRIILIALRCVDPDIKHRPKMGDVL 422
L S + P+L + P +E K I +C++ D RP D+L
Sbjct: 217 L-SYIVNMPN-----PELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 48/198 (24%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 158 QNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
++ + G G VY V ++ AVK L +++ E E+F+++ + ++KH NLV+L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
C ++ E++ GNL +L + + + + + YL +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQISSAMEYLEKK---N 124
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAEELSGRTSIF 335
+H ++ + N L+ + K++D GL++L G ++ + E L+ F
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 182
Query: 336 NEKSDVYSFGILIMEIVS 353
+ KSDV++FG+L+ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 63/273 (23%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKH---KNLVKL 214
+I G G VYR + A+K++ ++ ++ D +V + Q++ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+G ++G ++ EY + G+++ +L +A P+ II+ L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVR-----TLMKAGPIAEKYISVIIREVLVALKYIHKV-- 120
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEELSGR 331
++H ++K++NIL+ + N K+ D G+A L + ++S G ++A E+
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAAL----LNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391
++ K+D++S GI I E+ +G P YS + + A I P+L +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP--YSD--------VDAFRAMMLIPKSKPPRLEDN 225
Query: 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
K L+ + C+D + K R ++L+
Sbjct: 226 GYSKLLREFVAA---CLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 159 NVIASGDNGVVYRAVLLDNMRA-AVKLL--------MSNSVSEEEDFIEKVEAIGQVKHK 209
N I G G VY AV LD AVK + +++E +E +KH
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLE------LLKHP 59
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
NLVK +G V + + EY G L++ L + + R+ +Q +GLAYL
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVYTLQLL-EGLAYL 115
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC-ELRNS-----GY 323
H IVH ++K +NI LDH+ K+ D G A +T+ E S Y
Sbjct: 116 HSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN---TTTMGEEVQSLAGTPAY 169
Query: 324 LAEEL-SGRTSIFNEKS-DVYSFGILIMEIVSGRLP 357
+A E+ +G + ++ D++S G +++E+ +G+ P
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 26/195 (13%)
Query: 181 AVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
AVK+L N+ S E D + + + QV H +++KL+G C + +L+ EY G+L+ +
Sbjct: 34 AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93
Query: 240 LH----------GSLG----------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
L GS G + + LT + ++G+ YL E K+VH
Sbjct: 94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVH 150
Query: 280 HNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEK 338
++ + N+L+ KISD GL++ ++ + + S ++A E S I+ +
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE-SLFDHIYTTQ 209
Query: 339 SDVYSFGILIMEIVS 353
SDV+SFG+L+ EIV+
Sbjct: 210 SDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
+I G+ G V + + AVK + + ++ F+E+ + ++ HKNLV+L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA--FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
+V E + GNL +L + + + A+G+ YL K+VH
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++ + NIL+ K+SD GLA++ G ++ ++ + A E + + F+ KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVK---WTAPE-ALKHKKFSSKS 178
Query: 340 DVYSFGILIMEIVS-GRLP 357
DV+S+G+L+ E+ S GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 160 VIASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFGY 217
+ G G VY+A+ + + A+K++ +E I K + + Q +VK +G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE---IIKEISILKQCDSPYIVKYYGS 66
Query: 218 CVEGQNRILVYEYIDNG---NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ + +V EY G ++ + + +L E + I+ T KGL YLH +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA------ILYQTLKGLEYLHSN-- 118
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---YLAEELS 329
K +H ++K+ NILL+ K++D G++ ++ + RN+ G ++A E+
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSG------QLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+N K+D++S GI +E+ G+ P
Sbjct: 172 QEIG-YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 41/236 (17%)
Query: 160 VIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEED----FIEKVEAIGQVK-HKNLVK 213
+I G V A + + A+K+L + +E+ IEK E + ++ H ++K
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK-EVLTRLNGHPGIIK 66
Query: 214 LFGYCVEGQNRI-LVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L+ Y + + + V EY NG L Q++ GSL E TR + L YLH
Sbjct: 67 LY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-----CTRFYAAE-ILLALEYLH 119
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG-------- 322
I+H ++K NILLD + KI+D G AK+ P S ++ +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 323 -----------YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVF 366
Y++ EL + SD+++ G +I ++++G+ P ++ F
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 48/189 (25%), Positives = 96/189 (50%), Gaps = 21/189 (11%)
Query: 181 AVKLLMSNSVSEE-EDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ 238
AVK+L ++ ++ D + ++E + + KHKN++ L G C + ++ EY GNL++
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 239 WLHG------------SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286
+L + + +T+ + A+G+ YL K +H ++ + N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167
Query: 287 ILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLA-EELSGRTSIFNEKSDVYSF 344
+L+ + KI+D GLA+ ++ ++ T+ ++A E L R ++ +SDV+SF
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSF 225
Query: 345 GILIMEIVS 353
G+L+ EI +
Sbjct: 226 GVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+V +G + N + E++D G+L + P+ + KI +GL YL+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--------- 321
+I+H ++K SNIL++ K+ D G+ S EL NS
Sbjct: 121 N--VHRIMHRDIKPSNILVNSRGQIKLCDFGV------------SGELINSIADTFVGTS 166
Query: 322 GYLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ-------PQVFLIDWLK 372
Y++ E G+ ++ KSDV+S GI I+E+ G+ P +S + ++D L+
Sbjct: 167 TYMSPERIQGGKYTV---KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223
Query: 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK 417
+V + P+LP ++L+ + L DP + P+
Sbjct: 224 QIVQEPP------PRLPSSDFPEDLRDFVDACL-LKDPTERPTPQ 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 63/244 (25%), Positives = 115/244 (47%), Gaps = 36/244 (14%)
Query: 192 EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLT 251
+ DF+ + +GQ H N++ L G + + ++V EY++NG+L +L G+ T
Sbjct: 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FT 104
Query: 252 WDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL--HGPE 309
+ +++G A G+ YL + VH ++ + NIL++ + K+SD GL+++ PE
Sbjct: 105 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161
Query: 310 WSISTSCELRNSGYLAEELSGRTSI----FNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364
+ +T G + + +I F SDV+S+GI++ E++S G P
Sbjct: 162 AAYTTR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------ 210
Query: 365 VFLIDWLKSMVAQQKIAYVLDP-KLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
W M Q I + + +LP M L +++ L C D RPK ++
Sbjct: 211 -----W--EMSNQDVIKAIEEGYRLPAPMDCPAALHQLM---LDCWQKDRNERPKFEQIV 260
Query: 423 RMLE 426
+L+
Sbjct: 261 SILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 9e-13
Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 31/272 (11%)
Query: 167 GVVYRAVLLDNMRAAVKLLMSNSVSEEED-FIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225
G +R + R VK L +++ +E+ F+++V+ ++ H N+++ G C+E +
Sbjct: 14 GEAHR--GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 226 LVYEYIDNGNLQQWLHGSLG-EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284
LV E+ G+L+ +L + G A+ D ++ A GL +LH+ +H ++
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLAL 128
Query: 285 SNILLDHHWNPKISDVGLAKLHGPE-WSISTSCELRNSGYLAEELSG------RTSIFNE 337
N L + KI D GLA PE + I+ C +LA EL +
Sbjct: 129 RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 338 KSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKEL 397
KS+++S G+ + E+ + D P + LK +V +Q D KLP+ + +L
Sbjct: 189 KSNIWSLGVTMWELFTA---ADQPYPDLSDEQVLKQVVREQ------DIKLPK--PQLDL 237
Query: 398 K---RIILIALRC-VDPDIKHRPKMGDVLRML 425
K R + C +DP+ RP +V +L
Sbjct: 238 KYSDRWYEVMQFCWLDPE--TRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 158 QNVIASGDNGVVYRAVLLDN---MRAAVKLLMS-NSVSEEEDFIEKVEAIGQV-KHKNLV 212
Q+VI G+ G V +A + + M AA+K + S + DF ++E + ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGS-LGEAKP-----------LTWDTRMKIIQ 260
L G C L EY +GNL +L S + E P L+ +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
A+G+ YL + + +H ++ + NIL+ ++ KI+D GL++ G E + +
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 186
Query: 321 SGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
++A E S S++ SDV+S+G+L+ EIVS
Sbjct: 187 VRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 161 IASGDNGVVYRA----VLLDNMRAAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLVKLF 215
+ G GVV R + AVK L S+ +S+ +DF+++ + + H+NL++L+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLT--WDTRMKIIQGTAKGLAYLHEDI 273
G V ++V E G+L L ++ D ++I A G+ YL
Sbjct: 63 G-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK- 116
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--GYLAEELSGR 331
+ +H ++ + NILL KI D GL + E + A E S R
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLR 173
Query: 332 TSIFNEKSDVYSFGILIMEIVS-GRLP 357
T F+ SDV+ FG+ + E+ + G P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G G V+ ++ + AVK L ++S + F+E+ + ++H LV+L+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAK--PLTWDTRMKIIQGTAKGLAYLHEDIEPK-I 277
+ ++ EY+ G+L +L G P D +I A+G+AY IE K
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAY----IERKNY 124
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKL---------HGPEWSIS-TSCELRNSGYLAEE 327
+H +++++N+L+ KI+D GLA++ G ++ I T+ E N G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS---- 180
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F KSDV+SFGIL+ EIV+ G++P
Sbjct: 181 -------FTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 164 GDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223
GD G +++ +L +K+L + + E F E + Q+ HK+LV +G CV G
Sbjct: 20 GDYGELHKTEVL------LKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE 73
Query: 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY-LHEDIEPKIVHHNM 282
I+V EY+ G+L +L + ++W + AK LA+ LH + + H N+
Sbjct: 74 SIMVQEYVKFGSLDTYLKKN-KNLINISWKLEV------AKQLAWALHFLEDKGLTHGNV 126
Query: 283 KSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE---LRNSGYLAEELSGRTSIFNEKS 339
+ N+LL + K + KL P SI+ + L ++ E + +
Sbjct: 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAA 186
Query: 340 DVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKR 399
D +SFG + EI SG +P L ++ +Q+K+ + D P EL
Sbjct: 187 DKWSFGTTLWEIFSGG-----DKP-------LSALDSQKKLQFYEDRHQLPAPKWTELAN 234
Query: 400 IILIALRCVDPDIKHRPKMGDVLRML 425
+I +C+D + RP ++R L
Sbjct: 235 LI---NQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEED---------FIEKVEAIGQVKHK 209
+I SG G VY + AVK + SVS ++ + +++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLA 267
N+V+ G ++ + + EY+ G++ L +G+ E L ++ KGL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE--TLV----RNFVRQILKGLN 120
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----G 322
YLH I+H ++K +NIL+D+ KISD G++K + + R S
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
++A E+ +TS + K+D++S G L++E+++G+ P
Sbjct: 178 WMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 62/274 (22%), Positives = 123/274 (44%), Gaps = 20/274 (7%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKN 210
F + I G VYRA LLD + A+K + + + D I++++ + Q+ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
++K + +E +V E D G+L + + + + + T K L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
+++H ++K +N+ + K+ D+GL + + + + S L + Y
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390
+ +N KSD++S G L+ E+ + + P F D + +KI P LP
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP--------FYGDKMNLYSLCKKIEQCDYPPLPS 230
Query: 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
+EL++++ + C++PD + RP + V +
Sbjct: 231 DHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 35/211 (16%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ +G G V+ A + + AVK + S+S E F+ + + ++H LVKL V
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK---GLAYLHEDIEPKI 277
+ ++ E++ G+L +L G +PL K+I +A+ G+A++ +
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDFSAQIAEGMAFIEQR---NY 123
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKL---------HGPEWSIS-TSCELRNSGYLAEE 327
+H +++++NIL+ KI+D GLA++ G ++ I T+ E N G
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS---- 179
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F KSDV+SFGIL+MEIV+ GR+P
Sbjct: 180 -------FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 35/236 (14%)
Query: 196 FIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTR 255
F E + QV HK++V L+G CV I+V E+++ G L ++H ++ LT +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWK 107
Query: 256 MKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL-----DHHWNP--KISDVGLAKLHGP 308
K+ + A L+YL ED +VH N+ + NILL D P K+SD G+ P
Sbjct: 108 FKVAKQLASALSYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-----P 159
Query: 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV-SGRLPVDYSQPQVFL 367
+S + ++A E + + +D +SFG + EI +G +P
Sbjct: 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP---------- 209
Query: 368 IDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
LK +K + + PS KEL ++ C++ D RP ++R
Sbjct: 210 ---LKDKTLAEKERFYEGQCMLVTPSCKELADLM---THCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 46/179 (25%), Positives = 90/179 (50%), Gaps = 18/179 (10%)
Query: 191 SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR------ILVYEYIDNGNLQQW-LHGS 243
SE EDF+ + + + H N+++L G C++ +++ ++ +G+L + L+
Sbjct: 42 SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101
Query: 244 LGEAKPLTWDTRM--KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301
LG+ P T+M K + A G+ YL +H ++ + N +L+ + N ++D G
Sbjct: 102 LGD-CPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157
Query: 302 LAK--LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
L+K +G + ++ E L+ R ++ KSDV+SFG+ + EI + G+ P
Sbjct: 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL 211
DG + + A +N VL+ A L S + EDF+++V+ + ++ N+
Sbjct: 26 ADGLQDFSEKAFAENDNADAPVLV----AVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLH-------GSLGEAKPLTWDTRMKIIQGTAK 264
+L G C ++ EY++NG+L Q+L G +K L++ T + + A
Sbjct: 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
G+ YL VH ++ + N L+ ++ KI+D G S L +S Y
Sbjct: 142 GMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFG------------MSRNLYSSDYY 186
Query: 325 AEELSGRT----------SI----FNEKSDVYSFGILIMEIVS 353
+ GR S+ F KSDV++FG+ + EI++
Sbjct: 187 --RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 257 KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTS 315
KI T K L YL E++ KI+H ++K SNILLD + N K+ D G++ +L SI+ +
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKT 165
Query: 316 CELRNSG---YLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW 370
R++G Y+A E ++ +SDV+S GI + E+ +G+ P Y + W
Sbjct: 166 ---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP--YPK-------W 213
Query: 371 LKSMVAQQKIAYVLDPKLP---EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
++ P L E I + C+ D RPK ++L
Sbjct: 214 NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 167 GVVYRA--VLLDNMR----AAVKLLMSNSVSEE-EDFIEKVEAIGQV-KHKNLVKLFGYC 218
G V +A V LDN AVK+L ++ ++ D + ++E + + KHKN++ L G C
Sbjct: 26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85
Query: 219 VEGQNRILVYEYIDNGNLQQWLH------------GSLGEAKPLTWDTRMKIIQGTAKGL 266
+ +V EY +GNL+ +L + LT + A+G+
Sbjct: 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLA 325
+L K +H ++ + N+L+ KI+D GLA+ +H ++ T+ +G L
Sbjct: 146 EFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT-----NGRLP 197
Query: 326 ------EELSGRTSIFNEKSDVYSFGILIMEIVS 353
E L R ++ +SDV+SFG+L+ EI +
Sbjct: 198 VKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 62/274 (22%), Positives = 119/274 (43%), Gaps = 20/274 (7%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVK---LLMSNSVSEEEDFIEKVEAIGQVKHKN 210
F + I G VYRA LLD A+K + +D +++++ + Q+ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
++K +E +V E D G+L Q + + + + T K + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
+++H ++K +N+ + K+ D+GL + + + + S L + Y
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390
+ +N KSD++S G L+ E+ + + P F D + QKI P LP
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP--------FYGDKMNLFSLCQKIEQCDYPPLPT 230
Query: 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
++L+ ++ + C+ PD RP +G V ++
Sbjct: 231 EHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 161 IASGDNGVVYRAVLLDNMR--AAVKLLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKL 214
I G G VY+A A K+ M N E+E F I +++ + +++H N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 215 FGYCVE-GQNRI-LVYEYIDNGNLQQWLHG-----SLGEAKPLTWDTRMKIIQGTAKGLA 267
G+ I +V+EY+D+ +L L + + K MK + +GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY-----MKQL---LEGLQ 114
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTS--CELRNSGYL 324
YLH + I+H ++K SNIL+++ K++D GLA + T+ L Y
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL---WYR 168
Query: 325 AEE-LSGRTSIFNEKSDVYSFGILIMEIVSGR 355
E L G T + + D++S G ++ E+ G+
Sbjct: 169 PPELLLGATR-YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/257 (22%), Positives = 119/257 (46%), Gaps = 41/257 (15%)
Query: 181 AVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
AVK+L ++ DF+++++ + ++K+ N+++L G CV ++ EY++NG+L Q+
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 240 L-----HGSLGEAKPLTWDTRMKIIQGTAK---GLAYLHEDIEPKIVHHNMKSSNILLDH 291
L + A + + ++ + G+ YL VH ++ + N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGN 164
Query: 292 HWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEE--LSGRTSIFNEKSDVYSFGILI 348
H+ KI+D G+++ L+ ++ + ++A E L G+ F SDV++FG+ +
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK---FTTASDVWAFGVTL 221
Query: 349 MEIVSGRLPVDYSQPQVFLID---------WLKSMVAQQKIAYVLDPKLPEMPSRKELKR 399
E+ + + QP L D + ++ Q + Y+ L P
Sbjct: 222 WEMFT----LCKEQPYSLLSDEQVIENTGEFFRN---QGRQIYLSQTPLCPSP------- 267
Query: 400 IILIALRCVDPDIKHRP 416
+ + +RC DIK RP
Sbjct: 268 VFKLMMRCWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 28/279 (10%)
Query: 152 TDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL----MSNSVSEEEDFIEKVEAIGQV 206
F + I G VVY+A+ LLD A+K + M ++ +D +++++ + Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA-KARQDCLKEIDLLKQL 59
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
H N++K +E +V E D G+L + + + + + T K L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---Y 323
++H +I+H ++K +N+ + K+ D+GL G +S T+ G Y
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGL----GRFFSSKTTAAHSLVGTPYY 172
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
++ E + +N KSD++S G L+ E+ + + P F D + +KI
Sbjct: 173 MSPERI-HENGYNFKSDIWSLGCLLYEMAALQSP--------FYGDKMNLYSLCKKIEKC 223
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
P LP +EL+ ++ RC++PD + RP + VL
Sbjct: 224 DYPPLPADHYSEELRDLV---SRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
+ G G V+ + A+K L ++ E F+++ + + +++H LV L+ E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ +V E++ G+L +L G+ K L + + A G+AY+ +H
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 281 NMKSSNILLDHHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAEE-LSGRTSIFNEK 338
+++++NIL+ + KI+D GLA+L E++ + E L GR +I K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI---K 183
Query: 339 SDVYSFGILIMEIVS-GRLP 357
SDV+SFGIL+ E+V+ GR+P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 19/184 (10%)
Query: 178 MRAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGN 235
M+ AVK+L + SE E + +++ + + H+N+V L G C G +++ EY G+
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L +L LT + + AKG+A+L +H ++ + N+LL H
Sbjct: 126 LLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180
Query: 296 KISDVGLAK--LHGPEWSISTSCELRNSGYLAEELSGRTSIFNE----KSDVYSFGILIM 349
KI D GLA+ ++ + + + L ++A E SIFN +SDV+S+GIL+
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVK-WMAPE-----SIFNCVYTFESDVWSYGILLW 234
Query: 350 EIVS 353
EI S
Sbjct: 235 EIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/189 (27%), Positives = 97/189 (51%), Gaps = 21/189 (11%)
Query: 181 AVKLLMSNSVSEE-EDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ 238
AVK+L ++ ++ D + ++E + + KHKN++ L G C + ++ EY GNL++
Sbjct: 48 AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 239 WLHGSLGEAKPLTWDT-RMKIIQGT-----------AKGLAYLHEDIEPKIVHHNMKSSN 286
+L ++DT ++ Q T A+G+ YL K +H ++ + N
Sbjct: 108 YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164
Query: 287 ILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLA-EELSGRTSIFNEKSDVYSF 344
+L+ KI+D GLA+ +H ++ T+ ++A E L R ++ +SDV+SF
Sbjct: 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSF 222
Query: 345 GILIMEIVS 353
G+L+ EI +
Sbjct: 223 GVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 44/264 (16%)
Query: 160 VIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEK-----VEAIGQVKHKNLVK 213
V+ G GVV + A+K SE+++ ++K V+ + Q++H+N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE---SEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKP--LTWDTRMKIIQGTAKGLAYLHE 271
L LV+EY++ L + L EA P L D I + +AY H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELL-----EASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLA----- 325
I+H ++K NIL+ K+ D G A+ L S T Y+A
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYR 168
Query: 326 --EELSGRTSIFNEKSDVYSFGILIMEIVSGR--LPVDYSQPQVFLI-DWLKSMVAQQKI 380
E L G T+ + + DV++ G ++ E++ G P D Q++LI L + +
Sbjct: 169 APELLVGDTN-YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227
Query: 381 AYVLDP-----KLPEMPSRKELKR 399
+ +P PE + L+R
Sbjct: 228 LFSSNPRFAGVAFPEPSQPESLER 251
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 160 VIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK----HKNLVKL 214
VI G G VY+A A+K++ + + +EE+ I+ E ++ H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIK--EEYNILRKYSNHPNIATF 68
Query: 215 FG-------YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
+G + Q LV E G++ + G + K L + I++ T +GLA
Sbjct: 69 YGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG----- 322
YLHE+ K++H ++K NILL + K+ D G++ + ++ RN+
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA------QLDSTLGRRNTFIGTPY 178
Query: 323 YLAEEL----SGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
++A E+ + ++ +SDV+S GI +E+ G+ P
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 21/191 (10%)
Query: 179 RAAVKLLMSNSVSEE-EDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236
+ AVK+L S++ ++ D I ++E + + KHKN++ L G C + ++ EY GNL
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 237 QQWLHGSLGEAKPLTWDTRMKIIQG------------TAKGLAYLHEDIEPKIVHHNMKS 284
+++L ++ + A+G+ YL K +H ++ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168
Query: 285 SNILLDHHWNPKISDVGLAK--LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVY 342
N+L+ KI+D GLA+ H + +T+ L E L R I+ +SDV+
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVW 226
Query: 343 SFGILIMEIVS 353
SFG+L+ EI +
Sbjct: 227 SFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/189 (27%), Positives = 95/189 (50%), Gaps = 21/189 (11%)
Query: 181 AVKLLMSNSVSEE-EDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ 238
AVK+L N+ ++ D I ++E + + KHKN++ L G C + ++ EY GNL++
Sbjct: 48 AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLRE 107
Query: 239 WLH------------GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286
+L + + L++ + A+G+ YL + +H ++ + N
Sbjct: 108 FLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164
Query: 287 ILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLA-EELSGRTSIFNEKSDVYSF 344
+L+ KI+D GLA+ +H ++ TS ++A E L R ++ +SDV+SF
Sbjct: 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSF 222
Query: 345 GILIMEIVS 353
GIL+ EI +
Sbjct: 223 GILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 160 VIASGDNGVVYRAVLL---DNMRAAVKLLMSNSVSEEEDFIEKVE---AIGQVKHKNLVK 213
++ SG G V++ + + D+++ V + S + F E + A+G + H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLH---GSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L G C G + LV + G+L + SL + L W ++ AKG+ YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-GYLAEE-- 327
E ++VH N+ + NILL +I+D G+A L P+ E + ++A E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVS-------GRLPVD----------YSQPQVFLIDW 370
L GR + +SDV+S+G+ + E++S G P + +QPQ+ ID
Sbjct: 184 LFGR---YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240
Query: 371 LKSMVAQQKIAYVLDPKLPEMPS 393
MV I + P E+ +
Sbjct: 241 YMVMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 73/259 (28%), Positives = 116/259 (44%), Gaps = 41/259 (15%)
Query: 178 MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQ 237
+R +K+L + F E + QV H +L + G CV G I+V E++++G L
Sbjct: 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 238 QWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297
L G P+ W ++ + Q A L+YL ED +VH N+ + NILL
Sbjct: 105 VCLRKEKGRV-PVAW--KITVAQQLASALSYL-ED--KNLVHGNVCAKNILL-------- 150
Query: 298 SDVGLA-------KLHGPEWSIST-SCELR--NSGYLAEELSGRTSIFNEKSDVYSFGIL 347
+ +GLA KL P S + S E R ++A E + + +D +SFG
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTT 210
Query: 348 IMEIV-SGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALR 406
++EI G +P+ P ++++ Y +LPE PS KEL +I +
Sbjct: 211 LLEICFDGEVPLKERTP------------SEKERFYEKKHRLPE-PSCKELATLI---SQ 254
Query: 407 CVDPDIKHRPKMGDVLRML 425
C+ + RP +LR L
Sbjct: 255 CLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 181 AVKLLMS-NSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI--LVYEYIDNGNLQ 237
AVK L + +++ + + H+N+VK G C E + L+ EY+ G+L+
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 238 QWL-HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296
+L L A+ L + Q +G+AYLH +H ++ + N+LLD+ K
Sbjct: 97 DYLPKHKLNLAQLLLF------AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVK 147
Query: 297 ISDVGLAKLHGPE----WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV 352
I D GLAK PE + + + Y E L + + F+ SDV+SFG+ + E++
Sbjct: 148 IGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELL 204
Query: 353 S 353
+
Sbjct: 205 T 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKN 210
F + I G G V++ + DN V + + E ED IE ++ + Q
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+ K +G ++ ++ EY+ G+ L E PL I++ KGL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLH 118
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
+ K +H ++K++N+LL H K++D G+A + I + + ++A E+
Sbjct: 119 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVI- 173
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLI 368
+ S ++ K+D++S GI +E+ G P P +FLI
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKN 210
F + I G G V++ + DN V + + E ED IE ++ + Q
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+ K +G ++G ++ EY+ G+ L A P +++ KGL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLH 118
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
+ K +H ++K++N+LL + K++D G+A + I + + ++A E+
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVI- 173
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLI 368
+ S ++ K+D++S GI +E+ G P P +FLI
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVK---LLMSNSVSEEEDF---IEKVEAIGQVKHKNLV 212
V+ G G VY + AVK L SN ++ E+++ E+V+ + +KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+ G C++ + E++ G++ L+ G L E P+ +I+ G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE--PVFCKYTKQILD----GVAYLH 119
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK------LHGPEWSISTSCELRNSGY- 323
+ +VH ++K +N++L + K+ D G A+ LHG ++ S + + Y
Sbjct: 120 NN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPYW 174
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+A E+ S + KSD++S G + E+ +G+ P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 158 QNVIASGDNGVVYRAVL-LDNMR---AAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLV 212
+ ++ +G G + R L L + R A+ L + S + F+ + +GQ H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+L G G ++V EY+ NG L +L G+ L M ++ G A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLS-- 124
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
E VH + + +L++ KIS + E +I T+ ++ A + +
Sbjct: 125 -EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE-AIYTTMSGKSPVLWAAPEAIQY 182
Query: 333 SIFNEKSDVYSFGILIMEIVS 353
F+ SDV+SFGI++ E++S
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 67/262 (25%), Positives = 113/262 (43%), Gaps = 33/262 (12%)
Query: 181 AVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQNRI-LVYEYIDNGNLQQ 238
AVK L ++ DF ++E + ++H N+VK G C G+ + LV EY+ G+L+
Sbjct: 37 AVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD 96
Query: 239 WLHGS---LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
+L L K L + +++ KG+ YL + VH ++ + NIL++
Sbjct: 97 YLQKHRERLDHRKLLLYASQI------CKGMEYLGSK---RYVHRDLATRNILVESENRV 147
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSG---YLAEELSGRTSIFNEKSDVYSFGILIMEIV 352
KI D GL K+ + E S Y E L+ S F+ SDV+SFG+++ E+
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELF 205
Query: 353 SGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD--------PKLPEMPSRKELKRIILIA 404
+ S P F+ Q + ++++ P P P+ I I
Sbjct: 206 T-YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPA-----EIYAIM 259
Query: 405 LRCVDPDIKHRPKMGDVLRMLE 426
C + D RP ++ +E
Sbjct: 260 KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEE-DFIEKVEAIGQVKHKNLVKLFGYC 218
++ G+ G V++ L D AVK + E + F+ + + Q H N+VKL G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ Q +V E + G+ +L E K +K A G+AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQLVKFALDAAAGMAYLESK---NCI 115
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEELS-GRTSIFN 336
H ++ + N L+ + KISD G+++ +S S ++ E L+ GR ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR---YS 172
Query: 337 EKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR- 394
+SDV+S+GIL+ E S G P M QQ V P +
Sbjct: 173 SESDVWSYGILLWETFSLGVCP-------------YPGMTNQQAREQVEKGYRMSCPQKC 219
Query: 395 -KELKRIILIALRCVDPDIKHRPKMGDVLRML 425
++ +++ RC D ++RPK ++ + L
Sbjct: 220 PDDVYKVM---QRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 54/262 (20%), Positives = 109/262 (41%), Gaps = 62/262 (23%)
Query: 188 NSVSEEED----FIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLH-- 241
N+ SE+E+ +++ + ++ H +++++ G E + L E++ G++ L
Sbjct: 38 NTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY 97
Query: 242 GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD---HHWNPKIS 298
G+ EA + + +GL+YLHE+ +I+H ++K +N+L+D +I+
Sbjct: 98 GAFKEA------VIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIA 146
Query: 299 DVGLAKLHGPEWSISTSCELRNSGYLAEELSG----------RTSIFNEKSDVYSFGILI 348
D G A + + +G +L G R + DV+S G +I
Sbjct: 147 DFGAA--------ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198
Query: 349 MEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-----KIAYVLDPKLPEMPS--RKELKRII 401
+E+ + + P W + KIA P +P L+
Sbjct: 199 IEMATAKPP------------WNAEKHSNHLALIFKIASATTA--PSIPEHLSPGLRD-- 242
Query: 402 LIALRCVDPDIKHRPKMGDVLR 423
+ LRC++ + RP ++L+
Sbjct: 243 -VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 29/264 (10%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRA-AVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLVKLF 215
Q ++ G+ G VY+A L R AVK++ + +V ++ + ++E + + ++ +
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 216 G-YCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
G + VE NRI + E++D G+L ++ + E +I KGL YL
Sbjct: 66 GAFFVE--NRISICTEFMDGGSLD--VYRKIPE------HVLGRIAVAVVKGLTYLWS-- 113
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSGYLAEELSGRT 332
KI+H ++K SN+L++ K+ D G++ +L SI+ + N+ E +SG
Sbjct: 114 -LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPERISGEQ 169
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392
+ SDV+S GI ME+ GR P PQ+ S++ Q + ++D P +P
Sbjct: 170 --YGIHSDVWSLGISFMELALGRFPY----PQIQKNQ--GSLMPLQLLQCIVDEDPPVLP 221
Query: 393 SRKELKRIILIALRCVDPDIKHRP 416
+ ++ + +C+ K RP
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 51/214 (23%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 160 VIASGDNGVVYRAVLLDN--MRAAVKLLMSNSVSEEEDFIEK---------VEAIGQVKH 208
+I G G VY A+ + M A ++ + +++ D +K +E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 209 KNLVKLFGYCVEGQNRILVY-EYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKG 265
N+V+ G + + ++ EY+ G++ L +G E L + +G
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--QLV----RFFTEQVLEG 120
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY-L 324
LAYLH I+H ++K+ N+L+D KISD G++K + + ++ S + +
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 325 AEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
A E + + ++ K D++S G +++E+ +GR P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 37/180 (20%)
Query: 257 KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG--------LAKLHGP 308
KI K L YLH + ++H ++K SN+L++ + K+ D G +AK
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160
Query: 309 EWSISTSCELRNSGYLAEEL---SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV 365
+I C+ Y+A E ++ KSDV+S GI ++E+ +GR P D
Sbjct: 161 --TIDAGCK----PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD------ 208
Query: 366 FLIDWLKSMVAQQK-IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
W K+ Q K + P+LP E + + +C+ + K RP ++L+
Sbjct: 209 ---SW-KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV---NKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKN 210
F + I G G VY+ + DN V + + E ED IE ++ + Q
Sbjct: 6 FTKLERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLH-GSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
+ + +G ++G ++ EY+ G+ L G L E T I++ KGL YL
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYL 117
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELS 329
H + + +H ++K++N+LL + K++D G+A + I + + ++A E+
Sbjct: 118 HSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLI 368
+ S ++ K+D++S GI +E+ G P P +FLI
Sbjct: 174 -KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 83/318 (26%), Positives = 133/318 (41%), Gaps = 56/318 (17%)
Query: 122 TRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRA- 180
+ ++ + S SG SL E++ V N I SG G VY+ + R
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLY 102
Query: 181 AVKLLMSNSVSEEEDFIEK-----VEAIGQVKHKNLVKLFG-YCVEGQNRILVYEYIDNG 234
A+K++ N ED + + +E + V H N+VK + G+ ++L+ E++D G
Sbjct: 103 ALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGG 157
Query: 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294
+L+ G+ + D +I+ G +AYLH IVH ++K SN+L++ N
Sbjct: 158 SLE----GTHIADEQFLADVARQILSG----IAYLHRR---HIVHRDIKPSNLLINSAKN 206
Query: 295 PKISDVG----LAKLHGP-EWSIST----SCELRNSGYLAEELSGRTSIFNEKSDVYSFG 345
KI+D G LA+ P S+ T S E N+ G D++S G
Sbjct: 207 VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA------GDIWSLG 260
Query: 346 ILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIAL 405
+ I+E GR P + DW M A I P+ P SR E + I
Sbjct: 261 VSILEFYLGRFPFGVGRQG----DWASLMCA---ICMSQPPEAPATASR-EFRHFI---S 309
Query: 406 RCVDPDIKHRPKMGDVLR 423
C+ + R +L+
Sbjct: 310 CCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 68/286 (23%), Positives = 127/286 (44%), Gaps = 43/286 (15%)
Query: 161 IASGDNGVVYRAVLLD------NMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
+ G G+VY D R AVK + S S+ E +F+ + + ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAK------PLTWDTRMKIIQGTAKGLA 267
L G +GQ ++V E + +G+L+ +L EA+ P T +++ A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG----- 322
YL+ K VH ++ + N ++ H + KI D G+ + I + R G
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 323 --YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380
++A E S + +F SD++SFG+++ EI S QP + + +Q +
Sbjct: 185 VRWMAPE-SLKDGVFTTSSDMWSFGVVLWEITSLA-----EQP-------YQGLSNEQVL 231
Query: 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+V+D + P +R+ + C + K RP +++ +L+
Sbjct: 232 KFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 159 NVIASGDNGVVYRAVLLDN----MRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVK 213
VI G G VY L+D+ + AVK L + EE E F+++ + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 214 LFGYCVEGQNRILV-YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
L G C+ + LV Y+ +G+L+ ++ P D +Q AKG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--THNPTVKDLIGFGLQ-VAKGMEYLASK 117
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEW-SISTSCELR-NSGYLAEELS 329
K VH ++ + N +LD + K++D GLA+ ++ E+ S+ + ++A E S
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE-S 173
Query: 330 GRTSIFNEKSDVYSFGILIMEIVS 353
+T F KSDV+SFG+L+ E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 161 IASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEED-FIEKVEAIGQVKHKNLVKLFGYC 218
I G+ G V+ L DN AVK + + F+++ + Q H N+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK-I 277
+ Q +V E + G+ +L E L +++++ A G+ YL E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYL----ESKHC 115
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN--SGYLAEEL--SGRTS 333
+H ++ + N L+ KISD G+++ + +++ ++ + A E GR
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGR-- 172
Query: 334 IFNEKSDVYSFGILIMEIVS-GRLP 357
++ +SDV+SFGIL+ E S G +P
Sbjct: 173 -YSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 51/254 (20%)
Query: 187 SNSVSEEEDFIE-KVEAIGQVKHKNLVKLFGYCVEGQNRILV--YEYIDNGNLQQWL--H 241
S S+E +E +++ + ++H+ +V+ +G + + L EY+ G+++ L +
Sbjct: 41 SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY 100
Query: 242 GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301
G+L E+ TR K + +G++YLH ++ IVH ++K +NIL D N K+ D G
Sbjct: 101 GALTESV-----TR-KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 151
Query: 302 LAKLHGPEWSISTSCELRNSGYLA----------EELSGRTSIFNEKSDVYSFGILIMEI 351
+K + T C + +G + E +SG + K+DV+S G ++E+
Sbjct: 152 ASK------RLQTIC-MSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEM 202
Query: 352 VSGRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR-KELKRIILIALRCVD 409
++ + P +Y ++M A KIA P P++PS E R L C+
Sbjct: 203 LTEKPPWAEY-----------EAMAAIFKIA--TQPTNPQLPSHISEHARDF---LGCIF 246
Query: 410 PDIKHRPKMGDVLR 423
+ +HRP ++LR
Sbjct: 247 VEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 161 IASGDNGVVYRAVLLDNMRA-----AVKLLMS-NSVSEEEDFIEKVEAIGQVKHKNLVKL 214
+ SG+ G V + V MR A+K+L + N S ++ + + E + Q+ + +V++
Sbjct: 3 LGSGNFGCVKKGVY--KMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
G C E + +LV E G L ++L G E +T ++++ + G+ YL
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGK-- 114
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG------YLAEEL 328
VH ++ + N+LL + KISD GL+K G + S + R++G Y E +
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA---RSAGKWPLKWYAPECI 170
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVS 353
+ R F+ +SDV+S+GI + E S
Sbjct: 171 NFRK--FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 53/217 (24%), Positives = 103/217 (47%), Gaps = 38/217 (17%)
Query: 161 IASGDNGVVY----RAVLLDN--MRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
+ G G+VY + V+ D R A+K + + S+ E +F+ + + + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWL-------HGSLGEAKPLTWDTRMKIIQGT---A 263
L G +GQ +++ E + G+L+ +L + +A P + K+IQ A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP----SLKKMIQMAGEIA 129
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG- 322
G+AYL+ + K VH ++ + N ++ + KI D G+ + I + R G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGGK 180
Query: 323 ------YLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
+++ E S + +F SDV+SFG+++ EI +
Sbjct: 181 GLLPVRWMSPE-SLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 160 VIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSEEE-DFIEKVEAIGQVKHKNLVK 213
V+ SG G VY+ + + + A+K+L + + +F+++ + + H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLH---GSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L G C+ + LV + + +G L ++H ++G L W ++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELS 329
E ++VH ++ + N+L+ + KI+D GLA+ L G E + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 330 GRTSIFNEKSDVYSFGILIMEIVS-GRLPVD----------------YSQPQVFLIDWLK 372
F +SDV+S+G+ I E+++ G P D QP + ID
Sbjct: 184 HYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242
Query: 373 SMVAQQKIAYVLDPKLPEMPS 393
MV I PK E+ +
Sbjct: 243 VMVKCWMIDADSRPKFKELAA 263
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 49/243 (20%), Positives = 105/243 (43%), Gaps = 29/243 (11%)
Query: 189 SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAK 248
S E D + ++ + ++H N++ + + ++ ++ EY + G L + K
Sbjct: 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYD----KIVRQK 94
Query: 249 PLTWDTRMKI---IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305
++ M + Q ++Y+H+ I+H ++K+ NI L K+ D G++K+
Sbjct: 95 GQLFEEEMVLWYLFQ-IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKI 150
Query: 306 HGPEWSISTSCELRNSGYLAEEL-SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ 364
G E+S++ + + Y++ EL G +N KSD+++ G ++ E+++ + D + P
Sbjct: 151 LGSEYSMAETV-VGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPL 207
Query: 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
L + Q V+ E+ I + + D + RP +VL
Sbjct: 208 N-----LVVKIVQGNYTPVVSVYSSEL---------ISLVHSLLQQDPEKRPTADEVLDQ 253
Query: 425 LEP 427
Sbjct: 254 PLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 58/266 (21%), Positives = 119/266 (44%), Gaps = 27/266 (10%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G +G VY A+ + A++ + ++E I ++ + + K+ N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
G +V EY+ G+L + + + + + + + L +LH + +++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSN---QVIH 139
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY-LAEELSGRTSIFNEK 338
++KS NILL + K++D G PE S + + + Y +A E+ R + + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKA-YGPK 196
Query: 339 SDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELK 398
D++S GI+ +E++ G P P + + + PE+ + ++L
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP-------------LRALYLIATNGTPELQNPEKLS 243
Query: 399 RIILIAL-RCVDPDIKHRPKMGDVLR 423
I L RC+D D++ R ++L+
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 57/265 (21%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G +G V+ A+ + A+K + ++E I ++ + ++K+ N+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
G +V EY+ G+L + + + + + + + L +LH + +++H
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLHAN---QVIH 138
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++KS N+LL + K++D G PE S S + ++A E+ R + + K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-YGPKV 196
Query: 340 DVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKR 399
D++S GI+ +E+V G P P + + + PE+ + ++L
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP-------------LRALYLIATNGTPELQNPEKLSP 243
Query: 400 IILIAL-RCVDPDIKHRPKMGDVLR 423
I L RC++ D++ R ++L+
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 160 VIASGDNGVVYRAVLLDN----MRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVK 213
++ G+ G V L + ++ AVK + + + SE E+F+ + + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 214 LFGYCVEGQNR------ILVYEYIDNGNLQQWLHGSLGEAKP--LTWDTRMKIIQGTAKG 265
L G C E + +++ ++ +G+L +L S P L T +K + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSGYL 324
+ YL +H ++ + N +L ++D GL+ K++ ++ ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 325 A-EELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
A E L+ R ++ KSDV++FG+ + EI + G+ P
Sbjct: 183 AIESLADR--VYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 155 FAEQNVIASGDNGVVY--RAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKN 210
F + I G G VY R V + + A K+ S S E +D I++V + Q++H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEA--------KPLTWDTRMKIIQGT 262
++ G + LV EY LG A KPL I G
Sbjct: 77 TIEYKGCYLREHTAWLVMEY------------CLGSASDILEVHKKPLQEVEIAAICHGA 124
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNS 321
+GLAYLH + +H ++K+ NILL K++D G A L P S + T
Sbjct: 125 LQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPY----- 176
Query: 322 GYLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
++A E L+ ++ K DV+S GI +E+ + P
Sbjct: 177 -WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 205 QVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQG 261
++ H +VKL Y + + ++ LV EY G L L G E R +
Sbjct: 49 RINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-------RARFYAA 100
Query: 262 -TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELR 319
L YLH I++ ++K NILLD + K++D GLAK E S +T C
Sbjct: 101 EIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC--G 155
Query: 320 NSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378
YLA E L G+ + + D +S G+L+ E+++G+ P F + +
Sbjct: 156 TPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPP--------FYAE--DRKEIYE 203
Query: 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPD 411
KI + PE S E + +I L DP
Sbjct: 204 KILK-DPLRFPEFLSP-EARDLIS-GLLQKDPT 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 50/210 (23%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLV 212
F I G G VY+A+ + A+K++ +E + I++ ++ + Q + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
K +G ++G ++ EY G+ L + L I++ GL YLHE+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---YLAEE 327
+H ++K++NILL + K++D G++ ++++ RN+ G ++A E
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSG------QLTSTMSKRNTFVGTPFWMAPE 168
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ ++ ++EK+D++S GI +E+ G P
Sbjct: 169 VIKQSG-YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 19/224 (8%)
Query: 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAA-VKLLMSNSVSEEEDFI--EKV 200
I I D +++ G G ++ +L+D VK + ++ + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILV-YEYIDNGNLQQWLH-GSLGEA-KPLTWDTRMK 257
G + H+N++ + C+E V Y Y++ GNL+ +L LGEA P T+
Sbjct: 61 LLYG-LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 258 IIQGT--AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSIST 314
+ A G++YLH+ ++H ++ + N ++D KI+D L++ L ++
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
E R ++A E S ++ SDV+SFG+L+ E+++ G+ P
Sbjct: 177 DNENRPVKWMALE-SLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 62/241 (25%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFI---EKVEAIGQVKHKNLVKLFG 216
+ SG G VY+A L AAVK++ + +DF +++ + + KH N+V FG
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ + + EY G+LQ H + PL+ + + T +GLAYLH +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSG- 330
+H ++K +NILL + + K++D G+A I+ + R S ++A E++
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAA------KITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 331 -RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389
+ +N+ D+++ GI +E+ L QP +F + ++++ K + PKL
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL--AEL-----QPPMFDLHPMRALFLMSKSNF-QPPKLK 232
Query: 390 E 390
+
Sbjct: 233 D 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 60/244 (24%), Positives = 112/244 (45%), Gaps = 33/244 (13%)
Query: 161 IASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
+ G G VY+A + + AA K++ + S E ED++ +++ + H N+VKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
N ++ E+ G + + L +PLT + + T + L YLHE+ KI+H
Sbjct: 73 YENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEEL----SG 330
++K+ NIL + K++D G++ + + + + R+S ++A E+ +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKN------TRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390
+ ++ K+DV+S GI ++E+ P P L+ KS +P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-----------EPPTLA 229
Query: 391 MPSR 394
PSR
Sbjct: 230 QPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 61/287 (21%)
Query: 161 IASGDNGVVYRAVLLDNMRA-AVKLL--------MSNSVSEEEDFIEKVEAIGQVKHKNL 211
+ G G VY +D R AVK + V+ E I+ ++ + +H+ +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL---QHERI 66
Query: 212 VKLFGYCVEGQNRILVY-EYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
V+ +G C+ + ++ EY+ G+++ L +G+L E +T +I++G + Y
Sbjct: 67 VQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTET--VTRKYTRQILEG----VEY 119
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG------ 322
LH + IVH ++K +NIL D N K+ D G +K + T C +G
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK------RLQTIC-SSGTGMKSVTG 169
Query: 323 ---YLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW--LKSMVA 376
+++ E +SG + K+DV+S G ++E+++ + P W ++M A
Sbjct: 170 TPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPP------------WAEFEAMAA 215
Query: 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
KIA P P++PS + R + K RP ++LR
Sbjct: 216 IFKIA--TQPTNPQLPSHVSPDARNFLR-RTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 161 IASGDNGVVYRAVLLDNMR-----AAVKLLM--SNSVSEEEDFIEKVEAIGQVKHKNLVK 213
+ SG+ G V + + M+ AVK+L +N + +++ + + + Q+ + +V+
Sbjct: 3 LGSGNFGTVKKGMY--KMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ G C E ++ +LV E + G L ++L + K +T +++ + G+ YL E
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE---WSISTSCELRNSGYLAEELSG 330
VH ++ + N+LL KISD GL+K G + + T + Y E ++
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 331 RTSIFNEKSDVYSFGILIMEIVS 353
F+ KSDV+SFG+L+ E S
Sbjct: 173 YK--FSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 160 VIASGDNGVVYRA-VLLDNMRAAVKL--LMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
I G G +Y A D+ +K L V E+E ++V + ++KH N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL---HGSL-GEAKPLTWDTRMKIIQGTAKGLAYLHED 272
E +V EY D G+L + + G L E + L+W ++ + GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDR 120
Query: 273 IEPKIVHHNMKSSNILLDHHWN-PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR 331
KI+H ++KS NI L + K+ D G+A+ ++ +C + YL+ E+ +
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEIC-Q 175
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLPVD 359
+N K+D++S G ++ E+ + + P +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 57/299 (19%), Positives = 123/299 (41%), Gaps = 47/299 (15%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE---EDFI 197
I +ID T +I D +Y+ + +N ++ + +
Sbjct: 13 KCIESDDIDKYT-----SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITE 66
Query: 198 EKVEAIGQVKHKNLVKLFGYCVEGQNR----ILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
+++ + ++ N++K++G+ ++ + L+ EY G L++ L + K L++
Sbjct: 67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFK 122
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313
T++ + KGL L++ + N+ S + L+ ++ KI GL K+ S
Sbjct: 123 TKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKI----LSSP 176
Query: 314 TSCELRNSGYLAEELSGRTSIFNE---KSDVYSFGILIMEIVSGRLP---VDYSQPQVFL 367
+ Y + ++ IF+E K D+YS G+++ EI +G++P + +
Sbjct: 177 PFKNVNFMVYFSYKM--LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----- 229
Query: 368 IDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ ++ + + L P E+K I+ C D RP + ++L L
Sbjct: 230 ---IYDLIINKNNSLKLPLDCP-----LEIKCIV---EACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 39/243 (16%)
Query: 194 EDFIEKVEAIG-QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTW 252
D + +V I Q++H N+V+ + +E +V + I+ L + SL E K
Sbjct: 53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFT 111
Query: 253 DTRM-KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW- 310
+ R+ I L YLH+ E +IVH ++ +NI+L I+D GLAK PE
Sbjct: 112 EERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 311 ------SISTSCE--LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
+I SC ++N Y EK+DV++FG ++ ++ + + P YS
Sbjct: 170 LTSVVGTILYSCPEIVKNEPY------------GEKADVWAFGCILYQMCTLQ-PPFYST 216
Query: 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
+ L A + + V +P LPE +++ +I C+ PD + RP + V
Sbjct: 217 NMLSL--------ATKIVEAVYEP-LPEGMYSEDVTDVI---TSCLTPDAEARPDIIQVS 264
Query: 423 RML 425
M+
Sbjct: 265 AMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 64/270 (23%), Positives = 124/270 (45%), Gaps = 42/270 (15%)
Query: 181 AVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
AVK+L + + + DF+++V+ + ++K N+++L G CV+ ++ EY++NG+L Q+
Sbjct: 50 AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109
Query: 240 L------------HGSLGEAKPL---TWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284
L + ++ A L ++ + + + A G+ YL VH ++ +
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLAT 166
Query: 285 SNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEE--LSGRTSIFNEKSDV 341
N L+ + KI+D G+++ L+ ++ + ++A E L G+ F SDV
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK---FTTASDV 223
Query: 342 YSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA------QQKIAYVLDPKLPEMPSRK 395
++FG+ + EI+ + QP L D A Q + Y+ P P P
Sbjct: 224 WAFGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRP--PPCP--- 274
Query: 396 ELKRIILIALRCVDPDIKHRPKMGDVLRML 425
+ + + L+C D + RP D+ L
Sbjct: 275 --QGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 48/199 (24%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 161 IASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGY 217
I G +G+V++A + A+K + + + +++A+ +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEA-KPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
G +LV EY+ + L L + +PL ++ KG+AY+H +
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFN 336
I+H ++K +N+L+ KI+D GLA+L E S ++ Y A EL ++
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 337 EKSDVYSFGILIMEIVSGR 355
D+++ G + E+++G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 58/265 (21%), Positives = 116/265 (43%), Gaps = 25/265 (9%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G +G VY A+ + A+K + ++E I ++ + + K+ N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
G +V EY+ G+L + + + + + + + L +LH + +++H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHSN---QVIH 138
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++KS NILL + K++D G PE S S + ++A E+ R + + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-YGPKV 196
Query: 340 DVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKR 399
D++S GI+ +E+V G P P + + + PE+ + + L
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP-------------LRALYLIATNGTPELQNPERLSA 243
Query: 400 IILIAL-RCVDPDIKHRPKMGDVLR 423
+ L RC++ D+ R ++L+
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 160 VIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
V+ G G RA+L+ D A ++ + S S ED ++ + ++KH N+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA- 62
Query: 215 FGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKP----LTWDTRMKIIQGTAKGLAYL 269
F E + +V EY D G+L Q + G+ P L W +M + G+ ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELS 329
HE +++H ++KS NI L + K+ D G A+L + +C + Y
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEI 171
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+N KSD++S G ++ E+ + + P
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 60/288 (20%)
Query: 160 VIASGDNGVVYRAVLLDNMRA-AVKLLM----SNSVSEEEDFIE-KVEAIGQVKHKNLVK 213
++ G G VY D R AVK + S S+E + +E +++ + + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 214 LFGYCVEGQNRIL--VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
+G + R L E++ G+++ L S G LT + K + +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYG---ALTENVTRKYTRQILEGVSYLHS 124
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA------ 325
++ IVH ++K +NIL D N K+ D G +K + T C L +G +
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASK------RLQTIC-LSGTGMKSVTGTPY 174
Query: 326 ----EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW--LKSMVAQQK 379
E +SG + K+D++S G ++E+++ + P W ++M A K
Sbjct: 175 WMSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPP------------WAEFEAMAAIFK 220
Query: 380 IA-YVLDPKLPEMPS---RKELKRIILIALRCVDPDIKHRPKMGDVLR 423
IA +P LP S R LKRI + + K RP ++LR
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV--------EAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 39/272 (14%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G +G VY A+ + A+K + ++E I ++ + + KH N+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA------KGLAYLHEDI 273
G +V EY+ G+L + +T M Q A + L +LH +
Sbjct: 87 VGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEFLHSN- 134
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS 333
+++H ++KS NILL + K++D G PE S ++ + ++A E+ R +
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKA 191
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK-LPEMP 392
+ K D++S GI+ +E+V G P P L+++ Y++ PE+
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRAL-------YLIATNGTPELQ 236
Query: 393 SRKELKRIILIAL-RCVDPDIKHRPKMGDVLR 423
+ ++L I L RC++ D++ R ++L+
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 155 FAEQNVIASGDNGVVY--RAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKN 210
F + I G G VY R V + + A K+ S S E +D I++V+ + ++KH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
++ G + LV EY G+ L KPL I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH 142
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE--L 328
++H ++K+ NILL K++D G A + P S + ++A E L
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVIL 194
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358
+ ++ K DV+S GI +E+ + P+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 43/172 (25%), Positives = 85/172 (49%), Gaps = 17/172 (9%)
Query: 186 MSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLG 245
MS E E+ ++V + +KH N+V+ E N +V +Y + G+L + ++ G
Sbjct: 38 MSPK--EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG 95
Query: 246 ----EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301
E + L W ++ + L ++H+ KI+H ++KS NI L K+ D G
Sbjct: 96 VLFPEDQILDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG 146
Query: 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
+A++ ++ +C + YL+ E+ +N KSD+++ G ++ E+ +
Sbjct: 147 IARVLNSTVELARTC-IGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 67/241 (27%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVE 201
+ L+ + TD + I G G VY+ D AAVK+L + +S+ ++ IE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEAEY 69
Query: 202 AIGQV--KHKNLVKLFG------YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
I Q H N+VK +G V GQ LV E + G++ + + G L + L
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL-AKLHGPEWSI 312
I+ G GL +LH + +I+H ++K +NILL K+ D G+ A+L
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL------- 178
Query: 313 STSCELRNSG------YLAEEL----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
TS LR + ++A E+ ++ + DV+S GI +E+ G P+
Sbjct: 179 -TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 363 P 363
P
Sbjct: 238 P 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 62/271 (22%), Positives = 118/271 (43%), Gaps = 42/271 (15%)
Query: 176 DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234
+ AVK+L ++ + DF+++++ + ++K N+++L C+ ++ EY++NG
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 235 NLQQWL-------HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNI 287
+L Q+L + +++ T + + A G+ YL VH ++ + N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161
Query: 288 LLDHHWNPKISDVGLAK--LHGPEWSISTSCELRNSGYLAEE-LSGRTSIFNEKSDVYSF 344
L+ ++ KI+D G+++ G + I L E L G+ F SDV++F
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK---FTTASDVWAF 218
Query: 345 GILIMEIVSGRLPVDYSQ---PQV------FLIDWLKSMVAQQKIAYVLDPKL-PEMPSR 394
G+ + EI++ YSQ QV F D Q + Y+ P L P+ +
Sbjct: 219 GVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRD-------QGRQVYLPKPALCPDSLYK 271
Query: 395 KELKRIILIALRCVDPDIKHRPKMGDVLRML 425
+ L C + K RP ++ L
Sbjct: 272 --------LMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 155 FAEQNVIASGDNGVVY--RAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKN 210
F++ I G G VY R V + A K+ S S E +D I++V + +++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEA--------KPLTWDTRMKIIQGT 262
++ G + LV EY LG A KPL + G
Sbjct: 77 TIQYRGCYLREHTAWLVMEY------------CLGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
+GLAYLH ++H ++K+ NILL K+ D G A + P +
Sbjct: 125 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPY 176
Query: 323 YLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358
++A E L+ ++ K DV+S GI +E+ + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G G+V A R AVK + E +V + +H N+V+++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 220 EGQNRILVYEYIDNGNLQQWL-HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
G +V E+++ G L + H + E + T + K L++LH ++
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLHAQ---GVI 137
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSGRTS 333
H ++KS +ILL K+SD G +S R S ++A E+ R
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAPEVISR-L 190
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
+ + D++S GI+++E+V G P P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 46/190 (24%), Positives = 92/190 (48%), Gaps = 23/190 (12%)
Query: 181 AVKLLMS-NSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQW 239
A+K L N+ + +F ++ + ++ H N+V L G + Q +++EY++ G+L ++
Sbjct: 38 AIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEF 97
Query: 240 L-----HGSLGEAKPLTWDTRMKIIQG--------TAKGLAYLHEDIEPKIVHHNMKSSN 286
L H +G + + + G A G+ YL VH ++ + N
Sbjct: 98 LIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARN 154
Query: 287 ILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEE--LSGRTSIFNEKSDVYS 343
IL+ + KISD+GL++ ++ ++ L ++ E + G+ F+ SD++S
Sbjct: 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK---FSSDSDIWS 211
Query: 344 FGILIMEIVS 353
FG+++ EI S
Sbjct: 212 FGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 47/165 (28%), Positives = 91/165 (55%), Gaps = 18/165 (10%)
Query: 197 IEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDT 254
I ++ + ++KH+N+V+L +LV+EY+D +L++++ HG G P T +
Sbjct: 46 IREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKS 104
Query: 255 RMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG-PEWSIS 313
KG+A+ HE+ +++H ++K N+L++ K++D GLA+ G P ++
Sbjct: 105 FT---YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VN 155
Query: 314 T-SCELRNSGYLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGR 355
T S E+ Y A + L RT ++ D++S G ++ E+++GR
Sbjct: 156 TFSNEVVTLWYRAPDVLLGSRT--YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 62/250 (24%), Positives = 115/250 (46%), Gaps = 37/250 (14%)
Query: 183 KLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFGYCVEGQNRIL--VYEYIDNGNLQQW 239
KL + N+ E E+ + + Q+KH N+V + EG++ +L V + + G+L
Sbjct: 32 KLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHK 90
Query: 240 LHGSLGEAKP----LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L G+ P + W ++ A L YLHE I+H ++K+ N+ L
Sbjct: 91 LKEQKGKLLPENQVVEWFVQI------AMALQYLHEK---HILHRDLKTQNVFLTRTNII 141
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
K+ D+G+A++ + ++++ + Y++ EL +N KSDV++ G + E+ + +
Sbjct: 142 KVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLK 199
Query: 356 LPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIK 413
F + S+V + +++ KLP MP EL +I L P+
Sbjct: 200 --------HAFNAKDMNSLVYR-----IIEGKLPPMPKDYSPELGELIATML-SKRPE-- 243
Query: 414 HRPKMGDVLR 423
RP + +LR
Sbjct: 244 KRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 29/190 (15%)
Query: 179 RAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL- 236
R VK L +N S E+ +F+++ + ++H N+++ G CVE +LV+EY + G+L
Sbjct: 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLK 83
Query: 237 -----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291
+QW + + L RM A G+ ++H+ +H ++ N L
Sbjct: 84 SYLSQEQWHRRN-SQLLLL---QRMAC--EIAAGVTHMHKH---NFLHSDLALRNCFLTS 134
Query: 292 HWNPKISDVGLAKLHGPEWSISTS----CELRNSGYLAEELSGR------TSIFNEKSDV 341
K+ D G+ E I T LR +LA EL G T+ + S+V
Sbjct: 135 DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---WLAPELVGEFHGGLITAEQTKPSNV 191
Query: 342 YSFGILIMEI 351
++ G+ + E+
Sbjct: 192 WALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 72/283 (25%), Positives = 115/283 (40%), Gaps = 47/283 (16%)
Query: 155 FAEQNVIASGDNGVVYRAV--LLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKN 210
F + I G G VY A + + A K+ S + E +D I++V+ + Q+KH N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEA--------KPLTWDTRMKIIQGT 262
++ G ++ LV EY LG A KPL I G
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY------------CLGSASDLLEVHKKPLQEVEIAAITHGA 130
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
+GLAYLH ++H ++K+ NILL K++D G A P S +
Sbjct: 131 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPY 182
Query: 323 YLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380
++A E L+ ++ K DV+S GI +E+ +P +F ++ +M A I
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-------RKPPLFNMN---AMSALYHI 232
Query: 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
A P L + + C+ + RP ++LR
Sbjct: 233 AQNDSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 33/257 (12%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G G+V A + + + AVK + E +V + +H+N+V+++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 220 EGQNRILVYEYIDNGNLQQWL-HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
G +V E+++ G L + H + E + + K L+ LH ++
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHAQ---GVI 138
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSGRTS 333
H ++KS +ILL H K+SD G +S R S ++A EL R
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
+ + D++S GI+++E+V G P +++P LK+M + I L PKL +
Sbjct: 193 -YGPEVDIWSLGIMVIEMVDGEPPY-FNEPP------LKAM---KMIRDNLPPKLKNLHK 241
Query: 394 RKELKRIILIALRCVDP 410
+ L L DP
Sbjct: 242 VSPSLKGFLDRLLVRDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 154 GFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
GF E D G +Y LD R +K+ +++ E + + + G +
Sbjct: 6 GFGEVYGCRKADTGKMYAMKCLDKKR--IKMKQGETLALNERIMLSLVSTGDCP---FIV 60
Query: 214 LFGYCVEGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
Y +++ + + ++ G+L L HG E + + T + + GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA---KLHGPEWSISTSCELRNSGYLAEE 327
+V+ ++K +NILLD H + +ISD+GLA P S+ T GY+A E
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT------HGYMAPE 165
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ + + ++ +D +S G ++ +++ G P
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 42/281 (14%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-----KHKNLVKL 214
I G G V++ + + +AAVK+L D E++EA + H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-----DPIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 215 FGY-----CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
+G G LV E + G++ + G L + + I+ GL +L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL-AKLHGPEWSISTSCELRNSGYLAEEL 328
H + K +H ++K +NILL K+ D G+ A+L +TS + ++A E+
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEV 195
Query: 329 ----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384
S ++ + DV+S GI +E+ G P+ P M A KI
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----------MRALFKIPRNP 245
Query: 385 DPKL--PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
P L PE+ S E I +C+ D + RP + D+L+
Sbjct: 246 PPTLHQPELWS-NEFNDFI---RKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 65/277 (23%), Positives = 128/277 (46%), Gaps = 42/277 (15%)
Query: 160 VIASGDNGVVYRAVLL---DNMR--AAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVK 213
V+ SG G VY+ + + +N++ A+K+L N S ++ +++ + V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLH---GSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L G C+ + LV + + G L ++ +G L W ++ AKG++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
E ++VH ++ + N+L+ + KI+D GLA+L I + + G + +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARL----LDIDETEYHADGGKVPIKWMA 179
Query: 331 RTSI----FNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
SI F +SDV+S+G+ + E+++ G P D P + D L+
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIPDLLEK-----------G 227
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
+LP+ P + +I ++C D + RP+ +++
Sbjct: 228 ERLPQPPICT--IDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 14/179 (7%)
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
++ H LV L+ + +N LV + + G+L+ H L + + + I
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR--YH--LSQKVKFSEEQVKFWICEIVL 111
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSGY 323
L YLH I+H ++K NILLD + I+D +A K+ + STS GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP---GY 165
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382
+A E+ ++ D +S G+ E + G+ P + D +++ + Y
Sbjct: 166 MAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETADVLY 221
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 32/162 (19%)
Query: 161 IASGDNGVVYRA--VLLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKL 214
I G G V++A + A K+LM N E+E F + +++ + +KH+N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVNL 76
Query: 215 FGYC---VEGQNR-----ILVYEYIDN---GNLQQ-WLHGSLGEAKPLTWDTRMKIIQGT 262
C NR LV+E+ ++ G L + +L E K K+++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--------KVMKML 128
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304
GL Y+H + KI+H +MK++NIL+ K++D GLA+
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 36/171 (21%)
Query: 155 FAEQNVIASGDNGVVYRA-------------VLLDNMRAAVKLLMSNSVSEEEDFIEKVE 201
F + N I G G+VYRA V +DN R + + +S+ E +
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPI---SSLRE-------IT 58
Query: 202 AIGQVKHKNLVKLFGYCVEGQ--NRILVYEYIDNGNLQQWLHGSLGEAKPLTW-DTRMK- 257
+ ++H N+V+L V + LV EY + Q L SL + P + ++++K
Sbjct: 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-----QDL-ASLLDNMPTPFSESQVKC 112
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308
++ +GL YLHE+ I+H ++K SN+LL KI+D GLA+ +G
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 51/211 (24%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 153 DGFAEQNVIASGDNGVV----YRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH 208
D F + + +G+ GVV ++ L R + L + ++ + I +++ + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNS 62
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
+V +G + E++D G+L Q L EAK + + K+ +GLAY
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIAVLRGLAY 118
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-EE 327
L E + +I+H ++K SNIL++ K+ D G++ G + + Y++ E
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPER 173
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358
L G + ++ +SD++S G+ ++E+ GR P+
Sbjct: 174 LQG--THYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 45/199 (22%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDF--IEKVEAIGQVKHKNLVKLFG 216
V+ G G+V+ D +K + ++++E + + + + H N+++ +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+E + ++V EY G L +++ I+ + L LH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD-----EDTILHFFVQILLALHHVHTKL 121
Query: 277 IVHHNMKSSNILLDHHWNP-KISDVGLAKLHGPEWSISTSCELRNSGYLAEEL-SGRTSI 334
I+H ++K+ NILLD H KI D G++K+ + T Y++ EL G+
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPC--YISPELCEGKP-- 177
Query: 335 FNEKSDVYSFGILIMEIVS 353
+N+KSD+++ G ++ E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 71/295 (24%), Positives = 137/295 (46%), Gaps = 56/295 (18%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL---DNMR--AAVKLLM-SNSVSEEE 194
+RI LKE + F + V+ SG G VY+ + + + ++ A+K L + S +
Sbjct: 1 LRI-LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 54
Query: 195 DFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLH---GSLGEAKPLT 251
+ +++ + V + ++ +L G C+ + L+ + + G L ++ ++G L
Sbjct: 55 EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 113
Query: 252 WDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311
W ++ AKG+ YL E ++VH ++ + N+L+ + KI+D GLAKL G +
Sbjct: 114 WCVQI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164
Query: 312 ISTSCELRNSG------YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364
E G ++A E S I+ +SDV+S+G+ + E+++ G P D
Sbjct: 165 -----EYHAEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD----- 213
Query: 365 VFLIDWLKSMVAQQKIAYVLD--PKLPEMPSRKELKRIILIALRCVDPDIKHRPK 417
+ +I+ +L+ +LP+ P + +I ++C D RPK
Sbjct: 214 ---------GIPASEISSILEKGERLPQPPICT--IDVYMIMVKCWMIDADSRPK 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFI---EKVEAIGQVKHKNLVKLFG 216
I SG G VY+A ++ AA+K++ + EDF +++ + KH N+V FG
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ + E+ G+LQ H + PL+ + + T +GL YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSG- 330
+H ++K +NILL + + K++D G++ I+ + R S ++A E++
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 331 -RTSIFNEKSDVYSFGILIMEIVSGRLPV 358
R +N+ D+++ GI +E+ + P+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 41/165 (24%)
Query: 167 GVVYRAVLLDNMR--AAVKLLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLFGYCVE 220
G VY+A + R A K+LM N E++ F + +++ + ++KH N+V L VE
Sbjct: 22 GEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVPLIDMAVE 78
Query: 221 GQNRI--------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK-------- 264
++ +V Y+D+ L G L + +K+ + K
Sbjct: 79 RPDKSKRKRGSVYMVTPYMDHD-----LSGLLE-------NPSVKLTESQIKCYMLQLLE 126
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL-HGP 308
G+ YLHE+ I+H ++K++NIL+D+ KI+D GLA+ GP
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 48/199 (24%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 173 VLLDNMRA-----AVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKLFGYCVEGQN 223
V+L + A+K+L + V +++D +EK Q K L +L C + +
Sbjct: 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHS-CFQTVD 74
Query: 224 RI-LVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
R+ V EY++ G+L + G E + + + + + GL +LH I++
Sbjct: 75 RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHRR---GIIYR 125
Query: 281 NMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSD 340
++K N++LD + KI+D G+ K H + ++T Y+A E+ + + D
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFCGTPDYIAPEIIAYQP-YGKSVD 183
Query: 341 VYSFGILIMEIVSGRLPVD 359
+++G+L+ E+++G+ P D
Sbjct: 184 WWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
GL +LH+ +IV+ ++K N+LLD H N +ISD+GLA + GY+
Sbjct: 107 GLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGK-KIKGRAGTPGYM 161
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
A E+ + +++ D ++ G + E+++GR P
Sbjct: 162 APEVL-QGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 34/169 (20%)
Query: 206 VKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTA 263
++H LV L+G + N LV EY+ G L L G E A
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE--------------PVA 103
Query: 264 K--------GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSIST 314
+ L YLH IV+ ++K N+LLD KI+D G AK + G +++
Sbjct: 104 RFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160
Query: 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
+ E YLA E+ + + + D ++ GILI E+++G P P
Sbjct: 161 TPE-----YLAPEII-LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
GL LH++ +IV+ ++K NILLD H + +ISD+GLA +H PE + + GY+
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQ-TIKGRVGTVGYM 168
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
A E+ + + D ++ G L+ E+++G+ P
Sbjct: 169 APEVV-KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 57/258 (22%), Positives = 117/258 (45%), Gaps = 37/258 (14%)
Query: 191 SEEEDFIEK-----VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN---GNLQQWLHG 242
SE++ ++K + + Q++H+NLV L + LV+E++D+ +L+++ +G
Sbjct: 37 SEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG 96
Query: 243 SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302
L K + +G+ + H I+H ++K NIL+ K+ D G
Sbjct: 97 -------LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146
Query: 303 AK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR--LPVD 359
A+ L P + R Y A EL + + D+++ G L+ E+++G P D
Sbjct: 147 ARTLAAPGEVYTDYVATR--WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
Query: 360 YSQPQVF-LIDWLKSMVAQQKIAYVLDP-----KLPEMPSRKELKR--------IILIAL 405
Q++ +I L +++ + + + +P +LPE+ + L++ ++ +A
Sbjct: 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK 264
Query: 406 RCVDPDIKHRPKMGDVLR 423
+C+ D RP +L
Sbjct: 265 QCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 161 IASGDNGVVYRA--------VLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLV 212
I G GVVY+A V L +R L + + I ++ + ++ H N+V
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 213 KLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
KL + +N++ LV+E++ + +L++++ S PL + +GLA+ H
Sbjct: 63 KLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLP--LIKSYLFQLLQGLAFCHS 118
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR 331
+++H ++K N+L++ K++D GLA+ G T E+ Y A E+
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTLWYRAPEILLG 174
Query: 332 TSIFNEKSDVYSFGILIMEIVSGR--LPVDYSQPQVFLI 368
++ D++S G + E+V+ R P D Q+F I
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 21/187 (11%)
Query: 181 AVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGN 235
AVK+L + + +++D EK KH L +L C + ++R+ V EY++ G+
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS-CFQTKDRLFFVMEYVNGGD 82
Query: 236 LQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293
L + G E + + + + GL +LHE I++ ++K N+LLD
Sbjct: 83 LMFHIQRSGRFDEPRARFYAAEIVL------GLQFLHER---GIIYRDLKLDNVLLDSEG 133
Query: 294 NPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV 352
+ KI+D G+ K + ST C + Y+A E+ + D ++ G+L+ E++
Sbjct: 134 HIKIADFGMCKEGILGGVTTSTFCGTPD--YIAPEILSYQP-YGPAVDWWALGVLLYEML 190
Query: 353 SGRLPVD 359
+G+ P +
Sbjct: 191 AGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 27/250 (10%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G G+V A + R AVK++ E +V + +H+N+V+++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
G+ ++ E++ G L + L + + + + L YLH ++H
Sbjct: 89 VGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSGRTSI 334
++KS +ILL K+SD G IS R S ++A E+ RT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCA------QISKDVPKRKSLVGTPYWMAPEVISRT-P 193
Query: 335 FNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK-----SMVAQQKIAYVLDPKLP 389
+ + D++S GI+++E+V G P +S V + L+ + KI+ VL L
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPY-FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252
Query: 390 EMPSRKELKR 399
M +R+ +R
Sbjct: 253 RMLTREPQER 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (124), Expect = 4e-07
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 17/107 (15%)
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHG-----SLGEAKPLTWDTRMKIIQG 261
KH N+VKL + LV+EY D +L+++L S K + + ++++G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMY----QLLRG 110
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308
LAY H +I+H ++K NIL++ K++D GLA+ G
Sbjct: 111 ----LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGI 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 170 YRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229
Y A+ + + ++L V E+ + +V H +++LF + + ++ E
Sbjct: 28 YYALKVMAIPEVIRLKQEQHVHNEK------RVLKEVSHPFIIRLFWTEHDQRFLYMLME 81
Query: 230 YIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNI 287
Y+ G L +L G + L + + +I+ L YLH +IV+ ++K NI
Sbjct: 82 YVPGGELFSYLRNSGRFSNSTGLFYAS--EIVCA----LEYLHSK---EIVYRDLKPENI 132
Query: 288 LLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGI 346
LLD + K++D G AK L W++ + E YLA E+ N+ D ++ GI
Sbjct: 133 LLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE-----YLAPEVIQSKG-HNKAVDWWALGI 186
Query: 347 LIMEIVSGRLP 357
LI E++ G P
Sbjct: 187 LIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 65/289 (22%), Positives = 134/289 (46%), Gaps = 46/289 (15%)
Query: 160 VIASGDNGVVYRAVL-LDN---MRAAVKLLMS--NSVSEEEDFIEKVEAIGQVKHKNLVK 213
++ G+ G V A L ++ + AVK+L + S S+ E+F+ + + + H N++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 214 LFGYCVEGQNR------ILVYEYIDNGNLQQWLHGS-LGEAKPLTW--DTRMKIIQGTAK 264
L G + + + +++ ++ +G+L +L S +GE +P T T ++ + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFMIDIAS 124
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSGY 323
G+ YL +H ++ + N +L+ + ++D GL+ K++ ++ +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP---VDYSQPQVFLI--DWLKSMVAQ 377
LA E S +++ SDV++FG+ + EI++ G+ P V+ S+ +LI + LK
Sbjct: 182 LALE-SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK----- 235
Query: 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ P+ + + +C P+ K RP + LE
Sbjct: 236 ---------QPPDCLE-----DVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 49/159 (30%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKII 259
E +H LV LF C + ++ + V EY G+L +H + + ++
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL 112
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCEL 318
GL YLHE+ KIV+ ++K N+LLD KI+D GL K G ST C
Sbjct: 113 -----GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCG- 163
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+LA E+ TS + D + G+LI E++ G P
Sbjct: 164 -TPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQVK---HKNLVK 213
I G G V++A L N V L + EE I +V + ++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 214 LFGYC-VEGQNR----ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
LF C V +R LV+E++D +L +L P +T ++ +GL +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLLRGLDF 125
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH----------------GPE--- 309
LH ++VH ++K NIL+ K++D GLA+++ PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182
Query: 310 -WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
S +T +L + G + E+ R +F SDV G I++++ D+ +
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGEEDWPR 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 49/202 (24%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 161 IASGDNGVVY--RAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
+ G V+ R+ L +N+ A ++ + + I +V + +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 219 VEGQNRILVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
++ LV+EY+D +L+Q++ G++ + ++ + Q +GLAY H K
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH----NVKIFLYQ-ILRGLAYCHRR---K 124
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST---SCELRNSGYLAEELSGRTS 333
++H ++K N+L++ K++D GLA+ S+ T S E+ Y ++ +S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAK----SVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 334 IFNEKSDVYSFGILIMEIVSGR 355
++ + D++ G + E+ SGR
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLM---SNSVSEEEDFIEKVEAIGQV 206
+T+ + + + G G+V A L A+K +M S V + + E ++ + +
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHL 66
Query: 207 KHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
+H+N++ L + I V E + LH L ++PL + +G
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTD-----LH-RLLTSRPLEKQFIQYFLYQILRG 120
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L Y+H +VH ++K SNIL++ + + KI D GLA++ P+ + S Y A
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----YRA 173
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
E+ ++ + D++S G + E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 182 VKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL 240
VK L + SV E+ F+E+ + ++H NL++ G C E +LV E+ G+L+ +L
Sbjct: 27 VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL 86
Query: 241 HGSLGEAKPLTWDTRM--KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKIS 298
S +A+ +T D ++ A GL +LH++ +H ++ N LL KI
Sbjct: 87 R-SCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIG 142
Query: 299 DVGLAKLHGPEWSISTSCELRN-----SGYLAEELSGRTSIFNE--KSDVYSFGILIMEI 351
D GL+ E T +L + L +E+ G + ++ +S+V+S G+ I E+
Sbjct: 143 DYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 37/204 (18%)
Query: 181 AVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR--ILVYEYIDNGNLQ 237
AVK L S D +++E + + H+N+VK G C E L+ E++ +G+L+
Sbjct: 37 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 96
Query: 238 QWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297
++L + + + ++K KG+ YL + VH ++ + N+L++ KI
Sbjct: 97 EYLPRNKNK---INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKI 150
Query: 298 SDVGLAK--------------LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYS 343
D GL K L P + + C +++ Y+A SDV+S
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-------------SDVWS 197
Query: 344 FGILIMEIVSGRLPVDYSQPQVFL 367
FG+ + E+++ + S +FL
Sbjct: 198 FGVTLYELLT-YCDSESSPMTLFL 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 63/282 (22%), Positives = 123/282 (43%), Gaps = 44/282 (15%)
Query: 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH-KNLVKLFGYC 218
V+ +G G VY+ + + A +M + EEE+ ++ + + H +N+ +G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 219 VE----GQNR--ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
++ G + LV E+ G++ + + G A L D I + +GLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA--LKEDWIAYICREILRGLAHLHAH 140
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEE 327
K++H ++K N+LL + K+ D G++ + + RN+ ++A E
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRNTFIGTPYWMAPE 191
Query: 328 L----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLIDWLKSMVAQQKIA 381
+ + ++ +SD++S GI +E+ G P+ P +FLI
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------------ 239
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+P P++ S+K K+ I C+ + RP +L+
Sbjct: 240 --RNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 161 IASGDNGVVY--RAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
+ G VY R+ L DN+ A ++ + + I +V + +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
++ LV+EY+D +L+Q+L G + + + ++ + Q +GL Y H K++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLD-DCGNSINMH-NVKLFLFQ-LLRGLNYCHRR---KVL 126
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST---SCELRNSGYLAEELSGRTSIF 335
H ++K N+L++ K++D GLA+ SI T S E+ Y ++ ++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAK----SIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 336 NEKSDVYSFGILIMEIVSGR 355
+ + D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 161 IASGDNGVVYRAVLLDN-MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG-YC 218
+ G G VY+A + AA K++ + S E ED++ ++E + H +VKL G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+G+ I++ E+ G + + L + LT I + + L YLH KI+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLH---SMKII 132
Query: 279 HHNMKSSNILLDHHWNPKISDVGLA-----KLHGPEWSISTSCELRNSGYLAEELSGRTS 333
H ++K+ N+LL + K++D G++ L + I T + + E + + +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM--KDT 190
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373
++ K+D++S GI ++E+ P P L+ KS
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 230
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 170 YRAVLLDNMRA-----AVKLLMSNSVSEEEDFIEKVEAIGQV-----KHKNLVKLFGYCV 219
Y VLL ++ A+K++ V+++ED I+ V+ V H LV L C
Sbjct: 8 YAKVLLVRLKKTERIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVGLHS-CF 65
Query: 220 EGQNRIL-VYEYIDNGNLQQWLHGS--LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ ++R+ V EY++ G+L + L E + + + L YLHE
Sbjct: 66 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER---G 116
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFN 336
I++ ++K N+LLD + K++D G+ K G +TS Y+A E+ R +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYG 174
Query: 337 EKSDVYSFGILIMEIVSGRLPVDY----SQPQVFLIDWLKSMVAQQKI 380
D ++ G+L+ E+++GR P D P D+L ++ +++I
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 38/248 (15%)
Query: 192 EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL--VYEYIDNGNLQQWLHGSLGEAKP 249
E+ + +V + ++KHKN+V+ + N+ L + E+ D G+L + +
Sbjct: 55 EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 250 LTWDTRMKIIQGTAKGLAYLHEDIE----PKIVHHNMKSSNILLD-------------HH 292
+ + I + LAY H + +++H ++K NI L ++
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 293 WN----PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILI 348
N KI D GL+K G E S++ SC + E L T +++KSD+++ G +I
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 349 MEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCV 408
E+ SG+ P + LI LK + P++P + + K + ++ +
Sbjct: 234 YELCSGKTPFHKANNFSQLISELK--------------RGPDLPIKGKSKELNILIKNLL 279
Query: 409 DPDIKHRP 416
+ K RP
Sbjct: 280 NLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 153 DGFAEQNVIASGDNGVVY----RAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH 208
D F + + + +G+ GVV+ + L R + L + ++ + I +++ + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNS 62
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
+V +G + E++D G+L Q L +A + K+ KGL Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPEQILGKVSIAVIKGLTY 118
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-EE 327
L E + KI+H ++K SNIL++ K+ D G++ G + + Y++ E
Sbjct: 119 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPER 173
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358
L G + ++ +SD++S G+ ++E+ GR P+
Sbjct: 174 LQG--THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA---KLHGPEWSISTSCELRNS 321
GL ++H +V+ ++K +NILLD H + +ISD+GLA P S+ T
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT------H 159
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
GY+A E+ + ++ +D +S G ++ +++ G P
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 28/159 (17%)
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
+H N+VKL E V+EY++ GNL Q + + KP + II +GL
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLM--KDRKGKPFSESVIRSIIYQILQGL 112
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---- 322
A++H+ H ++K N+L+ KI+D GLA+ E+R+
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR------------EIRSRPPYTD 157
Query: 323 ------YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
Y A E+ R++ ++ D+++ G ++ E+ + R
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 30/175 (17%)
Query: 153 DGFAEQNVIASGDNGVVYRAV--LLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQV 206
D F I G G VY+A + A K+ + N E+E F I +++ + Q+
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQL 63
Query: 207 KHKNLVKLFGYCVEGQNRI----------LVYEYIDNGNLQQWLHGSLGEAKPLTW--DT 254
H+N+V L + Q+ + LV+EY+D+ L G L E+ + + D
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLL-ESGLVHFSEDH 117
Query: 255 RMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309
++ +GL Y H+ +H ++K SNILL++ K++D GLA+L+ E
Sbjct: 118 IKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 160 VIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKL 214
V+ G G V A L N A+K L + V E++D +E+ +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
F ++ V EY++ G+L + S + +II G L +LH+
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK-- 115
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEE-LSGRT 332
I++ ++K N+LLD + KI+D G+ K + E ST C + Y+A E L G+
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD--YIAPEILKGQK 172
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLP 357
+NE D +SFG+L+ E++ G+ P
Sbjct: 173 --YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 155 FAEQNVIASGDNGVVYRA--VLLDNMRAAVKLLMSN-------SVSEEEDFIEKVEAIGQ 205
+ E I G G VY+A + A K+ + S E ++++E+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE- 59
Query: 206 VKHKNLVKLFGYCVEGQNR-----ILVYEYIDNGNLQQWLHGSLGEAKP--LTWDTRMKI 258
H N+V+L C + LV+E++D Q L L + L +T +
Sbjct: 60 --HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDL 112
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316
++ +G+ +LH +IVH ++K NIL+ KI+D GLA+++ E ++ TS
Sbjct: 113 MRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-TSV 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 161 IASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEK-----VEAIGQVKHKNLVKL 214
I G GVV++ + + A+K + SE++ I+K + + Q+KH NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE---SEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKP--LTWDTRMKIIQGTAKGLAYLHED 272
+ LV+EY D+ L + E P + KII T + + + H+
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNEL------EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGR 331
+H ++K NIL+ K+ D G A+ L GP + R Y A EL
Sbjct: 120 ---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR--WYRAPELLVG 174
Query: 332 TSIFNEKSDVYSFGILIMEIVSG 354
+ + DV++ G + E+++G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 44/222 (19%), Positives = 83/222 (37%), Gaps = 47/222 (21%)
Query: 162 ASGDNGVV--YRAVLLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFGYC 218
D +V + + + A K+ + + E+ +++ + Q++H N++
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ +V + G+ + L E P I++ L Y+H +
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL--AIAFILKDVLNALDYIHSK---GFI 123
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---------------- 322
H ++K+S+IL +S G L G + S + G
Sbjct: 124 HRSVKASHIL--------LSGDGKVVLSG----LRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 323 --YLAEE-----LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+L+ E L G +NEKSD+YS GI E+ +G +P
Sbjct: 172 LPWLSPEVLQQNLQG----YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 170 YRAVLLDNMRA-----AVKLLMSNSVSEEED--FIEKVEAIGQVKHKN--LVKLFGYCVE 220
Y VLL ++ A+K++ V ++ED +++ + + + N LV L C +
Sbjct: 8 YAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHS-CFQ 66
Query: 221 GQNRI-LVYEYIDNGNLQQWLHGS--LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
+R+ LV EY++ G+L + L E + + I L +LHE I
Sbjct: 67 TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER---GI 117
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEELSGRTSIFN 336
++ ++K N+LLD + K++D G+ K GP + ST C N Y+A E+ R +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN--YIAPEIL-RGEEYG 174
Query: 337 EKSDVYSFGILIMEIVSGRLPVDY--SQPQVFLIDWLKSMVAQQKI 380
D ++ G+L+ E+++GR P D P + D+L ++ ++ I
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 41/238 (17%)
Query: 186 MSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLH--G 242
+ V E D + Q + +VKL+ Y +G+ + LV EY+ G+L L G
Sbjct: 36 QVDQVLTERDILS------QAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVG 88
Query: 243 SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302
SL E D I L YLH + I+H ++K NIL+D + + K++D GL
Sbjct: 89 SLDE------DVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGL 139
Query: 303 AKL-----HGPEWSISTSCE--LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
+K+ + + Y+A E+ ++ D +S G ++ E + G
Sbjct: 140 SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGI 198
Query: 356 LP-VDYSQPQVFL------IDWLK----SMVAQQKIAYVLDP---KLPEMPSRKELKR 399
P + ++F I+W + S A I+ +L P K S +E+K
Sbjct: 199 PPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 56/253 (22%), Positives = 107/253 (42%), Gaps = 25/253 (9%)
Query: 161 IASGDNGVVYRAVLLDN-MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I G G+V A + AVK + E +V + H+N+V ++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 220 EGQNRILVYEYIDNGNLQQWL-HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
G +V E+++ G L + H + E + T + + L+YLH ++
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQ---GVI 140
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY-LAEELSGRTSIFNE 337
H ++KS +ILL K+SD G E + L + Y +A E+ R +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLP-YGT 197
Query: 338 KSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKEL 397
+ D++S GI+++E++ G P +++P + A ++I L P++ + +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY-FNEP---------PLQAMRRIRDNLPPRVKDSHKVSSV 247
Query: 398 KRIILIALRCVDP 410
R L + +P
Sbjct: 248 LRGFLDLMLVREP 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 47/190 (24%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 171 RAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230
R+ L +N+ A ++ + + I +V + +KH N+V L + LV+EY
Sbjct: 25 RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84
Query: 231 IDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNIL 288
+D+ +L+Q+L G+L + ++ + Q +GL+Y H+ KI+H ++K N+L
Sbjct: 85 LDS-DLKQYLDNCGNLMSMH----NVKIFMFQ-LLRGLSYCHKR---KILHRDLKPQNLL 135
Query: 289 LDHHWNPKISDVGLAKLHGPEWSIST---SCELRNSGYLAEELSGRTSIFNEKSDVYSFG 345
++ K++D GLA+ S+ T S E+ Y ++ ++ ++ D++ G
Sbjct: 136 INEKGELKLADFGLARAK----SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191
Query: 346 ILIMEIVSGR 355
++ E+ +GR
Sbjct: 192 CILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 59/258 (22%)
Query: 187 SNSVSEEEDFIE-KVEAIGQVKHKNLVKLFGYCVEGQNRIL--VYEYIDNGNLQQWL--H 241
S S+E + +E +++ + ++H +V+ +G + + + L EY+ G+++ L +
Sbjct: 41 SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY 100
Query: 242 GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301
G+L E +T +I+QG ++YLH ++ IVH ++K +NIL D N K+ D G
Sbjct: 101 GALTEN--VTRRYTRQILQG----VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 151
Query: 302 LAKLHGPEWSISTSCELRNSGYLA----------EELSGRTSIFNEKSDVYSFGILIMEI 351
+K I T C + +G + E +SG + K+DV+S ++E+
Sbjct: 152 ASK------RIQTIC-MSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEM 202
Query: 352 VSGRLPVDYSQPQVFLIDW--LKSMVAQQKIA-YVLDPKLPEMPS---RKELKRIILIAL 405
++ + P W ++M A KIA P LP+ S R LK+I +
Sbjct: 203 LTEKPP------------WAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV--- 247
Query: 406 RCVDPDIKHRPKMGDVLR 423
+ K RP +LR
Sbjct: 248 -----EEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 49/227 (21%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH-KNLVKLFGYC 218
++ +G G VY+ + + A +M + EEE+ +++ + + H +N+ +G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 219 VEGQ------NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
++ LV E+ G++ + + G W I + +GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEE 327
K++H ++K N+LL + K+ D G++ + + RN+ ++A E
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRNTFIGTPYWMAPE 181
Query: 328 L----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ--VFLI 368
+ + ++ KSD++S GI +E+ G P+ P +FLI
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 21/187 (11%)
Query: 181 AVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGN 235
A+K+L + V +++D +EK K L +L C + +R+ V EY++ G+
Sbjct: 29 AIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGD 87
Query: 236 LQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293
L + G E + + + I GL +LH I++ ++K N++LD
Sbjct: 88 LMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSK---GIIYRDLKLDNVMLDSEG 138
Query: 294 NPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV 352
+ KI+D G+ K + W ++T Y+A E+ + + D ++FG+L+ E++
Sbjct: 139 HIKIADFGMCKEN--MWDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEML 195
Query: 353 SGRLPVD 359
+G+ P +
Sbjct: 196 AGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 9/104 (8%)
Query: 257 KIIQGTAK---GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313
++I +A+ G+ +LH IV+ +MK N+LLD N ++SD+GLA + + +
Sbjct: 96 RVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGK-T 150
Query: 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ +GY+A E+ + ++ D ++ G I E+V+GR P
Sbjct: 151 ITQRAGTNGYMAPEIL-KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 160 VIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKL 214
V+ G G V A L ++ R AVK+L + + +++D EK H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 215 FGYCVEGQNRIL-VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ C + +R+ V E+++ G+L + S + +I L +LH+
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA----LMFLHDK- 115
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS 333
I++ ++K N+LLDH + K++D G+ K G +TS Y+A E+ +
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEIL-QEM 171
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVD 359
++ D ++ G+L+ E++ G P +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 30/140 (21%)
Query: 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNIL 288
E++D G+L Q L +A + + KI +GL YL E KI+H ++K SNIL
Sbjct: 79 EHMDGGSLDQ----VLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNIL 132
Query: 289 LDHHWNPKISDVGLAKLHGPEWSISTSCELRNS---------GYLA-EELSGRTSIFNEK 338
++ K+ D G+ S +L +S Y++ E L G + + +
Sbjct: 133 VNSRGEIKLCDFGV------------SGQLIDSMANSFVGTRSYMSPERLQG--THYTVQ 178
Query: 339 SDVYSFGILIMEIVSGRLPV 358
SD++S G+ ++E+ GR P+
Sbjct: 179 SDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 198 EKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK 257
E+ + Q + + KL+ LV EY++ G+ L +LG L D +
Sbjct: 46 ERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLG---GLPEDWAKQ 101
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE 317
I G+ LH+ I+H ++K N+L+D + K++D GL++ + +
Sbjct: 102 YIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158
Query: 318 LRNSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP-QVF 366
YLA E + G ++ SD +S G +I E + G P P VF
Sbjct: 159 -----YLAPETILGVGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 40/265 (15%)
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
+Q LH + +PL+ D + +GL YLH I+H ++K N+L++ +
Sbjct: 86 MQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVL 142
Query: 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
KI D GLA++ P+ S + E+ Y A E+ + + D++S G + E++ R
Sbjct: 143 KICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
Query: 356 LPVDYSQP--QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIK 413
+ P Q+ LI + P L M S E R + LR
Sbjct: 203 ILFQAQSPIQQLDLI-----------TDLLGTPSLEAMRSACEGARAHI--LRG-----P 244
Query: 414 HRPKMGDVLRML------EPRDLLLR-----EEYRIKRA-ASYHNYPQKNKT---AVLCD 458
H+P VL L E LL R + RI A A H Y + + +C
Sbjct: 245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCK 304
Query: 459 ADISTHDEENRAHEPDHENPPWKKF 483
+T R + D E F
Sbjct: 305 CCYTT--SGGRVYTSDFEPSANPPF 327
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 161 IASGDNGVVYRA--------VLLDNMRAAV-KLLMSNSVSEEEDFIEKVEAIGQVKHKNL 211
I G G VY+A V L ++R + + S E ++++E H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE---AFDHPNI 64
Query: 212 VKLFGYCVEGQNR-----ILVYEYIDNGNLQQWLHGSLGEAKP--LTWDTRMKIIQGTAK 264
V+L C + LV+E++D Q L L + P L +T +++ +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306
GL +LH + IVH ++K NIL+ K++D GLA+++
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLF 215
I G GVVY+A L A+K + + E+E I ++ + ++ H N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET--EDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI---IQGTAKGLAYLHED 272
LV+E++D +L++++ ++ PLT I + +G+AY H
Sbjct: 65 DVVHSENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+++H ++K N+L+D K++D GLA+ G
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEED------FIEKVEAIGQVKHKNLVK 213
I G GVVY+A + N A+K + E+ED I ++ + +++H N+V+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL----EQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 214 LFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
L V + R+ LV+EY+D +L++ + S AK + + Q +G+AY H
Sbjct: 66 LQD-VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRL-IKTYLYQ-ILRGIAYCHSH 121
Query: 273 IEPKIVHHNMKSSNILLDHHWNP-KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR 331
+++H ++K N+L+D N K++D GLA+ G T E+ Y A E+
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH-EVVTLWYRAPEILLG 177
Query: 332 TSIFNEKSDVYSFGILIMEIVSGR--LPVDYSQPQVFLI 368
+ ++ D++S G + E+V+ + P D ++F I
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 160 VIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEEDFIEKVEAIGQV-----KHKNLVK 213
VI G V L R A+K++ V+++ED I+ V+ V H LV
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDED-IDWVQTEKHVFETASNHPFLVG 60
Query: 214 LFGYCVEGQNRI-LVYEYIDNGNLQQWLHGS--LGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L C + ++R+ V E++ G+L + L E + + + L +LH
Sbjct: 61 LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLH 113
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEELS 329
E I++ ++K N+LLD + K++D G+ K P + ST C N Y+A E+
Sbjct: 114 ER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN--YIAPEIL 168
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
R + D ++ G+L+ E+++GR P D
Sbjct: 169 -RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 33/129 (25%)
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG---------- 307
I+ G +GL YLH++ +H N+K+S+IL+ + +S GL+ L+
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 308 ----PEWSIST----SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-V 358
P++S S S EL L ++L G +N KSD+YS GI E+ +GR+P
Sbjct: 161 VYDFPQFSTSVLPWLSPEL-----LRQDLYG----YNVKSDIYSVGITACELATGRVPFQ 211
Query: 359 DYSQPQVFL 367
D + Q+ L
Sbjct: 212 DMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 19/110 (17%)
Query: 257 KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA------KLHGPEW 310
K+ K L YL E + ++H ++K SNILLD N K+ D G++ K
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171
Query: 311 SISTSCELRNSGYLAEE---LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ S C + Y+A E ++ ++DV+S GI ++E+ +G+ P
Sbjct: 172 TRSAGC----AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 226 LVYEYIDNGNLQQWLHGSLGEAKPLT-WDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284
LV +Y + G+L+Q + + + + IQ L +H ++H ++KS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV----LLAVHHVHSKHMIHRDIKS 171
Query: 285 SNILLDHHWNPKISDVGLAKLHGPEWSIS---TSCELRNSGYLAEELSGRTSIFNEKSDV 341
+NILL + K+ D G +K++ S T C Y+A E+ R +++K+D+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG--TPYYVAPEIWRRKP-YSKKADM 228
Query: 342 YSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRII 401
+S G+L+ E+++ + P D + V + +A DP LP S E++ I+
Sbjct: 229 FSLGVLLYELLTLKRPFDGENME---------EVMHKTLAGRYDP-LPPSIS-PEMQEIV 277
Query: 402 LIALRCVDPDIKHRPKMGDVLRM 424
AL DP K RP +L M
Sbjct: 278 -TALLSSDP--KRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 50/190 (26%), Positives = 94/190 (49%), Gaps = 27/190 (14%)
Query: 181 AVKLLMSNSVSEEED----FIEK-VEAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNG 234
A+K+L + + +++D +EK V A+ K L +L C + +R+ V EY++ G
Sbjct: 29 AIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLTQLHS-CFQTMDRLYFVMEYVNGG 86
Query: 235 NL----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290
+L QQ G E + + + I GL +LH I++ ++K N++LD
Sbjct: 87 DLMYHIQQV--GKFKEPHAVFYAAEIAI------GLFFLHSK---GIIYRDLKLDNVMLD 135
Query: 291 HHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIM 349
+ KI+D G+ K + + T C + Y+A E+ + + D ++FG+L+
Sbjct: 136 AEGHIKIADFGMCKENIFGGKTTRTFCGTPD--YIAPEIIAYQP-YGKSVDWWAFGVLLY 192
Query: 350 EIVSGRLPVD 359
E+++G+ P D
Sbjct: 193 EMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 52/229 (22%), Positives = 102/229 (44%), Gaps = 30/229 (13%)
Query: 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNS-VSEEEDFIEK 199
EI++ T F E+ + G VY+ L A+K L + E+F +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL-----HGSLGEA------- 247
+++H N+V L G + Q +++ Y + +L ++L H +G
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 248 KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LH 306
L + I+ A G+ +L +VH ++ + N+L+ N KISD+GL + ++
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 307 GPEWSISTSCELRNSGYLAEE--LSGRTSIFNEKSDVYSFGILIMEIVS 353
++ L +++ E + G+ SI SD++S+G+++ E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSI---DSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 17/169 (10%)
Query: 192 EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLH--GSLGEAKP 249
+E F EK E + + H +VKL+ + + ++ EY G L L G E
Sbjct: 37 QEHIFSEK-EILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--- 92
Query: 250 LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309
+ R I YLH I++ ++K N+LLD + K+ D G AK
Sbjct: 93 --YTARF-YIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146
Query: 310 WSISTSCELRNSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
T C Y+A E + + ++ D +S GIL+ E+++GR P
Sbjct: 147 QKTWTFCG--TPEYVAPEIILNKG--YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 14/97 (14%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
GL LH + +IV+ ++K NILLD + + +ISD+GLA + PE + + GY+
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE-TIRGRVGTVGYM 168
Query: 325 AEELSGRTSIFNEK----SDVYSFGILIMEIVSGRLP 357
A E+ + NE+ D + G LI E++ G+ P
Sbjct: 169 APEV-----VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 17/137 (12%)
Query: 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNIL 288
EY+D G+L + L+ + + D +I KGL +L E+ I+H ++K +N+L
Sbjct: 79 EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 289 LDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLA-EELSGRTS----IFNEKSD 340
++ + K+ D G++ ++ S N G Y+A E + + +SD
Sbjct: 136 VNGNGQVKLCDFGVSG------NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 341 VYSFGILIMEIVSGRLP 357
V+S G+ I+E+ GR P
Sbjct: 190 VWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 7/103 (6%)
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
++KHKN+V+L+ + LV+EY D +L+++ G+ P + M + K
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQL---LK 110
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
GLA+ H ++H ++K N+L++ + K++D GLA+ G
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 54/286 (18%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRA----AVKLLMSNSVSE---EEDFIEKVEA--IGQVKH 208
Q + G G VY L+ + +A +K+L V E E EA + ++ H
Sbjct: 5 QQRLGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNL----QQWLHG--SLGEAKPLTWDTRMKIIQGT 262
+VK +E ++ EY + +L ++ H +L E + W ++ +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL---- 117
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS- 321
G+ Y+H+ +I+H ++K+ NI L ++ KI D G+++L + SC+L +
Sbjct: 118 --GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL------LMGSCDLATTF 165
Query: 322 ----GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377
Y++ E ++ KSD++S G ++ E+ F S+V
Sbjct: 166 TGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMC--------CLAHAFEGQNFLSVVL- 215
Query: 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+I P LPE SR+ + I ++ D RP ++LR
Sbjct: 216 -RIVEGPTPSLPETYSRQ----LNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 167 GVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK------HKNLVKLFGYCV 219
VVY+A A+K + E +D I A+ ++K H N++ L
Sbjct: 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELKHPNIIGLLDVFG 72
Query: 220 EGQNRILVYEYIDNGNLQQWLHGS---LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
N LV+E+++ +L++ + L A D + ++ T +GL YLH +
Sbjct: 73 HKSNINLVFEFME-TDLEKVIKDKSIVLTPA-----DIKSYMLM-TLRGLEYLHSNW--- 122
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
I+H ++K +N+L+ K++D GLA+ G
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 13/99 (13%)
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--LHGPE--WSISTSCEL 318
A L +LH I++ ++K NILLD + K++D GL+K + + +S + E
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE- 163
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y+A E+ R + +D +SFG+L+ E+++G LP
Sbjct: 164 ----YMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 160 VIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFI--EKVEAIGQVKHKNLVKL 214
VI G G V A D AVK+L ++ +E++ I E+ + +KH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG-TAKGLAYLHEDI 273
+ V +Y++ G L L +P R + A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHS-- 114
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG--PEWSISTSCELRNSGYLAEELSGR 331
I++ ++K NILLD + ++D GL K G PE + ST C YLA E+ R
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCG--TPEYLAPEVL-R 169
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
++ D + G ++ E++ G LP YS+
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG-LPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 28/168 (16%)
Query: 153 DGFAEQNVIASGDNGVVYRAV--LLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQV 206
D + + N I G GVVYRA + A KL M E+E F + ++ + ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKL 61
Query: 207 KHKNLVKLFGYCV-EGQNRI-LVYEYIDNGNLQQWLHG-----SLGEAKPLTWDTRMKII 259
+H N+V + V ++I +V EY+++ +L+ + E K L +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL--------M 112
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
G+A+LH++ I+H ++K+SN+LL++ KI D GLA+ +G
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSN-SVSEEEDF 196
I+L I G G VY+ V + + AVK + S S E F
Sbjct: 7 DITLGRC------------IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF 54
Query: 197 IEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRM 256
+++ + Q H ++VKL G E +V E G L+ +L L + +
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ---VNKYSLDLASLI 110
Query: 257 KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTS 315
+ LAYL + VH ++ + N+L+ K+ D GL++ L + ++
Sbjct: 111 LYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK 167
Query: 316 CELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
+L E ++ R F SDV+ FG+ + EI+
Sbjct: 168 GKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 35/151 (23%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 206 VKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
V H +++++ V G +V + + +L +L ++PL D + I + +G
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEG 169
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL- 324
L YLH +I+H ++K+ NI ++ + V + L ++ + L +G +
Sbjct: 170 LRYLHAQ---RIIHRDVKTENIFIN-----DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 325 --AEELSGRTSIFNEKSDVYSFGILIMEIVS 353
A E+ R +N K+D++S GI++ E+++
Sbjct: 222 TNAPEVLARDK-YNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV--SEEEDFI--EKVEAIGQVKHKNLVKL 214
VI G G V A D AVK+L ++ +E+ I E+ + VKH LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 215 FGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG-TAKGLAYLHED 272
Y + +++ V +Y++ G L + H + P + R + A L YLH
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
I++ ++K NILLD + ++D GL K G E S +TS YLA E+ R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVL-RK 170
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
++ D + G ++ E++ G LP YS+
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG-LPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
GL LH + V+ ++K NILLD + + +ISD+GLA + PE S + GY+
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGE-SIRGRVGTVGYM 168
Query: 325 AEELSGRTSIFNEK----SDVYSFGILIMEIVSGRLP 357
A E+ + N++ D + G LI E++ G+ P
Sbjct: 169 APEV-----LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 160 VIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKL 214
++ G G V+ A L N A+K L + V ++D +EK +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ +N V EY++ G+L + P +II G L +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK-- 115
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAK--LHGPEWSISTSCELRNSGYLAEE-LSGR 331
IV+ ++K NILLD + KI+D G+ K + G + T C + Y+A E L G+
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPD--YIAPEILLGQ 171
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLP 357
+N D +SFG+L+ E++ G+ P
Sbjct: 172 K--YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L YLH +V+ ++K N++LD + KI+D GL K G + YLA
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
E+ + + D + G+++ E++ GRLP Y+Q
Sbjct: 164 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
GL +LH+ +I++ ++K N+LLD+ N +ISD+GLA + + T G++
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFM 164
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
A EL + ++ D ++ G+ + E+++ R P
Sbjct: 165 APELL-QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--LHGPEWSISTSCELRN 320
A+G+ +L K +H ++ + NILL + KI D GLA+ P++ L
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 321 SGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
E + + ++ +SDV+SFG+L+ EI S
Sbjct: 240 KWMAPESIFDK--VYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 45/197 (22%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDF--IEKVEAIGQVKHKNLVKLFGYC 218
+ G VY+ + N + ++S E F I + + +KH N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ V+EY+ +L Q++ G P ++ R+ + Q +GLAY+H I+
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRLFMFQ-LLRGLAYIHGQ---HIL 125
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEK 338
H ++K N+L+ + K++D GLA+ S + S E+ Y ++ + ++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 339 SDVYSFGILIMEIVSGR 355
D++ G + +E++ G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 207 KHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
+H L L Y + ++R+ V EY++ G L + H L + + D
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL--FFH--LSRERVFSEDRTRFYGAEIVSA 107
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L YLH KIV+ ++K N++LD + KI+D GL K G + + YLA
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLA 163
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
E+ + + D + G+++ E++ GRLP Y+Q
Sbjct: 164 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
GL L + +IV+ ++K NILLD + +ISD+GLA + PE + + GY+
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGE-TVRGRVGTVGYM 168
Query: 325 AEELSGRTSIFNEK----SDVYSFGILIMEIVSGRLP 357
A E+ I NEK D + G LI E++ G+ P
Sbjct: 169 APEV-----INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 25/190 (13%)
Query: 179 RAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ 238
+ K +M N + ++ + H +VK F +L+ EY G+L +
Sbjct: 95 KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK 154
Query: 239 WLHGSLGEAKPLTWDTRMKIIQGTAKGLAY------LHEDIEPKIVHHNMKSSNILLDHH 292
+ L E P Q GL + L E K++H ++KS+NI L
Sbjct: 155 QIKQRLKEHLPF---------QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 293 WNPKISDVGLAKLHGPEWSISTSCELRNS-----GYLAEELSGRTSIFNEKSDVYSFGIL 347
K+ D G +K ++S S S ++ +S YLA EL R +++K+D++S G++
Sbjct: 206 GIIKLGDFGFSK----QYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVI 260
Query: 348 IMEIVSGRLP 357
+ E+++ P
Sbjct: 261 LYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 160 VIASGDNGVVYRAVL-LDNMRAAVKLLMS----NSVSEEEDFIEKVEAIGQVKHKNLVKL 214
VI G G V A LD AVK+L N ++ E+ + VKH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 215 FGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI-IQGTAKGLAYLHED 272
Y + ++ V ++++ G L + H + P + R + A L YLH
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
IV+ ++K NILLD + ++D GL K G S +T+ YLA E+ R
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVI-RK 170
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
++ D + G ++ E++ G LP Y +
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG-LPPFYCR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 21/109 (19%)
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE--LRN 320
AKG+++L +H ++ + NILL H KI D GLA+ I ++
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR------DIRNDSNYVVKG 274
Query: 321 SGYLAEELSGRTSIFN----EKSDVYSFGILIMEIVS------GRLPVD 359
+ L + SIFN +SDV+S+GIL+ EI S +PVD
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 181 AVKLLMSNSV--SEEEDFI--EKVEAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGN 235
AVK+L ++ +EE I E+ + VKH LV L + + +++ V +YI+ G
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 82
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L L +P +I A L YLH IV+ ++K NILLD +
Sbjct: 83 LFYHLQRERCFLEPRARFYAAEI----ASALGYLHS---LNIVYRDLKPENILLDSQGHI 135
Query: 296 KISDVGLAKLH-GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG 354
++D GL K + + ST C YLA E+ + ++ D + G ++ E++ G
Sbjct: 136 VLTDFGLCKENIEHNGTTSTFCG--TPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYG 192
Query: 355 RLPVDYSQ 362
LP YS+
Sbjct: 193 -LPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 53/235 (22%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 178 MRAAVKLLMS--NSVSEEEDFIEKVEAIGQVKHKNLVKLF-----GYCVEGQNRILVYEY 230
+R AVK L S+ + ++ + +KH+N++ L +E N + + +
Sbjct: 43 LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102
Query: 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290
+ +L ++ + + LT D +I +GL Y+H I+H ++K SN+ ++
Sbjct: 103 LMGADLN-----NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 154
Query: 291 HHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIME 350
KI D GLA+ E + + Y A E+ +N+ D++S G ++ E
Sbjct: 155 EDCELKILDFGLARHTDDEMTGYVATRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAE 210
Query: 351 IVSGR--LPVDYSQPQVFLI---------DWLKSMVAQQKIAYVLDPKLPEMPSR 394
+++GR P Q+ LI + LK + ++ Y+ L +MP
Sbjct: 211 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI--QSLTQMPKM 263
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 29/158 (18%)
Query: 161 IASGDNGVVYRAVLLDNMRA-AVKLL---------MSNSVSEEEDFIEKVEAIGQVKHKN 210
I+ G G VY +N + AVK++ M + V E D A+ K
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERD------ALALSKSPF 65
Query: 211 LVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLA 267
+V L+ Y ++ N + LV EY+ G+++ LH G E + +K I A L
Sbjct: 66 IVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EMAVKYISEVALALD 118
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305
YLH I+H ++K N+L+ + + K++D GL+K+
Sbjct: 119 YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285
+VYE +D LH + ++ L+ D + +GL Y+H ++H ++K S
Sbjct: 86 IVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPS 137
Query: 286 NILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFG 345
N+LL+ + + KI D GLA+ + T + Y A EL S + DV+S G
Sbjct: 138 NLLLNANCDLKICDFGLARTTSEKGDFMTE-YVVTRWYRAPELLLNCSEYTTAIDVWSVG 196
Query: 346 ILIMEIVSGRLPV----DYSQPQVFLI 368
+ E++ GR P+ DY Q+ LI
Sbjct: 197 CIFAELL-GRKPLFPGKDYVH-QLKLI 221
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 33/165 (20%), Positives = 68/165 (41%), Gaps = 17/165 (10%)
Query: 154 GFAEQNVIASGDNGVVYRAVLLDNMRA---AVKLLMSNSVSEEEDF----IEKVEAIGQV 206
+ + I G G VY+A + A+K + ++ + ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIK-KFKGDKEQYTGISQSACREIALLREL 59
Query: 207 KHKNLVKLFGYCVEGQNRI--LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
KH+N+V L +E ++ L+++Y ++ Q + + ++
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLAKL 305
G+ YLH + ++H ++K +NIL+ KI D+GLA+L
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 45/200 (22%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLF 215
I G GVVY+ A+K + S EEE I ++ + +++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
++ L++E++ +L+++L SL + + + + + +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLD-SLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIF 335
+++H ++K N+L+D+ K++D GLA+ G + T E+ Y A E+ + +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-EVVTLWYRAPEVLLGSPRY 179
Query: 336 NEKSDVYSFGILIMEIVSGR 355
+ D++S G + E+ + +
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 7/108 (6%)
Query: 248 KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--L 305
K LT + + AKG+ +L K +H ++ + NILL + KI D GLA+
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
P++ L E + R ++ +SDV+SFG+L+ EI S
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 21/102 (20%)
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY 323
+GL Y+H ++H ++K SN+LL+ + + KI D GLA++ PE ++G+
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD--------HTGF 165
Query: 324 LAEELSGR---------TSIFNEKS-DVYSFGILIMEIVSGR 355
L E ++ R S K+ D++S G ++ E++S R
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 51/180 (28%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 249 PLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--LH 306
PLT + + A+G+ +L K +H ++ + NILL + KI D GLA+
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQV 365
P++ S L ++A E S ++ +SDV+SFG+L+ EI S G P Q
Sbjct: 227 DPDYVRKGSARLPLK-WMAPE-SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
Query: 366 FLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
LK + PE + E+ RI+ L C D K RP ++ +L
Sbjct: 285 EFCQRLKDGTRM---------RAPENAT-PEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 46/207 (22%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEE----DFIEKVEAIGQVK 207
D + + + G VY+ N + A+K++ + EEE I + + +K
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLK 61
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H N+V L + LV+EY+ + +L Q++ G P + + +GL+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHP---ENVKLFLFQLLRGLS 117
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
Y+H+ I+H ++K N+L+ K++D GLA+ S + S E+ Y +
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPD 173
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSG 354
+ ++ ++ D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 41/218 (18%)
Query: 179 RAAVKLLMSNSVSEEED---FIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL-VYEYIDNG 234
A+KLL +++ EE F + ++ H N+V L + V+EY+
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DH 291
L++ L L +++ LA H IVH ++K NI++
Sbjct: 65 TLRE----VLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 292 HWNPKISDVGLAKLHGP------EWSISTSCELRNS-GYLA-EELSGRTSIFNEKSDVYS 343
+ K+ D G+ L P +++ + E+ + Y A E+L G SD+Y+
Sbjct: 118 RPHAKVLDFGIGTL-LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV--TPNSDLYA 174
Query: 344 FGILIMEIVSGRL----------------PVDYSQPQV 365
+G++ +E ++G+ PVD S P
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPW 212
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLL---MSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
I SG G+V A + + AVK L N + + E V + V HKN++ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLN 87
Query: 217 YCV------EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK-IIQGTAKGLAYL 269
E Q+ LV E +D NL Q +H L RM ++ G+ +L
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIKHL 139
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELS 329
H I+H ++K SNI++ KI D GLA+ + ++ R Y A E+
Sbjct: 140 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY--YRAPEVI 194
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSG 354
+ E D++S G ++ E+V G
Sbjct: 195 LGMG-YKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 161 IASGDNGVV---YRAVLLDNMRAAVKLL---MSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
I SG G+V Y AVL N+ A+K L N + + E V + V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 81
Query: 215 FGYCV------EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK-IIQGTAKGLA 267
E Q+ LV E +D NL Q + L RM ++ G+
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDH-------ERMSYLLYQMLCGIK 133
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
+LH I+H ++K SNI++ KI D GLA+ G + ++ R Y A E
Sbjct: 134 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 188
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRL 356
+ + E D++S G ++ E+V ++
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQVKH 208
D + + I G G VY+A + + V L + +EE + ++ + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKL-VALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 209 KN-LVKLFGYCVE------GQNRI-LVYEYIDNGNLQQWLHGSL-GEAKPLTWDTRMKII 259
+V+L VE G+ + LV+EY+D+ +L++++ + G +PL T +
Sbjct: 60 SIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP-KISDVGLAKLHGPEWSI---STS 315
KG+A+ H+ ++H ++K N+L+D KI+D+GL G +SI S +
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL----GRAFSIPVKSYT 169
Query: 316 CELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG 354
E+ Y A E+ ++ ++ D++S G + E+
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 207 KHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
+H L L Y + +R+ V EY + G L + H L + T +
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSA 107
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYL 324
L YLH +V+ ++K N++LD + KI+D GL K ++ T C YL
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--TPEYL 162
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
A E+ + + D + G+++ E++ GRLP Y+Q
Sbjct: 163 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 207 KHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
+H L L Y + +R+ V EY + G L + H L + + D
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFSEDRARFYGAEIVSA 107
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L YLH E +V+ ++K N++LD + KI+D GL K G + + YLA
Sbjct: 108 LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLA 164
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
E+ + + D + G+++ E++ GRLP Y+Q
Sbjct: 165 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 11/96 (11%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--LHGPEWSISTSCELRNSG 322
GL +LH I++ ++K N++LD + KI+D G+ K + G + ST C +
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPD-- 161
Query: 323 YLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y+A E L G F+ D +SFG+L+ E++ G+ P
Sbjct: 162 YIAPEILQGLKYTFS--VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--LHGPEWSISTSCELRN 320
A+G+ +L VH ++ + N+LL KI D GLA+ +H + +S
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLP 302
Query: 321 SGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353
++A E S +++ SDV+S+GIL+ EI S
Sbjct: 303 VKWMAPE-SIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 161 IASGDNGVV---YRAVLLDNMRAAVKLL---MSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
I SG G+V Y A+L N+ A+K L N + + E V + V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGL 88
Query: 215 FGYCV------EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK-IIQGTAKGLA 267
E Q+ +V E +D NL Q + L RM ++ G+
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHE-------RMSYLLYQMLCGIK 140
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
+LH I+H ++K SNI++ KI D GLA+ G + ++ R Y A E
Sbjct: 141 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 195
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRL 356
+ + E D++S G ++ E++ G +
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 483 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.66 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.12 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.47 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.43 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.35 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.02 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.71 | |
| PLN02236 | 344 | choline kinase | 96.63 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.61 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.54 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.31 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 96.24 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.24 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.06 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.46 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.41 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.27 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.15 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.14 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.11 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.75 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.52 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=419.13 Aligned_cols=284 Identities=46% Similarity=0.801 Sum_probs=246.8
Q ss_pred cceeeehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEE
Q 046972 139 LGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218 (483)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 218 (483)
....|++.++..++++|...+.||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||||+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999999999999988766543145599999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEE
Q 046972 219 VEGQ-NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297 (483)
Q Consensus 219 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl 297 (483)
.+.+ +.+||+|||++|+|.++|+..... +++|..+++|+.++|+||+|||+.+.+.||||||||.|||||.++.+||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999864322 8999999999999999999999998888999999999999999999999
Q ss_pred eecccccccCC-CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC--chhhHHHHHHHH
Q 046972 298 SDVGLAKLHGP-EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ--PQVFLIDWLKSM 374 (483)
Q Consensus 298 ~DFGla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~--~~~~~~~~~~~~ 374 (483)
+|||+|+.... ........ .||.+|+|||++.. +..+.|+|||||||+|.||+||+.|.+... ....+.+|....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999976544 22211111 78999999999954 458999999999999999999999887653 344578888888
Q ss_pred HHhhhhhhhcCCCCC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 375 VAQQKIAYVLDPKLP-EMPSR-KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+.+..++|+.+. ..... .+...+..++.+|++.+|.+||+|.+++++|+
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 888899999999987 44443 67888999999999999999999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-53 Score=413.45 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=222.7
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+++..+.+.+.+.||+|.||.||+|.+++...||+|.+.... ...++|.+|+++|++|+|+|||+++|+|..+..++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 34445556667788999999999999999999999999998763 34578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
||||||+.|+|.+||+.. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+.
T Consensus 278 IVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999999999762 557788999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
...+.........-+..|.|||.+... .|+.|||||||||+||||+| |+.||.+....+.+... ..
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-----e~------- 419 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-----ER------- 419 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-----hc-------
Confidence 766665555555667789999999544 49999999999999999999 99999877764432211 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..++| .+..|+..+.++|..||+.+|++|||++.+...|+.
T Consensus 420 GyRlp--~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 420 GYRLP--RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred cCcCC--CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 13333 355688999999999999999999999988887754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-52 Score=406.84 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=215.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCC-eEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-NRILV 227 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv 227 (483)
..+.+...+.||.|+||+||+|.+++...||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. .+++|
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 334455567799999999999999877779999998764433 458999999999999999999999999887 79999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC-eeeecCCCCcEEEcCCC-CcEEeecccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK-IVHHNMKSSNILLDHHW-NPKISDVGLAKL 305 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-iiHrDlkp~NiLl~~~~-~~kl~DFGla~~ 305 (483)
|||+++|+|.+++++. ....+++..++.++.|||+||.|||++ + ||||||||+||||+.++ ++||||||+++.
T Consensus 119 tEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999999999753 467899999999999999999999999 7 99999999999999997 999999999987
Q ss_pred cCCCccccccccccCcccccccccCC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGR-TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..... ...+...||+.|||||++.+ ...|+.|+||||||++||||+||+.||.+..+....... .....
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v---------~~~~~ 263 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV---------VVGGL 263 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---------HhcCC
Confidence 65432 23344689999999999964 345999999999999999999999999887762221111 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+.+| ..++..+..+|.+||..||..||++.+++..|+...
T Consensus 264 Rp~~p----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 264 RPPIP----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCC----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 22222 236688999999999999999999999999997543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=391.03 Aligned_cols=257 Identities=23% Similarity=0.409 Sum_probs=215.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCC-eEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-NRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~E 229 (483)
++++..+.||+|..|+||+++++ +++.+|+|.+... .....++..+|+++++..+|||||.+||+|.... ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34455788999999999999976 4677899999655 3344578999999999999999999999999998 5999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||++|+|.+++. ..+.+++.....++.+|++||.|||. . +||||||||.|||++..|.+||||||.++.+..
T Consensus 159 YMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999995 34679999999999999999999996 5 999999999999999999999999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc-hhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP-QVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
. .....+||..|||||.+.+.. |+.++||||||++++|+.+|+.||....+ .....+ .+..+++..
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~---------Ll~~Iv~~p 298 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE---------LLCAIVDEP 298 (364)
T ss_pred h---hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH---------HHHHHhcCC
Confidence 4 345568999999999996554 99999999999999999999999987522 111111 223344444
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.|..+...++.++.+++..||++||.+|||+.|++++.+...
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 444444457789999999999999999999999999876544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=390.70 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=219.8
Q ss_pred HhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcch-------HHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSE-------EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
..+.|.+.+.||+|+||.|-+|. .++++.||||++....... .....+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 56778999999999999999999 5679999999997653222 234579999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcEEee
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPKISD 299 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~D 299 (483)
..||||||+.||+|.+++- ..+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999994 456788888899999999999999999 99999999999999876 7799999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS--IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
||+|+..+.... +.+.+||+.|.|||++...+ .+..++|+||+||+||-+++|.+||........+.+.+..
T Consensus 323 FGlAK~~g~~sf--m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 323 FGLAKVSGEGSF--MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred cchhhcccccee--hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 999998875433 34458999999999986543 3556899999999999999999999876655433332211
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhhH
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLRE 434 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~~ 434 (483)
+. ..+.+..+....++..+||.+||..||++|||+.|+|++.|..+.....
T Consensus 397 G~------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 397 GR------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred Cc------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 11 1122234566778999999999999999999999999999988766544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=380.41 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=206.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|...+.||.|+||+||+|+++ ++..||||.+.... ....+.+..|+.+|+.++|||||++++++..++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888899999999999999954 57899999998773 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC------CCcEEeecccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH------WNPKISDVGLA 303 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~------~~~kl~DFGla 303 (483)
||.||||.+||+. .+.+++..+..++.||+.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999964 45799999999999999999999999 99999999999999765 45899999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
+.+.+.... .+.+|++.|||||++. ...|+.|+|+||+|++||+|++|+.||...+..+.+..+ .+
T Consensus 163 R~L~~~~~a--~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~-----~k------ 228 (429)
T KOG0595|consen 163 RFLQPGSMA--ETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI-----KK------ 228 (429)
T ss_pred hhCCchhHH--HHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-----hc------
Confidence 988754333 3457999999999995 445999999999999999999999999877766544311 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
+....+..+......+.+++...+..+|.+|.++.+....
T Consensus 229 -~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 229 -GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred -cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1122222333333456677778888999999888776643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=369.52 Aligned_cols=259 Identities=21% Similarity=0.327 Sum_probs=214.8
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCccccccc-EEEeCCe-EEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFG-YCVEGQN-RILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~-~~lv 227 (483)
.+|.++++||.|+||+||+++ ..++..+|.|.+.-. .....++...|+.+|++|+|||||++++ .+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 447778999999999999998 668899999998744 3334578999999999999999999999 4555555 7999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-CeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP-KIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||.+|||...++......+.+++..+|+++.|++.||.++|++++. -|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999987777788899999999999999999999995432 3889999999999999999999999999988
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
..... -....+|||.||+||.+...+ |+.||||||+||++|||+.-+.||.+.+- ..+. ..+...
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~-~~L~------------~KI~qg 243 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNL-LSLC------------KKIEQG 243 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccH-HHHH------------HHHHcC
Confidence 65533 334468999999999997666 99999999999999999999999987631 1111 112233
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..|+.+...++.++..++..|+..||+.||+...+++.+.
T Consensus 244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 5555566778899999999999999999999665555443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=394.13 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=214.1
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
..|...+.||+|||..+|.++. ..|..||+|++.+. .....+...+||++.++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 78999999999764 3334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|+|..|+|..+++ ..+++++.+++.++.||+.||.|||++ +|||||||..|++|+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999996 457899999999999999999999999 999999999999999999999999999998765
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
+... ..+.+||+.|.|||++.+.+ ++..+||||+||+||-|+.|++||+..+-...+..+ + .-++.+
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--------k---~~~Y~~ 237 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--------K---LNEYSM 237 (592)
T ss_pred cccc-cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH--------H---hcCccc
Confidence 4222 23458999999999998666 899999999999999999999999865433222111 1 123444
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
|. ..+.+..+||.++|+.||.+|||+++|+.+-..
T Consensus 238 P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 238 PS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 43 233677889999999999999999999976544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=415.45 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=220.2
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEe
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 220 (483)
..+.+.+....+.||+|+||.||+|... +.+.||||.++..... ..++|.+|+++++.|+|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3455566777889999999999999843 3567999999887655 67899999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccC------C----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLG------E----AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
++.+|||+|||..|||.+||+.+.. . ..+++..+.+.|+.|||.||+||-++ .+|||||..+||||+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 9999999999999999999964321 1 23488999999999999999999999 999999999999999
Q ss_pred CCCCcEEeeccccccc-CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHH
Q 046972 291 HHWNPKISDVGLAKLH-GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~ 368 (483)
++..+||+|||+++.. ..++........-+..|||||.+..+. |+++||||||||+|||+++ |+.||.+..+++.+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI- 715 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI- 715 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHH-
Confidence 9999999999999854 344444444556778999999996555 9999999999999999999 99999887765432
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+....+ ...+..|+.++.+||..||+.+|++||+++||...|+.
T Consensus 716 ------------e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 716 ------------ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred ------------HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 22222333 23456778999999999999999999999999998864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=364.12 Aligned_cols=270 Identities=18% Similarity=0.216 Sum_probs=217.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+.|+...++|+|+||.||+|+.+ +|+.||||++...... -.+-.++|+++|++|+|||+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788899999999999999965 4889999999765432 23567999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||+. ++.+-|.. ....++...+..++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||.|+.+...
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 66666653 446688999999999999999999999 9999999999999999999999999999987642
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-----------
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ----------- 378 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----------- 378 (483)
....+..+.|.+|+|||++.+...|+..+||||+||++.||++|.+.|++..+-+++..+........
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 22234457899999999998877899999999999999999999999999988877766654322111
Q ss_pred hhhhhcCCCCC--CCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 379 KIAYVLDPKLP--EMPS---RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 379 ~~~~~~~~~~~--~~~~---~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.+..+.-|... .... .+...-+++++..||..||.+|++-++++.+-...+.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 01111111111 1111 1234578899999999999999999999987655333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=382.40 Aligned_cols=267 Identities=21% Similarity=0.366 Sum_probs=217.4
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchH-HHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.+++++...+.++||+|.||+|.+|...++..||||.++....... .+|..|+++|.+|+|||||.++|+|..++.+|+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 4567888999999999999999999998889999999998755544 899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|+|||++|||..|+..+... .+.-.....|+.||+.||+||.+. ++|||||.++|||++.++++||||||+++-+
T Consensus 613 I~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999754222 244556678999999999999998 9999999999999999999999999999843
Q ss_pred -CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 307 -GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS--GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 307 -~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..++.......+-+..|||+|.+..++ +++++|||+||+++||+++ ...||....+++...+ ...+...+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~---- 761 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQG---- 761 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCC----
Confidence 333344444556778999999987555 9999999999999999887 7889976655432221 111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+......+.-|+..+.++|.+||..|-++||+++++...|..
T Consensus 762 --~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 762 --RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred --cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 111112234566889999999999999999999999998864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=380.13 Aligned_cols=269 Identities=20% Similarity=0.237 Sum_probs=221.5
Q ss_pred HhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchH-HHHHHHHHHHhcCC-CCcccccccEEEeCC-eEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVK-HKNLVKLFGYCVEGQ-NRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~~l 226 (483)
.-++|...++||.|+||.||+|+ ...+..||||+++.....-+ -.=++|++.|++|+ |||||++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678999999999999999999 55688899999977643322 23478999999998 999999999999887 9999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||+. +|+.+++++ ++.|++..++.|+.||++||+|+|.+ |+.||||||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999975 999999854 68899999999999999999999999 9999999999999998889999999999976
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH--------HHhh
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM--------VAQQ 378 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~~ 378 (483)
... ...+..+.|.+|+|||++.+.+.|+.+.||||+||+++|+.+-++.|++.++.+++..+..-. ....
T Consensus 161 ~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 432 233445789999999999999999999999999999999999999999998877766554311 1112
Q ss_pred hhhhhcCCCCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 379 KIAYVLDPKLPEMPS-------RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+...++-.+|.... ..++.+..+++.+||.+||.+|||++|++++....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 222223323332211 12567899999999999999999999999987543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=364.10 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=209.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.++||+|+||.||.++.+ +++.+|+|++.+..- .+.+....|..+|.+++||+||+++..|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999954 578889999976532 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
+||+.||+|+..|+ ..+.+++..+..++..|+.||.|||++ +||||||||+|||||.+|+++|+|||+|+..-
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999995 557899999999999999999999999 99999999999999999999999999998543
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. ...+.+.+||+.|||||++.+.+ |+.++|+|||||++|||++|.+||...+.......+... . -+.
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~----k------~~~ 244 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG----K------LPL 244 (357)
T ss_pred cC-CCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----c------CCC
Confidence 32 22344468999999999998776 999999999999999999999999877654332222111 1 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRP----KMGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----t~~eil~~L~~~~ 429 (483)
.|. -...+..+++.+.|.+||++|. .+.+|-.+....+
T Consensus 245 ~p~----~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 245 PPG----YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCc----cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 121 1235788889999999999995 5666665554444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=345.14 Aligned_cols=270 Identities=20% Similarity=0.284 Sum_probs=222.6
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|...+.||+|.||.||+|+ ..+|+.||||++......+ ....++||+.|+.++|+||+.++++|-..+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999999 5578999999998764432 2568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||+. ||...+++ ....++..++..++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.++..
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 99999974 567799999999999999999999999 9999999999999999999999999999998866
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-----hhhhc
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK-----IAYVL 384 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 384 (483)
....... +-|.+|+|||++.+...|+..+||||.||++.||+-|.+-|++.++-+++..++.-...... +..+-
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 5444433 77999999999989888999999999999999999999999998887777766553211100 00000
Q ss_pred C----CCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 385 D----PKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 385 ~----~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
| ...|.. ....+..+..+|+.++|..||.+|+|+.|++++-.....
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 0 001110 122345677999999999999999999999998766543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=373.88 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=220.8
Q ss_pred HhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 225 (483)
..+.|+..++||+|+||.||+|+ ..+|+.||+|++..... ....-..+||.+|++|+||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34668888999999999999999 56789999999976643 2335678999999999999999999998876 6899
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
||+|||+. ||.-++.. ..-.|++.++..+++||+.||+|||.+ +|+|||||..|||||++|.+||+|||||++
T Consensus 195 lVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999987 99999863 345799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
+........+..+-|.+|+|||++.+...|+.++|+||.||||.||++|++.|.+.++-.++..+++-......-.+- -
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~ 346 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-V 346 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-c
Confidence 877766667777889999999999999899999999999999999999999999999887777666532111110000 0
Q ss_pred CCCCC-------C-CC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 386 PKLPE-------M-PS-------RKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 386 ~~~~~-------~-~~-------~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+|. . +. ...+...++|+..+|..||.+|.|+.++|+.-
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 11110 0 01 12235678899999999999999999999744
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=392.71 Aligned_cols=269 Identities=25% Similarity=0.416 Sum_probs=224.0
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
++......+.++||.|.||+||+|+++- ...||||.++.... ..+.+|+.|+.+|.+++||||+++.|+.+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3445668889999999999999999653 45689999987744 344789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.+||+|||++|+|+.||+.+ .+.|++.+...++++|+.||.||... ++|||||.++||||+.+..||++|||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999854 45699999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCccccccc--cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 304 KLHGPEWSISTSC--ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 304 ~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|.+.++.....++ ..-+..|.|||.+.-.. ++.++|||||||+|||.++ |..||.+..+++.+..+-
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe--------- 848 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE--------- 848 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHH---------
Confidence 9876544222222 23356899999996444 9999999999999999988 999998776654332211
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhhHHHHhhhh
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRA 441 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~~~~~~~~~ 441 (483)
.+.++| ++.+|+..|..||+.||++|-.+||.+.+|+..| +...+.+..++..
T Consensus 849 ---~gyRLP--pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l---DklIrnP~SLk~~ 901 (996)
T KOG0196|consen 849 ---QGYRLP--PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL---DKLIRNPNSLKTI 901 (996)
T ss_pred ---hccCCC--CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH---HHHhcCchhhccc
Confidence 135666 5678999999999999999999999999999999 4455555555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=369.36 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=215.2
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc---hHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 225 (483)
...+|.+++.||+|+|++|++|+. ..++.+|||++.+.... ..+....|-..|.+| .||.|++++..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346799999999999999999994 46889999998664222 224567888899999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|+||+++|+|.++|+ ..+.|++..++.++.+|+.||+|||++ |||||||||+|||||.+|++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999996 457899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCccc----------cc--cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 306 HGPEWSI----------ST--SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 306 ~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
+++.... .. ...+||..|.+||++.... .+..+|+|+|||+||.|+.|.+||.+.++...+..++.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~- 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA- 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-
Confidence 7543211 11 4468999999999996554 79999999999999999999999998876544433322
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
++..+|+.++ +...+|+.+.|..||.+|+|+.+|-++.-...
T Consensus 302 ----------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 302 ----------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ----------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 2344444444 67889999999999999999999998876544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=372.07 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=219.2
Q ss_pred HhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+...|....+||+|+.|.||.|. ..+++.||||++........+-.++|+.+|+..+|+|||++++.|...+++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34668888999999999999998 55688899999988887778889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||+||+|.+.+. ...+++.++..|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||.|..+...
T Consensus 351 ym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999983 45599999999999999999999999 9999999999999999999999999999877665
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.. .....+||+.|||||+..+.. |++|+||||||++++||+-|++||-..++-..+..+. ..-.|.+.
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa----------~ng~P~lk 490 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------TNGTPKLK 490 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh----------hcCCCCcC
Confidence 44 334558999999999997665 9999999999999999999999998766644332221 11122222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+..+.+++.+||+.|+++|+++.|+|++...
T Consensus 491 --~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 491 --NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred --CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 344556789999999999999999999999997654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=399.91 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=217.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC--C----cEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD--N----MRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
+.....++.+.||+|.||.||.|...+ + ..||+|.+... +.+...+|++|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445667778999999999999999653 3 24899998776 4455579999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 223 NRILVYEYIDNGNLQQWLHGSL---GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
..++++|||.||||..||+... .....++..+.+.++.|||+|+.||+++ ++|||||.++||||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999997531 1246688999999999999999999999 999999999999999999999999
Q ss_pred ccccccc-CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHh
Q 046972 300 VGLAKLH-GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 300 FGla~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
||+|+.+ ..++........-+..|||||.+.. ..|+.|+|||||||+|||++| |..||...++.+.+..+..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~----- 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE----- 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-----
Confidence 9999944 3333333333456678999999964 569999999999999999999 9999998777654433222
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..+++ ++..|+..+.++|.+||+.+|++||++..|++.+...
T Consensus 920 -------ggRL~--~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 920 -------GGRLD--PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred -------CCccC--CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 12333 4567888999999999999999999999999966543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=359.15 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=204.4
Q ss_pred CCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC--eEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ--NRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~E~ 230 (483)
++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 35567889999999999999654 8889999987664333567899999999999999999999854444 68999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeecccccccCC-
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKLHGP- 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~- 308 (483)
+++|+|.+++.+.. ..+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999997542 2699999999999999999999999 9999999999999999 79999999999987663
Q ss_pred -CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC-CchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 309 -EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYS-QPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 309 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
..........||+.|||||++..+.....++|||||||++.||+||..||... ....... ..... ...|
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~----~ig~~-----~~~P 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL----LIGRE-----DSLP 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH----HHhcc-----CCCC
Confidence 22233445689999999999975332335999999999999999999999753 1111110 00000 0123
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+|. ..+.+..+++.+|+..||++||||.++|++.....
T Consensus 243 ~ip~----~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 EIPD----SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 3333 34467888999999999999999999999886543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=354.68 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=216.1
Q ss_pred HHhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
...+.|++.++||.|..++||+|+ ...+..||||++..... .+.+.+.+|+..|+.++||||++++.+|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 445779999999999999999999 55678999999976533 4458899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|.||.+|++.++++.... ..+.+..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999976543 3499999999999999999999999 99999999999999999999999999876443
Q ss_pred CCcc---ccccccccCccccccccc-CCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 308 PEWS---ISTSCELRNSGYLAEELS-GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 308 ~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
.... .......||++|||||++ .....|+.|+||||||++..||.+|..||....+-..+..-+.. . ....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn----~-pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN----D-PPTL 252 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC----C-CCCc
Confidence 2221 111445899999999994 34445999999999999999999999999887775443322211 0 0000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.-..++........+.+.+++..||+.||.+|||+++++++-..
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 01122222233455789999999999999999999999976543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=365.66 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=212.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCC----Cc-chHHHHHHHHHHHhcCC-CCcccccccEEEeCC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSN----SV-SEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 222 (483)
...+.|.+.+.||+|+||.|++|+. .++..||+|++... .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456799999999999999999984 46799999976553 11 22356678999999998 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeecc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVG 301 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFG 301 (483)
..++|||||.||+|++++. ..+++.+.++..++.|++.|++|||++ +|+||||||+|+|++.+ +.+||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999996 357799999999999999999999999 99999999999999999 999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTS-IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
++.... ..........|++.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+.......+ ..
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki-----~~--- 237 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI-----RK--- 237 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH-----hc---
Confidence 999773 1223344568999999999997766 4468999999999999999999999875543322211 10
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+|.... +.++..|+.+||..||.+|+|+.+++++-|...
T Consensus 238 ---~~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ---GEFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---CCccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1123333321 467888999999999999999999998777654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=358.67 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=214.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+..++|+.++.||+|+||.||+|+- .+|..+|+|++.+.... ..+..+.|-.+|....+|+||+++..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3568899999999999999999994 46888999999876433 2356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
|||||++|||+..+|. ....|++.++..++.+++.|++.||+. |+|||||||+|+|||..|++||+||||+.-
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999995 567899999999999999999999999 999999999999999999999999999852
Q ss_pred cCC-----------------------Ccc-----c------------------cccccccCcccccccccCCCCCCCcch
Q 046972 306 HGP-----------------------EWS-----I------------------STSCELRNSGYLAEELSGRTSIFNEKS 339 (483)
Q Consensus 306 ~~~-----------------------~~~-----~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 339 (483)
+.. +.. . .....+|||.|+|||++.+.+ |+..+
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~c 369 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKEC 369 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccc
Confidence 210 000 0 011348999999999998777 99999
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC---
Q 046972 340 DVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP--- 416 (483)
Q Consensus 340 DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp--- 416 (483)
|+||||||+|||+.|.+||...++......+....... ..| .......+..+||.+||. ||++|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------~fP--~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------KFP--EEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------cCC--CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999999999888876554443321111 111 122233688899999999 999996
Q ss_pred CHHHHHHhccccch
Q 046972 417 KMGDVLRMLEPRDL 430 (483)
Q Consensus 417 t~~eil~~L~~~~~ 430 (483)
.++||-++...+..
T Consensus 438 G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 438 GAEEIKKHPFFKGV 451 (550)
T ss_pred cHHHHhcCCccccC
Confidence 58899888877653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=370.19 Aligned_cols=271 Identities=27% Similarity=0.391 Sum_probs=219.1
Q ss_pred ceeeehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccE
Q 046972 140 GIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGY 217 (483)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~ 217 (483)
+.+.+.+++++..+.+.+...||+|.||+||+|+|.+ .||||++...... ..+.|.+|+..+++-+|.||+-|.|+
T Consensus 379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cCCccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 3456678999999999999999999999999999865 5999999776443 34789999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEE
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl 297 (483)
|..+.. .||+-+|+|-+|+.+|+. ....|.....+.|+.||++||.|||.+ +|||||||..||++.++++|||
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEE
Confidence 998887 999999999999999984 346789999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCcc-ccccccccCcccccccccCCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 298 SDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRT--SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 298 ~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
+|||++........ .......|...|||||++... ..|++.+|||||||++|||++|..||.....++.+..
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm----- 604 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM----- 604 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-----
Confidence 99999975432211 111223456689999998643 3489999999999999999999999985444322111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+. ..+.+ .....++++++.+|+..||..++++||.+.+|+..|+...
T Consensus 605 VGrG~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 605 VGRGY----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred ecccc----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 01110 00111 1123467789999999999999999999999999886543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=372.25 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=216.8
Q ss_pred eeehHHHHHHhcCCcccceeccCCceEEEEEEEcC--C--cE-EEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccc
Q 046972 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD--N--MR-AAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVK 213 (483)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~ 213 (483)
.+..+.+++..++..+.++||+|+||.||+|.++. + .. ||||...... .....+|++|+++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34556788888999999999999999999999543 2 23 8999987532 334478999999999999999999
Q ss_pred cccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC
Q 046972 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293 (483)
Q Consensus 214 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~ 293 (483)
+||++.....+++|||+|+||+|.++|+.. ...++..+...++.+.|.||+|||++ ++|||||.++|||++.++
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence 999999999999999999999999999743 33699999999999999999999999 999999999999999999
Q ss_pred CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~ 372 (483)
.+||+|||+++... .+........-+..|+|||.+... .|+.++|||||||++||+++ |..||.+.........+.
T Consensus 300 ~vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~- 376 (474)
T KOG0194|consen 300 VVKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV- 376 (474)
T ss_pred eEEeCccccccCCc-ceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-
Confidence 99999999997543 222222222456789999999655 69999999999999999999 899998877543221110
Q ss_pred HHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+...+...+..+..++.+||..||++||+|.++.+.++...
T Consensus 377 ------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 377 ------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 111111223345578888899999999999999999999886543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.51 Aligned_cols=273 Identities=22% Similarity=0.253 Sum_probs=218.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchH--HHHHHHHHHHhcCCCCcccccccEEEeC--CeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 227 (483)
++|+..+.|++|+||.||+|+.+ ++..||+|+++....... -..++||.+|.+++|||||.+-.+.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 44777899999999999999954 577899999976542221 3568999999999999999999887643 678999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
||||+. ||...+... ..+|...++..++.|+++|++|||.+ .|+|||||++|+|+++.|.+||||||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 999999743 36899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh--hh--
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA--YV-- 383 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~-- 383 (483)
... ...+..+-|.+|+|||++.+...|+++.|+||+|||+.||+++++.|.+..+..++..++........-. ..
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 652 3344457789999999999999999999999999999999999999999988877777665432211100 00
Q ss_pred ---c-CCCCCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhh
Q 046972 384 ---L-DPKLPEMPSR---------KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLR 433 (483)
Q Consensus 384 ---~-~~~~~~~~~~---------~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~ 433 (483)
+ .-+++..+.. .....-++|+..+|..||.+|.|+.+.|++=+..+....
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 0 0111111111 023567889999999999999999999998877664443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=363.95 Aligned_cols=262 Identities=25% Similarity=0.368 Sum_probs=204.9
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEEEe
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVE 220 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 220 (483)
.+..++|++.+.||+|+||.||+|... .+..||+|++..... .....+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 456788999999999999999999742 346799999875432 3346789999999999 89999999998876
Q ss_pred C-CeEEEEEEecCCCCHHHHHhcccC------------------------------------------------------
Q 046972 221 G-QNRILVYEYIDNGNLQQWLHGSLG------------------------------------------------------ 245 (483)
Q Consensus 221 ~-~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 245 (483)
. ...++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 457899999999999999964211
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccC
Q 046972 246 ----EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRN 320 (483)
Q Consensus 246 ----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~ 320 (483)
...++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 023578889999999999999999999 999999999999999999999999999986533221 122233456
Q ss_pred cccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHH
Q 046972 321 SGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKR 399 (483)
Q Consensus 321 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (483)
..|+|||++.+. .++.++|||||||++|||++ |..||.+.......... ...+ ..... +..++..
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~-----~~~~~----~~~~~~~ 305 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----LKDG-----TRMRA----PENATPE 305 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HhcC-----CCCCC----CCCCCHH
Confidence 789999998554 48999999999999999997 99999865543222111 1111 11111 2233467
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 400 IILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 400 l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.+++.+||+.||++|||+.++++.|+.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=361.38 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=208.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.... +.+...+|+++++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788889999999999999954 5778899999775433 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||.| +|+.+|. ..+.++++.+..++.|++.||.|||++ +|+|||+||+|||++.+|.+|+||||+|+.++..
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999995 567899999999999999999999999 9999999999999999999999999999987764
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
. ...+...||+.|||||+..+. .|+..+|+||+||++|||++|++||-...- .+.++.+. .|+..
T Consensus 154 t-~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si----~~Lv~~I~--------~d~v~- 218 (808)
T KOG0597|consen 154 T-SVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSI----TQLVKSIL--------KDPVK- 218 (808)
T ss_pred c-eeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHH----HHHHHHHh--------cCCCC-
Confidence 3 333445799999999999644 599999999999999999999999953221 11111111 12222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
++......+..++...|.+||.+|.|-.+++.+..
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 23355678889999999999999999999997653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=332.58 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=210.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||.|+||+|.+++.+ ++..+|+|++.....- ..+...+|..+|+.+.||+++++++.|.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456888999999999999999965 4777899999765332 235678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||.+||.|+.+|+ ..+.+++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||.|+...
T Consensus 123 meyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999996 457799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. +.+-+||+.|+|||++...+ |+.++|.|||||++|||+.|.+||...++......++.. +-.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-----------~v~ 259 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-----------KVK 259 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----------ccc
Confidence 32 45568999999999997665 999999999999999999999999887764333322221 123
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHR-----PKMGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~R-----pt~~eil~~L~~~~ 429 (483)
+|... ..++.+|+.+.|+.|-.+| ....+|-.+.+...
T Consensus 260 fP~~f----s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 260 FPSYF----SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CCccc----CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 33333 3678889999999999999 34557777776654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=365.00 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=211.0
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++++.+.+..++.||.|+.|.||+|++. +..||||++..- -..+|+.|++|+||||+.|.|+|.....+||
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 46778888888999999999999999984 558999987432 2357889999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||..|-|++.|+ ...+++......+..+||.||.|||.+ +|||||||.-||||..+..+||+|||-++..
T Consensus 190 iMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999999996 567788899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... + ..-...||..|||||++.+.+ .++|+|||||||+||||+||..||.+.+.... +-.+-..
T Consensus 263 ~~~-S-TkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------IwGVGsN 326 (904)
T KOG4721|consen 263 SDK-S-TKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------IWGVGSN 326 (904)
T ss_pred hhh-h-hhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchhee-------------EEeccCC
Confidence 544 2 222357999999999996555 89999999999999999999999976543211 1111112
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+.-..+..|++-+.-|+++||+..|..||++.+++.+|+...
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 2222345567788999999999999999999999999996533
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=355.51 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=214.7
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.|+..+.||.|+||.||+|.. ..++.||+|++...... ..++..+|+.+|.+++++||.++||.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466678899999999999995 45788999999776443 4478899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
.||++.+.|+ ....+.+....-++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 94 ~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999995 445558888888999999999999999 999999999999999999999999999987766544
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
.. ...+||+.|||||++...+ |+.|+||||||++.+||.+|.+|+....+. +...++....|+.
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPm--------------rvlflIpk~~PP~ 230 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPM--------------RVLFLIPKSAPPR 230 (467)
T ss_pred cc-ccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcc--------------eEEEeccCCCCCc
Confidence 44 6679999999999997544 999999999999999999999999876652 2223344445555
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....+...+.+++..||.+||+.||+|.+++++-.
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 55567788999999999999999999999997543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.80 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=212.4
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchH---HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE---EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
-+|++.+.||+|.||.|-+|. ...|+.||||.+.+....+. -.+.+||++|..|+||||+++|.+|.+.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 468889999999999999999 57899999999987655444 35789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||..+|.|++|+. ..+.+++.+++++++||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999995 567899999999999999999999999 999999999999999999999999999988765
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.... .+.+|.+-|.+||++.+.++-++.+|-|||||+||-|++|.+||++.+-... ..+..-.....
T Consensus 206 ~kfL--qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--------vrQIs~GaYrE--- 272 (668)
T KOG0611|consen 206 KKFL--QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--------VRQISRGAYRE--- 272 (668)
T ss_pred ccHH--HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--------HHHhhcccccC---
Confidence 5333 3457899999999998888778899999999999999999999998764322 11111111222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
|+.+ .+..-||++||..||++|.|+.+|..+.|.
T Consensus 273 P~~P-----SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 273 PETP-----SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred CCCC-----chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 2223 356678889999999999999999987754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=364.01 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=211.4
Q ss_pred CcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
|.+++.||.|+-|.|-+|+ ..+|+.+|||++..... .......+||-+|+-+.||||+++|+++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 6678899999999999999 45799999999976522 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
++||.|++++- ..+++++.++++++.||+.|+.|+|.. +|+||||||+|+|||..+.+||+|||+|.+-.++.
T Consensus 94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999994 568899999999999999999999999 99999999999999999999999999998765554
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
-..+ .+|.+.|+|||++.+.++.+.++||||.|||||.|+||+.||++.+-...+.. +..+.+ .+|
T Consensus 167 lLeT--SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK-----V~~G~f------~MP- 232 (786)
T KOG0588|consen 167 LLET--SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK-----VQRGVF------EMP- 232 (786)
T ss_pred cccc--cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH-----HHcCcc------cCC-
Confidence 3333 47899999999999888788999999999999999999999986554332221 112211 122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.+..+|+.+||..||++|.|++||+++.+-
T Consensus 233 ---s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 233 ---SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred ---CcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 3334688899999999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.73 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=207.4
Q ss_pred HHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc--------------hHHHHHHHHHHHhcCCCCcccc
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS--------------EEEDFIEKVEAIGQVKHKNLVK 213 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hpnIv~ 213 (483)
....++|++.+.||+|.||.|-+|+. .+++.||+|++.+.... ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34557899999999999999999994 56889999999653221 1247889999999999999999
Q ss_pred cccEEEeC--CeEEEEEEecCCCCHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 214 LFGYCVEG--QNRILVYEYIDNGNLQQWLHGSLGEAKP-LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 214 ~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
++.+..+. +.+|||+|||..|.+...- ...+ +++.+++.++.+++.||+|||.+ |||||||||.|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 99998754 6789999999998876542 4455 99999999999999999999999 999999999999999
Q ss_pred CCCCcEEeecccccccCCC----ccccccccccCcccccccccCCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 291 HHWNPKISDVGLAKLHGPE----WSISTSCELRNSGYLAEELSGRT---SIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
.+|++||+|||.+...... .........||+.|+|||.+.++ ...+.+.||||+||+||.|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999999866322 12222346899999999998662 2356899999999999999999999986654
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+..+... .+ .+|.. .+....+.+||+++|.+||++|.+..+|..+++...
T Consensus 325 ~~l~~KIvn~--------pL---~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 LELFDKIVND--------PL---EFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHHHhcC--------cc---cCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 4332222111 11 11211 133468899999999999999999999999987644
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.35 Aligned_cols=265 Identities=20% Similarity=0.338 Sum_probs=204.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-----------------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-----------------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLV 212 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv 212 (483)
..++|++.++||+|+||.||+|.+.+ +..||+|.+..... ....+|.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45789999999999999999998543 23689999876533 3346799999999999999999
Q ss_pred ccccEEEeCCeEEEEEEecCCCCHHHHHhccc---------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 046972 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSL---------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277 (483)
Q Consensus 213 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 277 (483)
++++++.+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999985421 1123578889999999999999999999 99
Q ss_pred eeecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc--C
Q 046972 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS--G 354 (483)
Q Consensus 278 iHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t--g 354 (483)
+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.... ++.++|||||||++|||++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999986533221 1222334577899999985544 8999999999999999987 5
Q ss_pred CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 355 RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 355 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..||............ ........ . ...... +..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~-~~~~~~~~-~-~~~~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENA-GEFFRDQG-R-QVYLFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHH-HHHhhhcc-c-cccccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6788765543322211 11111000 0 000111 1123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=357.67 Aligned_cols=257 Identities=24% Similarity=0.297 Sum_probs=213.1
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 222 (483)
..+..++|.+.++||+|+||.|+++..+. ++.+|||++++.. .++.+....|.+++... +||.+++++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 34556889999999999999999999664 6778999998763 33446778888888777 5999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
++|+||||+.|||+..+. ....|++..+..++..|+.||.|||++ +||+||||.+|||||.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 999999999999955544 446799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
++..-. ....+.+..||+.|+|||++.+.. |+.++|+|||||+||||+.|..||.+.++++.+..++.
T Consensus 515 cKe~m~-~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------- 582 (694)
T KOG0694|consen 515 CKEGMG-QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------- 582 (694)
T ss_pred ccccCC-CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------
Confidence 985321 122556679999999999997665 99999999999999999999999998887765544322
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhccccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPRD 429 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~~ 429 (483)
.++..|.. .+.+...++.++|.+||++|.-+ .+|.++.-.+.
T Consensus 583 -d~~~yP~~----ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 583 -DEVRYPRF----LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -CCCCCCCc----ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 13444433 34788889999999999999754 67776665544
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.11 Aligned_cols=245 Identities=20% Similarity=0.342 Sum_probs=198.5
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCCCcccccccEEEe----CCeEEEEEEec
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNRILVYEYI 231 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~E~~ 231 (483)
..||+|++|.||+|.+ +|+.||+|.+....... .+.|.+|+.++.+++|||||+++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 67899999987653333 3678899999999999999999999977 35679999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++.. ...+++...+.++.|++.||.|||+. .+++||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 99999999963 35688999999999999999999973 17889999999999999999999999999865432
Q ss_pred ccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.....++..|+|||++.+. ..++.++|||||||++|||++|+.||............. . ....+..+
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~----~-----~~~~~~~~- 244 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII----N-----KNNSLKLP- 244 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----h-----cCCCCCCC-
Confidence 1234678899999998541 348999999999999999999999998665432221111 0 01111122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 245 ---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 245 ---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred ---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 2345689999999999999999999999998864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.80 Aligned_cols=248 Identities=19% Similarity=0.231 Sum_probs=201.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 68889999987542 223356789999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST 314 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 314 (483)
+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 9999995 345789999999999999999999999 9999999999999999999999999998753221 1122
Q ss_pred cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 315 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+........ .. .+..++.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~-----~~------~~~~~p~---- 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----LM------EEIRFPR---- 216 (323)
T ss_pred cceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH-----Hc------CCCCCCC----
Confidence 3346899999999986554 899999999999999999999999765443221111 00 1122222
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 395 KELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
.....+.+++.+||+.||++|| ++.+++++.+....
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 2336788999999999999999 89999988766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=356.77 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=219.9
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
.++++..+.+++...+||-|.||.||.|.|+. .-.||||.++... ...++|+.|+.+|+.++|||+|+++|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46888888889999999999999999999876 5678999986553 456899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|||+|||.+|+|.+||+.. +..-++.-..+.++.||+.||+||..+ ++|||||.++|||+..+-.+|++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999754 334466677889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
+++..+..........+..|.|||-+.-. .++.|+|||+|||+|||+.| |..||.+.+-.+. + .
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y-------------~ 477 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-Y-------------G 477 (1157)
T ss_pred hhhcCCceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-H-------------H
Confidence 99876644444444557789999988544 48999999999999999999 9999987653221 1 1
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
++....+-..+.+|+..+.+||+.||+++|.+||++.|+.+.++.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 112222223456777899999999999999999999999987754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=333.33 Aligned_cols=272 Identities=19% Similarity=0.255 Sum_probs=216.2
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCc-ccccccEEEeCC------
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKN-LVKLFGYCVEGQ------ 222 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~------ 222 (483)
..|...++||+|+||+||+|+ ..+|+.||+|++...... ......+|+.+++.|+|+| ||.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667789999999999999 456889999999766442 2356789999999999999 999999998877
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
.+++||||++. +|..++.........++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999975 99999975432224677789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh-
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA- 381 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 381 (483)
|+...... ...+..++|.+|+|||++.+...|++..||||+|||+.||++++..|.+..+..++..++.-........
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99766432 2245568899999999999887899999999999999999999999999888777666655332221111
Q ss_pred -h---hcC--CCCCCCC-CHHH----H---HHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 -Y---VLD--PKLPEMP-SRKE----L---KRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 -~---~~~--~~~~~~~-~~~~----~---~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. ..+ ..++... .... . ....+++.+||+.+|.+|.|+..++.+.....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 0 011 1111111 1111 1 37888999999999999999999999855444
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=369.94 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=210.6
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCC-cEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCccccccc-EEEe-----
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDN-MRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFG-YCVE----- 220 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~-~~~~----- 220 (483)
.+..-++++.+.|.+|||+.||+|+...+ ..+|+|++........+.+.+||++|+.|. |+|||.+++ ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456678899999999999999997776 999999999887777789999999999996 999999999 3321
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 221 -GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 221 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
.-+++|+||||.||.|-+++..+... .|++.++++|+.|+++|+.+||.. +++|||||||-+||||+.++..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 13568999999999999999766433 399999999999999999999985 67799999999999999999999999
Q ss_pred cccccccCCCc-c-------ccccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHH
Q 046972 300 VGLAKLHGPEW-S-------ISTSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLID 369 (483)
Q Consensus 300 FGla~~~~~~~-~-------~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~ 369 (483)
||.|...-... . ...-....|+.|+|||.+. ++..+++|+|||||||+||-||....||+....-
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 99987432111 1 1112236789999999864 3334899999999999999999999999865331
Q ss_pred HHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 370 WLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+++......+...++..|.+||..||+.||.+||++.++++.+..
T Consensus 265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 1222222222345778999999999999999999999999987643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.21 Aligned_cols=268 Identities=20% Similarity=0.324 Sum_probs=209.7
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
..++|++.+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4578999999999999999999965 577889998875532 23467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999963 35689999999999999999999985 1699999999999999999999999999975533
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH-------------
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV------------- 375 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------------- 375 (483)
. ......++..|+|||++.+.. ++.++|||||||++|||++|+.||........ ...+....
T Consensus 157 ~---~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 157 S---MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred c---ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCccccCc
Confidence 2 123346889999999986554 89999999999999999999999975543221 11111000
Q ss_pred ---------------------HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 ---------------------AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+.....+..+......++.+|+.+||+.||++|||+.+++++.+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 000011111111222222234568999999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.23 Aligned_cols=250 Identities=22% Similarity=0.258 Sum_probs=205.9
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999965 578899999865322 23356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999996 345689999999999999999999999 999999999999999999999999999986533
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. .....|++.|+|||++.+.. ++.++|||||||++|||++|+.||............. .. ...+
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-----~~------~~~~ 217 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-----AG------KLEF 217 (291)
T ss_pred C----cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hC------CcCC
Confidence 2 22346889999999986554 7999999999999999999999998765433221111 11 1122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
+.. ....+.+++.+||+.||.+||+ +.+++++.+...
T Consensus 218 ~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 218 PRH----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred Ccc----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 222 2357889999999999999995 999999887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.71 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=204.2
Q ss_pred HhcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..++|++.+.||+|+||.||+|.+. .+..||+|.+..... .....|.+|+..+..++||||++++|++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3467889999999999999999853 356889999876533 23467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999999642 34689999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
.............++..|+|||.+.+. .++.++|||||||++||+++ |..||........... . .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~----~-~~-----~~ 225 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA----V-ED-----GF 225 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----H-HC-----CC
Confidence 432222222223445689999988554 48999999999999999875 9999976654322111 1 11 01
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
... .+..++..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 226 ~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 226 RLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 111 12334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.51 Aligned_cols=264 Identities=24% Similarity=0.377 Sum_probs=207.8
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEE------cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVL------LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
.+.+..++|++.+.||+|+||.||+|.+ .++..||||++.... ....+.+.+|++++..+ +|||||+++++|
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3456667899999999999999999973 235679999987543 33446789999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC-----------------------------------------------------
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG----------------------------------------------------- 245 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------- 245 (483)
...+..++|||||++|+|.++++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999964211
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 246 ------------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 246 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 113578889999999999999999999 99999999999999999999999999998654
Q ss_pred CCcccc-ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 308 PEWSIS-TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 308 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
...... .....++..|+|||++.+. .++.++|||||||++|||++ |..||............+.. . ..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~-----~~ 335 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----G-----YR 335 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----C-----cc
Confidence 332211 1222345679999998654 48999999999999999998 89999765543332222111 1 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..+. ..+.++.+++.+||+.||++|||+.++++.|+.
T Consensus 336 ~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPE----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11111 123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=341.23 Aligned_cols=256 Identities=20% Similarity=0.220 Sum_probs=204.4
Q ss_pred CcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 155 FAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999995 5688999999865432 2234678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888532 234689999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. .....|+..|+|||++.+.. ++.++|||||||++|||++|+.||................ . .. ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~--------~~--~~ 222 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-K--------ED--QE 222 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-h--------cc--cc
Confidence 1 22346889999999996554 8999999999999999999999998665432211111110 0 00 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
..+...+..+.+|+.+||+.||.+||+ +++++++.+...
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 112223467889999999999999997 899998765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.43 Aligned_cols=266 Identities=17% Similarity=0.195 Sum_probs=204.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||.||+|+.+ +++.+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 577899999875422 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|++++.|..+.. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999877765543 235689999999999999999999999 9999999999999999999999999999876443
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH-----------HHhh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM-----------VAQQ 378 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~-----------~~~~ 378 (483)
.........++..|+|||++.+.. ++.++|||||||++|||++|+.||................ ....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 222333446888999999986554 8999999999999999999999998765443322211100 0000
Q ss_pred hhhhhcCCCCCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIAYVLDPKLPE------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.......+.... ......+..+.+++.+||+.||++|||+++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 000000000000 001113467899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.16 Aligned_cols=270 Identities=17% Similarity=0.238 Sum_probs=205.8
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999965 678899999865432 223467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|++ ++|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 688888863 235688999999999999999999999 9999999999999999999999999998754322
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh------h-
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA------Y- 382 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~- 382 (483)
. .......++..|+|||++.+...++.++|||||||++|||++|..||.+..+.................. .
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 1 1223346788999999986655589999999999999999999999987554322111111110000000 0
Q ss_pred -hcCC-CC----CCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 383 -VLDP-KL----PEMP-----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 383 -~~~~-~~----~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+ .. +... ....+..+.+++.+||+.||++|||+.+++++.+..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0000 00 0000 0011246788999999999999999999999877655
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=346.36 Aligned_cols=259 Identities=21% Similarity=0.211 Sum_probs=206.5
Q ss_pred CCcccceeccCCceEEEEEEE----cCCcEEEEEEecCCC----cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL----LDNMRAAVKLLMSNS----VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+|++.+.||+|+||.||+++. .+++.+|+|++.... ....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999985 357889999986432 12235678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999995 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..............||..|+|||++.+...++.++|||||||++|||++|+.||................. ..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------~~ 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-------KC 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-------cC
Confidence 65433222333456899999999986554578999999999999999999999975443222211111111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
++.++.. ....+.+++.+||+.||++|| ++++++++.+..+.
T Consensus 227 ~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 2333322 235788899999999999999 78899998876553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=340.31 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=205.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||.|+||.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999965 578899999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++ +|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 99999863 234578899999999999999999999 99999999999999999999999999997543221
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----------hhh
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA-----------QQK 379 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-----------~~~ 379 (483)
.......++..|+|||++.+...++.++|||||||++|||++|+.||.................. ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 12233467889999999866555899999999999999999999999876654433322211100 000
Q ss_pred hhhhcCCCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 380 IAYVLDPKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 380 ~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
......+.....+ ......++.+++.+||+.||.+|||++|++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 0000111110000 0112357889999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=338.15 Aligned_cols=265 Identities=20% Similarity=0.228 Sum_probs=210.2
Q ss_pred CcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC-----eEEEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-----NRILVY 228 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~ 228 (483)
|...+++|.|+||.||+|.... +..||||++..... --.+|+++|+.+.|||||+++-+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 5567899999999999999554 68999999876543 2357999999999999999998886432 235799
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeecccccccC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHG 307 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFGla~~~~ 307 (483)
|||+. +|..+++.....+..++.-.+.-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 99999976544567788888999999999999999998 99999999999999987 889999999999775
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--hhhhh--
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ--KIAYV-- 383 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~-- 383 (483)
..... ....-+..|+|||++.+...|+.+.||||.||++.||+-|++-|.+.+...++.++++-..... .+...
T Consensus 178 ~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 54322 3335678899999999988899999999999999999999999999888877777665321111 11110
Q ss_pred -----cCCCCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 -----LDPKLPEM-----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 -----~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+.+... .......+..+|+.++|..+|.+|.++.|++.+--...
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 11111111 22234578999999999999999999999998765444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=347.96 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=206.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC--CcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD--NMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 44678999999999999999998544 3579999886432 223457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999963 35689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...++....... ... .
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-----~~~------~ 244 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-----LEG------I 244 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH-----hcC------C
Confidence 5432 23346889999999986544 799999999999999999999999866543221111 111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
...|... ...+.+++.+||+.||++|+ ++++++++.+..+.
T Consensus 245 ~~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 245 IYFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 1222222 25678899999999999995 89999999876553
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=333.54 Aligned_cols=267 Identities=21% Similarity=0.298 Sum_probs=210.7
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecC--CCcchHHHHHHHHHHHhcCCCCcccccccEEEe-----CCeE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMS--NSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-----GQNR 224 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~ 224 (483)
..|...+.||.|+||.|+.|.. .+|..||+|++.. ......++..+|+++|+.++|+||+.+++.+.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455578899999999999995 4688999999974 344455788999999999999999999998865 3567
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|+|+|+| +.||...++ .+..++...+..++.||++||.|+|+. +|+||||||.|+|++.+..+||||||+|+
T Consensus 102 YiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred EEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 9999999 559999995 445699999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH---------
Q 046972 305 LHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM--------- 374 (483)
Q Consensus 305 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------- 374 (483)
...... ....+..+.|.+|.|||++.....|+.+.||||.|||+.||++|++.|.+.+.-.++..+..-.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 775421 1223556789999999999888889999999999999999999999998877554443322210
Q ss_pred -HHhhhh-hhhc-CCCCCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 -VAQQKI-AYVL-DPKLPEMPSR----KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 -~~~~~~-~~~~-~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...... .++. -|..|..+.. +.....++|+.+||..||.+|+|++|+|++.--
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 000000 0111 1222222211 233678899999999999999999999998753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=345.31 Aligned_cols=246 Identities=20% Similarity=0.208 Sum_probs=198.4
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||+|+||.||+|... +++.||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 4778999998643 223345788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999963 45689999999999999999999999 99999999999999999999999999997543221 12233
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..||+.|+|||++.+.. ++.++|||||||++|||++|+.||........... ... . ...++. ..
T Consensus 153 ~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~----~~~-~------~~~~~~----~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQ-E------PLRFPD----GF 216 (312)
T ss_pred ccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH----HHc-C------CCCCCC----cC
Confidence 46899999999986554 89999999999999999999999986554322111 110 0 112222 23
Q ss_pred HHHHHHHHHHccCCCCCCCC---CHHHHHHhccccch
Q 046972 397 LKRIILIALRCVDPDIKHRP---KMGDVLRMLEPRDL 430 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rp---t~~eil~~L~~~~~ 430 (483)
...+.+++.+||+.||.+|| ++.+++.+.+..+.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 36788999999999999997 46888887766553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=346.84 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=206.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 366888999999999999999965 57889999986542 12335788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999963 45688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. .....|++.|+|||++.+.. ++.++|||||||++|||++|+.||........... .. .. ...
T Consensus 170 ~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~----i~-~~------~~~ 233 (329)
T PTZ00263 170 DR----TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK----IL-AG------RLK 233 (329)
T ss_pred CC----cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH----Hh-cC------CcC
Confidence 32 12346889999999986554 79999999999999999999999976554322111 10 11 112
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
+|.. ....+.+++.+||+.||.+||+ +.+++.+.+..+
T Consensus 234 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 234 FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 2222 2357889999999999999997 799998877655
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=353.32 Aligned_cols=263 Identities=16% Similarity=0.203 Sum_probs=210.1
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
..+..++|++.+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445678999999999999999999965 57889999986431 2233457889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||++||+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 9999999999999999852 3578889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRT---SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
...............||+.|+|||++... ..++.++|||||||++|||++|+.||...........+. ...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~~~-- 263 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM----DHK-- 263 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH----cCC--
Confidence 86644322233345789999999987543 237899999999999999999999998765432221111 000
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~ 429 (483)
.....+. ....+..+.+++.+||+.+|.+ |+++.+++++.+..+
T Consensus 264 ---~~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 264 ---NSLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ---CcCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 0111121 1123468889999999999998 999999999887655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.23 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=210.5
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|++++.||.|-||.||+|+. +++-.||+|++.+... ...+++.+|+++-+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346788899999999999999995 4577889999976532 234689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
++||.++|+|+..|+.. ....+++...+.+..|+|.||.|+|.+ +||||||||+|+|++..+.+||+|||.+..-
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999743 456789999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. .....+.+||..|.+||...+.. ++..+|+|++|++.||++.|.+||..........++.+ ++-
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-----------~~~ 239 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-----------VDL 239 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-----------ccc
Confidence 3 22334458999999999986554 89999999999999999999999986663333222111 122
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..|.. .+....++|.+|+..+|.+|.+..|++.+.+.
T Consensus 240 ~~p~~----is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 240 KFPST----ISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred cCCcc----cChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 33322 23577889999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=346.91 Aligned_cols=259 Identities=18% Similarity=0.218 Sum_probs=209.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 47899999986542 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999995 345689999999999999999999999 999999999999999999999999999975433
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
......|++.|+|||++.+. .++.++|||||||++|||++|..||...+........... ........
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-------KETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-------cccccCCC
Confidence 22344689999999998655 4899999999999999999999999876554332221110 00011000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
...+....+.++.+++.+||..+|.+||++.+++++.+..+.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 110112334678899999999999999999999999876654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.81 Aligned_cols=247 Identities=21% Similarity=0.249 Sum_probs=200.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.||+|+||.||++... +++.+|+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 58899999997542 223357889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST 314 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 314 (483)
+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 9999985 345689999999999999999999999 9999999999999999999999999998753221 1122
Q ss_pred cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 315 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+........ . .....+|..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~----~-------~~~~~~p~~--- 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----L-------MEDIKFPRT--- 217 (328)
T ss_pred ccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh----c-------cCCccCCCC---
Confidence 3346899999999986544 899999999999999999999999765543221110 0 011222322
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 395 KELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
.+..+.+++.+||..||.+|| ++.+++++.+...
T Consensus 218 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 218 -LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred -CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 236788999999999999997 8999999876644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=351.07 Aligned_cols=258 Identities=19% Similarity=0.240 Sum_probs=204.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||.|+||+||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999965 57889999996532 122356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999875422
Q ss_pred Cccc-------------------------------------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHH
Q 046972 309 EWSI-------------------------------------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEI 351 (483)
Q Consensus 309 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 351 (483)
.... ......||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el 232 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEM 232 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHh
Confidence 1100 011235899999999986554 89999999999999999
Q ss_pred HcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHhcccc
Q 046972 352 VSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK---MGDVLRMLEPR 428 (483)
Q Consensus 352 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~eil~~L~~~ 428 (483)
++|..||............. . .......+. ....+..+.+++.+|+. +|.+|++ +.+++++.+..
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~----~-----~~~~~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKII----N-----WKETLQFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHH----c-----CCCccCCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence 99999998765433221111 0 000111111 11233577888889996 9999998 99999988765
Q ss_pred ch
Q 046972 429 DL 430 (483)
Q Consensus 429 ~~ 430 (483)
..
T Consensus 301 ~~ 302 (364)
T cd05599 301 GV 302 (364)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=323.64 Aligned_cols=259 Identities=19% Similarity=0.247 Sum_probs=211.0
Q ss_pred HhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
..+.|++-++||+|.|+.||++. ..+|+.+|+|.+..+.. .+.+++.+|+++.+.|+|||||++.+...+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34668888899999999999998 44688899998865533 3457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeeccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVGLAK 304 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFGla~ 304 (483)
+|+|.||+|..-+-. ...+++..+-+.+.||++||.|+|.+ +|||||+||+|+|+.. ..-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999877742 25578889999999999999999999 9999999999999953 3458999999999
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
.++.. .......||++|||||++.+.+ |+..+|||+.||+||-|+.|.+||.+.+....+..+.. +
T Consensus 162 ~l~~g--~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~-----g------ 227 (355)
T KOG0033|consen 162 EVNDG--EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA-----G------ 227 (355)
T ss_pred EeCCc--cccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-----c------
Confidence 87732 2223458999999999996555 99999999999999999999999987665433322211 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
+...+........++..+|+.+||..||.+|.|+.|.|.+.|..+.
T Consensus 228 ~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 228 AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 1223333334455688899999999999999999999998887654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.80 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=203.2
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4588889999999999999998888889999886443 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999642 23588999999999999999999999 9999999999999999999999999999865432222
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.... ++.++|||||||++|||++ |+.||............ ... ..+..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----~~~------~~~~~~~- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----SRG------FRLYRPK- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCC------CCCCCCC-
Confidence 222223456799999986544 8999999999999999999 99999765543222111 110 0111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+..+.+++.+||+.||++||++.++++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=334.16 Aligned_cols=257 Identities=22% Similarity=0.367 Sum_probs=208.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 44577899999999999999999988888999998765432 35689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.++++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999643 345688889999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||.+.... ++.++|||||||++|+|++ |..||...........+ .. ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-----~~-----~~~~-- 223 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-----QR-----GYRM-- 223 (261)
T ss_pred ceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-----Hc-----CCCC--
Confidence 222222234566799999985544 7899999999999999998 99999765443222111 00 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+ .....+..+.+++.+||..||++||++.++++.|+.
T Consensus 224 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 P--RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 111234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.32 Aligned_cols=247 Identities=20% Similarity=0.228 Sum_probs=199.9
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999954 68899999986542 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST 314 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 314 (483)
+|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 9999985 345689999999999999999999999 9999999999999999999999999998753221 1122
Q ss_pred cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 315 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
....|++.|+|||++.+. .++.++|||||||++|||++|+.||...+......... . ....+|.
T Consensus 153 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-----~------~~~~~p~---- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----M------EEIRFPR---- 216 (323)
T ss_pred ccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-----c------CCCCCCC----
Confidence 234688999999998654 48999999999999999999999997655433221111 0 1112222
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 395 KELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
..+..+.+++.+||+.||++|| ++.+++++.+...
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 2336788999999999999998 8999998776544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=354.07 Aligned_cols=264 Identities=23% Similarity=0.396 Sum_probs=206.3
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
.+.+..++|.+.+.||+|+||.||+|+.. ++..||+|++..... .....+.+|+++++.+ +|||||+++++|
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34566678999999999999999999842 235799999976533 3346788999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhccc------------------------------------------------------
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSL------------------------------------------------------ 244 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------ 244 (483)
...+..++|||||++|+|.++++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999985321
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 245 ------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 245 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
....++++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 0123578889999999999999999999 9999999999999999999999999999765332211
Q ss_pred -cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 313 -STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 313 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
......++..|+|||++.+.. ++.++|||||||++|||++ |+.||.............. . ...+..+.
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~-----~~~~~~~~ 338 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----R-----GYQMSRPD 338 (374)
T ss_pred eeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----c-----ccCccCCC
Confidence 112223456799999985544 8999999999999999997 9999976543322111111 0 11111221
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. .+.++.+++.+||+.||++|||+.++++.|+.
T Consensus 339 ~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 F----APPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 23678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=349.58 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=210.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999965 68899999986532 133467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999963 35789999999999999999999998 999999999999999999999999999986543
Q ss_pred Cc----------------------------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046972 309 EW----------------------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY 360 (483)
Q Consensus 309 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~ 360 (483)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCC
Confidence 32 1122334689999999998655 489999999999999999999999987
Q ss_pred CCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHhccccchhh
Q 046972 361 SQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-MGDVLRMLEPRDLLL 432 (483)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~eil~~L~~~~~~~ 432 (483)
.........+.. ......++... ..+..+.+++.+||. ||.+||+ +.+++++.+......
T Consensus 233 ~~~~~~~~~i~~---------~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 233 DTLQETYNKIIN---------WKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCHHHHHHHHhc---------cCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 664322211110 00011122111 134688899999997 9999999 999999887765433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.96 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=208.3
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4567799999999999999999998888889999986543 245679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999653 235689999999999999999999999 9999999999999999999999999999876533
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
..........+..|+|||++.+. .++.++|||||||++|||++ |+.||...........+ . . .....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~-~-----~~~~~- 224 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV----D-Q-----GYRMP- 224 (261)
T ss_pred cccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----H-c-----CCCCC-
Confidence 22111222234579999988554 48999999999999999999 99999765543222111 0 0 00011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.38 Aligned_cols=268 Identities=17% Similarity=0.217 Sum_probs=210.3
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEe
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 220 (483)
+.++.+..++|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999965 57788999985421 2233567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999952 3578889999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRT---SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
|+++..............||+.|+|||++... ..++.++|||||||++|||++|..||...+.......+. ..
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~----~~ 262 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM----NH 262 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH----cC
Confidence 99987654333333445789999999998543 237899999999999999999999998665432221111 00
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccchh
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~~~ 431 (483)
. .....+. ....+..+.+++.+||..++.+ |+++.+++++.+..+..
T Consensus 263 ~-----~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 263 K-----NSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred C-----CcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0 0011111 1123467888899999844443 78999999998765543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=330.17 Aligned_cols=261 Identities=21% Similarity=0.225 Sum_probs=217.5
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchH---HHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEE---EDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
..+..+.|++.+.||+|.-|+||++..++ +..+|+|++.+.....+ .+...|-+||+.++||.++.+|..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34455668889999999999999999766 47889999987654433 466779999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+|||||+||+|...+++. ..+.+++..++.++.+|+.||+|||-. |||.|||||+||||-++|++-|+||.|+
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred eEEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence 99999999999999998764 567899999999999999999999998 9999999999999999999999999987
Q ss_pred cccCC---------------------------------Ccc----------------------ccccccccCcccccccc
Q 046972 304 KLHGP---------------------------------EWS----------------------ISTSCELRNSGYLAEEL 328 (483)
Q Consensus 304 ~~~~~---------------------------------~~~----------------------~~~~~~~~~~~y~aPE~ 328 (483)
..... ... ......+||..|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 53210 000 01122478999999999
Q ss_pred cCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHcc
Q 046972 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCV 408 (483)
Q Consensus 329 ~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 408 (483)
+.+.+ .+.++|+|+|||++|||++|..||.+.+..+.+.+++.+ +..+|..+ ..+..+.+||++.|
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------~l~Fp~~~--~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------PLKFPEEP--EVSSAAKDLIRKLL 372 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------CCcCCCCC--cchhHHHHHHHHHh
Confidence 97766 799999999999999999999999999988777665443 34445433 44568899999999
Q ss_pred CCCCCCCCC----HHHHHHhccc
Q 046972 409 DPDIKHRPK----MGDVLRMLEP 427 (483)
Q Consensus 409 ~~dP~~Rpt----~~eil~~L~~ 427 (483)
.+||.+|.. +.||-++.-.
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred ccChhhhhccccchHHhhcCccc
Confidence 999999998 8888876644
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.68 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=199.3
Q ss_pred ceeccCCceEEEEEEE----cCCcEEEEEEecCCC----cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVL----LDNMRAAVKLLMSNS----VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.||+|+||.||+++. ..++.+|+|++.... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999986532 12235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++. ....+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999995 345688889999999999999999999 99999999999999999999999999987533221
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......|++.|+|||++.+.. ++.++|||||||++|||++|+.||...+......... .. ...++.
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~-----~~------~~~~~~ 221 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-----KG------KLNLPP 221 (323)
T ss_pred C-cccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cC------CCCCCC
Confidence 1 223346899999999986554 7899999999999999999999998765433221111 00 112222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
. ....+.+++.+||+.||++|| ++.+++++.+...
T Consensus 222 ~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 222 Y----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred C----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 2 235788999999999999999 8999999876544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.92 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=213.7
Q ss_pred HHHhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC-----C
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----Q 222 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 222 (483)
-+..++|++.++||+|||+-||++. ..++..+|+|++......+.+..++|++..++++||||++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3556789999999999999999999 567888999999998877888999999999999999999999987544 3
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|++++|+..|+|.+.+.....++.-+++.+.+.|+.+|++||.+||+. .+.+.||||||.|||+.+++.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999987766777899999999999999999999997 33599999999999999999999999999
Q ss_pred ccccCCCcc--------ccccccccCcccccccccCCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH
Q 046972 303 AKLHGPEWS--------ISTSCELRNSGYLAEELSGRT--SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 303 a~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~ 372 (483)
++.....-. ........|..|+|||++.-. ...++++|||||||+||+|+.|..||+..-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 875432110 111223567789999987532 3378999999999999999999999963221
Q ss_pred HHHHhhhhh-hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 373 SMVAQQKIA-YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 373 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.+. .+.++..........++.+.+++..||+.||.+||++.+++..+..
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111121 1122222221222366899999999999999999999999988753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.26 Aligned_cols=253 Identities=19% Similarity=0.265 Sum_probs=205.0
Q ss_pred CCcccceeccCCceEEEEEEEc-C-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-D-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.|.+.+.||.|+||.||+|... + +..||+|.+..........+.+|+.+++.++|||||++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999843 3 5678888776555444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++........++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999865444556789999999999999999999999 999999999999999999999999999986643322
Q ss_pred c-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 312 I-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 312 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... ... + ... ..+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~----~~~-~----~~~-~~~- 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ----VLY-G----KYD-PFP- 292 (478)
T ss_pred cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh-C----CCC-CCC-
Confidence 1 22334689999999998654 489999999999999999999999976543322111 110 0 011 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
...+..+.+++.+||..||++||++.+++..
T Consensus 293 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 293 ---CPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 2233678899999999999999999999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.67 Aligned_cols=264 Identities=17% Similarity=0.216 Sum_probs=208.3
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
......++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 44456688999999999999999999965 4778999998642 1223356889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999952 3578899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRT---SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
|...............||+.|+|||++.+. ..++.++|||||||++|||++|+.||...........+.. .
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~----~-- 262 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD----H-- 262 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--
Confidence 987644333233345789999999998543 2378899999999999999999999986654332211110 0
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~ 429 (483)
......+. ....+..+.+++.+||..++.+ |+++.+++++.+...
T Consensus 263 ---~~~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 263 ---KNSLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ---CcccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 00111121 1123457788888999865544 899999999987655
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.39 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=206.1
Q ss_pred hcCCcccceeccCCceEEEEEEEcCC------cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDN------MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||+|+||.||+|..... ..+++|.+..... .....|.+|++++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 35688899999999999999985432 5789998875533 2346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC
Q 046972 225 ILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH 292 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~ 292 (483)
+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999964311 115688899999999999999999999 99999999999999999
Q ss_pred CCcEEeecccccccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHH
Q 046972 293 WNPKISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDW 370 (483)
Q Consensus 293 ~~~kl~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~ 370 (483)
+.+||+|||+++...... ........++..|+|||.+.... ++.++|||||||++|||++ |..||.+.........
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~- 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM- 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence 999999999997543221 12223345678899999885544 8999999999999999998 9999976554322111
Q ss_pred HHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. ....+ ..+..++..+.+++.+||+.||.+||++.+++++|..
T Consensus 239 ----i~--------~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IR--------SRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HH--------cCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11111 1223455789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.91 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=198.9
Q ss_pred cCCcccceeccCCceEEEEEEEc--CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcC---CCCcccccccEEE-----e
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL--DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQV---KHKNLVKLFGYCV-----E 220 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~-----~ 220 (483)
++|++.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 4678999988654322 234566777776665 6999999999985 2
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 5999999643 234589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-- 378 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-- 378 (483)
|+++..... .......++..|+|||.+.+.. ++.++|||||||++|||++|+.||.+......+..+........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999865433 2223446789999999986544 89999999999999999999999987766544433332110000
Q ss_pred hhh-------hhcCCCCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIA-------YVLDPKLPE---MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~-------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
... ....+..+. .........+.+++.+||+.||++|||+.+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 000 000000000 000122356789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.21 Aligned_cols=269 Identities=20% Similarity=0.324 Sum_probs=206.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+..++|++.+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34578999999999999999999965 577888888765432 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999963 35688999999999999999999974 179999999999999999999999999987543
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----------
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA----------- 376 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------- 376 (483)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcc
Confidence 22 12233678899999998654 4899999999999999999999999754432111 00000000
Q ss_pred ---------------------hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 ---------------------QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+.....+.........++.+|+.+||+.||++|||+.+++++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000111111111111123467889999999999999999999998766544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=351.37 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=202.3
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.+|++.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+++++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999954 578899999865321 22356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999953 35688999999999999999999999 999999999999999999999999999853210
Q ss_pred Cc------------------------------------------cccccccccCcccccccccCCCCCCCcchhhHHHHH
Q 046972 309 EW------------------------------------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGI 346 (483)
Q Consensus 309 ~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv 346 (483)
.. ........||+.|+|||++.+.. ++.++|||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGv 232 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGV 232 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccc
Confidence 00 00011236899999999986554 899999999999
Q ss_pred HHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHH
Q 046972 347 LIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP---KMGDVLR 423 (483)
Q Consensus 347 ~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---t~~eil~ 423 (483)
++|||++|+.||....+........ . .......+ .....+..+.+++.+|+ .+|.+|+ ++.++++
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~----~-----~~~~~~~~--~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVI----N-----WETTLHIP--SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHh----c-----cCccccCC--CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999998766533221110 0 00001111 11123356777787866 5999999 9999999
Q ss_pred hccccchh
Q 046972 424 MLEPRDLL 431 (483)
Q Consensus 424 ~L~~~~~~ 431 (483)
+.+.....
T Consensus 301 h~~~~~~~ 308 (376)
T cd05598 301 HPFFKGID 308 (376)
T ss_pred CCCcCCCC
Confidence 87765543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.23 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=210.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
...+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999888999999999776655567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999753 345689999999999999999999999 99999999999999999999999999998654332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||............ . ....+.
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~------~~~~~~-- 224 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----T------AGYRMP-- 224 (261)
T ss_pred cc-ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----H------hCCcCC--
Confidence 22 2233456789999998654 48999999999999999998 89999765533222111 0 001111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 122344688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=337.90 Aligned_cols=251 Identities=26% Similarity=0.307 Sum_probs=199.8
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHH---hcCCCCcccccccEEEeCCeEEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAI---GQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 57899999986542 12234566666654 567899999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|..++. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999999884 34689999999999999999999999 99999999999999999999999999987432
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. ........|++.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+ .. . .+.
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i----~~-~------~~~ 219 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----VN-D------EVR 219 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-C------CCC
Confidence 21 11223346889999999986544 899999999999999999999999876543322111 11 0 122
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
.+. ..+..+.+++.+||+.||.+|| ++.+++++.+..+.
T Consensus 220 ~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 220 YPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 222 2236788999999999999999 68888888766553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=344.68 Aligned_cols=259 Identities=18% Similarity=0.197 Sum_probs=207.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||+||+|... +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999954 688899999875422 23356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999642 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CccccccccccCcccccccccCC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 309 EWSISTSCELRNSGYLAEELSGR-----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..........||+.|+|||++.. ...++.++|||||||++|||++|+.||...........+. ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~----~~~~---- 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM----NFQR---- 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH----cCCC----
Confidence 33333334468899999999852 3347899999999999999999999997665433222111 1000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+. ....+..+.+++.+||. ||.+|||+.+++.+.+...
T Consensus 227 -~~~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 227 -FLKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred -ccCCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 011111 11233678889999998 9999999999998876544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.35 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=205.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
...+|.+.+.||+|+||.||+|... .++.+|+|.+... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3456888999999999999999965 4778999988654 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999643 234689999999999999999999999 9999999999999999999999999999866443
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||.+.+.. ++.++|||||||++|||++ |..||.......... . +.....+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~----~------~~~~~~~~~ 226 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----L------LEKGYRMER 226 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----H------HHCCCCCCC
Confidence 222222223456799999885444 8999999999999999998 999997654332111 1 111111122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+ ..++..+.+++.+||..||++|||+.++++.|+.
T Consensus 227 ~----~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 227 P----EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred C----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 2 2334688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.64 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=218.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc---hHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 225 (483)
..+.|++.+.||.|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||++++++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999999665 899999999776443 3468999999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC----CCcEEeecc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH----WNPKISDVG 301 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~----~~~kl~DFG 301 (483)
+|||+|.||.|++.+... .+++..+..++.||+.|+.|||+. ||+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999643 399999999999999999999998 99999999999999543 479999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+|..... .......+||+.|+|||++...+ |+..+||||+||++|.|++|..||.+.........+.. +
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-----~--- 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-----G--- 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-----C---
Confidence 9998766 33445568999999999996444 99999999999999999999999998876554432211 1
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+..+...+.......+.+++.+||..||.+|+|+.++|++.|...
T Consensus 254 ---~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 254 ---DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 224444555666788999999999999999999999999987554
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=328.99 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=203.7
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....|.+|+.++.+++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 46788899999999999999987777899999875433 34679999999999999999999999998888999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999642 23689999999999999999999999 9999999999999999999999999998865433222
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||...... ++.++|||||||++|||++ |..||........... ... . ..+..+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~-~-----~~~~~~~- 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK----VSQ-G-----LRLYRPH- 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----Hhc-C-----CCCCCCC-
Confidence 222234556799999986544 8999999999999999999 9999976554321111 100 0 0111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..+..+.+++.+||+.||.+||++.++++.|+
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 22368899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.06 Aligned_cols=248 Identities=19% Similarity=0.229 Sum_probs=199.7
Q ss_pred ceeccCCceEEEEEEE-cCCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 159 NVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.||+|+||.||+|.. .++..+|+|++.... ......+..|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 467899999987542 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
+|..++. ....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9999985 34568999999999999999999997 6 99999999999999999999999999987532221 12
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||..|+|||++.+.. ++.++|||||||++|||++|+.||............ . .....++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-----~------~~~~~~p~~-- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----L------MEEIRFPRT-- 218 (325)
T ss_pred cccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-----h------cCCCCCCCC--
Confidence 22346899999999986544 899999999999999999999999765543221111 0 011222222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 394 RKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
....+.+++.+||+.||++|+ ++.+++++.+....
T Consensus 219 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 219 --LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 235788899999999999996 89999998776543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=336.66 Aligned_cols=247 Identities=23% Similarity=0.277 Sum_probs=194.3
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.||+|.+.... ....+.+..|..++..+ +||||+++++++......++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 47789999986532 12334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999999953 35689999999999999999999999 99999999999999999999999999997543221 12
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+ .. ..+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~-------~~~~~~~~-- 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI----LN-------DRPHFPRW-- 218 (316)
T ss_pred cccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hc-------CCCCCCCC--
Confidence 23346899999999986554 899999999999999999999999876543322111 00 11222222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHH-HHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMG-DVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~-eil~~L~~~~ 429 (483)
....+.+++.+||+.||.+||++. +++++.....
T Consensus 219 --~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 219 --ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred --CCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 335778899999999999999875 6766655433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=347.53 Aligned_cols=257 Identities=18% Similarity=0.240 Sum_probs=200.8
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.|+..+.||+|+||+||+|+.. +++.+|+|++..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999854 578899999965422 233578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999963 35688999999999999999999999 9999999999999999999999999998643110
Q ss_pred cc----------------------------------------------ccccccccCcccccccccCCCCCCCcchhhHH
Q 046972 310 WS----------------------------------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYS 343 (483)
Q Consensus 310 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwS 343 (483)
.. .......||..|+|||++.+.. ++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwS 233 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWS 233 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceee
Confidence 00 0011246899999999986554 899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHHHH
Q 046972 344 FGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALR--CVDPDIKHRPKMGDV 421 (483)
Q Consensus 344 lGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rpt~~ei 421 (483)
|||++|||++|..||....+........ ........+. ......++.+++.+ |+..+|..||++.++
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~---------~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVI---------NWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHH---------ccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999998765433221111 0000111111 11233567778877 556667779999999
Q ss_pred HHhccccc
Q 046972 422 LRMLEPRD 429 (483)
Q Consensus 422 l~~L~~~~ 429 (483)
+.+.+...
T Consensus 303 l~hp~f~~ 310 (381)
T cd05626 303 KAHPFFSE 310 (381)
T ss_pred hcCcccCC
Confidence 99877654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=344.26 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=217.0
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcC-----CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEe
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 220 (483)
..++.++..+..+.||+|.||.||.|.+.+ .-.||||..+.++ ..+.+.|+.|..+|+.++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 345566677778899999999999999643 2347999988764 4456889999999999999999999999975
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
...++|||+++-|.|..||+. +...++......++.||+.||.|||+. ++|||||..+|||+...-.+||+||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred -cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 568999999999999999984 456789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
|+++.+........+...-+..|||||.+. -..++.++|||-|||.+||++. |..||.+-.+.+.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------------- 601 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------------- 601 (974)
T ss_pred chhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------------
Confidence 999998877666666666778999999985 4449999999999999999998 9999987654321
Q ss_pred hhhhcCC-CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 380 IAYVLDP-KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 380 ~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+..+-+. ++| .+++|+..+..|+.+||..||.+||.+.++...|...
T Consensus 602 I~~iEnGeRlP--~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 602 IGHIENGERLP--CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred EEEecCCCCCC--CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 1111122 222 4557778999999999999999999999999888653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.93 Aligned_cols=268 Identities=19% Similarity=0.227 Sum_probs=202.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC--------
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-------- 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-------- 221 (483)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999964 57889999885432 2345799999999999999999887432
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeec
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDV 300 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DF 300 (483)
..+++||||+++ +|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 78887754434557799999999999999999999999 999999999999998665 6999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--h
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--Q 378 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~ 378 (483)
|+|+....... .....+|+.|+|||++.+...++.++|||||||++|||++|.+||.+......+..+....... .
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986543221 2234678899999998665568999999999999999999999998776554444332211000 0
Q ss_pred hhh----hhcCCCCCCC--------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 379 KIA----YVLDPKLPEM--------PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 379 ~~~----~~~~~~~~~~--------~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+. ...+..++.. .+...+.++.+|+.+||..||.+|||+.|++++.+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 000 0000011111 1112346789999999999999999999999887653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.27 Aligned_cols=265 Identities=16% Similarity=0.215 Sum_probs=201.0
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+..++|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++|||||++++++......++||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 34578999999999999999999954 57889999643 245789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|++. ++|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 163 e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 69999985 335688999999999999999999999 999999999999999999999999999975432
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc-------hhhHHHHHHHHHH-----
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP-------QVFLIDWLKSMVA----- 376 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~----- 376 (483)
..........||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ...+..++.....
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ccccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 2222233447899999999986554 89999999999999999999988743321 1111111110000
Q ss_pred ----hhhhh---------hhcCCCCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 ----QQKIA---------YVLDPKLPEM--PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ----~~~~~---------~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+. ....+..... .....+.++.+++.+||+.||.+|||+.|++++.+...
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000 0000100000 00123467889999999999999999999998776543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.47 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=198.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57889999986532 22345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999999853 35689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+ . .. ....+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i----~-~~------~~~~~~--- 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI----L-ND------EVVYPT--- 217 (320)
T ss_pred ccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH----h-cC------CCCCCC---
Confidence 2334689999999998654 4899999999999999999999999876543322111 1 00 111222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH------HHHHHhccccch
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKM------GDVLRMLEPRDL 430 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~------~eil~~L~~~~~ 430 (483)
.....+.+++.+||+.||++||++ ++++.+.+....
T Consensus 218 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 218 -WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 223678899999999999999998 888887766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=331.89 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=206.0
Q ss_pred hcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|.+.+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568888999999999999998643 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 225 ILVYEYIDNGNLQQWLHGSL----------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996532 1234578899999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~ 372 (483)
+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||............
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~-- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--
Confidence 99999999975432211 1122334567899999986554 8999999999999999998 99999765543221110
Q ss_pred HHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
. ....+ ..+...+..+.+++.+||..||++||++.|+++.|.
T Consensus 238 ---~--------~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---T--------QGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---H--------cCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 11111 112234468899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=348.32 Aligned_cols=257 Identities=18% Similarity=0.232 Sum_probs=200.3
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.|+..+.||+|+||+||+|+.. +++.+|+|.+..... .....+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999954 577899999865422 223578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999953 35688999999999999999999999 9999999999999999999999999997532100
Q ss_pred c----------------------------------------------cccccccccCcccccccccCCCCCCCcchhhHH
Q 046972 310 W----------------------------------------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYS 343 (483)
Q Consensus 310 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwS 343 (483)
. ........||+.|+|||++.+.. ++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwS 233 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS 233 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEe
Confidence 0 00011236899999999986554 899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHH
Q 046972 344 FGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK---MGD 420 (483)
Q Consensus 344 lGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~e 420 (483)
|||++|||++|+.||...++......... .......|. ......++.+++.+|+ .||.+|++ +.+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~---------~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVIN---------WQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHc---------cCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999999987654332211110 001111111 1122356777777765 59999997 999
Q ss_pred HHHhccccch
Q 046972 421 VLRMLEPRDL 430 (483)
Q Consensus 421 il~~L~~~~~ 430 (483)
++++.+....
T Consensus 302 i~~hp~f~~~ 311 (382)
T cd05625 302 IKAHPFFKTI 311 (382)
T ss_pred HhcCCCcCCc
Confidence 9987765543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=349.32 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=207.1
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCC-CCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVK-HKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 218 (483)
.+.+..++|++.++||+|+||.||+|.... +..||+|++..... ...+.+.+|+++++++. |||||++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 345567889999999999999999998532 34699999975433 33467999999999996 99999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC-----------------------------------------------------
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG----------------------------------------------------- 245 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------- 245 (483)
.+.+..|+|||||++|+|.++|.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999999864210
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 246 ---------------------------------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 246 ---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
....+++..+..++.||+.||.|||++ +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 113478888999999999999999999 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCch
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~ 364 (483)
||++.++.+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999986543221 1222335667899999986544 8999999999999999997 99999765432
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....... ... .... .+..++..+.+++.+||+.||++||++.++.+.|+.
T Consensus 347 ~~~~~~~----~~~-----~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 347 STFYNKI----KSG-----YRMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHHHHHH----hcC-----CCCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 2211111 000 1111 122344688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=337.00 Aligned_cols=247 Identities=19% Similarity=0.259 Sum_probs=198.6
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 46789999986532 22335677889988866 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99999985 335689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....|+..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.. . +...|..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-----~------~~~~p~~-- 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----D------DVLYPVW-- 218 (321)
T ss_pred ccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc-----C------CCCCCCC--
Confidence 23346889999999986544 89999999999999999999999987665433221110 0 1112221
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRP-------KMGDVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rp-------t~~eil~~L~~~~ 429 (483)
....+.+++.+||+.||++|| ++.+++++.+...
T Consensus 219 --~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 219 --LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred --CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 236788999999999999999 8999998876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.50 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=197.8
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.||+|++..... .....+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 578899999975422 2235678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99999985 345799999999999999999999999 9999999999999999999999999998742211 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc----hhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP----QVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.....||..|+|||++.+.. ++.++|||||||++|||++|+.||..... .....++........ ...+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~p 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------QIRIP 225 (329)
T ss_pred cccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC------CCCCC
Confidence 23346899999999986544 89999999999999999999999963221 111111111111111 12223
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHhccccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPK------MGDVLRMLEPRD 429 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt------~~eil~~L~~~~ 429 (483)
.. .+..+.+++.+||+.||.+||+ +.+++++.+...
T Consensus 226 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 226 RS----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CC----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 22 2357888999999999999997 789998876654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.32 Aligned_cols=259 Identities=21% Similarity=0.366 Sum_probs=208.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999954 68899999875432 223357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.........+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999864333445688999999999999999999999 999999999999999999999999999886543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... ......++..|+|||.+.+.. ++.++|+||||+++|||++|+.||....... ..+... +. ....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~------~~---~~~~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--FSLCQK------IE---QCDY 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccH--HHHHHH------Hh---cCCC
Confidence 321 122335778899999986554 7899999999999999999999996543221 111111 11 1122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..+....+..+.+++.+||..+|++||++.++++.+..
T Consensus 226 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 333334455789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=333.82 Aligned_cols=249 Identities=33% Similarity=0.546 Sum_probs=194.6
Q ss_pred ccceeccCCceEEEEEEEc-----CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 157 EQNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.+.||.|.||.||+|.+. .+..|+||.+..... ...+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 367789999965433 3467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.++|... ....+++..++.++.||+.||.|||++ +++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999754 346789999999999999999999999 99999999999999999999999999998763221
Q ss_pred -cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 311 -SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 311 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
............|+|||.+.... ++.++||||||+++|||++ |+.||.......... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~----~~~~~~------~~~- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE----KLKQGQ------RLP- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH----HHHTTE------ETT-
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc----cccccc------cce-
Confidence 22233345677899999985444 8999999999999999999 789997664432211 111111 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+..++..+.+++.+||..||++|||+.++++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1223447899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=344.60 Aligned_cols=270 Identities=20% Similarity=0.235 Sum_probs=212.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-C-----CcccccccEEEeCC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-H-----KNLVKLFGYCVEGQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~ 222 (483)
...-+|.+.+.||+|+||.|.+|.. .+++.||||+++.... -..+...|+.+|..|+ | -|+|+++++|...+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3344789999999999999999995 4588999999976532 3356778999999996 3 38999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC--CcEEeec
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW--NPKISDV 300 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~--~~kl~DF 300 (483)
++|||+|.+. -+|+++|+.+ ...+++...++.|+.||+.||.+||+. +|||+||||+||||.+.+ .+||+||
T Consensus 262 HlciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence 9999999995 4999999875 556799999999999999999999999 999999999999997654 5899999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH-------
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS------- 373 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~------- 373 (483)
|.|........ ...-+..|+|||++.+.+ |+.+.||||||||+.||++|.+.|.+.++.+++..+..-
T Consensus 336 GSSc~~~q~vy----tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 336 GSSCFESQRVY----TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred ccccccCCcce----eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 99987654322 445677899999998887 999999999999999999999999998877666544431
Q ss_pred HHHhh-hhhh---------------------------------hcCCCCC-CCC------CHHHHHHHHHHHHHccCCCC
Q 046972 374 MVAQQ-KIAY---------------------------------VLDPKLP-EMP------SRKELKRIILIALRCVDPDI 412 (483)
Q Consensus 374 ~~~~~-~~~~---------------------------------~~~~~~~-~~~------~~~~~~~l~~l~~~cl~~dP 412 (483)
+.... +... ..+...| ... ....-..+.+++.+||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 00000 0000 0111112 000 01223578999999999999
Q ss_pred CCCCCHHHHHHhccccchh
Q 046972 413 KHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 413 ~~Rpt~~eil~~L~~~~~~ 431 (483)
.+|+|+.+++++.+.....
T Consensus 491 ~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGTS 509 (586)
T ss_pred hhcCCHHHHhcCccccccc
Confidence 9999999999988766433
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.69 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=206.8
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCC-----eEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-----NRI 225 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 225 (483)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 468899999986532 223467889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888884 345789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH----------
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV---------- 375 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---------- 375 (483)
.............++..|+|||++.+...++.++|||||||++|||++|+.||...++...+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 5443333333446788999999987666689999999999999999999999987665433322211000
Q ss_pred Hhhhhhhhc-CCCCCCC------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 AQQKIAYVL-DPKLPEM------PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ~~~~~~~~~-~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+. .+..+.. ........+.+++.+||+.||++|||+.+++++.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000000000 0110100 11122467889999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=328.07 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=205.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|++.++||+|+||.||+|...++..||+|.+..... ..+.|.+|+++++.++||||+++++++. ....++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 34567999999999999999999987777899999875332 3467899999999999999999999874 456799999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999643 234578999999999999999999999 9999999999999999999999999999866543
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||+..+.. ++.++|||||||++|||++ |..||........... . .. ..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~------~~----~~ 220 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V------ER----GY 220 (262)
T ss_pred ccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----H------hc----CC
Confidence 322222334567899999885544 8999999999999999999 8889976554322111 0 00 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.......+..+.+++.+||+.||++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 111123345788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.55 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=199.9
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCC-CcccccccEEEeCCeEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKH-KNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 228 (483)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999965 46789999986532 2234578889999999976 56888999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999995 335688999999999999999999999 999999999999999999999999999874321
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. ........||..|+|||++.+.. ++.++|||||||++|||++|+.||...........+. . ....+
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----~-------~~~~~ 220 (324)
T cd05587 154 G-GKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM----E-------HNVSY 220 (324)
T ss_pred C-CCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----c-------CCCCC
Confidence 1 11222346899999999986554 8999999999999999999999998665433221111 0 11222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~ 428 (483)
+.. ....+.+++.+||..||.+|++. .+++++....
T Consensus 221 ~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~ 261 (324)
T cd05587 221 PKS----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261 (324)
T ss_pred CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence 222 23678899999999999999986 6777765543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=326.98 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=202.9
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....|.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45788899999999999999988778899999865433 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999643 23689999999999999999999999 9999999999999999999999999999765432221
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.+.. ++.++|||||||++|||++ |+.||....+..... . +........+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~------~~~~~~~~~~-- 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----S------VSAGYRLYRP-- 223 (256)
T ss_pred ccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----H------HHcCCcCCCC--
Confidence 122223345799999986544 8999999999999999999 899997654432211 1 1111111122
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 --KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 123468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=327.42 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=205.7
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 45577899999999999999999988888899999876443 3567999999999999999999999875 456899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999643 234689999999999999999999999 9999999999999999999999999999865443
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||...+. .++.++|||||||++|||++ |..||........... .. ....+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~------~~~~~~~ 224 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VE------RGYRMPC 224 (260)
T ss_pred ccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH------cCCCCCC
Confidence 22222223455679999988544 48899999999999999999 8999976543322111 11 0011111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+...+..+.+++.+||..||++|||+.++++.|+.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22334679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.69 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=198.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566788999999999999965 578999999865533 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+.. ...+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 345778889999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 311 SISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. ......|+..|+|||++.. ....+.++|||||||++|||++|+.||......... ...... .....+
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~------~~~~~~ 294 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA-SLMCAI------CMSQPP 294 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHH------hccCCC
Confidence 1 1233478999999998742 222456899999999999999999999743322111 111000 000111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. .......+.+++.+||+.||++|||+.|++++.+...
T Consensus 295 ~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 295 EA----PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred CC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 11 2233468899999999999999999999999876544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=344.49 Aligned_cols=259 Identities=20% Similarity=0.231 Sum_probs=200.2
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||+||+|... +++.+|+|++..... .....+.+|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999865 578999999865321 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||+||+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999996 345789999999999999999999999 999999999999999999999999999875432
Q ss_pred Ccc----------------------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcC
Q 046972 309 EWS----------------------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG 354 (483)
Q Consensus 309 ~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg 354 (483)
... .......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhC
Confidence 100 0012346899999999986554 89999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHhccccch
Q 046972 355 RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVD--PDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 355 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~Rpt~~eil~~L~~~~~ 430 (483)
+.||...........+.. .. ....+|... .....+.+++.+++. .++..||++++++++.+....
T Consensus 233 ~~Pf~~~~~~~~~~~i~~-----~~----~~~~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 233 YPPFCSETPQETYKKVMN-----WK----ETLIFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCCCCHHHHHHHHHc-----Cc----CcccCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 999987654332221110 00 011122111 122456666666443 334456899999998776554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=339.55 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=200.8
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeC-----CeEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QNRI 225 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 225 (483)
+|++.+.||+|+||.||+|+.. ++..||+|++... .......+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999954 6889999998643 222345788999999999999999999988643 2479
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|||||. ++|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 69999985 335689999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCcc--ccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH----------
Q 046972 306 HGPEWS--ISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK---------- 372 (483)
Q Consensus 306 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~---------- 372 (483)
...... .......++..|+|||++.+. ..++.++|||||||++|||++|+.||.+......+..+..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 112334688999999998542 3489999999999999999999999976554322111100
Q ss_pred -HHHHh--hhhhhhcCCCCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 373 -SMVAQ--QKIAYVLDPKLPEMPS---RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 373 -~~~~~--~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..... ...........+.... ......+.+++.+||+.||++|||+++++++.+...
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000 0000000111111000 012356789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=346.11 Aligned_cols=257 Identities=17% Similarity=0.206 Sum_probs=201.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999854 67889999986532 123356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999995 345689999999999999999999999 999999999999999999999999999963211
Q ss_pred Ccc-------------c---------------------------------cccccccCcccccccccCCCCCCCcchhhH
Q 046972 309 EWS-------------I---------------------------------STSCELRNSGYLAEELSGRTSIFNEKSDVY 342 (483)
Q Consensus 309 ~~~-------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 342 (483)
... . ......||+.|+|||++.+.. ++.++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw 232 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWW 232 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeE
Confidence 000 0 001236899999999986554 89999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHH
Q 046972 343 SFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHR---PKMG 419 (483)
Q Consensus 343 SlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---pt~~ 419 (483)
||||++|||++|..||...........+.. . .....++. ......++.+++.+||. +|.+| +++.
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~----~-----~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIIN----W-----RETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHc----c-----CCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999999976654332211110 0 00111121 11233578889999997 67765 5999
Q ss_pred HHHHhccccc
Q 046972 420 DVLRMLEPRD 429 (483)
Q Consensus 420 eil~~L~~~~ 429 (483)
+++.+.+...
T Consensus 301 ~~l~hp~~~~ 310 (377)
T cd05629 301 EIKSHPFFRG 310 (377)
T ss_pred HHhcCCCcCC
Confidence 9999887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=330.63 Aligned_cols=253 Identities=20% Similarity=0.199 Sum_probs=200.0
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||+|+||+||+|... +++.+|+|.+...... ..+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 6788999998654322 225678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++.........+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 998854333456789999999999999999999999 999999999999999999999999999976543321 1223
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..|+..|+|||.+.+.. ++.++|||||||++|||++|+.||............... ..... ...+...
T Consensus 157 ~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---------~~~~~--~~~~~~~ 224 (280)
T cd05608 157 YAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------ILNDS--VTYPDKF 224 (280)
T ss_pred cCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---------hcccC--CCCcccC
Confidence 46788999999986554 899999999999999999999999765432211111111 11111 1112234
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 397 LKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
+..+.+++.+||+.||++|| ++++++++.+..+
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 46788999999999999999 7788888765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=331.08 Aligned_cols=260 Identities=20% Similarity=0.360 Sum_probs=204.6
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
++..++|++.+.||+|+||.||+|... .+..+|+|.+..... ....+|.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346678999999999999999999853 246799998865432 3345789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCC------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGE------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~ 295 (483)
...++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999999642211 23467888999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~ 373 (483)
||+|||+++........ ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||...........
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~---- 233 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF---- 233 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 99999999755432221 112234567899999986544 8999999999999999999 7899976554322111
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.. ....+. .+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 234 ~~---------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VM---------EGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH---------cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 111111 11223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.37 Aligned_cols=257 Identities=21% Similarity=0.213 Sum_probs=205.3
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.|+..+.||+|+||+||++... +++.||+|.+...... ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999964 5788999998654322 23457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999988542 235689999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.. .....|+..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.... . . .+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~---------~-~~ 221 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-K---------E-DQ 221 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh-h---------h-cc
Confidence 21 12336788999999986544 8999999999999999999999998655432221111110 0 0 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
...+...+..+.+++.+||..||++|| ++++++++.+...
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 111223446788999999999999999 8999998876654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=340.09 Aligned_cols=263 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYCV 219 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 219 (483)
+.++.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+.++.++ +||||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3456678999999999999999999743 246899999875432 2335688999999999 8999999999886
Q ss_pred e-CCeEEEEEEecCCCCHHHHHhcccCC----------------------------------------------------
Q 046972 220 E-GQNRILVYEYIDNGNLQQWLHGSLGE---------------------------------------------------- 246 (483)
Q Consensus 220 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~---------------------------------------------------- 246 (483)
. +...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 45688999999999999998532110
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccC
Q 046972 247 -----AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRN 320 (483)
Q Consensus 247 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~ 320 (483)
...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 13688999999999999999999999 999999999999999999999999999986533221 222333556
Q ss_pred cccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHH
Q 046972 321 SGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKR 399 (483)
Q Consensus 321 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (483)
..|+|||++.+.. ++.++|||||||++|||++ |..||.+......+...+ ... .....+ ...+..
T Consensus 239 ~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~-----~~~~~~----~~~~~~ 304 (337)
T cd05054 239 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL----KEG-----TRMRAP----EYATPE 304 (337)
T ss_pred ccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH----hcc-----CCCCCC----ccCCHH
Confidence 7899999886554 8999999999999999998 999997654433222111 111 111111 223467
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 400 IILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 400 l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.+++.+||+.+|++||++.+++++|..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.01 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=213.2
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCe-EEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN-RILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~ 228 (483)
++|...+++|.|+||.+++++.+ +.+.+++|.+...... .++...+|+.++++++|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999854 5678899988765433 34578999999999999999999999998888 89999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
+||+||+|.+.+... ++.-+++..+..++.|++.|+.|||++ .|+|||||+.||+++.+..+||+|||+|+.++.
T Consensus 84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999754 246689999999999999999999999 999999999999999999999999999999877
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......||+.|++||.+.+.+ |+.|+|||||||++|||++-+++|...+.......+... ...
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~---------~~~--- 224 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG---------LYS--- 224 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc---------cCC---
Confidence 64 2344568999999999996665 999999999999999999999999877654433322211 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+..++.++..++..||..+|..||++.++|.+.
T Consensus 225 --Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 225 --PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred --CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 12344557899999999999999999999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=355.53 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=207.3
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCC--
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-- 222 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 222 (483)
.....++|.+.+.||+|+||+||+|.. .+++.||+|++..... .....+.+|+..+..++|+||+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557899999999999999999984 4688999999866532 33457889999999999999999988775432
Q ss_pred ------eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 223 ------NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 223 ------~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 36899999999999999976544557799999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 297 l~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
|+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... ...
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~----~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH----KTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHh
Confidence 999999986543221 1223456899999999996544 8999999999999999999999997654322111 111
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..... .++ ...+..+.+++.+||+.||.+||++.+++.+.
T Consensus 259 -----~~~~~-~~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 259 -----AGRYD-PLP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred -----cCCCC-CCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 11111 122 22346788999999999999999999998763
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=333.87 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=198.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.+|+|.+.... ......+..|++++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 47789999987542 22345677899998887 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT 152 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence 99999985 335689999999999999999999999 9999999999999999999999999998743211 111
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....|+..|+|||++.+.. ++.++|||||||++|||++|+.||........... .. . .....+.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~----i~-~------~~~~~~~--- 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS----IL-E------DEVRYPR--- 217 (318)
T ss_pred ccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH----HH-c------CCCCCCC---
Confidence 22346889999999986554 89999999999999999999999976554322111 11 0 0112222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~~ 429 (483)
..+..+.+++.+||+.||.+||++ .+++++.+...
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 218 -WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred -cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 233678899999999999999999 99998876654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.50 Aligned_cols=247 Identities=20% Similarity=0.242 Sum_probs=197.4
Q ss_pred ceeccCCceEEEEEEE----cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 159 NVIASGDNGVVYRAVL----LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
+.||+|+||.||++.. .+++.+|+|++..... .....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578899999875422 233467889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999995 345689999999999999999999999 99999999999999999999999999997643321 1
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (483)
......|+..|+|||.+.+.. ++.++|||||||++|||++|+.||............. .. ...++..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~-----~~------~~~~p~~- 220 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL-----KA------KLGMPQF- 220 (318)
T ss_pred ceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH-----cC------CCCCCCC-
Confidence 223346889999999986544 7899999999999999999999998665432221110 00 1112222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 393 SRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 393 ~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
.+..+.+++.+||+.||++||+ +.+++.+.+...
T Consensus 221 ---~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 221 ---LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred ---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 2367889999999999999999 555666655443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.91 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=204.0
Q ss_pred hcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+|+||.||+|.+.. ...+|+|.+..... .....|.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678899999999999999999643 45789998865533 334679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999643 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC-ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 307 GPE-WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 307 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
... .........++..|+|||.+... .++.++|||||||++|||++ |..||......... . .... . .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~---~~~~-~-----~ 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-K---AVED-G-----Y 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-H---HHHc-C-----C
Confidence 421 11122223445689999988544 48999999999999999998 99999655432211 1 1100 0 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+ .+..++..+.+++.+||+.+|++||++.+++++|..
T Consensus 226 --~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 --RLP--PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --CCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 001 112344688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=336.29 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=199.7
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-Cc----EEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NM----RAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+|+..+.||+|+||.||+|.+.. +. .||+|.+.... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3568899999999999999998543 33 38999986543 23456899999999999999999999998764 567
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999642 34588899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCcccc-ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWSIS-TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+...... .. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~----~~~~~----- 227 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS----ILEKG----- 227 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HH----HHhCC-----
Confidence 65332211 12223456799999986544 8999999999999999998 9999976543221 11 11110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+. +..+...+.+++.+||..||.+||++.+++..+..
T Consensus 228 --~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 228 --ERLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred --CCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111 11234678899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.04 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=206.8
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++..++|++.++||+|+||.||+|...+++.+|+|.+..... ....+.+|+.+++.++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 355678999999999999999999988899999999875543 3467999999999999999999999874 45689999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999998643 335689999999999999999999998 999999999999999999999999999976553
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
..........++..|+|||.+.... ++.++|||||||++|||++ |+.||........... . .......
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~------~~~~~~~ 223 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----L------ERGYRMP 223 (260)
T ss_pred CCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----H------HcCCCCC
Confidence 2222222234567899999985444 7899999999999999999 9999976554322111 1 0001111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+ ...+..+.+++.+||..+|++||++++++..|+.
T Consensus 224 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RP----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 2234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.41 Aligned_cols=262 Identities=17% Similarity=0.187 Sum_probs=203.2
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 5789999998642 1223356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999963 235689999999999999999999999 999999999999999999999999999976544
Q ss_pred CccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 309 EWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..........||+.|+|||++.. ...++.++|||||||++|||++|+.||...........+ .....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i----~~~~~----- 225 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI----MNHKE----- 225 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH----HcCCC-----
Confidence 32222233468999999999852 234788999999999999999999999765433221111 10000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHhccccch
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIK--HRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~Rpt~~eil~~L~~~~~ 430 (483)
...++.. ....+..+.+++.+||..+++ .||++.+++++.+....
T Consensus 226 ~~~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 226 HFQFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred cccCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0111111 111345778888887765444 48899999999876553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.09 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=205.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999842 24568899887665555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 226 LVYEYIDNGNLQQWLHGSL---------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999996432 1223589999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 297 l~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|+|||+++....... .......++..|+|||.+... .++.++|||||||++|||++ |..||............
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i---- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI---- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----
Confidence 999999985533211 112233456789999998544 48999999999999999998 99999765543221111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... ....+. ..+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 236 -~~~~-----~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 236 -TQGR-----VLQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred -HcCC-----cCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1110 011111 233578999999999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.32 Aligned_cols=269 Identities=19% Similarity=0.265 Sum_probs=206.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|.+.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999965 577899999865432 2335678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++ +|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 89888853 234578899999999999999999999 99999999999999999999999999997543321
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----------hhh
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA-----------QQK 379 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-----------~~~ 379 (483)
. ......++..|+|||.+.+...++.++|||||||++|||++|+.||...+.............. ...
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1 1223467889999998866555899999999999999999999999876654333222211000 000
Q ss_pred hhhhcCCCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 IAYVLDPKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+..... ........+.+++.+||+.||.+|||+.|++++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000000000000 00122357789999999999999999999999776544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=323.92 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=207.8
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||.|+||.||+|.. .++..+++|.+..... ....++.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 5788999998765322 23357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++.........+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999865433456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... ...... + .....
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~------~---~~~~~ 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKK------I---EQCDY 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhh------h---hcCCC
Confidence 221 122345788899999985544 7899999999999999999999997543321 111111 1 11112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..+....+..+.+++.+||..||++|||+.+|++.+..
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 222233455789999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=332.55 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=196.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57789999987542 22335677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence 99999885 345689999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc----hhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP----QVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.....||..|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+........ ...+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------~~~~p 225 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------QIRIP 225 (329)
T ss_pred cccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC------CCCCC
Confidence 23346899999999986554 89999999999999999999999953211 111111111111111 12233
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHhccccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPK------MGDVLRMLEPRD 429 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt------~~eil~~L~~~~ 429 (483)
.. ....+.+++.+||+.||++||+ +.+++++.+...
T Consensus 226 ~~----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 226 RS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CC----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 22 2357888999999999999998 478888776544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.91 Aligned_cols=246 Identities=22% Similarity=0.253 Sum_probs=193.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHH-HHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVE-AIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 688899999865321 22234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 99999995 345789999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+........ .. . ...++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~-~------~~~~~~--- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI----LN-K------PLRLKP--- 217 (323)
T ss_pred cccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH----Hc-C------CCCCCC---
Confidence 23346899999999986544 899999999999999999999999865543222111 10 0 111121
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH----HHHHHhcccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKM----GDVLRMLEPR 428 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~----~eil~~L~~~ 428 (483)
..+..+.+++.+||+.||.+||++ .+++++.+..
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 123678899999999999999998 4777665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=332.11 Aligned_cols=247 Identities=21% Similarity=0.266 Sum_probs=195.6
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... ++..||+|.+.... ......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 57889999986542 22335567788887754 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 99999985 335688999999999999999999999 9999999999999999999999999998743211 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||..|+|||++.+.. ++.++|||||||++|||++|+.||...+....... . . ...+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~----~-~------~~~~~~~~~-- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES----I-R------VDTPHYPRW-- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----H-H------hCCCCCCCC--
Confidence 23346899999999986554 89999999999999999999999976554322111 1 0 012223322
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-HHHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKM-GDVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~-~eil~~L~~~~ 429 (483)
...++.+++.+||+.||++||++ ++++++.+...
T Consensus 219 --~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 219 --ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred --CCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 23578889999999999999998 47776665544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=332.94 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=199.5
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+..|..++..+ +||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 467899999875422 2234567788888777 5899999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999985 335689999999999999999999999 999999999999999999999999999975332
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+. . . ....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~----~-~------~~~~ 220 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----E-H------NVAY 220 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH----h-C------CCCC
Confidence 21 1223346899999999986554 8999999999999999999999998765433221111 0 0 1122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~ 428 (483)
|. ....++.+++.+||+.||.+|++. .+++++....
T Consensus 221 p~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~ 261 (323)
T cd05616 221 PK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261 (323)
T ss_pred CC----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence 22 233678899999999999999985 6777665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.31 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=209.1
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++..++|++.+.||.|+||.||+|...+++.+|+|.+..... ..+++.+|+.+++.++||||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 356688999999999999999999988888899999875433 4567999999999999999999999999889999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999653 234689999999999999999999999 999999999999999999999999999986653
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
...........+..|+|||.+.+.. ++.++|||||||++|||++ |+.||............. . .....
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~----~------~~~~~ 224 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE----R------GYRMP 224 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----c------CCCCC
Confidence 2221122223456799999986544 8999999999999999998 999997655433221110 0 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+ ...+..+.+++.+||..||++||++.++++.|+.
T Consensus 225 ~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RP----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11 1224678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.35 Aligned_cols=258 Identities=20% Similarity=0.241 Sum_probs=202.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 57889999986432 223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||++||+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999995 345689999999999999999999999 999999999999999999999999999875422
Q ss_pred Ccc----------------------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcC
Q 046972 309 EWS----------------------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG 354 (483)
Q Consensus 309 ~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg 354 (483)
... .......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccC
Confidence 100 0011346899999999986554 89999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHhccccch
Q 046972 355 RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK---MGDVLRMLEPRDL 430 (483)
Q Consensus 355 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~eil~~L~~~~~ 430 (483)
+.||....+........ . . ......|.. ......+.+++.+++ .||.+|++ +.+++++.+..+.
T Consensus 233 ~~Pf~~~~~~~~~~~i~----~-~----~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 233 YPPFCSETPQETYRKVM----N-W----KETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCCCHHHHHHHHH----c-C----CCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 99998766543221111 0 0 000111111 112356777777876 49999984 7899988776553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=330.87 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=195.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhc-CCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQ-VKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 46789999987542 2233556777888776 4899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999999953 35688999999999999999999999 99999999999999999999999999987432211 11
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||..|+|||++.+.. ++.++|||||||++|||++|..||...+....... . . ...+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----i-~------~~~~~~~~~-- 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS----I-R------MDNPCYPRW-- 218 (316)
T ss_pred eeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH----H-H------hCCCCCCcc--
Confidence 22346889999999986544 89999999999999999999999986554322111 1 0 011222222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHH-HHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMG-DVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~-eil~~L~~~~ 429 (483)
....+.+++.+||+.||++||++. +++++.+...
T Consensus 219 --~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 219 --LTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred --CCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 235788899999999999999997 7777655433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=322.24 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=204.0
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|.+.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+++++.++|||++++++++. .+..++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 34467888999999999999999987777899998765432 3467899999999999999999999875 456799999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999643 234588999999999999999999998 9999999999999999999999999999865433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||...+.. ++.++|||||||++|||++ |+.||....+...... . .....+..
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~------~~~~~~~~ 224 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----V------ERGYRMPC 224 (260)
T ss_pred cccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H------HcCCCCCC
Confidence 222222234566799999885444 8999999999999999999 9999976554322111 1 00011111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+...+..+.+++.+||..||.+||++.++++.|+.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 ----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=328.48 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=206.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 456888899999999999999843 34568899887666555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC
Q 046972 226 LVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~ 293 (483)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999964321 224588999999999999999999999 999999999999999999
Q ss_pred CcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWL 371 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~ 371 (483)
.+||+|||++........ .......++..|+|||.+... .++.++|||||||++|||++ |..||..........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--- 236 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--- 236 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 999999999975543221 122334567789999988654 48999999999999999999 999997655432111
Q ss_pred HHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
. .. ....+. ....++..+.+++.+||+.||++|||+.++++.|...
T Consensus 237 -~-~~--------~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 237 -C-IT--------QGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -H-Hh--------CCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1 01 111111 1122346788999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=320.60 Aligned_cols=259 Identities=22% Similarity=0.381 Sum_probs=208.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7889999988642 2223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999965434456689999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... ..+.... ......
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---------~~~~~~ 225 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK---------IEKCDY 225 (267)
T ss_pred CC-cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhh---------hhcCCC
Confidence 21 1122345778899999885544 899999999999999999999999654321 1111111 111112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..+.......+.+++.+||..+|++|||+.++++.|..
T Consensus 226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 222222445688899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.33 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=196.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 68889999876543 23346799999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc-cc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS-TS 315 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~-~~ 315 (483)
.+++.. ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999963 234588999999999999999999999 99999999999999999999999999987543321111 11
Q ss_pred ccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 316 CELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 316 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
....+..|+|||.+.+.. ++.++|||||||++|||++ |..||........... +....... .+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~----------~~~~~~~~----~~~ 219 (252)
T cd05084 155 MKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA----------IEQGVRLP----CPE 219 (252)
T ss_pred CCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH----------HHcCCCCC----Ccc
Confidence 112345699999985544 8999999999999999998 9999975443221110 00111111 122
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 395 KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.++..+.+++.+||+.||++|||+.++++.|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=322.82 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=203.7
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++.+++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45789999999999999999996 46788999998765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999853 35689999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.......++..|+|||.+.. ...++.++|||||||++|||++|+.||....+......+ .. .....+..
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~---~~~~~~~~ 231 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SK---SNFQPPKL 231 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ec---CCCCCCCC
Confidence 11223457788999998742 233788999999999999999999999644332111000 00 00001111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+ .....+..+.+++.+||..||++|||+++++++|
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 0112346888999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=326.05 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=202.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
..++|.+.+.||+|+||.||+|.+.+ +..|++|.+..... .....|..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678899999999999999999754 56788888765432 334679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC---CcEE
Q 046972 224 RILVYEYIDNGNLQQWLHGSLG---EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW---NPKI 297 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~---~~kl 297 (483)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999964321 123589999999999999999999999 999999999999998764 5899
Q ss_pred eecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHH
Q 046972 298 SDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 298 ~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
+|||+++....... ........+..|+|||++.+.. ++.++|||||||++|||++ |..||........... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF----VT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH
Confidence 99999986532211 1112223356799999985544 8999999999999999997 9999986554322111 00
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.. ..... +..++..+.+++.+||+.||++||++.+++++|.
T Consensus 236 ~~------~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GG------GRLDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC------CcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 01111 2233468889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=326.61 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=202.1
Q ss_pred hcCCcccceeccCCceEEEEEEE-----cCCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-----LDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|++.+.||+|+||.||+|.. ..+..+++|.+..... .....+.+|+++++.++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 35688889999999999999984 2457899999875433 23367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC
Q 046972 226 LVYEYIDNGNLQQWLHGSLG-------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH 292 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~ 292 (483)
+||||+++|+|.+++..... ....+++.++..++.|++.||.|||++ +++||||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853211 123578889999999999999999999 99999999999999999
Q ss_pred CCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHH
Q 046972 293 WNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDW 370 (483)
Q Consensus 293 ~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~ 370 (483)
+.+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||....+... ...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-IEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH
Confidence 9999999999976533211 1122234566799999986544 8999999999999999999 9999976543221 111
Q ss_pred HHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..... .... +..++..+.+++.+||+.||++||++.++++.|.
T Consensus 239 ----~~~~~-----~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 ----VRKRQ-----LLPC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ----HHcCC-----cCCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11110 0111 1223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=318.17 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=198.6
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHH
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQ 237 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 237 (483)
+.||.|+||.||+|...++..+|+|.+...... ....+.+|+++++.++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998765432 3357899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccccccc
Q 046972 238 QWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE 317 (483)
Q Consensus 238 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 317 (483)
+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998632 34578999999999999999999999 999999999999999999999999999975433222222222
Q ss_pred ccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 318 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
.++..|+|||++... .++.++|||||||++||+++ |..||........... . ........+ ...
T Consensus 155 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~----~------~~~~~~~~~----~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ----V------EKGYRMSCP----QKC 219 (250)
T ss_pred CCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----H------HcCCCCCCC----CCC
Confidence 445679999998544 48999999999999999998 9999976544321111 0 001111111 223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 397 LKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+..+.+++.+||..+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.71 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=206.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
+..++|++.+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 456788999999999999999998643 36799999865532 33467899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLG------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 99999999999999999964322 123478899999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 297 l~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|+|||+++....... .......++..|+|||.+.... ++.++|||||||++|||++ |..||........... .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~----~ 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF----V 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH----H
Confidence 999999976543221 1223335677899999885444 8999999999999999998 9999976554332111 1
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
... ..+..+. .++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 -~~~-----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 -IDG-----GHLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -hcC-----CCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 0111222 23478899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=331.60 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=196.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.+|+|++..... ...+.+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 567899999976422 2335678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 99999885 335699999999999999999999999 9999999999999999999999999998743211 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh--hHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV--FLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ...+......... ...+|..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~p~~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------PIRIPRF 225 (327)
T ss_pred eecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------CCCCCCC
Confidence 23346899999999986544 8999999999999999999999996432211 1111111111111 1122322
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHhccccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKM------GDVLRMLEPRD 429 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~eil~~L~~~~ 429 (483)
.+..+.+++.+||+.||++|+++ .+++++.....
T Consensus 226 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 226 ----LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 23567889999999999999984 68887765543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.51 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=207.5
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++++..++|++.+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+.++..+ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345666789999999999999999998643 36789998875432 2335788999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSL------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
...+..+++|||+++|+|.++++... .....+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 99999999999999999999996421 2345689999999999999999999999 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCch
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~ 364 (483)
||++.++.+||+|||+++....... .......++..|+|||.+... .++.++|||||||++|||++ |..||......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999999986543221 112223345679999987544 48999999999999999998 99999765533
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... . ... ..+. .+..+...+.+++.+||..||++|||+.++++.|+.
T Consensus 242 ~~~~~----~-~~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 242 ELFKL----L-KEG-----YRME----KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHH----H-HcC-----CcCC----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 22111 0 000 0111 112334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=325.86 Aligned_cols=260 Identities=21% Similarity=0.372 Sum_probs=206.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-----CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEe-CC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~ 222 (483)
+..++|.+.+.||+|+||.||+|...+ +..|++|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456789999999999999999999765 6788999886543 2334678999999999999999999998776 46
Q ss_pred eEEEEEEecCCCCHHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEe
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGE----AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKIS 298 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~ 298 (483)
..++++||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999653221 25689999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHH
Q 046972 299 DVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 299 DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
|||+++.+..... .......++..|+|||++.+.. ++.++|||||||++||+++ |+.||...++.. ...+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~---- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLK---- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHH----
Confidence 9999986533221 1122234566799999985544 8999999999999999999 999997654422 111111
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. ... + ....++..+.+++.+||..||++|||+.++++.|..
T Consensus 234 ~~-----~~~--~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 234 DG-----YRL--A--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred cC-----CCC--C--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00 011 1 112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=326.35 Aligned_cols=265 Identities=20% Similarity=0.339 Sum_probs=202.8
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC---------------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCccccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD---------------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKL 214 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~ 214 (483)
..++|++.+.||+|+||.||+|...+ ...||+|.+..... .....|.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34679999999999999999987542 23489999876532 334679999999999999999999
Q ss_pred ccEEEeCCeEEEEEEecCCCCHHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLG--------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 215 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999954211 113478889999999999999999999 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCc
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS--GRLPVDYSQP 363 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t--g~~Pf~~~~~ 363 (483)
|+++.++.+||+|||+++....... .......++..|+|||...+.. ++.++|||||||++|||++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999975433221 1122234567899999886554 8999999999999999998 6778876554
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
................. .. ... ....+..+.+++.+||+.||++||++.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~--~~-~~~----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQ--IY-LSQ----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhcccc--cc-CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 33222211111000000 00 001 1123368999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=332.39 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=192.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHH-HHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVE-AIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|+.. ++..+|+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 578899999865322 12234555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 99999885 345688999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....|++.|+|||.+.+. .++.++|||||||++|||++|..||...+.......+ .. . ...++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----~~-~------~~~~~~--- 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI----LH-K------PLQLPG--- 217 (321)
T ss_pred cccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH----hc-C------CCCCCC---
Confidence 2334688999999998654 4899999999999999999999999766533221111 10 0 111221
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHH----HHHHhcccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMG----DVLRMLEPR 428 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~----eil~~L~~~ 428 (483)
.....+.+++.+||+.||.+||++. +++++.+..
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~ 255 (321)
T cd05603 218 -GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255 (321)
T ss_pred -CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence 2335788999999999999999764 666555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=340.27 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=206.6
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCC-CCcccccccEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVK-HKNLVKLFGYCV 219 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 219 (483)
+++..++|.+.+.||+|+||.||+|++. .+..||+|++...... ..+.+.+|++++.++. |||||++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 5566677888999999999999999864 2467999999765332 2357899999999997 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccC------------------------------------------------------
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLG------------------------------------------------------ 245 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 245 (483)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999964311
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 246 ----------------------------------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 246 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
....+++..++.++.||+.||.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113467788899999999999999998 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCc
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQP 363 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~ 363 (483)
|||++.++.+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999986432211 1122235677899999986544 8999999999999999998 8999976543
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.......+ ... ..+..+ ..++..+.+++.+||..+|.+||++.+|++.|+.
T Consensus 348 ~~~~~~~~----~~~-----~~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 NEQFYNAI----KRG-----YRMAKP----AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred hHHHHHHH----HcC-----CCCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 32221111 100 111112 2234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=342.88 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=207.6
Q ss_pred cCCcccceeccCCceEEEEEEEcC--C--cEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD--N--MRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+...+.++||+|+||.|++|.|+. | ..||||.+...... ...+|++|+.+|.+|+|||++++||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445557889999999999999763 3 34799999877554 55899999999999999999999999987 778999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
||+++.|+|.+.|++ .....|.......++.|||.||.||.++ ++|||||..+|+||...-.+|||||||.+.++
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999986 3456788889999999999999999999 99999999999999999999999999999876
Q ss_pred CCcccc--ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 308 PEWSIS--TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 308 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
...... .....-+..|+|||.+.. ..++.++|||+|||++|||+| |..||.+......+..+. .
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-----~------- 330 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-----A------- 330 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-----c-------
Confidence 543222 122234567999999954 449999999999999999999 999999877654332211 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+++ -+..|+++++++++.||..+|.+|||+..|.+.+
T Consensus 331 ~erLp--RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCC--CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11222 3456789999999999999999999999997543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=327.00 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=202.5
Q ss_pred cCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.+|.+.+.||+|+||.||+|...+ +..||+|++...... ..+.+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 447778899999999999998643 477999998755332 2367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC
Q 046972 226 LVYEYIDNGNLQQWLHGSL------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~ 293 (483)
+++||+++++|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||.|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1124578889999999999999999999 999999999999999999
Q ss_pred CcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWL 371 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~ 371 (483)
.+||+|||+++....... .......+++.|+|||.+.... ++.++|||||||++|||++ |..||.+.......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence 999999999886543221 1122334567899999986544 8999999999999999998 88898765443211
Q ss_pred HHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
... . +.... ..+..++..+.+++.+||+.||.+||++.+|+..|+
T Consensus 237 ~~i-~--------~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 237 EMI-R--------NRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHH-H--------cCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111 1 11111 112334578899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.14 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=207.6
Q ss_pred CCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.|..++.||.|+||.||-|+ .++...||||++.-...+. -++++.|++.|.+++|||+|.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36778899999999999999 4567889999986553333 2688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||- |+-.|++.- ..+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.+||+|||.|....+.
T Consensus 107 YCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 995 588888853 357899999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 310 WSISTSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
...+||+.|||||++. ..+.|+-++||||||+++.||.-.++|+...+.-. ....+...-.|.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----------ALYHIAQNesPt 244 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQNESPT 244 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----------HHHHHHhcCCCC
Confidence 4568999999999976 34569999999999999999999999986544322 222333333444
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+ .+.+.+..+..++..||++-|.+|||.++++.+.
T Consensus 245 L---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 245 L---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred C---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 4 4667778888999999999999999999999765
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=325.70 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=201.5
Q ss_pred CCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235688888865533 334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhccc--------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 227 VYEYIDNGNLQQWLHGSL--------------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 1124588999999999999999999998 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCch
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~ 364 (483)
||+++++.+||+|||+++....... .......++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999975432211 112223456689999988544 48999999999999999998 99999765543
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
... +.. . ....... +..++..+.+++.+||+.||++||++.++++.|+.
T Consensus 237 ~~~-~~~----~-----~~~~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 237 RLF-NLL----K-----TGYRMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred HHH-HHH----h-----CCCCCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 211 111 1 0011111 22334688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=324.20 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=204.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+|...++||+|+||.||+|... ++..+++|.+..........|.+|+++++.++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456788999999999999999742 35678999887666556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 226 LVYEYIDNGNLQQWLHGSLG-----------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
++|||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999964321 113588999999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~ 372 (483)
+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||...........
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--- 236 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC--- 236 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH---
Confidence 99999999975533221 1122234467899999886554 8999999999999999998 9999965443322111
Q ss_pred HHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
... ...... +..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 237 -~~~------~~~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -ITQ------GRELER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHc------CccCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 011111 1233467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=323.57 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=197.1
Q ss_pred cCCcccceeccCCceEEEEEEEcC-Cc----EEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NM----RAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
++|++.+.||+|+||.||+|.+.. +. .+++|.+..... ....++..|+..++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 568888999999999999999643 33 467787754432 22357788888999999999999999875 455788
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999963 235689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 307 GPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 307 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..... .......++..|+|||.+.... ++.++|||||||++|||++ |..||.+...... .+. ...+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~----~~~~-----~ 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDL----LEKG-----E 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH----HHCC-----C
Confidence 43321 1222334667899999985544 8999999999999999998 9999976654321 111 1111 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+..+ ..+...+.+++.+||..||.+|||+.++++.|..
T Consensus 229 ~~~~~----~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 RLAQP----QICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred cCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111 1233577889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.86 Aligned_cols=265 Identities=20% Similarity=0.340 Sum_probs=203.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-----------------CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-----------------DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLV 212 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv 212 (483)
+.++|++.+.||+|+||.||++... +...+|+|++.... ......|.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4567999999999999999998632 23468999987553 23446899999999999999999
Q ss_pred ccccEEEeCCeEEEEEEecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLG-------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 213 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
++++++...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999965321 123478889999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCC
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS--GRLPVDYSQ 362 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t--g~~Pf~~~~ 362 (483)
|||++.++.+||+|||+++.+...... ......++..|+|||...... ++.++|||||||++|||++ |..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999765332211 112223456799999875544 8999999999999999998 778887554
Q ss_pred chhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
........ ........ ... ..+ .+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 239 ~~~~~~~~-~~~~~~~~-~~~---~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQVIENT-GEFFRDQG-RQV---YLP--KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHHHHHHH-HHHHhhcc-ccc---cCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 43322111 11000000 000 011 11224468899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.04 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=203.1
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc-----hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS-----EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
++|.+.+.||+|+||.||+|.. .+++.+++|.+...... ....+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 46889999988654221 22468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999963 35688999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCccccc--cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 307 GPEWSIST--SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 307 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
........ ....++..|+|||.+.+.. ++.++|||||||++|||++|+.||........... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~-----~~~~~ 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----I-----ATQPT 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----H-----hccCC
Confidence 43221111 2235677899999986554 89999999999999999999999975543221111 0 00011
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+.++ ......+.+++.+||..+|.+|||+.+++++.+
T Consensus 225 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 225 NPQLP----SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred CCCCC----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 12222 233467889999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=324.42 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=198.5
Q ss_pred CcccceeccCCceEEEEEEE-----cCCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVL-----LDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRIL 226 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 226 (483)
|.+.+.||+|+||+||++.. .++..||+|.+..... .....|.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988763 3577899999876532 3446789999999999999999999988654 45789
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++.. ..+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999953 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH---HHhhhhh
Q 046972 307 GPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM---VAQQKIA 381 (483)
Q Consensus 307 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~---~~~~~~~ 381 (483)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|..||....... .+..... .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhh
Confidence 432211 11222445679999988544 48999999999999999999999986543211 0000000 0000111
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.......+..++..+.+++.+||+.||++|||++++++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111111111122345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.03 Aligned_cols=266 Identities=21% Similarity=0.344 Sum_probs=204.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 567788888765422 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.++++. ...+++..+..++.||+.||.|||+. .+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999963 35689999999999999999999973 18999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH--------------
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA-------------- 376 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------------- 376 (483)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.... ..+......
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCC
Confidence 12234678899999998554 488999999999999999999999965442211 111100000
Q ss_pred ----------hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 ----------QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
............+..+.......+.+++.+||..||++|||+.+++++.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000111111111122224467889999999999999999999999887544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=319.81 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=206.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++..++|.+.+.||+|+||.||+|...++..+++|.+.... ...+.|.+|+++++.++|+||+++++++.. ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45667899999999999999999998788889999886543 234678999999999999999999999887 7789999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999653 235678889999999999999999998 999999999999999999999999999986543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
..........++..|+|||++... .++.++|+|||||++|++++ |+.||........... . ... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~----~~~-----~~~~ 223 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-L----ERG-----YRMP 223 (260)
T ss_pred CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-H----hCC-----CCCC
Confidence 322222233456679999998544 48999999999999999999 9999976543322111 1 000 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+..+.+++.+||+.||++||++.++++.|..
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112234678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.32 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=205.3
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.+|++.+.||.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999985 467899999997766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999852 3578899999999999999999999 999999999999999999999999999875443211
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||....+......+. .. ..+.. .
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----~~------~~~~~--~ 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----TN------GTPEL--Q 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----cC------CCCCC--C
Confidence 122336788999999986544 7899999999999999999999997665432221110 00 01111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+......+.+++.+||..||++|||+.+++++.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 12233467889999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=307.68 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=211.2
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc----h----HHHHHHHHHHHhcC-CCCcccccccEEEe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS----E----EEDFIEKVEAIGQV-KHKNLVKLFGYCVE 220 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 220 (483)
..+.|.-.+.||.|..+.|-++.. .+++..|+|++...... . .++-.+|+.+|+++ .||||+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 456677788899999999998884 46788999988643221 1 14567899999998 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
+...++|+|.|+.|.|+|+|. ..-.+++.....|++|+..|++|||.+ +||||||||+|||++++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999994 556799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccC-----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSG-----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
|.|..+.+..... ..+||++|+|||.+. +.+.|+..+|+||+||++|.|+.|.+||.....-.. .++.
T Consensus 168 GFa~~l~~GekLr--elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-----LR~I 240 (411)
T KOG0599|consen 168 GFACQLEPGEKLR--ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-----LRMI 240 (411)
T ss_pred ceeeccCCchhHH--HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-----HHHH
Confidence 9999877654333 347999999999874 234589999999999999999999999964322111 1222
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
..++ ..+...-+.+.+....+|+.+||+.||.+|.|++|+|.+......
T Consensus 241 meGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 241 MEGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred Hhcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 2221 223333445666788999999999999999999999998766443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.79 Aligned_cols=266 Identities=16% Similarity=0.220 Sum_probs=203.3
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999965 688999999865422 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
++ ++|.+++.... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 69999986432 235689999999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----------hhh
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA-----------QQK 379 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-----------~~~ 379 (483)
. ......++..|+|||.+.+...++.++|||||||++|||++|+.||.................. ...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 1223456788999998865555789999999999999999999999866543332222111100 000
Q ss_pred hhhhcCCCCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 380 IAYVLDPKLP---EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 380 ~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.......... .......+.++.+++.+||..||.+|||+.+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~ 283 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence 0000000000 000111346778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=372.46 Aligned_cols=258 Identities=29% Similarity=0.523 Sum_probs=203.9
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
..|...+.||+|+||.||+|.. .++..||+|.+...... ...|++.+++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999996 57889999998654322 234688999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.++++ .++|..+..++.||++||+|||..+.++|+||||||+||+++.++..++. ||.+.....
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999994 27899999999999999999996555599999999999999999888876 666543221
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc-hhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP-QVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.....++..|+|||++... .++.++|||||||++|||+||+.||..... .....+|..............++.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1223678899999998654 489999999999999999999999964332 223344443333333344445555433
Q ss_pred C--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 391 M--PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 391 ~--~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
. ....+..++.+++.+||+.||++|||+.|+++.|+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2 3345667889999999999999999999999999643
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=317.94 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=213.3
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
|.+.++||+|+||.||+|.++ .|+.+|+|.+... .+.++...|+.++.++..|+||++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 666889999999999999855 5889999998654 3678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+..+.++. ..++++++++..+++..++||+|||-. .-||||||+.|||++-+|.+||+|||.|..+... ...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 999999973 568899999999999999999999998 8899999999999999999999999999876544 233
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC--C
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE--M 391 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 391 (483)
..+..||+.|||||++..-+ |+.++||||||++..||..|++||.+..+-... ..+....|+ .
T Consensus 186 RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~PPPTF~ 250 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTKPPPTFK 250 (502)
T ss_pred hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCCCCCCCC
Confidence 45678999999999996655 899999999999999999999999876552110 011111111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.+...+.++.+++++||.++|++|-|+-+++++...++.
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 234567899999999999999999999999998765543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.99 Aligned_cols=246 Identities=20% Similarity=0.220 Sum_probs=193.3
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||+|+||.||+++.. +++.+|+|.+..... .....+..|++++++++||||+++++++......++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999954 588999999864322 1234566799999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9988543 234588999999999999999999999 99999999999999999999999999987654322 1223
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..++..|+|||++.+.. ++.++|||||||++|||++|+.||................ .....+. .....
T Consensus 154 ~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT---------LEDEVKF-EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh---------hcccccc-ccccC
Confidence 46788999999986555 8999999999999999999999997654322211111111 1111110 11123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 397 LKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
+.++.+++.+||+.||++||++.|+++.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 4678999999999999999999665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=360.75 Aligned_cols=263 Identities=23% Similarity=0.333 Sum_probs=204.1
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC--
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-- 221 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 221 (483)
..+...++|++.+.||.|+||+||+|... .+..+|+|.+..... .....|..|+.+++.|+|||||+++++|...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34556678999999999999999999965 466788898865432 2346789999999999999999999988653
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC----CCeeeecCCCCcEEEcC------
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE----PKIVHHNMKSSNILLDH------ 291 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiHrDlkp~NiLl~~------ 291 (483)
..+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999997543345679999999999999999999998410 15999999999999964
Q ss_pred -----------CCCcEEeecccccccCCCccccccccccCcccccccccCC-CCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046972 292 -----------HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR-TSIFNEKSDVYSFGILIMEIVSGRLPVD 359 (483)
Q Consensus 292 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~el~tg~~Pf~ 359 (483)
.+.+||+|||++........ .....||+.|+|||++.. ...++.++|||||||+||||++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23489999999986543221 223468999999998753 2347899999999999999999999997
Q ss_pred CCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 360 YSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.......+...+. . .+.++ ....+..+.+||.+||..+|.+||++.+++.+.
T Consensus 245 ~~~~~~qli~~lk----~-------~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~ 296 (1021)
T PTZ00266 245 KANNFSQLISELK----R-------GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296 (1021)
T ss_pred cCCcHHHHHHHHh----c-------CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence 6554322211111 0 11111 122346788999999999999999999999643
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.49 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred cCCcccceeccCCceEEEEEEEcC-C--cEEEEEEecCC-CcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-N--MRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 227 (483)
++|++.+.||+|+||.||+|...+ + ..+++|.+... .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998654 3 24688877643 223346789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCc
Q 046972 228 YEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~ 295 (483)
|||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999964321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~ 374 (483)
||+|||++...... ........+..|+|||.+.... ++.++|||||||++|||++ |..||...........
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----- 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----- 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----
Confidence 99999998643211 1111222345799999885544 8999999999999999997 9999976654322111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+........+ ..++..+.+++.+||+.||.+|||++++++.|..
T Consensus 231 -----~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 231 -----LPQGYRMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred -----HhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0000111112 2234678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.07 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=194.2
Q ss_pred eeccCCceEEEEEEEc---CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 160 VIASGDNGVVYRAVLL---DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
.||+|+||.||+|.+. ++..+|+|++..... ...+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 577899998865432 23467899999999999999999999875 45678999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc--
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI-- 312 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-- 312 (483)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||.||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999953 34689999999999999999999999 9999999999999999999999999999865433221
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+... .++.++|||||||++|||++ |..||......... .. ...+ ..+..+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~----i~~~-----~~~~~~~- 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QM----IESG-----ERMECPQ- 221 (257)
T ss_pred ecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH----HHCC-----CCCCCCC-
Confidence 11222345689999988544 48899999999999999998 99999765443211 11 1111 1112222
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.++.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 222 ---~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 ---RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 344688899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=322.68 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=198.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCc----EEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNM----RAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|++.+.||.|+||+||+|.+. ++. .||+|++..... .....+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467888999999999999999853 343 479999875533 334678999999999999999999999875 4578
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+++||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999632 34689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
....... ......++..|+|||...+.. ++.++|||||||++|||++ |..||........ ..++. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~----~~----- 227 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLE----KG----- 227 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH----CC-----
Confidence 6432211 122223456799999986554 8999999999999999998 9999975443221 11111 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.... .+..++..+.+++.+||..||++||++.++++.|.
T Consensus 228 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 228 ERLP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred CcCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0111 12234468889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=330.44 Aligned_cols=238 Identities=24% Similarity=0.275 Sum_probs=187.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHH-HHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVE-AIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||+||+|+.. +++.+|+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 467899999865321 12234444444 57788999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 99999995 345688889999999999999999999 9999999999999999999999999999753221 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+......... . . ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~-~------~~~~~---- 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL----N-K------PLQLK---- 216 (325)
T ss_pred cccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH----h-C------CcCCC----
Confidence 23346899999999986544 8999999999999999999999998655433221111 0 0 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMGD 420 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~e 420 (483)
......+.+++.+||+.||.+||++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 122357888999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.40 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=196.7
Q ss_pred CcccceeccCCceEEEEEEEcCCc---EEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeC------Ce
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNM---RAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------QN 223 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~ 223 (483)
|.+.+.||+|+||.||+|.+.++. .+|+|.+.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999976543 58999886542 23346789999999999999999999987532 24
Q ss_pred EEEEEEecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 224 RILVYEYIDNGNLQQWLHGSL--GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999884221 2334589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 302 LAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 302 la~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
+++........ ......++..|+|||...+. .++.++|||||||++|||++ |+.||......... . .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~---~~-~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-D---YL-RQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H---HH-HcCC
Confidence 99865433211 12223456789999998654 48999999999999999999 89999765432211 1 11 1110
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... ...++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 232 -----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 -----RLKQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred -----CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111 12234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.77 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=207.3
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+.+.|++.+.||.|+||.||+|.... +..+++|.+........+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 34678899999999999999999654 78899999877665566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|..++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999988753 235689999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 310 WSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
. .......++..|+|||++.. ...++.++|||||||++|||++|..||...........+ . ....
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~------~~~~ 232 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----A------KSEP 232 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH----h------cCCC
Confidence 1 11223357788999998742 233688999999999999999999999765532221111 0 0011
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+... .+......+.+++.+||..||++||++.+++++.....
T Consensus 233 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 233 PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1111 11233457889999999999999999999998766544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.49 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=201.2
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 467889999986553 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999997653 367888999999999999999999 9999999999999999999999999999765432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||............. .......+...+.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~~~~~~ 219 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL------QLLQCIVDEDPPV 219 (279)
T ss_pred --cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH------HHHHHHhccCCCC
Confidence 122346788999999986554 8999999999999999999999996533211100000 0001111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+......++.+++.+||+.||++||++++++++.+...
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 112223357889999999999999999999999876544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=329.66 Aligned_cols=246 Identities=22% Similarity=0.242 Sum_probs=192.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHH-HHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVE-AIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|... +++.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999954 68899999986542 122345555654 57779999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 99999985 345789999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....|+..|+|||++.+.. ++.++|||||||++|||++|..||...+........ .. . ....+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~----~~-~------~~~~~~--- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI----LH-K------PLVLRP--- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH----Hc-C------CccCCC---
Confidence 23346899999999986544 899999999999999999999999866543222111 10 0 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHH----HHHHhcccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMG----DVLRMLEPR 428 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~----eil~~L~~~ 428 (483)
.....+.+++.+||+.||.+||++. +++++.+..
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 1235778899999999999999885 566654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=328.35 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=204.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcC--------CcEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++..++|.+.+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|++++..+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4445779999999999999999998532 3469999987643 23346788999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
...+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||++ +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999965321 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCch
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~ 364 (483)
|+++.++.+||+|||+++........ ......++..|+|||.+.+. .++.++|||||||++|||++ |..||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999755432111 12222345679999988554 48999999999999999998 88999754432
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
... ... ... ..... +...+..+.+++.+||..+|.+|||+.++++.|..
T Consensus 250 ~~~-~~~----~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 250 ELF-KLL----KEG-----HRMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHH-HHH----HcC-----CCCCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 211 111 100 01111 12334688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.48 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=204.5
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
..++|++.+.||.|+||.||+|... ++.+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3467888999999999999999874 77899999976644 457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999643 223689999999999999999999999 99999999999999999999999999998653221
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.....+..|+|||.+... .++.++|||||||++|||++ |..||......... .. .... .....+
T Consensus 157 ----~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~----~~~~-----~~~~~~ 221 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PH----VEKG-----YRMEAP 221 (256)
T ss_pred ----ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HH----HhcC-----CCCCCc
Confidence 123345679999988544 48899999999999999997 99999755432211 11 1000 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+..+.+++.+||..+|++|||+.++++.|..
T Consensus 222 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 ----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 2234688899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.82 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=199.3
Q ss_pred CcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCe-----
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN----- 223 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 223 (483)
|.+.+.||+|+||.||+|.... +..+|+|++..... .....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998643 36799999875432 234678999999999999999999998876554
Q ss_pred -EEEEEEecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 224 -RILVYEYIDNGNLQQWLHGSL--GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 224 -~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
.+++|||+++|+|..++.... .....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 301 GLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 301 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
|+++........ .......+..|+|||.+.+. .++.++|||||||++|||++ |..||....+..... ... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~----~~~-~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD----YLR-HG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cC
Confidence 999865432211 11122345679999988544 48999999999999999999 999997655432211 110 00
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+ ..+...+.+++.+||+.||++|||+.++++.|+.
T Consensus 232 -----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 -----NRLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred -----CCCCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111122 2344689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=323.01 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=209.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||.|+||.||+|... ++..+|+|.+........+.|..|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467888999999999999999964 5788999998766555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++... ...+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998632 35689999999999999999999999 99999999999999999999999999987543321
Q ss_pred cccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 311 SISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. ......++..|+|||.+.. ...++.++|||||||++|||++|+.||...........+ .....+
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~ 226 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI----------LKSEPP 226 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH----------hcCCCC
Confidence 1 2223467888999998742 233678999999999999999999999765443221111 000111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.+. .+......+.+++.+||+.||.+||++.+++++.+..+.
T Consensus 227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 111 112334678899999999999999999999998765554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.41 Aligned_cols=257 Identities=22% Similarity=0.241 Sum_probs=203.4
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
|+..+.||+|+||+||+|... +++.+|+|.+...... ....+.+|+++++.++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999964 5788999998654322 234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999988642 234699999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
......|+..|+|||.+.+.. ++.++|+|||||++|||++|..||...........+.... ... ....
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~-~~~------~~~~-- 224 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-LET------EEVY-- 224 (285)
T ss_pred --cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh-hcc------cccc--
Confidence 112346889999999986544 8999999999999999999999998655432222211111 000 0111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccch
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRDL 430 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~~ 430 (483)
.......+.+++.+||+.||++||+ +.+++.+-+..+.
T Consensus 225 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 225 --SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred --CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 1223357788999999999999999 7788887665554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.79 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=206.1
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYCV 219 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 219 (483)
+.+..++|.+.+.||+|+||.||+|... .+..+|+|++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3455677999999999999999999742 245789998875532 3346789999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
..+..++||||+++|+|.++++.. ....+++.++..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence 999999999999999999999643 223489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHh
Q 046972 300 VGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 300 FGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
||+++....... .......++..|+|||.+.... ++.++|||||||++|||++ |..||........+..... .
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~ 259 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----E 259 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----c
Confidence 999986543221 1122234567899999885554 8999999999999999998 9999976654332222111 0
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ..+..+ ...+..+.+++.+||..+|++|||+.++++.|..
T Consensus 260 ~-----~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 G-----YRMAQP----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C-----CcCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1 011111 1223578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.52 Aligned_cols=265 Identities=22% Similarity=0.347 Sum_probs=204.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-----------------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-----------------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLV 212 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv 212 (483)
..++|++.+.||+|+||.||+|.... +..+|+|.+..... ...+.+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34678999999999999999998543 24579999876533 3456789999999999999999
Q ss_pred ccccEEEeCCeEEEEEEecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLG-------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 213 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
++++++...+..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999965321 123689999999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCC
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS--GRLPVDYSQ 362 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t--g~~Pf~~~~ 362 (483)
||+++.++.++|+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999975433221 1222335567899999986544 8999999999999999998 778886554
Q ss_pred chhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....+... ....... ...........++.++.+++.+||+.||.+|||+.++++.|.
T Consensus 239 ~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENA-GHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHH-Hhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 33222111 1100000 000000011223468999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.78 Aligned_cols=240 Identities=23% Similarity=0.368 Sum_probs=190.1
Q ss_pred ceeccCCceEEEEEEEcC-------------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 159 NVIASGDNGVVYRAVLLD-------------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+.||+|+||.||+|.... ...+++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2357888876654445567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC-------cEEe
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-------PKIS 298 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~-------~kl~ 298 (483)
+||||+++|+|..++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999999863 235689999999999999999999999 9999999999999987664 8999
Q ss_pred ecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCchhhHHHHHHHHHHh
Q 046972 299 DVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV-SGRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 299 DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~-tg~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|..||......... ....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----~~~~- 223 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----RFYE- 223 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----HHHh-
Confidence 99998754321 22356778999998865555899999999999999998 588888654322110 0000
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..... .......+.+++.+||+.||.+||++.+|++.+
T Consensus 224 --------~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 --------GQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------cCccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00110 011235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=325.62 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=198.2
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+|...+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999965 57889999986532 223356788899988885 578889999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999995 335689999999999999999999999 999999999999999999999999999875432
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......||..|+|||++.+.. ++.++|||||||++|||++|+.||............. . .....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----~-------~~~~~ 220 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM----E-------HNVSY 220 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----h-------CCCCC
Confidence 21 1122346889999999986554 8999999999999999999999998765432221111 0 01122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~ 428 (483)
|. ..+..+.+++.+||+.||.+|++. .++.++....
T Consensus 221 p~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 221 PK----SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred Cc----cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 22 233578889999999999999985 5666654433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.68 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=202.5
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
.+|++.+.||.|+||.||+|.+.++..+|+|.+..... ....|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788999998865433 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999963 234588999999999999999999999 9999999999999999999999999998765433222
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.+. .++.++|||||||++|||++ |..||.......... .. ........+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~------~~~~~~~~~~- 224 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE----TI------NAGFRLYKPR- 224 (256)
T ss_pred ccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----HH------hCCCCCCCCC-
Confidence 22222345689999988544 48999999999999999998 999997655332211 11 0001111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+..+.+++.+||+.+|++|||+.++++.|
T Consensus 225 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 ---LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1236789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.18 Aligned_cols=263 Identities=17% Similarity=0.235 Sum_probs=191.3
Q ss_pred cceeccCCceEEEEEEEc---CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEEEEEEecC
Q 046972 158 QNVIASGDNGVVYRAVLL---DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRILVYEYID 232 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~ 232 (483)
.++||+|+||.||+|+.. +++.+|+|.+..... ...+.+|+++++.++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 457899999865432 3457889999999999999999999864 456789999986
Q ss_pred CCCHHHHHhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE----cCCCCcEEeecccc
Q 046972 233 NGNLQQWLHGSL-----GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLA 303 (483)
Q Consensus 233 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DFGla 303 (483)
++|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58988875321 1223588999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh---------hHHHHHH
Q 046972 304 KLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV---------FLIDWLK 372 (483)
Q Consensus 304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~---------~~~~~~~ 372 (483)
+....... .......+|+.|+|||++.+...++.++|||||||++|||++|+.||....... .+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 87643321 122345778999999998765568999999999999999999999997543211 1111110
Q ss_pred HH--------HHhhh-------hhhhcCCCCCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 373 SM--------VAQQK-------IAYVLDPKLPE--------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 373 ~~--------~~~~~-------~~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.. ..... ........... .........+.+++.+||+.||.+|||++|++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 00 00000 00000000000 000001245789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.26 Aligned_cols=240 Identities=25% Similarity=0.406 Sum_probs=189.9
Q ss_pred eeccCCceEEEEEEEcC-------------------------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCccccc
Q 046972 160 VIASGDNGVVYRAVLLD-------------------------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 214 (483)
.||+|+||.||+|.+.. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13478888865544445678999999999999999999
Q ss_pred ccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-
Q 046972 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW- 293 (483)
Q Consensus 215 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~- 293 (483)
++++.+....++||||+++|+|..++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999863 345688999999999999999999999 999999999999997654
Q ss_pred ------CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCchhh
Q 046972 294 ------NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV-SGRLPVDYSQPQVF 366 (483)
Q Consensus 294 ------~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~-tg~~Pf~~~~~~~~ 366 (483)
.+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988643221 22356778999998865555899999999999999995 69999976544321
Q ss_pred HHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 367 LIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
. ... .. ....+... ...+.+++.+||+.+|++|||+.++++.|.
T Consensus 231 ~-~~~----~~-------~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E-RFY----EK-------KHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-HHH----Hh-------ccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 110 00 11122111 246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=316.58 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=193.9
Q ss_pred eeccCCceEEEEEEEc---CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCC
Q 046972 160 VIASGDNGVVYRAVLL---DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
.||+|+||.||+|.+. .+..||+|++..... ...+.|.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 345689999876533 23467999999999999999999999885 456899999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc--
Q 046972 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS-- 313 (483)
Q Consensus 236 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~-- 313 (483)
|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999963 235689999999999999999999999 99999999999999999999999999998654332211
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (483)
.....++..|+|||.+.... ++.++|||||||++|||++ |..||.......... ....+ ..+. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~-----~~~~----~ 219 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-----FIEQG-----KRLD----C 219 (257)
T ss_pred cCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-----HHHCC-----CCCC----C
Confidence 12223356799999885444 7999999999999999996 999997655432111 11111 1111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 393 SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 393 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..++.++.+++.+||..||++||++.++.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 22344788899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.44 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=205.7
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc--------CCcEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++..++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455678899999999999999999742 23468999886543 23346789999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
......++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999965321 124578889999999999999999999 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCch
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~ 364 (483)
||++.++.+||+|||+++........ ......++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999866433221 22233456789999988554 48999999999999999998 88898765432
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
... ... ... .... .+..++..+.+++.+||..+|.+|||+.++++.|..
T Consensus 247 ~~~----~~~-~~~-----~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 247 ELF----KLL-KEG-----HRMD----KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred HHH----HHH-HcC-----CcCC----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 211 111 100 0011 122344688899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.79 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=202.1
Q ss_pred HHHhcCCcccceeccCCceEEEEEEE------cCCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEEEe
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVL------LDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVE 220 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 220 (483)
+++.++|++.+.||.|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45667899999999999999999973 3467899999976433 2345788999999999 68999999998865
Q ss_pred C-CeEEEEEEecCCCCHHHHHhcccCC-----------------------------------------------------
Q 046972 221 G-QNRILVYEYIDNGNLQQWLHGSLGE----------------------------------------------------- 246 (483)
Q Consensus 221 ~-~~~~lv~E~~~~g~L~~~l~~~~~~----------------------------------------------------- 246 (483)
. ...++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 5678999999999999999642110
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-cccc
Q 046972 247 ----------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTS 315 (483)
Q Consensus 247 ----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~ 315 (483)
...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12467888899999999999999999 999999999999999999999999999976532211 1122
Q ss_pred ccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 316 CELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 316 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
...++..|+|||.+.+. .++.++|||||||++|||++ |..||............. ... .....+..
T Consensus 240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~-----~~~~~~~~--- 306 (343)
T cd05103 240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----KEG-----TRMRAPDY--- 306 (343)
T ss_pred CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH----hcc-----CCCCCCCC---
Confidence 23456679999988544 48999999999999999997 999997654332211111 101 11112221
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 395 KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+.+++.+||+.||++|||+.+++++|+.
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.80 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=205.8
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc--------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGY 217 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 217 (483)
++...++|.+.+.||+|+||.||+|... ....+|+|.+..... .....+..|+++++.+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3555678899999999999999999742 245689998875432 3346788999999999 69999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
+...+..++||||+++|+|.+++..... ....+++.++..++.||+.||.|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 9999999999999999999999965321 124588999999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCc
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQP 363 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~ 363 (483)
|||++.++.+||+|||+++....... .......++..|+|||.+.+. .++.++|||||||++|||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986543211 112222344579999998654 48999999999999999999 8999976544
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...... .... ..... +..++.++.+++.+||..||++|||+.++++.|...
T Consensus 243 ~~~~~~-----~~~~-----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 243 EELFKL-----LREG-----HRMDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHHHH-----HHcC-----CCCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 322111 1111 00111 123346788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=330.96 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=200.3
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCC-----
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ----- 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 222 (483)
..++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 58899999986542 233467889999999999999999999986543
Q ss_pred -eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 223 -NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 223 -~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
..|+||||+++ +|...+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999975 6777663 2478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA----- 376 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----- 376 (483)
+++...... ......+|..|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+..............
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 997543321 223346788999999986544 899999999999999999999999876543322211111000
Q ss_pred ----hhhhhhh--cCCCCCCC----------------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 377 ----QQKIAYV--LDPKLPEM----------------PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 377 ----~~~~~~~--~~~~~~~~----------------~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
....... ..+..+.. ........+.+++.+||+.||++|||+.|++++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 0000000 00111100 0011235688999999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.64 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=204.9
Q ss_pred CcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
|++.+.||.|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5678889999999999999654 667788888666555567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|..++.+ ...++++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999998853 235789999999999999999999999 999999999999999999999999999876533211 2
Q ss_pred ccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 314 TSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.....++..|+|||++. ....++.++|||||||++|||++|+.||.............. . ..+..+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~-----~~~~~~ 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-----S-----EPPTLA 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh-----c-----CCCCCC
Confidence 22346788999999874 223477899999999999999999999976554322221111 0 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+...+..+.+++.+||+.||.+||++.+++++.+...
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 11223467899999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.73 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=206.5
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhc--CCCCcccccccEEEeC----C
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQ--VKHKNLVKLFGYCVEG----Q 222 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~----~ 222 (483)
.....+..+.+.||+|.||+||+|.|+ |..||||++... +++.+.+|.++... |+|+||+.|++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344567888999999999999999995 558999999655 55678888888776 4999999999987544 3
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeecCCCCcEEEcCCCCcEE
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI-----EPKIVHHNMKSSNILLDHHWNPKI 297 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDlkp~NiLl~~~~~~kl 297 (483)
+++||++|.+.|+|+|||. ...++....++++..+|.||+|||..+ +|.|.|||||..||||.+++.+-|
T Consensus 283 QLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 6799999999999999994 467999999999999999999999543 789999999999999999999999
Q ss_pred eecccccccCCCc---cccccccccCcccccccccCCCCC---C--CcchhhHHHHHHHHHHHcC----------CCCCC
Q 046972 298 SDVGLAKLHGPEW---SISTSCELRNSGYLAEELSGRTSI---F--NEKSDVYSFGILIMEIVSG----------RLPVD 359 (483)
Q Consensus 298 ~DFGla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~---~--~~~~DvwSlGv~l~el~tg----------~~Pf~ 359 (483)
+|+|||....... .......+||..|||||++...-. + -..+||||||.++||+.-. ..||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998664432 223455689999999999864421 1 1468999999999998842 46776
Q ss_pred CCCchhhHHHHHHHHHHhhhhhhhcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 360 YSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+-.+.+-..+.++.....++ +.|..|. ..+.+++..+.++|+.||..||.-|.|+-.+-+.|...
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCCCCCCHHHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 54333222222222222222 3344443 33557788999999999999999999998888777543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.64 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=196.9
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcC---CCCcccccccEEEe-----CC
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQV---KHKNLVKLFGYCVE-----GQ 222 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~ 222 (483)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 5788999988654221 223566777776655 79999999998864 34
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++ +|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999974 999998643 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh-
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA- 381 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 381 (483)
++...... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||........+..+...........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98654321 122346788999999986554 89999999999999999999999977665443333222110000000
Q ss_pred --------hhcCCCCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 382 --------YVLDPKLPE---MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 382 --------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....+..+. .........+.+++.+||+.||++|||+.+++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 000000000 001123457789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=314.77 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=204.4
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999964 5788999988643 233457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999753 245789999999999999999999998 99999999999999999999999999998665432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.. .....++..|+|||+..+.. ++.++|+|||||++|||++|+.||.......... . ......+.
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~---------~~~~~~~~ 220 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALIL----K---------IIRGVFPP 220 (256)
T ss_pred ch-hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH----H---------HHcCCCCC
Confidence 22 22335778899999986554 7899999999999999999999997655322111 1 01111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
........+.+++.+||+.+|++||++.++++..
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 1113446889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.06 Aligned_cols=261 Identities=17% Similarity=0.184 Sum_probs=202.7
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||++..+. ++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999654 6778999985421 122345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999632 34689999999999999999999999 999999999999999999999999999975543
Q ss_pred CccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 309 EWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..........||+.|+|||++.. ...++.++|||||||++|||++|+.||............. .. ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~----~~-----~~ 225 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----NH-----KE 225 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh----CC-----Cc
Confidence 32223334578999999998752 3347899999999999999999999998655433221111 00 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRD 429 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~ 429 (483)
....+.. ....+..+.+++.+||..++.+ |+++.+++++.+...
T Consensus 226 ~~~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 226 RFQFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred cccCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 1111111 1223467888888988665444 789999999876654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.25 Aligned_cols=261 Identities=17% Similarity=0.185 Sum_probs=204.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 57789999986421 122345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||++||+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999632 35689999999999999999999999 999999999999999999999999999986654
Q ss_pred CccccccccccCcccccccccCCC----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 309 EWSISTSCELRNSGYLAEELSGRT----SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..........|++.|+|||++.+. ..++.++|||||||++|||++|+.||...+.......+ .... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i----~~~~-----~ 225 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI----MNHE-----E 225 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH----HcCC-----C
Confidence 433333345689999999988542 34788999999999999999999999765543222111 1000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRD 429 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~ 429 (483)
...++.. ....+..+.+++.+||..++.+ |+++++++++.+...
T Consensus 226 ~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 226 RFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 0111111 1123467888898999876654 578999998877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.77 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=203.8
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
++..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4567889999999999999999997542 4578999886543 23345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLG------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~ 295 (483)
+..++||||+++|+|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999964221 123456778899999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 296 kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~ 373 (483)
||+|||+++....... .......++..|+|||.+.... ++.++|||||||++|||++ |..||......... ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~ 233 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KF 233 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH
Confidence 9999999985433221 1122234567799999985544 8999999999999999999 78899765433211 11
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. .+...+. .+..++..+.+++.+||+.||++|||+.++++.|..
T Consensus 234 ~---------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 234 V---------MDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred H---------HcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1111111 111233689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.32 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=199.2
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-Cc--EEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NM--RAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+|+||.||+|.+.. +. .+++|.+.... ......+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4578889999999999999999643 43 35777765432 23346788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 227 VYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999964321 123588999999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~ 373 (483)
+||+|||+++..... ........+..|+|||.+.+. .++.++|||||||++|||+| |..||.......... .
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----K 235 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH----H
Confidence 999999998643211 111222345679999988544 48999999999999999998 999997554332111 1
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ........+ ...+..+.+++.+||+.+|++||++.++++.|..
T Consensus 236 ~------~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 L------PQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred H------hcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 000111111 1233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.10 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 159 NVIASGDNGVVYRAVLLD---NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998643 45689998866543 33457899999999999999999999999999999999999999
Q ss_pred CHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-c
Q 046972 235 NLQQWLHGSLG-EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-I 312 (483)
Q Consensus 235 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~ 312 (483)
+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999964322 233567778889999999999999999 999999999999999999999999999975433221 1
Q ss_pred cccccccCcccccccccCCCC------CCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 313 STSCELRNSGYLAEELSGRTS------IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
......++..|+|||++.+.. .++.++|||||||++|||++ |+.||....+....... . .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT----V-REQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----h-hcccCCCCC
Confidence 122335677899999875321 25789999999999999996 99999765543321110 0 011111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+... ......+.+++.+|| .+|++|||+.+|+..|+
T Consensus 233 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2211 122356788888999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.94 Aligned_cols=269 Identities=17% Similarity=0.242 Sum_probs=206.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999865 57889999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
++ ++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 599998864 234688999999999999999999999 99999999999999999999999999997543221
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH--hhhhhhh-----
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA--QQKIAYV----- 383 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~----- 383 (483)
. ......++..|+|||.+.+...++.++|||||||++|||++|+.||...+.............. .......
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1 1223356788999999866555889999999999999999999999876543322211110000 0000000
Q ss_pred -cCCCCCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 -LDPKLPEM-------PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 -~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+.. ........+.+++.+||+.||.+|||+.+++++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00011110 01123457889999999999999999999999877644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.19 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=202.9
Q ss_pred CcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHH--HHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEE--DFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
|++.+.||+|+||+||+|.... ++.+|+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999765 558999999877544432 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++++|.+++. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999996 346689999999999999999999999 999999999999999999999999999975421 12
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
.......++..|+|||+......++.++||||||+++|+|++|..||........... ...............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~------ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-IEKILKRPLPSSSQQ------ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-HHHHHHTHHHHHTTS------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh-hhhcccccccccccc------
Confidence 2334457788999999986344589999999999999999999999987632222111 111111110000000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.......+.+++.+||+.||++||++.+++++.+
T Consensus 226 -~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 226 -SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp -HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred -cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 0001168899999999999999999999998754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=332.68 Aligned_cols=247 Identities=21% Similarity=0.228 Sum_probs=193.4
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcC---CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQV---KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
||+|+||+||+|+.. +++.||+|++...... ....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 5889999998643221 223455667776655 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999985 345689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||..|+|||++.+...++.++|||||||++|||++|+.||........... . ... ...++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~----i-~~~------~~~~~~--- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----I-AFG------KVRFPK--- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH----H-HcC------CCCCCC---
Confidence 23346899999999986555589999999999999999999999976554322111 1 001 111221
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC----CHHHHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRP----KMGDVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rp----t~~eil~~L~~~~ 429 (483)
......+.+++.+||+.||.+|| ++.+++++.+..+
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 12235778899999999999998 6788888766544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=336.21 Aligned_cols=260 Identities=21% Similarity=0.310 Sum_probs=213.2
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcE-EEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMR-AAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+.+.+...||.|+||.||+|..++... .|.|++...+....++|+-||++|+.+.||+||++++.|...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 335556779999999999999776544 4778887777777799999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
.||-....+- .-+.++++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+.......
T Consensus 112 ~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 112 GGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred CCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence 9999988874 3467899999999999999999999999 99999999999999999999999999987543322
Q ss_pred ccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 312 ISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.......||+.|||||+.. ....|+.++||||||++|.||..+.+|-..-++-..+..+. ..-.|.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----------KSePPT 254 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----------KSEPPT 254 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh----------hcCCCc
Confidence 2234568999999999864 23348999999999999999999999987655543332221 112232
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchh
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~ 431 (483)
+- .+......+.+++.+||.+||..||++.+++++.+..+..
T Consensus 255 Ll--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 255 LL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred cc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 22 2445667899999999999999999999999988765443
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.23 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=202.7
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
|+..+.||+|+||.||+|... +++.+|+|.+...... ....+.+|+.+++.++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667889999999999999965 5788999998654322 224578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998543 234589999999999999999999998 99999999999999999999999999987553322
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. .....|+..|+|||++.+.. ++.++|||||||++|||++|+.||........... ....... .....+
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~------~~~~~~- 225 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKE------VQEEYS- 225 (285)
T ss_pred c--ccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhh------hhhhcC-
Confidence 1 12346889999999986554 89999999999999999999999976543211111 1111000 001111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
......+.+++.+||+.||++||| +.+++++.+...
T Consensus 226 ---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 226 ---EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ---ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 223357889999999999999999 899998876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.84 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=196.0
Q ss_pred CcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhc--CCCCcccccccEEEeCC----eEEEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQ--VKHKNLVKLFGYCVEGQ----NRILVY 228 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~----~~~lv~ 228 (483)
..+.+++|+|.||.||+|++.+ +.||||++... +.+.|..|-++.+. ++|+||++|+++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3446779999999999999854 79999998543 45678888888765 58999999999877655 789999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------CCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI------EPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
||.+.|+|.+||. ...++|....+|+..+++||+|||+.. +++|+|||||.+||||..|+++.|+|||+
T Consensus 288 ~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999994 467999999999999999999999653 67899999999999999999999999999
Q ss_pred ccccCCCcc-ccccccccCcccccccccCCCCCCC-----cchhhHHHHHHHHHHHcCCCCCC-CCCch-----------
Q 046972 303 AKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFN-----EKSDVYSFGILIMEIVSGRLPVD-YSQPQ----------- 364 (483)
Q Consensus 303 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwSlGv~l~el~tg~~Pf~-~~~~~----------- 364 (483)
|..+.+... ......+||..|||||++.+.-.+. .+.||||+|.+||||++...-+. +..++
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 998765433 2334479999999999986543333 46899999999999998543332 11111
Q ss_pred -hhHHHHHHHHHHhhhhhhhcCCCCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 -VFLIDWLKSMVAQQKIAYVLDPKLPEMPSR-KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.++..-. +..-..|.+|..... .....+.+.+..||+.||+.|.|+.=+-+.+..
T Consensus 443 hPt~e~mq~~V-----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 443 HPTLEEMQELV-----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred CCCHHHHHHHH-----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 1111111111 111123333322111 234678889999999999999999877776654
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.32 Aligned_cols=255 Identities=26% Similarity=0.458 Sum_probs=202.2
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-C---cEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-N---MRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|+..+.||+|+||.||+|.... + ..+++|.+.... ....+.+..|+++++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578889999999999999999643 3 368999886553 3334679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999963 235689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCcccc--ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 307 GPEWSIS--TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 307 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
....... ......+..|+|||++... .++.++|||||||++|||++ |+.||......... ..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~~-~----- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIND-G----- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhc-C-----
Confidence 4322111 1112234579999998554 47999999999999999998 99999765443211 11110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ..+ ....++..+.+++.+||..||++||++.++++.|..
T Consensus 227 ~--~~~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 227 F--RLP--APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred C--CCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 111 122344688999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=321.99 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=206.6
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.+|++.+.||.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 568899999987665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999984 24589999999999999999999999 999999999999999999999999999876543322
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...++........ . . ..+.+ .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~----~-~-----~~~~~--~ 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----T-N-----GTPEL--Q 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----h-c-----CCccc--C
Confidence 122335788899999985544 7899999999999999999999998765432221110 0 0 00111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+...+..+.+++.+||..||.+||++.+++++-+.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 122334678889999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=338.12 Aligned_cols=270 Identities=19% Similarity=0.214 Sum_probs=197.4
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC------CCcccccccEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK------HKNLVKLFGYC 218 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~ 218 (483)
.+++...++|++.++||+|+||+||+|... .++.||||++..... ....+..|++++..++ |++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 445667789999999999999999999964 577899999864321 2234556666666654 45688899988
Q ss_pred EeC-CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCC---
Q 046972 219 VEG-QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHW--- 293 (483)
Q Consensus 219 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~--- 293 (483)
... .+.|+|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5789999998 7799999853 3568999999999999999999997 5 999999999999998765
Q ss_pred -------------CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046972 294 -------------NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY 360 (483)
Q Consensus 294 -------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~ 360 (483)
.+||+|||.+..... ......||..|+|||++.+.. |+.++|||||||++|||++|+.||.+
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998864322 223457899999999996654 89999999999999999999999987
Q ss_pred CCchhhHHHHHHHHH-------Hh------hhhhhh---cCCCCCC-----------CCCHHHHHHHHHHHHHccCCCCC
Q 046972 361 SQPQVFLIDWLKSMV-------AQ------QKIAYV---LDPKLPE-----------MPSRKELKRIILIALRCVDPDIK 413 (483)
Q Consensus 361 ~~~~~~~~~~~~~~~-------~~------~~~~~~---~~~~~~~-----------~~~~~~~~~l~~l~~~cl~~dP~ 413 (483)
.+....+..+..... .. ..+... ..+.... .........+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 665433222111000 00 000000 0000000 00001124677999999999999
Q ss_pred CCCCHHHHHHhccccc
Q 046972 414 HRPKMGDVLRMLEPRD 429 (483)
Q Consensus 414 ~Rpt~~eil~~L~~~~ 429 (483)
+|||+.|++++.+...
T Consensus 428 ~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 428 KRLNARQMTTHPYVLK 443 (467)
T ss_pred hCCCHHHHhcCccccc
Confidence 9999999999877543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.80 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=199.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-----CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 225 (483)
++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56888999999999999999743 577899999876655556789999999999999999999998754 34679
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999632 34589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH----hhh
Q 046972 306 HGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA----QQK 379 (483)
Q Consensus 306 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~~~ 379 (483)
....... ......++..|+|||.+.+. .++.++|||||||++|||++|..|+...... .......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchHH
Confidence 5433221 11122334569999998554 4899999999999999999987776432211 0000000000 000
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+...............++..+.+++.+||..+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 000011111111122344689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=318.10 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=203.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|.+.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 356788899999999999999854 5788999998766544456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++. ....+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999985 335689999999999999999999999 99999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 311 SISTSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.......|+..|+|||++. ....++.++|||||||++|+|++|..||....+....... .. . ....+..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~-~---~~~~~~~ 231 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TK-S---NFQPPKL 231 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hc-c---CCCCCcc
Confidence 1223346788999999873 2334789999999999999999999998654432211110 00 0 0011111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.. ....+..+.+++.+||..||++||++.+++++.
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 11 112335788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=329.73 Aligned_cols=263 Identities=19% Similarity=0.244 Sum_probs=201.4
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC------C
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------Q 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 222 (483)
.++|.+.+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999985 4678899999865422 2335678999999999999999999988643 3
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++++|++ +++|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 568999998 789998884 34689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-----
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ----- 377 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 377 (483)
++..... .....++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+.......
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 2334678899999998665558999999999999999999999997665433322221110000
Q ss_pred -----hhhhhhcCCCCCCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 378 -----QKIAYVLDPKLPEMPSR-------KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 378 -----~~~~~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...... ...++..+.. .....+.+++.+||..||.+|||+.+++++.+..
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 241 KKISSEHARKY-IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HhcchhhHHHH-hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 000000 0001111110 1124578999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=323.31 Aligned_cols=251 Identities=19% Similarity=0.272 Sum_probs=213.2
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchH--HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+-|.+.+.||+|.|..|-+|+ .-.|..||||++.+...... ..+.+|++.|+-++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457778899999999999998 45789999999988755443 578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE-cCCCCcEEeecccccccCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL-DHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl-~~~~~~kl~DFGla~~~~~ 308 (483)
+-++|+|++||-+ ....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+ .+-|-+||.|||.+..+.+
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999964 346799999999999999999999998 99999999999877 4568899999999988877
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.....+ .+|...|.|||++.+..+-.+++||||||||||.|++|+.||+..++.+.+-.++.. .+.
T Consensus 172 G~kL~T--sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-----------KYt- 237 (864)
T KOG4717|consen 172 GKKLTT--SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-----------KYT- 237 (864)
T ss_pred cchhhc--ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-----------ccc-
Confidence 654444 368889999999988886678999999999999999999999987776544332211 122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+.....++.+||..||..||++|.+.++|...-|
T Consensus 238 ---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 238 ---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ---CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 33455678899999999999999999999986543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.01 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=204.3
Q ss_pred hcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||.|+||.||+|+.+ +.+.+++|.+...... ....+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 367888999999999999999964 2457899988665433 346799999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGE-----AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
++||||+++|+|.+++...... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999644211 12689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
||++...............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-----~~~~ 234 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----LQAG 234 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-----HHcC
Confidence 9998754332222233335567799999885544 7899999999999999999 8889975443321111 1111
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..+......++..+.+++.+||+.||.+|||+.+++..|.
T Consensus 235 --------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 --------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=313.82 Aligned_cols=254 Identities=21% Similarity=0.321 Sum_probs=191.8
Q ss_pred eeccCCceEEEEEEEcCC---cEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCC
Q 046972 160 VIASGDNGVVYRAVLLDN---MRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985443 345667665443 2345689999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC-ccccc
Q 046972 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE-WSIST 314 (483)
Q Consensus 236 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~-~~~~~ 314 (483)
|.++++........+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++...... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999975433334567778889999999999999998 9999999999999999999999999998642211 11122
Q ss_pred cccccCcccccccccCCC------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 315 SCELRNSGYLAEELSGRT------SIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 315 ~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
....++..|+|||++... ..++.++|||||||++|||++ |..||....+........ . .......++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI----K-DQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----h-hcccccCCCc
Confidence 234567889999987421 125789999999999999997 677886555433222211 1 1111222333
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+.. ....+.+++..|| .+|++||+++++++.|.
T Consensus 234 ~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 2356778888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.90 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=203.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
..++|+..+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4567899999999999999999853 467899999875532 334679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhccc------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 224 RILVYEYIDNGNLQQWLHGSL------------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
.++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999996321 1123578889999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCc
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQP 363 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~ 363 (483)
||+++.++.+||+|||+++....... ........+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999875432211 1112223456799999885544 8999999999999999998 8889875543
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.... .. .. +..... .+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 239 ~~~~----~~-~~--------~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 EEVI----YY-VR--------DGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHH----HH-Hh--------cCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3211 11 11 111111 11123468899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.87 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=202.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
+..++|.+.+.||+|+||.||+|...+ ...+++|...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345678889999999999999998643 2468899886654 3445689999999999999999999998875 457
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 8999999999999999642 34589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..............++..|+|||.+... .++.++|||||||++|||++ |..||........... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~------ 224 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IENG------ 224 (270)
T ss_pred ecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcC------
Confidence 6543322222223345679999988544 48999999999999999996 9999976654322211 1100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... +..++..+.+++.+||..+|.+|||+.++++.|..
T Consensus 225 ~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 225 ERLPM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01111 12334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.49 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=201.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC------
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------ 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 221 (483)
..++|++.+.||+|+||.||+|... .++.+|+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 578899999875422 2346788999999999999999999988644
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
...++||||+++ +|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 356999999975 7777774 2478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh----
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ---- 377 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---- 377 (483)
+++...... ......+|..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+........+......
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998654322 223346789999999986554 8999999999999999999999998765433322221111000
Q ss_pred -----hhhhhhc----------------CCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 378 -----QKIAYVL----------------DPKLPE--MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 378 -----~~~~~~~----------------~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
....... +...+. .........+.+++.+||+.||++|||+.|++++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0000000 000000 00111235778999999999999999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=314.46 Aligned_cols=267 Identities=19% Similarity=0.304 Sum_probs=220.4
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccc
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLF 215 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~ 215 (483)
...+++.+..++++...++.+|.||.||+|.|+ +.+.|.+|.++....+ ....++.|..++..+.|||+..+.
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 345788888999999999999999999999654 4556778887765333 336789999999999999999999
Q ss_pred cEEEeC-CeEEEEEEecCCCCHHHHHhcc----cCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 216 GYCVEG-QNRILVYEYIDNGNLQQWLHGS----LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 216 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
+++... ...+.++.++..|+|..||... ......++..+...++.|++.||+|||.. ++||.||.++||+++
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 998654 5678899999999999999721 12345678889999999999999999999 999999999999999
Q ss_pred CCCCcEEeecccccc-cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHH
Q 046972 291 HHWNPKISDVGLAKL-HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368 (483)
Q Consensus 291 ~~~~~kl~DFGla~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~ 368 (483)
+..++||+|=.+++. +..++.........+..||+||.+... .|+.++|||||||+||||+| |+.||...++.+..
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~- 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME- 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-
Confidence 999999999999985 455666677777888899999999655 49999999999999999999 99999877765422
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+..++ .++ ..+.+|+++++.+|..||..+|++||+++|++.-|.+
T Consensus 509 ----~ylkdG-------yRl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 ----HYLKDG-------YRL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----HHHhcc-------cee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 112211 122 2355788999999999999999999999999998864
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=314.31 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=201.7
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+|++.+.||.|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999954 5788999988643 3334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++... ....+++..++.++.||+.||.|||++ +|+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999998643 335688999999999999999999999 999999999999999999999999999976543221
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+........ .. ...+.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-----~~--------~~~~~- 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-----CQ--------GSYKP- 219 (255)
T ss_pred -ccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH-----hc--------CCCCC-
Confidence 112345788899999986544 899999999999999999999999765432221110 00 11111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
.+...+..+.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=331.18 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=201.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeC------
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------ 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 221 (483)
..++|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999954 57889999987542 23346788999999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
...|+||||+++ +|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 7888774 2478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA----- 376 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----- 376 (483)
+++...... ......+|..|+|||++.+.. ++.++|||||||++|||++|+.||...+........+.....
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998654322 223346789999999986554 899999999999999999999999876654333222211000
Q ss_pred ----hhhhhhhc--CCCC--------------CC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 377 ----QQKIAYVL--DPKL--------------PE--MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 377 ----~~~~~~~~--~~~~--------------~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+.... .+.. +. .........+.+++.+||+.||.+|||+.+++++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00000000 0000 00 00011235688999999999999999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.57 Aligned_cols=265 Identities=20% Similarity=0.314 Sum_probs=206.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
..++|++.+.||+|+||+||+|... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3467888999999999999999965 57889999886543 233468899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. .+.+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999999853 35689999999999999999999973 1899999999999999999999999999865422
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. ......++..|+|||++.+. .++.++|||||||++|+|++|+.||................. ..+........
T Consensus 157 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (284)
T cd06620 157 S---IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQEPP 230 (284)
T ss_pred h---ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH--HHHHHHhhccC
Confidence 1 12234678899999998654 488999999999999999999999976543211000000000 00111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..+....+..+.+++.+||+.||++|||+.++++++..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 222222355688999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.02 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=202.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+|+||.||+|... .+..+|+|.+..... .....|.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888999999999999999854 233689998865432 234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999642 34689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCccccc--cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 307 GPEWSIST--SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 307 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
........ ....++..|+|||.+.... ++.++|+|||||++||+++ |..||........... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~-~----- 225 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IEE-G----- 225 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----HhC-C-----
Confidence 43322111 1122345799999986544 8999999999999999887 9999976554322111 100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ..+ .....+..+.+++.+||+.+|.+||++.++++.|..
T Consensus 226 ~--~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 226 Y--RLP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred C--cCC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 111 112234678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.88 Aligned_cols=267 Identities=22% Similarity=0.347 Sum_probs=207.1
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEE-
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCV- 219 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~- 219 (483)
+.+..+....++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556667789999999999999999999864 57789999875432 2345688899999999 6999999999884
Q ss_pred ----eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCc
Q 046972 220 ----EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295 (483)
Q Consensus 220 ----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~ 295 (483)
.+...++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34568999999999999999864433456788999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~ 371 (483)
||+|||+++....... ......++..|+|||++.. ...++.++|||||||++|||++|+.||............
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~- 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI- 241 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-
Confidence 9999999976543211 2223468889999998742 233788999999999999999999999765432221110
Q ss_pred HHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+... .+..+...+.+++.+||+.||++|||+.++++++.
T Consensus 242 ---------~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 242 ---------PRNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ---------cccCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 000011110 11122357889999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=321.66 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=206.3
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999995 468899999997766556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999842 4578899999999999999999999 999999999999999999999999999876543321
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...++....... ......+..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------------~~~~~~~~~ 236 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------ATNGTPELQ 236 (297)
T ss_pred -CcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------------ccCCCCCCC
Confidence 122346788899999986544 789999999999999999999999765542211100 000110111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+......+.+++.+||..||++||++.+++++-+.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 122334678889999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=327.06 Aligned_cols=263 Identities=18% Similarity=0.262 Sum_probs=193.9
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+...+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999965 4677888875332 2356899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+. |+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 699998863 345689999999999999999999999 999999999999999999999999999975332
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCch--hhHHHHHHHHHHhhhhhhhcC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQ--VFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~P-f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.. ......||..|+|||++.+.. ++.++|||||||++|||+++..| |...... .....................
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred Cc--ccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 21 122346889999999986554 89999999999999999985444 4432211 110000000000000000000
Q ss_pred CCCCCCC--------------------------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 386 PKLPEMP--------------------------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 386 ~~~~~~~--------------------------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..++... .......+.+++.+||+.||.+|||+.|++++.+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 0011000 001224566789999999999999999999987643
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=315.58 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=191.8
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 159 NVIASGDNGVVYRAVLLD---NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.||+|+||.||+|...+ ...+++|.+..... .....|.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997543 34678887765432 23357899999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-c
Q 046972 235 NLQQWLHGSLGE-AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-I 312 (483)
Q Consensus 235 ~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~ 312 (483)
+|.+++...... ....++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999654221 23456788899999999999999999 999999999999999999999999999875432211 1
Q ss_pred cccccccCcccccccccCC------CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 313 STSCELRNSGYLAEELSGR------TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
......++..|+|||+... ...++.++|||||||++|||++ |..||....+...+... ..... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~~~~-~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV----VREQD-IKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH----hhccC-ccCCC
Confidence 1223345677999998632 2346889999999999999999 88899765543322111 11110 01111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+.. ....+..+.+++..|| .||++|||+++|++.|.
T Consensus 233 ~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 PQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Ccc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 2233466777888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=336.56 Aligned_cols=262 Identities=18% Similarity=0.256 Sum_probs=196.6
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
..+|.+.+.||+|+||.||+|.... ++.||+|.... ..+.+|++++++++|||||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999654 67899996422 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+. ++|.+++.. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 699999863 234699999999999999999999999 99999999999999999999999999998654322
Q ss_pred cc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC-c------hhhHHHHHHHHHHh-hhhh
Q 046972 311 SI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ-P------QVFLIDWLKSMVAQ-QKIA 381 (483)
Q Consensus 311 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~-~------~~~~~~~~~~~~~~-~~~~ 381 (483)
.. ......||..|+|||++.+.. ++.++|||||||+||||++|..|+.... . ...+..++...... ..+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 122346899999999986554 8999999999999999999876553221 1 11122211110000 0000
Q ss_pred ----------------hhcCCCCCCCCCH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 ----------------YVLDPKLPEMPSR---KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ----------------~~~~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+........ .....+.+|+.+||+.||.+|||+.|+|++.+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 0000000000001 112468889999999999999999999998664
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.87 Aligned_cols=266 Identities=19% Similarity=0.221 Sum_probs=204.9
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|+..+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 588999998865422 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|..++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888774 334689999999999999999999998 9999999999999999999999999999866443
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh----------
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK---------- 379 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 379 (483)
.. ......++..|+|||.+.+...++.++|||||||++|||++|+.||.+..+......+.........
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 21 1223356788999999865555789999999999999999999999876654333222111100000
Q ss_pred -hhhhcCCCCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 380 -IAYVLDPKLPEMP-----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 380 -~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
......+...... ....+..+.+++.+||+.||++||++.+++.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000000000000 0122467889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=317.66 Aligned_cols=258 Identities=20% Similarity=0.324 Sum_probs=203.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999965 68899999886542 22346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|..++... .....+++..+..++.||+.||.|||++ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999999998643 1234789999999999999999999963 28999999999999999999999999998755322
Q ss_pred cccccccccCcccccccccCCCC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 311 SISTSCELRNSGYLAEELSGRTS-----IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
......++..|+|||.+.+.. .++.++|||||||++|+|++|+.||........... +..+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----------~~~~~~ 224 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ----------LSAIVD 224 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH----------HHHHhh
Confidence 122335777899999874332 258899999999999999999999975443221111 111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+. .+..+..++.+++.+||+.+|++||++.+++.+.+.
T Consensus 225 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 225 GDPPT-LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred cCCCC-CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 11111 122355788899999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.45 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=198.7
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEE-eCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV-EGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E~ 230 (483)
.++|.+.+.||+|+||.||+|... +..+++|.+.... ..+.|.+|+.+++.++|+||+++++++. ..+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457888999999999999999864 6788999885432 3467899999999999999999999765 45678999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.++++.. ....+++..++.++.||+.||+|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999643 234588999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
......+..|+|||++... .++.++|||||||++|||++ |+.||......... ... .. ...+.
T Consensus 156 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~-~~-----~~~~~-- 219 (256)
T cd05082 156 ---QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRV-EK-----GYKMD-- 219 (256)
T ss_pred ---CCCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-hc-----CCCCC--
Confidence 1222345679999998554 48999999999999999998 99999754432211 110 00 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....++..+.+++.+||+.||++|||+.++++.|..
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 122344688999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=312.30 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=202.8
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEecCCCcch-HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|.... +..+++|.+....... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 7889999997664433 57899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 234 GNLQQWLHGSLGE-----AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 234 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
++|.+++...... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999753211 47799999999999999999999999 999999999999999999999999999987654
Q ss_pred Ccc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 309 EWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 309 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... .......++..|+|||.+... .++.++|||||||++|||++ |..||.......... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~------~~~~ 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE----YLRK------GYRL 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc------CCCC
Confidence 321 122334567889999998655 48999999999999999999 699998764432211 1110 0111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..+ ...+.++.+++.+||..||.+|||+.++++.|+
T Consensus 227 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKP----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112 223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.25 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=199.8
Q ss_pred cCCcccceeccCCceEEEEEEEcC-C---cEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-N---MRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
++|.+.+.||.|+||.||+|.... + ..||+|.+... ......+|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999999653 2 35999998754 233346899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|.+++... ...+++.+++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999642 34689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccccc--ccc--ccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 308 PEWSIST--SCE--LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 308 ~~~~~~~--~~~--~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... ... ..+..|+|||.+.... ++.++|||||||++|||++ |..||.......... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i~------~ 226 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AIE------Q 226 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HHH------c
Confidence 3221111 111 1234699999986544 8999999999999999987 999997655432111 110 0
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+...+ .+..++..+.+++.+||..+|.+||++.+++..|+
T Consensus 227 --~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 227 --DYRLP--PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred --CCcCC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01111 11234467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.40 Aligned_cols=241 Identities=23% Similarity=0.393 Sum_probs=190.8
Q ss_pred ceeccCCceEEEEEEEcC--------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.||.|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998543 234788887655444456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC--------cEEeeccc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN--------PKISDVGL 302 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~--------~kl~DFGl 302 (483)
+++|+|.++++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999643 33689999999999999999999999 9999999999999987765 59999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR-LPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+...... ....++..|+|||++.+...++.++|||||||++|||++|. .||......... ... .
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~----~----- 219 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFY----E----- 219 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHH----H-----
Confidence 8654322 22356778999999876555799999999999999999984 666543332111 000 0
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....++.. ...++.+++.+||+.||++|||++++++.|.
T Consensus 220 --~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 --DRHQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --ccccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01222222 2257889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=314.65 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=202.9
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+..++.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344556666778999999999999954 5678999998776655667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeeccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPL--TWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAK 304 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~ 304 (483)
+||+++++|.+++... ...+ ++..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||++.
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 84 MEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999642 2334 7888899999999999999999 9999999999999976 6789999999987
Q ss_pred ccCCCccccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
....... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.......... .. .. ...
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~----~~--~~~ 228 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FK----VG--MFK 228 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hh----hh--hhc
Confidence 6533211 12223578899999987543 237899999999999999999999996543221100 00 00 000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..+..+ ......+.+++.+||+.+|.+|||+.+++++.+
T Consensus 229 ~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 229 IHPEIP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred cCCCCC----cccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 112222 233467889999999999999999999998753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=332.62 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=203.0
Q ss_pred eeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHH
Q 046972 160 VIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ 238 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~ 238 (483)
+||+|.||+||-|++.+ ..++|||-+........+-+.+||.+.++|+|.|||+++|++..++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999655 45679999987776677789999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-CCCCcEEeecccccccCCCcccccc
Q 046972 239 WLHGSLGEAKPL--TWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-HHWNPKISDVGLAKLHGPEWSISTS 315 (483)
Q Consensus 239 ~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~ 315 (483)
+|+. .-+++ .+...-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++.+..- ...+.
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TE 734 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTE 734 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccc
Confidence 9974 44566 7888889999999999999999 999999999999996 5689999999999876543 23344
Q ss_pred ccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 316 CELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 316 ~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
+..||..|||||++..+ ..|+.++|||||||++.||.||++||-.-...... +...+. +-+.|..| .
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGm--yKvHP~iP----e 802 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGM--YKVHPPIP----E 802 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcc--eecCCCCc----H
Confidence 56799999999998744 34999999999999999999999999643332110 111111 11233333 4
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 395 KELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+.+...+|.+|+.+||.+||++.++|+..
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 5567888999999999999999999999754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=333.34 Aligned_cols=265 Identities=17% Similarity=0.217 Sum_probs=202.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc---CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL---DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
+...+|.+.+.||.|+||.||+|... .+..||+|.+... ..+.+|+++++.++|||||++++++......|+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34567999999999999999999753 3567899987543 235689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||++. ++|.+++. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 69999984 346789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh---hHHHHHHHHHHh-----
Q 046972 307 GPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV---FLIDWLKSMVAQ----- 377 (483)
Q Consensus 307 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~----- 377 (483)
..... .......||..|+|||++.... ++.++|||||||++|||++|+.||.+..... .+..........
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 43322 1223446899999999986544 8999999999999999999999997654322 111111110000
Q ss_pred --------hhhhhhcCCCCCCCC-C-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 378 --------QKIAYVLDPKLPEMP-S-----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 378 --------~~~~~~~~~~~~~~~-~-----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..+........+... + .....++.+++.+||..||++|||+.+++.+.+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 000000000000000 0 11235678899999999999999999999987654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.32 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=206.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467889999999999999999964 5778999999776555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999998632 25689999999999999999999999 99999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRT--SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. ......++..|+|||.+... ..++.++|||||||++|||++|..||....+......... .. ...+..
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-----~~---~~~~~~ 226 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-----SN---FPPPKL 226 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cc---CCCccc
Confidence 1 12234577789999998544 2478999999999999999999999976554322211100 00 000111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
......+..+.+++.+||..||.+|||+.+++.+
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=312.98 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=195.2
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
++||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+++++.+.|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998533 26799999876644 24467999999999999999999999876 4567999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++.. ...+++..++.++.|++.||+|||.. +++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999963 23689999999999999999999999 99999999999999999999999999998664332211
Q ss_pred c--cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 314 T--SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 314 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ....++..|+|||.+.... ++.++|||||||++|||++ |..||...++.... ..+. .. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~~~----~~-----~~~~--- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLE----SG-----ERLP--- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHH----cC-----CcCC---
Confidence 1 1122345799999985544 8999999999999999998 99999765543221 1111 11 0011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+..++..+.+++.+||..||++||++.++++.|+..
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122346788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=327.09 Aligned_cols=264 Identities=22% Similarity=0.342 Sum_probs=206.1
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcC--------CcEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCccccccc
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFG 216 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 216 (483)
++++...+|++.+.||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 455666779999999999999999997421 2368999887543 22346899999999999 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCC
Q 046972 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284 (483)
Q Consensus 217 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp 284 (483)
++...+..+++|||+++|+|.+++..... ....+++.+++.++.||+.||.|||++ +++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 99999999999999999999999964321 234578899999999999999999999 999999999
Q ss_pred CcEEEcCCCCcEEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 046972 285 SNILLDHHWNPKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQ 362 (483)
Q Consensus 285 ~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~ 362 (483)
+|||++.++.+||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|||++ |..||....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999865432211 122233456799999985544 8999999999999999998 899997654
Q ss_pred chhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...... .. ... ..... +..++..+.+++.+||+.+|++|||+.++++.|...
T Consensus 242 ~~~~~~----~~-~~~-----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 242 VEELFK----LL-KEG-----HRMDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHHHHH----HH-HcC-----CCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 332211 11 100 01111 123346788999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.04 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=198.6
Q ss_pred ceeccCCceEEEEEEEcC--C--cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLLD--N--MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3589999987655 455789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc-
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI- 312 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~- 312 (483)
|+|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999975321 5689999999999999999999999 9999999999999999999999999999866432211
Q ss_pred -cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 313 -STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 313 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
......++..|+|||.+.... ++.++|||||||++|||++ |+.||............ .... ...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~-------~~~~- 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEG-------ERLE- 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcC-------CcCC-
Confidence 112235667899999885444 8999999999999999998 99999765543322111 1000 0111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11223468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=317.34 Aligned_cols=253 Identities=22% Similarity=0.378 Sum_probs=203.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.|+..+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34666788999999999999854 57789999886543 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++. ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999984 34688999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......++..|+|||.+.+.. ++.++|||||||++|||++|+.||....+...... .....+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------------~~~~~~~ 219 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--------------IPKNSPP 219 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--------------hhcCCCC
Confidence 1222235778899999986554 89999999999999999999999975443221110 0111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+..+.+++.+||+.+|++||++.+++++.+...
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 122234467889999999999999999999999765433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=310.66 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=198.9
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHH
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQ 237 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 237 (483)
++||.|+||.||+|...+++.|++|.+...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4568999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccc-cc
Q 046972 238 QWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST-SC 316 (483)
Q Consensus 238 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~-~~ 316 (483)
+++... ...+++..+..++.+++.||.|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999642 34678999999999999999999999 999999999999999999999999999976542211111 12
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRK 395 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (483)
...+..|+|||.+.+. .++.++|+|||||++|||++ |..||........... +....... .+..
T Consensus 155 ~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----------~~~~~~~~----~~~~ 219 (251)
T cd05041 155 KQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER----------IESGYRMP----APQL 219 (251)
T ss_pred CcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----------HhcCCCCC----CCcc
Confidence 2335569999988554 48999999999999999999 8999976554321111 00000111 1223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 396 ELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 396 ~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=322.31 Aligned_cols=263 Identities=18% Similarity=0.258 Sum_probs=190.7
Q ss_pred cceeccCCceEEEEEEEcC---CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEEEEEEecC
Q 046972 158 QNVIASGDNGVVYRAVLLD---NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRILVYEYID 232 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~ 232 (483)
..+||+|+||.||+|...+ +..+|+|.+..... ...+.+|+++++.++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3679999999999999653 46799998865432 3467899999999999999999998854 467799999986
Q ss_pred CCCHHHHHhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE----cCCCCcEEeecccc
Q 046972 233 NGNLQQWLHGSL-----GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLA 303 (483)
Q Consensus 233 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DFGla 303 (483)
++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 48888874221 1234588999999999999999999999 99999999999999 56678999999999
Q ss_pred cccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh-----HHHHHHHHHH
Q 046972 304 KLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF-----LIDWLKSMVA 376 (483)
Q Consensus 304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~-----~~~~~~~~~~ 376 (483)
+....... .......+|..|+|||++.+...++.++|||||||++|||+||+.||........ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86643321 1223346788999999986655589999999999999999999999975432210 0000000000
Q ss_pred ---------------hh---hhhh-hcCCCCC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 377 ---------------QQ---KIAY-VLDPKLP--------EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 377 ---------------~~---~~~~-~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.. .... ....... ..........+.+++.+||+.||.+|||+.|++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 00 0000 0000000 0000011246788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.16 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=208.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
..|+..+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34777889999999999999965 57889999987553 33446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++. ..++++.++..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999985 24588899999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......++..|+|||.+.+.. ++.++|+|||||++|||++|..||....+..... ......++
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------~~~~~~~~ 219 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------------LIPKNNPP 219 (277)
T ss_pred c-ccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------hhhcCCCC
Confidence 1 222335677899999986544 7999999999999999999999997655432111 01111122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhh
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLR 433 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~ 433 (483)
......+..+.+++.+||+.+|++||++.+++++........+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 2334556789999999999999999999999988765444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=324.35 Aligned_cols=268 Identities=17% Similarity=0.193 Sum_probs=197.9
Q ss_pred ccceeccC--CceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 157 EQNVIASG--DNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 157 ~~~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+.++||+| +||+||++.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45779999 7899999985 4688899999875532 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999643 234589999999999999999999999 999999999999999999999999986543211100
Q ss_pred -c-----cccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH--------
Q 046972 312 -I-----STSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA-------- 376 (483)
Q Consensus 312 -~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------- 376 (483)
. ......++..|+|||++.+. ..++.++|||||||++|||++|+.||..................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 01122456779999998643 34889999999999999999999999764433222111110000
Q ss_pred -hhhhh-----hhcCC----------CC-------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 -QQKIA-----YVLDP----------KL-------PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 -~~~~~-----~~~~~----------~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+. ...+. .. ...........+.+++.+||+.||++|||+.+++++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00000 00000 00 00011123457889999999999999999999999876544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=314.79 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=193.1
Q ss_pred ceeccCCceEEEEEEEcC-Cc--EEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLLD-NM--RAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|...+ +. .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999754 33 46888876432 33446789999999999 799999999999999999999999999
Q ss_pred CCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 234 GNLQQWLHGSL------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 234 g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
|+|.+++.... .....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999996432 1123578999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
++...... ........+..|+|||++... .++.++|||||||++|||++ |..||.......... ...
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~----- 225 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLP----- 225 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HHh-----
Confidence 98632211 111122335679999998544 48999999999999999997 999997654322111 110
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.......+ ......+.+++.+||..||.+|||+.++++.|..
T Consensus 226 -~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 226 -QGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred -CCCCCCCC----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00011111 1233678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=318.17 Aligned_cols=265 Identities=18% Similarity=0.259 Sum_probs=200.1
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|++.+.||.|+||.||+|... +|..+|+|.+...... ....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999965 5788999998654222 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
++ ++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 588888753 235689999999999999999999999 99999999999999999999999999998654332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch-hhHHHHHHHHHHh-----hhhhhhc
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDWLKSMVAQ-----QKIAYVL 384 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~-----~~~~~~~ 384 (483)
. ......++..|+|||.+.+...++.++|||||||++|||++|..||....+. ..+.......... ..+....
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1 1223456788999999866555799999999999999999998886443332 2221111100000 0000000
Q ss_pred C----CCCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 385 D----PKLPEM-----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 385 ~----~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+ +..+.. .....+..+.+++.+||+.||.+|||+.+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0 011100 01123467889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=317.75 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=207.0
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|++.+.||.|+||.||+|... +++.+++|.+..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 688999999876542 2346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+ +++|.+++... ..++++.+++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998642 36699999999999999999999999 99999999999999999999999999998665432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-----------
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK----------- 379 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----------- 379 (483)
........++..|+|||.+.+...++.++|||||||++|||++|..||....+................
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 222334467889999999866555789999999999999999998888765543332222211100000
Q ss_pred hhhhcCCCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 380 IAYVLDPKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 380 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
......+..+.. ...+....+.+++.+||..||.+|||+++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 000000000000 00122378899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=311.27 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=205.0
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|+..+.||.|+||.||+|...+ +..+++|.+..... .+++.+|+++++.++||||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999765 78899999865432 57899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999963 345789999999999999999999999 99999999999999999999999999998654432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||....+....... .....+...
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~- 220 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----------PNKPPPTLS- 220 (256)
T ss_pred c-ccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh----------ccCCCCCCC-
Confidence 1 22233577889999998655 4899999999999999999999999765443211100 000001111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+......+.+++.+||+.||++|||+.+++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~ 254 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence 1223346789999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=318.68 Aligned_cols=265 Identities=19% Similarity=0.280 Sum_probs=203.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|+..+.||+|+||.||+|... +++.+|+|++...... ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 5789999988654322 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|..+.. ....+++..+..++.||+.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988774 234589999999999999999999999 9999999999999999999999999999865433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----------hh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA-----------QQ 378 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-----------~~ 378 (483)
. .......++..|+|||++.+...++.++|||||||++|||++|+.||.................. ..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 2 12223457888999999866555789999999999999999999999765533222111110000 00
Q ss_pred hhhhhcCCCCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 379 KIAYVLDPKLPEMP-----SRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 379 ~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.......+...... ....+..+.+++.+||+.||++||++.+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 00000001110000 112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.85 Aligned_cols=249 Identities=23% Similarity=0.422 Sum_probs=202.7
Q ss_pred cccceeccCCceEEEEEEEc-C----CcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLL-D----NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
...++||.|+||+||+|.+- . .-+||+|++... ......++++|+-.|.+|+|||+++++|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34678999999999999853 3 345799998765 4445578999999999999999999999998776 789999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||++|+|.+|++. ....+..+..+.+..|||+||.|||.+ .+|||||..+||||.....+|+.|||+|+....+
T Consensus 778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999985 445688889999999999999999999 9999999999999999999999999999987654
Q ss_pred cc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 310 WS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 310 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. .......-.+.|||-|.+... .|+.++|||||||++||++| |..||.+....+ +......+ .+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~g-------eR 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKG-------ER 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhcc-------cc
Confidence 32 222333445689999988544 49999999999999999999 999998765432 11111111 12
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
++ .+..|..++..++.+||..|+..||+++++...+.
T Consensus 919 Ls--qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 919 LS--QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred CC--CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 22 34567789999999999999999999999986553
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=314.71 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=201.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeC------C
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEG------Q 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~------~ 222 (483)
+.+.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3466888899999999999999964 57788999886543 3446788999999998 699999999998753 4
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 679999999999999999643 235689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
+....... .......|+..|+|||++.. ...++.++|||||||++|||++|..||...........
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--------- 227 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------- 227 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---------
Confidence 97653321 12233467889999998752 22478899999999999999999999975443221110
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
... ...+.......+..+.+++.+||..||.+|||+.+++++.+
T Consensus 228 -~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 228 -IPR---NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred -Hhc---CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 000 00111112233467889999999999999999999998653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.24 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=201.2
Q ss_pred CCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+|+..+.||.|+||.||+|...+++.+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888889999988654211 124688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999953 34688999999999999999999999 99999999999999999999999999987542
Q ss_pred CC-----ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 308 PE-----WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 308 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
.. .........++..|+|||++.+.. ++.++|||||||++|+|++|..||...+........ .. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~-~~ 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GA-HR 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------hh-cc
Confidence 21 111122345788899999986544 789999999999999999999999754432211100 00 00
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
...+.++. .....+.+++.+||+.+|.+||++.+++++-
T Consensus 225 ~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 225 GLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred CCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 01122222 2346788999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.01 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=200.4
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch---------HHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE---------EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
+|.+.+.||.|+||.||+|... +++.+|+|.+....... .+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999854 57889999886543321 1468899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||+|+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999953 35688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccc-----cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 304 KLHGPEWSI-----STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 304 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
+........ ......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------- 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--------- 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH---------
Confidence 866422111 111234678899999986544 78999999999999999999999976543221110
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+.....+..+. ..+..+.+++.+||+.||.+||++.+++++-
T Consensus 224 -~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 265 (267)
T cd06628 224 -IGENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265 (267)
T ss_pred -HhccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence 11111222222 2346788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=309.72 Aligned_cols=252 Identities=18% Similarity=0.304 Sum_probs=205.1
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|+..+.||.|+||.||.++. .++..+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999984 457889999886543 33346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++... ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999643 235689999999999999999999998 99999999999999999999999999998654432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......++..|+|||...+.. ++.++|||||||++|||++|..||............. ....+.
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------------~~~~~~ 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------------QGNYTP 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------------cCCCCC
Confidence 2 223346788999999986554 7899999999999999999999997655432221111 111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+..+.+++.+||..||.+||++.++++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 11233467889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.98 Aligned_cols=258 Identities=20% Similarity=0.293 Sum_probs=199.3
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.|.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 578999999875422 22357999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 229 EYIDNGNLQQWLHGSLG-------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
||++||+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123456778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc-----------------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch
Q 046972 302 LAKLHGPEW-----------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ 364 (483)
Q Consensus 302 la~~~~~~~-----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~ 364 (483)
+++...... ........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 998652110 00111236899999999986554 899999999999999999999999764432
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHhcc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-MGDVLRMLE 426 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~eil~~L~ 426 (483)
..... .. ..++. ...+....+..+.+++.+||+.||++||+ ++++++.|+
T Consensus 238 ki~~~--------~~---i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 238 KISYR--------DV---ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred hhhhh--------hh---ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11100 00 00110 00111233467889999999999999965 555655554
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=314.45 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=206.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46788899999999999999965 57889999986553 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.. ..+++..++.++.|++.||.|||++ +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999953 2789999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...++...... +.....+..+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~----------~~~~~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----------IPKNNPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH----------hhhcCCCCCcc
Confidence 1223346778899999986555 89999999999999999999999976543221110 01111122221
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+..+.+++.+||..||++|||+++++++.+...
T Consensus 221 ---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 221 ---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ---cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 114467889999999999999999999998765433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.11 Aligned_cols=268 Identities=18% Similarity=0.214 Sum_probs=205.5
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc-----hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS-----EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+|.+.+.||.|+||.||+|... +++.|++|.+...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 5889999999765432 234577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+ +|+|.+++... ...+++..++.++.||++||.|||++ +++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999642 13689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--------hh
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--------QK 379 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------~~ 379 (483)
.... ......++..|+|||.+.+...++.++|||||||++|||++|..||....+...+.......... ..
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 4321 12223557789999988655557899999999999999999988887665543322221110000 00
Q ss_pred hhhhcCCCC-CCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 IAYVLDPKL-PEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~~~~~~~-~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......... +.. .....+..+.+++.+||+.||++|||+.+++++-+..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 000000000 000 01123467889999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=298.63 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=204.2
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcch-HHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSE-EEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++++....||.|+.|.||+++++. |...|||.+..+.... .++.+..+.++..-+ +|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344556779999999999999665 7788999998775443 367888888877664 8999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
.|. ..+..+++. -.+++++..+-++...+++||.||-+++ +|||||+||+|||+|+.|++||||||++-.+...
T Consensus 172 lMs-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 994 366666653 4567999999999999999999999874 9999999999999999999999999999765442
Q ss_pred ccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
...+...|.+.|||||.+.- ...|+-++||||||++|+||.||+.||.+.+.+-... .++.....|.
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l---------tkvln~ePP~ 314 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL---------TKVLNEEPPL 314 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH---------HHHHhcCCCC
Confidence 23344478889999999863 3458999999999999999999999998766432111 1111122344
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
++... +.+..+.+++..||++|+.+||...+++++..-.
T Consensus 315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 44322 2667899999999999999999999999876543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=318.26 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=202.6
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
|.....||+|+||.||++... ++..+|+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444567999999999999854 5788999998665555557789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
++|.+++. ...+++.+++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 104 ~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 99999984 23588999999999999999999999 999999999999999999999999999875433221 1
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....++..|+|||...+.. ++.++|||||||++|||++|+.||........... +.....+..+. .
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~--~ 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR----------IRDNLPPRVKD--S 241 (292)
T ss_pred CceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------HHhcCCCcccc--c
Confidence 22346788999999985544 79999999999999999999999976554322111 11111222111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+.+++.+||..||.+|||+.+++++.+...
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 123357888999999999999999999998755443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.55 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=201.3
Q ss_pred CCcccceeccCCceEEEEEEEcC--CcEEEEEEecCCC----------cchHHHHHHHHHHHhc-CCCCcccccccEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLD--NMRAAVKLLMSNS----------VSEEEDFIEKVEAIGQ-VKHKNLVKLFGYCVE 220 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 220 (483)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999765 6789999875321 1122467788888865 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999985433345678999999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
||++....... ......++..|+|||...+.. ++.++||||||+++|||++|+.||.......... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~------ 224 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT----K------ 224 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH----H------
Confidence 99998654432 223346788899999986544 8999999999999999999999996544322111 1
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.................+.+++.+||+.||++||++.|+..++.
T Consensus 225 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 ---IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01111111111223467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.40 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=189.6
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEE-eCCeEEEEEEecC
Q 046972 159 NVIASGDNGVVYRAVLLD----NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV-EGQNRILVYEYID 232 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E~~~ 232 (483)
+.||+|+||.||+|.+.+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 356899988543 2334468889999999999999999999876 4556789999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS- 311 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 311 (483)
+|+|.+++... ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999642 23467778889999999999999998 999999999999999999999999999975432211
Q ss_pred --ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 312 --ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 312 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.......++..|+|||.+.... ++.++|||||||++|||++ |..||........ .... .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~----~~~~---------~~~~~ 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI----TVYL---------LQGRR 220 (262)
T ss_pred eecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHH---------hcCCC
Confidence 1111234566899999885544 8999999999999999999 5666764433211 1111 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+. .+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 221 ~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 221 LL-QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 10 111234678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=316.93 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=198.0
Q ss_pred CCcccceeccCCceEEEEEEE-----cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-----LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRI 225 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 225 (483)
.|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+++++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999984 347789999987553 23346799999999999999999999998775 5679
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||++|++|.+++... ...+++.++..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999632 24589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH----HHHHhhh
Q 046972 306 HGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK----SMVAQQK 379 (483)
Q Consensus 306 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~----~~~~~~~ 379 (483)
....... ......++..|+|||.+.+.. ++.++|||||||++|||++++.|+...... ...... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTL--FLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccch--hhhhcccccccccHHHH
Confidence 5432211 112234566799999886544 899999999999999999987765321110 000000 0000000
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.......... .....++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 236 VRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0000011111 1122345789999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.15 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=196.2
Q ss_pred ceeccCCceEEEEEEEcC-------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLD-------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.||+|+||.||+|...+ +..+++|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 359999999999998643 25789998865432 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-----CcEEeeccc
Q 046972 231 IDNGNLQQWLHGSLG---EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-----NPKISDVGL 302 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-----~~kl~DFGl 302 (483)
+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964321 234578899999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 303 AKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 303 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |+.||........... . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~----~-~---- 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH----V-T---- 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH----H-h----
Confidence 975432211 1112234567899999986544 8999999999999999998 9999975543221111 0 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.. .........+..+.+++.+||..+|.+||++.++++.|.
T Consensus 228 ----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 ----AG-GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----cC-CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 011112234568889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=307.64 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=189.9
Q ss_pred ceeccCCceEEEEEEEcCCc-----------EEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 159 NVIASGDNGVVYRAVLLDNM-----------RAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999976543 4677776554333 6789999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-------CcEEeec
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-------NPKISDV 300 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-------~~kl~DF 300 (483)
|||+++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999643 22689999999999999999999999 999999999999999887 7999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
|++..... .....++..|+|||++... ..++.++|||||||++|||++ |..||.......... .. .
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~----~-- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FY----Q-- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HH----h--
Confidence 99976433 1223456679999998654 358999999999999999999 688886554321111 00 0
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+... ...+.+++.+||..+|.+|||+.++++.|+
T Consensus 221 -----~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -----DQHRLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----cCCCCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111111 157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=308.03 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=200.6
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe-CCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E 229 (483)
+|++.+.||.|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999954 467899999865432 234578899999999999999999998764 446799999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++... ....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999643 235689999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.. ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....... .. . ..++
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~-~--------~~~~ 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR----II-E--------GKLP 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-h--------cCCC
Confidence 21 222345788899999986554 78999999999999999999999975543221111 10 0 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
. .+......+.+++.+||+.||++|||+.+++++.
T Consensus 221 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 221 P-MPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred C-CccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 1 1223446888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=321.99 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=205.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCC--cchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l 226 (483)
+....|++.++||+||.+.||++...+.+.+|+|++.... .....-|.+|+.+|.+|+ |.+||++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4456799999999999999999998888888888776543 334478999999999995 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||-+ -||..+|++... ..+.-.++.+..|++.|+.++|.. ||||.||||.|+|+-++ .+||+|||+|..+
T Consensus 438 vmE~Gd-~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred Eeeccc-ccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 999975 599999975422 223237889999999999999999 99999999999999764 8999999999877
Q ss_pred CCCc-cccccccccCcccccccccCCCC----------CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 307 GPEW-SISTSCELRNSGYLAEELSGRTS----------IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 307 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
..+. +......+||..||+||.+.... ..++++||||||||||+|++|+.||.....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------ 577 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------ 577 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------------
Confidence 6543 33445679999999999875221 257899999999999999999999963221
Q ss_pred HhhhhhhhcCC----CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 376 AQQKIAYVLDP----KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 376 ~~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...++..+.+| .+|..+... +++++|+.||.+||++|||+.++|++..-
T Consensus 578 ~~aKl~aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 578 QIAKLHAITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQHPFL 630 (677)
T ss_pred HHHHHHhhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence 22345566666 344444332 38999999999999999999999986543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.53 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=204.4
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCC---CCcccccccEEEeCCeEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVK---HKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.|+..+.||.|+||.||+|.. .++..+|+|.+.... ......+.+|+.+++.++ ||||+++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 468899999986543 234467889999999986 999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.++++. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999852 3689999999999999999999999 999999999999999999999999999986654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......++..|+|||.+.+...++.++|||||||++|+|++|..||.......... .+.....+.+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----------~~~~~~~~~~ 222 (277)
T cd06917 154 NS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----------LIPKSKPPRL 222 (277)
T ss_pred Cc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----------ccccCCCCCC
Confidence 32 222334678889999988655557899999999999999999999997654321110 0011111112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+ .......+.+++.+||+.||++||++.+++.+.+...
T Consensus 223 ~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 223 E---DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred C---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 1 1124468899999999999999999999998765533
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.50 Aligned_cols=266 Identities=18% Similarity=0.271 Sum_probs=199.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||.|+||.||+|... +++.||+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999965 678899999865432 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++ +|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 999998642 34688999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh---hhh------
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ---KIA------ 381 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~------ 381 (483)
. ......++..|+|||.+.+...++.++|||||||++|||++|+.||.................... ...
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1 112234577899999886555588999999999999999999999976553211111111000000 000
Q ss_pred hhcCCCCCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 382 YVLDPKLPEMP---------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 382 ~~~~~~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.......+... .......+.+++.+||+.||++|||+.+++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 00000000000 0001156788999999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=315.46 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=205.4
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeC--
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEG-- 221 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-- 221 (483)
.++.-..++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 33444578899999999999999999996 467889999886542 2345678899999998 799999999998754
Q ss_pred ---CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEe
Q 046972 222 ---QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKIS 298 (483)
Q Consensus 222 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~ 298 (483)
...++||||+++|+|.++++........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEe
Confidence 357999999999999999865433456789999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCccccccccccCcccccccccCCCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 299 DVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS----IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 299 DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|||++........ ......++..|+|||.+.... .++.++|||||||++|||++|+.||....+......+.
T Consensus 171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~--- 246 (291)
T cd06639 171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--- 246 (291)
T ss_pred ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---
Confidence 9999886543211 112335788899999874332 26889999999999999999999997654432221110
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....+... ........+.+++.+||+.||++||++.+++++.+
T Consensus 247 -------~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 247 -------RNPPPTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred -------cCCCCCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 00011111 11223457889999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.30 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=200.4
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-C----cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-N----MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|++.+.||+|+||.||+|.... + ..+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4668889999999999999998643 2 2588998866543 234678999999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999642 34589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCcccc-ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWSIS-TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
........ .....++..|+|||.+... .++.++|+|||||++||+++ |+.||......... . . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~---~-~~~~----- 227 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-D---L-LEKG----- 227 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-H---H-HhCC-----
Confidence 65332211 1122235679999988544 48999999999999999999 99999766543211 1 1 1100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+ ..+...+.+++.+||..||.+||++.++++.|..
T Consensus 228 ~~~~~~----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 228 ERLPQP----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred CCCCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001111 1233578889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=307.63 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=200.7
Q ss_pred CcccceeccCCceEEEEEEEcC-----CcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+++.+.||.|+||.||+|...+ +..+|+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999654 378999999765443 4578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999996421 12289999999999999999999999 999999999999999999999999999986654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
..........++..|+|||.+. ...++.++|||||||++|+|++ |..||........... .. .. ....
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~-~~-----~~~~ 224 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LK-KG-----YRLP 224 (258)
T ss_pred ccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----Hh-cC-----CCCC
Confidence 3222221233678899999884 4448999999999999999998 8889876443222111 10 00 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+ ...+..+.+++.+||..||++|||+.++++.|
T Consensus 225 ~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KP----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 12446889999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.26 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=201.8
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
|.....||.|+||.||+|... +++.+|+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334557999999999999854 6889999998765545556789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
++|..++. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 103 GALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 99999874 24588999999999999999999999 999999999999999999999999999875543321 1
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.||....+......+ ... ..+.. ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~-----~~~~~--~~~ 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDS-----PPPKL--KNA 240 (297)
T ss_pred ccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hcc-----CCCCc--ccc
Confidence 22346788999999986544 899999999999999999999999765543222111 000 00000 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
......+.+++.+||+.||++||++.+++++....
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 12235788899999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.70 Aligned_cols=266 Identities=18% Similarity=0.239 Sum_probs=202.8
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|+..+.||.|+||.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999965 578899998865432 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+. ++|.+++... ....+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6899998643 345689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-----------h
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-----------K 379 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-----------~ 379 (483)
. ......++..|+|||.+.+...++.++|||||||++|||+||+.||.................... .
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1 122335678899999886655568899999999999999999999987655433332222110000 0
Q ss_pred hhhhcCCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 380 IAYVLDPKLPEM---PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 380 ~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.........+.. ........+.+++.+||+.||.+|||+++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 000000000000 00112356788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=317.01 Aligned_cols=256 Identities=21% Similarity=0.248 Sum_probs=205.7
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|+..+.||+|+||.||+|...+ ++.+|+|.+...... ..+.+..|+++++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368889999999999999999654 889999999765433 3357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+.+++|.+++... ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999999643 345789999999999999999999999 999999999999999999999999999875432
Q ss_pred Ccc----------------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046972 309 EWS----------------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY 360 (483)
Q Consensus 309 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~ 360 (483)
... .......|+..|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 110 0111235788899999986554 79999999999999999999999986
Q ss_pred CCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHhccc
Q 046972 361 SQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK----MGDVLRMLEP 427 (483)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt----~~eil~~L~~ 427 (483)
.+....+..... . ....+. ....+..+.+++.+||..||++||| +.+++.+-+.
T Consensus 235 ~~~~~~~~~~~~-----~------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 235 SNRDETFSNILK-----K------EVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred CchHHHHHHHhc-----C------CccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 665433222110 0 111111 1114478999999999999999999 8888886544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.63 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=205.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|+..+.||.|+||.||+|... +++.+++|.+..... .....+.+|+++++.++||||+++++++......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999976 578899998876533 3446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
+++++|.+++... ...+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999643 2678999999999999999999999 8 9999999999999999999999999998755322
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch-hhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ....+..... .....
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~ 221 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------VNEPP 221 (265)
T ss_pred Hh---hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH---------hcCCC
Confidence 11 115678889999998655 4899999999999999999999999754321 1111111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..+.......+.+++.+||..||++|||+.+++.+.+.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 222222245678999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=308.39 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=207.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999954 57789999986543 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999996432 125689999999999999999999999 99999999999999999999999999987654332
Q ss_pred cc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 311 SI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 311 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. ......++..|+|||.+.....++.++|+|||||++|||++|+.||.............. . ..+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~------~~~~ 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----N------DPPS 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----C------CCCC
Confidence 21 122335788899999986654589999999999999999999999976554332221111 0 1111
Q ss_pred CCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 388 LPEMP-SRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 388 ~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
++... ....+..+.+++.+||..||++||++.+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p 265 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence 11111 123457889999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.52 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=202.9
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRILVY 228 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 228 (483)
+|++.+.||.|+||.||+|.. .++..+|+|.+..... ...+.+..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 4578899998865432 234578899999999999999999998764 45679999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh-----hCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH-----EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
||+++++|.+++.........+++..++.++.||+.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754445677999999999999999999999 77 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
......... .....++..|+|||.+.... ++.++|+||||+++|+|++|+.||......... . . ....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~---~-~~~~----- 225 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-S---K-IKEG----- 225 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH-H---H-HhcC-----
Confidence 876543221 22346788999999986544 789999999999999999999999865532211 1 1 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+.+ +...+..+.+++.+||+.+|++||++.+++++.
T Consensus 226 ~~~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 226 KFRRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred CCCCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 11112 223446889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=313.08 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=200.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHH-HhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEA-IGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||.||+|+.. ++..||+|.+..... .....+..|+.. ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 588999999876532 233456667665 666789999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|++ |+|.+++.........+++..++.++.||+.||.|||++ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 689988865434456799999999999999999999985 28999999999999999999999999999865332
Q ss_pred ccccccccccCcccccccccCCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRT---SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. ......++..|+|||.+.+. ..++.++|+|||||++|||++|+.||........ . .... ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~-~~~~---------~~~ 223 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--Q-LKQV---------VEE 223 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--H-HHHH---------Hhc
Confidence 1 11224577889999987532 2368899999999999999999999964332111 0 1110 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+..+....+..+.+++.+||..+|++||++.+++++.+...
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 1111122234468899999999999999999999998665433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.44 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=197.8
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
++|++.+.||+|+||.||+|.. .++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999975 66789999886542 346789999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999653 234588999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......+..|+|||.+.+. .++.++|+|||||++|||++ |+.||.......... . .... ..+ .
T Consensus 154 -~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~-~~~~-----~~~----~ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE----C-VEKG-----YRM----E 217 (254)
T ss_pred -CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH----H-HhCC-----CCC----C
Confidence 1122335679999988544 48999999999999999998 999997655432111 1 1100 011 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122344678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.29 Aligned_cols=269 Identities=19% Similarity=0.211 Sum_probs=201.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCC-CCcccccccEEEeCCe-----
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQN----- 223 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~----- 223 (483)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 5889999987654322 2357889999999995 6999999999987665
Q ss_pred EEEEEEecCCCCHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeecc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGE-AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVG 301 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFG 301 (483)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 899988643222 45689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh--
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK-- 379 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-- 379 (483)
+++....... ......+++.|+|||.+.+...++.++|||||||++|+|++|..||....+................
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9976533211 1122356778999998765555799999999999999999999999876554333222211100000
Q ss_pred hhhh-------cCCCCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 380 IAYV-------LDPKLPE----MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 380 ~~~~-------~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.... ..+.... .........+.+++.+||..||.+||++.+++.+-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 0000 0000000 000123467889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.51 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=204.7
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEe-
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVE- 220 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~- 220 (483)
++.+...+.+.|++.+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555556778899999999999999999996 457889999875543 2345688899999998 79999999999853
Q ss_pred -----CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCc
Q 046972 221 -----GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295 (483)
Q Consensus 221 -----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~ 295 (483)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 45789999999999999999643 234578888999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~ 371 (483)
+|+|||++........ ......++..|+|||.+.. ...++.++|||||||++|||++|..||....+......
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 9999999875432211 1223467888999998742 23478899999999999999999999975543221110
Q ss_pred HHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.. ....+......++..+.+++.+||+.||.+|||+.+++++.
T Consensus 238 --------~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 238 --------IP---RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred --------Hh---hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 00 01111111223456899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.10 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=201.6
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-----chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-----SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+|+..+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 788999998865431 2336789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
+||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999963 34688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
... ......++..|+|||.+.....++.++|+|||||++|+|++|+.||...........+ .... ..+.
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~-----~~~~ 222 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRSK-----ELPP 222 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----Hhcc-----cCCC
Confidence 332 1233457888999998854434789999999999999999999999765432221111 0000 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+ ......+.+++.+||+.+|.+||++.+++.+.
T Consensus 223 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 223 IP----DHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred cC----CCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 12 22336788899999999999999999999764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=309.37 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=201.1
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc----------hHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS----------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
+|...+.||.|+||.||+|... +++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 6888999987532110 1245788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++|+|.++++. ...+++..+..++.||+.||.|||++ +++||||+|+||+++.++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999963 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccc-cccccccCcccccccccCCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 303 AKLHGPEWSI-STSCELRNSGYLAEELSGRTS-IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 303 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
++........ ......++..|+|||.+.... .++.++|+||||+++|||++|..||..........+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~----- 225 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL----G----- 225 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh----h-----
Confidence 9765432211 122335778899999875443 3789999999999999999999999654332211110 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+..+.......+..+.+++.+||..||.+|||+.+++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 0011122222222234578899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=309.69 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=204.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCC------
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQ------ 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~------ 222 (483)
..++|++.+.||.|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999999975 567899998865543 346799999999999 7999999999997654
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999865433356789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
+....... .......++..|+|||.+.. ...++.++|||||||++|+|++|+.||...........+.
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------- 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP------- 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-------
Confidence 87654322 12233467888999998743 2346789999999999999999999997544332221110
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....+... ........+.+++.+||..||++|||+.+++++.+
T Consensus 232 ---~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 232 ---RNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred ---ccCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 00111111 12234568899999999999999999999998653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=315.42 Aligned_cols=254 Identities=19% Similarity=0.258 Sum_probs=198.3
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||.||++... .++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 467899998865532 22357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||++|++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999953 35689999999999999999999999 999999999999999999999999999863211
Q ss_pred Cc--------------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 309 EW--------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 309 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
.. ........++..|+|||.+.... ++.++|+|||||++|||++|..||.+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~---- 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---- 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----
Confidence 00 00111235677899999986544 899999999999999999999999765543221111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHhcc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM---GDVLRMLE 426 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~---~eil~~L~ 426 (483)
.. . ....+..+ ...+..+.+++.+||+.||++||++ .+++++.+
T Consensus 229 ~~-~---~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 229 IS-D---DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred Hh-c---ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 00 0 00111111 1234678999999999999999985 55555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=316.66 Aligned_cols=254 Identities=23% Similarity=0.412 Sum_probs=197.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCc----EEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNM----RAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+...... ....+.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999864 333 4688888655332 234788999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 899999999999999632 34588999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
....... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+..... ...+ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~----- 227 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDL----LEKG----- 227 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH----HHCC-----
Confidence 5432211 122234466899999985544 8999999999999999997 999997654221 1111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+ .+..+...+.+++.+||..||++||++.++++.|..
T Consensus 228 --~~~~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 228 --ERLP--QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred --CCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 112234678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=312.30 Aligned_cols=266 Identities=21% Similarity=0.312 Sum_probs=202.6
Q ss_pred cCCcccceeccCCceEEEEEEEc-----CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEe--CCeE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNR 224 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 224 (483)
+.|.+.+.||+|+||.||+|.+. .+..+|+|.+...... ....|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3678999999766443 45789999999999999999999999877 5678
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++++|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999642 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH---HHHhhh
Q 046972 305 LHGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS---MVAQQK 379 (483)
Q Consensus 305 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~---~~~~~~ 379 (483)
........ ......++..|+|||..... .++.++|||||||++|||++|..|+......... +... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 234 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTR 234 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHH
Confidence 76532211 11122345569999988554 4889999999999999999999998643321100 0000 000000
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+...+........+..++..+.+++.+||+.||++|||+.+++++|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 001111111111122344689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=312.84 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=204.7
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
++|.+.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788899999999999999985 467889999986555455577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999952 3578899999999999999999999 999999999999999999999999999876543322
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......++..|+|||.+.... ++.++|||||||++|++++|+.||...+........ . ..+.....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~----~--------~~~~~~~~ 236 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----A--------TNGTPELQ 236 (293)
T ss_pred -ccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh----h--------cCCCCCCC
Confidence 122335778899999986544 789999999999999999999999765543211110 0 01111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
........+.+++.+||..+|++||++.+++.+-..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 122234578899999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.71 Aligned_cols=278 Identities=15% Similarity=0.214 Sum_probs=194.8
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcCC--cEEEEE--------------Eec---CCCcchHHHHHHHHHHHhcCCC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDN--MRAAVK--------------LLM---SNSVSEEEDFIEKVEAIGQVKH 208 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~--~~vavK--------------~~~---~~~~~~~~~~~~E~~~l~~l~h 208 (483)
.+...++|++.+.||+|+||+||+|..+.. ..+++| .+. .........+.+|+.++++++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 344568899999999999999999875421 111211 111 1111223568899999999999
Q ss_pred CcccccccEEEeCCeEEEEEEecCCCCHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcE
Q 046972 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSL-GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNI 287 (483)
Q Consensus 209 pnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~Ni 287 (483)
||||++++++...+..|+|+|++. ++|.+++.... ..........+..++.||+.||.|||++ +||||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 999999999999999999999995 58888875321 1122334567788999999999999999 999999999999
Q ss_pred EEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCc--h
Q 046972 288 LLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRL-PVDYSQP--Q 364 (483)
Q Consensus 288 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~-Pf~~~~~--~ 364 (483)
|++.++.+||+|||+++.+............||..|+|||++.+.. ++.++|||||||++|||++|.. ||..... .
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999999876544333333457899999999986554 8999999999999999999875 4433221 1
Q ss_pred hhHHHHHHHHHH-hh-------h-hhhhcCCC---CCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 365 VFLIDWLKSMVA-QQ-------K-IAYVLDPK---LPEMPS-----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 365 ~~~~~~~~~~~~-~~-------~-~~~~~~~~---~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+...+..... .. . ...+.... .+.... .....++.+++.+||+.||++|||+.|++.+.+.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 222221111000 00 0 00000000 000000 0122467788899999999999999999998776
Q ss_pred cch
Q 046972 428 RDL 430 (483)
Q Consensus 428 ~~~ 430 (483)
...
T Consensus 458 ~~~ 460 (501)
T PHA03210 458 SAE 460 (501)
T ss_pred hcC
Confidence 443
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.22 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=204.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 578999999865422 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++.. ...+++..+..++.||+.||.|||++ +++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999963 35789999999999999999999998 999999999999999999999999999986543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. .....++..|+|||.+... .++.++||||||+++|+|++|..||............ . . ....+
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~------~~~~~ 217 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI----L-E------GKVRF 217 (290)
T ss_pred C----CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----h-c------CCccC
Confidence 3 2233578889999988654 4789999999999999999999999765532211111 0 0 01122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
+.. ....+.+++.+||..||.+|+ ++++++++.+..+
T Consensus 218 ~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 218 PSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred Ccc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 222 236788999999999999999 8899998876544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=305.99 Aligned_cols=251 Identities=19% Similarity=0.304 Sum_probs=202.6
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|++.+.||.|+||.||++.. .+++.+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999985 467889999986532 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++... ....+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999999642 234578999999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.. .....++..|+|||+..+.. ++.++|+|||||++|+|++|+.||...........+ . ....+.
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~----~---------~~~~~~ 220 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI----I---------RGSYPP 220 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH----h---------cCCCCC
Confidence 11 12235778899999986544 789999999999999999999999765433221111 1 111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+......+.+++.+||+.+|.+||++.+++++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 221 -VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred -CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 1223346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=311.58 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=204.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 57889999886542 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|++++.|..+.. ....+++.+++.++.||+.||.|||++ +++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776664 335589999999999999999999999 9999999999999999999999999999876544
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--hhhh-hhcCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--QKIA-YVLDP 386 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~ 386 (483)
.........++..|+|||++.+...++.++||||||+++|+|++|+.||........+.......... .... ...++
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 32223334677889999998666358999999999999999999999997655433222111100000 0000 00000
Q ss_pred -----CCCC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 387 -----KLPE---------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 387 -----~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+. ..+...+..+.+++.+||..||++|||+++++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 0000 01112257889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=310.99 Aligned_cols=266 Identities=18% Similarity=0.221 Sum_probs=198.8
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|.+.+.||+|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 367889999999999999999854 5889999998654322 23467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 688887753 234578888999999999999999999 9999999999999999999999999999754332
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh-HHHHHHHHH--------Hhhhh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF-LIDWLKSMV--------AQQKI 380 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~--------~~~~~ 380 (483)
.. ......++..|+|||.+.+...++.++|||||||++|||++|..||....+... +........ .....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11 122335688899999986544478899999999999999999999976554211 111100000 00000
Q ss_pred h----hhcCCCCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 381 A----YVLDPKLPEMP-----SRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 381 ~----~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
. .......+... .......+.+++.+||..||.+|||+.+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~ 289 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence 0 00000000000 001135678899999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.95 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=214.5
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc--------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCccccccc
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFG 216 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~ 216 (483)
.+++..++..+.+.||+|.||.|++|... ....||||++..... .+.+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777777888889999999999999843 145689999987644 4457899999999999 6999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhccc---CC-------C--CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCC
Q 046972 217 YCVEGQNRILVYEYIDNGNLQQWLHGSL---GE-------A--KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284 (483)
Q Consensus 217 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp 284 (483)
+|...+..++|+||+..|+|.+||+... .. . ..++..+.+.++.|||.||+||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999997543 00 1 2388999999999999999999999 999999999
Q ss_pred CcEEEcCCCCcEEeecccccccCCCccccccccc--cCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 046972 285 SNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL--RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYS 361 (483)
Q Consensus 285 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~ 361 (483)
+|||+..+..+||+|||+|+.............. -+..|||||.+.. ..|+.++|||||||+||||+| |..||.+.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999965544333322222 3557999999965 569999999999999999999 99999874
Q ss_pred CchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 362 QPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+.++++. ......+..|..++.++|+.||+.+|++||++.++.+.++.
T Consensus 526 ~~~~~l~~~l~~-------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 526 PPTEELLEFLKE-------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CcHHHHHHHHhc-------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 433322222211 11112344566899999999999999999999999999976
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.70 Aligned_cols=245 Identities=23% Similarity=0.398 Sum_probs=197.5
Q ss_pred cceeccCCceEEEEEEEc-CCcEEE---EEEecC-CCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCe--EEEEEEe
Q 046972 158 QNVIASGDNGVVYRAVLL-DNMRAA---VKLLMS-NSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN--RILVYEY 230 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~-~~~~va---vK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~E~ 230 (483)
..+||+|+|-+||+|.+. +|..|| ||.-.. ......+.|..|+.+|+.|+|||||++|+++.+... ..+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999964 455564 332221 133344789999999999999999999999988766 6789999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeecccccccCCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHGPE 309 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFGla~~~~~~ 309 (483)
|..|+|..|+++ .+.++...+..+++||++||.|||++ .|+|||||||.+||+|+.+ |.+||+|+|||+.....
T Consensus 125 ~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999964 45678889999999999999999997 7799999999999999765 88999999999987544
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
. .....|||.|||||+.. ..|++.+||||||+.++||+|+..||.......+.+..+........+..+-|
T Consensus 200 ~---aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d---- 270 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD---- 270 (632)
T ss_pred c---cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC----
Confidence 2 23368999999999984 33999999999999999999999999877776665544333222222222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.++.++|.+||.. ..+|||+.|+|+.-
T Consensus 271 --------Pevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 271 --------PEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred --------HHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 4778888899999 99999999999744
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=307.92 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=204.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 228 (483)
++|+..+.||.|++|.||+|... +++.+|+|.+..... .....+.+|+++++.++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999964 578899998875433 3446789999999999999999999988653 4689999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998864333456688999999999999999999999 999999999999999999999999999875432
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch-hhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
... ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||...... ....+...... .. ..+.
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-----~~~~ 227 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NM-----PNPE 227 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cC-----Cchh
Confidence 211 1234677899999985544 899999999999999999999999765321 11111111111 00 0111
Q ss_pred CCCCCC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 388 LPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
++.... ......+.+++.+||..||.+|||+.|++++.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 111111 123467889999999999999999999999877644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=315.78 Aligned_cols=269 Identities=18% Similarity=0.238 Sum_probs=200.8
Q ss_pred CCcccceeccCCceEEEEEEEc---CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL---DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRI 225 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 225 (483)
+|.+.+.||+|+||.||+|... .+..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999965 47899999997643 22336778899999999999999999999988 8899
Q ss_pred EEEEecCCCCHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC----CCCcEEeec
Q 046972 226 LVYEYIDNGNLQQWLHGSLGE-AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH----HWNPKISDV 300 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~----~~~~kl~DF 300 (483)
+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 788777543222 24789999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh---------hHHH
Q 046972 301 GLAKLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV---------FLID 369 (483)
Q Consensus 301 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~---------~~~~ 369 (483)
|++........ .......++..|+|||.+.+...++.++|||||||++|+|++|+.||....... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 122234567889999987665558899999999999999999999997654432 0111
Q ss_pred HHHHHH-----------Hhhhhhh----hcCCCCCCCCC-H------HHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 370 WLKSMV-----------AQQKIAY----VLDPKLPEMPS-R------KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 370 ~~~~~~-----------~~~~~~~----~~~~~~~~~~~-~------~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
++..+. ....... ......+.... . .....+.+++.+||+.||++|||+.+++++.+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 110000 0000000 00000110000 0 22356889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=308.17 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=202.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+-|++.+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34777889999999999999864 678899998765432 2336788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++. ...+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999984 24688999999999999999999999 99999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......++..|+|||.+... .++.++|+|||||++|+|++|..||.......... .. .....+.+
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~------~~~~~~~~-- 221 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF----LI------PKNNPPTL-- 221 (277)
T ss_pred h-hhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH----HH------hcCCCCCC--
Confidence 1 12233577889999998544 47899999999999999999999997544321111 00 00011112
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+..+.+++.+||..+|.+||++.+++++.....
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred --CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 2223467889999999999999999999999754443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.86 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=202.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.+.|...+.||.|+||+||+|... +++.||+|.+..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999964 688999998864322 2235788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++ |+|.+++.. ....+++..+..++.||+.||.|||+. +++||||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 578777753 234689999999999999999999999 99999999999999999999999999987553
Q ss_pred CCccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.. ....++..|+|||++.. ...++.++|||||||++|||++|..||...+........ ..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-------------~~ 228 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------AQ 228 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-------------hc
Confidence 32 23356788999998742 344789999999999999999999999765433221110 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+......++..+.+++.+||..||++||++.+++.+.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 11122223345578999999999999999999999998766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.06 Aligned_cols=252 Identities=19% Similarity=0.285 Sum_probs=196.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-----chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-----SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNR 224 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 224 (483)
.+|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 578999998853311 1235788899999999999999999988764 467
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999963 34578889999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... .......++..|+|||.+.+.. ++.++|||||||++|||++|+.||........... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~-------- 221 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----I-------- 221 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----H--------
Confidence 5432111 1122235778899999986544 78999999999999999999999975433221111 0
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+..+ ..+......+.+++.+||. +|++||++++++++.+
T Consensus 222 ~~~~~~~-~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 222 ATQPTNP-VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred hcCCCCC-CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 0111111 1223344677888889984 9999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.75 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=201.0
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc------chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV------SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
+|+..+.||+|+||.||+|.. .++..+|+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 5688899999864321 123578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKL 305 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~ 305 (483)
||||+++++|.+++.. ..++++..+..++.||+.||.|||++ +++|+||||+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999963 35688999999999999999999999 999999999999998776 599999999976
Q ss_pred cCCCccc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEWSI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+ ... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~-----~~~ 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKI-----ASA 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHH-----hcc
Confidence 5433111 11223577889999998554 4789999999999999999999999754432211111 000 000
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+. .+......+.+++.+||..||.+||++.+++++..
T Consensus 227 ~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 227 TTAPS----IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred CCCCC----CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 11111 22334468889999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.95 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=203.4
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|...+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 6889999998766443 457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999953 34578899999999999999999999 99999999999999999999999999998664432
Q ss_pred cccc---cccccCcccccccccCCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 311 SIST---SCELRNSGYLAEELSGRTS--IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 311 ~~~~---~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.... ....++..|+|||++.... .++.++||||||+++|||++|+.||............ +.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~ 224 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH---------VGAGHK 224 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH---------HhcCCC
Confidence 2211 1235678899999985432 2789999999999999999999999755432111100 011112
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+.++.. ......+.+++.+||+.||.+|||+.+++.+-
T Consensus 225 ~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~ 262 (264)
T cd06626 225 PPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262 (264)
T ss_pred CCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 223221 12246788999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=306.50 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=195.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-----chHHHHHHHHHHHhcCCCCcccccccEEEe--CCeE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-----SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNR 224 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 224 (483)
.+|+..+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 588999998864321 123568899999999999999999998875 3567
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+++|||+++++|.+++.. ...+++...+.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999953 34588999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~---------~~~~ 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK---------IATQ 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH---------HhcC
Confidence 5532111 111223577889999998654 488999999999999999999999975543221110 0011
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+.++. .....+.+++ +||..+|++||++++++++..
T Consensus 225 ~~~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 225 PTNPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred CCCCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 11222222 2235566666 688899999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=303.16 Aligned_cols=250 Identities=19% Similarity=0.337 Sum_probs=201.1
Q ss_pred CCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|+..+.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 4678899999865432 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccccCCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKLHGPE 309 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~ 309 (483)
+++++|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999643 234589999999999999999999999 999999999999998654 5799999999865433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
. ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......... . .....+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~-----~~~~~~ 222 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-----G-----TFAPIS 222 (256)
T ss_pred c--cccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-----c-----CCCCCC
Confidence 2 112245778899999986544 78999999999999999999999976654332211110 0 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
...+..+.+++.+||..||.+|||+.+++++.
T Consensus 223 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 223 ----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred ----CCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 12346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=309.60 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=202.4
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEEEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILVYE 229 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E 229 (483)
|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999966 47889999997653 22335788999999999999999999999888 88999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++ +|.+++... ...+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 999988532 25789999999999999999999999 9999999999999999999999999999866543
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--hhh---h--
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ--KIA---Y-- 382 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~---~-- 382 (483)
.........++..|+|||.+.+...++.++|||||||++|||++|+.||.................... ... .
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 322223345677899999876555578999999999999999999999987665433322221100000 000 0
Q ss_pred ---hcCC--CCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 383 ---VLDP--KLP----EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 383 ---~~~~--~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
...+ ..+ ......++..+.+++.+||..||.+||++.+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 0000 000 000011256789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.51 Aligned_cols=264 Identities=19% Similarity=0.250 Sum_probs=201.5
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
|++.+.||.|++|.||+|... ++..||+|++...... ....+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999964 6889999998654322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
+ ++|.+++.... ...+++..++.++.|++.||.|||++ +++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 69999986432 24689999999999999999999998 999999999999999999999999999976543211
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-----------hh
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-----------KI 380 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~ 380 (483)
......++..|+|||++.+...++.++|||||||++|+|++|+.||...........+........ ..
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 122235578899999876555578999999999999999999999987655433333221100000 00
Q ss_pred hhhcC---CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 381 AYVLD---PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 381 ~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..... ...........+..+.+++.+||+.||.+|||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 00000 0000000112235788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=311.81 Aligned_cols=262 Identities=22% Similarity=0.262 Sum_probs=202.2
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 227 (483)
++|++.+.||.|+||.||+|... +++.+++|.+...... ....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999975 5788999998654322 224577899999999999999999999877 889999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++ +|.+++... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 999998642 23689999999999999999999999 99999999999999999999999999998665
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH--------hhh
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA--------QQK 379 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 379 (483)
.... ......++..|+|||.+.+...++.++|+|||||++|||++|..||.................. ...
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 4321 1223456788999998866555789999999999999999999999866544333222111000 000
Q ss_pred hhh------------hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 380 IAY------------VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 380 ~~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+.. .....++.. .....+.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~t~~ell~~~ 291 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPAL---SLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291 (293)
T ss_pred cchhcccccccccchhhhcccccc---CCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence 000 001111111 0246788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=274.92 Aligned_cols=268 Identities=18% Similarity=0.249 Sum_probs=215.2
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|...++||+|.||+||+|+.+ .+..||+|.+......+ ....++|+.+++.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566788999999999999954 57788999987654332 26789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
|.. +|..|... -++.+..+.+..++.|+++||.|+|++ ++.||||||.|.|++.+|.+||+|||+++.++...
T Consensus 83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 99999863 456688999999999999999999999 99999999999999999999999999999887653
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhh-----hhhhc
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQK-----IAYVL 384 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 384 (483)
. .....+-|.+|.+|.++.+...|++..|+||-||++.|+.. |++.|++.+-..++..+++....... +..+-
T Consensus 156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 3 23445678999999999888889999999999999999998 88889988877777766654322111 11222
Q ss_pred CCCCCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 385 DPKLPEMPSR---------KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 385 ~~~~~~~~~~---------~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
|....+.++. +....-.+++.+.|.-+|.+|.++++.+++....+
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 2222221111 11234467888999999999999999998875443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.11 Aligned_cols=255 Identities=21% Similarity=0.364 Sum_probs=206.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||.|+||.||+|... +++.+++|++..... .....+.+|+..+.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999966 488999999876644 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
+++++|.+++.. ...+++..++.++.|++.||.|||+ . +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999963 3678999999999999999999999 8 9999999999999999999999999999865433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
... .....++..|+|||.+... .++.++|+||||+++|+|++|..||....... ..+..... .....+
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~---------~~~~~~ 221 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAI---------CDGPPP 221 (264)
T ss_pred CCc-ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccC-HHHHHHHH---------hcCCCC
Confidence 221 1233567889999998655 48999999999999999999999997664211 11111111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.......+..+.+++.+||..+|++||++.+++++-+
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 1111114478999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=313.45 Aligned_cols=270 Identities=22% Similarity=0.257 Sum_probs=204.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 226 (483)
.++|++.+.||.|+||.||+|... ++..||+|.+....... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367889999999999999999964 58899999986543221 23567899999999999999999998765 56899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+.+ +|.+++... ...+++.+++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 899988632 35689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-h----h-
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-K----I- 380 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-~----~- 380 (483)
.... .......++..|+|||.+.+...++.++|||||||++|||++|+.||...++...+........... . +
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 4332 1122234577899999986655589999999999999999999999987665443333222100000 0 0
Q ss_pred --hhhcCCCCCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 --AYVLDPKLPEMP-------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 --~~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......++... .......+.+++.+||+.||++|||+.+++.+.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000000000000 0012457788999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.40 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=204.4
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+|+..+.||.|++|.||+|+.. ++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 578899999876533 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++ +|.+++.... ....+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8999886432 235689999999999999999999998 999999999999999999999999999976543211
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--hhh-----hhc
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ--KIA-----YVL 384 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~-----~~~ 384 (483)
......++..|++||.+.+...++.++|||||||++|+|++|+.||...+................ ... ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 122345678899999886655578999999999999999999999987665433332221110000 000 000
Q ss_pred CCCCCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 385 DPKLPEMP-------SRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 385 ~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
....+... ....+..+.+++.+||+.||.+||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 01111100 012245788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.31 Aligned_cols=250 Identities=18% Similarity=0.245 Sum_probs=193.7
Q ss_pred eeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHH---HhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 160 VIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEA---IGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
.||+|+||.||++... +++.+|+|.+...... ....+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 5788999988654221 22334455443 334479999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 999999985 335699999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (483)
......++..|+|||.+.....++.++|||||||++|||++|..||......... ..... .......++
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~------~~~~~~~~~--- 219 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM------TLTVNVELP--- 219 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHH------hhcCCcCCc---
Confidence 1123367889999998854444789999999999999999999999754432111 01110 011122222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccchh
Q 046972 393 SRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDLL 431 (483)
Q Consensus 393 ~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~~ 431 (483)
...+..+.+++.+||..||.+|| ++.+++++.......
T Consensus 220 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 220 -DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 23346888999999999999999 699999998776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=304.21 Aligned_cols=261 Identities=18% Similarity=0.199 Sum_probs=197.5
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCcccccccEEEeC--CeEEEEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEG--QNRILVYE 229 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~E 229 (483)
|++.+.||+|+||.||+|... ++..+|+|.+.... ........+|+..+.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999954 57889999886542 222334567898999885 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|++ |+|.+++... ...+++..++.++.||+.||.|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888888532 35689999999999999999999999 9999999999999999 99999999999865433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh------hh--hh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ------QK--IA 381 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------~~--~~ 381 (483)
... ....++..|+|||.+.....++.++|||||||++|||++|..||...+.......... .... .. ..
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD-VLGTPDAEVLKKFRKS 229 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH-HcCCCCHHHHHhhccc
Confidence 221 2235678899999765555578999999999999999999999987654332221111 0000 00 00
Q ss_pred hhcCCCCCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 382 YVLDPKLPEMP-------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 382 ~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+...+... ....+..+.+++.+||+.||++||++.+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00011111100 1123578999999999999999999999998743
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.12 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=202.6
Q ss_pred CcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
|...+.||+|++|.||+|.. .++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567899999999999985 46788999988655545556789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999999953 4588999999999999999999999 999999999999999999999999998875433211 1
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...++..... .. .....+.... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~------~~~~~~~~~~--~ 238 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RI------RDNLPPKLKN--L 238 (285)
T ss_pred cccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HH------HhcCCCCCcc--c
Confidence 22345788999999986544 8999999999999999999999997654322111 10 0001111111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+..+.+++.+||+.||++|||+.+++++.....
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 113368899999999999999999999998765433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=304.89 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=196.2
Q ss_pred CcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCC------
Q 046972 155 FAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------ 222 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 222 (483)
|.+.+.||+|+||.||+|.+. .+..+|+|++..... ...+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 367899999876532 23467899999999999999999999886542
Q ss_pred eEEEEEEecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 223 NRILVYEYIDNGNLQQWLHGSL--GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
..++++||+.+|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999999874321 1223578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 301 GLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 301 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
|+++........ ......++..|++||.+.... ++.++|||||||++|||++ |+.||........... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY----LIKGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH----HHcCC
Confidence 999865432211 112224456799999885444 7899999999999999999 8999875543221111 10000
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... ....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 233 ------~~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 233 ------RLKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred ------cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0111 11234689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.81 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=200.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|...+.||+|+||.||++... +++.+|+|.+..... .....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666788999999999999964 578999999875432 34467899999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 230 YIDNGNLQQWLHGS-LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 230 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|+.. +|.++.... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 665543211 11236789999999999999999999963 2899999999999999999999999999975533
Q ss_pred CccccccccccCcccccccccCCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRT--SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
.. ......++..|+|||.+... ..++.++|||||||++|||++|+.||...... ....... .....+
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~------~~~~~~ 229 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---FDQLTQV------VKGDPP 229 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---HHHHhhh------cCCCCC
Confidence 21 11223578889999998655 35899999999999999999999999754311 1111110 001112
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.++.......+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 2222222335578899999999999999999999999876544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=308.94 Aligned_cols=269 Identities=20% Similarity=0.251 Sum_probs=201.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||.|+||.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56889999999999999999965 678899999865432 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeecccccccCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKLHGP 308 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~ 308 (483)
|++ ++|.+++... ....+++..+..++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5888888532 233467888899999999999999999 9999999999999985 45789999999976543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--hh------h
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--QK------I 380 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~------~ 380 (483)
.. .......++..|+|||.+.+...++.++|||||||++|+|++|+.||....+.............. .. +
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 21 112233567889999988655557899999999999999999999998665443322221100000 00 0
Q ss_pred hhh--cCCCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 381 AYV--LDPKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 381 ~~~--~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
... ..+..+.. ........+.+++.+||+.||++||++.+++++-+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 000 00000000 0111235688999999999999999999999875543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.33 Aligned_cols=268 Identities=19% Similarity=0.284 Sum_probs=200.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeC-----CeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 224 (483)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 367999999999999999999854 68899999986432 22345688999999999999999999987654 357
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++|+||+. ++|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 48988874 35689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH--hhhh
Q 046972 305 LHGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA--QQKI 380 (483)
Q Consensus 305 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~~~ 380 (483)
........ ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 65432111 1122467888999998755445899999999999999999999999765433222111110000 0000
Q ss_pred hhhcC----------CCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 381 AYVLD----------PKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 381 ~~~~~----------~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..+.+ +..+... .......+.+++.+||+.||++|||+.+++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 00000 0000000 011235788999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.24 Aligned_cols=268 Identities=23% Similarity=0.246 Sum_probs=202.9
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCC----
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ---- 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 222 (483)
...++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 578899999865422 23356788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 223 ------NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 223 ------~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
..++|+||+++ +|..++.. ....+++..++.++.||+.||.|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 78787753 234689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 297 l~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
|+|||++...............++..|+|||.+.+...++.++|||||||++|||++|+.||........+..+.. ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~-~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR-LCG 235 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhC
Confidence 9999999866443222222334577899999886555578999999999999999999999976554333322211 110
Q ss_pred hhhhh---hhc--------CCCC--CC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 377 QQKIA---YVL--------DPKL--PE---MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 377 ~~~~~---~~~--------~~~~--~~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..... ... ++.. .. ......+..+.+++.+||+.||.+||++.+++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 300 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 00000 000 0000 00 00011246789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=304.81 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=207.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
..+.|+..+.||+|+||.||+|... ++..+++|.+..... ....+.+|+++++.++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3456888889999999999999976 688899999876544 45678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999996431 3799999999999999999999998 9999999999999999999999999988654332
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.. ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||....+......+. . ...+
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~----~---------~~~~ 234 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT----T---------KGIP 234 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----h---------cCCC
Confidence 11 122335678899999986544 8999999999999999999999997655432211110 0 0111
Q ss_pred CC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 390 EM-PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 390 ~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. .....+..+.+++.+||+.+|.+||++.+++++.....
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 11 11224467889999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=302.34 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=202.0
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+|++.+.||.|+||.||+|... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 588899999975432 234688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+.+++|.+++.. ..++++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999953 35789999999999999999999999 9999999999999999999999999998765433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|..||....... ......... . ..+..+
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~-----~-~~~~~~ 222 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQE-----T-ADVLYP 222 (258)
T ss_pred c--cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhc-----c-ccccCc
Confidence 2 223345778899999986554 8999999999999999999999998665421 111111000 0 111222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHh
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKM--GDVLRM 424 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~--~eil~~ 424 (483)
...+..+.+++.+||+.||.+||++ .+++++
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 223 ----ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ----ccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 2233788899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.50 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=200.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeC------
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------ 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 221 (483)
..++|+..+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 6889999998643 222335678899999999999999999988643
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999996 589888842 288889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH-------
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM------- 374 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~------- 374 (483)
+++....... .....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+............
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986544322 22335788899999986554 8999999999999999999999997655332221111100
Q ss_pred -----------HHhhh------hhhhcC----CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 -----------VAQQK------IAYVLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 -----------~~~~~------~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... +..... +..........+..+.+++.+||+.||++|||+.+++++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 00000 000000 000000011234678899999999999999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=299.83 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=205.9
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|++.+.||+|+||.||++... ++..+++|.+..... .....+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 678899999875432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999965434456789999999999999999999999 9999999999999999999999999999876543
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
......++..|+|||...+.. ++.++|+||||+++|||++|+.||...+....... . .....+.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~--------~~~~~~~ 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-----V--------QRGKYPP 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----H--------hcCCCCC
Confidence 222345788899999986544 78899999999999999999999976654321111 0 1111221
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+.....++.+++.+||..+|++||++.+++++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 1224557899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=304.05 Aligned_cols=262 Identities=18% Similarity=0.203 Sum_probs=187.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCC----cEEEEEEecCCCcchH-----------HHHHHHHHHHhcCCCCcccc
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDN----MRAAVKLLMSNSVSEE-----------EDFIEKVEAIGQVKHKNLVK 213 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~ 213 (483)
++..++|.+.++||+|+||.||+|...++ ..+|+|+......... .....+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 35557899999999999999999996553 4556665432221111 11233444566778999999
Q ss_pred cccEEEeCC----eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE
Q 046972 214 LFGYCVEGQ----NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL 289 (483)
Q Consensus 214 ~~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl 289 (483)
+++++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999776543 3477888874 477777642 23457888899999999999999999 99999999999999
Q ss_pred cCCCCcEEeecccccccCCCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 290 DHHWNPKISDVGLAKLHGPEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 290 ~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
+.++.+||+|||+|+.+..... .......||+.|+|||+..+.. ++.++|||||||++|||++|..||.....
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999986532211 1112236899999999986554 89999999999999999999999987643
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.......... ..+..+..+... ...+++.+.+++..||..+|++||++.++++.++
T Consensus 239 ~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAKC----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhHH----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 3222111110 001111111111 1122367889999999999999999999998763
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=312.59 Aligned_cols=269 Identities=18% Similarity=0.245 Sum_probs=203.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe----CCeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 225 (483)
++|++.+.||.|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999954 588999999875422 334677889999999999999999998763 35689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+. |+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 69999985 345589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCccc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH-------
Q 046972 306 HGPEWSI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV------- 375 (483)
Q Consensus 306 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------- 375 (483)
....... ......++..|+|||.+.+...++.++|||||||++|||++|+.||...........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5332111 112336788899999986655589999999999999999999999976554322211111000
Q ss_pred ---HhhhhhhhcC--CCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 ---AQQKIAYVLD--PKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ---~~~~~~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+....+ +...... ....+..+.+++.+||+.||.+|||+.+++.+.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 0000000000 0000000 1123478999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=299.68 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=200.9
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|.+.+.||.|+||.||+|..+ ++..+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 478899999865422 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC-cEEeecccccccCCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-PKISDVGLAKLHGPE 309 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~-~kl~DFGla~~~~~~ 309 (483)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999643 234579999999999999999999999 9999999999999998864 699999999866543
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
... .....++..|+|||...... ++.++|+|||||++|||++|..||...+....... .. .....+ .
T Consensus 156 ~~~-~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-----~~~~~~-~- 222 (257)
T cd08225 156 MEL-AYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----IC-----QGYFAP-I- 222 (257)
T ss_pred ccc-ccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh-----cccCCC-C-
Confidence 221 12235788899999885544 88999999999999999999999975543222111 10 011111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.......+.+++.+||..+|++|||+.+++++.+
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 1122357889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=307.58 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=199.2
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.|...+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999954 678899999864422 223578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|++ |+|.+++.. ...++++.++..++.|++.||.|||++ +++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 488887753 245689999999999999999999999 9999999999999999999999999998754322
Q ss_pred ccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
....++..|+|||.+.. ...++.++|||||||++|||++|..||...........+.. ..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------~~ 240 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NE 240 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------cc
Confidence 23457788999998742 33478999999999999999999999976543222211111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+..........+.+++.+||+.+|.+||++.++++++..
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1111222344678899999999999999999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=293.55 Aligned_cols=259 Identities=18% Similarity=0.260 Sum_probs=205.4
Q ss_pred HhcCCccc-ceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEe----CCe
Q 046972 151 VTDGFAEQ-NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVE----GQN 223 (483)
Q Consensus 151 ~~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~ 223 (483)
.+++|.+. ++||-|-.|.|..+..+ +++.+|+|++... ....+|+++.-.. .|||||++++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35667665 57999999999999854 5788999998543 4567888876555 59999999998864 356
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeec
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDV 300 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DF 300 (483)
+.+|||+|+||.|+..++++ ....+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 67899999999999999865 446799999999999999999999998 9999999999999964 556899999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|.|+.-.... ...+...|+.|.|||+++. ..|+..+|+||+||++|-|++|.+||........... .+.....
T Consensus 209 GFAK~t~~~~--~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg-Mk~rI~~--- 281 (400)
T KOG0604|consen 209 GFAKETQEPG--DLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKRRIRT--- 281 (400)
T ss_pred ccccccCCCc--cccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh-HHhHhhc---
Confidence 9998654332 2334467899999999954 4599999999999999999999999975554221111 1111111
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
-...+|..-+...++...++|+.+|..+|.+|.|+++++.+.+...
T Consensus 282 ---gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 282 ---GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ---cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 1355666667777889999999999999999999999998876543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=303.34 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=196.6
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||+|+||+||+|... +++.+|+|.+..... .....+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 578899999865322 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++...... .....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 9999643 224689999999999999999999999 9999999999999999999999999998765432 12223
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..++..|+|||.+.+.. ++.++|||||||++|+|++|+.||............... .. ......+ ...
T Consensus 154 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~--~~~~~~~----~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-----TL--EMAVEYP----DKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-----cc--cccccCC----ccC
Confidence 45677899999986554 899999999999999999999999765442211111100 00 0011111 223
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 397 LKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
...+.+++.+||+.||.+|| ++.+++.+.+..+
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 46788999999999999999 7777887765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.92 Aligned_cols=266 Identities=19% Similarity=0.237 Sum_probs=197.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCC-------
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------- 222 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------- 222 (483)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56899999999999999999965 5889999988654222 2345678999999999999999999987654
Q ss_pred -eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 223 -NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 223 -~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
..++||||+. ++|.+++.. ....+++.+++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 3599999996 489888853 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-
Q 046972 302 LAKLHGPEWSI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ- 377 (483)
Q Consensus 302 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~- 377 (483)
++......... ......++..|+|||.+.+...++.++||||||+++|||++|+.||........... +......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSI 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCC
Confidence 99765432211 112335677899999876555578899999999999999999999976654322211 1111000
Q ss_pred --hh------hhhhcCCCCCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 378 --QK------IAYVLDPKLPEMP---------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 378 --~~------~~~~~~~~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.. .........+... .......+.+++.+||..||.+|||+++++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 00 0000000000000 0011246778999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=303.65 Aligned_cols=258 Identities=19% Similarity=0.214 Sum_probs=202.2
Q ss_pred CCcccceeccCCceEEEEEEE----cCCcEEEEEEecCCCc----chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 154 GFAEQNVIASGDNGVVYRAVL----LDNMRAAVKLLMSNSV----SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+|++.+.||.|+||.||+|.. .++..+|+|++..... ...+.+.+|++++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 3678899999865322 2235688899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999963 35688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..............++..|+|||.+... ..++.++|||||||++|+|++|..||...........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK------- 226 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-------
Confidence 6543322222334578899999998543 23678999999999999999999999754332222222211111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
..+..+ ......+.+++.+||+.||++|| ++.+++.+.....
T Consensus 227 ~~~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 227 SEPPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred cCCCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 111122 22346788999999999999997 7888888755433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=310.92 Aligned_cols=266 Identities=20% Similarity=0.237 Sum_probs=197.5
Q ss_pred ceeccC--CceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASG--DNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
..||.| +||+||+|... .++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999964 6899999998754322 236788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc-
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI- 312 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~- 312 (483)
|+|.+++.... ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+|++|||.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999997542 24588999999999999999999998 9999999999999999999999999865432111000
Q ss_pred -----cccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH-----------
Q 046972 313 -----STSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV----------- 375 (483)
Q Consensus 313 -----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------- 375 (483)
......++..|+|||++.+. ..++.++|||||||++|||++|..||.................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00112345569999998653 3378999999999999999999999976554332221111000
Q ss_pred ------------H----hhhhh-----hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 ------------A----QQKIA-----YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ------------~----~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. ..... ......+.......+...+.+++.+||+.||++|||+.+++++.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0 00000 000111111123345678999999999999999999999999877544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=296.12 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=204.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+.-++|..+++||+|.||.|.+++- ..++.+|+|++++.-.-. ...-+.|-++|+..+||.+..+--.|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4557788899999999999999994 468889999997753322 345677889999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||..||.|+-+|. ....+++...+.+-..|+.||.|||++ +||.||||.+|.|+|.+|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999999885 457799999999999999999999999 999999999999999999999999999984
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
-- .+...+...+||+.|+|||++. ...|+.++|+|.+||++|||++|+.||...+....+.-++. .+
T Consensus 318 ~I-~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----------ed 384 (516)
T KOG0690|consen 318 EI-KYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----------ED 384 (516)
T ss_pred cc-cccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------hh
Confidence 32 2233455678999999999995 45599999999999999999999999986665443322211 12
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHh
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRM 424 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~ 424 (483)
-++|...+ .+...|+...|.+||.+|.. +.||.++
T Consensus 385 ~kFPr~ls----~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 LKFPRTLS----PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccCCccCC----HHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 33443333 46667777999999999953 4555543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.63 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=196.7
Q ss_pred cceeccCCceEEEEEE-EcCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCC------eEEEEEE
Q 046972 158 QNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------NRILVYE 229 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~E 229 (483)
.+.||+|+||.||+|+ -..|..||||.+.... ....+...+|+++|++|+|||||+++++-.... ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4669999999999999 4569999999998753 345578899999999999999999999765433 4589999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC--CCC--cEEeecccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH--HWN--PKISDVGLAKL 305 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~--~~~--~kl~DFGla~~ 305 (483)
||.||||+..|++. .+...+++.+.+.++.+++.||.|||++ +|+||||||.||++-. +|+ .||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999876 4668899999999999999999999999 9999999999999843 343 69999999998
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-------
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ------- 378 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------- 378 (483)
+..+. .....+||..|++||+..+...|+..+|.|||||++||++||..||..........++........
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 77654 455568999999999996556699999999999999999999999965444322222222111111
Q ss_pred -------hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 046972 379 -------KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP 416 (483)
Q Consensus 379 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 416 (483)
.+.....-..|..........+-.++..+|..+|.+|-
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 01100011112223344556677778888999999998
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.04 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=205.2
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
+|+..+.||.|++|.||+|... ++..+++|++..........+.+|++.++.++||||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999975 678899999977655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+++|.+++... ...+++..+..++.|++.||.|||.+ +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999642 25789999999999999999999998 999999999999999999999999999986654322
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (483)
.....++..|+|||.+.... ++.++||||||+++|+|++|+.||...+........ . ....+..+.
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~------~~~~~~~~~-- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI----A------TNGPPGLRN-- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----H------hcCCCCcCc--
Confidence 23346788899999986554 789999999999999999999999765432221110 0 011111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 393 SRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 393 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.......+.+++.+||+.||++|||+.+++++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 111236789999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=300.11 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=198.0
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||.|+||.||+|... +++.+++|.+..... ...+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 478999999875432 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++.+ ...+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999963 34588999999999999999999998 99999999999999999999999999998664432 1223
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..++..|++||.+.... ++.++|+||||+++|+|++|..||....... ......... ....+..|. ..
T Consensus 152 ~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~-----~~~~~~~~~----~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILK-----GNGKLEFPN----YI 219 (262)
T ss_pred ccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhc-----cCCCCCCCc----cc
Confidence 35788899999985544 7899999999999999999999997665311 111111110 011112222 22
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHHhcccc
Q 046972 397 LKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPR 428 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~ 428 (483)
...+.+++.+||+.||++||+ +.|++++.+..
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 468999999999999999999 89998876543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=311.67 Aligned_cols=267 Identities=18% Similarity=0.240 Sum_probs=201.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCcccccccEEEeC--CeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEG--QNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~ 225 (483)
.++|++.+.||.|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888999999999999999965 5788999988643 222335677899999999 999999999998653 4679
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 599999852 2688899999999999999999998 999999999999999999999999999986
Q ss_pred cCCCcc----ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH-------
Q 046972 306 HGPEWS----ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM------- 374 (483)
Q Consensus 306 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~------- 374 (483)
...... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543321 122234578899999987665557899999999999999999999997655433222111110
Q ss_pred -------HHhhhhhhhcCCCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 -------VAQQKIAYVLDPKLP--EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 -------~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+......... .......+..+.+++.+||+.||.+|||+.+++++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 000000000000000 00011134678999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.12 Aligned_cols=267 Identities=19% Similarity=0.206 Sum_probs=218.3
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEE
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
.+.++.+..++|.+.++||+|+||.|.+++.+. ++.+|.|++.+- ...+..-|.+|-.+|..-+.+-||+++-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 346777888999999999999999999999654 677899998662 2334467899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
+..++|+|||||+||||..++.+ ...+++.+++.++..|+.||.-||+. |+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 99999999999999999999963 34799999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
||.+-.+..+........+|||.|.+||++. +.+.|+..+|+||+||++|||++|..||....--.....++..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-- 296 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-- 296 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--
Confidence 9999988888788888889999999999875 2256899999999999999999999999644322222222111
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHhccccc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK---MGDVLRMLEPRD 429 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~eil~~L~~~~ 429 (483)
.. .-.+|. ..+.+....+||.+.+ -+|+.|.. ++++-.+....+
T Consensus 297 --k~-----~l~FP~--~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 297 --KE-----SLSFPD--ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred --hh-----hcCCCc--ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence 00 012231 1224467777777644 57888887 999999887655
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=296.82 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=206.5
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|.+.+.||.|+||.||++... ++..+++|.+..... .....+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 588899999876543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.........+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999975433357799999999999999999999999 99999999999999999999999999998655432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......+++.|+|||...... ++.++|+||||+++|+|++|..||.......... ... .. ..+.++.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~-~~-----~~~~~~~ 225 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL----KIL-KG-----QYPPIPS 225 (258)
T ss_pred -ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH----HHh-cC-----CCCCCCC
Confidence 1223346788899999875544 7899999999999999999999997655322111 110 00 0111221
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.....+.+++.+||..+|++|||+.+++++.
T Consensus 226 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 256 (258)
T cd08215 226 ----QYSSELRNLVSSLLQKDPEERPSIAQILQSP 256 (258)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence 3346888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.13 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=212.2
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
...|.+.+.||+|.|+.|.+|+. .++..||+|.+.+..... .+.+.+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45688899999999999999994 468899999998764433 356899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+.+|.+++|+.. .+...+..+..++.|+.+|++|||++ .|||||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999963 45566688899999999999999999 999999999999999999999999999998764
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. ......|++.|.|||++.+....++.+|+||+|++||-|+.|..||++..-..... ..+. -..++
T Consensus 208 ~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------rvl~--gk~rI 274 (596)
T KOG0586|consen 208 GL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------RVLR--GKYRI 274 (596)
T ss_pred cc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------hhee--eeecc
Confidence 32 33445789999999999888877899999999999999999999998765432111 1110 11223
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchh
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~ 431 (483)
|...+ .++.++++++|..+|.+|++.+++.+.-|.....
T Consensus 275 p~~ms----~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 275 PFYMS----CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred cceee----chhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 33233 4667788899999999999999999877765433
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=308.00 Aligned_cols=267 Identities=20% Similarity=0.220 Sum_probs=199.3
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCC------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------ 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 222 (483)
.++|++.+.||.|+||.||+|... +++.+|+|.+...... ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467999999999999999999965 5788999988654322 2246788999999999999999999875433
Q ss_pred --eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 223 --NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 223 --~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
..++||||+.+ +|...+.. ....+++..+..++.||++||.|||++ +++||||||+||+++.++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 78887753 335699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccc----------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHH
Q 046972 301 GLAKLHGPEWSI----------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW 370 (483)
Q Consensus 301 Gla~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~ 370 (483)
|+++........ ......++..|+|||.+.+...++.++|||||||++|||++|+.||.+.........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432111 1122356778999998765555789999999999999999999999876654333222
Q ss_pred HHHHHHh--------hhhhh----hcCCCCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 371 LKSMVAQ--------QKIAY----VLDPKLPEMPS---RKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 371 ~~~~~~~--------~~~~~----~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
....... ..+.. ......+.... ......+.+++.+||+.||++|||+.+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence 2110000 00000 00011111000 11225788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=311.13 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=201.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeC-----Ce
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QN 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 223 (483)
.++|.+.+.||.|+||+||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999954 5889999998654 222345678899999999999999999988654 34
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||+. ++|.+++. ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 69999985 345699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH---------
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM--------- 374 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------- 374 (483)
....... .......++..|+|||.+.....++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8654321 112234567889999988654458999999999999999999999997654322111111000
Q ss_pred -HHhhhhhhhc--CCCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 -VAQQKIAYVL--DPKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 -~~~~~~~~~~--~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.......... .+..+.. .....+..+.+++.+||+.||++|||+.+++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 0000000000 0000000 0112446789999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=294.35 Aligned_cols=273 Identities=19% Similarity=0.226 Sum_probs=203.9
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-----CcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEe-CCe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQN 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~ 223 (483)
...|+..+.||+|+||.||+|...+ ++.+|+|++....... .....+|+.+++.++||||+.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999996322 3468999987653221 2567899999999999999999999987 788
Q ss_pred EEEEEEecCCCCHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC----CCcEEe
Q 046972 224 RILVYEYIDNGNLQQWLHGSL-GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH----WNPKIS 298 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~----~~~kl~ 298 (483)
++|++||.+. ||...|+-+. ...+.++...+..|+.||+.|+.|||++ =|+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 9999985321 2346789999999999999999999999 89999999999999887 899999
Q ss_pred ecccccccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch---------hhH
Q 046972 299 DVGLAKLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ---------VFL 367 (483)
Q Consensus 299 DFGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~---------~~~ 367 (483)
|||+++.+..... ......+-|.+|+|||++.+...|+.+.||||.|||+.||+|-.+.|.+.... .++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998765432 23344577899999999999999999999999999999999999888664322 111
Q ss_pred HHHHHHHHH--hhh-------------hhhh----cCCC-CCCCCC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 368 IDWLKSMVA--QQK-------------IAYV----LDPK-LPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 368 ~~~~~~~~~--~~~-------------~~~~----~~~~-~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..++.-... ... +..+ .++. +...+. ..-....++|+.++|..||.+|.|+++.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111110000 000 0000 0000 000000 00012367888999999999999999999876
Q ss_pred ccc
Q 046972 426 EPR 428 (483)
Q Consensus 426 ~~~ 428 (483)
...
T Consensus 339 yF~ 341 (438)
T KOG0666|consen 339 YFT 341 (438)
T ss_pred ccc
Confidence 543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.48 Aligned_cols=258 Identities=19% Similarity=0.268 Sum_probs=210.0
Q ss_pred ceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 159 NVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
+.||+|+|+.|--+. ..++..+|||++.+.....+.+..+|++++.+.+ |+||++++++|+++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 569999999999988 7789999999999887778889999999999995 99999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEeecccccccCC-----
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKISDVGLAKLHGP----- 308 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DFGla~~~~~----- 308 (483)
...|+ ...-|++.++..+.++|+.||.|||.+ ||.||||||+|||..+... +|||||.+..-...
T Consensus 164 LshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99996 456799999999999999999999999 9999999999999976654 79999988753221
Q ss_pred -CccccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch----------hhHHHHHHH
Q 046972 309 -EWSISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ----------VFLIDWLKS 373 (483)
Q Consensus 309 -~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~----------~~~~~~~~~ 373 (483)
.......+.+|+..|||||+.. ....|+.++|.||||||||-|++|.+||.+.-.. ..-.+.+.+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1122234457888999999853 3345899999999999999999999999754321 111111111
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+ ...+|..-+...+.+..+++...|..|+.+|.++.+++.+.+...
T Consensus 317 sIQEG------kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 317 SIQEG------KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred HHhcc------CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 12222 245666666677788889999999999999999999999776544
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=298.62 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=194.5
Q ss_pred eeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHH---HHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 160 VIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKV---EAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
.||+|+||.||+|... +++.||+|.+...... ....+..|. ++++..+||||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 5789999998754322 122344443 34455689999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
||+|..++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 999999985 345699999999999999999999998 9999999999999999999999999998755322
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (483)
......|+..|+|||.+.+...++.++|||||||++|||++|+.||.......... ... ......+.++..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~------~~~~~~~~~~~~- 221 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDR------MTLTMAVELPDS- 221 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHH------HhhccCCCCCCc-
Confidence 12234678899999998655458999999999999999999999997653321110 000 011112233322
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccchh
Q 046972 393 SRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDLL 431 (483)
Q Consensus 393 ~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~~ 431 (483)
.+..+.+++.+||..||.+|| ++.+++++.+..+..
T Consensus 222 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 222 ---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred ---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 246788999999999999999 999999887765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=310.06 Aligned_cols=269 Identities=18% Similarity=0.201 Sum_probs=202.8
Q ss_pred cCCc-ccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch--------------HHHHHHHHHHHhcCCCCccccccc
Q 046972 153 DGFA-EQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE--------------EEDFIEKVEAIGQVKHKNLVKLFG 216 (483)
Q Consensus 153 ~~~~-~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~~~~ 216 (483)
++|. +.+.||.|+||+||+|... +++.||+|.+....... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3577999999999999954 68899999986543222 124789999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 217 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
++...+..++||||+. |+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 69999985 335689999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCc-------------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 297 ISDVGLAKLHGPEW-------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 297 l~DFGla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
|+|||+++...... ........++..|+|||.+.+...++.++|||||||++|||++|..||...++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654110 11112234577899999986655578999999999999999999999987765
Q ss_pred hhhHHHHHHHHHHhhh--hhhh--------cCCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 364 QVFLIDWLKSMVAQQK--IAYV--------LDPKLPEM---PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~--~~~~--------~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+............ +... .....+.. .....+..+.+++.+||+.||++|||+++++.+.+...
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 4433222211100000 0000 00000000 00122467889999999999999999999998876543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.56 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=200.9
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCc-chHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 225 (483)
.+..++|++.+.||.|+||.||+|...+ ++.+|+|.+..... .....+..|+.++.... ||||+++++++.+....+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3455778899999999999999999765 88999999875432 23356777887776664 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+||||+. ++|.+++.. ....+++..+..++.||+.||.|||+ . +|+||||+|+||+++.++.+||+|||++.
T Consensus 91 ~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 91 ICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence 9999985 588887753 23478999999999999999999997 5 89999999999999999999999999987
Q ss_pred ccCCCccccccccccCcccccccccCCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRT---SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
....... .....++..|+|||.+.+. ..++.++|||||||++|||++|+.||....... +........
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~---- 234 (296)
T cd06618 164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQE---- 234 (296)
T ss_pred hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcC----
Confidence 6543211 1223567789999988543 237889999999999999999999996533221 111111110
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+..+. ...+...+.+++.+||..||.+||++.+++++.+...
T Consensus 235 --~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 235 --EPPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --CCCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0111111 1123467899999999999999999999999876544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=306.98 Aligned_cols=262 Identities=22% Similarity=0.229 Sum_probs=211.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+..+.|+.-++||+||||.||-++.+ +|+-+|.|.+.+... ..+.-.++|-.+|.+++.+.||.+--.|...+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 45577899999999999999999854 577788887754322 22345788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|+..|+||||.-+|.... ...+++..++.++.+|+.||++||+. +||.|||||+|||||+.|+++|+|+|+|..
T Consensus 262 lVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999998886542 36799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
+...... ...+||.+|||||++.+.. |+...|+|||||++|||+.|+.||..........+.-+...
T Consensus 337 i~~g~~~--~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~---------- 403 (591)
T KOG0986|consen 337 IPEGKPI--RGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL---------- 403 (591)
T ss_pred cCCCCcc--ccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh----------
Confidence 7654332 3348999999999997665 99999999999999999999999976554433222211111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccch
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRDL 430 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~~ 430 (483)
.-+..++.+.+++..++....|++||++|.. +.++-++.-.++.
T Consensus 404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred -cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 1123344556678888888999999999964 5577776655543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.41 Aligned_cols=266 Identities=18% Similarity=0.210 Sum_probs=195.6
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCC
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
.+.+|.|+++.||++.. +++.+|+|++... .......+.+|+++++.++||||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44455555555555544 6889999998765 23344689999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc----
Q 046972 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS---- 311 (483)
Q Consensus 236 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~---- 311 (483)
|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999753 234588999999999999999999999 999999999999999999999999998864422111
Q ss_pred --ccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH----hhh-----
Q 046972 312 --ISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA----QQK----- 379 (483)
Q Consensus 312 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~~~----- 379 (483)
.......++..|+|||++... ..++.++|||||||++|||++|..||..........+....... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 111223566789999998543 34789999999999999999999999865543322211110000 000
Q ss_pred --hhh----hcCCC----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 --IAY----VLDPK----LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 --~~~----~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... ..++. .+.........++.+++.+||..||++|||+.+++++.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 000 00000 001111233467889999999999999999999999887543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.07 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=198.5
Q ss_pred cceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 158 QNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
...||+|+||.||+|.. .++..+|+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35699999999999986 46888999998655544556799999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 99884 23578999999999999999999999 99999999999999999999999999987543321 11223
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..++..|+|||.+.+.. ++.++|+|||||++|+|++|..||........... . .....+.+.. ....
T Consensus 176 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~---------~~~~~~~~~~--~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-I---------RDNLPPKLKN--LHKV 242 (292)
T ss_pred cccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H---------HhhCCcccCC--cccC
Confidence 45788899999885444 78999999999999999999999976544322111 1 0111111111 1122
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 397 LKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.+++.+||+.||.+||++.+++++-..
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence 3578889999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=304.56 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=200.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+.|...+.||+|+||.||+|... ++..+++|.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999964 5778999988643 2223357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+. |+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588887753 235688999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...........+. ..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------------~~ 229 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------QN 229 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-------------hc
Confidence 2 23356788999998742 2347889999999999999999999986544322111110 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+..........+.+++.+||..+|++||++.+++++.+...
T Consensus 230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1122222334467889999999999999999999999877544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=296.55 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=197.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-----cchHHHHHHHHHHHhcCCCCcccccccEEEeC--CeE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-----VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNR 224 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 224 (483)
.+|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999954 58899999875321 12335788999999999999999999998764 467
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+++|||+++++|.+++.. ...+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999953 34588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... .......++..|+|||.+.+.. ++.++|+|||||++|||++|+.||........... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~-----~~~ 224 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----I-----ATQ 224 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----H-----HcC
Confidence 6532111 1112235788899999986544 78999999999999999999999975433221111 0 000
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
...+.+| ......+.+++.+||. +|..||++.+++.+.
T Consensus 225 ~~~~~~p----~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 225 PTKPMLP----DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred CCCCCCC----cccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 1112222 3344678899999999 579999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.26 Aligned_cols=255 Identities=20% Similarity=0.228 Sum_probs=197.8
Q ss_pred CCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCc----chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSV----SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+|++.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3777899999999999999843 467899999864322 2235688999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999853 35688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTS-IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..............++..|+|||...+.. ..+.++||||||+++|||++|..||...........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 226 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK------- 226 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------
Confidence 65443222223345788999999875432 3678999999999999999999999654332222221111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..+..+. .....+.+++.+||+.||++|||+.++.+.|.
T Consensus 227 ~~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 SKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cCCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 1122222 23357888999999999999999776655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=297.92 Aligned_cols=263 Identities=23% Similarity=0.277 Sum_probs=200.4
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEec
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
|.+.+.||.|+||.||+|... +++.+++|.+..... .......+|+..+.+++ ||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 477899999865432 23334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
+|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999986431 34689999999999999999999999 999999999999999999999999999976543211
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH--------HHhhhhhhh
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM--------VAQQKIAYV 383 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~ 383 (483)
.....++..|+|||.+.+...++.++|+||||+++|||++|+.||................ .........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 1223567889999987655557899999999999999999999997765443322211100 000000001
Q ss_pred cCCCCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 384 LDPKLPEMPS-------RKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 384 ~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+...+.... ......+.+++.+||+.||++|||+.|++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 1111111000 01136788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.40 Aligned_cols=264 Identities=19% Similarity=0.245 Sum_probs=203.7
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
|...+.||.|++|.||+|... +++.+++|.+...... ....+.+|++++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999964 6888999998655332 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++ +|.+++... ...+++..++.++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 899888642 25789999999999999999999999 99999999999999999999999999998665442
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--hhhhhh------
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--QKIAYV------ 383 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~------ 383 (483)
.......++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+............... ......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 122234577789999998665458999999999999999999999997665433322221110000 000000
Q ss_pred cCCCCCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 384 LDPKLPE-------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 384 ~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+. ......+..+.+++.+||+.||.+||++.+++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0000000 011234578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.77 Aligned_cols=243 Identities=21% Similarity=0.231 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch---HHHHHHHHHH-HhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE---EEDFIEKVEA-IGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||.|+||.||+|... +++.+|+|.+....... ...+..|..+ ....+||||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 57899999986543221 2234455444 4455899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
++|.++++. ...+++..+..++.||+.||.|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999953 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....++..|+|||.+.+.. ++.++||||||+++|||++|..||............ .... ...+....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~------~~~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-----LSRR------INWPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----Hhcc------cCCCCccc
Confidence 22335778899999986654 799999999999999999999999765543322111 1111 01111112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHH---HHHHhc
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMG---DVLRML 425 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~---eil~~L 425 (483)
..++..+.+++.+||+.||++||++. |++.+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 23447889999999999999999765 555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=311.12 Aligned_cols=267 Identities=20% Similarity=0.305 Sum_probs=200.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC----------
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG---------- 221 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---------- 221 (483)
.+|.+.+.||.|+||.||+|... ++..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999964 5789999998766555567789999999999999999999876543
Q ss_pred ----CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcE
Q 046972 222 ----QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPK 296 (483)
Q Consensus 222 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~k 296 (483)
...++||||++ ++|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 59999884 24588999999999999999999999 9999999999999974 55789
Q ss_pred EeecccccccCCCcccc--ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWSIS--TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 297 l~DFGla~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|+|||+++......... .....++..|+|||.+.....++.++|||||||++|+|++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999997654321111 1223567789999987555558899999999999999999999997665433222211110
Q ss_pred HH-----hh----hh-hhhc-CCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 VA-----QQ----KI-AYVL-DPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 ~~-----~~----~~-~~~~-~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.. .. .. .... ....+..+. .....++.+++.+||+.||++|||+.+++.+-+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 00 00 00 0000 000000000 11236788999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.25 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=195.4
Q ss_pred eccCCceEEEEEEEcC-CcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLLD-NMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||.|+||.||+|.... ++.+++|.+..... ...+.+.+|++++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 88999999865543 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-----
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS----- 311 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~----- 311 (483)
.+++.+. ..+++..++.++.||+.||+|||++ +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999632 3689999999999999999999999 999999999999999999999999999875432211
Q ss_pred --ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 312 --ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 312 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.......++..|+|||...... ++.++||||||+++|+|++|..||............ .. . ....+
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~-~------~~~~~ 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI----LN-G------KIEWP 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hc-C------CcCCC
Confidence 1223345677899999986554 789999999999999999999999766543222111 00 0 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHhcc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKM---GDVLRMLE 426 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~---~eil~~L~ 426 (483)
.. ...+..+.+++.+||+.+|++|||+ .+++++.+
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 11 1124688899999999999999999 66665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=296.07 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=190.3
Q ss_pred hcCCccccee--ccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVI--ASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~l--g~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|.+.+.+ |.|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++++...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 4567777666 99999999999954 577889998865432221 22222212 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeeccccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKLH 306 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~~ 306 (483)
|||+++|+|.+++.. ...+++.++..++.||++||.|||+. +++||||||+||+++.++ .++|+|||+++..
T Consensus 88 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 88 MDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999963 24799999999999999999999999 999999999999999998 9999999998765
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... ....++..|+|||++.+.. ++.++|||||||++|||++|..||............+... ...
T Consensus 161 ~~~-----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~ 225 (267)
T PHA03390 161 GTP-----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR---------QQK 225 (267)
T ss_pred CCC-----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh---------hcc
Confidence 432 2235788899999986554 8999999999999999999999998554332111111110 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPK-MGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~eil~~L~~ 427 (483)
.. ......+..+.+++.+||+.||.+||+ +++++++-+.
T Consensus 226 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 226 KL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred cC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 11 111234468899999999999999996 6999987553
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=292.69 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=204.8
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRILVY 228 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 228 (483)
+|...+.||+|++|.||+|... ++..+++|.+..... ...+.+.+|+..+++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 688899999876543 3457889999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999963 23789999999999999999999998 999999999999999999999999999986654
Q ss_pred Cccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.... ......++..|+|||...... ++.++||||||+++|+|++|..||......... ... .....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~---------~~~~~ 220 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---LYK---------IGSSG 220 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHh---------ccccC
Confidence 3221 123346778899999986554 799999999999999999999999766522111 000 00011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+...+..+.+++.+||..||.+||++.+++++.+
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 111122233478999999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.10 Aligned_cols=268 Identities=22% Similarity=0.270 Sum_probs=205.7
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCC-----eEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-----NRI 225 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 225 (483)
+|.+.+.||.|+||.||+|... ++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999965 48899999987653 334467999999999999999999999998775 789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||.|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 589999853 34799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-------
Q 046972 306 HGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA------- 376 (483)
Q Consensus 306 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------- 376 (483)
...... .......++..|+|||.+.+...++.++|+|||||++|+|++|+.||..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 644321 12233457888999999876645899999999999999999999999876643322221110000
Q ss_pred ---hhhhhhhcC--CCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 ---QQKIAYVLD--PKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ---~~~~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+. +..... .....+..+.+++.+||+.||.+|||+.+++.+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000000000 000000 00113467889999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.04 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=192.3
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC---------
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--------- 221 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------- 221 (483)
.+|+..+.||+||||.||+++.+ +|+.+|||+|..+.. ..-....+|+++|++|+|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 56788889999999999999954 899999999987752 2225688999999999999999998765310
Q ss_pred --------------------------------------------------------------------------------
Q 046972 222 -------------------------------------------------------------------------------- 221 (483)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (483)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEEecCCCCHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHHHHhh
Q 046972 222 ------------------------------QNRILVYEYIDNGNLQQWLHGSLGEAKPL-TWDTRMKIIQGTAKGLAYLH 270 (483)
Q Consensus 222 ------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~~i~~~l~~LH 270 (483)
..+||-||||+..+|.++++++. .. .....|+++++|+.||.|+|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHH
Confidence 01478899999988888886431 12 46788999999999999999
Q ss_pred hCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC-----------------CCccccccccccCcccccccccCCCC
Q 046972 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG-----------------PEWSISTSCELRNSGYLAEELSGRTS 333 (483)
Q Consensus 271 ~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~ 333 (483)
++ |||||||||.||+++.+..+||+|||+|.... .......+..+||.-|+|||++.+..
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998611 01112344568999999999997666
Q ss_pred --CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC--CCHHHHHHHHHHHHHccC
Q 046972 334 --IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM--PSRKELKRIILIALRCVD 409 (483)
Q Consensus 334 --~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~ 409 (483)
.|+.|+|+|||||||+||+. ||...-+.. ..+..+-++.+|.. ...+....-..+|.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------------SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHH------------HHHHhcccCCCCCCcccccccchHHHHHHHHHhc
Confidence 69999999999999999996 575433322 22223334444443 122222345567889999
Q ss_pred CCCCCCCCHHHHHH
Q 046972 410 PDIKHRPKMGDVLR 423 (483)
Q Consensus 410 ~dP~~Rpt~~eil~ 423 (483)
.||.+||||.|+|.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999996
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.81 Aligned_cols=255 Identities=25% Similarity=0.298 Sum_probs=204.0
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
-++.....||.|.||.||-|. ..+|...|+|-+...... ......+|..++..++|||+|+++|+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 445667789999999999999 456777899988654332 23567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||.+|+|.+.++ .++..++.....+..|++.|+.|||++ |||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1315 yC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999995 334466666778899999999999999 9999999999999999999999999999876554
Q ss_pred cc---ccccccccCcccccccccCCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 310 WS---ISTSCELRNSGYLAEELSGRTS--IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 310 ~~---~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
.. .......||+.|||||++.+.. ....+.||||+||+..||+||+.||...+.+-... ..+...-
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM---------y~V~~gh 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM---------YHVAAGH 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH---------hHHhccC
Confidence 31 2223458999999999987542 25679999999999999999999997655432211 1112222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.|.+|.. .+.+-.+++.+||..||++|-++.|++++=..
T Consensus 1459 ~Pq~P~~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1459 KPQIPER----LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred CCCCchh----hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 3444433 55677888999999999999999998886543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=297.91 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=202.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 227 (483)
++|.+.+.||.|+||.||+|... +++.+++|++.... ......+.+|++++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999965 68899999986532 223357889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999963 34799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCcc-------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHH
Q 046972 308 PEWS-------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI 368 (483)
Q Consensus 308 ~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~ 368 (483)
.... .......++..|+|||...... ++.++||||||+++|++++|+.||........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 3321 1222335678899999886544 7899999999999999999999998665322211
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHhc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM----GDVLRML 425 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~----~eil~~L 425 (483)
. .. ......+. ..+..+.+++.+||+.||.+||++ ++++++.
T Consensus 233 ~----~~-------~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 233 K----IL-------KLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred H----HH-------hcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 1 10 01112222 223678899999999999999999 8888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=300.31 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=198.7
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
|...+.||+|+||+||+|... ++..+++|.+..... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999854 578899999865322 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+. |+|.+++.. ...++++.+++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 588888753 235689999999999999999999999 999999999999999999999999999864322
Q ss_pred cccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.....++..|+|||++.. ...++.++|||||||++|||++|..||...+........ . ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~----~---------~~~~ 237 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----A---------QNDS 237 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----H---------hcCC
Confidence 223467888999998742 344788999999999999999999999765543222111 0 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+.......+..+.+++.+||+.+|.+||++.+++.+.+...
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 11122223356888999999999999999999998766544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=289.78 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=203.4
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+|++.+.||.|+||.||+|... +++.+++|.+..... .....+.+|++++.+++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578899999977654 3446899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999953 36789999999999999999999999 99999999999999999999999999998665432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.. .....++..|+|||...+.. ++.++||||||+++|+|++|..||....+...... .. ....+..+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~------~~~~~~~~~ 221 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IV------QDDHPPLPE 221 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh------ccCCCCCCC
Confidence 21 22346788899999986554 78999999999999999999999975543221111 00 011122222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
.....+.+++.+||..+|++|||+.+++..
T Consensus 222 ----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 ----GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 233678899999999999999999999865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=305.53 Aligned_cols=271 Identities=21% Similarity=0.255 Sum_probs=204.4
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
..++....++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566779999999999999999999985 4688999999875422 2235688899999999999999999988643
Q ss_pred ------CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCc
Q 046972 222 ------QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295 (483)
Q Consensus 222 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~ 295 (483)
...+++++++ +++|.+++. ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467888887 789999884 24589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
||+|||+++..... .....++..|+|||.+.+...++.++|||||||++|||++|+.||.................
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998754322 22335678899999876544578999999999999999999999976554332222111100
Q ss_pred Hh----------h---hhhhhcCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 AQ----------Q---KIAYVLDPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ~~----------~---~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. . ...... +..+.... ......+.+++.+||+.||.+||++.+++.+.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHh-cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 0 000000 01111000 012357889999999999999999999998865443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=296.87 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=198.0
Q ss_pred CcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc--hHHHHHHHHHHHhcC---CCCcccccccEEEeCCe-----
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS--EEEDFIEKVEAIGQV---KHKNLVKLFGYCVEGQN----- 223 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~----- 223 (483)
|++.+.||.|+||.||+|..+. ++.+|+|.+...... ....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999764 889999999754222 224566787776655 69999999999988776
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.+++|||+++ +|.+++... ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 899998643 223589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
........ .....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+.............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 86643321 12234677899999986554 8999999999999999999999998766554443333221110000000
Q ss_pred ---------cCCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 384 ---------LDPKLPEM---PSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 384 ---------~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.....+.. ........+.+++.+||+.||.+||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 00000000 0112346778999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=303.93 Aligned_cols=265 Identities=19% Similarity=0.277 Sum_probs=201.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEe-CCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 225 (483)
...++|++.+.||.|+||.||+|... ++..+|+|.+.... ....+.+.+|++++..++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45678999999999999999999854 68899999886532 2234678899999999999999999999875 56789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+ +++|.++++ ...+++..+..++.|++.||.|||++ +|+||||+|+||+++.++.+||+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 569999884 34578888899999999999999999 999999999999999999999999999875
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH-----------H
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS-----------M 374 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~-----------~ 374 (483)
.... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...........+... .
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 122356778999998755455899999999999999999999999766543222111110 0
Q ss_pred HHhhhhhhhcCCCCCC-CCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 VAQQKIAYVLDPKLPE-MPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~-~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
................ .+. ......+.+++.+||+.+|++|||+.+++.+-+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 0000000000000000 000 1234688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=306.67 Aligned_cols=265 Identities=19% Similarity=0.267 Sum_probs=200.6
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCC-----
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ----- 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 222 (483)
..++|++.+.||+|+||.||+|.. .++..||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 46889999998643222 2356889999999999999999999987553
Q ss_pred -eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 223 -NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 223 -~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
..++||||+ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 779998884 34689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH-------
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM------- 374 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~------- 374 (483)
++...... .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||................
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99765332 1223567889999988654457899999999999999999999998665432222211100
Q ss_pred ---HHhhhhhhhcC--CCCC-C---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 ---VAQQKIAYVLD--PKLP-E---MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 ---~~~~~~~~~~~--~~~~-~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
........... +... . .........+.+++.+||+.||++|||+.+++.+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 00000000000 0000 0 00112335688999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.09 Aligned_cols=272 Identities=18% Similarity=0.259 Sum_probs=211.4
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCC-C-C----cccccc
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-H-K----NLVKLF 215 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----nIv~~~ 215 (483)
+-++..+...++|.+..++|+|.||.|-.+.... +..||+|+++.-. ...+..+-|+++|.++. + | -+|++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 4455667778999999999999999999998554 5788999886543 23456778999999993 2 2 478899
Q ss_pred cEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC----
Q 046972 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---- 291 (483)
Q Consensus 216 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---- 291 (483)
+||.-.++.|+|+|.+ |.++++||..+ ...+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999999 66999999754 567899999999999999999999999 9999999999999832
Q ss_pred ----------------CCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC
Q 046972 292 ----------------HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355 (483)
Q Consensus 292 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~ 355 (483)
+..+||+|||.|+..... ....+.|..|.|||++.+-+ ++.++||||+||||+|+++|.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccc
Confidence 345899999999865433 24456789999999998887 899999999999999999999
Q ss_pred CCCCCCCchhhHHHHHHHHHH--------hh-h-------------------hhhhcCCCCCC----CCCHHHHHHHHHH
Q 046972 356 LPVDYSQPQVFLIDWLKSMVA--------QQ-K-------------------IAYVLDPKLPE----MPSRKELKRIILI 403 (483)
Q Consensus 356 ~Pf~~~~~~~~~~~~~~~~~~--------~~-~-------------------~~~~~~~~~~~----~~~~~~~~~l~~l 403 (483)
..|+..++.+.+ .++..... .. . ..+..++..|. .....+..+|++|
T Consensus 307 ~LFqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 307 TLFQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred eecccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 999987765543 12211111 11 0 01111111110 1223455789999
Q ss_pred HHHccCCCCCCCCCHHHHHHhccc
Q 046972 404 ALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 404 ~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.+||..||.+|+|+.|++.+...
T Consensus 386 l~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred HHHHHccCccccccHHHHhcCHHh
Confidence 999999999999999999987654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=294.45 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=196.3
Q ss_pred CCcccceeccCCceEEEEEEEcC-CcEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSN-----SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+|.+.+.||+|+||.||++.... +..+++|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998654 334555554431 122334677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999865433456799999999999999999999999 9999999999999976 469999999987653
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.... ......++..|+|||...+.. ++.++|+||||+++|+|++|..||......... .. .....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~---------~~~~~ 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV----LR---------IVEGP 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH---------HHcCC
Confidence 3211 122345678899999885444 788999999999999999999999654322111 11 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.+ ..+...+..+.+++.+||..||++||++.+++++.
T Consensus 222 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 258 (260)
T cd08222 222 TP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP 258 (260)
T ss_pred CC-CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence 11 12334557889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.41 Aligned_cols=266 Identities=22% Similarity=0.335 Sum_probs=217.2
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEe----
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVE---- 220 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~---- 220 (483)
.+.-.++.|++.++||.|.+|.||+++ .++++.+|+|+...... ..++...|.++++.. +|||++.++|++..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 334456779999999999999999999 55688889998866543 345677788888887 69999999999863
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 221 -GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 221 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
++.+|||||||.||+..|++++.. +..+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.+||+|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 578999999999999999998764 67799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCC----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRT----SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
||++..+..+.. ...+..||+.|||||++... ..|+..+|+||||++..||.-|.+|+.+..+...+..
T Consensus 167 FGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------ 239 (953)
T KOG0587|consen 167 FGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------ 239 (953)
T ss_pred eeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------
Confidence 999987765532 34456899999999998643 2377899999999999999999999987665332211
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchh
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~ 431 (483)
-.-+|...-.-+.+..+++.++|..||.+|-++||++.+++++.......
T Consensus 240 ------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 240 ------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred ------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 11112222223567789999999999999999999999999987665433
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=304.56 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=197.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC------C
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------Q 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 222 (483)
.++|...+.||+|+||.||+|... ++..+|+|++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999954 688999999865422 2235688999999999999999999998754 3
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 8877652 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH--------
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM-------- 374 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~-------- 374 (483)
++..... .....++..|+|||.+.+...++.++|||||||++|||++|+.||...+............
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 8754322 2233567889999998654458899999999999999999999998655432222211100
Q ss_pred --HHhhhhhhhc--CCCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 --VAQQKIAYVL--DPKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 --~~~~~~~~~~--~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.......... .+..+... .......+.+++.+||+.||++||++.+++.+-+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 0000000000 00111000 011235688999999999999999999999875543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=305.99 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=202.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCe----
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN---- 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 223 (483)
..++|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3577999999999999999999965 57889999886542 2233567889999999999999999998876654
Q ss_pred --EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 224 --RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 224 --~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
.++|+||+ +++|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 679999985 24689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH-----
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA----- 376 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----- 376 (483)
++...... .....++..|+|||.+.+...++.++|||||||++|||++|+.||..................
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99865432 223356788999998755445789999999999999999999999766543322221110000
Q ss_pred -----hhhhhhhcC--CCCCC-CC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 -----QQKIAYVLD--PKLPE-MP---SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 -----~~~~~~~~~--~~~~~-~~---~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+. +..+. .. ....+..+.+++.+||..||++|||+.+++++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 000000000 00000 00 0112467899999999999999999999998876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=287.68 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=202.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHH-hcCCCCcccccccEEEeCCeEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAI-GQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
++..++++.+..||.|+||+|++-.++ .|+..|||++..+.. .+..+++.|.+.. +.-+.||||++||.+..++..|
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 344566666788999999999998854 588899999987654 4557889998864 4457999999999999999999
Q ss_pred EEEEecCCCCHHHHHhc-ccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHG-SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|.||+|+- +|..+.+. .......++++.+-+|....+.||.||-+. ..|||||+||+|||++..|.+||||||++-
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchH
Confidence 99999964 77665421 112445688888889999999999999987 599999999999999999999999999997
Q ss_pred ccCCCccccccccccCcccccccccCCCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSI-FNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
.+... ...+...|...|||||.+..... |+-+|||||||++|||+.||+.||...+. ..+.+.......
T Consensus 217 qLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gd----- 286 (361)
T KOG1006|consen 217 QLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGD----- 286 (361)
T ss_pred hHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCC-----
Confidence 65432 23344577888999999875544 89999999999999999999999976543 111111111110
Q ss_pred cCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 384 LDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 384 ~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.|.+.. ....+....+..++..||.+|-.+||...++.++.-
T Consensus 287 -pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 287 -PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred -CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 111111 111234578999999999999999999999987653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.16 Aligned_cols=264 Identities=21% Similarity=0.324 Sum_probs=201.9
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
|+..+.||+|+||.||+|... +++.+++|.+.... ....+.+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999965 48899999987653 223367889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
+ ++|.+++... ...+++..++.++.|++.||.|||++ +|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5999999642 14689999999999999999999999 999999999999999999999999999986543321
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--hh---hhhh--c
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--QK---IAYV--L 384 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~---~~~~--~ 384 (483)
......++..|+|||.+.+...++.++|||||||++|||++|+.||................... .. +... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 22233456789999998665458999999999999999999999997765433322221110000 00 0000 0
Q ss_pred CCCCCCC---C----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 385 DPKLPEM---P----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 385 ~~~~~~~---~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+...+.. . .......+.+++.+||..||++||++.+++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 0011100 0 0112467899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.41 Aligned_cols=265 Identities=19% Similarity=0.215 Sum_probs=196.1
Q ss_pred CCcccceeccCCceEEEEEEEcC---CcEEEEEEecCCC--cchHHHHHHHHHHHhcC-CCCcccccccEEEeC----Ce
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLD---NMRAAVKLLMSNS--VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEG----QN 223 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~~ 223 (483)
+|++.+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788999999999999999653 6789999886432 22245788999999999 599999999875432 45
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++++||+. ++|.+++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899985 69999985 345789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH------
Q 046972 304 KLHGPEWSI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM------ 374 (483)
Q Consensus 304 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~------ 374 (483)
+........ ......++..|+|||.+.+...++.++|||||||++|+|++|..||...+....+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432111 12234678899999987554458999999999999999999999997655332222111110
Q ss_pred -----HHhhh--hhhhcC--CCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 375 -----VAQQK--IAYVLD--PKLP-EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 375 -----~~~~~--~~~~~~--~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..... ...... +..+ ..........+.+++.+||+.||++|||+.+++.+-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000 000000 0000 0001112367889999999999999999999997754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.44 Aligned_cols=145 Identities=26% Similarity=0.358 Sum_probs=130.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||.||+|... +++.||+|++...... ....+..|+.++..++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999976 5789999998754322 2367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
||+.+++|.+++.. ...+++..++.++.||+.||.|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999953 34688899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.91 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=201.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEe--------C
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--------G 221 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~ 221 (483)
..|....+||+|.||+||+|+.+ +++.||+|++.-. ...-....++|+++|..|.|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666778999999999999954 5677787766432 11223567899999999999999999998852 2
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
...|+||++|+. ||..+|.. ....++..++..++.+++.||.|+|.+ .|+|||+||.|+|++.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999986 99999953 335688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcc---ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH--HH
Q 046972 302 LAKLHGPEWS---ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM--VA 376 (483)
Q Consensus 302 la~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~~ 376 (483)
+++.+..... ...+..+-|.+|++||.+.+...|+++.|||.-||++.||+||.+-+.+..+...+..+-.-. ..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9987643322 123445668999999999998889999999999999999999999998887765543322100 00
Q ss_pred ---------hhhhhhhcCCCCCCCCCH---HHH------HHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 377 ---------QQKIAYVLDPKLPEMPSR---KEL------KRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 377 ---------~~~~~~~~~~~~~~~~~~---~~~------~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
......+-.+.++..... +.. .+..+|+.++|..||.+|+++.+++.+-..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 000000000111111111 111 256788889999999999999999976544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.05 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=207.8
Q ss_pred cceeccCCceEEEEEEE-cCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 158 QNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
.++||.|.||+||-|.. ++|+.||||++.+... ..+..+.+|+.+|.+++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999994 5799999999976533 3346789999999999999999999999999999999999965
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcEEeecccccccCCCcc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DFGla~~~~~~~~ 311 (483)
|..+.|-. .+.+.+++.....++.||+.||+|||-+ +|+|+||||+|||+... ..+||||||.|+.++....
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 66666543 2567799999999999999999999999 99999999999999654 4689999999999876432
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
....+||+.|+|||++.+.+ |+..-|+||.||++|--++|..||+...+... .. .-... -.|+.
T Consensus 723 --RrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-------QI---QNAaF---MyPp~ 786 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-------QI---QNAAF---MYPPN 786 (888)
T ss_pred --hhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhH-------Hh---hcccc---ccCCC
Confidence 23458999999999997666 99999999999999999999999975543211 11 11111 23555
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhh
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLL 432 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~ 432 (483)
++.+.....++||...|+..-.+|-|....+.+.|-.+..+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 67777788999999999999999999999998777655443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=282.34 Aligned_cols=241 Identities=22% Similarity=0.260 Sum_probs=194.5
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
||.|+||.||++... +++.+++|.+...... ....+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 4888999998765332 345789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 316 (483)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999953 34689999999999999999999998 99999999999999999999999999997654321 12233
Q ss_pred cccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHH
Q 046972 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396 (483)
Q Consensus 317 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
..++..|++||...+.. .+.++|+||||+++|+|++|..||......... ..... .....+.. .
T Consensus 153 ~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~-------~~~~~~~~----~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY----EKILK-------DPLRFPEF----L 216 (250)
T ss_pred CcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHhc-------CCCCCCCC----C
Confidence 46778899999986544 788999999999999999999999755432111 11110 11122222 2
Q ss_pred HHHHHHHHHHccCCCCCCCCCH---HHHHHhc
Q 046972 397 LKRIILIALRCVDPDIKHRPKM---GDVLRML 425 (483)
Q Consensus 397 ~~~l~~l~~~cl~~dP~~Rpt~---~eil~~L 425 (483)
+..+.+++.+||..||++||++ .+++++.
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~ 248 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAHP 248 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccHHHHHhCC
Confidence 3678899999999999999999 6766654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=293.40 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=205.0
Q ss_pred HhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcc-hH------HHHHHHHHHHhcCCCCcccccccEEE-eC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS-EE------EDFIEKVEAIGQVKHKNLVKLFGYCV-EG 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-~~------~~~~~E~~~l~~l~hpnIv~~~~~~~-~~ 221 (483)
..++|-.+.+||.|||+.||+|. +..++.||||+-..+... ++ +...+|.++.+.|.||.||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 45678888999999999999999 456777889887544222 21 35678999999999999999999986 55
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEe
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKIS 298 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~ 298 (483)
+..|-|+|||+|.||.-||+ ..+.+++.+++.|+.||+.||.||.+. +++|||-||||.||||.+ .|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 67789999999999999996 457799999999999999999999985 789999999999999954 4779999
Q ss_pred ecccccccCCCccc------cccccccCcccccccccCC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHH
Q 046972 299 DVGLAKLHGPEWSI------STSCELRNSGYLAEELSGR---TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLID 369 (483)
Q Consensus 299 DFGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~ 369 (483)
|||+++.+..+... .+....||.+|++||.+.- .+.++.|+||||+|||+|.+++|+.||........+.+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999988654322 2345689999999998653 34589999999999999999999999987655433221
Q ss_pred HHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 370 WLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+.....-.+|..+ -...+..++|++||+..-++|....++.....
T Consensus 696 -------eNTIlkAtEVqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy 743 (775)
T KOG1151|consen 696 -------ENTILKATEVQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY 743 (775)
T ss_pred -------hhchhcceeccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence 1111111222233221 22357788899999999999999988876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.05 Aligned_cols=244 Identities=19% Similarity=0.236 Sum_probs=196.3
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.++.|.+...+|.|+|+.|-.+.. .+++..++|++..... +-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467888899999999999999884 4577889999976522 234566555554 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE-cCCCCcEEeecccccccC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL-DHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl-~~~~~~kl~DFGla~~~~ 307 (483)
|++.||-|.+.+.. .. ....++..|+.+|+.|+.|||++ |+|||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~----~~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KP-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh----cc-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999888842 22 22277888999999999999999 99999999999999 689999999999998765
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. .....-|..|.|||+....+ |++++|+||||++||+|++|+.||........+ ...... +.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei----~~~i~~--------~~ 530 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI----HTRIQM--------PK 530 (612)
T ss_pred hh----hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHH----HHhhcC--------Cc
Confidence 54 22335578899999997555 999999999999999999999999876655221 111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+...+....+|+.+||+.||.+||++.++..+.+.
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 123344678889999999999999999999988776
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.56 Aligned_cols=245 Identities=20% Similarity=0.279 Sum_probs=199.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSV---SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+...+|.+..+||+|+||.|.+|..++ ...+|||++++.-. .+.+--+.|-++|+-. +-|.+++++.+|+..+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 445678889999999999999998665 45679999876522 2223346677777766 468999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|+||||+.||+|--.++ +-+.+.+..+..++..|+-||-|||++ |||.||||.+||||+.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999999996 446688889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..-.. ...+.+..||+.|+|||++.-.+ |+..+|+|||||+||||+.|++||++.+++..+..+....
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------- 566 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------- 566 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence 53222 23345568999999999996555 9999999999999999999999999988876654443221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM 418 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 418 (483)
-. ++...+.+..+++...|.+.|.+|...
T Consensus 567 -vs----yPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 -VS----YPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -Cc----CcccccHHHHHHHHHHhhcCCccccCC
Confidence 11 233344677888889999999999643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.43 Aligned_cols=257 Identities=19% Similarity=0.217 Sum_probs=212.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcE-EEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMR-AAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+...++.....||.|+||.|=++..+.... +|+|.+++. .....+....|-++|...+.|.||++|-.|.+...+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 445667777889999999999999765543 788877654 3334467888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
|+||-|-||.|+..|+ ..+.|....+..++..+++|++|||++ +||.|||||+|++++.+|-+||.|||.|+.
T Consensus 497 mLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 497 MLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence 9999999999999996 457789999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
++.... +-+.+||+.|.|||++...+ .+.++|.||||+++|||++|.+||.+.++-.....+++..-.-
T Consensus 570 i~~g~K--TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------- 638 (732)
T KOG0614|consen 570 IGSGRK--TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------- 638 (732)
T ss_pred hccCCc--eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------
Confidence 876533 34458999999999998777 7999999999999999999999999888765544444332111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
..+....+...+++++....+|.+|.. +.+|-++-|...
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 122333467788888999999999976 677877766544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=278.13 Aligned_cols=225 Identities=18% Similarity=0.179 Sum_probs=177.6
Q ss_pred CCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhc
Q 046972 164 GDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHG 242 (483)
Q Consensus 164 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 242 (483)
|.||.||+++. .+++.+|+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 467889999986543 233455555566799999999999999999999999999999999953
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcc
Q 046972 243 SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322 (483)
Q Consensus 243 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 322 (483)
...+++..+..++.|++.||.|||++ +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 34589999999999999999999999 9999999999999999999999999988755432 122345667
Q ss_pred cccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHH
Q 046972 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIIL 402 (483)
Q Consensus 323 y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 402 (483)
|+|||...+.. ++.++||||+||++|||++|+.|+....... .......+|. .....+.+
T Consensus 148 y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~~~~----~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLNIPE----WVSEEARS 207 (237)
T ss_pred ccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccCCcc----cCCHHHHH
Confidence 99999885444 7899999999999999999998875332110 0000111222 22357888
Q ss_pred HHHHccCCCCCCCCCH-----HHHHHh
Q 046972 403 IALRCVDPDIKHRPKM-----GDVLRM 424 (483)
Q Consensus 403 l~~~cl~~dP~~Rpt~-----~eil~~ 424 (483)
++.+||+.||++||++ ++++.+
T Consensus 208 li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHHHccCCHHHhcCCCccchHHHHcC
Confidence 9999999999999996 566554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.54 Aligned_cols=268 Identities=19% Similarity=0.283 Sum_probs=210.4
Q ss_pred CcccceeccCCceEEEEEE-EcCCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeCC-----eEEE
Q 046972 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-----NRIL 226 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~l 226 (483)
.+-.+.||.|+||.||.+. -++|+.||.|++..- .....+.+.+|+++|..++|.|++..++...... ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4456889999999999998 467999999988653 2334478999999999999999999999876543 4578
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
++|+|.. ||...+- ....++.+.+.-++.||++||.|||+. +|.||||||.|.|++.+..+||||||+|+..
T Consensus 135 ~TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 9999964 8888883 567788899999999999999999999 9999999999999999999999999999988
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH----------
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA---------- 376 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------- 376 (483)
..+....++..+-|..|.|||++.+...|+.+.||||.||++.||+-.+..|....+.+++.-+.. ...
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd-LLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID-LLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH-HhCCCcHHHHHHH
Confidence 777777777778889999999999988899999999999999999999999988777655433221 111
Q ss_pred -hhhhhhhcC-----CCCCC---CCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchh
Q 046972 377 -QQKIAYVLD-----PKLPE---MPS-RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 377 -~~~~~~~~~-----~~~~~---~~~-~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~ 431 (483)
.+--..++. |.++. ..+ ...-.+...+..+++..||.+|.+..+.+.++......
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 010011111 11111 111 12224566777899999999999999999887654433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=282.43 Aligned_cols=289 Identities=19% Similarity=0.242 Sum_probs=213.0
Q ss_pred ccCCccceeeehHHHHHHh-cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC----
Q 046972 134 VSGMRLGIRISLKEIDIVT-DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK---- 207 (483)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---- 207 (483)
..++..|..-.+...++.. .+|.+.++||.|.|++||+|.+. +.+.||+|+.+... ...+..+.||++|++++
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCC
Confidence 3444555545555556555 89999999999999999999955 45678999876542 23467889999999983
Q ss_pred -C---CcccccccEEE----eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 046972 208 -H---KNLVKLFGYCV----EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279 (483)
Q Consensus 208 -h---pnIv~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 279 (483)
| .+||++++.|. ++.++|||+|++ |-+|..+|... ..+.++...+..|++||+.||.|||..| +|||
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIH 211 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIH 211 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--Cccc
Confidence 3 37999999996 457899999999 67999999764 5677999999999999999999999986 9999
Q ss_pred ecCCCCcEEEcC--------------------------------------------------------------------
Q 046972 280 HNMKSSNILLDH-------------------------------------------------------------------- 291 (483)
Q Consensus 280 rDlkp~NiLl~~-------------------------------------------------------------------- 291 (483)
-||||+|||+..
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 999999999800
Q ss_pred --------------------------------------------------------------------------------
Q 046972 292 -------------------------------------------------------------------------------- 291 (483)
Q Consensus 292 -------------------------------------------------------------------------------- 291 (483)
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence
Q ss_pred ------------------CCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc
Q 046972 292 ------------------HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353 (483)
Q Consensus 292 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t 353 (483)
+.+|||+|||-|...... .+....|..|+|||++.+.+ |++.+||||++|++|||+|
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaT 446 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELAT 446 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhc
Confidence 001566777766543322 23345677899999998877 9999999999999999999
Q ss_pred CCCCCCCCCch------hhHHHH---HHHHH----Hhhh-hhhhcCC--------CCCCC-----------CCHHHHHHH
Q 046972 354 GRLPVDYSQPQ------VFLIDW---LKSMV----AQQK-IAYVLDP--------KLPEM-----------PSRKELKRI 400 (483)
Q Consensus 354 g~~Pf~~~~~~------~~~~~~---~~~~~----~~~~-~~~~~~~--------~~~~~-----------~~~~~~~~l 400 (483)
|...|+..... ..+..+ +..+. ..++ -..+++. ++... .+.+++.++
T Consensus 447 GDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~f 526 (590)
T KOG1290|consen 447 GDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQF 526 (590)
T ss_pred CceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHH
Confidence 99999654432 222211 11110 0010 0111111 11111 345678899
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHhccccchhhh
Q 046972 401 ILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLR 433 (483)
Q Consensus 401 ~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~ 433 (483)
.+++.-||+.+|++||||.+.+++.+-.....+
T Consensus 527 sdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 527 SDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 999999999999999999999999987764443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.09 Aligned_cols=274 Identities=18% Similarity=0.228 Sum_probs=188.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-----------------cCCcEEEEEEecCCCcchHHHH--------------HH
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-----------------LDNMRAAVKLLMSNSVSEEEDF--------------IE 198 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~ 198 (483)
+..++|.+.++||+|+||.||+|.. ..++.||||++........++| ..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4578899999999999999999964 2356799999865433333333 34
Q ss_pred HHHHHhcCCCCcc-----cccccEEEe--------CCeEEEEEEecCCCCHHHHHhcccC--------------------
Q 046972 199 KVEAIGQVKHKNL-----VKLFGYCVE--------GQNRILVYEYIDNGNLQQWLHGSLG-------------------- 245 (483)
Q Consensus 199 E~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~-------------------- 245 (483)
|+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766544 677887753 3567999999999999999964211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCccccc
Q 046972 246 EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325 (483)
Q Consensus 246 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~a 325 (483)
....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112346778899999999999999999 99999999999999999999999999997654332222333445789999
Q ss_pred ccccCCCCC-------------------C--CcchhhHHHHHHHHHHHcCCC-CCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 326 EELSGRTSI-------------------F--NEKSDVYSFGILIMEIVSGRL-PVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 326 PE~~~~~~~-------------------~--~~~~DvwSlGv~l~el~tg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
||.+..... | ..+.||||+||++|+|++|.. ||................. ......
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~--~~~r~~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL--NRWRMY 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH--HHHHhh
Confidence 998753210 1 234799999999999999875 7653221100000000000 000000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDI---KHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rpt~~eil~~L~~~ 428 (483)
..................+++.++|..+| .+|+|++|++++.+..
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 00111111122334678889999999876 6899999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.76 Aligned_cols=270 Identities=17% Similarity=0.132 Sum_probs=175.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-----CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccE------EE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY------CV 219 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------~~ 219 (483)
..++|.+.+.||+|+||.||+|.+.+ +..||+|++..... .+.+..+ .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999654 58899998754321 1222222 1122223333333222 23
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCC
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGE----------------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMK 283 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlk 283 (483)
.....++||||+++++|.+++...... ........+..++.||+.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999999998642100 01112344668999999999999999 99999999
Q ss_pred CCcEEEcC-CCCcEEeecccccccCCCccccccccccCcccccccccCCCC---------------------CCCcchhh
Q 046972 284 SSNILLDH-HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS---------------------IFNEKSDV 341 (483)
Q Consensus 284 p~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv 341 (483)
|+|||++. ++.+||+|||+|+.+............+++.|+|||.+.... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 578999999999865443333334457889999999653221 13456799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH-HhhhhhhhcCCCCCCCC------CHHHHHHHHHHHHHccCCCCCC
Q 046972 342 YSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV-AQQKIAYVLDPKLPEMP------SRKELKRIILIALRCVDPDIKH 414 (483)
Q Consensus 342 wSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~ 414 (483)
|||||+||||+++..|++.. ...+...+.... ..........+...... .........+|+.+||+.||++
T Consensus 363 wSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999999977664321 111111111100 00001111111110000 0001134558999999999999
Q ss_pred CCCHHHHHHhccccc
Q 046972 415 RPKMGDVLRMLEPRD 429 (483)
Q Consensus 415 Rpt~~eil~~L~~~~ 429 (483)
|||+.+++++.+...
T Consensus 441 R~ta~e~L~Hpff~~ 455 (566)
T PLN03225 441 RISAKAALAHPYFDR 455 (566)
T ss_pred CCCHHHHhCCcCcCC
Confidence 999999999876543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=254.78 Aligned_cols=212 Identities=21% Similarity=0.322 Sum_probs=177.3
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCcccccccEEEeCC
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 222 (483)
..+++..+.+.-...||+|++|.|-+-++ .+|+..|+|.+...- .+..+..++|+.+..+. .+|.+|.|||......
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 34667777777788999999999988774 578889999997663 34456788999876554 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++.||.|+- +|..|-+.-...+..+++...-+|+..++.||.|||++ ..+||||+||.|||++.+|++|+||||+
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999965 89888766656778899999999999999999999998 6999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGR---TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~ 362 (483)
+-.+...- ..+...|...|||||.+.. ...|+-++||||||+++.||.+++.||+...
T Consensus 196 sG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 196 SGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 97665432 2222456778999998753 2248999999999999999999999997544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=265.34 Aligned_cols=238 Identities=25% Similarity=0.380 Sum_probs=193.1
Q ss_pred CceEEEEEEEcC-CcEEEEEEecCCCcch-HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhc
Q 046972 165 DNGVVYRAVLLD-NMRAAVKLLMSNSVSE-EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHG 242 (483)
Q Consensus 165 ~fg~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 242 (483)
+||.||+|...+ +..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999997765544 67899999999999999999999999999999999999999999999963
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcc
Q 046972 243 SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322 (483)
Q Consensus 243 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 322 (483)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 2233467788
Q ss_pred cccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH-HHHHHHH
Q 046972 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR-KELKRII 401 (483)
Q Consensus 323 y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 401 (483)
|++||...... ++.++||||||+++|+|++|..||..........+... .......... ..+..+.
T Consensus 152 ~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG------------KPKPPFPPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh------------ccCCCCccccccCCHHHH
Confidence 99999986444 78899999999999999999999976433222211111 1111110100 1346889
Q ss_pred HHHHHccCCCCCCCCCHHHHHHh
Q 046972 402 LIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 402 ~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
+++.+||..+|++||++.+++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHccCCchhccCHHHHhhC
Confidence 99999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.85 Aligned_cols=206 Identities=21% Similarity=0.289 Sum_probs=174.0
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchH---HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEE---EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
...|...+.||-|+||+|.+++- ++...+|.|.+.+.+.-.+ .....|-.||+.-..+-||++|-.|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35577788999999999999994 4456679998876544333 3567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++|||+-.+|- .-+.|.+..++.++..+..|+++.|.- |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999985 446789999999999999999999998 99999999999999999999999999996321
Q ss_pred ---------CC--------------------------------ccccccccccCcccccccccCCCCCCCcchhhHHHHH
Q 046972 308 ---------PE--------------------------------WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGI 346 (483)
Q Consensus 308 ---------~~--------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv 346 (483)
.. ........+||+.|+|||++.+.+ |+..+|+||.||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gv 859 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGV 859 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhH
Confidence 00 001112347999999999998777 899999999999
Q ss_pred HHHHHHcCCCCCCCCCchh
Q 046972 347 LIMEIVSGRLPVDYSQPQV 365 (483)
Q Consensus 347 ~l~el~tg~~Pf~~~~~~~ 365 (483)
|||||+.|+.||-...+..
T Consensus 860 il~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHHhhCCCCccCCCCCc
Confidence 9999999999998776643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=290.16 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=187.1
Q ss_pred cceeccCCce-EEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEecCCCC
Q 046972 158 QNVIASGDNG-VVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 158 ~~~lg~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
.+.+|.|+-| .||+|.+ +++.||||++..... .-..+|+..|+.- +|||||++++.-.+++.+||..|.|.. +
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 4568999987 5899988 677999999865432 3457899999887 699999999999999999999999964 9
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---C--CCcEEeecccccccCCCc
Q 046972 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---H--WNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 236 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~--~~~kl~DFGla~~~~~~~ 310 (483)
|.+++...............+.++.|+++||++||+. +||||||||.||||+. + ..++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999975311111111135578899999999999998 9999999999999976 2 468999999999876543
Q ss_pred c--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 311 S--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 311 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
+ .......||.+|+|||.+.... -+.++||+||||++|+.++ |.+||...-..+. +++.. ...
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~-----------~~~ 731 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTG-----------NYT 731 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcC-----------ccc
Confidence 3 2345568999999999996554 5779999999999999999 5999975332110 00000 011
Q ss_pred CCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 388 LPEM-PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+... +..++ +..+||.+|++.||..||++.+|+.+.-.-+
T Consensus 732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 1111 11112 6778888999999999999999998775433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=261.69 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=196.2
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCCcccccccEEEeCC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 222 (483)
+.+..++|.++++||.|+|..|.++++. +.+.+|+|++++.-. .+......|-.+..+- +||.+|.++.+|+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3455678999999999999999999955 466789998876422 2334556677666665 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
++++|.||++||+|--.++ ....++++.++.+...|+.||.|||++ |||.||||.+|+|+|..|++||+|+|+
T Consensus 325 rlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred eEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence 9999999999999987775 557799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC---CCchhhHHHHHHHHHHhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY---SQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~---~~~~~~~~~~~~~~~~~~~ 379 (483)
++.--.. -..+.+..||+.|.|||.+.+. .|...+|+|+|||+++||+.|+.||+. .+++....+++.+..-...
T Consensus 398 cke~l~~-gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 398 CKEGLGP-GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred hhcCCCC-CcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 9853222 2234556899999999999554 499999999999999999999999963 2333333333333322222
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK 417 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt 417 (483)
-+.|...+ -....+++.-|.+||++|..
T Consensus 476 ------iriprsls----vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 ------IRIPRSLS----VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ------ccccceee----hhhHHHHHHhhcCCcHHhcC
Confidence 12333333 34445666889999999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.28 Aligned_cols=262 Identities=18% Similarity=0.285 Sum_probs=201.8
Q ss_pred hcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeC--CeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEG--QNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv 227 (483)
.++|++.+++|.|.|++||.|. ..++..++||++++- ..+...+|+++|..|. ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678999999999999999998 567888999998765 3467889999999996 99999999998765 455799
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeeccccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLH 306 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFGla~~~ 306 (483)
+||+.+.|...+. ..++.-.+..++.++++||.|+|+. ||+|||+||.|+++|.. -.++|+|+|+|...
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998887765 4577788999999999999999999 99999999999999976 45899999999877
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC-CCchhhHHHHHHHHHHhhhhh----
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY-SQPQVFLIDWLKSMVAQQKIA---- 381 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~---- 381 (483)
.+.... ...+.+..|--||++-.-..|+-.-|+|||||+|..|+..+.||-. .++..++..+++-........
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 654332 2335566778899987777789999999999999999998888854 444455554443111110000
Q ss_pred --hhcCCCCCC----------------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 382 --YVLDPKLPE----------------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 382 --~~~~~~~~~----------------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
-.++|.+.. ....-...+.++++.+.|..|-.+|+|+.|.+.+....
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 011221111 00001126788999999999999999999999887544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=270.89 Aligned_cols=274 Identities=19% Similarity=0.228 Sum_probs=214.0
Q ss_pred eeehHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC------CCccccc
Q 046972 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK------HKNLVKL 214 (483)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~ 214 (483)
.+.+.-.++.-.+|.+....|+|-|++|.+|... .|+.||||+|..+.. ..+.=+.|+++|++|+ --|++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3455566778899999999999999999999944 478999999987643 2345678999999995 3489999
Q ss_pred ccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-C
Q 046972 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-W 293 (483)
Q Consensus 215 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~ 293 (483)
+-.|...+++|||||-+. .+|.+.|+.. +..-.|....+..++.|+.-||..|-.- +|+|.||||.||||+.. .
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999884 5999999876 3556788889999999999999999987 99999999999999876 4
Q ss_pred CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH-
Q 046972 294 NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK- 372 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~- 372 (483)
.+||||||.|...+... .+...-...|.|||++.+.+ |+...|+||.||+||||+||+..|++..+...+.-.+.
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 57999999998665432 22223455799999998877 89999999999999999999999999887655432221
Q ss_pred ------HHHHhhhhh-hhcC--------------------------C------------CCCCCCCHHHHHHHHHHHHHc
Q 046972 373 ------SMVAQQKIA-YVLD--------------------------P------------KLPEMPSRKELKRIILIALRC 407 (483)
Q Consensus 373 ------~~~~~~~~~-~~~~--------------------------~------------~~~~~~~~~~~~~l~~l~~~c 407 (483)
.++..+.+. .-+| | ++|. -.......|.+|+.+|
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d-eq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD-EQPKIVQQLRDLLDKM 729 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc-hhHHHHHHHHHHHHHH
Confidence 111111110 0011 1 1111 1224457889999999
Q ss_pred cCCCCCCCCCHHHHHHhcc
Q 046972 408 VDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 408 l~~dP~~Rpt~~eil~~L~ 426 (483)
|..||++|.|..++|++..
T Consensus 730 l~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPF 748 (752)
T ss_pred hccChhhcCCHHHHhcCCc
Confidence 9999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-34 Score=282.34 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=209.9
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+.++|.....+|.|+||.||+++. +.+..+|+|+++.....+..-..+|+-+++..+|||||.++|.+...+.++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 457788999999999999999994 5688899999988777676778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||.||+|++.-+ -.+++++.++..+++..++||.|||+. +=+|||||-.|||+++.|.+|++|||.+..++..
T Consensus 93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999875 457899999999999999999999999 9999999999999999999999999999876544
Q ss_pred ccccccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 310 WSISTSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. ......||+.|||||+.. +.+.|+.++|||++|++..|+---+.|-....+...+.-+-+. ..-.|.
T Consensus 166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS--------~~qpp~ 236 (829)
T KOG0576|consen 166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS--------GFQPPT 236 (829)
T ss_pred hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--------CCCCCc
Confidence 22 234458999999999853 3344999999999999999999888886655543322211111 011122
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+. ........+.++++.||.++|++||+++.+|++.
T Consensus 237 lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 237 LK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred cc--CCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 21 1223456788999999999999999999988744
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=251.00 Aligned_cols=262 Identities=22% Similarity=0.262 Sum_probs=196.7
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeC------Ce
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------QN 223 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~ 223 (483)
.+|.-.+.+|.|.- .|..|. .-.+++||+|++... .....+...+|..++..++|+||++++.+|+-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34666777888887 565555 335788999988655 222336788999999999999999999999754 35
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+|||||. ++|...+. ..++......|+.|++.|+.|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 699999996 59999885 2356678899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH-----------
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK----------- 372 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~----------- 372 (483)
+.-+.. ...+..+.|..|.|||++.+.+ |.+.+||||+||++.||++|+..|.+.+--.+......
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 865544 3455567888999999998887 99999999999999999999999986543222211111
Q ss_pred ---HHH----H--hhhhhhhcCCCCCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 373 ---SMV----A--QQKIAYVLDPKLPEMP-------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 373 ---~~~----~--~~~~~~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
... . .+.........+|... +........+++.+||..||++|.+++++|.+...+
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000 0 0000001111122111 112345678889999999999999999999988654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=235.06 Aligned_cols=212 Identities=29% Similarity=0.502 Sum_probs=182.2
Q ss_pred eccCCceEEEEEEEcC-CcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHH
Q 046972 161 IASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ 238 (483)
Q Consensus 161 lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~ 238 (483)
||.|++|.||++...+ ++.+++|.+...... ....+.+|++.++.+.|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998766443 34679999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeecccccccCCCcccccccc
Q 046972 239 WLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKLHGPEWSISTSCE 317 (483)
Q Consensus 239 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 317 (483)
++... ...+++..++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 99632 14688999999999999999999999 9999999999999999 89999999999986544321 12334
Q ss_pred ccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHH
Q 046972 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKEL 397 (483)
Q Consensus 318 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (483)
.+...|++||.......++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 5677899999986542578999999999999999
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 398 KRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 398 ~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
..+.+++.+|+..||.+||++.++++.+
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3677888899999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=262.93 Aligned_cols=197 Identities=19% Similarity=0.330 Sum_probs=169.8
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchH--------HHHHHHHHHHhcCC---CCcccccccEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEE--------EDFIEKVEAIGQVK---HKNLVKLFGYCVE 220 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---hpnIv~~~~~~~~ 220 (483)
.+|+..+.+|+|+||.|++|.++. ...|++|.+.+..--.. -..-.||++|+.|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458999999999999999999664 66788998865422111 12456999999997 9999999999999
Q ss_pred CCeEEEEEEe-cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 221 GQNRILVYEY-IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 221 ~~~~~lv~E~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
++..||+||- -+|-||+++|. ....+++.++..|+.||+.|+++||.+ +|||||||-+|+.++.+|.+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 9999999996 56789999995 556799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~ 359 (483)
||.|...... ......||..|.|||++++....+..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998754322 34456899999999999888877888999999999999999998884
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=236.35 Aligned_cols=249 Identities=19% Similarity=0.335 Sum_probs=183.9
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccE-EEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGY-CVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~-~~~~~~~~lv~ 228 (483)
.+.|.+.+.||+|.||.+-++.++. ++.+++|-+... .....+|.+|...--.| .|.||+.-|++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3679999999999999999999765 566788877544 34567899999876666 58999998864 66778888999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc--CCCCcEEeeccccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD--HHWNPKISDVGLAKLH 306 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~--~~~~~kl~DFGla~~~ 306 (483)
||++.|||.+-+ ....+.+.....++.|+++|+.|+|++ ++||||||.+||||- +..++||||||+.+..
T Consensus 102 E~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999988 446788899999999999999999999 999999999999993 3357999999999865
Q ss_pred CCCccccccccccCcccccccccCCC----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCch-hhHHHHHHHHHHhhhhh
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRT----SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 381 (483)
+...... .-+..|.+||+.... -...+.+|+|.||+++|.++||..||+..... ....+|.. +..
T Consensus 174 g~tV~~~----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~-w~~----- 243 (378)
T KOG1345|consen 174 GTTVKYL----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ-WLK----- 243 (378)
T ss_pred Cceehhh----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-Hhc-----
Confidence 5432211 223458899876422 12467799999999999999999999843322 22222221 111
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ei 421 (483)
...+.+|..+ ......+..+.++-|..+|++|--..++
T Consensus 244 -rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 244 -RKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred -ccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHH
Confidence 1122333221 1233567778889999999999444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=235.65 Aligned_cols=199 Identities=27% Similarity=0.405 Sum_probs=171.0
Q ss_pred CcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
|.+.+.||.|++|.||+|...+ ++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999765 888999999876554 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 233 NGNLQQWLHGSLGEAKP-LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
+++|.+++... .. +++..+..++.+++.++.|||+. +++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999642 23 78999999999999999999999 999999999999999999999999999986644321
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY 360 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~ 360 (483)
.......++..|++||.......++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1223345677899999873333477899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=246.71 Aligned_cols=270 Identities=20% Similarity=0.311 Sum_probs=204.9
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 222 (483)
+....+.|...++||+|.|++||++.+. ....||+|.+...+.. .....|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445677999999999999999999843 4678999999776543 4588999999999 5899999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeecc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVG 301 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFG 301 (483)
..++|+||++.-+..+++. .++..++..+++.++.||.++|.+ |||||||||.|+|.+.. +.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 9999999999999999883 366788999999999999999999 99999999999999865 557899999
Q ss_pred cccccC-----------------C------------------Cc--------cccccccccCcccccccccCCCCCCCcc
Q 046972 302 LAKLHG-----------------P------------------EW--------SISTSCELRNSGYLAEELSGRTSIFNEK 338 (483)
Q Consensus 302 la~~~~-----------------~------------------~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 338 (483)
+|.... . .+ ........||++|.|||++.+.+..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997210 0 00 0111235799999999999988888999
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCchh-hHHHHHH---H--HHH----hhh--h----------------hhh-cCCC--
Q 046972 339 SDVYSFGILIMEIVSGRLPVDYSQPQV-FLIDWLK---S--MVA----QQK--I----------------AYV-LDPK-- 387 (483)
Q Consensus 339 ~DvwSlGv~l~el~tg~~Pf~~~~~~~-~~~~~~~---~--~~~----~~~--~----------------~~~-~~~~-- 387 (483)
+||||.|||++-+++++.||-...++. .+.+++. . +.+ .+. + ..+ ....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999996554432 2222211 0 000 000 0 000 0000
Q ss_pred ------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 388 ------LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 388 ------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
-+.......+..+++++.+||..||.+|.|+++.|++.-..+
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000011122347889999999999999999999999887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=275.54 Aligned_cols=199 Identities=19% Similarity=0.272 Sum_probs=141.5
Q ss_pred cCCC-CcccccccEE-------EeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 046972 205 QVKH-KNLVKLFGYC-------VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276 (483)
Q Consensus 205 ~l~h-pnIv~~~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 276 (483)
.++| +||++++++| ......+++|||+ +++|.++|.. ....+++.+++.++.||+.||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3456 6888888887 2334567788987 5699999963 245699999999999999999999999 9
Q ss_pred eeeecCCCCcEEEcC-------------------CCCcEEeecccccccCCCc---------------cccccccccCcc
Q 046972 277 IVHHNMKSSNILLDH-------------------HWNPKISDVGLAKLHGPEW---------------SISTSCELRNSG 322 (483)
Q Consensus 277 iiHrDlkp~NiLl~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~~~~~ 322 (483)
|+||||||+||||+. ++.+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456677777765321100 000112357888
Q ss_pred cccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHH
Q 046972 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIIL 402 (483)
Q Consensus 323 y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 402 (483)
|+|||++.+.. |+.++|||||||+||||++|..|+..... . ..... .....+.. . ........
T Consensus 181 Y~APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~----~~~~~-----~~~~~~~~----~-~~~~~~~~ 243 (793)
T PLN00181 181 YTSPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--T----MSSLR-----HRVLPPQI----L-LNWPKEAS 243 (793)
T ss_pred eEChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--H----HHHHH-----HhhcChhh----h-hcCHHHHH
Confidence 99999986555 89999999999999999999888653211 1 11100 00111111 0 11234567
Q ss_pred HHHHccCCCCCCCCCHHHHHHhccc
Q 046972 403 IALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 403 l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
++.+||+.||.+||++.|++++.+.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhchhh
Confidence 8889999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=211.92 Aligned_cols=167 Identities=22% Similarity=0.238 Sum_probs=125.5
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.++++.+ ..++++.+++.++.||+.||.|||++ + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 7999999632 45699999999999999999999998 6 999999999999999 9999865432
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
...|++.|+|||++.+.. ++.++|||||||++|||++|+.||............+.. .. .. ..+... ...
T Consensus 63 --~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~---~~--~~-~~~~~~-~~~ 132 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN---GM--PA-DDPRDR-SNL 132 (176)
T ss_pred --cCCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH---Hh--cc-CCcccc-ccH
Confidence 125789999999996554 899999999999999999999999755432221111110 00 00 000000 011
Q ss_pred HHHHH--HHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 394 RKELK--RIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 394 ~~~~~--~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... .+.+++.+||..||.+||++.++++++...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22223 689999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=222.35 Aligned_cols=178 Identities=16% Similarity=0.146 Sum_probs=134.0
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc--CCcEEEEEEecCCC-----cchHHHHHHHHHHHhcCCCCcccccccEEEe
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL--DNMRAAVKLLMSNS-----VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 220 (483)
.....++|.+.+.||+|+||+||+|++. +++.+|||++.... ....+.|.+|+++|++++|+|++..+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3455678999999999999999999864 56778999875431 1234578999999999999999853322
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecC-CCCcEEEcCCCCcEEee
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNM-KSSNILLDHHWNPKISD 299 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDl-kp~NiLl~~~~~~kl~D 299 (483)
.+..++||||++|++|.. +. ... ...++.|+++||.|||++ +|+|||| ||+|||++.++.+||+|
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 245799999999999973 21 111 146788999999999999 9999999 99999999999999999
Q ss_pred cccccccCCCccc-------cccccccCcccccccccCCC-----CCCCcchhhH
Q 046972 300 VGLAKLHGPEWSI-------STSCELRNSGYLAEELSGRT-----SIFNEKSDVY 342 (483)
Q Consensus 300 FGla~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dvw 342 (483)
||+|+.+...... ......++..|+|||.+... ...+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999866443211 11244677789999987532 1234456776
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=208.49 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=187.9
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchH--HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCC
Q 046972 157 EQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+..+|.+...|+.|+|++.++ .+++|++.......+ ++|.+|.-.|+.+.||||..++|.|....++.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345688899999999999766 455676655433333 68999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEe--ecccccccCCCccc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKIS--DVGLAKLHGPEWSI 312 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~--DFGla~~~~~~~~~ 312 (483)
+|+..|+.. ..-.++..++.+++.+|++||+|||+. .+-|.---|....+++|++.+++|. |--. +.
T Consensus 273 slynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kf--------sf 341 (448)
T KOG0195|consen 273 SLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKF--------SF 341 (448)
T ss_pred HHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccccee--------ee
Confidence 999999753 344567789999999999999999997 3334455789999999999888774 3111 22
Q ss_pred cccccccCcccccccccCCCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSI--FNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
........+.|++||.+.+.+. --.++|+|||++++|||.|...||..-.+-+.-..+.. .-+....|
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------eglrv~ip- 411 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------EGLRVHIP- 411 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------ccccccCC-
Confidence 2233355678999999875532 23689999999999999999999987766432222111 11222333
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
++.+..+.+||.-|+..||.+||.+..++-.|+.
T Consensus 412 ---pgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 412 ---PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ---CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 3344678889999999999999999999988764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-24 Score=207.41 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=198.2
Q ss_pred CcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCC-cccccccEEEeCCeEEEEEEe
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHK-NLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~E~ 230 (483)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999976 78899998766433 357899999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccccCCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKLHGPE 309 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~ 309 (483)
+.+++|.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999877532111 3688999999999999999999999 999999999999999998 6999999999855443
Q ss_pred ccc-----cccccccCcccccccccCCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCc---hhhHHHHHHHHHHhhh
Q 046972 310 WSI-----STSCELRNSGYLAEELSGRT--SIFNEKSDVYSFGILIMEIVSGRLPVDYSQP---QVFLIDWLKSMVAQQK 379 (483)
Q Consensus 310 ~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~---~~~~~~~~~~~~~~~~ 379 (483)
... ......++..|++||.+... ..++...|+||+|++++++++|..||..... .......+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cC
Confidence 221 23556889999999998663 4588999999999999999999999876553 1111111111 00
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
.. .................+.+++.+|+..+|..|.+..+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000001100001123567888889999999999999887765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=211.93 Aligned_cols=256 Identities=15% Similarity=0.172 Sum_probs=190.3
Q ss_pred CCcccceeccCCceEEEEEEEcCC--cEEEEEEecCCCcchHHHHHHHHHHHhcCCC----CcccccccEE-EeCCeEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLDN--MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH----KNLVKLFGYC-VEGQNRIL 226 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~-~~~~~~~l 226 (483)
+|.+.+.||+|+||.||.|..... ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996654 4788888766533332367788888888863 5888888888 47778899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-----CCcEEeecc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-----WNPKISDVG 301 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-----~~~kl~DFG 301 (483)
||+.+ |.+|.++..... .+.++..++..++.|++.+|++||+. |++||||||.|++++.. ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 789999885442 57899999999999999999999999 99999999999999865 358999999
Q ss_pred ccc--ccCCCcc-----c-c-ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH
Q 046972 302 LAK--LHGPEWS-----I-S-TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 302 la~--~~~~~~~-----~-~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~ 372 (483)
+|+ ....... . . .....||..|+++....+.. .+.+.|+||++.++.|+..|..||..............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 998 3211110 1 1 12345999999999886665 79999999999999999999999976554322111111
Q ss_pred HHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
. ........ . ....+..+..+...+-..+..++|....+...+.
T Consensus 252 ~-----~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~ 295 (322)
T KOG1164|consen 252 D-----PRKLLTDR-F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK 295 (322)
T ss_pred H-----hhhhcccc-c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence 1 00111111 1 1112245556665666689999999999988854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=235.16 Aligned_cols=260 Identities=20% Similarity=0.181 Sum_probs=189.2
Q ss_pred cccceeccCCceEEEEEEE-cCCcEEEEEEecCC--CcchH----HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSN--SVSEE----EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
...+.+|.|++|.|+.+.. ......+.|..... ..... ..+..|+.+-..|+|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999997777763 23333444433210 11112 12566777888899999998888777666665569
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||++ ||+.++.. ...+...++..++.|++.|+.|+|.. ||.|||+|++|+++..+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999952 34688889999999999999999999 999999999999999999999999999987654
Q ss_pred Ccc---ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 309 EWS---ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 309 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
... .......|...|+|||++.+...-....||||.|+++..|++|+.||.......... ...... ...-.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~---~~~~~ 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYS---DQRNI 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccc---ccccc
Confidence 433 334455788899999999877755678999999999999999999997655432211 000000 00000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..-+.......+.....++.++|+.||.+|.|+++|++.-|.+.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 01111122334467788999999999999999999998766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=185.54 Aligned_cols=255 Identities=16% Similarity=0.196 Sum_probs=187.7
Q ss_pred HHhcCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC-CcccccccEEEeCCeEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH-KNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv 227 (483)
+..+.|.+.++||+|+||.+|.|. ..+|..||+|+-..+. ...++.-|.++...|++ ..|..+..+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 445789999999999999999999 6789999999865442 23467889999999975 6788888888888888999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcEEeeccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPKISDVGLAK 304 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DFGla~ 304 (483)
||+. |.+|.+++.- ....++..+++.++.|++.-++|+|.+ ++|||||||+|.|..-+ ..+.|+|||+|+
T Consensus 90 MdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 8899998852 346688999999999999999999999 99999999999999755 347899999998
Q ss_pred ccCCCc------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh--HHHHHHHHHH
Q 046972 305 LHGPEW------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF--LIDWLKSMVA 376 (483)
Q Consensus 305 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~ 376 (483)
...... ........||..|.+-....+.. .+..-|+=|+|.+|.++--|..||++-..... -.+.+.+...
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 653321 12233457888898766554443 57889999999999999999999987654321 1111111111
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~ 423 (483)
...+..+. .+.+.++...+.-|=..--++-|...-+-+
T Consensus 242 s~~ie~LC---------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 242 STPIEVLC---------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred CCCHHHHh---------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 11111111 122356666666777776777777654443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=192.03 Aligned_cols=173 Identities=13% Similarity=0.202 Sum_probs=135.0
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHH---------HHHHHHHHhcCCCCcccccccEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEED---------FIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
++..++|...++||.|+||.||++.. ++..+|+|.+.+........ +.+|++.+.+++||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 46789999999999999999999765 57789999997654333322 688999999999999999998866
Q ss_pred eC--------CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC
Q 046972 220 EG--------QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291 (483)
Q Consensus 220 ~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~ 291 (483)
.. ...++||||++|.+|.++.. +++ ....+++.+|..+|.. |++|||+||.|++++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 35789999999999988742 222 2456899999999999 9999999999999999
Q ss_pred CCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHH
Q 046972 292 HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIV 352 (483)
Q Consensus 292 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~ 352 (483)
++ ++|+|||........... ..+..... |..++|+||||+++.-+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~-y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERH-YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhH-hcccccccceeEeehHHH
Confidence 98 999999988644221110 11222232 668999999999987554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=189.53 Aligned_cols=201 Identities=18% Similarity=0.266 Sum_probs=167.5
Q ss_pred cCCcccceeccCCceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
-.|.++++||+|+||.++.|. +-++..||||.-... .+..++..|.+..+.| ..++|.+++-+...+.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 458889999999999999999 668999999985433 2345677888888887 478999999888888888999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-----CcEEeecccccc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-----NPKISDVGLAKL 305 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-----~~kl~DFGla~~ 305 (483)
+ |.+|.|+.. ..+..|+..++..++.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|+.
T Consensus 106 L-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 789999886 3567799999999999999999999999 999999999999997654 378999999986
Q ss_pred cCCCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 306 HGPEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 306 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
...... .......||..||+--...+.+ .+..-|+=|||-++++.+-|..||.+-..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 643322 1223347899999977766665 68999999999999999999999987543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=186.42 Aligned_cols=139 Identities=17% Similarity=0.225 Sum_probs=109.1
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--h-------H-----------------HHHHHHHHHHhcCCCCcc
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--E-------E-----------------EDFIEKVEAIGQVKHKNL 211 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~hpnI 211 (483)
.+.||+|+||.||+|...+|+.||+|++...... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999999754211 1 0 122349999999988777
Q ss_pred cccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCCeeeecCCCCcEEEc
Q 046972 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL-HEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 212 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrDlkp~NiLl~ 290 (483)
.....+.. ...+|||||++|++|...+. ....+++..+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54333322 22389999999988765532 235688999999999999999999 688 999999999999998
Q ss_pred CCCCcEEeeccccccc
Q 046972 291 HHWNPKISDVGLAKLH 306 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~ 306 (483)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=179.69 Aligned_cols=140 Identities=19% Similarity=0.215 Sum_probs=111.4
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--h------------------------HHHHHHHHHHHhcCCCCcc
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--E------------------------EEDFIEKVEAIGQVKHKNL 211 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnI 211 (483)
.+.||+|+||.||+|...+|+.||||++...... . ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999778999999998765211 0 1224578999999999987
Q ss_pred cccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEc
Q 046972 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 212 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~ 290 (483)
.....+... ..++||||++|+++..... ....++...+..++.|++.++.++|+ . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 2489999999886544321 22457788899999999999999999 8 999999999999999
Q ss_pred CCCCcEEeecccccccC
Q 046972 291 HHWNPKISDVGLAKLHG 307 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~ 307 (483)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=175.02 Aligned_cols=186 Identities=14% Similarity=0.089 Sum_probs=138.7
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchH----HHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEec
Q 046972 157 EQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE----EDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
....|+.|+||+||.+.. .+..++.+.+........ ..|.+|+++|++|+ |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356799999999997765 677777776655433222 35789999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecC-CCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNM-KSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDl-kp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
.|.+|...+. . . ...++.|++.+|.++|++ ||+|||| ||.|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~----~-~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPP----R-G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhh----h-h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999976541 1 1 134778999999999999 9999999 7999999999999999999998654432
Q ss_pred cc----c--------ccccccCcccccccccCCCCCCC-cchhhHHHHHHHHHHHcCCCCCCCC
Q 046972 311 SI----S--------TSCELRNSGYLAEELSGRTSIFN-EKSDVYSFGILIMEIVSGRLPVDYS 361 (483)
Q Consensus 311 ~~----~--------~~~~~~~~~y~aPE~~~~~~~~~-~~~DvwSlGv~l~el~tg~~Pf~~~ 361 (483)
.. . ......++.|+.|+...-....+ ...+.++-|+-+|.++|++.|....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0 11123566777777543221123 5678999999999999998887543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=205.32 Aligned_cols=225 Identities=21% Similarity=0.200 Sum_probs=178.7
Q ss_pred eeccCCceEEEEEE----EcCCcEEEEEEecCCCcch--HHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEecC
Q 046972 160 VIASGDNGVVYRAV----LLDNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 160 ~lg~G~fg~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
.+|+|+||.|++++ ...+..+|.|++....... ......|-.++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 3346677888776543221 124566777888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
||+|...+. ....+.+.....+...++-|++++|+. +|+|||+|++||+++.+|++|+.|||+++..-..
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--- 150 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--- 150 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhh---
Confidence 999999884 445677888888889999999999999 9999999999999999999999999999865332
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (483)
...+||..|||||++. + ...++|.||||++++||+||..||.. +....... .....
T Consensus 151 --~~~cgt~eymApEI~~-g--h~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~-----------~~~~~ 206 (612)
T KOG0603|consen 151 --KIACGTYEYRAPEIIN-G--HLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILK-----------AELEM 206 (612)
T ss_pred --hhcccchhhhhhHhhh-c--cCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhh-----------hccCC
Confidence 1127899999999995 2 57899999999999999999999976 11111111 11123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH
Q 046972 393 SRKELKRIILIALRCVDPDIKHRPKM 418 (483)
Q Consensus 393 ~~~~~~~l~~l~~~cl~~dP~~Rpt~ 418 (483)
+........+++.+++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 44455677788889999999999755
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=198.69 Aligned_cols=216 Identities=28% Similarity=0.397 Sum_probs=161.6
Q ss_pred HhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe-eeec
Q 046972 203 IGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI-VHHN 281 (483)
Q Consensus 203 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-iHrD 281 (483)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.....+.++|+.||.|||.. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4578999999999999999999999999999999999963 456788889999999999999999987 44 9999
Q ss_pred CCCCcEEEcCCCCcEEeecccccccCCCc-cccccccccCcccccccccCCCC------CCCcchhhHHHHHHHHHHHcC
Q 046972 282 MKSSNILLDHHWNPKISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTS------IFNEKSDVYSFGILIMEIVSG 354 (483)
Q Consensus 282 lkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwSlGv~l~el~tg 354 (483)
+++.||+++..+.+||+|||+........ ...........-|.|||.+.... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987664210 01111112344699999986531 146789999999999999999
Q ss_pred CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 355 RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR-KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 355 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..||+.........+.+..... ....+..|..... .....+..++.+||..+|.+||+++++-..+....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999864433222222222111 0111222222222 33347889999999999999999999987776543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=175.88 Aligned_cols=136 Identities=15% Similarity=0.254 Sum_probs=106.7
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-----CCCcccccccEEEeCC---eEE-E
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-----KHKNLVKLFGYCVEGQ---NRI-L 226 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~---~~~-l 226 (483)
...+.||+|+||.||. +......+||++........+.+.+|+++++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467899999999996 433333478988765444567899999999999 5799999999998763 434 7
Q ss_pred EEEe--cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH-HHhhhCCCCCeeeecCCCCcEEEcC----CCCcEEee
Q 046972 227 VYEY--IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL-AYLHEDIEPKIVHHNMKSSNILLDH----HWNPKISD 299 (483)
Q Consensus 227 v~E~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiHrDlkp~NiLl~~----~~~~kl~D 299 (483)
|+|| +++|+|.+++++ ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 557999999953 235554 35677888787 999999 9999999999999974 34799999
Q ss_pred cccc
Q 046972 300 VGLA 303 (483)
Q Consensus 300 FGla 303 (483)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=211.74 Aligned_cols=248 Identities=20% Similarity=0.191 Sum_probs=179.5
Q ss_pred CCcccceeccCCceEEEEEEEcCCcEEEEEEecCCC-cchHHHHH---HHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNS-VSEEEDFI---EKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++...+.||.+.|=.|.+|+.++|. |+||++.+.. .-....|. +|++ ...++|||++.+.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667889999999999999998886 8899887654 33334444 4444 555689999999888777777789999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc--cC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL--HG 307 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~--~~ 307 (483)
|... +|+|.|. ...-+...+..-|+.|++.||..+|.. ||+|+|||.+||||+.=.-+.|+||..-+- +.
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 9999994 444567778888999999999999999 999999999999999888899999976541 22
Q ss_pred CCcccc----ccccccCcccccccccCCC----------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHH
Q 046972 308 PEWSIS----TSCELRNSGYLAEELSGRT----------SIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 308 ~~~~~~----~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~ 372 (483)
.+.... ..+...-.+|.|||.+-.. +..+++.||||+||++.||++ |++||.-. ++..+-.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~ 249 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRS 249 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhc
Confidence 211111 1112233479999986431 125788999999999999999 89998521 1111000
Q ss_pred H--HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 373 S--MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 373 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ......++.+-| ..+..++..|++.||.+|.++++.|+.-.+
T Consensus 250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 0 000011111111 367888999999999999999999987544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=181.05 Aligned_cols=192 Identities=20% Similarity=0.242 Sum_probs=136.6
Q ss_pred CCCcccccccEEEeC---------------------------CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHH
Q 046972 207 KHKNLVKLFGYCVEG---------------------------QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKII 259 (483)
Q Consensus 207 ~hpnIv~~~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 259 (483)
.|||||++.++|.+. ..+|+||.-++. +|..|+. ....+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 599999999988632 245899988865 9999994 3445667778899
Q ss_pred HHHHHHHHHhhhCCCCCeeeecCCCCcEEE--cCCCC--cEEeecccccccCC-----CccccccccccCcccccccccC
Q 046972 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILL--DHHWN--PKISDVGLAKLHGP-----EWSISTSCELRNSGYLAEELSG 330 (483)
Q Consensus 260 ~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl--~~~~~--~kl~DFGla~~~~~-----~~~~~~~~~~~~~~y~aPE~~~ 330 (483)
.|+++|+.|||.+ ||.|||+|.+|||+ ++|+. +.|+|||++-.-.. .+........|+...||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999998 44443 68899998753221 2222333446778899999875
Q ss_pred CCCC-----CCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHH
Q 046972 331 RTSI-----FNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIAL 405 (483)
Q Consensus 331 ~~~~-----~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 405 (483)
..+. --.|+|.|+.|.+.||++....||....+- .+.. ..+. ...+|. .+..++..+.+++.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~---r~Yq--------e~qLPa-lp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDT---RTYQ--------ESQLPA-LPSRVPPVARQLVF 491 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eech---hhhh--------hhhCCC-CcccCChHHHHHHH
Confidence 3321 236899999999999999999999653221 0000 0001 112332 22344467888888
Q ss_pred HccCCCCCCCCCHHH
Q 046972 406 RCVDPDIKHRPKMGD 420 (483)
Q Consensus 406 ~cl~~dP~~Rpt~~e 420 (483)
..|+.||.+|++..-
T Consensus 492 ~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNI 506 (598)
T ss_pred HHhcCCccccCCccH
Confidence 999999999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=178.38 Aligned_cols=234 Identities=20% Similarity=0.293 Sum_probs=149.5
Q ss_pred CcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc---hHHHHHHHHHHHhcCC----------CCcccccccEEE-
Q 046972 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVK----------HKNLVKLFGYCV- 219 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------hpnIv~~~~~~~- 219 (483)
+...+.||.|+|+.||.+++.. ++.+|+|+....... ..+++.+|.-....+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4457789999999999999765 788999988654322 2356666665554432 222222233222
Q ss_pred --------eCC--------eEEEEEEecCCCCHHHHHh---cccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeee
Q 046972 220 --------EGQ--------NRILVYEYIDNGNLQQWLH---GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280 (483)
Q Consensus 220 --------~~~--------~~~lv~E~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHr 280 (483)
... +.+++|+-+. +||.+++. ........+.......+..|+++.+++||.. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 2367888774 59988863 2212223344556677889999999999999 99999
Q ss_pred cCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCC-------CCCCcchhhHHHHHHHHHHHc
Q 046972 281 NMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT-------SIFNEKSDVYSFGILIMEIVS 353 (483)
Q Consensus 281 Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwSlGv~l~el~t 353 (483)
||+|+|++++.+|.++|+||+.....+..... ...+..|.+||..... -.++.+.|.|+||+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765543222 2345678999976332 237889999999999999999
Q ss_pred CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 046972 354 GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHR 415 (483)
Q Consensus 354 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 415 (483)
|+.||+...+..... . .+. . .. +.++.+..||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~---------~----~f~-~----C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE---------W----DFS-R----CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG---------G----GGT-T----SS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc---------c----cch-h----cC-CcCHHHHHHHHHHccCCcccC
Confidence 999998654432100 0 011 1 11 344788999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=197.93 Aligned_cols=209 Identities=21% Similarity=0.305 Sum_probs=148.5
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.+|...++|..|+||.||.++++. .+++|.|+ .++.. +++- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-------------------
Confidence 567788999999999999998764 45667743 22211 1111 33333444444
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC--
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE-- 309 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~-- 309 (483)
||-...++ ..++++.. ++.+++|||+. +|+|||+||+|.||+.-|++|++|||+++.....
T Consensus 136 --gDc~tllk----~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLK----NIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcc----cCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 56666664 33344432 27799999998 9999999999999999999999999998743111
Q ss_pred ------------ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh
Q 046972 310 ------------WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 310 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
........+||+.|.|||++...+ |+..+|+|++|+|+||.+.|..||.+..+++.+...+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-- 275 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-- 275 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc--
Confidence 011123358999999999998777 99999999999999999999999999988776654443211
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM 418 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 418 (483)
..++. ......+..+++.+.|+.+|..|--.
T Consensus 276 ---------~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 276 ---------EWPEE-DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred ---------ccccc-CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11111 11222578888889999999999533
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=169.42 Aligned_cols=141 Identities=17% Similarity=0.181 Sum_probs=110.9
Q ss_pred CCcccceeccCCceEEEEEE--EcCCcEEEEEEecCCCcc------------------------hHHHHHHHHHHHhcCC
Q 046972 154 GFAEQNVIASGDNGVVYRAV--LLDNMRAAVKLLMSNSVS------------------------EEEDFIEKVEAIGQVK 207 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 207 (483)
.|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38889999999999999998 568999999998754211 0123568999999997
Q ss_pred CCc--ccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC-eeeecCCC
Q 046972 208 HKN--LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK-IVHHNMKS 284 (483)
Q Consensus 208 hpn--Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-iiHrDlkp 284 (483)
+.+ +.+++++ ...++||||++|++|..+.. ....+....+..++.||+.++.+||.. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 532 3333432 23589999999988877652 223456667789999999999999999 9 99999999
Q ss_pred CcEEEcCCCCcEEeeccccccc
Q 046972 285 SNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 285 ~NiLl~~~~~~kl~DFGla~~~ 306 (483)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998744
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=191.96 Aligned_cols=199 Identities=17% Similarity=0.163 Sum_probs=156.6
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC---CCcccccccEEEeCC
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK---HKNLVKLFGYCVEGQ 222 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~ 222 (483)
.+.++-.+.|.+.+.||+|+||.||+|...+++.||+|+=.+....+- ---.+++.+|+ -+.|..+..+..-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 345566788999999999999999999988899999999877655432 22223333343 234555666666667
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-------CCCc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-------HWNP 295 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-------~~~~ 295 (483)
.-++|+||.+.|+|.+++. ..+.++|..++.++.|++.-+++||.. +|||+||||+|+||.. ...+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 7789999999999999995 567789999999999999999999999 9999999999999943 3458
Q ss_pred EEeecccccccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC
Q 046972 296 KISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355 (483)
Q Consensus 296 kl~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~ 355 (483)
+|+|||.+-.+..-. ........+|-.+-++|...+.+ ++..+|.|.|+.+++-|+.|+
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 999999986432111 12333446777888999886655 999999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=163.31 Aligned_cols=134 Identities=19% Similarity=0.344 Sum_probs=113.3
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcch--------HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE--------EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.||+|++|.||+|.+ .+..+++|+........ ...+.+|++++..+.|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 66678889865433211 13578899999999999998888887778888999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
++|++|.+++... .. .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998521 11 7788999999999999999 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=158.89 Aligned_cols=137 Identities=19% Similarity=0.146 Sum_probs=109.2
Q ss_pred CCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc----------------------hHHHHHHHHHHHhcCCCCc-
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS----------------------EEEDFIEKVEAIGQVKHKN- 210 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hpn- 210 (483)
.|.+.+.||.|+||.||+|...+++.+|||++...... ....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 38888999999999999999888999999987643210 0123677888898887774
Q ss_pred -ccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE
Q 046972 211 -LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL 289 (483)
Q Consensus 211 -Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl 289 (483)
++..++ ....++||||++|++|..... . .....++.+++.++.++|+. +++||||||.||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 245689999999999977542 0 23467889999999999998 99999999999999
Q ss_pred cCCCCcEEeecccccccC
Q 046972 290 DHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 290 ~~~~~~kl~DFGla~~~~ 307 (483)
+.++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=182.20 Aligned_cols=137 Identities=18% Similarity=0.251 Sum_probs=112.0
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc-------chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV-------SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..|...+.||+|+||+||+|.+.+...++.+.+..... ...+.+.+|++++..++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 44566789999999999999976654443333322111 11246889999999999999998888887777889
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||++|++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999884 3467899999999999999 99999999999999 577899999999974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=158.69 Aligned_cols=130 Identities=22% Similarity=0.374 Sum_probs=106.8
Q ss_pred eeccCCceEEEEEEEcCCcEEEEEEecCCCcc--------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.||+|+||.||+|.+ ++..+++|........ ....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 5678888886543211 1245778999999999887766666666677789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|++|.+++... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988421 11 7889999999999999 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=178.66 Aligned_cols=174 Identities=18% Similarity=0.304 Sum_probs=130.7
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
.+|+.|++|.-.+|.+||.++ ......++.....++.|++.|++| + +.+|||+||.||....+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999654 234456777889999999999999 6 999999999999999999999999999
Q ss_pred ccccCCCc-----cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHH
Q 046972 303 AKLHGPEW-----SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 303 a~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
........ ....+...||..||+||.+.+. .|+.++||||||++|+|+++ -..+|..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er---------------- 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFER---------------- 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHH----------------
Confidence 87654433 2344556899999999999544 49999999999999999998 3333321
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ei 421 (483)
..-+..+-+..+|+....+.+ .-..|+.+++...|.+||++.+.
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 112222334444432222222 33567779999999999955443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-18 Score=182.20 Aligned_cols=261 Identities=19% Similarity=0.228 Sum_probs=191.4
Q ss_pred cCCcccceeccCCceEEEEEEEcC--CcEEEEEEecCCC--cchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD--NMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 227 (483)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346667779999999998887533 4445666664443 122233445777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH-EDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKL 305 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~ 305 (483)
+||..||++.+.+.. ......+...+-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998831 12224555677788999999999999 87 999999999999999999 999999999987
Q ss_pred cCC--Ccccccccccc-CcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhH-HHHHHHHHHhhhhh
Q 046972 306 HGP--EWSISTSCELR-NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL-IDWLKSMVAQQKIA 381 (483)
Q Consensus 306 ~~~--~~~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~ 381 (483)
+.. ..........| ++.|+|||...+........|+||.|+++.-+++|..|+......... ..|...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-------- 246 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-------- 246 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc--------
Confidence 654 22223333466 899999999877555788999999999999999999999765443211 111000
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+.........+++.+++..+|..|.+.+++-..-+...
T Consensus 247 ---~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 ---KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 001111223333356777788999999999999999877655443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.2e-17 Score=145.79 Aligned_cols=135 Identities=21% Similarity=0.236 Sum_probs=96.6
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchH--HHH----------------------HHHHHHHhcCCCCc--c
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDF----------------------IEKVEAIGQVKHKN--L 211 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~--~~~----------------------~~E~~~l~~l~hpn--I 211 (483)
.+.||+|+||+||+|...+++.||||++........ ..+ ..|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987899999999875432111 111 24555555554332 3
Q ss_pred cccccEEEeCCeEEEEEEecCCCCHHHH-HhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEE
Q 046972 212 VKLFGYCVEGQNRILVYEYIDNGNLQQW-LHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILL 289 (483)
Q Consensus 212 v~~~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl 289 (483)
.+.+++ ...++||||++++++... +... ... ..+..++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 245899999999543321 1110 011 5678899999999999999 7 99999999999999
Q ss_pred cCCCCcEEeeccccccc
Q 046972 290 DHHWNPKISDVGLAKLH 306 (483)
Q Consensus 290 ~~~~~~kl~DFGla~~~ 306 (483)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=148.06 Aligned_cols=135 Identities=17% Similarity=0.209 Sum_probs=104.4
Q ss_pred cceec-cCCceEEEEEEEcCCcEEEEEEecCCC-------------cchHHHHHHHHHHHhcCCCCcc--cccccEEEeC
Q 046972 158 QNVIA-SGDNGVVYRAVLLDNMRAAVKLLMSNS-------------VSEEEDFIEKVEAIGQVKHKNL--VKLFGYCVEG 221 (483)
Q Consensus 158 ~~~lg-~G~fg~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~ 221 (483)
...|| .||.|+||.+... +..+++|.+.... ......+.+|++++..|+|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999998874 6678888774321 1123467889999999998775 6677765432
Q ss_pred C----eEEEEEEecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 222 Q----NRILVYEYIDN-GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 222 ~----~~~lv~E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
. ..++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||++ ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 699999842 234543 357899999999999 999999999999999998999
Q ss_pred Eeecccccc
Q 046972 297 ISDVGLAKL 305 (483)
Q Consensus 297 l~DFGla~~ 305 (483)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=136.95 Aligned_cols=135 Identities=20% Similarity=0.159 Sum_probs=112.9
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC--CcccccccEEEeCCeEEEEEEecCCC
Q 046972 157 EQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH--KNLVKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~E~~~~g 234 (483)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999755 6889998865533 5678899999999976 58999998888778899999999987
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 235 NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 235 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
.+..+ +......++.+++.+|.+||.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4456677889999999999985334799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.1e-15 Score=149.46 Aligned_cols=250 Identities=18% Similarity=0.162 Sum_probs=184.0
Q ss_pred HHhcCCcccceecc--CCceEEEEEEE---cCCcEEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCcccccccEEEeC
Q 046972 150 IVTDGFAEQNVIAS--GDNGVVYRAVL---LDNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEG 221 (483)
Q Consensus 150 ~~~~~~~~~~~lg~--G~fg~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 221 (483)
...+.+.+...+|. |.+|.||.+.. .++..+|+|.-+.. .......=.+|+...+.+ .|+|.|+.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34455777888999 99999999885 35777888874332 223333446677777777 499999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH----HHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcE
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK----GLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPK 296 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~k 296 (483)
+..++-+|+|. .+|..+... ....++...++..+.+... ||.++|+. +++|-|+||.||+...+ ..++
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred Ccceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence 99999999995 689888863 3344777888888999988 99999999 99999999999999999 8899
Q ss_pred EeecccccccCCCccc----cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC--CchhhHHHH
Q 046972 297 ISDVGLAKLHGPEWSI----STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYS--QPQVFLIDW 370 (483)
Q Consensus 297 l~DFGla~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~--~~~~~~~~~ 370 (483)
++|||+...++...-. ......+...|++||...+. ++.+.|+|++|.+..+..+|..+.... .....+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-- 339 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-- 339 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--
Confidence 9999999877654311 11222566779999998443 899999999999999999986665433 2111100
Q ss_pred HHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHh
Q 046972 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424 (483)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~ 424 (483)
...++..+-..-...+...+..+++.+|..|++++.+...
T Consensus 340 --------------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 340 --------------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --------------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0011211111222455557889999999999999887753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=147.46 Aligned_cols=142 Identities=20% Similarity=0.193 Sum_probs=99.7
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchH----------------------------------------HHHH
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE----------------------------------------EDFI 197 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 197 (483)
.+.||.|++|.||+|++.+|+.||||+..+...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999866421110 0244
Q ss_pred HHHHHHhcC----CCCcccccccEE-EeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH-HHHHhhh
Q 046972 198 EKVEAIGQV----KHKNLVKLFGYC-VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK-GLAYLHE 271 (483)
Q Consensus 198 ~E~~~l~~l----~hpnIv~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~ 271 (483)
+|++.+.++ +|.+-+.+-.++ ......++||||++|++|.++.... ..... ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHh
Confidence 555555554 222222222222 2234568999999999999886421 11122 3345666655 4778898
Q ss_pred CCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 272 ~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
. |++|+|+||.||+++.++.++++|||++..++.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5e-14 Score=131.07 Aligned_cols=206 Identities=23% Similarity=0.305 Sum_probs=141.2
Q ss_pred HHhcCCCCcccccccEEEeC-----CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 046972 202 AIGQVKHKNLVKLFGYCVEG-----QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276 (483)
Q Consensus 202 ~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 276 (483)
-|-++-|.|||+++.|+.+. .+..+++|||..|+|..+|++.......+....-.+++.||+.||.|||+ +.|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 34455799999999998754 34688999999999999998766667778888888999999999999999 6889
Q ss_pred eeeecCCCCcEEEcCCCCcEEeecccccc---cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc
Q 046972 277 IVHHNMKSSNILLDHHWNPKISDVGLAKL---HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS 353 (483)
Q Consensus 277 iiHrDlkp~NiLl~~~~~~kl~DFGla~~---~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t 353 (483)
|+|+++..+-|++..+|-+|+.----... .............+.++|.+||.-... ..+.++|||+||+...||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888742111000 000111122233456789999975433 36789999999999999998
Q ss_pred CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 354 GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 354 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+..--..........+-. ...+...-++. =..++.+|++-.|..||++.+++.+..
T Consensus 278 lEiq~tnseS~~~~ee~i-----a~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENI-----ANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred heeccCCCcceeehhhhh-----hhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcCce
Confidence 764322211111000000 00011111111 123455899999999999999886653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-14 Score=146.13 Aligned_cols=147 Identities=18% Similarity=0.161 Sum_probs=95.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcch----------------------------------HH-
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSE----------------------------------EE- 194 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~- 194 (483)
....|.. +.||.|++|.||+|++++ |+.||||+..+.-... .+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3455776 789999999999999887 9999999997652110 01
Q ss_pred -----HHHHHHHHHhcC----CCCcccccccEEEe-CCeEEEEEEecCCCCHHHH--HhcccCCCCCCCHHHHHHHHHHH
Q 046972 195 -----DFIEKVEAIGQV----KHKNLVKLFGYCVE-GQNRILVYEYIDNGNLQQW--LHGSLGEAKPLTWDTRMKIIQGT 262 (483)
Q Consensus 195 -----~~~~E~~~l~~l----~hpnIv~~~~~~~~-~~~~~lv~E~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~i 262 (483)
+|.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.|.++ +.........+....+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 133444433333 13333333233322 3456799999999999875 32111111123334444444444
Q ss_pred HHHHHHhhhCCCCCeeeecCCCCcEEEcCCC----CcEEeecccccccCC
Q 046972 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHW----NPKISDVGLAKLHGP 308 (483)
Q Consensus 263 ~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DFGla~~~~~ 308 (483)
. .. |++|+|+||.||+++.++ .++++|||+...++.
T Consensus 277 f-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 35 999999999999999988 899999999876644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1e-12 Score=116.81 Aligned_cols=130 Identities=18% Similarity=0.178 Sum_probs=95.1
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCccc-ccccEEEeCCeEEEEEEecCCCCH
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLV-KLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
.+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.+++ +++++. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999874 67899998755432 223467889888888655544 444443 3345899999999877
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI--EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
...- . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5420 0 11345678999999999971 11259999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.3e-13 Score=135.03 Aligned_cols=250 Identities=17% Similarity=0.174 Sum_probs=180.4
Q ss_pred HHHhcCCcccceeccCCceEEEEEEE--cCCcEEEEEEecCCCcchH--HHHHHHHHHHhcC-CCCcccccccEEEeCCe
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVL--LDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQV-KHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 223 (483)
.....+|.+...||.|.|+.|+.... .++..+++|.+........ ..-+.|+-+...+ .|.+++.+...+..-.+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34556788899999999999998874 3577889998876643332 2235677776666 48999998888877778
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeeccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGL 302 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFGl 302 (483)
.++--|||.++++...+. ....+.+...+.+..|++.++.++|+. .++|+|+||.||++..+ +..++.|||+
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 889999999999888762 345577778899999999999999998 99999999999999886 7889999999
Q ss_pred ccccCCCccccccccccCcccc-cccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYL-AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+..+... ... ....-+++ ..|.+.....+..+.|++|||..+.|.++|...-..... ..
T Consensus 414 ~t~~~~~---~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------------~~ 473 (524)
T KOG0601|consen 414 WTRLAFS---SGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------------SL 473 (524)
T ss_pred cccccee---ccc-ccccccccccchhhccccccccccccccccccccccccCcccCccccc----------------ce
Confidence 8643211 111 12223344 355555665688999999999999999998643321111 11
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+....++..+.. ...+..+...+...++..||.+.++..+...
T Consensus 474 ~i~~~~~p~~~~~--~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 TIRSGDTPNLPGL--KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeecccccCCCch--HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111222222221 1566677778999999999999988876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.5e-11 Score=121.75 Aligned_cols=166 Identities=17% Similarity=0.166 Sum_probs=123.9
Q ss_pred EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHH
Q 046972 174 LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253 (483)
Q Consensus 174 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~ 253 (483)
..++..|.|...............+-++.|+.++||||+++++.+...+..|+|+|-+. -|..+++. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 44677787777765544333456778889999999999999999999999999999874 67777742 2255
Q ss_pred HHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCC
Q 046972 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS 333 (483)
Q Consensus 254 ~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 333 (483)
.+..-+.||+.||.|||..+ +++|++|.-..|+|+..|..||++|-++........ ..........|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 66677899999999999664 999999999999999999999999988754322110 001111122356676653322
Q ss_pred CCCcchhhHHHHHHHHHHHcC
Q 046972 334 IFNEKSDVYSFGILIMEIVSG 354 (483)
Q Consensus 334 ~~~~~~DvwSlGv~l~el~tg 354 (483)
-..|.|-|||++||++.|
T Consensus 182 ---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 ---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cchhhhhHHHHHHHHhCc
Confidence 357999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.8e-11 Score=110.00 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=97.9
Q ss_pred cceeccCCceEEEEEEEcC-------CcEEEEEEecCCCc--ch--------------------HHH----HHHHHHHHh
Q 046972 158 QNVIASGDNGVVYRAVLLD-------NMRAAVKLLMSNSV--SE--------------------EED----FIEKVEAIG 204 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~--~~--------------------~~~----~~~E~~~l~ 204 (483)
...||.|-=+.||.|...+ +..+|||+...... .. ... ..+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998543 47899998843210 00 112 237899998
Q ss_pred cCC--CCcccccccEEEeCCeEEEEEEecCCCCHHH-HHhcccCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCCeeee
Q 046972 205 QVK--HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQ-WLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL-HEDIEPKIVHH 280 (483)
Q Consensus 205 ~l~--hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHr 280 (483)
++. .-++...+++ ...++||||+.++.+.. .++ ...++..+...+..+++.+|..| |.. ++||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 884 3456666654 45689999997654432 222 22345556777889999999999 888 99999
Q ss_pred cCCCCcEEEcCCCCcEEeeccccccc
Q 046972 281 NMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 281 Dlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||++.|||+++ +.+.|+|||.+...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999974 67999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.3e-13 Score=140.58 Aligned_cols=246 Identities=19% Similarity=0.211 Sum_probs=168.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+.+.+.+-+..|.|+.++.+.-. .+...+.|+.... .....+....+-.++-..+||.++...-.+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 45566667888999988877622 2322333332211 1111122233333333345688887766666778899999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
+|..+++|...|+.. ...+..-+......+..+++|||.. .+.|||++|.|.|...++..+++|||.....+-
T Consensus 884 ~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999643 3456566677778889999999997 799999999999999999999999984432110
Q ss_pred ---------------------C---------ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 046972 309 ---------------------E---------WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358 (483)
Q Consensus 309 ---------------------~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf 358 (483)
. .........+|+.|.+||...+.. ....+|+|++|++++|.++|..||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 001123347889999999987665 678899999999999999999999
Q ss_pred CCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046972 359 DYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM-PSRKELKRIILIALRCVDPDIKHRPKMG 419 (483)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 419 (483)
....++..+..+ .....++. -+........+++.+.+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni-------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENI-------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhcc-------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 887775543221 11111111 1122335677888899999999998776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.8e-11 Score=109.79 Aligned_cols=142 Identities=19% Similarity=0.262 Sum_probs=108.4
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCC--CcccccccEEEeC---CeEEEEEEecC
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKH--KNLVKLFGYCVEG---QNRILVYEYID 232 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~---~~~~lv~E~~~ 232 (483)
+.|+.|.++.||++...+|..+++|....... .....+..|++++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987768899999765432 134568899999999865 4456677766553 25689999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------------
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI--------------------------------------- 273 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 273 (483)
|.+|.+.+. ...++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 988877542 134677777788888888888888521
Q ss_pred --------------CCCeeeecCCCCcEEEcC--CCCcEEeecccccc
Q 046972 274 --------------EPKIVHHNMKSSNILLDH--HWNPKISDVGLAKL 305 (483)
Q Consensus 274 --------------~~~iiHrDlkp~NiLl~~--~~~~kl~DFGla~~ 305 (483)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.5e-10 Score=99.27 Aligned_cols=129 Identities=23% Similarity=0.356 Sum_probs=97.8
Q ss_pred eeccCCceEEEEEEEcCCcEEEEEEecCCCcch--------HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE--------EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.+++|+=+.+|.+.+.+.. +++|.-.++.... .....+|+++++++.--.|..-+=+..+.+...|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775544 5555543332211 135678999999886544444444556777888999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+|-.|.+++... ...++..+-.-+.-||.+ ||+|+||.++||++..+. +.++|||++.
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999999532 145667777788899999 999999999999998875 9999999986
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.8e-10 Score=97.65 Aligned_cols=142 Identities=17% Similarity=0.269 Sum_probs=102.1
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
...+-+|+=+.|+++.+. |+.++||.-...... ...+..+|+++|.++.--.|..-.=++.+...-+|+||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 567889999999999884 555555543322111 12567889999998864444433345566667789999
Q ss_pred ecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEeecccccc
Q 046972 230 YIDN-GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKISDVGLAKL 305 (483)
Q Consensus 230 ~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DFGla~~ 305 (483)
|++| .++.+++..... . .....-...++..|-+.+.-||.+ +|||+||..+||++..++. +.+.|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~-~-~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME-D-ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHcc-C-cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 588899865422 1 122223367889999999999999 9999999999999976654 58999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.4e-09 Score=105.08 Aligned_cols=217 Identities=15% Similarity=0.197 Sum_probs=150.0
Q ss_pred ceEEEEEE-EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEE----eCCeEEEEEEecCC-CCHHHH
Q 046972 166 NGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV----EGQNRILVYEYIDN-GNLQQW 239 (483)
Q Consensus 166 fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~E~~~~-g~L~~~ 239 (483)
-.+.|++. ..+|..+++|++.............-++.++++.|+|||++.+++. .+..+++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35889998 5688899999994433323223345577889999999999999887 34567999999986 688877
Q ss_pred Hhcc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 240 LHGS-----------LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 240 l~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
-... ...+...++..+|.++.|+..||.++|+. |+.-+-|.|.+||++.+.+++|...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5321 12345578899999999999999999999 999999999999999999999988777654433
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhH-HHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL-IDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 387 (483)
+. + +.+.. -.+-|.=.||.+++.|.||..--...+..... .+.+
T Consensus 446 d~--------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------------- 490 (655)
T KOG3741|consen 446 DP--------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------------- 490 (655)
T ss_pred CC--------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh----------------
Confidence 21 0 11111 23568999999999999986432111111110 1100
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....+.++.+++.-....++.+ -++.+++.+.-
T Consensus 491 -----~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 491 -----TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred -----hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 1122345666666666677765 66777776553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.4e-09 Score=98.00 Aligned_cols=140 Identities=14% Similarity=0.111 Sum_probs=99.1
Q ss_pred eeccCCceEEEEEEEcCCcEEEEEEecCCCcch-----------HHHHHHHHHHHhcCCCC--cccccccEEEe-----C
Q 046972 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE-----------EEDFIEKVEAIGQVKHK--NLVKLFGYCVE-----G 221 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hp--nIv~~~~~~~~-----~ 221 (483)
.+-......|+++.+ +|+.+.||......... ...+.+|...+..|..- .++..+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344344455677665 66789999774433111 11477898888887432 23344455443 2
Q ss_pred CeEEEEEEecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-------CC
Q 046972 222 QNRILVYEYIDNG-NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-------HW 293 (483)
Q Consensus 222 ~~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-------~~ 293 (483)
...++|||++++. +|.+++.... ..+.+......++.+++..+.-||.. ||+|+|+++.|||++. ++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3568999999886 8999985321 23456677789999999999999999 9999999999999975 46
Q ss_pred CcEEeecccccc
Q 046972 294 NPKISDVGLAKL 305 (483)
Q Consensus 294 ~~kl~DFGla~~ 305 (483)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.5e-09 Score=94.24 Aligned_cols=125 Identities=23% Similarity=0.299 Sum_probs=82.0
Q ss_pred EEEEEEEcCCcEEEEEEecCCCc--ch------------------------HHHHHHHHHHHhcCCCC--cccccccEEE
Q 046972 168 VVYRAVLLDNMRAAVKLLMSNSV--SE------------------------EEDFIEKVEAIGQVKHK--NLVKLFGYCV 219 (483)
Q Consensus 168 ~V~~~~~~~~~~vavK~~~~~~~--~~------------------------~~~~~~E~~~l~~l~hp--nIv~~~~~~~ 219 (483)
.||.|...++..+|+|....... .. .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998854211 10 12467899999999754 566666442
Q ss_pred eCCeEEEEEEecC--CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 220 EGQNRILVYEYID--NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY-LHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 220 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. ||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 65554443211 1123456677788886665 5687 99999999999999988 999
Q ss_pred Eeeccccccc
Q 046972 297 ISDVGLAKLH 306 (483)
Q Consensus 297 l~DFGla~~~ 306 (483)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.4e-08 Score=95.81 Aligned_cols=269 Identities=13% Similarity=0.137 Sum_probs=161.7
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEE------EeCC-eEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYC------VEGQ-NRILV 227 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~------~~~~-~~~lv 227 (483)
...+.||+|+-+.+|-.--- ...+.|+..........+. +..|... .||-+-.=+.|= -+++ ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34677999999999854311 1234566655544333322 3333333 466443311111 1222 25677
Q ss_pred EEecCCC-CHHHHHh--cccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 228 YEYIDNG-NLQQWLH--GSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 228 ~E~~~~g-~L~~~l~--~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|..+.|- -...+++ .+.....-..|..+++.++.++.+.+-||+. |.+-+|+.++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8877664 2333332 1112344578999999999999999999999 99999999999999999999998743322
Q ss_pred ccCCCccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcC-CCCCCCCC-----chhhHHHHHHHH
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSG-RLPVDYSQ-----PQVFLIDWLKSM 374 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg-~~Pf~~~~-----~~~~~~~~~~~~ 374 (483)
.. .......+.+|...|.+||.-.- +..-+...|-|.|||++++++.| ++||.+.. +.....++....
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 22 12234456788999999997531 11246779999999999999995 99997532 111111111110
Q ss_pred HHh-hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHhccccchhhhH
Q 046972 375 VAQ-QKIAYVLDPKLPEMPSRKELKRIILIALRCVDP--DIKHRPKMGDVLRMLEPRDLLLRE 434 (483)
Q Consensus 375 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rpt~~eil~~L~~~~~~~~~ 434 (483)
... .+-..-..+.-...+..-.+..+..+..+|+.. ++.-|||++..+..|......+.+
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 000 000000111111112223345677777789876 367899999999888665544443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-09 Score=111.56 Aligned_cols=159 Identities=21% Similarity=0.167 Sum_probs=107.1
Q ss_pred HHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-------c-cccccccCcccccccccCC
Q 046972 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-------I-STSCELRNSGYLAEELSGR 331 (483)
Q Consensus 260 ~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-------~-~~~~~~~~~~y~aPE~~~~ 331 (483)
.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+.+........ . ..........|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999987 5999999999999999999999999998764332111 0 1111234456999999976
Q ss_pred CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCC
Q 046972 332 TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDP 410 (483)
Q Consensus 332 ~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 410 (483)
. ..+.++|+||+||++|.+.. |+.-+........ .. .....+..-....+.+.+.++.+-+.+++..
T Consensus 184 ~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~----------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 T-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YS----------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred c-cccccccceeeeeEEEEEecCCcchhhccCCcch-hh----------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 4 47899999999999999995 5555543322111 00 0001111111112234447888888899999
Q ss_pred CCCCCCCHHHHHHhccccchhh
Q 046972 411 DIKHRPKMGDVLRMLEPRDLLL 432 (483)
Q Consensus 411 dP~~Rpt~~eil~~L~~~~~~~ 432 (483)
++.-||++.++.......+...
T Consensus 252 ~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred CcccCcchhhhhcccccCCchh
Confidence 9999998888876665554433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-08 Score=88.92 Aligned_cols=134 Identities=21% Similarity=0.200 Sum_probs=97.3
Q ss_pred CcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc----------------------hHHHHHHHHHHHhcCCCC--c
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS----------------------EEEDFIEKVEAIGQVKHK--N 210 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp--n 210 (483)
..++..||.|-=+.||.|....|.++|+|.=.....+ ......+|.++|..|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4557889999999999999989999999965322111 112467899999998644 6
Q ss_pred ccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 211 Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
|.+.+++ +...+||||.+|-.|...- +.....-.++..|+.-+.-+-.. ||||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7766664 4568999999986654421 12233344555555555555555 999999999999999
Q ss_pred CCCCcEEeeccccc
Q 046972 291 HHWNPKISDVGLAK 304 (483)
Q Consensus 291 ~~~~~kl~DFGla~ 304 (483)
.+|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.9e-08 Score=87.59 Aligned_cols=105 Identities=18% Similarity=0.230 Sum_probs=81.8
Q ss_pred HHHHHHHHHHhcCC--CCcccccccEEEeC----CeEEEEEEecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 046972 194 EDFIEKVEAIGQVK--HKNLVKLFGYCVEG----QNRILVYEYIDNG-NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266 (483)
Q Consensus 194 ~~~~~E~~~l~~l~--hpnIv~~~~~~~~~----~~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l 266 (483)
..+.+|...+..|. .-.+...+++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 46778888777774 23345555655542 2458999999884 899999632 2256667788999999999
Q ss_pred HHhhhCCCCCeeeecCCCCcEEEcCCC---CcEEeecccccc
Q 046972 267 AYLHEDIEPKIVHHNMKSSNILLDHHW---NPKISDVGLAKL 305 (483)
Q Consensus 267 ~~LH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DFGla~~ 305 (483)
.-||.+ ||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 999999999999999887 789999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.8e-08 Score=98.55 Aligned_cols=142 Identities=20% Similarity=0.211 Sum_probs=91.9
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHH----------------------------------------HHHH
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEE----------------------------------------DFIE 198 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 198 (483)
..|+.++-|.||+|++.+|+.||||+..++-....+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999999765322110 1344
Q ss_pred HHHHHhcCC-----CCcccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 046972 199 KVEAIGQVK-----HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273 (483)
Q Consensus 199 E~~~l~~l~-----hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 273 (483)
|...+.++. .|+|.--.=+..-.+...|+|||++|--+.+...- ....++...+.....++. +..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhc-
Confidence 555444442 23322111122224566899999999888887421 113344333222222222 2222223
Q ss_pred CCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 274 ~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|++|.|..|.||+++.+|++.+.|||+...+.+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.5e-07 Score=80.90 Aligned_cols=138 Identities=13% Similarity=0.111 Sum_probs=101.0
Q ss_pred eccCCceEEEEEEEcCCcEEEEEEecCC---C---cchHHHHHHHHHHHhcCCC--CcccccccEEEe--C--CeEEEEE
Q 046972 161 IASGDNGVVYRAVLLDNMRAAVKLLMSN---S---VSEEEDFIEKVEAIGQVKH--KNLVKLFGYCVE--G--QNRILVY 228 (483)
Q Consensus 161 lg~G~fg~V~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~--~--~~~~lv~ 228 (483)
-|.||.+.|++..+.+. .+-+|.-... + ......|.+|+..|..|.. -.+.+...+... + -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56789999999776444 6888876421 1 2245789999999998853 234444422211 1 2358999
Q ss_pred EecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC--cEEeeccccc
Q 046972 229 EYIDN-GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN--PKISDVGLAK 304 (483)
Q Consensus 229 E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~--~kl~DFGla~ 304 (483)
|-++| -+|.+++... .-.+.+......++.+|+..++-||.. |+.|+|+.+.|||++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 6899998532 223457777889999999999999999 9999999999999986667 8999997665
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.2e-07 Score=91.58 Aligned_cols=141 Identities=18% Similarity=0.170 Sum_probs=91.5
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchH-------------------------------------HHHHHHH
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE-------------------------------------EDFIEKV 200 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~E~ 200 (483)
.+.||.-+.|.||+|+.++|..||||+-++.-.... -+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 367999999999999999999999999866422210 0155555
Q ss_pred HHHhcC----CCCc------ccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 046972 201 EAIGQV----KHKN------LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270 (483)
Q Consensus 201 ~~l~~l----~hpn------Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 270 (483)
+-..++ .|-+ |.+++-.+ .....|+||||+|.-+.|.-.- ....++...+..-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHhc
Confidence 543333 3444 33333322 3467899999999866654310 2234555444433333322222222
Q ss_pred hCCCCCeeeecCCCCcEEEcC----CCCcEEeecccccccCC
Q 046972 271 EDIEPKIVHHNMKSSNILLDH----HWNPKISDVGLAKLHGP 308 (483)
Q Consensus 271 ~~~~~~iiHrDlkp~NiLl~~----~~~~kl~DFGla~~~~~ 308 (483)
|++|+|-.|.||++.. ++.+.+.|||+......
T Consensus 321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999984 67899999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=4e-06 Score=77.99 Aligned_cols=139 Identities=17% Similarity=0.208 Sum_probs=84.7
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc--ccccccEEEeCCeEEEEEEecCCCC-
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN--LVKLFGYCVEGQNRILVYEYIDNGN- 235 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~E~~~~g~- 235 (483)
..||.|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24467788876533 3345688999998885332 4667788777778889999999863
Q ss_pred HHHHH---------------------hcccCCCCCCCHHHHHHHHH----------HHHH-HHHHhhhC-CCCCeeeecC
Q 046972 236 LQQWL---------------------HGSLGEAKPLTWDTRMKIIQ----------GTAK-GLAYLHED-IEPKIVHHNM 282 (483)
Q Consensus 236 L~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------~i~~-~l~~LH~~-~~~~iiHrDl 282 (483)
+...+ +.-......+... ...+.. .+.. ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100011111100 000000 0111 11222211 1336789999
Q ss_pred CCCcEEEcCCCCcEEeeccccc
Q 046972 283 KSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 283 kp~NiLl~~~~~~kl~DFGla~ 304 (483)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.7e-06 Score=74.66 Aligned_cols=139 Identities=13% Similarity=0.199 Sum_probs=92.7
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHH---------HHHHHHHHhcCC---CCccccccc
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEED---------FIEKVEAIGQVK---HKNLVKLFG 216 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---hpnIv~~~~ 216 (483)
++..++|...+++-......|.+-.. +|+.+++|..........+. ..+++..+.++. -...+.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45668888888888877777766655 56788999876654332222 223333333332 222333333
Q ss_pred EEEe-----CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC
Q 046972 217 YCVE-----GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291 (483)
Q Consensus 217 ~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~ 291 (483)
+... ....+|+|||++|-.|.++.. +++ .+...|+.++.-||.. |++|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 3322 234468999999988776542 222 2456677889999999 9999999999999996
Q ss_pred CCCcEEeeccccc
Q 046972 292 HWNPKISDVGLAK 304 (483)
Q Consensus 292 ~~~~kl~DFGla~ 304 (483)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 64 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.6e-08 Score=100.25 Aligned_cols=185 Identities=14% Similarity=0.062 Sum_probs=133.0
Q ss_pred CcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc-ccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN-LVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.....+++|+++.+++.+-...+...++.+... ....-++++|.+++||| .+..++-+..+...+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3344558899999999988555555555555333 34566889999999999 88888888888888999999988
Q ss_pred C-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 234 G-NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 234 g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
| +-..... .....+..-+...+.+.-.+++++||+. .=+||| ||+... +..|..||+....+....
T Consensus 319 ~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 319 GRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 7 2211110 0111222334445566667899999986 568998 887766 578999999987765543
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf 358 (483)
......+++.|+|||+..+.. +..+.|+|++|+-..+|.-|-+|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCC
Confidence 344557899999999886554 889999999999777777776664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.4e-06 Score=76.08 Aligned_cols=144 Identities=19% Similarity=0.227 Sum_probs=95.1
Q ss_pred HhcCCcccce---eccCCceEEEEEEEcCCcEEEEEEecCCCcchHH------------------------HHHHHHHHH
Q 046972 151 VTDGFAEQNV---IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEE------------------------DFIEKVEAI 203 (483)
Q Consensus 151 ~~~~~~~~~~---lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~E~~~l 203 (483)
...+..+... |+.|--..||+|...++..+|+|+.......... ....|+.-|
T Consensus 43 L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL 122 (268)
T COG1718 43 LLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNL 122 (268)
T ss_pred HhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHH
Confidence 3344444444 5556777899999888999999998654222110 134566666
Q ss_pred hcCC--CCcccccccEEEeCCeEEEEEEecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeee
Q 046972 204 GQVK--HKNLVKLFGYCVEGQNRILVYEYIDNG-NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280 (483)
Q Consensus 204 ~~l~--hpnIv~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHr 280 (483)
.++. +-.+.+-+++. +-.|||||+... .-.-.| ..-++...++..+..++++.+.-|-.. .++||+
T Consensus 123 ~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHg 191 (268)
T COG1718 123 KRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHG 191 (268)
T ss_pred HHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccc
Confidence 6663 33444444443 346899998643 111111 122333346778888999999988872 299999
Q ss_pred cCCCCcEEEcCCCCcEEeeccccccc
Q 046972 281 NMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 281 Dlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||..-|||+. ++.+.++|||-|...
T Consensus 192 DLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 192 DLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cchhhheEEE-CCeEEEEECcccccc
Confidence 9999999999 779999999988643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.2e-06 Score=75.71 Aligned_cols=143 Identities=20% Similarity=0.224 Sum_probs=83.6
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCC--cccccccEEEe---CCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK--NLVKLFGYCVE---GQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~---~~~~~lv~E~~~~ 233 (483)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+... ....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999877 58999986544 3456778888888877422 35566665433 3356899999999
Q ss_pred CCHHH----------------HH---hcccCCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhhC
Q 046972 234 GNLQQ----------------WL---HGSLGEAKPLTWDT---------RMKI------------IQGTAK-GLAYLHED 272 (483)
Q Consensus 234 g~L~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~~ 272 (483)
..+.. .+ +.......++.... .... ...+.. .+..++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 11101111111110 0000 111222 23333321
Q ss_pred ----CCCCeeeecCCCCcEEEc-CCCCcEEeeccccc
Q 046972 273 ----IEPKIVHHNMKSSNILLD-HHWNPKISDVGLAK 304 (483)
Q Consensus 273 ----~~~~iiHrDlkp~NiLl~-~~~~~kl~DFGla~ 304 (483)
....++|+|+.|.|||++ .++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 234799999999999999 55556799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.5e-05 Score=75.28 Aligned_cols=141 Identities=15% Similarity=0.137 Sum_probs=84.2
Q ss_pred eeccCCc-eEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEecCCCCHH
Q 046972 160 VIASGDN-GVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYIDNGNLQ 237 (483)
Q Consensus 160 ~lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~ 237 (483)
.|..|.. ..||+.... +..+++|...... ......|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555655 789998764 4678888875443 334667888887773 344567777777666789999999998776
Q ss_pred HHH-------------------hcccCCCCCCCHH--HHHHHHH--------------------HHHHHHHHhhh----C
Q 046972 238 QWL-------------------HGSLGEAKPLTWD--TRMKIIQ--------------------GTAKGLAYLHE----D 272 (483)
Q Consensus 238 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~ 272 (483)
... +.......++... ....-.. .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 1110001111100 0000000 01111222211 1
Q ss_pred CCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 273 ~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13468999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.6e-05 Score=86.42 Aligned_cols=149 Identities=13% Similarity=0.218 Sum_probs=92.6
Q ss_pred cceeccCCceEEEEEEEcCC---cEEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCcc--cccccEEEeC---CeEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLDN---MRAAVKLLMSNS-VSEEEDFIEKVEAIGQVK-HKNL--VKLFGYCVEG---QNRILV 227 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~---~~~~lv 227 (483)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |++| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886554 367777764432 223457889999999995 6665 7778887664 467899
Q ss_pred EEecCCCCHHH--------------------H---HhcccCC-------CCCCC--HHHHHHHH---------------H
Q 046972 228 YEYIDNGNLQQ--------------------W---LHGSLGE-------AKPLT--WDTRMKII---------------Q 260 (483)
Q Consensus 228 ~E~~~~g~L~~--------------------~---l~~~~~~-------~~~l~--~~~~~~i~---------------~ 260 (483)
|||++|..+.+ . |+..... ..+.. ..++..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999864321 1 1111000 01111 11121111 1
Q ss_pred HHHHHHHHhhhCCC--------CCeeeecCCCCcEEEcCC-CC-cEEeeccccccc
Q 046972 261 GTAKGLAYLHEDIE--------PKIVHHNMKSSNILLDHH-WN-PKISDVGLAKLH 306 (483)
Q Consensus 261 ~i~~~l~~LH~~~~--------~~iiHrDlkp~NiLl~~~-~~-~kl~DFGla~~~ 306 (483)
.+...+++|..+.. +.+||+|+++.|||++.+ +. +-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 13334567754332 359999999999999853 33 568999988753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1e-05 Score=72.84 Aligned_cols=104 Identities=19% Similarity=0.230 Sum_probs=81.7
Q ss_pred HHHHHHHhcCCC-CcccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 046972 197 IEKVEAIGQVKH-KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275 (483)
Q Consensus 197 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 275 (483)
..|.-++..+++ +++++++|+| -.++|.||...+++...- .........+|..+.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357778888875 6999999999 236799999877664320 0001223468999999999999999999986544
Q ss_pred CeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 276 ~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
.+.-.|++++|+-+++++++|+.|...+-.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 688899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.5e-05 Score=68.45 Aligned_cols=132 Identities=19% Similarity=0.269 Sum_probs=92.5
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCC----------------cchHHHHHHHHHHHhcCC------CCcccccc
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNS----------------VSEEEDFIEKVEAIGQVK------HKNLVKLF 215 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~~~ 215 (483)
...||.|+.-.||. +.+.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999985 4556667888887665 122345667776555554 88999999
Q ss_pred cEEEeCCeEEEEEEecCC------CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE
Q 046972 216 GYCVEGQNRILVYEYIDN------GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL 289 (483)
Q Consensus 216 ~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl 289 (483)
|+..++.-.-+|+|.+.+ .+|.++++ ...++. ..... +-+-..||-.+ .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999888999998653 36888884 234554 33333 33445677777 99999999999999
Q ss_pred cCCC----CcEEee-cccc
Q 046972 290 DHHW----NPKISD-VGLA 303 (483)
Q Consensus 290 ~~~~----~~kl~D-FGla 303 (483)
.... .+.|+| ||..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 5432 467777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.1e-05 Score=68.80 Aligned_cols=125 Identities=25% Similarity=0.371 Sum_probs=89.7
Q ss_pred cCCcccceeccCCc-eEEEEEEEcCCcEEEEEEecC---CCc------------------chHHHHHHHHHHHhcCC---
Q 046972 153 DGFAEQNVIASGDN-GVVYRAVLLDNMRAAVKLLMS---NSV------------------SEEEDFIEKVEAIGQVK--- 207 (483)
Q Consensus 153 ~~~~~~~~lg~G~f-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 207 (483)
..++..+.||.|.- |.||++.. +|+.+|+|+... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 566999999321 000 01125888998877774
Q ss_pred CCcc--cccccEEEeC------------------CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 046972 208 HKNL--VKLFGYCVEG------------------QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267 (483)
Q Consensus 208 hpnI--v~~~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 267 (483)
+.++ |+++||..-. ....||.||.+... .+.. .-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 5566 9999988422 12357888776532 2222 23456777889
Q ss_pred HhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 268 ~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.+|.. ||+-+|++++|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99998 9999999999986 3589999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=70.62 Aligned_cols=78 Identities=8% Similarity=0.075 Sum_probs=56.6
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC---CcccccccEEEe---CCeEEEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH---KNLVKLFGYCVE---GQNRILVYE 229 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~---~~~~~lv~E 229 (483)
.-.+.||.|..+.||+....++ .+.+|.... ......|..|.+.|+.|.- -.+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3356799999999999876555 466676432 1123578899999888842 367888887754 366899999
Q ss_pred ecCCCCH
Q 046972 230 YIDNGNL 236 (483)
Q Consensus 230 ~~~~g~L 236 (483)
+++|+++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.4e-05 Score=81.65 Aligned_cols=198 Identities=21% Similarity=0.211 Sum_probs=133.2
Q ss_pred HHHHHHHhcCCCCcccccccEEEeCCeE----EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 046972 197 IEKVEAIGQVKHKNLVKLFGYCVEGQNR----ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272 (483)
Q Consensus 197 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~----~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 272 (483)
.-|+..+..+.|+|++.++.|-...... .+..|+|..-++...++ .-..++....+.+..++.+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 4466678888999999999987654333 34567888888888885 456788889999999999999999998
Q ss_pred CCCCeeeecCCCC---cEEEcCCCCcEEe--ecccccccCCCccccccccccCcccccccccCCCC-CCCcchhhHHHHH
Q 046972 273 IEPKIVHHNMKSS---NILLDHHWNPKIS--DVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS-IFNEKSDVYSFGI 346 (483)
Q Consensus 273 ~~~~iiHrDlkp~---NiLl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGv 346 (483)
...|.-+-.. +-..+.++....+ ||+..+.......... ...+..|-++|...... ......|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 6666555554 4445566666766 8888775544322221 23344466777664332 1234469999999
Q ss_pred HHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 347 LIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 347 ~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+..+..|..+-....- .....+.... ..+.+...+|+..++++|+++.+++.+..
T Consensus 381 l~~~~~~~~~i~~~~~~----------------~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV----------------PVSLLDVLST--------SELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHhhhhhcCcccccccc----------------hhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 99999987654321110 0001111110 14566677999999999999999998764
Q ss_pred c
Q 046972 427 P 427 (483)
Q Consensus 427 ~ 427 (483)
.
T Consensus 437 ~ 437 (1351)
T KOG1035|consen 437 L 437 (1351)
T ss_pred c
Confidence 4
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00018 Score=67.37 Aligned_cols=73 Identities=12% Similarity=0.184 Sum_probs=44.3
Q ss_pred ceeccCCce-EEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCC---cccccccEEEeC---CeEEEEEEec
Q 046972 159 NVIASGDNG-VVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK---NLVKLFGYCVEG---QNRILVYEYI 231 (483)
Q Consensus 159 ~~lg~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~---~~~~lv~E~~ 231 (483)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766666 58875 235677764432 2345788899988877421 234444433222 2348899999
Q ss_pred CCCCHH
Q 046972 232 DNGNLQ 237 (483)
Q Consensus 232 ~~g~L~ 237 (483)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00017 Score=62.89 Aligned_cols=127 Identities=18% Similarity=0.240 Sum_probs=86.3
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccc-cccEEEeCCeEEEEEEecCCCC
Q 046972 157 EQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK-LFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
..+.|++|.+|.||+|.+.++ .+|+|+-..++ ....+..|+++|..+.-.++.. ++.+. ..++.|||..|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 356799999999999998655 78888765443 4567889999999887655543 33332 2345699999988
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCC--CcEEEcCCCCcEEeecccccc
Q 046972 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS--SNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 236 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp--~NiLl~~~~~~kl~DFGla~~ 305 (483)
|.++-.. ..-.+ ...++++---|-.. ||-|..|.- .||++.+ +.+.|+||.-|+.
T Consensus 99 L~~~~~~-------~~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG-------GDRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc-------ccHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 8876531 02222 23344554444444 888888864 4555555 4899999998863
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00025 Score=67.38 Aligned_cols=139 Identities=12% Similarity=0.070 Sum_probs=77.6
Q ss_pred eccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcc-cccccEEEeCCeEEEEEEecCCCCHHH-
Q 046972 161 IASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL-VKLFGYCVEGQNRILVYEYIDNGNLQQ- 238 (483)
Q Consensus 161 lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~~g~L~~- 238 (483)
+..|-...+|+.. .++..+++|........-.-+..+|.++++.+....+ .++++.+ . -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 5567788999887 4566788887544322111235678888888753323 3344332 2 368999999866532
Q ss_pred -------------H---HhcccCCCCCCCHHH-HHHHHHHH---------HHHHHHhhhC-----CCCCeeeecCCCCcE
Q 046972 239 -------------W---LHGSLGEAKPLTWDT-RMKIIQGT---------AKGLAYLHED-----IEPKIVHHNMKSSNI 287 (483)
Q Consensus 239 -------------~---l~~~~~~~~~l~~~~-~~~i~~~i---------~~~l~~LH~~-----~~~~iiHrDlkp~Ni 287 (483)
. |+.......+++... ......++ ..-+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 121111112222221 11111111 1112222111 123689999999999
Q ss_pred EEcCCCCcEEeecccccc
Q 046972 288 LLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 288 Ll~~~~~~kl~DFGla~~ 305 (483)
++++++ +.|.||..|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00078 Score=67.65 Aligned_cols=75 Identities=17% Similarity=0.197 Sum_probs=53.5
Q ss_pred ceeccCCceEEEEEEEcCC-cEEEEEEecCC------C-cchHHHHHHHHHHHhcCC---CCcccccccEEEeCCeEEEE
Q 046972 159 NVIASGDNGVVYRAVLLDN-MRAAVKLLMSN------S-VSEEEDFIEKVEAIGQVK---HKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv 227 (483)
+.||.|.+..||++...+| +.++||.-.+. . ....+.+..|.+.|..+. -.++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5699999999999998776 48999985421 1 123456777888887763 2456777776 34557899
Q ss_pred EEecCCCC
Q 046972 228 YEYIDNGN 235 (483)
Q Consensus 228 ~E~~~~g~ 235 (483)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00069 Score=63.38 Aligned_cols=73 Identities=14% Similarity=0.119 Sum_probs=46.4
Q ss_pred ceeccCCceEEEEEEEcC--CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCC-cccccccEEEeCCeEEEEEEecCCCC
Q 046972 159 NVIASGDNGVVYRAVLLD--NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK-NLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
+.|..|-...+|+....+ +..+++|+...... ...+..+|+.++..+... -.+++++.+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999988654 66888887654321 112234688888877433 3344444332 247999999876
Q ss_pred H
Q 046972 236 L 236 (483)
Q Consensus 236 L 236 (483)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0031 Score=61.95 Aligned_cols=142 Identities=15% Similarity=0.169 Sum_probs=75.2
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-----CCCcccccc-c--EEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-----KHKNLVKLF-G--YCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~-~--~~~~~~~~~lv~E~ 230 (483)
+.|+.|....+|+....++ .+++|+.... .......|+.++..| ..|.++.-. | +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999886555 6888887521 122333344444444 233333211 1 12235567899999
Q ss_pred cCCCCHH-----------HHH---hcccC-------CCCCCCH-HHHHH------------HHHH-HHHHHHHhhhC---
Q 046972 231 IDNGNLQ-----------QWL---HGSLG-------EAKPLTW-DTRMK------------IIQG-TAKGLAYLHED--- 272 (483)
Q Consensus 231 ~~~g~L~-----------~~l---~~~~~-------~~~~l~~-~~~~~------------i~~~-i~~~l~~LH~~--- 272 (483)
++|..+. ..| +.... ....+.+ ..... .+.+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9986431 111 11100 0011111 11111 1111 11122333211
Q ss_pred -CCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 273 -IEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 273 -~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
.+.++||+|+.|.|||++.+...-|.||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24589999999999999977556899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0044 Score=60.58 Aligned_cols=144 Identities=15% Similarity=0.146 Sum_probs=80.0
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC--CcccccccE------EEeCCeEEEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH--KNLVKLFGY------CVEGQNRILVYE 229 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~------~~~~~~~~lv~E 229 (483)
.+.++.|.-..+|+....++ .+++|+..... .......|++++..|.. -.+.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34567777789999876545 67788765432 12344556666666532 123344331 122456789999
Q ss_pred ecCCCCHH-----------HH---HhcccCC---C--C---CCCHHHHH------------HHHHHHHHHHHHhhh----
Q 046972 230 YIDNGNLQ-----------QW---LHGSLGE---A--K---PLTWDTRM------------KIIQGTAKGLAYLHE---- 271 (483)
Q Consensus 230 ~~~~g~L~-----------~~---l~~~~~~---~--~---~l~~~~~~------------~i~~~i~~~l~~LH~---- 271 (483)
|++|..+. .. ++..... . . .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99985431 11 1111000 0 0 00111100 011123344555542
Q ss_pred CCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 272 ~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
....+++|+|+.+.|++++.++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 124589999999999999998777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00097 Score=64.77 Aligned_cols=143 Identities=15% Similarity=0.158 Sum_probs=83.3
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCC--cccccccE------EEeCCeEEEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK--NLVKLFGY------CVEGQNRILVYE 229 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~------~~~~~~~~lv~E 229 (483)
.+.|..|....+|+....+ ..+++|+... ........|++++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4557777778999987644 4688888754 2334566677777776422 24444431 233456689999
Q ss_pred ecCCCCHHH-----------HH---hccc---CC----CCCCCHHHHH----------HHHHHHHHHHHHhhh----CCC
Q 046972 230 YIDNGNLQQ-----------WL---HGSL---GE----AKPLTWDTRM----------KIIQGTAKGLAYLHE----DIE 274 (483)
Q Consensus 230 ~~~~g~L~~-----------~l---~~~~---~~----~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~ 274 (483)
|++|..+.. .+ +... .. .....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999866421 11 1100 00 0111111110 011123334455443 123
Q ss_pred CCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 275 ~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
.+++|+|+.|.|||++.++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=4.1e-05 Score=85.39 Aligned_cols=161 Identities=15% Similarity=0.124 Sum_probs=114.5
Q ss_pred HHHHHHHHhcCCCCcccccccEEE--eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 046972 196 FIEKVEAIGQVKHKNLVKLFGYCV--EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273 (483)
Q Consensus 196 ~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 273 (483)
.+.|...++...|++++....=.. ...+.+..++|+.+|++++.|-+...+..++....+.....+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555666678998876655433 234558899999999999999765555555554444444444355555555432
Q ss_pred --CCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHH
Q 046972 274 --EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEI 351 (483)
Q Consensus 274 --~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 351 (483)
..-.+|++||+-|.++..+-.+|++++|+.+...+. ........+++-|+.|+...+-. ++.++|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHH
Confidence 224689999999999999999999999999854433 22233346677788888875544 78889999999999999
Q ss_pred HcCCCCC
Q 046972 352 VSGRLPV 358 (483)
Q Consensus 352 ~tg~~Pf 358 (483)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 9888776
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.00047 Score=65.76 Aligned_cols=132 Identities=14% Similarity=0.098 Sum_probs=91.0
Q ss_pred CcccceeccCCceEEEEEEEcCCcEEEEEEecCC--Ccch--------------------HHHHHHHHHHHhcCC-CC-c
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSN--SVSE--------------------EEDFIEKVEAIGQVK-HK-N 210 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~--------------------~~~~~~E~~~l~~l~-hp-n 210 (483)
+..+++||-|.=+.||.+-..+|++.++|.-... +... +-...+|+..|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 6678899999999999999888888887754221 1100 113467888888874 32 3
Q ss_pred ccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 211 Iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
|.+.+++ ++.++|||++.|-.|...-+ ..... .+...+..-+.-|..+ |+||+|..-=||+++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeee-------cCChH---HHHHHHHHHHHHHHHc---CceecccchheeEEe
Confidence 4555554 46789999999877765331 11122 2333344445556666 999999999999999
Q ss_pred CCCCcEEeecccc
Q 046972 291 HHWNPKISDVGLA 303 (483)
Q Consensus 291 ~~~~~kl~DFGla 303 (483)
+++.++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999744
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00064 Score=68.60 Aligned_cols=49 Identities=16% Similarity=0.301 Sum_probs=39.5
Q ss_pred HHHHHHHHHHHhcCCCCcccccccEEEeC-CeEEEEEEecCCCCHHHHHhc
Q 046972 193 EEDFIEKVEAIGQVKHKNLVKLFGYCVEG-QNRILVYEYIDNGNLQQWLHG 242 (483)
Q Consensus 193 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~g~L~~~l~~ 242 (483)
..+.+....+++.+.|+|+.+++++.... .+..+|+|++ +-+|.+++..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 35677888999999999999999987644 3467899999 5699999853
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0056 Score=59.61 Aligned_cols=140 Identities=17% Similarity=0.232 Sum_probs=95.6
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCC--cchH------------------------HHHHHHHHHHhcCCCCcc
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNS--VSEE------------------------EDFIEKVEAIGQVKHKNL 211 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~------------------------~~~~~E~~~l~~l~hpnI 211 (483)
...|..|--.-||.|.-.+|..+|||+++..- ..++ -....|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45567788889999999999999999885321 1111 123557777777764443
Q ss_pred cccccEEEeCCeEEEEEEecCCCCH-HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 212 VKLFGYCVEGQNRILVYEYIDNGNL-QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 212 v~~~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
..---... ....|||+|+..-.. .-.| ....++...+..+-.|++.-|.-|-+.| ++||.||.--|+|+-
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 32111111 123689999853211 1112 3455777788899999999999998876 899999999999985
Q ss_pred CCCCcEEeecccccccC
Q 046972 291 HHWNPKISDVGLAKLHG 307 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~ 307 (483)
+ |.+.++|.+-+....
T Consensus 300 d-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEHD 315 (520)
T ss_pred C-CEEEEEEccccccCC
Confidence 5 589999998776443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0089 Score=58.23 Aligned_cols=141 Identities=21% Similarity=0.249 Sum_probs=81.2
Q ss_pred ceeccCCceEEEEEEEcC-------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc-ccccccEEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLD-------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN-LVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~E~ 230 (483)
+.+..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+.... ..++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 346666677999988654 4788888865432 22234567877777774322 344555543 2 358999
Q ss_pred cCCCCHHHH-----------------HhcccCC--C---CCCC--HHHHH--------------------------HHHH
Q 046972 231 IDNGNLQQW-----------------LHGSLGE--A---KPLT--WDTRM--------------------------KIIQ 260 (483)
Q Consensus 231 ~~~g~L~~~-----------------l~~~~~~--~---~~l~--~~~~~--------------------------~i~~ 260 (483)
++|..+... ++..... . ...+ +.... .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998766431 1111011 0 0111 11110 0112
Q ss_pred HHHHHHHHhhh------CCCCCeeeecCCCCcEEEcCC----CCcEEeeccccc
Q 046972 261 GTAKGLAYLHE------DIEPKIVHHNMKSSNILLDHH----WNPKISDVGLAK 304 (483)
Q Consensus 261 ~i~~~l~~LH~------~~~~~iiHrDlkp~NiLl~~~----~~~kl~DFGla~ 304 (483)
.+..-+.+|-. .....++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 134578999999999999985 789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.011 Score=56.84 Aligned_cols=75 Identities=17% Similarity=0.269 Sum_probs=47.5
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC---CCCcccccccEEEeCCeEEEEEEecC
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV---KHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
+..+.++.|....+|+.. .+++.+.||.-... ....|..|.+-|+.| .--.+.+.+++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 335678889999999887 67788999987522 234577788777776 34567888998887777899999998
Q ss_pred CC
Q 046972 233 NG 234 (483)
Q Consensus 233 ~g 234 (483)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.02 Score=56.81 Aligned_cols=141 Identities=17% Similarity=0.199 Sum_probs=78.0
Q ss_pred ceeccCCceEEEEEEEcC-----CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcc-cccccEEEeCCeEEEEEEecC
Q 046972 159 NVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL-VKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~ 232 (483)
..|..|-.-.+|++...+ ++.+++|+....... .-+-.+|..+++.+..-++ .++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345457777899987533 357888877554321 1223668888777753333 3455655332 5899998
Q ss_pred CCCHHHH-----------------HhcccCCCC--CCCHHHHHHHHHH-----------------HHHHHHHh----hh-
Q 046972 233 NGNLQQW-----------------LHGSLGEAK--PLTWDTRMKIIQG-----------------TAKGLAYL----HE- 271 (483)
Q Consensus 233 ~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------i~~~l~~L----H~- 271 (483)
+.+|... ++....... ...+.....+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 111100111 1122222222211 11112222 21
Q ss_pred CCCCCeeeecCCCCcEEEcC-CCCcEEeeccccc
Q 046972 272 DIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAK 304 (483)
Q Consensus 272 ~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~ 304 (483)
.....++|+|+++.|||+++ ++.+.++||..|.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11337899999999999986 4679999998775
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.02 Score=54.94 Aligned_cols=31 Identities=26% Similarity=0.382 Sum_probs=25.6
Q ss_pred CCeeeecCCCCcEEEcCCCC-cEEeecccccc
Q 046972 275 PKIVHHNMKSSNILLDHHWN-PKISDVGLAKL 305 (483)
Q Consensus 275 ~~iiHrDlkp~NiLl~~~~~-~kl~DFGla~~ 305 (483)
+.++|+|+.|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 36899999999999997555 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.025 Score=54.99 Aligned_cols=137 Identities=19% Similarity=0.276 Sum_probs=79.6
Q ss_pred eeccCCceEEEEEEEcCCcEEEEEEecC--CCcchHHHHHHHHHHHhcCCC--CcccccccEEEeCC--eEEEEEEecCC
Q 046972 160 VIASGDNGVVYRAVLLDNMRAAVKLLMS--NSVSEEEDFIEKVEAIGQVKH--KNLVKLFGYCVEGQ--NRILVYEYIDN 233 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~--~~~lv~E~~~~ 233 (483)
.+..|..-.+|..... +++++++ ... ..........+|.++++.+.- --+...++.|.++. ..+.||+|++|
T Consensus 32 ~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 32 EISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 3433333344444433 6777777 321 222333566778888887642 23455677777666 66999999998
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHH-HHHHHH-----------------------------------------------
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKII-QGTAKG----------------------------------------------- 265 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~-~~i~~~----------------------------------------------- 265 (483)
..+.+.+.. .... ..++ ..+++.
T Consensus 110 e~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 110 EVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 433222100 0000 0011 122233
Q ss_pred ---HHHhhhCC-----CCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 266 ---LAYLHEDI-----EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 266 ---l~~LH~~~-----~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
..+|+.+. .+.++|+|+.+.|++++++.-+=+.||+++..-.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 33444332 2368999999999999999889999999987543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.043 Score=53.60 Aligned_cols=29 Identities=21% Similarity=0.261 Sum_probs=25.4
Q ss_pred CCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 275 ~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999988 578899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.016 Score=52.64 Aligned_cols=151 Identities=14% Similarity=0.125 Sum_probs=91.3
Q ss_pred CCceEEEEEEEcCCcEEEEEEecC-CCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhc
Q 046972 164 GDNGVVYRAVLLDNMRAAVKLLMS-NSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHG 242 (483)
Q Consensus 164 G~fg~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 242 (483)
|+..+.-.+..+-| ...+|++.. +..-...-|..+.+++++++ .|+++..- +.-..-++.|+|...
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 34455555543334 344555543 33324566788899999886 46666632 344567899998531
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcc
Q 046972 243 SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322 (483)
Q Consensus 243 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 322 (483)
+... ..++..=+++|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+..-. . +.-
T Consensus 140 -----~i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-----------~V~ 196 (308)
T PF07387_consen 140 -----KINF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-----------QVN 196 (308)
T ss_pred -----ccch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h-----------eee
Confidence 1111 11111124677788853 35899999999999999999999999775421 0 111
Q ss_pred cccccccCCCCCCCcchhhHHHHHHHHHHHcC
Q 046972 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSG 354 (483)
Q Consensus 323 y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg 354 (483)
|.--|+. . .+.++.+-+|=.-++++...
T Consensus 197 ~vN~~Y~--~--lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 197 MVNIEYE--S--LTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred EEeeecc--c--cChHHHHHHHHHHHHHHHHH
Confidence 3332222 1 46677777777777777653
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.084 Score=53.12 Aligned_cols=80 Identities=13% Similarity=0.132 Sum_probs=51.7
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCc-------chHHHHHHHHHHHhcCC---CCcccccccEEEeCCeEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV-------SEEEDFIEKVEAIGQVK---HKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv 227 (483)
.+.||.|..-.||+.... ++.++||.-..... ....+-..|.+.|+.+. -.++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998864 55688887652111 12233344466665553 247888888876 446789
Q ss_pred EEecCC--CCHHHHH
Q 046972 228 YEYIDN--GNLQQWL 240 (483)
Q Consensus 228 ~E~~~~--g~L~~~l 240 (483)
|||+++ ..|.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3454443
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.004 Score=50.95 Aligned_cols=30 Identities=27% Similarity=0.197 Sum_probs=12.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 046972 23 LIVTLTLLFLLIFIAILFLYIFIFHRRKKS 52 (483)
Q Consensus 23 ~i~~~~~~~~~i~l~~~~~~~~~~~rrk~~ 52 (483)
+++|++++++.++++|++++|+++|+|||.
T Consensus 66 i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~ 95 (122)
T PF01102_consen 66 IIGIIFGVMAGVIGIILLISYCIRRLRKKS 95 (122)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 333333344444444444555555555553
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.054 Score=53.48 Aligned_cols=79 Identities=14% Similarity=0.130 Sum_probs=49.4
Q ss_pred eeccCCceEEEEEEEcCC-cEEEEEEecCC------C-cchHHHHHHHHHHHhcCC--CC-cccccccEEEeCCeEEEEE
Q 046972 160 VIASGDNGVVYRAVLLDN-MRAAVKLLMSN------S-VSEEEDFIEKVEAIGQVK--HK-NLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv~ 228 (483)
.||.|....||++...++ +.++||.-.+- + .-...+..-|.+.|.... -| .+.+++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999997654 57888875421 1 122244556777776653 34 44445443 345556899
Q ss_pred EecCC-CCHHHHH
Q 046972 229 EYIDN-GNLQQWL 240 (483)
Q Consensus 229 E~~~~-g~L~~~l 240 (483)
|+++. ..|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99854 3454544
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.087 Score=51.73 Aligned_cols=137 Identities=18% Similarity=0.245 Sum_probs=78.4
Q ss_pred CceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC---CCc---cccccc----EEEeCCeEEEEEEecCCC
Q 046972 165 DNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK---HKN---LVKLFG----YCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 165 ~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpn---Iv~~~~----~~~~~~~~~lv~E~~~~g 234 (483)
.-..+|+....+++. ++|+.... ....+...|+..+..|. .+- |...=| ....+...+-|++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345789888777765 88887665 34455666666666652 221 222212 111223677899999998
Q ss_pred CHHH------------HH---hc----cc----CCCCCCCHHH-------------HHHHHHHHHHHHHHhhhCC----C
Q 046972 235 NLQQ------------WL---HG----SL----GEAKPLTWDT-------------RMKIIQGTAKGLAYLHEDI----E 274 (483)
Q Consensus 235 ~L~~------------~l---~~----~~----~~~~~l~~~~-------------~~~i~~~i~~~l~~LH~~~----~ 274 (483)
.+.. ++ +. .. .......|.. ......++...+..+.+.. .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7772 11 11 10 0011122320 0112334444455444332 2
Q ss_pred CC---eeeecCCCCcEEEcCCCC-cEEeeccccc
Q 046972 275 PK---IVHHNMKSSNILLDHHWN-PKISDVGLAK 304 (483)
Q Consensus 275 ~~---iiHrDlkp~NiLl~~~~~-~kl~DFGla~ 304 (483)
.. +||+|+.|.||+++.+.. +.+.|||-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999999875 8899999764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.47 Score=46.71 Aligned_cols=70 Identities=13% Similarity=0.069 Sum_probs=43.0
Q ss_pred CceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC--Cccccc---cc--EEEeCCeEEEEEEecCCCC
Q 046972 165 DNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH--KNLVKL---FG--YCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 165 ~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~---~~--~~~~~~~~~lv~E~~~~g~ 235 (483)
.-..||+....++..+++|+..... ....+...|++.+..|.. -.++.. -| ...-++..+.|+++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3457999888778889999875332 234556667777666521 112221 22 2233456788999998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.13 Score=47.11 Aligned_cols=75 Identities=17% Similarity=0.214 Sum_probs=50.5
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC---CCCcccccccEEEeCCeEEEEEEecCCCC
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV---KHKNLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
+.+.-|.--..|... .+..++-||+-. ......|..|+.-|..| +.-+|.+++.+-.+.++.|+||||++-|.
T Consensus 22 ~~v~gG~inea~~v~-dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLR-DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEee-cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 345445444445443 356778888732 22345677787666555 45678888888889999999999999865
Q ss_pred HH
Q 046972 236 LQ 237 (483)
Q Consensus 236 L~ 237 (483)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.06 Score=53.41 Aligned_cols=61 Identities=20% Similarity=0.240 Sum_probs=41.4
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCCCCeeeecCCCCcEEEcCC
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY-LHEDIEPKIVHHNMKSSNILLDHH 292 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiHrDlkp~NiLl~~~ 292 (483)
..|+=+|+.|-++..+++ ....++.....++.--+.|+-- |--. +.+|.|+.|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEEec
Confidence 356677899999999984 2334555555555555555432 2223 89999999999999543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.066 Score=53.59 Aligned_cols=81 Identities=15% Similarity=0.120 Sum_probs=51.2
Q ss_pred cceeccCCceEEEEEEEcC-CcEEEEEEecCC-----C-cchHHHHHHHHHHHhcCC--CC-cccccccEEEeCCeEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLD-NMRAAVKLLMSN-----S-VSEEEDFIEKVEAIGQVK--HK-NLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv 227 (483)
.+.||.|.-..||++...+ ++.++||.-.+- + .-..++..-|.+.|+.+. -| ++.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4568999999999999743 567888875431 1 123355666777777653 34 45555554 34455789
Q ss_pred EEecCC-CCHHHHH
Q 046972 228 YEYIDN-GNLQQWL 240 (483)
Q Consensus 228 ~E~~~~-g~L~~~l 240 (483)
||+++. ..|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 999854 3344444
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.38 Score=54.83 Aligned_cols=142 Identities=16% Similarity=0.272 Sum_probs=78.3
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-------CCCcccccc-cE----EEe-CC--e
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-------KHKNLVKLF-GY----CVE-GQ--N 223 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~-~~----~~~-~~--~ 223 (483)
+.|+ |..-.+|+....++..+++|+...... ......|.+.|..| .-|.+++-. |- ... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 455788998877888899999876532 22333344444333 334444432 11 111 22 4
Q ss_pred EEEEEEecCCCCHHHH-----------------Hh----cc--cCCCCCCCHH-----------------HHHHHHHHHH
Q 046972 224 RILVYEYIDNGNLQQW-----------------LH----GS--LGEAKPLTWD-----------------TRMKIIQGTA 263 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~-----------------l~----~~--~~~~~~l~~~-----------------~~~~i~~~i~ 263 (483)
.+-+++|.+|..|.+. ++ +. ......+.|. ....++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999777651 01 00 0011112221 1122223333
Q ss_pred HHHH-----HhhhCCCCCeeeecCCCCcEEEcCCC--CcE-Eeeccccc
Q 046972 264 KGLA-----YLHEDIEPKIVHHNMKSSNILLDHHW--NPK-ISDVGLAK 304 (483)
Q Consensus 264 ~~l~-----~LH~~~~~~iiHrDlkp~NiLl~~~~--~~k-l~DFGla~ 304 (483)
.... .|. ..+.++||.|+.+.|||++.++ .+. |.|||-+.
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 122 2345899999999999999875 454 99999775
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.16 Score=49.73 Aligned_cols=31 Identities=19% Similarity=0.223 Sum_probs=27.8
Q ss_pred CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 274 ~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+.+++|+|+.+.|+|++.++.+-++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4489999999999999999899999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.12 Score=51.05 Aligned_cols=141 Identities=18% Similarity=0.266 Sum_probs=75.0
Q ss_pred eeccCCceEEEEEEEcC----CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcc-cccccEEEeCCeEEEEEEecCCC
Q 046972 160 VIASGDNGVVYRAVLLD----NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL-VKLFGYCVEGQNRILVYEYIDNG 234 (483)
Q Consensus 160 ~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~~g 234 (483)
.|..|=.-.+|+....+ +..+++|+...... ..-+-.+|..+++.+..-++ .++++++. .+ +|.+|++|-
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34446666788886543 23788887654322 11233567888777754344 34555552 22 589999876
Q ss_pred CHHH--------------H---HhcccCC-CC-CCCHHHHHHHHHHH----------------------HHHHHHh---h
Q 046972 235 NLQQ--------------W---LHGSLGE-AK-PLTWDTRMKIIQGT----------------------AKGLAYL---H 270 (483)
Q Consensus 235 ~L~~--------------~---l~~~~~~-~~-~l~~~~~~~i~~~i----------------------~~~l~~L---H 270 (483)
.|.. . ++..... .. +-.+.....+..++ ..-+..+ .
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 0 1111101 11 11222222222111 1112111 1
Q ss_pred -h-CCCCCeeeecCCCCcEEEcC-CCCcEEeecccccc
Q 046972 271 -E-DIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKL 305 (483)
Q Consensus 271 -~-~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~~ 305 (483)
. ....-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11224789999999999975 56899999988753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.097 Score=51.24 Aligned_cols=72 Identities=19% Similarity=0.218 Sum_probs=55.9
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|++|++- |++|.. + ..-.+.++..|+.+.+.-+.-|..+ ...=|||+.-.||||+ +|.+-|+||-+
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 346677764 444422 1 2346788899999998888888876 3788999999999999 99999999999
Q ss_pred cccc
Q 046972 303 AKLH 306 (483)
Q Consensus 303 a~~~ 306 (483)
+|.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9853
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.28 Score=47.48 Aligned_cols=142 Identities=18% Similarity=0.194 Sum_probs=0.0
Q ss_pred ccCCceEEEEEEEcC---------CcEEEEEEecCCCcchH-----HHHHHHHHHHhcC-------------CCCccccc
Q 046972 162 ASGDNGVVYRAVLLD---------NMRAAVKLLMSNSVSEE-----EDFIEKVEAIGQV-------------KHKNLVKL 214 (483)
Q Consensus 162 g~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l-------------~hpnIv~~ 214 (483)
|.|-.|.+|++...- ...++||.......... ..|.+|+.+.+.+ ......++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Q ss_pred ccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH--HHHHhhhCCCC-----------------
Q 046972 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK--GLAYLHEDIEP----------------- 275 (483)
Q Consensus 215 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~--~l~~LH~~~~~----------------- 275 (483)
+....+....+|||| ||...--........+++.++..++..+|+ |..+......+
T Consensus 82 ~~~~~~~~~~~lvlE-----DL~~~g~~~~~~~~~l~~~~~~~~l~~LA~fHA~s~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (294)
T PF02958_consen 82 YYADEDPGDEVLVLE-----DLSEKGYRMGDRRDGLDLEHAELVLKKLAKFHAASWALEEKDPELFEELSSGLFEEPFFR 156 (294)
T ss_pred EEeccCCCceeeehh-----hhhhcCCcccccccCCCHHHHHHHHHHHHHHHHHHHHHHHhCchhhhhccccceeccchh
Q ss_pred -----------------------------------------------------------CeeeecCCCCcEEEcCCCC--
Q 046972 276 -----------------------------------------------------------KIVHHNMKSSNILLDHHWN-- 294 (483)
Q Consensus 276 -----------------------------------------------------------~iiHrDlkp~NiLl~~~~~-- 294 (483)
-++|+|++..|||+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~ 236 (294)
T PF02958_consen 157 EELEEWFEEFFEQGLKAFIESLDDEWPEYEEYSEKLEALLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGK 236 (294)
T ss_pred hhhhHHHHHHHHHHHHHHHHHHhhccchhhhhhHHHHHHHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccc
Q ss_pred ---cEEeecccccccCC
Q 046972 295 ---PKISDVGLAKLHGP 308 (483)
Q Consensus 295 ---~kl~DFGla~~~~~ 308 (483)
+++.||-+++.-.+
T Consensus 237 ~~~~~liDfQ~~~~g~p 253 (294)
T PF02958_consen 237 PIDVVLIDFQLARYGSP 253 (294)
T ss_pred cccceeeccccccCCCc
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 483 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-123
Identities = 105/310 (33%), Positives = 175/310 (56%), Gaps = 18/310 (5%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS-EEEDFIEKV 200
R SL+E+ + +D F+ +N++ G G VY+ L D AVK L E F +V
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
E I H+NL++L G+C+ R+LVY Y+ NG++ L PL W R +I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELR 319
G+A+GLAYLH+ +PKI+H ++K++NILLD + + D GLAKL + + ++T
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT----A 194
Query: 320 ---NSGYLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP----QVFLIDW 370
G++A E +G++S EK+DV+ +G++++E+++G+ D ++ V L+DW
Sbjct: 195 VRGTIGHIAPEYLSTGKSS---EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430
+K ++ ++K+ ++D L +E++++I +AL C RPKM +V+RMLE L
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
Query: 431 LLREEYRIKR 440
R E K
Sbjct: 312 AERWEEWQKE 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-114
Identities = 101/293 (34%), Positives = 164/293 (55%), Gaps = 17/293 (5%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE 201
R+ L +++ T+ F + +I G G VY+ VL D + A+K S E+F ++E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 202 AIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG 261
+ +H +LV L G+C E IL+Y+Y++NGNL++ L+GS ++W+ R++I G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS---ISTSCEL 318
A+GL YLH I+H ++KS NILLD ++ PKI+D G++K G E +ST +
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLST--VV 201
Query: 319 RNS-GYLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKS 373
+ + GY+ E + GR EKSDVYSFG+++ E++ R + S P V L +W
Sbjct: 202 KGTLGYIDPEYFIKGR---LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
++ ++DP L + + L++ A++C+ + RP MGDVL LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 93/304 (30%), Positives = 161/304 (52%), Gaps = 32/304 (10%)
Query: 142 RISLKEIDIVTDGFAEQ------NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE--- 192
S E+ VT+ F E+ N + G GVVY+ + +N AVK L +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 193 -EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLT 251
++ F ++++ + + +H+NLV+L G+ +G + LVY Y+ NG+L L G PL+
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLS 131
Query: 252 WDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311
W R KI QG A G+ +LHE+ +H ++KS+NILLD + KISD GLA+ +++
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA-SEKFA 187
Query: 312 ---ISTSCELR---NSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ 364
+++ R + Y+A E L G KSD+YSFG++++EI++G VD +
Sbjct: 188 QTVMTS----RIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 365 VFLIDWLKSMVAQQK-IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
L+D + + ++K I +D K+ + S ++ + +A +C+ RP + V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 424 MLEP 427
+L+
Sbjct: 300 LLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 8e-69
Identities = 71/315 (22%), Positives = 129/315 (40%), Gaps = 39/315 (12%)
Query: 140 GIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEK 199
G+ + + + + V A G G V++A L N AVK+ + +
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYE 68
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQN----RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTR 255
V ++ +KH+N+++ G G + L+ + + G+L +L ++W+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNEL 123
Query: 256 MKIIQGTAKGLAYLHEDI-------EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308
I + A+GLAYLHEDI +P I H ++KS N+LL ++ I+D GLA
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 309 EWS-ISTSCELRNSGYLA-EELSGRTSI---FNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
S T ++ Y+A E L G + + D+Y+ G+++ E+ S D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 364 QVFL-----------IDWLKSMVAQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPD 411
+ L ++ ++ +V +K P L + + + C D D
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 412 IKHRPKMGDVLRMLE 426
+ R G V +
Sbjct: 300 AEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-51
Identities = 82/292 (28%), Positives = 136/292 (46%), Gaps = 37/292 (12%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKV 200
I +++I + I +G G V+RA AVK+LM E +F+ +V
Sbjct: 34 IPWCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREV 85
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+ +++H N+V G + N +V EY+ G+L + LH S G + L R+ +
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAY 144
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
AKG+ YLH P IVH N+KS N+L+D + K+ D GL++L + S S
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS----A 199
Query: 321 SG---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVA 376
+G ++A E+ R NEKSDVYSFG+++ E+ + + P + + QV V
Sbjct: 200 AGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVG 252
Query: 377 QQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427
+ ++P + ++ II C + RP ++ +L P
Sbjct: 253 FKC----KRLEIPRNLN--PQVAAII---EGCWTNEPWKRPSFATIMDLLRP 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 74/301 (24%), Positives = 137/301 (45%), Gaps = 46/301 (15%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEE------- 193
++ EI+ + I G G+V++ L+ + A+K L+ E
Sbjct: 15 TLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 194 EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
++F +V + + H N+VKL+G +V E++ G+L L +A P+ W
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWS 122
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-----HHWNPKISDVGLAKLHGP 308
+++++ A G+ Y+ + P IVH +++S NI L K++D GL++
Sbjct: 123 VKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 309 EWSISTSCELRNSGYLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVF 366
+ S S L N ++A E + + EK+D YSF +++ I++G P +YS ++
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 367 LIDWLKSMVAQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
I +M+ ++ L P +PE P L+ +I C D K RP +++ L
Sbjct: 238 FI----NMIREEG----LRPTIPEDCPP--RLRNVI---ELCWSGDPKKRPHFSYIVKEL 284
Query: 426 E 426
Sbjct: 285 S 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-49
Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 49/301 (16%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKV 200
I ++++I +I G G VY + A++L+ +E+ + F +V
Sbjct: 30 IPFEQLEI-------GELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREV 80
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
A Q +H+N+V G C+ + ++ L + L + +I Q
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQ 137
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
KG+ YLH I+H ++KS N+ D + I+D GL + G + +LR
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 321 S----GYLAEEL--------SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI 368
+LA E+ F++ SDV++ G + E+ + P +
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--F-------- 243
Query: 369 DWLKSMVAQQKIAYVLDPKLPEMPSR---KELKRIILIALRCVDPDIKHRPKMGDVLRML 425
K+ A+ I + P + KE+ I+ L C + + RP ++ ML
Sbjct: 244 ---KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML 297
Query: 426 E 426
E
Sbjct: 298 E 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 32/287 (11%)
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAI 203
SL ID + V+ G GVV +A A+K + S SE + FI ++ +
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQL 55
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA 263
+V H N+VKL+G C+ LV EY + G+L LHG+ T M +
Sbjct: 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCS 112
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-PKISDVGLAKLHGPEWSISTSCELRNSG 322
+G+AYLH ++H ++K N+LL KI D G A + + ++
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAA 168
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVAQQKIA 381
++A E+ S ++EK DV+S+GI++ E+++ R P + P A + +
Sbjct: 169 WMAPEVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------------AFRIMW 215
Query: 382 YVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
V + P + K ++ ++ RC D RP M ++++++
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLM---TRCWSKDPSQRPSMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 4e-48
Identities = 63/327 (19%), Positives = 119/327 (36%), Gaps = 54/327 (16%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKV 200
+ + E + D +I G G VY+ L D AVK+ ++FI +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEK 56
Query: 201 E--AIGQVKHKNLVKLFGYCVEG-----QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWD 253
+ ++H N+ + +LV EY NG+L ++L W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWV 111
Query: 254 TRMKIIQGTAKGLAYLHEDIE------PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+ ++ +GLAYLH ++ P I H ++ S N+L+ + ISD GL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 308 PEWSISTSCELRNS-------GYLA-EELSGRTSI-----FNEKSDVYSFGILIMEIVSG 354
+ E + Y+A E L G ++ ++ D+Y+ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 355 -------------RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE--MPSRKELKR 399
++ + ++ +V+++K PK PE + ++
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRS 287
Query: 400 IILIALRCVDPDIKHRPKMGDVLRMLE 426
+ C D D + R +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-48
Identities = 75/299 (25%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE----EEDFIE 198
I E+ + + +I G G VYRA AVK + + E+ +
Sbjct: 4 IDFAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 199 KVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
+ + +KH N++ L G C++ N LV E+ G L + L G K + D +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNW 110
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD--------HHWNPKISDVGLAKLHGPEW 310
A+G+ YLH++ I+H ++KSSNIL+ + KI+D GLA+
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
Query: 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW 370
+S + ++A E+ R S+F++ SDV+S+G+L+ E+++G +P +
Sbjct: 171 KMSAAGAYA---WMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVP--F---------- 214
Query: 371 LKSMVAQQKIAYVLDPKL-PEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ + V KL +PS + +++ C +PD RP ++L L
Sbjct: 215 -RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM---EDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 40/292 (13%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKV 200
I K+++ + +G +++ VK+L S DF E+
Sbjct: 7 IDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 201 EAIGQVKHKNLVKLFGYCVE--GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
+ H N++ + G C + L+ ++ G+L LH G + +K
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKF 116
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
A+G+A+LH +EP I H + S ++++D +IS + S + +
Sbjct: 117 ALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRM 169
Query: 319 RNSGYLAEEL--SGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMV 375
++A E +D++SF +L+ E+V+ +P D S ++ + V
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KV 223
Query: 376 AQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
A + L P +P + + +++ C++ D RPK ++ +LE
Sbjct: 224 ALEG----LRPTIPPGISP--HVSKLM---KICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 75/313 (23%), Positives = 135/313 (43%), Gaps = 32/313 (10%)
Query: 130 IRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNS 189
+++ G R + + +I I SG G VY+ + AVK+L +
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTA 58
Query: 190 VSEE--EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEA 247
+ + + F +V + + +H N++ GY +V ++ + +L LH
Sbjct: 59 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA---SE 114
Query: 248 KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+ I + TA+G+ YLH I+H ++KS+NI L KI D GLA
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 308 PEWSISTSCELRNS-GYLAEEL--SGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQP 363
+L S ++A E+ ++ ++ +SDVY+FGI++ E+++G+LP + +
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDV 421
+ MV + L P L ++ S K +KR++ C+ RP +
Sbjct: 232 DQII-----EMVGRGS----LSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRI 279
Query: 422 LRMLEPRDLLLRE 434
L +E L RE
Sbjct: 280 LAEIEE---LARE 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-46
Identities = 58/285 (20%), Positives = 102/285 (35%), Gaps = 37/285 (12%)
Query: 159 NVIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
V+ G G + + +K L+ + F+++V+ + ++H N++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
+ + + EYI G L+ + W R+ + A G+AYLH I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG------- 330
+H ++ S N L+ + N ++D GLA+L E + + +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 331 -----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
++EK DV+SFGI++ EI+ P +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP------------RTMDFGLNVR 237
Query: 386 PKL-PEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427
L P I +RC D D + RP + LE
Sbjct: 238 GFLDRYCPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWLET 279
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-44
Identities = 70/328 (21%), Positives = 126/328 (38%), Gaps = 54/328 (16%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE 201
R K+I + I G G V+ + AVK+ + +EE + + E
Sbjct: 33 RTIAKQIQM-------VKQIGKGRYGEVWMG-KWRGEKVAVKVFFT---TEEASWFRETE 81
Query: 202 --AIGQVKHKNLVKLFGYCVEGQNRI----LVYEYIDNGNLQQWLHGSLGEAKPLTWDTR 255
++H+N++ ++G L+ +Y +NG+L +L L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSM 136
Query: 256 MKIIQGTAKGLAYLHEDIE-----PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310
+K+ + GL +LH +I P I H ++KS NIL+ + I+D+GLA +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 311 SISTSCELRNSG---YLA-EELSGRTSI----FNEKSDVYSFGILIMEIVSG-------- 354
+ G Y+ E L + +D+YSFG+++ E+
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 355 --RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE-LKRIILIALRCVDPD 411
+LP P + ++ +V +K L P P S E L+++ + C +
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 412 IKHRPKMGDVLRMLEPRDLLLREEYRIK 439
R V + L + E IK
Sbjct: 313 PASRLTALRVKKTLAK----MSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 58/299 (19%), Positives = 114/299 (38%), Gaps = 43/299 (14%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE--AIGQVKHKNLVKLF 215
+ G G V+R AVK+ S +E+ + + E ++H+N++
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 216 GYCVEGQNRI----LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
+ ++ L+ Y + G+L +L L + ++I+ A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHI 123
Query: 272 DIE-----PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---Y 323
+I P I H ++KS NIL+ + I+D+GLA +H + G Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 324 LA-----EELSGRTSIFNEKSDVYSFGILIMEIVSG----------RLPVDYSQPQVFLI 368
+A E + ++ D+++FG+++ E+ + P P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 369 DWLKSMVAQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ ++ +V + P +P S L + + C + R + + L
Sbjct: 244 EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 74/324 (22%), Positives = 131/324 (40%), Gaps = 46/324 (14%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVE 201
R + I + Q I G G V+R AVK+ S EE + + E
Sbjct: 38 RTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAE 86
Query: 202 --AIGQVKHKNLVKLFGYCVEGQNRI----LVYEYIDNGNLQQWLHGSLGEAKPLTWDTR 255
++H+N++ + LV +Y ++G+L +L+ +T +
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGM 141
Query: 256 MKIIQGTAKGLAYLHEDIE-----PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310
+K+ TA GLA+LH +I P I H ++KS NIL+ + I+D+GLA H
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 311 SISTSCELRNSG---YLA-EELSGRTSI----FNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
G Y+A E L ++ +++D+Y+ G++ EI +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 363 P-QVFLIDWLKSMVA-QQKIAYVLDPKL-PEMPSRKE----LKRIILIALRCVDPDIKHR 415
Q+ D + S + ++ V + KL P +P+R + L+ + I C + R
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321
Query: 416 PKMGDVLRMLEPRDLLLREEYRIK 439
+ + L L ++ IK
Sbjct: 322 LTALRIKKTLSQ----LSQQEGIK 341
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 65/299 (21%), Positives = 112/299 (37%), Gaps = 59/299 (19%)
Query: 158 QNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVKLF 215
I G+ G V+ L DN AVK + F+++ + Q H N+V+L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
G C + Q +V E + G+ +L E L T ++++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG----- 330
+H ++ + N L+ KISD G+++ + Y A
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSRE------------EADGVYAASGGLRQVPVK 280
Query: 331 -------RTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382
++ +SDV+SFGIL+ E S G P Y ++ QQ +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP--Y-----------PNLSNQQTREF 327
Query: 383 VLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYR 437
V P P + R++ +C + RP + + L+ +R+ +R
Sbjct: 328 VEKGGRLPCPELCPD--AVFRLM---EQCWAYEPGQRPSFSTIYQELQS----IRKRHR 377
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 58/273 (21%), Positives = 121/273 (44%), Gaps = 27/273 (9%)
Query: 158 QNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
++ + G G VY V ++ AVK L ++ E E+F+++ + ++KH NLV+L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
C ++ E++ GNL +L + ++ + + + + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIF 335
+H N+ + N L+ + K++D GL++ + G ++ + E L + F
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKF 396
Query: 336 NEKSDVYSFGILIMEIVS-GRLPV-DYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
+ KSDV++FG+L+ EI + G P QV+ ++ + Y + + P
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEK---DYRM-ERPEGCP- 445
Query: 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+++ ++ C + RP ++ + E
Sbjct: 446 -EKVYELM---RACWQWNPSDRPSFAEIHQAFE 474
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 27/272 (9%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ + G G V+ R A+K L + E F+++ + + +++H+ LV+L+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
E I V EY+ G+L +L G K L + + A G+AY+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFN 336
VH +++++NIL+ + K++D GLA+ + E++ + E F
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFT 359
Query: 337 EKSDVYSFGILIMEIVS-GRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394
KSDV+SFGIL+ E+ + GR+P +V V + Y + P PE P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER---GYRM-PCPPECP-- 407
Query: 395 KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ L ++ +C + + RP + LE
Sbjct: 408 ESLHDLM---CQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 27/272 (9%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ + G G V+ R A+K L + E F+++ + + +++H+ LV+L+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
E I V EY+ G+L +L G K L + + A G+AY+
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFN 336
VH +++++NIL+ + K++D GLA+ + E++ + E F
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFT 442
Query: 337 EKSDVYSFGILIMEIVS-GRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394
KSDV+SFGIL+ E+ + GR+P +V V + Y + P PE P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER---GYRM-PCPPECP-- 490
Query: 395 KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ L ++ +C + + RP + LE
Sbjct: 491 ESLHDLM---CQCWRKEPEERPTFEYLQAFLE 519
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ SG GVV AVK++ S E++F ++ + + ++ H LVK +G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
C + +V EYI NG L +L K L +++ +G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL------AEELSGR 331
+H ++ + N L+D K+SD G+ + + + + G A E
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRY------VLDDQYVSSVGTKFPVKWSAPE-VFH 178
Query: 332 TSIFNEKSDVYSFGILIMEIVS-GRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389
++ KSDV++FGIL+ E+ S G++P Y+ +V V+Q + L +
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQ---GHRL-YRPH 228
Query: 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEY 436
I I C + RP +L +E L ++++
Sbjct: 229 LAS-----DTIYQIMYSCWHELPEKRPTFQQLLSSIE--PLREKDKH 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 35/276 (12%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ + +G G V+ A + + AVK + S E F+ + + ++H LVKL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
+ I + E++ G+L +L G + A+G+A++ +
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCEL--RNSGYLAEELSGRTSI 334
+H +++++NIL+ KI+D GLA+ + E++ + + + A E +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---APE-AINFGS 361
Query: 335 FNEKSDVYSFGILIMEIVS-GRLPVDY---SQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390
F KSDV+SFGIL+MEIV+ GR+P Y S P+V + + Y + P+
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVI------RALER---GYRM-PRPEN 409
Query: 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
P +EL I+ +RC + RP + +L+
Sbjct: 410 CP--EELYNIM---MRCWKNRPEERPTFEYIQSVLD 440
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
I SG G+V+ L+ + A+K + + EEDFIE+ E + ++ H LV+L+G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
C+E LV E++++G L +L G +T + + +G+AYL E +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL--------- 328
+H ++ + N L+ + K+SD G+ + + + Y +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF------------VLDDQYTSSTGTKFPVKWAS 173
Query: 329 --SGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
S ++ KSDV+SFG+L+ E+ S G++P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 59/277 (21%), Positives = 104/277 (37%), Gaps = 54/277 (19%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVK--LLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
I G VY+ + + A + SE + F E+ E + ++H N+V+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 217 YCVEGQNR----ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+LV E + +G L+ +L K + + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 273 IEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHG----------PEWSISTSCELRNS 321
P I+H ++K NI + + KI D+GLA L PE+ + E+
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF---MAPEMYEE 204
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
Y +E DVY+FG+ ++E+ + P YS+ ++ +
Sbjct: 205 KY------------DESVDVYAFGMCMLEMATSEYP--YSE--------CQNAAQIYRRV 242
Query: 382 Y--VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
V ++ E+K II C+ + R
Sbjct: 243 TSGVKPASFDKVAI-PEVKEII---EGCIRQNKDERY 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 57/291 (19%), Positives = 116/291 (39%), Gaps = 50/291 (17%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ +G GVV A+K++ S E++FIE+ + + + H+ LV+L+G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
C + + ++ EY+ NG L +L +++ + + + YL +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL--------- 328
+H ++ + N L++ K+SD GL++ + + Y +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY------------VLDDEYTSSVGSKFPVRWSP 189
Query: 329 --SGRTSIFNEKSDVYSFGILIMEIVS-GRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVL 384
S F+ KSD+++FG+L+ EI S G++P ++ + +AQ L
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQ---GLRL 240
Query: 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435
+ +++ I C RP +L + ++ EE
Sbjct: 241 -YRPHLAS-----EKVYTIMYSCWHEKADERPTFKILLSNILD---VMDEE 282
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 65/312 (20%), Positives = 120/312 (38%), Gaps = 61/312 (19%)
Query: 160 VIASGDNGVVYRAVL--------LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL 211
+ G +++ V L +K+L + E F E + ++ HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
V +G CV G ILV E++ G+L +L + + ++++ + A + +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFLEE 131
Query: 272 DIEPKIVHHNMKSSNILLDHHWNP--------KISDVGLAKLHGPEWSISTSCELRNSGY 323
+ ++H N+ + NILL + K+SD G++ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDI 176
Query: 324 L-------AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMV 375
L E N +D +SFG + EI S G P L ++
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------------LSALD 223
Query: 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435
+Q+K+ + D P EL +I C+D + HRP ++R L L +
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLNS---LFTPD 277
Query: 436 YRIKRAASYHNY 447
+ + +H++
Sbjct: 278 LVPRGSHHHHHH 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 56/285 (19%), Positives = 107/285 (37%), Gaps = 36/285 (12%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
+ G V L D A+K ++ + + E+ + + H N+++L YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 219 VEGQNR----ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ + L+ + G L + + LT D + ++ G +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG----------YL 324
H ++K +NILL P + D+G + S + Y
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ--ACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 325 AEEL--SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI-A 381
A EL + +E++DV+S G ++ ++ G P + + + K +
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--------YDMVFQKGDSVALAVQN 262
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ P+ P S L +++ + VDP RP + +L LE
Sbjct: 263 QLSIPQSPRHSS--ALWQLLNSMMT-VDP--HQRPHIPLLLSQLE 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ +G G V+ + + AVK L S + F+ + + Q++H+ LV+L+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
+ I + EY++NG+L +L LT + + + A+G+A++ E
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL--------- 328
+H +++++NIL+ + KI+D GLA+L + ++ Y A E
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARL------------IEDNEYTAREGAKFPIKWTA 178
Query: 329 --SGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ F KSDV+SFGIL+ EIV+ GR+P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 64/293 (21%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220
G V+ A + M AVK L +++ +DF + E + ++H+++VK +G C +
Sbjct: 29 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 88
Query: 221 GQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
G I+V+EY+ +G+L ++L L + I A G+ Y
Sbjct: 89 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 148
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL 328
L VH ++ + N L+ + KI D G+++ ++ ++ Y
Sbjct: 149 LASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR------------DVYSTDYYRVGG 193
Query: 329 SGR-----TS-------IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMV 375
F +SDV+SFG+++ EI + G+ P + Q +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQ-----------LS 240
Query: 376 AQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ I + ++ E P KE+ ++ L C + + R + ++ ++L
Sbjct: 241 NTEVIECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIYKILH 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 65/300 (21%), Positives = 118/300 (39%), Gaps = 63/300 (21%)
Query: 159 NVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLV 212
+ G G V+ A + M AVK L S S +DF + E + ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWL-----------HGSLGEAKPLTWDTRMKIIQG 261
+ FG C EG+ ++V+EY+ +G+L ++L G PL + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS 321
A G+ YL VH ++ + N L+ KI D G+++ ++ ++
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR------------DIYST 211
Query: 322 GYLAEELSGR-----TS-------IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368
Y F +SDV+SFG+++ EI + G+ P + Q
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQ------ 263
Query: 369 DWLKSMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ + I + + E P E+ I+ C + + R + DV L+
Sbjct: 264 -----LSNTEAIDCITQGRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARLQ 315
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 159 NVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ + G G VY V ++ AVK L ++ E E+F+++ + ++KH NLV+L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
C ++ E++ GNL +L + ++ + + + + YL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL--------- 328
+H ++ + N L+ + K++D GL++L + Y A
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRL------------MTGDTYTAHAGAKFPIKWTA 180
Query: 329 --SGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
S + F+ KSDV++FG+L+ EI + G P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 85/406 (20%), Positives = 149/406 (36%), Gaps = 60/406 (14%)
Query: 64 PISPKNHVHPHNTFSTSSLDRRLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNRCTR 123
PI P H H H+ +S+ +L ++ S +L + + S N +
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELS---TSLYKKAGSENLYFQ 59
Query: 124 AQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDN----MR 179
+I S L + I + VI G G VY LLDN +
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 180 AAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL-VYEYIDNGNLQ 237
AVK L + E F+ + + H N++ L G C+ + L V Y+ +G+L+
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 238 QWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297
++ E T + AKG+ +L K VH ++ + N +LD + K+
Sbjct: 180 NFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 233
Query: 298 SDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT--------------SIFNEKSDVYS 343
+D GLA+ ++ + + + F KSDV+S
Sbjct: 234 ADFGLAR------------DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281
Query: 344 FGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS--RKELKRI 400
FG+L+ E+++ G P Y + Y+L + P L +
Sbjct: 282 FGVLLWELMTRGAPP--YP-----------DVNTFDITVYLLQGRRLLQPEYCPDPLYEV 328
Query: 401 ILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRIKRAASYHN 446
+ L+C P + RP +++ + E+ + A+Y N
Sbjct: 329 M---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 371
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 158 QNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLV 212
+ +I SGD+G V L ++ A+K L + + DF+ + +GQ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+L G G+ ++V EY++NG+L +L G+ T + +++G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL 170
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG-- 330
VH ++ + N+L+D + K+SD GL+++ L + A +G
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV------------LEDDPDAAYTTTGGK 215
Query: 331 -----------RTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F+ SDV+SFG+++ E+++ G P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 49/290 (16%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
I G+ G V + AVK + +++ + F+ + + Q++H NLV+L G
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 218 CVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
VE + + +V EY+ G+L +L L D +K + + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL-----AEELSGR 331
VH ++ + N+L+ K+SD GL K S++ +++G L A E + R
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK------EASST---QDTGKLPVKWTAPE-ALR 187
Query: 332 TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD----P 386
F+ KSDV+SFGIL+ EI S GR+P Y + + + V
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP--YP-----------RIPLKDVVPRVEKGYKMD 234
Query: 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEY 436
P + + C D RP + LE + E +
Sbjct: 235 APDGCP-----PAVYEVMKNCWHLDAAMRPSFLQLREQLE--HIKTHELH 277
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 73/319 (22%), Positives = 141/319 (44%), Gaps = 49/319 (15%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSEE-EDFIEK 199
EI Q VI +G+ G VY+ +L + A+K L + ++ DF+ +
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKII 259
+GQ H N+++L G + + +++ EY++NG L ++L GE + + ++
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGML 153
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
+G A G+ YL VH ++ + NIL++ + K+SD GL+++ + + +
Sbjct: 154 RGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT---T 207
Query: 320 NSGYL-----AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKS 373
+ G + A E + F SDV+SFGI++ E+++ G P Y
Sbjct: 208 SGGKIPIRWTAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERP--YW-----------E 253
Query: 374 MVAQQKIAYVLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429
+ + + + D P + P I + ++C + RPK D++ +L+
Sbjct: 254 LSNHEVMKAINDGFRLPTPMDCP-----SAIYQLMMQCWQQERARRPKFADIVSILDK-- 306
Query: 430 LLLREEYRIKRAASYHNYP 448
L+R +K A +
Sbjct: 307 -LIRAPDSLKTLADFDPRV 324
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 57/294 (19%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
I G+ G V + AVK + +++ + F+ + + Q++H NLV+L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 218 CVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
VE + + +V EY+ G+L +L L D +K + + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA---------EE 327
VH ++ + N+L+ K+SD GL K E ++ E
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK------------EASSTQDTGKLPVKWTAPEA 357
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD- 385
L + F+ KSDV+SFGIL+ EI S GR+P Y + + + V
Sbjct: 358 LREK--KFSTKSDVWSFGILLWEIYSFGRVP--YP-----------RIPLKDVVPRVEKG 402
Query: 386 ---PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEY 436
P + ++ C D RP + LE + E +
Sbjct: 403 YKMDAPDGCPP--AVYDVM---KNCWHLDAATRPTFLQLREQLE--HIRTHELH 449
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 56/299 (18%), Positives = 119/299 (39%), Gaps = 62/299 (20%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
G+VY V R A+K + S+ E +F+ + + + ++V+L G
Sbjct: 39 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98
Query: 220 EGQNRILVYEYIDNGNLQQWL------HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+GQ +++ E + G+L+ +L + P + +++ A G+AYL+ +
Sbjct: 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN- 157
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR-- 331
K VH ++ + N ++ + KI D G+ + ++ + Y + G
Sbjct: 158 --KFVHRDLAARNCMVAEDFTVKIGDFGMTR------------DIYETDYYRKGGKGLLP 203
Query: 332 ----------TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380
+F SDV+SFG+++ EI + P Y + +Q +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQG-----------LSNEQVL 250
Query: 381 AYVLDPKLPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYR 437
+V++ L + P L ++ C + K RP +++ ++ + +R
Sbjct: 251 RFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKE---EMEPGFR 303
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRA-----AVKLLMSN-SVSEEEDFIE 198
LKE + V+ SG G VY+ + + A+K L S ++ ++
Sbjct: 12 LKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 199 KVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
+ + V + ++ +L G C+ ++ + + + G L ++ + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN---IGSQYLLNW 122
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
AKG+ YL + ++VH ++ + N+L+ + KI+D GLAKL G E
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYH 175
Query: 319 RNSGYL-----AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
G + A E S I+ +SDV+S+G+ + E+++ G P
Sbjct: 176 AEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/328 (22%), Positives = 132/328 (40%), Gaps = 64/328 (19%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEE-EDFIEKV 200
KE+D + V+ +G+ G V L + A+K L ++ DF+ +
Sbjct: 40 KELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+GQ H N+++L G + + ++V EY++NG+L +L + T + +++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLR 154
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
G A G+ YL + VH ++ + NIL++ + K+SD GL ++ L +
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV------------LED 199
Query: 321 SGYLAEELSG-------------RTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVF 366
A G F SDV+S+GI++ E++S G P Y
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YW----- 252
Query: 367 LIDWLKSMVAQQKIAYVLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
M Q I V + P + P + + L C D +RPK ++
Sbjct: 253 ------EMSNQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 423 RMLEPRDLLLREEYRIKRAASYHNYPQK 450
+L+ L+R +K S P
Sbjct: 302 SILDK---LIRNPGSLKIITSAAARPSN 326
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 45/297 (15%), Positives = 84/297 (28%), Gaps = 46/297 (15%)
Query: 160 VIASGDNGVVYRAVLLD-NMRAAVKLLM---SNSVSEEEDFIEKVEAIGQVKHKNLVKLF 215
+ GD VV+ ++ A+K+ NS SE E E A ++ ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 216 GYC----------VEGQ----------------NRILVYEYI--DNGNLQQWLHGSLGEA 247
V+ Q N +L+ D L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 248 KPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+ + A L +VH + N+ + + DV G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 308 PEWSISTSCELRNSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF 366
Y E L+ T+ F + + G+ I + LP P +
Sbjct: 246 T----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 367 LIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
W + + + +P +K +I R ++ D + R + +
Sbjct: 302 G-SWKRPSLRVPGTDSLAFGSCTPLPD--FVKTLI---GRFLNFDRRRRLLPLEAME 352
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 59/288 (20%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
G VY + ++ AVK L S +E DF+ + I + H+N+V+ G +
Sbjct: 44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 220 EGQNRILVYEYIDNGNLQQWLHGS---LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ R ++ E + G+L+ +L + + L + + + A G YL E+
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---H 160
Query: 277 IVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR-- 331
+H ++ + N LL KI D G+A+ ++ + Y +
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------------DIYRASYYRKGGCAMLP 208
Query: 332 ---TS-------IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380
IF K+D +SFG+L+ EI S G +P Y S Q+ +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YP-----------SKSNQEVL 255
Query: 381 AYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+V + P + RI+ +C + RP +L +E
Sbjct: 256 EFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIE 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 65/320 (20%), Positives = 115/320 (35%), Gaps = 51/320 (15%)
Query: 158 QNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLV 212
+ + G+ G V AVK L + ++ DF +++ + + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 213 KLFGYCVEGQNR--ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
K G + LV EY+ +G L+ +L L + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG 144
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL-- 328
+ VH ++ + NIL++ + KI+D GLAKL L Y+ E
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKL----------LPLDKDYYVVREPGQ 191
Query: 329 ---------SGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKS---MV 375
S +IF+ +SDV+SFG+++ E+ + S FL
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPA 249
Query: 376 AQQKIAYVLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431
+ + + + P P P E+ ++ C P + RP + L+ L
Sbjct: 250 LSRLLELLEEGQRLPAPPACP--AEVHELM---KLCWAPSPQDRPSFSALGPQLD--MLW 302
Query: 432 LREEYRIKRAASYHNYPQKN 451
A + H + +
Sbjct: 303 SGSRGCETHAFTAHPEGKHH 322
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 45/286 (15%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK----VEAIGQVKHKNLVKLF 215
+ G VY A + N++ A+K + E+E+ +++ V Q+ H+N+V +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
E LV EYI+ L +++ PL+ DT + G+ + H+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM--- 130
Query: 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIF 335
+IVH ++K NIL+D + KI D G+AK T+ L Y + E + +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA-KGEAT 189
Query: 336 NEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY--VLDPKLPEMPS 393
+E +D+YS GI++ E++ G P + V+ IA + D +P + +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETA-----------VS---IAIKHIQDS-VPNVTT 234
Query: 394 R------KELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPR 428
+ L +IL A D +R K D+ +L
Sbjct: 235 DVRKDIPQSLSNVILRATE-KDKA--NRYKTIQEMKDDLSSVLHEN 277
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 64/296 (21%), Positives = 114/296 (38%), Gaps = 59/296 (19%)
Query: 159 NVIASGDNGVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNL 211
+ G G VY + ++ AVK L S +E DF+ + I + H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGS---LGEAKPLTWDTRMKIIQGTAKGLAY 268
V+ G ++ R ++ E + G+L+ +L + + L + + + A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L E+ +H ++ + N LL KI D G+A+ ++ +GY
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------------DIYRAGYYR 241
Query: 326 EELSGR-----TS-------IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372
+ IF K+D +SFG+L+ EI S G +P Y
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YP----------- 288
Query: 373 SMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
S Q+ + +V + P + RI+ +C + RP +L +E
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 157 EQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNL 211
VI G GVVY +D ++ A+K L + + E F+ + + + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 212 VKLFGYCVEGQNRIL-VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+ L G + + + Y+ +G+L Q++ + T + A+G+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYL----- 324
E K VH ++ + N +LD + K++D GLA+ + E+ S + L
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWT 195
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
A E S +T F KSDV+SFG+L+ E+++ G P
Sbjct: 196 ALE-SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 42/295 (14%)
Query: 158 QNVIASGDNGVVYRAVLLDN----MRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLV 212
VI G G VY LLDN + AVK L + E F+ + + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 213 KLFGYCVEGQNRIL-VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
L G C+ + L V Y+ +G+L+ ++ E T + AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYL-----A 325
K VH ++ + N +LD + K++D GLA+ ++ E S + L A
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMA 200
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384
E S +T F KSDV+SFG+L+ E+++ G P Y + Y+L
Sbjct: 201 LE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YP-----------DVNTFDITVYLL 246
Query: 385 DPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP-RDLLLREEY 436
+ P L ++ L+C P + RP +++ + + E Y
Sbjct: 247 QGRRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 158 QNVIASGDNGVVYRAVLLDN---MRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLV 212
Q+VI G+ G V +A + + M AA+K + S + DF ++E + ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGS------------LGEAKPLTWDTRMKIIQ 260
L G C L EY +GNL +L S A L+ +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
A+G+ YL + + +H ++ + NIL+ ++ KI+D GL+ R
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS---------------RG 191
Query: 321 SGYLAEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLP 357
++ GR S++ SDV+S+G+L+ EIVS G P
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 50/298 (16%), Positives = 119/298 (39%), Gaps = 60/298 (20%)
Query: 158 QNVIASGDNGVVYRAVLLDN----MRAAVKLLMSNSVSEEE--DFIEKVEAIGQVKHKNL 211
++ G+ G V A L ++ AVK+L ++ ++ + +F+ + + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 212 VKLFGYCVEGQNRI------LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTA 263
KL G + + + ++ ++ +G+L +L L T ++ + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY 323
G+ YL +H ++ + N +L ++D GL++ ++ + Y
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR------------KIYSGDY 192
Query: 324 LAEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDW 370
+ + + +++ SDV++FG+ + EI++ G+ P Y+
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YA--------- 241
Query: 371 LKSMVAQQKIAYVLDPKLPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ + Y++ + P +E+ ++ +C D K RP + LE
Sbjct: 242 --GIENAEIYNYLIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELE 294
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRA-----AVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNL 211
V+ SG G V++ V + + +K++ S + + + AIG + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
V+L G C ++ V +Y+ G+L + G L + AKG+ YL E
Sbjct: 78 VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEE 133
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG------YLA 325
+VH N+ + N+LL +++D G+A L P+ +L S ++A
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-----DKQLLYSEAKTPIKWMA 185
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
E S + +SDV+S+G+ + E+++ G P
Sbjct: 186 LE-SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-23
Identities = 54/302 (17%), Positives = 107/302 (35%), Gaps = 65/302 (21%)
Query: 159 NVIASGDNGVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNL 211
+ G VY+ L A+K L E+F + +++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKII 259
V L G + Q +++ Y +G+L ++L L + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
A G+ YL +VH ++ + N+L+ N KISD+GL + E+
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR------------EVY 179
Query: 320 NSGYLAEELSGR-----TS-------IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVF 366
+ Y + + F+ SD++S+G+++ E+ S G P Y
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCG---- 233
Query: 367 LIDWLKSMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRM 424
Q + + + ++ P + ++ + C + RP+ D+
Sbjct: 234 -------YSNQDVVEMIRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFKDIHSR 283
Query: 425 LE 426
L
Sbjct: 284 LR 285
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 57/297 (19%), Positives = 113/297 (38%), Gaps = 59/297 (19%)
Query: 158 QNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSVSEEE--DFIEKVEAIGQVKHKNL 211
++ G+ G V L +++ AVK + ++ S+ E +F+ + + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 212 VKLFGYCVEGQNRI-----LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAK 264
++L G C+E ++ ++ ++ G+L +L K + T +K + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
G+ YL +H ++ + N +L ++D GL+K ++ + Y
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK------------KIYSGDYY 203
Query: 325 AEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWL 371
+ + ++ KSDV++FG+ + EI + G P Y
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YP---------- 251
Query: 372 KSMVAQQKIAYVLDPKLPEMPS--RKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ + Y+L + P EL I+ C D RP + LE
Sbjct: 252 -GVQNHEMYDYLLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLE 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 51/226 (22%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRA-----AVKLLMSNSVSEE-EDFIE 198
LKE + V+ SG G VY+ + + A+K L + + ++ ++
Sbjct: 12 LKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 199 KVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
+ + V + ++ +L G C+ ++ + + + G L ++ + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN---IGSQYLLNW 122
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
AKG+ YL + ++VH ++ + N+L+ + KI+D GLAKL G E E
Sbjct: 123 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEY 174
Query: 319 RNSG------YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
G ++A E S I+ +SDV+S+G+ + E+++ G P
Sbjct: 175 HAEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 34/214 (15%)
Query: 158 QNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLV 212
+ G+ G V AVK L ++ DF ++E + ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 213 KLFGYCVEGQNR--ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
K G C R L+ EY+ G+L+ +L + ++ KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL-- 328
+ +H ++ + NIL+++ KI D GL K+ + +E
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKV----------LPQDKEFFKVKEPGE 178
Query: 329 ---------SGRTSIFNEKSDVYSFGILIMEIVS 353
S S F+ SDV+SFG+++ E+ +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 161 IASGDNGVVYRAVL---LDNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVKLFG 216
+ G+ G V + V + A+K+L + + E+ + + + + Q+ + +V+L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
C + + +LV E G L ++L G E + +++ + G+ YL E
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI-- 334
VH ++ + N+LL + KISD GL+K G + +S Y A +G+ +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD----------DSYYTARS-AGKWPLKW 179
Query: 335 ----------FNEKSDVYSFGILIMEIVS-GRLP 357
F+ +SDV+S+G+ + E +S G+ P
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 68/283 (24%), Positives = 122/283 (43%), Gaps = 31/283 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEE--DFIEKVEAIGQVKHK 209
+ + I +G G + D K L S++E E + +V + ++KH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 210 NLVKLFGYCVEGQNRIL--VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
N+V+ + ++ N L V EY + G+L + E + L + ++++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 268 YLHE--DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG--- 322
H D ++H ++K +N+ LD N K+ D GLA++ + S + + G
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF----VGTPY 181
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD-YSQPQVFLIDWLKSMVAQQKIA 381
Y++ E R S +NEKSD++S G L+ E+ + P +SQ ++ KI
Sbjct: 182 YMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-----------GKIR 229
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
++P S EL II L + HRP + ++L
Sbjct: 230 EGKFRRIPYRYS-DELNEIITRMLN-LKDY--HRPSVEEILEN 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 38/220 (17%)
Query: 158 QNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEE---EDFIEKVEAIGQVKHKN 210
+ G GVV R + AVK L + +S+ +DFI +V A+ + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
L++L+G + +V E G+L L G T + A+G+ YL
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE 138
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
+ +H ++ + N+LL KI D GL + + Y+ +E
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----------DDHYVMQE-HR 184
Query: 331 RTSI------------FNEKSDVYSFGILIMEIVS-GRLP 357
+ F+ SD + FG+ + E+ + G+ P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 160 VIASGDNGVVYRAVLLDNMRA---AVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKL 214
+ SG+ G V + AVK+L + + +++ + + + Q+ + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
G C E ++ +LV E + G L ++L + + + ++++ + G+ YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL------ 328
VH ++ + N+LL KISD GL+K + + Y A+
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD----------ENYYKAQTHGKWPVK 185
Query: 329 -----SGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F+ KSDV+SFG+L+ E S G+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 34/214 (15%)
Query: 158 QNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLV 212
+ G+ G V AVK L ++ DF ++E + ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 213 KLFGYCVEGQNR--ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
K G C R L+ EY+ G+L+ +L + ++ KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL-- 328
+ +H ++ + NIL+++ KI D GL K+ Y +E
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKV----------LPQDKEYYKVKEPGE 209
Query: 329 ---------SGRTSIFNEKSDVYSFGILIMEIVS 353
S S F+ SDV+SFG+++ E+ +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 50/289 (17%), Positives = 103/289 (35%), Gaps = 42/289 (14%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVK--LLMSNSVSEEEDFIEKVEAIGQV-KHKN 210
F E I SG+ G V++ V LD A+K +E++ + +V A + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+V+ F E + ++ EY + G+L + + ++ +GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS---------ISTSCELRNS 321
+VH ++K SNI + P + + T
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 322 --G---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376
G +LA E+ K+D+++ + ++ ++
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE-------------PLPRNGDQ 236
Query: 377 QQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLR 423
+I +LP +P +E ++ + PD + RP +++
Sbjct: 237 WHEIR---QGRLPRIPQVLSQEFTELL---KVMIHPDPERRPSAMALVK 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 49/297 (16%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
F E V+ G G V +A LD+ A+K + ++ + + +V + + H+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 214 LFGYCVEGQNRI-------------LVYEYIDNGNLQQWLH-GSLGEAKPLTWDTRMKII 259
+ +E +N + + EY +NG L +H +L + + W ++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLF 122
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
+ + L+Y+H I+H ++K NI +D N KI D GLAK I
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 320 NSG-------------YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF 366
G Y+A E+ T +NEK D+YS GI+ E++ + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-FSTGMERVNIL 238
Query: 367 LIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ ++ P + K K+II +D D RP +L
Sbjct: 239 KK--------LRSVSIEFPPDFDDNKM-KVEKKII---RLLIDHDPNKRPGARTLLN 283
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 26/212 (12%)
Query: 158 QNVIASGDNGVVYRAVLLDN----MRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLV 212
++ G G VY V ++ + AVK ++ +E F+ + + + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
KL G E I + E G L +L + L T + K +AYL
Sbjct: 77 KLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI 132
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL------AE 326
VH ++ NIL+ K+ D GL++ I + S +
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRY------IEDEDYYKASVTRLPIKWMSP 183
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
E S F SDV+ F + + EI+S G+ P
Sbjct: 184 E-SINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 40/266 (15%)
Query: 167 GVVYRAVLLDNMRA-AVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222
G VY A + A+K+L + + E +VE ++H N+++L+GY
Sbjct: 23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-FHDA 81
Query: 223 NRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHN 281
R+ L+ EY G + + L + I A L+Y H +++H +
Sbjct: 82 TRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRD 134
Query: 282 MKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEE-LSGRTSIFNE 337
+K N+LL KI+D G + H P + C G YL E + GR +E
Sbjct: 135 IKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLC-----GTLDYLPPEMIEGRM--HDE 186
Query: 338 KSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKEL 397
K D++S G+L E + G+ P + + ++I+ V + P+ + +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTY----------QETYKRISRV-EFTFPDFVT-EGA 234
Query: 398 KRIILIALRCVDPDIKHRPKMGDVLR 423
+ +I R + + RP + +VL
Sbjct: 235 RDLI---SRLLKHNPSQRPMLREVLE 257
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 57/294 (19%), Positives = 111/294 (37%), Gaps = 46/294 (15%)
Query: 158 QNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNL 211
+ G G V + AVK L S D +++E + + H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 212 VKLFGYCVEGQNR--ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
VK G C E L+ E++ +G+L+++L + + + ++K KG+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL- 328
+ VH ++ + N+L++ KI D GL K E Y ++
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA----------IETDKEYYTVKDDR 189
Query: 329 ----------SGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLID-WLKSMVA 376
S F SDV+SFG+ + E+++ + +I M
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 377 QQKIAYVLD----PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ + + + P P P E+ +++ +C + +R +++ E
Sbjct: 250 TRLVNTLKEGKRLPCPPNCP--DEVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 36/161 (22%), Positives = 73/161 (45%), Gaps = 18/161 (11%)
Query: 206 VKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWL--HGSLGE--AKPLTWDTRMKIIQ 260
+K++ + G + + + ++YEY++N ++ ++ L + + II+
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
+Y+H E I H ++K SNIL+D + K+SD G ++ + + I S
Sbjct: 159 SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKGSR---- 211
Query: 321 SG---YLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
G ++ E S +S K D++S GI + + +P
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 73/310 (23%)
Query: 159 NVIASGDNGVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNL 211
I G G V++A AVK+L S + DF + + + + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWL--------------------HGSLGEAKPLT 251
VKL G C G+ L++EY+ G+L ++L S PL+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 252 WDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311
++ I + A G+AYL E K VH ++ + N L+ + KI+D GL++
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR------- 222
Query: 312 ISTSCELRNSGYLAEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLPV 358
+ ++ Y + + + + +SDV+++G+++ EI S G P
Sbjct: 223 -----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP- 276
Query: 359 DYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS--RKELKRIILIALRCVDPDIKHRP 416
Y M ++ I YV D + P EL ++ C RP
Sbjct: 277 -YYG-----------MAHEEVIYYVRDGNILACPENCPLELYNLM---RLCWSKLPADRP 321
Query: 417 KMGDVLRMLE 426
+ R+L+
Sbjct: 322 SFCSIHRILQ 331
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 63/344 (18%), Positives = 132/344 (38%), Gaps = 44/344 (12%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEE--DFIEKVEAIGQVKHK 209
+ + I G G D + +K + + +S +E + +V + +KH
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
N+V+ E + +V +Y + G+L + ++ G D + L ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHV 141
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-----GYL 324
H+ KI+H ++KS NI L ++ D G+A++ ++++ EL + YL
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV------LNSTVELARACIGTPYYL 192
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVAQQKIAYV 383
+ E+ +N KSD+++ G ++ E+ + + S + KI
Sbjct: 193 SPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-----------LKIISG 240
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM--LEPR------DLLLREE 435
P + S +L+ ++ + +P + RP + +L + R L+ EE
Sbjct: 241 SFPPVSLHYS-YDLRSLVSQLFK-RNP--RDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296
Query: 436 YRIKRAASYHNYPQKNKTAVLCDADISTHDEENRAHEPDHENPP 479
+ +K + + + P K IS + P
Sbjct: 297 FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 26/212 (12%)
Query: 158 QNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLV 212
I G G V++ + + + A+K + + E F+++ + Q H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
KL G E ++ E G L+ +L L + + + LAYL
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK 135
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL------AE 326
+ VH ++ + N+L+ + K+ D GL++ + S + S A
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAP 186
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
E S F SDV+ FG+ + EI+ G P
Sbjct: 187 E-SINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 58/291 (19%), Positives = 111/291 (38%), Gaps = 54/291 (18%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
F E +I SG G V++A +D +K + E +V+A+ ++ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVH 68
Query: 214 LFGYCVEGQNRI----------------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK 257
G + E+ D G L+QW+ G + L ++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALE 126
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE 317
+ + KG+ Y+H K+++ ++K SNI L KI D GL + + S
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182
Query: 318 LRNSG---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374
G Y++ E + ++ D+Y+ G+++ E++
Sbjct: 183 ----GTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTA---------------F 222
Query: 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
+ + D + ++ K+ K ++ L P + RP ++LR L
Sbjct: 223 ETSKFFTDLRDGIISDIFD-KKEKTLLQKLLS-KKP--EDRPNTSEILRTL 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 3e-21
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 158 QNVIASGDNGVVYRAVLL---DNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVK 213
+ G+ G V + V + A+K+L + + E+ + + + + Q+ + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
L G C + + +LV E G L ++L G E + +++ + G+ YL E
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 455
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL-----AEEL 328
VH N+ + N+LL + KISD GL+K G + S T+ R++G A E
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---RSAGKWPLKWYAPE- 509
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
F+ +SDV+S+G+ + E +S G+ P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 63/281 (22%), Positives = 124/281 (44%), Gaps = 30/281 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL-MSNSVSEEE--DFIEKVEAIGQVKH 208
F + I G VYRA LLD + A+K + + + + + D I++++ + Q+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
N++K + +E +V E D G+L + + + + + T K L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---Y 323
+H +++H ++K +N+ + K+ D+GL + S+ +S G Y
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYY 202
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
++ E +N KSD++S G L+ E+ + + P F D + +KI
Sbjct: 203 MSPERIHENG-YNFKSDIWSLGCLLYEMAALQSP--------FYGDKMNLYSLCKKIEQC 253
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
P LP +EL++++ + + DP + RP + V +
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCIN-PDP--EKRPDVTYVYDV 291
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 50/226 (22%)
Query: 167 GVVYRAVLLD--------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFG 216
G V A + + AVK+L + + + D + ++E + + KHKN++ L G
Sbjct: 49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKIIQGTAK 264
C + ++ EY GNL+++L + + +T+ + A+
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
G+ YL K +H ++ + N+L+ + KI+D GLA+ ++ N Y
Sbjct: 169 GMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR------------DINNIDYY 213
Query: 325 AEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ +GR ++ +SDV+SFG+L+ EI + G P
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218
G V A ++ AVK+L S E+E + +++ + + +H+N+V L G C
Sbjct: 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 219 VEGQNRILVYEYIDNGNLQQWL----------HGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
G +++ EY G+L +L + + A+G+A+
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL--HGPEWSISTSCEL--RNSGYL 324
L +H ++ + N+LL + KI D GLA+ + + + + L + ++
Sbjct: 180 LA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK---WM 233
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
A E S ++ +SDV+S+GIL+ EI S G P
Sbjct: 234 APE-SIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 57/232 (24%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
G V +A AVK+L N S SE D + + + QV H +++KL+G C
Sbjct: 37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96
Query: 220 EGQNRILVYEYIDNGNLQQWL--------------------HGSLGEAKPLTWDTRMKII 259
+ +L+ EY G+L+ +L + + LT +
Sbjct: 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
++G+ YL E K+VH ++ + NIL+ KISD GL++ ++
Sbjct: 157 WQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR------------DVY 201
Query: 320 NSGY-------------LAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
+A E S I+ +SDV+SFG+L+ EIV+ G P
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 40/221 (18%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218
G V A M AVK+L + ++E E + +++ + + H N+V L G C
Sbjct: 37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96
Query: 219 VEGQNRILVYEYIDNGNLQQWL--------------HGSLGEAKPLTWDTRMKIIQGTAK 264
G +++ EY G+L +L + L + + AK
Sbjct: 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG-- 322
G+A+L +H ++ + NILL H KI D GLA+ I G
Sbjct: 157 GMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD------IKNDSNYVVKGNA 207
Query: 323 -----YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
++A E S ++ +SDV+S+GI + E+ S G P
Sbjct: 208 RLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 57/278 (20%), Positives = 107/278 (38%), Gaps = 38/278 (13%)
Query: 160 VIASGDNGVVYRAVLLD----NMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
I G G V++ + + M A+K S S E F+++ + Q H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
G E ++ E G L+ +L L + + + LAYL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESK-- 510
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTS 333
+ VH ++ + N+L+ + K+ D GL++ + + ++ +L E ++ R
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-- 567
Query: 334 IFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD----PKL 388
F SDV+ FG+ + EI+ G P + + + I + + P
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP--F-----------QGVKNNDVIGRIENGERLPMP 614
Query: 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
P P + + +C D RP+ ++ L
Sbjct: 615 PNCP-----PTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 59/304 (19%), Positives = 117/304 (38%), Gaps = 72/304 (23%)
Query: 161 IASGDNGVVYRAV--LLDNMRA-AVKLLMSNSVSEEEDFIEK----VEAIGQVKHKNLVK 213
+ G V+ A R AVK+L ++ ++ + F + + + H +V
Sbjct: 20 LGFGGMSEVHLARDLRDH--RDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 214 LFGY-CVEGQNRILVY---EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
++ E L Y EY+D L+ +H P+T +++I + L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 132
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG------- 322
H++ I+H ++K +NI++ K+ D G+A+ + + +
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA-----DSGNSVTQTAAVIGTAQ 184
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382
YL+ E + R + +SDVYS G ++ E+++G P P V+ +AY
Sbjct: 185 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VS---VAY 229
Query: 383 -----------VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLE 426
L +L ++L AL +P+ +R + D++R+
Sbjct: 230 QHVREDPIPPSARHEGLSA-----DLDAVVLKALA-KNPE--NRYQTAAEMRADLVRVHN 281
Query: 427 PRDL 430
Sbjct: 282 GEPP 285
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 37/215 (17%)
Query: 158 QNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNL 211
+ G G V AVK L +++ + + ++++ + + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 212 VKLFGYCVE--GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
+K G C + + LV EY+ G+L+ +L + + Q +G+AYL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYL 150
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL- 328
H +H ++ + N+LLD+ KI D GLAK + Y E
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA----------VPEGHEYYRVREDG 197
Query: 329 ----------SGRTSIFNEKSDVYSFGILIMEIVS 353
+ F SDV+SFG+ + E+++
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 41/206 (19%), Positives = 81/206 (39%), Gaps = 20/206 (9%)
Query: 160 VIASGDNGVVYRA--VLLDNMRA-AVKLLMSNSVSEEEDFIEKVE----AIGQVKHKNLV 212
++ G G VY A + + R A+KL MS ++S + F +++ G+++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRE--RIVALKL-MSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+ + + I+ +L L PL + I++ L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-EELSGR 331
H ++K NIL+ + D G+A E + Y+A E S
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 332 TSIFNEKSDVYSFGILIMEIVSGRLP 357
+ ++D+Y+ ++ E ++G P
Sbjct: 211 HA--TYRADIYALTCVLYECLTGSPP 234
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 51/281 (18%), Positives = 98/281 (34%), Gaps = 60/281 (21%)
Query: 160 VIASGDNGVVYRAV--LLDNMRAAVKLLMSNSVSEEEDFIE--KVEA--IGQVKHKNLVK 213
IA G G +Y A+ ++ +K L+ S + + E + +V H ++V+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 214 LFGYCVEGQNRI------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
+F + VE +R +V EY+ +L++ L + + L+
Sbjct: 144 IFNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALS 196
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-E 326
YLH +V++++K NI+L K+ D+G S G+ A E
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE 247
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386
+ + +D+Y+ G + + + L
Sbjct: 248 IVRTGPT---VATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLPE 286
Query: 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPK----MGDVLR 423
P + + R++ R +DPD + R M L
Sbjct: 287 DDPVLKTYDSYGRLL---RRAIDPDPRQRFTTAEEMSAQLT 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 50/226 (22%)
Query: 167 GVVYRAVLLD--------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFG 216
G V A + + AVK+L S+ + + D I ++E + + KHKN++ L G
Sbjct: 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKIIQGTAK 264
C + ++ EY GNL+++L + S + L+ + A+
Sbjct: 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
G+ YL K +H ++ + N+L+ KI+D GLA+ ++ + Y
Sbjct: 203 GMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR------------DIHHIDYY 247
Query: 325 AEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ +GR I+ +SDV+SFG+L+ EI + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 50/226 (22%)
Query: 167 GVVYRAVLLD--------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFG 216
G V A + + AVK+L + + + D + ++E + + KHKN++ L G
Sbjct: 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKIIQGTAK 264
C + ++ EY GNL+++L + + +T+ + A+
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
G+ YL K +H ++ + N+L+ + KI+D GLA+ ++ N Y
Sbjct: 215 GMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR------------DINNIDYY 259
Query: 325 AEELSGR------------TSIFNEKSDVYSFGILIMEIVS-GRLP 357
+ +GR ++ +SDV+SFG+L+ EI + G P
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 42/271 (15%)
Query: 160 VIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
V+ G G+VY L N A+K + + E++ +KHKN+V+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 219 VEGQNRILVYEYIDNGNLQQWL---HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
E + E + G+L L G L + + + +GL YLH++
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI----GFYTKQILEGLKYLHDN--- 141
Query: 276 KIVHHNMKSSNILLDHHW-NPKISDVGLAKLHGPEWSISTSCELRNS--G---YLAEE-L 328
+IVH ++K N+L++ + KISD G +K ++ + G Y+A E +
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSK------RLAGINPCTETFTGTLQYMAPEII 195
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQ--VFLIDWLKSMVAQQKIAYVLD 385
+ + +D++S G I+E+ +G+ P + +PQ +F + K
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH----------- 244
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
P++PE S E K I L+C +PD R
Sbjct: 245 PEIPESMS-AEAKAFI---LKCFEPDPDKRA 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 39/220 (17%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218
G V A AVK+L + SE + +++ + + H N+V L G C
Sbjct: 41 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100
Query: 219 -VEGQNRILVYEYIDNGNLQQWL------------HGSLGEAKPLTWDTRMKIIQGTAKG 265
G +++ E+ GNL +L LT + + AKG
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG--- 322
+ +L K +H ++ + NILL KI D GLA+ I + G
Sbjct: 161 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGDAR 211
Query: 323 ----YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
++A E + ++ +SDV+SFG+L+ EI S G P
Sbjct: 212 LPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 55/319 (17%), Positives = 120/319 (37%), Gaps = 58/319 (18%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVK-LLMSNSVSEEEDFIEKVEAIGQVKHKN 210
F + G GVV+ A +D+ A+K + + N E + +V+A+ +++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 211 LVKLFGYCVEGQNRI------------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
+V+ F +E + + NL+ W++G + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHI 123
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
A+ + +LH ++H ++K SNI K+ D GL + T
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 319 RNSG-----------YLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF 366
+ Y++ E++ G + ++ K D++S G+++ E++ P +V
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELLY---PFSTQMERVR 235
Query: 367 LIDWLKSMVAQQKIAYVLDPKLPEMPSRK--ELKRIILIALRCVDPDIKHRPKMGDVLR- 423
+ + + K P + ++K ++ + P RP+ +++
Sbjct: 236 TL---------TDV---RNLKFPPLFTQKYPCEYVMV---QDMLSPSPMERPEAINIIEN 280
Query: 424 -----MLEPRDLLLREEYR 437
+ P +LR+ R
Sbjct: 281 AVFEDLDFPGKTVLRQRSR 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 44/268 (16%)
Query: 167 GVVYRAVLLDNMRA-AVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222
G VY A N A+K+L + + + E ++E ++H N+++++ Y +
Sbjct: 28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY-FHDR 86
Query: 223 NRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
RI L+ E+ G L + L HG E ++ A L Y HE K++H
Sbjct: 87 KRIYLMLEFAPRGELYKELQKHGRFDE------QRSATFMEELADALHYCHER---KVIH 137
Query: 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEE-LSGRTSIF 335
++K N+L+ + KI+D G + H P T C G YL E + G+T
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTMC-----GTLDYLPPEMIEGKT--H 189
Query: 336 NEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRK 395
+EK D++ G+L E + G P D ++I V D K P S
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSH----------TETHRRIVNV-DLKFPPFLS-D 237
Query: 396 ELKRIILIALRCVDPDIKHRPKMGDVLR 423
K +I + + R + V+
Sbjct: 238 GSKDLI---SKLLRYHPPQRLPLKGVME 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 56/292 (19%), Positives = 112/292 (38%), Gaps = 47/292 (16%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGY 217
V+A G VY A + A+K L+SN + I++V + ++ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 218 CV-------EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
GQ L+ + G L ++L + PL+ DT +KI T + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
+P I+H ++K N+LL + K+ D G A S + + EE++
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT--ISHYPDYSWSAQRRALVEEEITR 210
Query: 331 RTSIF---------------NEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375
T+ EK D+++ G ++ + + P + + +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-----------AKL 259
Query: 376 AQQKIAYVLDPKLPEMPSR-KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
Y +P ++ +I + + + R + +V+ L+
Sbjct: 260 RIVNGKY----SIPPHDTQYTVFHSLI---RAMLQVNPEERLSIAEVVHQLQ 304
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 167 GVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218
G V A +++ AVK+L SE E + +++ + Q+ H+N+V L G C
Sbjct: 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 219 VEGQNRILVYEYIDNGNLQQWL-------------------HGSLGEAKPLTWDTRMKII 259
L++EY G+L +L + LT++ +
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
AKG+ +L VH ++ + N+L+ H KI D GLA+ I +
Sbjct: 179 YQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR------DIMSDSNYV 229
Query: 320 NSG-------YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
G ++A E S I+ KSDV+S+GIL+ EI S G P
Sbjct: 230 VRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 63/280 (22%), Positives = 101/280 (36%), Gaps = 39/280 (13%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQV-KH 208
F + + G G V++ D AVK MS + + +V + +V +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
V+L EG L E +LQQ L ++ T LA+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAH 172
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLA 325
LH +VH ++K +NI L K+ D GL G + G Y+A
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMA 224
Query: 326 EE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384
E L G + +DV+S G+ I+E+ + L Q L
Sbjct: 225 PELLQGS---YGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---------QGY---L 269
Query: 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
P+ S EL+ ++ + ++PD K R +L +
Sbjct: 270 PPEFTAGLS-SELRSVL---VMMLEPDPKLRATAEALLAL 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 53/270 (19%), Positives = 101/270 (37%), Gaps = 41/270 (15%)
Query: 158 QNVIASGDNGVVYRAVLLDN-MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFG 216
Q + G G V+R + AVK + EE + A + +V L+G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-----LVACAGLSSPRIVPLYG 117
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
EG + E ++ G+L Q + G L E D + + +GL YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE------DRALYYLGQALEGLEYLHTR-- 169
Query: 275 PKIVHHNMKSSNILLDHHWNP-KISDVGLAKLHGPEWSISTSCELRNS--G---YLAEEL 328
+I+H ++K+ N+LL + + D G A + S + G ++A E+
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQV-FLIDWLKSMVAQQKIAYVLDP 386
+ K D++S +++ +++G P Y + + I ++
Sbjct: 228 VMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPI----R 276
Query: 387 KLPEMPSRKELKRIILIALRCVDPDIKHRP 416
++P + + I + + HR
Sbjct: 277 EIPPSCA-PLTAQAI---QEGLRKEPVHRA 302
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 48/234 (20%), Positives = 92/234 (39%), Gaps = 28/234 (11%)
Query: 150 IVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVK 207
+ +++ G V+R A+K+ + S D + E + ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 208 HKNLVKLFGY--CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
HKN+VKLF ++++L+ E+ G+L L A L + +++ G
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGG 124
Query: 266 LAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLAKLHGPEWSISTSCELRNS 321
+ +L E+ IVH N+K NI+ D K++D G A+ + +
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY----- 176
Query: 322 G---YLAEELSGRTSI-------FNEKSDVYSFGILIMEIVSGRLP-VDYSQPQ 364
G YL ++ R + + D++S G+ +G LP + P+
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 36/308 (11%), Positives = 81/308 (26%), Gaps = 59/308 (19%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--------EEEDFIEK----------- 199
V+ D A V + +EE +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 200 ------VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI-------DNGNLQQWLHGSLGE 246
+ VK K+ ++ ++ ++ + + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 247 AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306
K L R+++ + LA LH +VH ++ +I+LD ++
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 307 GPEWSISTSCELRNSGYLAEEL----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362
G AE + ++ D ++ G+ I I LP +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-NTDD 320
Query: 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422
+ +W+ +P+ ++ ++ + + R +
Sbjct: 321 AALGGSEWIFR----------SCKNIPQ-----PVRALL---EGFLRYPKEDRLLPLQAM 362
Query: 423 RMLEPRDL 430
E L
Sbjct: 363 ETPEYEQL 370
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 53/270 (19%), Positives = 104/270 (38%), Gaps = 46/270 (17%)
Query: 167 GVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKV----EAIGQVKHKNLVKLFGYCVEG 221
+ D A K++ + + + EK+ + H+++V G+ E
Sbjct: 29 AKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGF-FED 86
Query: 222 QNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ + +V E +L + +L E + R ++ G YLH + +++
Sbjct: 87 NDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLGCQYLHRN---RVI 137
Query: 279 HHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSG---YLAEE-LSGRTS 333
H ++K N+ L+ KI D GLA K+ C G Y+A E LS +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-----GTPNYIAPEVLSKKG- 191
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
+ + DV+S G ++ ++ G+ P F LK +I + +P+ +
Sbjct: 192 -HSFEVDVWSIGCIMYTLLVGKPP--------FETSCLKET--YLRIKKN-EYSIPKHIN 239
Query: 394 RKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+I + + D RP + ++L
Sbjct: 240 -PVAASLI---QKMLQTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 53/270 (19%), Positives = 104/270 (38%), Gaps = 46/270 (17%)
Query: 167 GVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKV----EAIGQVKHKNLVKLFGYCVEG 221
+ D A K++ + + + EK+ + H+++V G+ E
Sbjct: 55 AKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGF-FED 112
Query: 222 QNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ + +V E +L + +L E + R ++ G YLH + +++
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTE-----PEAR-YYLRQIVLGCQYLHRN---RVI 163
Query: 279 HHNMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSG---YLAEE-LSGRTS 333
H ++K N+ L+ KI D GLA K+ C G Y+A E LS +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-----GTPNYIAPEVLSKKG- 217
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
+ + DV+S G ++ ++ G+ P F LK +I + +P+ +
Sbjct: 218 -HSFEVDVWSIGCIMYTLLVGKPP--------FETSCLKET--YLRIKKN-EYSIPKHIN 265
Query: 394 RKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+I + + D RP + ++L
Sbjct: 266 -PVAASLI---QKMLQTDPTARPTINELLN 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 43/292 (14%)
Query: 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIG-- 204
+++ D + G GVV + + AVK + + S+E+ + I
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
V V +G + + E +D +L ++ + + + + D KI K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG-- 322
L +LH + ++H ++K SN+L++ K+ D G+ S L +
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGI------------SGYLVDDVAK 166
Query: 323 --------YLAEE---LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371
Y+A E ++ KSD++S GI ++E+ R P Y W
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YD-------SWG 217
Query: 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+++ P+LP E +C+ + K RP ++++
Sbjct: 218 TPFQQLKQVVEEPSPQLPADKFSAEFVDFT---SQCLKKNSKERPTYPELMQ 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 48/234 (20%), Positives = 92/234 (39%), Gaps = 28/234 (11%)
Query: 150 IVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVK 207
+ +++ G V+R A+K+ + S D + E + ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 208 HKNLVKLFGY--CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
HKN+VKLF ++++L+ E+ G+L L A L + +++ G
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGG 124
Query: 266 LAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLAKLHGPEWSISTSCELRNS 321
+ +L E+ IVH N+K NI+ D K++D G A+ + +
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY----- 176
Query: 322 G---YLAEELSGRTSI-------FNEKSDVYSFGILIMEIVSGRLP-VDYSQPQ 364
G YL ++ R + + D++S G+ +G LP + P+
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 50/280 (17%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNL--VKL 214
I SG + V++ + A+K + + + + ++ + +++ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ Y + Q +V E N +L WL + K + R + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKL---HGPEWSISTSC--------ELRNSGY 323
IVH ++K +N L+ K+ D G+A + E
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
+ E S + KSDV+S G ++ + G+ P Q+ + I
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------HAIIDPN 237
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ + P++P K+L+ ++ C+ D K R + ++L
Sbjct: 238 HEIEFPDIPE-KDLQDVL---KCCLKRDPKQRISIPELLA 273
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-18
Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 41/268 (15%)
Query: 167 GVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVE---AI-GQVKHKNLVKLFGYCVEG 221
VYRA + + A+K++ ++ + +++V+ I Q+KH ++++L+ Y E
Sbjct: 25 AGVYRAESIHTGLEVAIKMIDKKAM-YKAGMVQRVQNEVKIHCQLKHPSILELYNY-FED 82
Query: 222 QNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
N + LV E NG + ++L KP + + + G+ YLH I+H
Sbjct: 83 SNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHR 136
Query: 281 NMKSSNILLDHHWNPKISDVGLA-KLHGPEWSISTSCELRNSG---YLAEE-LSGRTSIF 335
++ SN+LL + N KI+D GLA +L P T C G Y++ E +
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-----GTPNYISPEIATRSA--H 189
Query: 336 NEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRK 395
+SDV+S G + ++ GR P F D +K+ K+ D ++P S
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP--------FDTDTVKNT--LNKVVLA-DYEMPSFLS-I 237
Query: 396 ELKRIILIALRCVDPDIKHRPKMGDVLR 423
E K +I + + + R + VL
Sbjct: 238 EAKDLI---HQLLRRNPADRLSLSSVLD 262
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 50/280 (17%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNL--VKL 214
I SG + V++ + A+K + + + + ++ + +++ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ Y + Q +V E N +L WL + K + R + + + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKL---HGPEWSISTSC--------ELRNSGY 323
IVH ++K +N L+ K+ D G+A + E
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
+ E S + KSDV+S G ++ + G+ P Q+ + I
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------HAIIDPN 256
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ + P++P K+L+ ++ C+ D K R + ++L
Sbjct: 257 HEIEFPDIPE-KDLQDVL---KCCLKRDPKQRISIPELLA 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 36/302 (11%), Positives = 80/302 (26%), Gaps = 60/302 (19%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEED----------------------- 195
V+ D A V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 196 -----FIEKVEAIGQVKHKNLVKLFGYC--VEGQNRILVYE--YIDNGNLQQWLHGSLGE 246
FI + + + K ++++ + +R +Y + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 247 AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306
K L R+++ + LA LH +VH ++ +I+LD ++
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 307 GPEWSISTSC-----ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYS 361
G S S EL R ++ D ++ G++I I LP
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---- 312
Query: 362 QPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421
+ + + + +P+ ++ ++ + + R
Sbjct: 313 ----I---TKDAALGGSEWIFRSCKNIPQ-----PVRALL---EGFLRYPKEDRLLPLQA 357
Query: 422 LR 423
+
Sbjct: 358 ME 359
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEK 199
+ K ++ D F + + + +G+ GVV++ + A KL+ + I +
Sbjct: 21 LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 200 -VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
++ + + +V +G + E++D G+L Q L +A + K+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKV 136
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
KGL YL E + KI+H ++K SNIL++ K+ D G+ S +L
Sbjct: 137 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV------------SGQL 182
Query: 319 RNS---------GYLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+S Y++ E L G ++ +SD++S G+ ++E+ GR P
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 50/280 (17%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNL--VKL 214
I SG + V++ + A+K + + + + ++ + +++ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ Y + Q +V E N +L WL + K + R + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKL---HGPEWSISTSC--------ELRNSGY 323
IVH ++K +N L+ K+ D G+A + E
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
+ E S + KSDV+S G ++ + G+ P Q+ + I
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------HAIIDPN 284
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ + P++P K+L+ ++ C+ D K R + ++L
Sbjct: 285 HEIEFPDIPE-KDLQDVL---KCCLKRDPKQRISIPELLA 320
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 57/333 (17%), Positives = 108/333 (32%), Gaps = 44/333 (13%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLF-- 215
+ +G G V R + + A+K + + ++ + ++ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 216 ----GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
+L EY + G+L+++L+ L ++ + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 272 DIEPKIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSG---YLA 325
+ +I+H ++K NI+L KI D+G AK + G YLA
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-----GTLQYLA 191
Query: 326 -EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPV-DYSQPQVFLI-----------DWLK 372
E L + + D +SFG L E ++G P QP + +
Sbjct: 192 PELLEQKK--YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLL 432
A + + + P +L+R + L + G +
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM-WHQR-----QRGTDPQNPNVGCFQA 303
Query: 433 REEYRIKRAASYHNYPQKNKTAVLCDADISTHD 465
+ + S N + + +
Sbjct: 304 LDSILSLKLLSVMNMVSGRVHTYPVTENENLQN 336
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 33/291 (11%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIG 204
+ D + + I G G V + V AVK + S +E+ + +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 205 --QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262
+V+ +G + + E + + + + + + KI T
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL-AKLHGPEWSISTSCELRNS 321
K L +L E KI+H ++K SNILLD N K+ D G+ +L + + + R++
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDA 186
Query: 322 G---YLAEE---LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375
G Y+A E S ++ +SDV+S GI + E+ +GR P + + V
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS----VFDQLTQV 242
Query: 376 AQQKIAYVLDPKLPEMPSRK---ELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ P+L R+ + C+ D RPK ++L+
Sbjct: 243 VKGDP-----PQLSNSEEREFSPSFINFV---NLCLTKDESKRPKYKELLK 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 37/282 (13%)
Query: 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
F ++V+ G G + + DN AVK ++ S + ++ + + H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE--HPNVIRY 83
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWL---HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
F + Q + + E LQ+++ + +P+T ++Q T GLA+LH
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT------LLQQTTSGLAHLHS 136
Query: 272 DIEPKIVHHNMKSSNILL-----DHHWNPKISDVGLAK-LHGPEWSISTSCELRNS-GYL 324
IVH ++K NIL+ ISD GL K L S S + + G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 325 AEEL--SGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
A E+ D++S G + ++S G P S + I A
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------LLGA 244
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
LD PE + +I + + D + RP VL+
Sbjct: 245 CSLDCLHPEKHEDVIARELI---EKMIAMDPQKRPSAKHVLK 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 56/277 (20%), Positives = 114/277 (41%), Gaps = 37/277 (13%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
+ I G +G VY A+ + A++ + ++E I ++ + + K+ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ G +V EY+ G+L + + + + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---YLAEEL 328
+++H ++KS NILL + K++D G I+ R++ G ++A E+
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEV 187
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
R + + K D++S GI+ +E++ G P P + A IA P+L
Sbjct: 188 VTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENP----------LRALYLIATNGTPEL 236
Query: 389 PEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLR 423
P + + + L +D + R ++L+
Sbjct: 237 QN-PEKLSAIFRDFLNRCL-EMDVE--KRGSAKELLQ 269
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 72/307 (23%), Positives = 133/307 (43%), Gaps = 44/307 (14%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLV 212
F + I G G V++ + A+K++ + + E ED +++ + Q +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
K +G ++ ++ EY+ G+ L E PL I++ KGL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---YLAEE 327
K +H ++K++N+LL H K++D G+A ++ + RN+ G ++A E
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAG------QLTDTQIKRNTFVGTPFWMAPE 189
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387
+ +++ ++ K+D++S GI +E+ G P +S+ L M I P
Sbjct: 190 VIKQSA-YDSKADIWSLGITAIELARGEPP--HSE--------LHPMKVLFLIPKNNPPT 238
Query: 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL------RMLEPRDLL--LREEYRIK 439
L S K LK + L +P RP ++L R + L L + Y+
Sbjct: 239 LEGNYS-KPLKEFVEACL-NKEP--SFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRW 294
Query: 440 RAASYHN 446
+A H+
Sbjct: 295 KAEQSHD 301
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKN 210
D + Q VI SG VV A + A+K + + + ++ +++++A+ Q H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNL----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
+V + V LV + + G++ + + ++ L T I++ +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL-AKLHGPEWSISTSCELRNS--G- 322
YLH++ +H ++K+ NILL + +I+D G+ A L +R + G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK--VRKTFVGT 189
Query: 323 --YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
++A E+ + ++ K+D++SFGI +E+ +G P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 65/313 (20%), Positives = 121/313 (38%), Gaps = 57/313 (18%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
+ + G G VY+A AA K++ + S E ED+I ++E + H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
L G ++ E+ G + + + LT + + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGL-AKLHG-----------PEW---SISTSCEL 318
+I+H ++K+ N+L+ + +++D G+ AK P W + +
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378
+++ Y + K+D++S GI ++E+ P + + L M
Sbjct: 195 KDTPY------------DYKADIWSLGITLIEMAQIEPP--HHE--------LNPMRVLL 232
Query: 379 KIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVL-----RMLEPRDLL 431
KIA P L PS+ E + + IAL +P + RP +L + L
Sbjct: 233 KIAKSDPPTLLT-PSKWSVEFRDFLKIAL-DKNP--ETRPSAAQLLEHPFVSSITSNKAL 288
Query: 432 --LREEYRIKRAA 442
L E + +
Sbjct: 289 RELVAEAKAEVME 301
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 59/303 (19%), Positives = 106/303 (34%), Gaps = 52/303 (17%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEK 199
+ I + + + SG G V++ AVK + + EE I
Sbjct: 13 LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72
Query: 200 VEAI--GQVKHKNLVKLFGYCVEGQNRILVYEYIDNG--NLQQWLHGSLGEAKPLTWDTR 255
+ +V+ FG + + + E + L++ + G + E
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE------RIL 126
Query: 256 MKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTS 315
K+ K L YL E + ++H ++K SNILLD K+ D G+ S
Sbjct: 127 GKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGI------------S 172
Query: 316 CELRNSG----------YLAEE----LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYS 361
L + Y+A E ++ ++DV+S GI ++E+ +G+ P Y
Sbjct: 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YK 230
Query: 362 QPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS-RKELKRIILIALRCVDPDIKHRPKMGD 420
+ K+ P LP + + + C+ D + RPK
Sbjct: 231 -------NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV---KDCLTKDHRKRPKYNK 280
Query: 421 VLR 423
+L
Sbjct: 281 LLE 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 66/320 (20%), Positives = 123/320 (38%), Gaps = 47/320 (14%)
Query: 141 IRISLKEIDIVTD---GFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDF 196
+ +L+ + D I G G+V A + AVK++ E
Sbjct: 30 FKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL 89
Query: 197 IEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRM 256
+V + +H N+V+++ + G+ ++ E++ G L + L +
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIA 144
Query: 257 KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316
+ + + LAYLH ++H ++KS +ILL K+SD G IS
Sbjct: 145 TVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA------QISKDV 195
Query: 317 ELRNS--G---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371
R S G ++A E+ R+ + + D++S GI+++E+V G P P
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSP-------- 246
Query: 372 KSMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVL-----RM 424
+ A +++ PKL + L+ + L DP R ++L
Sbjct: 247 --VQAMKRLRDSPPPKLKN-SHKVSPVLRDFLERML-VRDPQ--ERATAQELLDHPFLLQ 300
Query: 425 LEPRDLL--LREEYRIKRAA 442
+ L L + YR + +
Sbjct: 301 TGLPECLVPLIQLYRKQTST 320
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 42/224 (18%), Positives = 80/224 (35%), Gaps = 29/224 (12%)
Query: 152 TDGFAEQNVIASGDN--GVVYRAV-LLDNMRAAVKLL-MSNSVSEEEDFIEK-VEAIGQV 206
+ VI G V A V+ + + +E F++ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
H N+V + +V ++ G+ + + + + I+QG K L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKAL 141
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA------------KLHGPEWSIST 314
Y+H VH ++K+S+IL+ +S + P++S+
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 315 SCELRNSGYLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+L+ E L ++ KSD+YS GI E+ +G +P
Sbjct: 199 LP------WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 36/245 (14%), Positives = 79/245 (32%), Gaps = 29/245 (11%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDN------MRAAVKLLMSNSVSEEEDFIEK 199
E + + +++ G VY A D + +K+ + E +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL-HGSLGEAKPLTWDTRMKI 258
+E + +K + + +LV E G L + K + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP-----------KISDVGLA---K 304
+ +H+ +I+H ++K N +L + + + D+G + K
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 305 LHGPEWSISTSCELRNSGYLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
L + CE SG+ E LS + +N + D + + ++ G ++
Sbjct: 235 LFPKGTIFTAKCET--SGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 364 QVFLI 368
Sbjct: 291 GECKP 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 145 LKEIDIVTDG---FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKV 200
L E + F + G G VY+A+ A+K + S+ ++ I+++
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEI 75
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+ Q ++VK +G + + +V EY G++ + K LT D I+Q
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQ 132
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
T KGL YLH + +H ++K+ NILL+ + K++D G+A ++ + RN
Sbjct: 133 STLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG------QLTDTMAKRN 183
Query: 321 S--G---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ G ++A E+ +N +D++S GI +E+ G+ P
Sbjct: 184 TVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPP 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 35/210 (16%), Positives = 75/210 (35%), Gaps = 38/210 (18%)
Query: 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNIL 288
+ NL+ W++ + I A+ + +LH ++H ++K SNI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDR-EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIF 196
Query: 289 LDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG-----------YLA-EELSGRTSIFN 336
K+ D GL + T + Y++ E++ G ++
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN--YS 254
Query: 337 EKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRK- 395
K D++S G+++ E++ M + I V + K P + ++K
Sbjct: 255 HKVDIFSLGLILFELLYSFST---------------QMERVRIITDVRNLKFPLLFTQKY 299
Query: 396 -ELKRIILIALRCVDPDIKHRPKMGDVLRM 424
+ ++ + P RP+ D++
Sbjct: 300 PQEHMMV---QDMLSPSPTERPEATDIIEN 326
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 31/280 (11%), Positives = 84/280 (30%), Gaps = 52/280 (18%)
Query: 160 VIASGDNGVVYRAV--LLDNMRA-AVKLLMSNSVSEE---EDFIEKVEAIGQVKHKNLVK 213
++A+ LD R A+ + V + ++ + + + ++ + +
Sbjct: 38 FHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ ++V E+I G+LQ+ + ++ +Q A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 274 EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS 333
+ S + +S G L P + +
Sbjct: 149 --GVALSIDHPSRVR--------VSIDGDVVLAYP-------------ATMPDA------ 179
Query: 334 IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
N + D+ G + ++ R P+ + + L + Q +D +P
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF--- 234
Query: 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLR 433
++ + +++ D I+ + ++++
Sbjct: 235 --QISAVAARSVQ-GDGGIRSASTLLNLMQQATAVADRTE 271
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK----VEAIGQVKHKNLVKLF 215
I G+ V A +L A+K++ ++ ++K V + + H N+VKLF
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS--LQKLFREVRIMKILNHPNIVKLF 80
Query: 216 GYCVEGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+E + + L+ EY G + +L HG + E + R K Q + Y H+
Sbjct: 81 -EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSKFRQ-IVSAVQYCHQK 133
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
+IVH ++K+ N+LLD N KI+D G + + C Y A EL
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP--YAAPELFQGK 188
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLPVD 359
+ DV+S G+++ +VSG LP D
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 64/302 (21%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 144 SLKEIDIVTDG-----FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFI 197
SL EID+ F ++ +G G VY+ + AA+K+ M + EEE+
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIK 68
Query: 198 EKVEAIGQV-KHKNLVKLFG-YCVEGQNRI-----LVYEYIDNGNLQQWLHGSLGEAKPL 250
+++ + + H+N+ +G + + + LV E+ G++ + + G L
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTL 126
Query: 251 TWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310
+ I + +GL++LH+ K++H ++K N+LL + K+ D G++
Sbjct: 127 KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA------ 177
Query: 311 SISTSCELRNS--G---YLAEEL----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYS 361
+ + RN+ G ++A E+ + ++ KSD++S GI +E+ G P
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--LC 235
Query: 362 QPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDV 421
+ M A I P+L K+ + I L + RP +
Sbjct: 236 D--------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL-VKNH--SQRPATEQL 284
Query: 422 LR 423
++
Sbjct: 285 MK 286
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKNLVKLF 215
+ G G V L + AVK+L + + + K++ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDV-VGKIKREIQNLKLFRHPHIIKL- 76
Query: 216 GYCV-EGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
Y V +V EY+ G L ++ HG + E ++ Q + Y H
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE------MEARRLFQQILSAVDYCHR 129
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEEL 328
+VH ++K N+LLD H N KI+D GL+ + + TSC G Y A E+
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEV 181
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
+ D++S G+++ ++ G LP D
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 159 NVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLF 215
+ SG G V + ++ A+K++ SVS +E+V + + H N++KL+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ + +N LV E G L + E D II+ G+ YLH+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-----DAA-VIIKQVLSGVTYLHKH- 155
Query: 274 EPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-EELS 329
IVH ++K N+LL + KI D GL+ + + + + Y+A E L
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR 211
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ ++EK DV+S G+++ +++G P
Sbjct: 212 KK---YDEKCDVWSIGVILFILLAGYPP 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 52/236 (22%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLL----------------------MSNSVSEEEDFI 197
I G GVV A DN A+K+L + I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 198 EKVE---AIGQ-VKHKNLVKLFGYCV-EGQNR---ILVYEYIDNGNLQQWLHGSLGEAKP 249
E+V AI + + H N+VKL V + N +V+E ++ G + + KP
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKP 133
Query: 250 LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GP 308
L+ D Q KG+ YLH KI+H ++K SN+L+ + KI+D G++ G
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 309 EWSISTSCELRNSG---YLA-EELSGRTSIFN-EKSDVYSFGILIMEIVSGRLPVD 359
+ +S + G ++A E LS IF+ + DV++ G+ + V G+ P
Sbjct: 191 DALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 25/214 (11%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKNLVKL 214
++ G G V + R AVK+L + + V+ + +++HKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 215 FG-YCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
E + ++ +V EY G + + S+ E K GL YLH
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS---ISTSCELRNSG---YLA- 325
IVH ++K N+LL KIS +G+A+ P + TS G +
Sbjct: 129 ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-----GSPAFQPP 180
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
E +G + K D++S G+ + I +G P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 62/295 (21%), Positives = 100/295 (33%), Gaps = 50/295 (16%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLL---MSNSVSEEEDFIEKVEAIGQVKHKNLVKLF 215
++ G +G V AVK + + E + + H N+++ +
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----DDHPNVIRYY 75
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMK-IIQGTAKGLAYLHED 272
+ + E N NLQ + E L + +++ A G+A+LH
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 273 IEPKIVHHNMKSSNILLDHHWNP-------------KISDVGLAKLHGPEWSISTSCELR 319
KI+H ++K NIL+ ISD GL K S S L
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS-SFRTNLN 190
Query: 320 N----SGYLA-EELSGRTSIF-----NEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368
N SG+ A E L ++ D++S G + I+S G+ P
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--------- 241
Query: 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
D + + LD + LI+ + +D D RP VLR
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS-QMIDHDPLKRPTAMKVLR 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 159 NVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKL 214
V+ G G V + AVK++ V ++E + +V+ + Q+ H N++KL
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
+ + + LV E G L + E D +II+ G+ Y+H++
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAA-RIIRQVLSGITYMHKN 145
Query: 273 IEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-EEL 328
KIVH ++K N+LL N +I D GL+ + + Y+A E L
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVL 200
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
G ++EK DV+S G+++ ++SG P
Sbjct: 201 HGT---YDEKCDVWSTGVILYILLSGCPP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 34/219 (15%)
Query: 159 NVIASGDNGVVYRAV-LLDNMRAAVK-------------LLMSNSVSEEEDFIEKVEAIG 204
+ SG G V + A+K N E+ ++ +
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGT 262
+ H N++KLF + + LV E+ + G L + + E I++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA------ANIMKQI 155
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELR 319
G+ YLH+ IVH ++K NILL + N KI D GL+ ++ +
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--G 210
Query: 320 NSGYLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+ Y+A E L + +NEK DV+S G+++ ++ G P
Sbjct: 211 TAYYIAPEVLKKK---YNEKCDVWSCGVIMYILLCGYPP 246
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFGYC 218
+ G G V AV + AVK++ + + I+K + + H+N+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 219 VEGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
N L EY G L + + E + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------PDAQRFFHQLMAGVVYLHGI--- 124
Query: 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKL---HGPEWSISTSCELRNSG---YLAEELS 329
I H ++K N+LLD N KISD GLA + + E ++ C G Y+A EL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELL 179
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
R E DV+S GI++ +++G LP D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 155 FAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIG---QVKHKN 210
F++ I G G VY A + ++ A+K + + E + + ++ + +++H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 211 LVKLFGYCVEGQNRILVYEYIDNG--NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
++ G + LV EY +L + L E + + G +GLAY
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------VTHGALQGLAY 169
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS--G---Y 323
LH ++H ++K+ NILL K+ D G ++ NS G +
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----------SASIMAPANSFVGTPYW 216
Query: 324 LAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
+A E L+ ++ K DV+S GI +E+ + P
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 159 NVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLF 215
++ G G V + + AVK++ S + + +VE + ++ H N++KLF
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ + +V E G L + E D +II+ G+ Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFSGITYMHKH- 140
Query: 274 EPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA-EELS 329
IVH ++K NILL + + KI D GL+ + + Y+A E L
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR 196
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLP 357
G ++EK DV+S G+++ ++SG P
Sbjct: 197 GT---YDEKCDVWSAGVILYILLSGTPP 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK 209
V D + + +G GVV+R A K +M+ S++E ++++ + ++H
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWL---HGSLGEAKPLTWDTRMKIIQGTAKGL 266
LV L + +++YE++ G L + + H + E + ++ ++ KGL
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCKGL 268
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSGYL 324
++HE+ VH ++K NI+ + K+ D GL P+ S+ + + +
Sbjct: 269 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFA 323
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
A E++ + +D++S G+L ++SG P
Sbjct: 324 APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSP 355
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKNLVKLF 215
+ G G V L + AVK+L + + + K+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDV-VGKIRREIQNLKLFRHPHIIKL- 81
Query: 216 GYCV-EGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
Y V + I +V EY+ G L ++ +G L E ++ Q G+ Y H
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE------KESRRLFQQILSGVDYCHR 134
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEEL 328
+VH ++K N+LLD H N KI+D GL+ + + TSC G Y A E+
Sbjct: 135 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEV 186
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
+ D++S G+++ ++ G LP D
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLL----MSNSVSEEEDFIEKVE---AI-GQVKHKN 210
+ SG G V A + A++++ + + E D VE I ++ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
++K+ + + ++ +V E ++ G L + + L EA + + Y
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAVQY 254
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSG--- 322
LHE+ I+H ++K N+LL KI+D G +K+ G + T C G
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-----GTPT 306
Query: 323 YLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLP--VDYSQPQVF 366
YLA E +S T+ +N D +S G+++ +SG P +Q +
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVKHKNLVKLFGYC 218
+ G G V AV + AVK++ + + I+K + + H+N+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 219 VEGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
N L EY G L + + E + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------PDAQRFFHQLMAGVVYLHGI--- 124
Query: 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKL---HGPEWSISTSCELRNSG---YLAEELS 329
I H ++K N+LLD N KISD GLA + + E ++ C G Y+A EL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELL 179
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
R E DV+S GI++ +++G LP D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 9e-13
Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
I G G V AV +R A K + V + + F +++E + + H N+++L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 219 VEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ + LV E G L + + E+ D +I++ +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAA-RIMKDVLSAVAYCHKL---N 126
Query: 277 IVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEE-LS 329
+ H ++K N L K+ D GLA P + T G Y++ + L
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTPYYVSPQVLE 181
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVF 366
G + + D +S G+++ ++ G P + +V
Sbjct: 182 GL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVE----AIGQVKHKNLVKLF 215
+ G G V A + A+K + + + + +VE + ++H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM-HMRVEREISYLKLLRHPHIIKL- 74
Query: 216 GYCV-EGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
Y V I +V EY G L ++ + E D + Q + Y H
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE------DEGRRFFQQIICAIEYCHR 126
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEEL 328
KIVH ++K N+LLD + N KI+D GL+ + + TSC G Y A E+
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEV 178
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
+ DV+S GI++ ++ GRLP D
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 28/211 (13%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLM-SNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
+ SG G V+ + +K + S E ++E + + H N++K+F
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 218 CVEGQNRILVYEYIDNGNL------QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
+ N +V E + G L Q +L E ++++ LAY H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG-----YVA-ELMKQMMNALAYFHS 142
Query: 272 DIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE- 327
+VH ++K NIL H KI D GLA+L + + + + Y+A E
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG--TALYMAPEV 197
Query: 328 LSGRTSIFNEKSDVYSFGILIMEI-VSGRLP 357
K D++S G+ +M ++G LP
Sbjct: 198 FKRD---VTFKCDIWSAGV-VMYFLLTGCLP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 42/203 (20%), Positives = 83/203 (40%), Gaps = 18/203 (8%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK 209
V D + + SG GVV+R V K + + ++ ++ + Q+ H
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
L+ L + +L+ E++ G L + E ++ + ++ +GL ++
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSG---YL 324
HE IVH ++K NI+ + KI D GLA P+ + + +
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-----ATAEFA 217
Query: 325 AEELSGRTSIFNEKSDVYSFGIL 347
A E+ R + +D+++ G+L
Sbjct: 218 APEIVDREPV-GFYTDMWAIGVL 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 63/328 (19%), Positives = 125/328 (38%), Gaps = 45/328 (13%)
Query: 69 NHVHPHNTFSTSSLDR-RLLSCNTMSEIEMNLSKPDLQFMFSDRWSSGTSTNRCTRAQAN 127
+H H H++ + ++ R + + + + F+ S R S N A+
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKL 61
Query: 128 GNIRRSVSGMRLGIRISLKEIDIV---TDGFAEQ----NVIASGDNGVVYRAV-LLDNMR 179
+ + + + ++ F ++ +VI G + VV R V
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 180 AAVKLLMSNSVSEEEDFIEKVEAIGQ---------VKHKNLVKLFGYCVEGQNRILVYEY 230
AVK++ + + +E+V + H +++ L LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 231 IDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNIL 288
+ G L +L +L E +TR I++ + +++LH + IVH ++K NIL
Sbjct: 182 MRKGELFDYLTEKVALSEK-----ETR-SIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232
Query: 289 LDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEE-LSGRTSIF----NEKSD 340
LD + ++SD G + P + C G YLA E L ++ D
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLRELC-----GTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 341 VYSFGILIMEI-VSGRLP-VDYSQPQVF 366
+++ G+ I+ ++G P Q +
Sbjct: 288 LWACGV-ILFTLLAGSPPFWHRRQILML 314
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 19/205 (9%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
I SG+ GV L AVK + + +E E + ++H N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE-IINHRSLRHPNIVRFKE-VI 85
Query: 220 EGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ ++ EY G L + + G E D Q G++Y H +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSE------DEARFFFQQLLSGVSYCHSM---Q 136
Query: 277 IVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI 334
I H ++K N LLD P KI D G +K ++ Y+A E+ R
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--YIAPEVLLRQEY 194
Query: 335 FNEKSDVYSFGILIMEIVSGRLPVD 359
+ +DV+S G+ + ++ G P +
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 167 GVVYRAV-LLDNMRAAVKLL----MSNSVSEEEDFIEKVE---AI-GQVKHKNLVKLFGY 217
G V A + A+K++ + + E D VE I ++ H ++K+ +
Sbjct: 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83
Query: 218 CVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
+ ++ +V E ++ G L + + L EA + + YLHE+
Sbjct: 84 -FDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAVQYLHEN--- 133
Query: 276 KIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSG---YLAEE-L 328
I+H ++K N+LL KI+D G +K+ G + T C G YLA E L
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-----GTPTYLAPEVL 188
Query: 329 SGRTSI-FNEKSDVYSFGILIMEIVSGRLP--VDYSQPQVF 366
+ +N D +S G+++ +SG P +Q +
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 38/230 (16%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVK--------LLMSNSVSEEEDFIEK-VEAIGQVK-H 208
++ G + VV R + AVK + V E + K V+ + +V H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGL 266
N+++L LV++ + G L +L +L E +TR KI++ + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-KIMRALLEVI 137
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---Y 323
LH+ IVH ++K NILLD N K++D G + P + C G Y
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-----GTPSY 189
Query: 324 LAEE-LSGRTSIF----NEKSDVYSFGILIMEIV-SGRLP-VDYSQPQVF 366
LA E + + ++ D++S G+ IM + +G P Q +
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGV-IMYTLLAGSPPFWHRKQMLML 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 31/213 (14%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVK------LLMSNSVSEEEDFIEKVEAI 203
V D + + SG +V + + A K S E+ +V +
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQG 261
QV H N++ L + +L+ E + G L +L SL E + I Q
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----EATSFIKQ- 123
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAKLHGPEWSISTSCE 317
G+ YLH KI H ++K NI+L P K+ D GLA
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 318 LRNSG---YLAEELSGRTSIFNEKSDVYSFGIL 347
G ++A E+ + ++D++S G++
Sbjct: 180 ----GTPEFVAPEIVNYEPL-GLEADMWSIGVI 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 46/200 (23%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
++ ++ G G V++ ++ A K++ + + ++E+ ++ + Q+ H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 214 LFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLT-WDTRMKIIQGTAKGLAYLHED 272
L+ + +LV EY+D G L + + E+ LT DT + + Q +G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQ-ICEGIRHMHQM 206
Query: 273 IEPKIVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSG---YLAEE 327
I+H ++K NIL + KI D GLA+ + P + + G +LA E
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-----GTPEFLAPE 258
Query: 328 LSGRTSIFNEKSDVYSFGIL 347
+ + + +D++S G++
Sbjct: 259 VVNYDFV-SFPTDMWSVGVI 277
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 8e-11
Identities = 64/517 (12%), Positives = 163/517 (31%), Gaps = 154/517 (29%)
Query: 69 NHVHPHNTFSTSSLD---RRLLS-----------CNTMSEIEMN-LSKPDLQFMFSDRWS 113
+H H H F T + +LS C + ++ + LSK ++ +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIM---- 56
Query: 114 SGTSTNR------CTRAQANGNIRRSVSGMRLGIRISL-KEIDIVTDGFAEQNVIASGDN 166
S + + ++ +++ V L + + S
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEEMVQKFVEE-------VLRINYKFLMSPIKTEQRQPSMMT 109
Query: 167 G--VVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224
+ R L ++ + K +VS + +++ +A+ +++ V + G V G +
Sbjct: 110 RMYIEQRDRLYNDNQVFAKY----NVSRLQPYLKLRQALLELRPAKNVLIDG--VLGSGK 163
Query: 225 -ILVYEYIDNGNLQQ-------WLHGSLGEAKPLTWDTRMKIIQG--------------T 262
+ + + +Q WL +L + +T ++++Q
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWL--NLKNCN--SPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 263 AKGLAYLHEDIEPK----IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
+ + I+ + + ++ ++L + N K + + + SC++
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN-----------AFNLSCKI 268
Query: 319 ----RNSGYLAEELSG--RTSIFNEKSDV-----YSFGIL--IMEIVSGRLPVDYSQPQV 365
R + + LS T I + + +L ++ LP +V
Sbjct: 269 LLTTRFKQ-VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-----REV 322
Query: 366 FLIDWLK-SMVAQQKIAYVLDPKLPEMPSR---------KELKRIILIALRCVDP-DIKH 414
+ + S++A+ + + + +L II +L ++P + +
Sbjct: 323 LTTNPRRLSIIAE---------SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 415 R-------PK----MGDVLRML-------EPRDLL-------LREEYRIKRAASYHNYPQ 449
P +L ++ + ++ L E+ + S +
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 450 KNKTAVLCDADISTHD------EENRAHEPDHENPPW 480
+ K V + + + H + + D PP+
Sbjct: 434 ELK--VKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 8e-11
Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 35/216 (16%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVK------LLMSNSVSEEEDFIEKVEAI 203
V D + + SG +V + A K L S E+ +V +
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTR--MKII 259
+++H N++ L + +L+ E + G L +L SL E + +K I
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-----EATQFLKQI 117
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAKLHGPEWSISTS 315
G+ YLH +I H ++K NI+L P K+ D G+A
Sbjct: 118 ---LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 316 CELRNSG---YLAEELSGRTSIFNEKSDVYSFGILI 348
G ++A E+ + ++D++S G++
Sbjct: 172 F-----GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFG 216
++ G G V + + AVK++ S + + +VE + ++ H N++KLF
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
+ + +V E G L + E D +II+ G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFSGITYMHKH-- 140
Query: 275 PKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE-LSG 330
IVH ++K NILL + + KI D GL+ + + Y+A E L G
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG--TAYYIAPEVLRG 197
Query: 331 RTSIFNEKSDVYSFGILIMEIV-SGRLP 357
++EK DV+S G+ I+ I+ SG P
Sbjct: 198 T---YDEKCDVWSAGV-ILYILLSGTPP 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 47/215 (21%), Positives = 80/215 (37%), Gaps = 31/215 (14%)
Query: 161 IASGDNGVVYRAV-LLDNMRAAVKLL----MSNSVSEEEDFIEKV----EAIGQVKHKNL 211
+ SG G V+ AV N VK + + E+ + KV + +V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 212 VKLFGYCVEGQNRI-LVYE-YIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLA 267
+K+ E Q LV E + +L ++ H L E I + +
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE------PLASYIFRQLVSAVG 144
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YL 324
YL I+H ++K NI++ + K+ D G A T C G Y
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTIEYC 196
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
A E+ + +++S G+ + +V P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 47/213 (22%), Positives = 79/213 (37%), Gaps = 31/213 (14%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVK------LLMSNSVSEEEDFIEKVEAI 203
V D + + SG +V + + A K S E+ +V +
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQG 261
QV H N++ L + +L+ E + G L +L SL E + I+
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----EAT-SFIKQ 123
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAKLHGPEWSISTSCE 317
G+ YLH KI H ++K NI+L P K+ D GLA
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 318 LRNSG---YLAEELSGRTSIFNEKSDVYSFGIL 347
G ++A E+ + ++D++S G++
Sbjct: 180 ----GTPEFVAPEIVNYEPL-GLEADMWSIGVI 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 52/282 (18%), Positives = 98/282 (34%), Gaps = 61/282 (21%)
Query: 129 NIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVK---- 183
+ S R + + + + + I G GVV A+ A+K
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 184 -LLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL----QQ 238
+ + + E +V + ++ H N+ +L+ + Q LV E G+L
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 239 WLHGSLGEAKPLTWDTRM--------------------------------KIIQGTAKGL 266
++ S G+ T++ I++ L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 267 AYLHEDIEPKIVHHNMKSSNILL--DHHWNPKISDVGLAKLH-----GPEWSISTSCELR 319
YLH I H ++K N L + + K+ D GL+K G + ++T
Sbjct: 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA--- 235
Query: 320 NSG---YLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
G ++A E L+ + K D +S G+L+ ++ G +P
Sbjct: 236 --GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVK 207
+D + + + G VV R V + A K++ + +S + + + +++
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKG 265
H N+V+L E LV++ + G L + + EA D IQ +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILES 117
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSG 322
+AY H + IVH N+K N+LL K++D GLA + G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----G 169
Query: 323 ---YLAEELSGRTSIFNEKSDVYSFGILIMEIV-SGRLP-VDYSQPQVF 366
YL+ E+ + +++ D+++ G+ I+ I+ G P D Q +++
Sbjct: 170 TPGYLSPEVLKKDP-YSKPVDIWACGV-ILYILLVGYPPFWDEDQHRLY 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
V+ SG V+ L A+K + + + ++ + ++KH+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 219 VEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ LV + + G L + G E D +IQ + YLHE+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DAS-LVIQQVLSAVKYLHEN---G 126
Query: 277 IVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEELSG 330
IVH ++K N+L + + I+D GL+K+ +ST+C G Y+A E+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTAC-----GTPGYVAPEVLA 180
Query: 331 RTSIFNEKSDVYSFGILIMEIV-SGRLP-VDYSQPQVF 366
+ +++ D +S G+ I I+ G P + ++ ++F
Sbjct: 181 QKP-YSKAVDCWSIGV-ITYILLCGYPPFYEETESKLF 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMK 257
+ +V + Y +++ + + ++ G+L L HG EA M+
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------DMR 295
Query: 258 I-IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316
GL ++H +V+ ++K +NILLD H + +ISD+GLA + S
Sbjct: 296 FYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASV 351
Query: 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
GY+A E+ + ++ +D +S G ++ +++ G P
Sbjct: 352 G--THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 20/244 (8%)
Query: 109 SDRWSSGTSTNRCTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGV 168
S + + + + + + I D ++D F ++ + G +
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 169 VYRAVLLDNMRA-AVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227
VYR + A+K+L +++ ++ + ++ H N++KL LV
Sbjct: 69 VYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 228 YEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285
E + G L + G E D ++ + +AYLHE+ IVH ++K
Sbjct: 127 LELVTGGELFDRIVEKGYYSER-----DAA-DAVKQILEAVAYLHEN---GIVHRDLKPE 177
Query: 286 NILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVY 342
N+L KI+D GL+K+ + + T C GY A E+ + + + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG--TPGYCAPEILRGCA-YGPEVDMW 234
Query: 343 SFGI 346
S GI
Sbjct: 235 SVGI 238
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFG 216
+ G VV R V + A K++ + +S + + + +++H N+V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
E LV++ + G L + + EA D IQ + +AY H +
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILESIAYCHSN-- 147
Query: 275 PKIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSG---YLAEEL 328
IVH N+K N+LL K++D GLA + G YL+ E+
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GTPGYLSPEV 201
Query: 329 SGRTSIFNEKSDVYSFGILIMEIV-SGRLP-VDYSQPQVF 366
+ +++ D+++ G+ I+ I+ G P D Q +++
Sbjct: 202 LKKDP-YSKPVDIWACGV-ILYILLVGYPPFWDEDQHRLY 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 47/213 (22%), Positives = 82/213 (38%), Gaps = 31/213 (14%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVK------LLMSNSVSEEEDFIEKVEAI 203
V D + + SG VV + ++ A K S ED +V +
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQG 261
+++H N++ L + IL+ E + G L +L SL E + + ++
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA------TEFLKQ 122
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAKLHGPEWSISTSCE 317
G+ YLH +I H ++K NI+L P KI D GLA
Sbjct: 123 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 318 LRNSG---YLAEELSGRTSIFNEKSDVYSFGIL 347
G ++A E+ + ++D++S G++
Sbjct: 179 ----GTPEFVAPEIVNYEPL-GLEADMWSIGVI 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 47/260 (18%), Positives = 99/260 (38%), Gaps = 25/260 (9%)
Query: 113 SSGTSTNRCTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRA 172
SS + + G+ + + KE + + + ++ SG G VY
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 173 V-LLDNMRAAVKLLMSNSVSEEEDFIEK------VEAIGQVKHK--NLVKLFGYCVEGQN 223
+ + DN+ A+K + + +S+ + V + +V +++L + +
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 224 RILVYEYIDN-GNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+L+ E + +L ++ G+L E R + + + H ++H
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCHNC---GVLHR 173
Query: 281 NMKSSNILLD-HHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS 339
++K NIL+D + K+ D G L + + R Y E +
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRV--YSPPEWIRYHRYHGRSA 230
Query: 340 DVYSFGILIMEIVSGRLPVD 359
V+S GIL+ ++V G +P +
Sbjct: 231 AVWSLGILLYDMVCGDIPFE 250
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 35/160 (21%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVK-LLMSNSVSEEEDF----IEKVEAIGQVK 207
+ + + + G GVVY+A A+K + + E+E I ++ + ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H N+V L + LV+E+++ +L++ L + L + +G+A
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVA 133
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+ H+ +I+H ++K N+L++ K++D GLA+ G
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 34/147 (23%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 167 GVVYRAVLLDNMR--AAVKLLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLFGYCVE 220
G+V + D R A K L S+ +++ + +++ + Q++H+NLV L C +
Sbjct: 39 GMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ LV+E++D+ + L L + K + G+ + H I+H
Sbjct: 96 KKRWYLVFEFVDH-TILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHR 148
Query: 281 NMKSSNILLDHHWNPKISDVGLAKLHG 307
++K NIL+ K+ D G A+
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 31/208 (14%), Positives = 77/208 (37%), Gaps = 29/208 (13%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK 209
+ + + + G+ G+V+R V K + +++ +++ + +H+
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHR 61
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNL-----QQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
N++ L + ++++E+I ++ + E + + +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQV---CE 113
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSG 322
L +LH I H +++ NI+ + KI + G A+ P +
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-----T 165
Query: 323 ---YLAEELSGRTSIFNEKSDVYSFGIL 347
Y A E+ + + +D++S G L
Sbjct: 166 APEYYAPEVHQHDVV-STATDMWSLGTL 192
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 41/185 (22%), Positives = 82/185 (44%), Gaps = 20/185 (10%)
Query: 205 QVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK-----I 258
+V + +V L Y E + + LV ++ G+++ ++ + + R I
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQI 298
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCE 317
+ G L +LH+ I++ ++K N+LLD N +ISD+GLA +
Sbjct: 299 VSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377
G++A EL ++ D ++ G+ + E+++ R P ++ + LK V +
Sbjct: 352 --TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRVLE 407
Query: 378 QKIAY 382
Q + Y
Sbjct: 408 QAVTY 412
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGY 217
V+ G + V + L+ + AVK++ +VE + Q + H+N+++L +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 218 CVEGQNRILVYEYIDNGNL----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
E LV+E + G++ + H + EA + ++ + A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQDV---ASALDFLH--- 128
Query: 274 EPKIVHHNMKSSNILLDHHWNP---KISDVGLAKL--HGPEWSISTSCELRNS----GYL 324
I H ++K NIL +H KI D L + S ++ EL Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 325 AEE----LSGRTSIFNEKSDVYSFGILIMEIV-SGRLP 357
A E S SI++++ D++S G+ I+ I+ SG P
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGV-ILYILLSGYPP 225
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAK 264
KH+N+V+L+ LV+E++DN +L++++ + L + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
GLA+ HE+ KI+H ++K N+L++ K+ D GLA+ G
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 56/282 (19%), Positives = 100/282 (35%), Gaps = 54/282 (19%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAI-----------GQVK 207
++ G G V+ L D ++ A+K++ N V +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP-LSDSVTCPLEVALLWKVGAGGG 96
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGN-LQQWL--HGSLGEAKPLTWDTRMKIIQGTAK 264
H +++L + + +LV E L ++ G LGE +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-----PSR-CFFGQVVA 150
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNP-KISDVGLAKLHGPEWSISTSCELRNSGY 323
+ + H +VH ++K NIL+D K+ D G L + + R Y
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRV--Y 204
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
E R + V+S GIL+ ++V G +P + Q+I
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----------------RDQEI--- 245
Query: 384 LDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLR 423
L+ +L P+ + +I RC+ P RP + ++L
Sbjct: 246 LEAEL-HFPAHVSPDCCALI---RRCLAPKPSSRPSLEEILL 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 30/224 (13%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVK-----LLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
VI G VV R + + AVK S+ ED + +KH ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 214 LFGYCVEGQNRILVYEYIDNGNL------QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
L +V+E++D +L + EA ++ + L
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-----VAS-HYMRQILEALR 144
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNP---KISDVGLAK-LHGPEWSISTSCELRNSGY 323
Y H++ I+H ++K +LL N K+ G+A L +
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--GTPHF 199
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIV-SGRLPVDYSQPQVF 366
+A E+ R + + DV+ G+ I+ I+ SG LP ++ ++F
Sbjct: 200 MAPEVVKREP-YGKPVDVWGCGV-ILFILLSGCLPFYGTKERLF 241
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 7/103 (6%)
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
Q+KH NLV L + LV+EY D+ + L + + I T +
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY---QRGVPEHLVKSITWQTLQ 113
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
+ + H+ +H ++K NIL+ H K+ D G A+L
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMR--AAVKLLMSNSVSEEEDF----IEKVEAIGQV 206
+ F + I G GVVY+A A K+ + E E I ++ + ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKEL 59
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
H N+VKL LV+E++ +L++++ S + + +GL
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGL 116
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
A+ H +++H ++K N+L++ K++D GLA+ G
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 34/168 (20%), Positives = 68/168 (40%), Gaps = 32/168 (19%)
Query: 161 IASGDNGVVYRAVLLD---NMRAAVKLLMSNSVSEEEDFIEKVEAIGQV------KHKNL 211
+ G G VY+A D + A+K + E + A ++ KH N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGI--SMSACREIALLRELKHPNV 80
Query: 212 VKLFGYCVEGQNRI--LVYEYIDNGNLQQWLH-----GSLGEAKPLTWDTRMKIIQGTAK 264
+ L + +R L+++Y ++ +L + + + L ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAKLHGP 308
G+ YLH + ++H ++K +NIL+ KI+D+G A+L
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 13/180 (7%)
Query: 205 QVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI-IQGT 262
+V + +V L Y E ++ + LV ++ G+L+ ++ + + R
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEI 295
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
GL LH + +IV+ ++K NILLD H + +ISD+GLA +I G
Sbjct: 296 CCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG--TVG 350
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382
Y+A E+ + D ++ G L+ E+++G+ P + + + ++ +V + Y
Sbjct: 351 YMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPEEY 408
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEK-VEAIGQVK 207
+ + VI +G GVV++A L+++ A+K V +++ F + ++ + VK
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK-----KVLQDKRFKNRELQIMRIVK 90
Query: 208 HKNLVKLFGYCVEGQNRI------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG 261
H N+V L + ++ LV EY+ + + + + +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP-KISDVGLAK-LHGPEWSISTSCELR 319
+ LAY+H I H ++K N+LLD K+ D G AK L E ++S C
Sbjct: 150 LLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 320 NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
Y A EL + + D++S G ++ E++ G+
Sbjct: 207 ---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 17/161 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMR--AAVKLLMSNSVSEEEDF----IEKVEAIGQV 206
+ + + + + G VY+ A ++ + + EE I +V + +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDL 57
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
KH N+V L ++ LV+EY+D +L+Q+L + + +GL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGL 113
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307
AY H K++H ++K N+L++ K++D GLA+
Sbjct: 114 AYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 6e-09
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 15/146 (10%)
Query: 167 GVVYRAVLLDNMRAAVK-LLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLFGYCVEG 221
GVVY+A A+K + + E+E I ++ + ++KH N+VKL+
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72
Query: 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHN 281
+ +LV+E++D +L++ L L T + G+AY H+ +++H +
Sbjct: 73 KRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD 125
Query: 282 MKSSNILLDHHWNPKISDVGLAKLHG 307
+K N+L++ KI+D GLA+ G
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFG 151
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL--MSNSVSEEEDFIEKVEAIGQVK 207
TDG+ + I G V R + NM AVK++ +EE + + + +
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRY-----GQ 74
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKG 265
H N++ L +G+ +V E + G L + E + ++ K
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITKT 128
Query: 266 LAYLHEDIEPKIVHHNMKSSNILL-DHHWNP---KISDVGLAK-LHGPEWSISTSCELRN 320
+ YLH +VH ++K SNIL D NP +I D G AK L + T C
Sbjct: 129 VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC---- 181
Query: 321 SG---YLAEELSGRTSIFNEKSDVYSFGILIMEIV-SGRLP 357
++A E+ R ++ D++S G+ ++ + +G P
Sbjct: 182 -YTANFVAPEVLERQG-YDAACDIWSLGV-LLYTMLTGYTP 219
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 7e-09
Identities = 31/147 (21%), Positives = 70/147 (47%), Gaps = 16/147 (10%)
Query: 167 GVVYRAV-LLDNMRAAVK-LLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLFGYCVE 220
G V++A + A+K + + + ++E + ++ + ++KHKN+V+L
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
+ LV+E+ D +L+++ L + + KGL + H ++H
Sbjct: 73 DKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 281 NMKSSNILLDHHWNPKISDVGLAKLHG 307
++K N+L++ + K+++ GLA+ G
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFG 152
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMR--AAVKLLMSNSVSEEEDF----IEKVEAIGQV 206
+ + I G G V++A + A K+LM N E+E F + +++ + +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLL 73
Query: 207 KHKNLVKLFGYCVEGQNRI--------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
KH+N+V L C + LV+++ ++ +L L T ++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRV 129
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308
+Q GL Y+H + KI+H +MK++N+L+ K++D GLA+
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 18/120 (15%)
Query: 246 EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305
LT + + AKG+ +L K +H ++ + NILL KI D GLA+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR- 241
Query: 306 HGPEWSISTSCELRNSG-------YLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357
I + G ++A E + ++ +SDV+SFG+L+ EI S G P
Sbjct: 242 -----DIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 24/102 (23%), Positives = 39/102 (38%), Gaps = 9/102 (8%)
Query: 159 NVIASGDNGVVYRAVLLD------NMRAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKN 210
+ G G V A AVK+L + SE + +++ + + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 211 LVKLFGYCVEGQNRILV-YEYIDNGNLQQWLHGSLGEAKPLT 251
+V L G C + ++V E+ GNL +L E P
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 33/166 (19%), Positives = 67/166 (40%), Gaps = 22/166 (13%)
Query: 153 DGFAEQNVIASGDNGVVYRA--VLLDNMRAAVKLLMSNSVSEEEDF----IEKVEAIGQV 206
D + + G G VY+A + + A ++ + + EEE I +V + ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKEL 90
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
+H+N+++L L++EY + L + + ++ + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNP-----KISDVGLAKLHG 307
+ H + +H ++K N+LL KI D GLA+ G
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 35/147 (23%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 167 GVVYRAV-LLDNMRAAVK-LLMSNSVSEEEDF----IEKVEAIGQVKHKNLVKLFGYCVE 220
VY+A N A+K + + + ++ + +++ + ++ H N++ L
Sbjct: 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83
Query: 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
N LV+++++ +L+ + + + LT + T +GL YLH+ I+H
Sbjct: 84 KSNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHR 136
Query: 281 NMKSSNILLDHHWNPKISDVGLAKLHG 307
++K +N+LLD + K++D GLAK G
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFG 216
+ G VV R V +L A ++ + +S + + + +KH N+V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 217 YCVEGQNRILVYEYIDNGNLQQWL--HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
E + L+++ + G L + + EA D IQ + + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEA-----DAS-HCIQQILEAVLHCHQM-- 129
Query: 275 PKIVHHNMKSSNILLDHHWNP---KISDVGLAK-LHGPEWSISTSCELRNS-GYLAEELS 329
+VH N+K N+LL K++D GLA + G + + + GYL+ E+
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA---GTPGYLSPEVL 185
Query: 330 GRTSIFNEKSDVYSFGILIMEI-VSGRLP-VDYSQPQVF 366
+ + + D+++ G+ I+ I + G P D Q +++
Sbjct: 186 RKDP-YGKPVDLWACGV-ILYILLVGYPPFWDEDQHRLY 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFI--EKVEAIGQVK 207
+ + VI +G GVVY+A L D A+K V +++ F E ++ + ++
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKNRE-LQIMRKLD 105
Query: 208 HKNLVKLFGYCVEGQNRI------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG 261
H N+V+L + + LV +Y+ + + + L +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP-KISDVGLAKLHGP-EWSISTSCELR 319
+ LAY+H I H ++K N+LLD K+ D G AK E ++S C
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 320 NSGYLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGR 355
Y A EL IF DV+S G ++ E++ G+
Sbjct: 222 ---YRAPEL-----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 40/175 (22%), Positives = 75/175 (42%), Gaps = 28/175 (16%)
Query: 153 DGFAEQNVIASGDNGVVYRA-------------VLLDNMRAAVKLLMSNSVSEEEDFIEK 199
+ I G G VY+A V + N L ++V E +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE----VAL 64
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRI-----LVYEYIDNGNLQQWLHGSLGEAKPLTWDT 254
+ + +H N+V+L C + LV+E++D +L+ +L + L +T
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA--PPPGLPAET 121
Query: 255 RMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309
+++ +GL +LH + IVH ++K NIL+ K++D GLA+++ +
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 57/265 (21%), Positives = 100/265 (37%), Gaps = 44/265 (16%)
Query: 113 SSGTSTNRCTRAQANGNIRRSVSGMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRA 172
T AQ + + + +K+ I+ D V+ G NG V +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 173 V-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYC---VEGQNRI-L 226
+ A+K + + +VE + + ++V++ G+ + +
Sbjct: 82 FNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 227 VYEYIDNGNL----QQWLHGSLGE--AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280
V E +D G L Q + E A + MK I + + YLH I H
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSI---GEAIQYLHSI---NIAHR 185
Query: 281 NMKSSNILLDHHWNP----KISDVGLAKLHGPEWSISTSCELRNSG---YLAEELSGRTS 333
++K N+L P K++D G AK S++T C Y+A E+ G
Sbjct: 186 DVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSLTTPC-----YTPYYVAPEVLGPEK 239
Query: 334 IFNEKSDVYSFGILIMEIV-SGRLP 357
+++ D++S G+ IM I+ G P
Sbjct: 240 -YDKSCDMWSLGV-IMYILLCGYPP 262
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 47/242 (19%), Positives = 84/242 (34%), Gaps = 37/242 (15%)
Query: 135 SGMRLGIRISLKEIDI-VTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSE 192
S M L + E D F + + G G V M A+K V +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQ 58
Query: 193 EEDF----IEKVEAIGQVKHKNLVKLFGYCVEGQNR--------ILVYEYIDNGNLQQWL 240
+ F ++ ++ + + H N+V+L +V EY+ + L +
Sbjct: 59 DPRFRNRELQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC 116
Query: 241 HGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISD 299
+ + + LH + H ++K N+L++ K+ D
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 300 VGLAKLHGP-EWSISTSCELRNSGYLAEELSGRTSIFNEKS-----DVYSFGILIMEIVS 353
G AK P E +++ C Y A EL IF + D++S G + E++
Sbjct: 176 FGSAKKLSPSEPNVAYICSRY---YRAPEL-----IFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 354 GR 355
G
Sbjct: 228 GE 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 39/216 (18%)
Query: 160 VIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEEED----FIEKVEAIGQVKHKNLVKL 214
++ G V A L R A+K+L + +E E+ + + ++ H VKL
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER-DVMSRLDHPFFVKL 95
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKIIQGTAK-------- 264
+ + + Y NG L +++ GS E +
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--------------CTRFYTAEIVS 141
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG-- 322
L YLH I+H ++K NILL+ + +I+D G AK+ PE + + G
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGTA 196
Query: 323 -YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y++ EL + SD+++ G +I ++V+G P
Sbjct: 197 QYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 37/172 (21%), Positives = 75/172 (43%), Gaps = 24/172 (13%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAV---KLLMSNSVSEEEDF-------IEKVEA 202
+ I G G V++A L N V ++ + EE + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRH 67
Query: 203 IGQVKHKNLVKLF----GYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK 257
+ +H N+V+LF + + ++ LV+E++D +L +L + +T
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV--PEPGVPTETIKD 124
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309
++ +GL +LH ++VH ++K NIL+ K++D GLA+++ +
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 43/204 (21%), Positives = 76/204 (37%), Gaps = 33/204 (16%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKH-KNLVKLF 215
+ G VV + + A K L ++ + + ++ + K ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWL----HGSLGEAKPLTWDTR--MKIIQGTAKGLAYL 269
IL+ EY G + + E D +K I +G+ YL
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN-----DVIRLIKQI---LEGVYYL 147
Query: 270 HEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---Y 323
H++ IVH ++K NILL + KI D G+++ G + G Y
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-----GTPEY 199
Query: 324 LAEELSGRTSIFNEKSDVYSFGIL 347
LA E+ I +D+++ GI+
Sbjct: 200 LAPEILNYDPI-TTATDMWNIGII 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 40/205 (19%), Positives = 80/205 (39%), Gaps = 32/205 (15%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGY 217
V+ G NG V + A+K + + ++V+ Q ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 218 CVEGQNRI----LVYEYIDNGNL----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
+ ++ E ++ G L Q+ + E + +I++ + +L
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-----EAA-EIMRDIGTAIQFL 144
Query: 270 HEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAE 326
H I H ++K N+L + K++D G AK ++ T C Y+A
Sbjct: 145 HSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCY--TPYYVAP 198
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEI 351
E+ G +++ D++S G+ IM I
Sbjct: 199 EVLGPEK-YDKSCDMWSLGV-IMYI 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 13/98 (13%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG-- 322
L YL +I+H +MK NILLD H + I+D +A + E I+T G
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-----GTK 178
Query: 323 -YLAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y+A E S + + ++ D +S G+ E++ GR P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 24/161 (14%)
Query: 205 QVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKI-IQ 260
+H L L Y + +R+ V EY + G L L E R +
Sbjct: 204 NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------RARFYGA 255
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELR 319
L YLH + +V+ ++K N++LD + KI+D GL K ++ T C
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--- 310
Query: 320 NSG---YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
G YLA E+ + D + G+++ E++ GRLP
Sbjct: 311 --GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGY 217
+ G + + V N AVK++ S E + +++ A+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 218 CVEGQNRILVYEYIDNGNL----QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ + LV E ++ G L ++ H S EA + M+ + ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKL---VSAVSHMHDV- 125
Query: 274 EPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELS 329
+VH ++K N+L + + KI D G A+L P+ T C Y A EL
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELL 181
Query: 330 GRTSIFNEKSDVYSFGIL--IM 349
+ ++E D++S G++ M
Sbjct: 182 NQNG-YDESCDLWSLGVILYTM 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 35/166 (21%)
Query: 205 QVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLH--GSLGEAKPLTWDTRMKI-IQ 260
+H L L Y + +R+ V EY + G L L E R +
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFYGA 112
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELR 319
L YLH +V+ ++K N++LD + KI+D GL K ++ T C
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--- 166
Query: 320 NSG---YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
G YLA E + + D + G+++ E++ GRLP
Sbjct: 167 --GTPEYLAPE------VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 14/99 (14%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK--LHGPEWSISTSCELRNSG 322
L +LH+ I++ ++K NILLD + + ++D GL+K + C G
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-----G 222
Query: 323 ---YLAEE-LSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y+A + + G S ++ D +S G+L+ E+++G P
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 38/198 (19%), Positives = 74/198 (37%), Gaps = 35/198 (17%)
Query: 136 GMRLGIRISLKEIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEE 194
G + + +K+ I+ D V+ G NG V + + A+K + +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCP 55
Query: 195 DFIEKVEAIGQV-KHKNLVKLFGYC---VEGQNRI-LVYEYIDNGNL----QQWLHGSLG 245
+VE + + ++V++ G+ + +V E +D G L Q +
Sbjct: 56 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115
Query: 246 EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW---NPKISDVGL 302
E + +I++ + + YLH I H ++K N+L K++D G
Sbjct: 116 ER-----EAS-EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 303 AK-----LHGPE---WSI 312
AK + WS+
Sbjct: 167 AKETTGEKYDKSCDMWSL 184
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 45/250 (18%), Positives = 89/250 (35%), Gaps = 49/250 (19%)
Query: 136 GMRLGIRISLKEID----IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS 191
GM+ +++++ + + Q I+SG G V V + + A+K + +
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 192 EEED--FIEKVEA---------IGQVKHKNLVKLFG----YCVEGQNRI-LVYEYIDNGN 235
+ + H N++ L + +++ LV E + +
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119
Query: 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP 295
L Q +H ++ + GL LHE +VH ++ NILL + +
Sbjct: 120 LAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDI 173
Query: 296 KISDVGLAKLHGPE----------WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFG 345
I D LA+ + W Y A EL + F + D++S G
Sbjct: 174 TICDFNLAREDTADANKTHYVTHRW------------YRAPELVMQFKGFTKLVDMWSAG 221
Query: 346 ILIMEIVSGR 355
++ E+ + +
Sbjct: 222 CVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 45/235 (19%), Positives = 93/235 (39%), Gaps = 41/235 (17%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-- 207
D + + G V+ A+ + +N + VK+L ++K + ++K
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------VKKKKIKREIKIL 84
Query: 208 -----HKNLVKLFGYCV----EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
N++ L + + LV+E+++N + +Q + LT
Sbjct: 85 ENLRGGPNIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFY 135
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKLHGPEWSISTSCE 317
+ K L Y H I+H ++K N+++DH H ++ D GLA+ + P +
Sbjct: 136 MYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPV----DYSQPQVFLI 368
R + EL +++ D++S G ++ ++ + P D Q+ I
Sbjct: 193 SRY--FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRI 244
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 33/159 (20%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 205 QVKHKNLVKLF-----GYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
++H+N++ L ++ LV ++ +L + + + L D +
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK-----HEKLGEDRIQFL 133
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS--ISTSC 316
+ KGL Y+H I+H ++K N+ ++ KI D GLA+ E + + T
Sbjct: 134 VYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW 190
Query: 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
Y A E+ + + D++S G ++ E+++G+
Sbjct: 191 ------YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 43/313 (13%), Positives = 92/313 (29%), Gaps = 59/313 (18%)
Query: 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLL--------------MSNSVSEEEDFI 197
T+ I G G V++ + D+ A+K++ + E
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 198 EKVEAI---GQVKHKNLVKLFG-YCVEG---QNRILVYEYIDNGN------------LQQ 238
+++ + + + + L +CV+G + +++ ++ Q
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 239 WL------HGSLGE---AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL 289
++ G E K + T I+ LA + H ++ N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLL 195
Query: 290 DHHWNPKISDVGLAK-----LHGPEWSI---STSCELRNSGYLAEELSGRTSIF----NE 337
K+ K G + SI + S R+ + ++S +F +
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255
Query: 338 KSDVYSF-GILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKE 396
+ D+Y P +L D + + + +E
Sbjct: 256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC-NTPAMKQIKRKIQE 314
Query: 397 LKRIILIALRCVD 409
R +L D
Sbjct: 315 FHRTMLNFSSATD 327
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 22/100 (22%), Positives = 41/100 (41%), Gaps = 16/100 (16%)
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTS--CELRNSG- 322
L +H +H ++K N+LLD + K++D G E + G
Sbjct: 181 LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GT 232
Query: 323 --YLAEEL---SGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y++ E+ G + + D +S G+ + E++ G P
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 21/102 (20%), Positives = 46/102 (45%), Gaps = 17/102 (16%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTS--CELRNSG 322
+ +H+ VH ++K NIL+D + + +++D G + ++ +S G
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-----G 238
Query: 323 ---YLAEEL----SGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y++ E+ G + + D +S G+ + E++ G P
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
L YLH IV+ ++K NILLD + ++D GL K + + ST C G
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-----GT 202
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
YLA E + +++ D + G ++ E++ G P
Sbjct: 203 PEYLAPE------VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
L YLHE I++ ++K N+LLD + K++D G+ K P + ST C G
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-----GT 173
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E I + D ++ G+L+ E+++GR P
Sbjct: 174 PNYIAPE------ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
GL +L I++ ++K N++LD + KI+D G+ K + + T C G
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-----GT 505
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E I + D ++FG+L+ E+++G+ P
Sbjct: 506 PDYIAPE------IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEA------- 202
V + + + + SG G V A +R AVK L F + A
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYREL 79
Query: 203 --IGQVKHKNLVKLF-----GYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDT 254
+ +KH+N++ L +E N + LV + +L + + LT D
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLTDDH 133
Query: 255 RMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS--I 312
+I +GL Y+H I+H ++K SN+ ++ KI D GLA+ E + +
Sbjct: 134 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190
Query: 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
+T Y A E+ +N+ D++S G ++ E+++GR
Sbjct: 191 ATRW------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
L YLHE I++ ++K N+LLD + K++D G+ K P + ST C G
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-----GT 216
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E I + D ++ G+L+ E+++GR P
Sbjct: 217 PNYIAPE------ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
L +LH+ I++ ++K N+LLDH + K++D G+ K + +T C G
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-----GT 187
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E I E D ++ G+L+ E++ G P
Sbjct: 188 PDYIAPE------ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 42/217 (19%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLM---SNSVSEEEDFIEKVEAIGQV 206
+ + + SG G V A+ + A+K L + + + + E + + +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE-LLLLKHM 80
Query: 207 KHKNLVKLF-----GYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+H+N++ L + LV ++ +LQ+ + + + ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYLVY 133
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS--ISTSCEL 318
KGL Y+H +VH ++K N+ ++ KI D GLA+ E + + T
Sbjct: 134 QMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
Y A E+ +N+ D++S G ++ E+++G+
Sbjct: 189 ----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 13/97 (13%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
GL +LH IV+ ++K NILLD + KI+D G+ K + + +T C G
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-----GT 181
Query: 323 --YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357
Y+A E+ +N D +SFG+L+ E++ G+ P
Sbjct: 182 PDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 24/100 (24%)
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSISTSCELRNSG-- 322
YLH +++ ++K N+L+D +++D G AK + G W T C G
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---TLC-----GTP 202
Query: 323 -YLAEELSGRTSIFNE---KS-DVYSFGILIMEIVSGRLP 357
LA E+ I ++ K+ D ++ G+LI E+ +G P
Sbjct: 203 EALAPEI-----ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
L +LH+ I++ ++K NI+L+H + K++D GL K T C G
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-----GT 184
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E I D +S G L+ ++++G P
Sbjct: 185 IEYMAPE------ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
GL +L I++ ++K N++LD + KI+D G+ K + + T C G
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-----GT 184
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E I + D ++FG+L+ E+++G+ P
Sbjct: 185 PDYIAPE------IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 23/102 (22%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH-GPEWSISTSCELRNSG- 322
L +LH I++ ++K NILLD + K++D GL+K E + C G
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-----GT 189
Query: 323 --YLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E + N + D +SFG+L+ E+++G LP
Sbjct: 190 VEYMAPE------VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 36/107 (33%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG---------PEWSISTS 315
L YLH I++ ++K NILLD + + KI+D G AK P+
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD------ 168
Query: 316 CELRNSGYLAEELSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
Y+A E + + K D +SFGILI E+++G P
Sbjct: 169 -------YIAPE------VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 29/137 (21%), Positives = 57/137 (41%), Gaps = 19/137 (13%)
Query: 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285
++ EY+ + L + L + + + + I + + ++H I H ++K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQ 170
Query: 286 NILLD-HHWNPKISDVGLAK-LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKS---- 339
N+L++ K+ D G AK L E S++ C Y A EL +
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF---YRAPEL-----MLGATEYTPS 222
Query: 340 -DVYSFGILIMEIVSGR 355
D++S G + E++ G+
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 36/221 (16%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEA------- 202
V + I SG G+V A + + A+K L F + A
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYREL 112
Query: 203 --IGQVKHKNLVKLF-----GYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDT 254
+ V HKN++ L +E + LV E +D NL Q + L +
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHER 165
Query: 255 RMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST 314
++ G+ +LH I+H ++K SNI++ KI D GLA+ G + ++
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222
Query: 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
R Y A E+ + E D++S G ++ E+V +
Sbjct: 223 YVVTR--YYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 19/157 (12%)
Query: 205 QVKHKNLVKLF-----GYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
V HKN++ L +E + +V E +D NL Q + L + +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYL 132
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCEL 318
+ G+ +LH I+H ++K SNI++ KI D GLA+ G + ++
Sbjct: 133 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
R Y A E+ + E D++S G ++ E++ G
Sbjct: 190 R--YYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 22/104 (21%), Positives = 40/104 (38%), Gaps = 19/104 (18%)
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI--STSCELRNSG 322
+ +H VH ++K NILLD + +++D G + ++ + G
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-----G 225
Query: 323 ---YLAEE-LSGRTSIFNEKS-----DVYSFGILIMEIVSGRLP 357
YL+ E L S D ++ G+ E+ G+ P
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 45/230 (19%), Positives = 95/230 (41%), Gaps = 50/230 (21%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEA------- 202
V + + I G G+V A L+ +R A+K + F +
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREI 76
Query: 203 --IGQVKHKNLVKLFG----YCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTR 255
+ + +H+N++ + +E + +V + ++ +L + L + L+ D
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-----TQHLSNDHI 130
Query: 256 MKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTS 315
+ +GL Y+H ++H ++K SN+LL+ + KI D GLA+
Sbjct: 131 CYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR--------VAD 179
Query: 316 CELRNSGYLAE----------ELSGRTSIFNEKSDVYSFGILIMEIVSGR 355
+ ++G+L E E+ + + + D++S G ++ E++S R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 483 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.82 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.75 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 96.4 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.32 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 96.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.11 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 95.83 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.75 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.64 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.86 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 91.97 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 91.28 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 90.07 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.55 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.63 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.29 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=454.43 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=214.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
+..++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34567889999999999999999864 467899999987766667889999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 224 RILVYEYIDNGNLQQWLHGSL---------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
.+||||||++|+|.++|+... .....++|.+++.++.||+.||.|||++ +||||||||+||||+.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999996532 2346799999999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~ 372 (483)
+||+|||+|+........ ......||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+.......
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~--- 242 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--- 242 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999866543322 233456899999999996554 9999999999999999999 9999987665432211
Q ss_pred HHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 373 SMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. .+ ..+.. +..++.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 243 -i~-~~-----~~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 243 -IT-QG-----RVLQR----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp -HH-HT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HH-cC-----CCCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 11 11122 23455789999999999999999999999998853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=450.39 Aligned_cols=263 Identities=26% Similarity=0.383 Sum_probs=209.8
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.+++..++|.+.++||+|+||+||+|++++ .||||++..... ...+.|.+|++++++++|||||+++|++.+ +.+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 345677889999999999999999998654 589999865432 334789999999999999999999998864 568
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+||||||+||+|.++|+. ....+++.+++.|+.|||.||+|||++ +||||||||+||||+.++.+||+|||+|+
T Consensus 107 ~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp EEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred EEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCce
Confidence 999999999999999973 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCc-cccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 305 LHGPEW-SISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
...... ........||+.|||||++.+ ...|+.++|||||||+||||+||+.||.+.++.......+. .
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~----~---- 252 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG----R---- 252 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----T----
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh----c----
Confidence 764322 223345589999999999853 23489999999999999999999999987665433322111 1
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....|.++. .+..++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 253 ~~~~p~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 253 GYASPDLSK-LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp TCCCCCSTT-SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCCCCCccc-ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112222221 233456789999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=451.04 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
..++|.+.++||+|+||+||+|+++ ++..||||++........++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467888999999999999999875 4788999999877666678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC
Q 046972 225 ILVYEYIDNGNLQQWLHGSLG-----------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~ 293 (483)
|||||||++|+|.++|+.... ...+++|.+++.|+.||+.||+|||++ +||||||||+||||+.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999975422 235799999999999999999999999 999999999999999999
Q ss_pred CcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWL 371 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~ 371 (483)
.+||+|||+|+....... .......||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.........
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-- 272 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-- 272 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH--
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 999999999986644322 2334457899999999996554 9999999999999999999 9999987665432211
Q ss_pred HHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. .+ ..+..| ..++.++.+|+.+||+.||++|||+.||+++|+.
T Consensus 273 --i~-~g-----~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 273 --IT-QG-----RELERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp --HH-HT-----CCCCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred --HH-cC-----CCCCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 11 11 122222 2345789999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-59 Score=451.58 Aligned_cols=259 Identities=20% Similarity=0.289 Sum_probs=211.8
Q ss_pred HhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
..+++++.++||+|+||+||+|.+. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3455777899999999999999863 46789999997653 3345789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC
Q 046972 224 RILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~ 291 (483)
.+||||||++|||.++|..... ....+++.+++.|+.|||.||+|||++ +||||||||+||||+.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 9999999999999999964321 124689999999999999999999999 9999999999999999
Q ss_pred CCCcEEeecccccccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHH
Q 046972 292 HWNPKISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLID 369 (483)
Q Consensus 292 ~~~~kl~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~ 369 (483)
++.+||+|||+|+...... ........||+.|||||++.+. .|+.++|||||||+||||+| |..||.+.+.......
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998654332 2233445789999999998654 49999999999999999999 8999987665432211
Q ss_pred HHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 370 WLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. ....++ .+..++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 260 -----i~--------~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 260 -----IR--------NRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -----HH--------TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----HH--------cCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11 111111 233456789999999999999999999999999965
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=450.78 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=215.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.+.|++.++||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999975 5889999999765555556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
|+||+|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999953 4599999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. .....+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+ .....+.++
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i----------~~~~~~~~~- 291 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------RDNLPPRLK- 291 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----------HHSSCCCCS-
T ss_pred C-cccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH----------HcCCCCCCC-
Confidence 2 234458999999999996554 899999999999999999999999876654332211 111122222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+.++.+|+.+||+.||++|||+.|++++.+...
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 12334578899999999999999999999999877654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-58 Score=449.57 Aligned_cols=254 Identities=17% Similarity=0.285 Sum_probs=206.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.|.+|+++|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999965 588999999976533 334689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
||+||+|.++|... ....+++.+++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999643 345689999999999999999999999 9999999999999999999999999999876533
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.. ......||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+....+..+.. .. .+..+
T Consensus 179 ~~-~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-----~~-----~~~~~ 246 (350)
T 4b9d_A 179 VE-LARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-----GS-----FPPVS 246 (350)
T ss_dssp HH-HHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----TC-----CCCCC
T ss_pred cc-cccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-----CC-----CCCCC
Confidence 21 223457999999999996554 89999999999999999999999987665433322211 10 11122
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.++.+|+.+||+.||++|||+.|++++.+.
T Consensus 247 ----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 247 ----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 2344688999999999999999999999986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=434.42 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=202.5
Q ss_pred cccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEe----CCeEEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNRILVY 228 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~ 228 (483)
++.++||+|+||+||+|.+. ++..||+|++.... ....+.|.+|++++++++|||||++++++.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999975 47889999996543 2344679999999999999999999999875 35579999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEcC-CCCcEEeecccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLDH-HWNPKISDVGLAKL 305 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~~-~~~~kl~DFGla~~ 305 (483)
|||+||+|.++++. ...+++..+..++.||+.||+|||++ + ||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999964 35799999999999999999999998 7 999999999999974 78999999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.... ......||+.|||||++.+ . |+.++|||||||+||||+||+.||.+......+...+ ..
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i------------~~ 244 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------TS 244 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH------------TT
T ss_pred CCCC---ccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH------------Hc
Confidence 5432 2334579999999999854 3 9999999999999999999999997665543322111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...|...+...+.++.+|+.+||+.||++|||+.|++++.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 1111111222335788999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-57 Score=452.43 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=215.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.+.|++.++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999975 5889999999876655667799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
|+||+|.++++. ..+++.++..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999953 4599999999999999999999999 99999999999999999999999999998765442
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. .....+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+ .....+.++
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i----------~~~~~~~~~- 368 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------RDNLPPRLK- 368 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----------HHSCCCCCS-
T ss_pred c-cccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH----------HcCCCCCCc-
Confidence 2 234458999999999996554 899999999999999999999999876654332211 111122222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+.++.+|+.+||+.||++|||+.|++++.+...
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 11233468899999999999999999999999877544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=436.85 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=208.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999965 58899999996532 223467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||+||+|.++|+. .+.+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999963 35799999999999999999999999 999999999999999999999999999997754
Q ss_pred Cc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. .......+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+.. ....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-----------~~~~ 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-----------LEYD 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------TCCC
T ss_pred CCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----------CCCC
Confidence 32 22344568999999999996554 89999999999999999999999987665433222211 1223
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVL 422 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil 422 (483)
+|... +.++.+|+.+||+.||++|||++|++
T Consensus 253 ~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 34333 36788999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=426.29 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=197.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999954 689999999975432 23467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||| +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999963 35799999999999999999999999 999999999999999999999999999986654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. ......||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+.......+ . .. .+.+
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i----~-~~------~~~~ 231 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI----S-NG------VYTL 231 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-HT------CCCC
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----H-cC------CCCC
Confidence 32 2234579999999999977665578999999999999999999999876543322111 1 11 1223
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
|.. .+.++.+|+.+||+.||++|||++|++++.+.
T Consensus 232 p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 232 PKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 332 33678899999999999999999999997764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=446.30 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=218.8
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCC-Cccccc
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKH-KNLVKL 214 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-pnIv~~ 214 (483)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||++...... ..+.|.+|+++|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3456788899999999999999999999999653 357999999766443 34689999999999965 999999
Q ss_pred ccEEEeC-CeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeec
Q 046972 215 FGYCVEG-QNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHN 281 (483)
Q Consensus 215 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 281 (483)
+|+|.+. +.++||||||++|+|.++|+.... ....+++.+++.++.|||.||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 568999999999999999965321 135689999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCcEEeecccccccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCC
Q 046972 282 MKSSNILLDHHWNPKISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVD 359 (483)
Q Consensus 282 lkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~ 359 (483)
|||+|||++.++.+||+|||+|+...... ........||+.|||||++.+. .|+.++|||||||+||||+| |+.||.
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998764432 2334456789999999999654 49999999999999999998 999998
Q ss_pred CCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 360 YSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+......+...+. .+ ..+..|. .++.++.++|.+||+.||++|||+.+|+++|+.
T Consensus 290 ~~~~~~~~~~~i~----~g-----~~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 290 GVKIDEEFCRRLK----EG-----TRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp TCCCSHHHHHHHH----HT-----CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHH----cC-----CCCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 7665433322211 11 1222332 344789999999999999999999999999854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-57 Score=439.10 Aligned_cols=249 Identities=19% Similarity=0.222 Sum_probs=204.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+.|++.++||+|+||.||+|+.+ +|+.||||++..... +.+|+.+++.++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45888899999999999999975 588999999975432 247999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccccCCCc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKLHGPEW 310 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~ 310 (483)
+||+|.++|+. .+.+++.++..++.||+.||+|||++ +||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999964 35699999999999999999999999 999999999999999987 69999999998765432
Q ss_pred cc----cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 311 SI----STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 311 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
.. ......||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.........+... .... .
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~~----~ 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----PPPI----R 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----CCGG----G
T ss_pred cccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----CCCc----h
Confidence 21 123347999999999996654 899999999999999999999999876655443332211 1000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.++ ..++..+.+++.+||+.||++|||+.|++++|.
T Consensus 277 ~~~----~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 277 EIP----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp GSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 112 233468889999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=432.22 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=203.4
Q ss_pred cCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
++|++.+.||+|+||+||+|+.. .++.||+|++..... .....+.+|+++|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999863 467899999975422 223468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||+||+|.++|.. ...+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999964 35799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
.... .......||+.|||||++.+.. |+.++|||||||+||||+||+.||.+.+....+..+.. . .+
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-----~------~~ 243 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-----A------KL 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----C------CC
T ss_pred cCCC-ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc-----C------CC
Confidence 4332 2233457999999999996554 89999999999999999999999987665443322211 1 12
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~~ 429 (483)
.+|.. .+.++.+|+.+||+.||++|||+ +|++++.+..+
T Consensus 244 ~~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 244 GMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 23332 34678899999999999999984 78998877654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=424.00 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=200.3
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC----eEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ----NRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~ 228 (483)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578899999999999999998 578999999864321 1123345666677899999999999998654 579999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI-----EPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
|||++|+|.++|+. .++++..++.++.|++.||+|||+++ .++||||||||+||||+.++.+||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999963 45899999999999999999999752 458999999999999999999999999999
Q ss_pred cccCCCcc---ccccccccCcccccccccCCCC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCch----------h
Q 046972 304 KLHGPEWS---ISTSCELRNSGYLAEELSGRTS-----IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ----------V 365 (483)
Q Consensus 304 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~----------~ 365 (483)
+....... .......||+.|||||++.+.. .|+.++|||||||+||||+||..||...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 87643322 1223457999999999985431 2678999999999999999998776433211 0
Q ss_pred hHHHHHHHHHHhhhhhhhcCCCCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 366 FLIDWLKSMVAQQKIAYVLDPKLPEMP-SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+.. .......+|.+|... ...++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 236 ~~~~~~~~----~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 236 PSVEEMRK----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHH----HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHH----HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 00111111 112222344444322 23566789999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=415.47 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=192.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCC--------
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-------- 222 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------- 222 (483)
++|++.+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999965 588999999975533 34467999999999999999999999987654
Q ss_pred ----eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEe
Q 046972 223 ----NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKIS 298 (483)
Q Consensus 223 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~ 298 (483)
.+|+|||||+||+|.+++.... ......+..++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999997432 223356677899999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCccc-----------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhH
Q 046972 299 DVGLAKLHGPEWSI-----------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL 367 (483)
Q Consensus 299 DFGla~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~ 367 (483)
|||+|+........ .....+||+.|||||++.+.. |+.++|||||||++|||++ ||....+..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~~-- 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERV-- 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHHH--
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHHH--
Confidence 99999876543211 123347999999999996554 9999999999999999996 775322111
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 368 IDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+ ....+...|+. .......+.+|+.+||+.||++|||+.|++++.+..+
T Consensus 235 -~~~---------~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 235 -RTL---------TDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp -HHH---------HHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred -HHH---------HHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 111 11112222211 1223356778999999999999999999999766544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=413.69 Aligned_cols=268 Identities=17% Similarity=0.229 Sum_probs=207.3
Q ss_pred HhcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 225 (483)
..+.|++.++||+|+||+||+|+.+ .++.||+|.+.... ....+.+|+++|+.+ +|||||++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 46789999986653 345688999999998 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFGla~ 304 (483)
+|||||+||+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999993 489999999999999999999999 99999999999999877 789999999998
Q ss_pred ccCCCcc---------------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 046972 305 LHGPEWS---------------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357 (483)
Q Consensus 305 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~P 357 (483)
....... ......+||+.|+|||++.+...|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5533211 1123347999999999997766689999999999999999999999
Q ss_pred CCCCCchh-hHHHHHHHHHHhhhh-------------------------hh--hcCCCCCC------------CCCHHHH
Q 046972 358 VDYSQPQV-FLIDWLKSMVAQQKI-------------------------AY--VLDPKLPE------------MPSRKEL 397 (483)
Q Consensus 358 f~~~~~~~-~~~~~~~~~~~~~~~-------------------------~~--~~~~~~~~------------~~~~~~~ 397 (483)
|....+.. .+..+..-....... .. ..+...|. ......+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 97655442 222222110000000 00 00000000 0111223
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 398 KRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 398 ~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.++.+|+.+||+.||++|||++|++++.+..+.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 578899999999999999999999999887653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=419.18 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=212.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe------CCe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE------GQN 223 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~ 223 (483)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999965 688999999976533 234678999999999999999999998764 367
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
+|||||||+ |+|.+++. ....+++.++..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 68999995 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCc---cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-
Q 046972 304 KLHGPEW---SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK- 379 (483)
Q Consensus 304 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~- 379 (483)
+.+.... ........||+.|+|||++.+...|+.++||||+||++|||++|+.||.+.+....+..+.........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8664321 122345689999999999877666899999999999999999999999987766555444332111000
Q ss_pred ---------h---hhhcCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 ---------I---AYVLDPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ---------~---~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .....+..+ .+. .....++.+|+.+||..||++|||+.|++++.+...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQP-VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCC-CCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCC-CCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0 000111111 000 112367889999999999999999999999887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=430.45 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=215.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999975 5889999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC--CCcEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH--WNPKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~--~~~kl~DFGla~~~~~ 308 (483)
|+||+|.++|.. ....+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999953 345799999999999999999999999 99999999999999854 8899999999998765
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.... ....||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+.. .+..+
T Consensus 310 ~~~~--~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~-----------~~~~~ 375 (573)
T 3uto_A 310 KQSV--KVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-----------CDWNM 375 (573)
T ss_dssp TSEE--EEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT-----------TCCCC
T ss_pred CCce--eeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh-----------CCCCC
Confidence 4322 3347999999999997655 89999999999999999999999987765443322110 11222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+.......+..+.+|+.+||+.||.+|||+.|++++.+..
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 2222223446888999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=422.07 Aligned_cols=259 Identities=18% Similarity=0.227 Sum_probs=209.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHH---HHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDF---IEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
..++|++.++||+|+||.||+|+.+ +|+.||+|++..... .....+ ..++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3478999999999999999999965 588999999964311 112223 344677888899999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
+|||||||+||+|.++|.. .+.+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|
T Consensus 267 lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999964 35699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
+.+... .....+||+.|||||++.++..|+.++|||||||+||||++|+.||.+...... ........ .
T Consensus 340 ~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~-------~ 408 (689)
T 3v5w_A 340 CDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTL-------T 408 (689)
T ss_dssp EECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHH-------H
T ss_pred eecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhc-------C
Confidence 876543 233458999999999996555599999999999999999999999976443221 11111111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccchh
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRDLL 431 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~~~ 431 (483)
....+|.. .+.++.+|+.+||+.||.+|++ ++||+++.+..+..
T Consensus 409 ~~~~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 409 MAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp CCCCCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred CCCCCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 12233333 3367889999999999999998 79999988876643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=394.60 Aligned_cols=288 Identities=34% Similarity=0.639 Sum_probs=242.8
Q ss_pred eeeehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccEEE
Q 046972 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
..+++.++.+..++|.+.+.||+|+||.||+|...+++.||+|++...... ....+.+|+++++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 457889999999999999999999999999999888999999999765322 2246899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
..+..++||||+++|+|.+++.........+++..++.++.||+.||.|||+++.++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987655666799999999999999999999997666999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC----CCchhhHHHHHHHHH
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY----SQPQVFLIDWLKSMV 375 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~----~~~~~~~~~~~~~~~ 375 (483)
||+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.. .........+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999876554444444556899999999985544 89999999999999999999999962 222333444444433
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+....+..+.......++..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 444455566666677778888999999999999999999999999999997643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=389.29 Aligned_cols=282 Identities=33% Similarity=0.573 Sum_probs=235.6
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
+++.++....++|.+.+.||+|+||.||+|.+.+++.||+|++........+.+.+|+++++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33445555778999999999999999999998889999999998776667788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999975544445799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh--hHHHHHHHHHHhhh
Q 046972 303 AKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV--FLIDWLKSMVAQQK 379 (483)
Q Consensus 303 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~~ 379 (483)
++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....+.. ....+.........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 986543221 2223346889999999985544 8999999999999999999999997655432 23333333333444
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+...+++.+.......++..+.+++.+||+.||++|||+.+++++|+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5556666666667788899999999999999999999999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=374.60 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=214.1
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999995 56889999999766555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999953 3589999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....+......... . ..+..
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~------~~~~~-- 236 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----N------GTPEL-- 236 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----H------CSCCC--
T ss_pred c-ccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C------CCCCC--
Confidence 2 233457899999999986554 89999999999999999999999987665433222111 0 11111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+...+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 122334478899999999999999999999999776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.59 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=211.6
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999997 578899999996643 234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999964 35689999999999999999999999 999999999999999999999999999986654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....||+.|+|||++.+....+.++|||||||++|||++|+.||.+.+......... .. ....
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-----~~------~~~~ 233 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL-----RG------KYRI 233 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HC------CCCC
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hC------CCCC
Confidence 322 2345789999999999766645689999999999999999999998766443221111 11 1223
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
|.. .+..+.+++.+||..||.+|||+.|++++.+..
T Consensus 234 p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 234 PFY----MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp CTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred CCC----CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 322 236788999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.44 Aligned_cols=264 Identities=28% Similarity=0.461 Sum_probs=204.7
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
....+++..++|++.+.||+|+||+||+|.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3445566778899999999999999999987 6788999999766433 336799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEcCCCCcEEee
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 99999999999999999996421 123489999999999999999999998 8 99999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||............ .
T Consensus 183 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~----~---- 252 (309)
T 3p86_A 183 FGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV----G---- 252 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----H----
T ss_pred CCCCccccccc-cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H----
Confidence 99998654332 2233457899999999996554 899999999999999999999999876543322111 0
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
........+ ...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 -~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 253 -FKCKRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp -HSCCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hcCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001112222 2334678999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=381.93 Aligned_cols=262 Identities=22% Similarity=0.353 Sum_probs=213.0
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc--------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345678999999999999999999863 345799999976533 2346799999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
.+.+..|+||||+++|+|.+++..... ....+++.+++.++.||+.||.|||++ +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999975421 124589999999999999999999999 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCch
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQ 364 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~ 364 (483)
||++.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999986644322 2233446778999999986544 8999999999999999999 99999876654
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... ... ...+..+ ..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 313 ~~~~~-----~~~-----~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 ELFKL-----LKE-----GHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GHHHH-----HHT-----TCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH-----Hhc-----CCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 32211 111 1111222 23447899999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=366.62 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=211.7
Q ss_pred CcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
|...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 667789999999999999976 6899999999877666678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
|+|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 127 ~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 99999984 34689999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (483)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||........... +.....+.+. ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~----------~~~~~~~~~~--~~ 264 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----------LRDSPPPKLK--NS 264 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------HHHSSCCCCT--TG
T ss_pred cccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------HhcCCCCCcC--cc
Confidence 2345789999999998654 489999999999999999999999986654332211 1111111111 12
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 394 ~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
...+..+.+++.+||+.||++|||+.+++++.+....
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 2334678899999999999999999999998776543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=364.89 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=214.3
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 44567999999999999999999998899999999976543 34679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999963 345689999999999999999999999 9999999999999999999999999999876554
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||.+.+.. ++.++|||||||++|||++ |+.||............ ........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~----------~~~~~~~~ 228 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------STGFRLYK 228 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----------HTTCCCCC
T ss_pred ccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----------hcCccCCC
Confidence 444444456678899999985444 8999999999999999999 99999876554322111 11111222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+. ..+..+.+++.+||+.||++|||+.+++++|+.
T Consensus 229 ~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 229 PR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 22 233678899999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=369.40 Aligned_cols=271 Identities=18% Similarity=0.245 Sum_probs=211.8
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
..++|++.+.||+|+||+||+|+..+++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3467999999999999999999998899999999975432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++ +|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..+.
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 88888863 345699999999999999999999999 999999999999999999999999999987653
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh--------h
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK--------I 380 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--------~ 380 (483)
... ......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+......... +
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 322 2233467999999999876556899999999999999999999999877766544443321110000 0
Q ss_pred hhhcCCC---CCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPK---LPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~---~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....... ..... ......++.+|+.+||+.||++|||+.|++++.+..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 0000000 00000 0112357889999999999999999999999876554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=374.90 Aligned_cols=257 Identities=19% Similarity=0.254 Sum_probs=211.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.+.|.+.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999975 5889999999765322 346899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC----CcEEeec
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW----NPKISDV 300 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DF 300 (483)
++||||++||+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999995 446799999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+..+.. .
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~-----~-- 233 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA-----V-- 233 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT-----T--
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----c--
Confidence 9998765432 223457899999999986544 89999999999999999999999987655433222110 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...++.......+..+.+++.+||..||.+|||+.|++++.+...
T Consensus 234 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 234 ----SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ----CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 111111001122367889999999999999999999999887653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=368.26 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=211.1
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999975 5889999998653 122346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999963 35689999999999999999999999 99999999999999999999999999998543
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+. . ....
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----~-------~~~~ 223 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----M-------EEIR 223 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----H-------CCCC
T ss_pred cC-CCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH----c-------CCCC
Confidence 22 12233457899999999986554 8999999999999999999999998665433221111 1 1122
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
+|.. .+..+.+++.+||+.||++|| ++.+++++.+....
T Consensus 224 ~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 224 FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 3322 336788999999999999999 99999998876553
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.81 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=209.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|.+.+.||+|+||+||+|... ++..||+|.+........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467889999999999999999975 5888999998776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++|+|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999974 245699999999999999999999999 99999999999999999999999999998654332
Q ss_pred ccc-------------ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHH-HHHHHHH
Q 046972 311 SIS-------------TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLID-WLKSMVA 376 (483)
Q Consensus 311 ~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~-~~~~~~~ 376 (483)
... .....||+.|+|||++.+. .++.++|||||||++|||++|..||........... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~--- 238 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG--- 238 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH---
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc---
Confidence 211 1144789999999999654 489999999999999999999999875433211000 0000
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+. ++..+.+++.+||+.||++|||+.++++.|+...
T Consensus 239 --~~~~~~~~~--------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 239 --FLDRYCPPN--------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp --HHHHTCCTT--------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cccccCCCC--------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011111122 2247889999999999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=362.61 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=215.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++..++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++.+++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 345678999999999999999999999888999999976543 3467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999643 34589999999999999999999999 999999999999999999999999999987665
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
..........+|..|+|||.+.+.. ++.++|||||||++|||++ |+.||............ .......
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----------~~~~~~~ 225 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----------SQGHRLY 225 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----------HTTCCCC
T ss_pred hhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----------HcCCCCC
Confidence 5444444456677899999986544 8999999999999999999 99999866654322111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+. ..+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 226 ~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 226 RPH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCC----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 222 22367889999999999999999999999997543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=363.90 Aligned_cols=268 Identities=21% Similarity=0.272 Sum_probs=209.2
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||+|+||.||+|+..+++.+|+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999988999999999655332 236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++ +|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 99999963 335689999999999999999999999 99999999999999999999999999998664332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-----hh--hh
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK-----IA--YV 383 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~--~~ 383 (483)
. ......+|+.|+|||++.+...++.++|||||||++|||++|+.||..................... .. ..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 1 2233467999999999866556899999999999999999999999877655443333221110000 00 00
Q ss_pred cCCCCCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPE-------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.++..+. ......+..+.+++.+||+.||++|||+.|++++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 1111110 00112346788999999999999999999999987644
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.48 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=208.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
+..++|.+.+.||+|+||.||+|.+. .+..||||++.... ....+.|.+|+.+++.++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34567999999999999999999974 34569999997653 33446899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.++++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999963 335699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
....... .......+|..|+|||++.+.. ++.++|||||||++|||++ |..||............ .
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----------~ 268 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV----------E 268 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH----------H
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----------H
Confidence 7654322 1222335577899999985444 8999999999999999999 99999776554322111 1
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...... .+..++..+.+++.+||..||.+|||+.++++.|+..
T Consensus 269 ~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 269 EGYRLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp TTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 1223447899999999999999999999999999653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=380.82 Aligned_cols=258 Identities=17% Similarity=0.210 Sum_probs=209.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
..++|++.+.||+|+||.||+|... +++.+|+|++...... ..+.+.+|+++++.++|||||++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999864 6888999999765432 346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc---CCCCcEEeeccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD---HHWNPKISDVGLAK 304 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DFGla~ 304 (483)
||||+||+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999963 35699999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+. ..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-----~~------ 228 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-----AG------ 228 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----HT------
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----hC------
Confidence 6654322 22345789999999998654 48999999999999999999999998765443222111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
....+.......+..+.+++.+||+.||.+|||+.|++++.+..
T Consensus 229 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 229 AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 11112112223446889999999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=370.09 Aligned_cols=259 Identities=23% Similarity=0.260 Sum_probs=209.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999976 688999999865533 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999995 445799999999999999999999999 9999999999999999999999999999865322
Q ss_pred c-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 W-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. ........||+.|+|||++.+...++.++|||||||++|||++|+.||............ ... ...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~---------~~~ 226 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKE---------KKT 226 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH---HHT---------TCT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hhc---------ccc
Confidence 2 122334578999999999876664588999999999999999999999866543221111 000 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...........+.+|+.+||+.||.+|||+.|++++.+...
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 11112334468889999999999999999999999877643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=391.38 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=215.4
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+++..++|.+.+.||+|+||.||+|.+.++..||||.+.... ...+.|.+|++++++++|||||++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 45567788899999999999999999999889999999997654 35678999999999999999999999986 66789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.++++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 999999999999999643 123578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
.............++..|+|||++... .++.++|||||||++|||++ |+.||.+......... . ... .
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~-----~ 402 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----L-ERG-----Y 402 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----H-HHT-----C
T ss_pred cCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcC-----C
Confidence 654333333334567789999998544 48999999999999999999 9999987654332211 1 111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... +..++..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 403 ~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 403 RMPR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 223457899999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=373.29 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=207.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45578999999999999999999975 47899999986532 22345688999999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999964 35699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.. .
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-----~------ 239 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----D------ 239 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----C------
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc-----C------
Confidence 54322 22234457899999999986554 89999999999999999999999987665433222211 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHhccccch
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM------GDVLRMLEPRDL 430 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~eil~~L~~~~~ 430 (483)
....|.. ....+.+++.+||+.||.+||++ .+++++.+..+.
T Consensus 240 ~~~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 EVVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCCCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 1222322 23678899999999999999999 889998877654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=383.77 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=211.6
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.+.+..++|.+.+.||+|+||.||+|.+. +++.||+|.+..... ...+.|.+|++++++++|||||++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 44566788999999999999999999986 688999999876532 2335789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.++++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 188 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999999642 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcccc-ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 305 LHGPEWSIS-TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 305 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
......... .....++..|+|||.+.... ++.++|||||||++|||++ |..||......... .....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-----~~~~~----- 330 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-----EFVEK----- 330 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-----HHHHT-----
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHc-----
Confidence 654332211 12234567899999985444 8999999999999999998 99999876543221 11111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...... +..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 331 ~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 331 GGRLPC----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp TCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 111112 22344688999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=384.40 Aligned_cols=267 Identities=17% Similarity=0.221 Sum_probs=217.1
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEe
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 220 (483)
+.++.+..++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.+++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455567789999999999999999999976 478899999864211 122458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
.+..|+|||||+||+|.++++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999953 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTS---IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
|+|+..............||+.|+|||++.+.. .++.++|||||||++|||++|+.||...+.......+.....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-- 290 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-- 290 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--
Confidence 999877655444445568999999999986443 267899999999999999999999987665443333222110
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccch
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRDL 430 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~~ 430 (483)
....|. ....+..+.+|+.+||..+|.+ ||+++||+++.+..+.
T Consensus 291 -------~~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 291 -------SLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp -------HCCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred -------cccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 011111 0112367889999999999998 9999999999887654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=373.82 Aligned_cols=257 Identities=19% Similarity=0.238 Sum_probs=211.7
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.+.|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 5788999999776655667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC--CCCcEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH--HWNPKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~ 308 (483)
+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999963 335699999999999999999999999 9999999999999974 57799999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.........+. . . ....
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~----~-~------~~~~ 269 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK----R-C------DWEF 269 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----H-C------CCCC
T ss_pred Ccc--eeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH----h-C------CCCC
Confidence 322 22346899999999996544 8999999999999999999999998765433222111 0 0 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+.......+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 2212223346889999999999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=366.69 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=211.1
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.+.|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999975 5889999998754322 357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC----CcEEeec
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW----NPKISDV 300 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DF 300 (483)
++||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999995 346799999999999999999999999 999999999999999887 7999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|+++...... ......||+.|+|||++.... ++.++|||||||++|+|++|..||.+............
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------- 231 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------- 231 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--------
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh--------
Confidence 9998765332 223347899999999986544 89999999999999999999999987654332221110
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.....+.......+..+.+++.+||+.||++|||+.+++++.+....
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 232 ---VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp ---TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ---cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 01111110011223678899999999999999999999998876553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=358.83 Aligned_cols=278 Identities=32% Similarity=0.564 Sum_probs=226.0
Q ss_pred eeehHHHHHHhcCCccc------ceeccCCceEEEEEEEcCCcEEEEEEecCCC----cchHHHHHHHHHHHhcCCCCcc
Q 046972 142 RISLKEIDIVTDGFAEQ------NVIASGDNGVVYRAVLLDNMRAAVKLLMSNS----VSEEEDFIEKVEAIGQVKHKNL 211 (483)
Q Consensus 142 ~~~~~~~~~~~~~~~~~------~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnI 211 (483)
.++..++.-.+++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+++++.++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 46777888888877766 8999999999999986 67899999986532 2335789999999999999999
Q ss_pred cccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC
Q 046972 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291 (483)
Q Consensus 212 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~ 291 (483)
+++++++.+.+..++||||+++|+|.+++.... ...++++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999996432 345699999999999999999999999 9999999999999999
Q ss_pred CCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHH
Q 046972 292 HWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW 370 (483)
Q Consensus 292 ~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~ 370 (483)
++.+||+|||+++....... .......||+.|+|||.+.+. ++.++|||||||++|+|++|..||...........+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 99999999999986544322 223334689999999998543 789999999999999999999999876554433333
Q ss_pred HHHHHHh-hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 371 LKSMVAQ-QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 371 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....... ..+...+++.++. .....+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 2222211 1233344444433 456777899999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=363.61 Aligned_cols=272 Identities=18% Similarity=0.232 Sum_probs=215.8
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCC--eEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ--NRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 227 (483)
.++|.+.+.||+|+||+||+|.... ++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4678899999999999999999764 8899999997543 234577889999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE----cCCCCcEEeecccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLA 303 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DFGla 303 (483)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997542 234499999999999999999999999 99999999999999 77888999999999
Q ss_pred cccCCCccccccccccCcccccccccCC-------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGR-------TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
+....... .....||..|+|||++.. ...++.++|||||||++|||++|+.||..........+.+.....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 87654322 233468999999998742 344899999999999999999999999765544333333333322
Q ss_pred hhhhh--------------hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 QQKIA--------------YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ~~~~~--------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..... ..-....+..........+.+++.+||+.||++|||+.|+++++....
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 21100 000111222345677889999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=366.66 Aligned_cols=256 Identities=16% Similarity=0.243 Sum_probs=209.8
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999976 47789999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC--CCCcEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH--HWNPKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~ 308 (483)
|+||+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999953 234699999999999999999999999 9999999999999987 78999999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+.. . ....
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-----~------~~~~ 222 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-----A------EYTF 222 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----T------CCCC
T ss_pred CCc--cccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc-----C------CCCC
Confidence 322 23346899999999986554 79999999999999999999999987665433222111 0 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+.......+..+.+++.+||..||.+|||+.|++++.+..
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 1000112246889999999999999999999999977653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=360.21 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=212.2
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+++..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++|
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3455678999999999999999999999888999999976543 346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999642 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
...........+|..|+|||.+.+.. ++.++|||||||++|||++ |+.||........... +......
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----------~~~~~~~ 240 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----------IAQGLRL 240 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----------HHTTCCC
T ss_pred ccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----------HhcccCC
Confidence 54333444456678899999986444 8999999999999999998 9999987664332211 1111122
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.. .+..+.+++.+||+.||.+|||+.+++++|..
T Consensus 241 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 241 YRPHL----ASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCc----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 22222 23678899999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.03 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=211.1
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999975 58899999986532 12346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999963 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+. . . ...
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~-~------~~~ 221 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----N-A------ELR 221 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----H-C------CCC
T ss_pred Cc----cccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----h-C------CCC
Confidence 32 23457899999999986554 8999999999999999999999998765433222111 1 1 122
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccchh
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDLL 431 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~~ 431 (483)
+|.. .+..+.+++.+||..||.+|| ++++++++.+..+..
T Consensus 222 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 222 FPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred CCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 3322 236788999999999999999 899999988776543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=361.01 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=204.2
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578999999999999999999965 578999999865432 233678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||++||+|.+++.. ..++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999964 35699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+........... ... .+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----~~~------~~ 230 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI----QDS------VP 230 (294)
T ss_dssp -------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH----SSC------CC
T ss_pred ccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----hcc------CC
Confidence 544333444457899999999986554 8999999999999999999999998766433221111 000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRP-KMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~eil~~L~~ 427 (483)
..+.......+..+.+++.+||+.||.+|| +++++.+.|..
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 000001122336889999999999999998 88888887754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=372.85 Aligned_cols=256 Identities=18% Similarity=0.251 Sum_probs=209.5
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
..++|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4577999999999999999999975 588999999976533 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcEEeeccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPKISDVGLAK 304 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DFGla~ 304 (483)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999995 345689999999999999999999999 99999999999999865 459999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+ ...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----~~~------ 245 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-----KAG------ 245 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHT------
T ss_pred EecCCc--ccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhC------
Confidence 765332 223357899999999986544 899999999999999999999999876543322111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+.......+..+.+++.+||+.||++|||+.+++++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 1112221222345788999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=363.98 Aligned_cols=251 Identities=20% Similarity=0.224 Sum_probs=210.3
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999975 58899999986532 12346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++||+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999643 4689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+. . . ...
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----~-~------~~~ 256 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV----S-G------KVR 256 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----H-C------CCC
T ss_pred CC----cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH----c-C------CCC
Confidence 32 23457899999999986554 8999999999999999999999998765433222111 1 1 122
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
+|.. .+..+.+++.+||+.||.+||+ +++++++.+...
T Consensus 257 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 2322 3367889999999999999998 999999887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.56 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=202.8
Q ss_pred HhcCCcccceeccCCceEEEEEEE----cCCcEEEEEEecCCCc----chHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL----LDNMRAAVKLLMSNSV----SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 456799999999999999999997 4788999999976432 23356889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999963 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.. .
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-----~---- 236 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-----C---- 236 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----T----
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----C----
Confidence 97543221 1223447899999999986554 89999999999999999999999987654432222111 0
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccchh
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDLL 431 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~~ 431 (483)
...++.. .+..+.+++.+||+.||.+|| ++.+++++.+..+..
T Consensus 237 --~~~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 237 --KLNLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp --CCCCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred --CCCCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 1222322 236788999999999999999 888999988876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=379.98 Aligned_cols=271 Identities=17% Similarity=0.197 Sum_probs=219.2
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEE
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
.+.++.+..++|++.++||+|+||+||+|+... ++.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345666778999999999999999999999765 67899999864211 11234889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
+.+..|+|||||+||+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999964 245699999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
||+|+..............||+.|+|||++. +...|+.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999876554444444568999999999985 233489999999999999999999999987665443333221110
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHhccccch
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKH--RPKMGDVLRMLEPRDL 430 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~eil~~L~~~~~ 430 (483)
...+|.. ....+..+.+|+.+||..+|++ ||+++|++++.+....
T Consensus 299 ---------~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 299 ---------RFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp ---------HCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ---------cccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 0111211 0112367889999999998888 9999999998877543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=357.36 Aligned_cols=269 Identities=18% Similarity=0.243 Sum_probs=207.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 578899999975533 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++ +|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..+..
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 66666643 346699999999999999999999999 9999999999999999999999999999876533
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch-hhHHHHHHHHHHhhh-----hhhh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDWLKSMVAQQK-----IAYV 383 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~-----~~~~ 383 (483)
. .......+|+.|+|||++.+...++.++|||||||++|||++|..||...... ..+..+......... ....
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 2 22334578999999999876666899999999999999999988886444333 222222211100000 0000
Q ss_pred cC----CCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 LD----PKLP-----EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 ~~----~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+ +..+ ..........+.+++.+||+.||++|||++|++++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 00 0000 0011123467889999999999999999999999877654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=363.29 Aligned_cols=273 Identities=18% Similarity=0.295 Sum_probs=199.7
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357899999999999999999964 588999999975532 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 230 YIDNGNLQQWLHGSL--GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|++ |+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999986432 2235689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-----hhhh
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-----KIAY 382 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-----~~~~ 382 (483)
.... ......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+........ ....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3321 223347899999999986655589999999999999999999999987766544433322111000 0000
Q ss_pred --hcCCCCCCC------------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 383 --VLDPKLPEM------------PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 383 --~~~~~~~~~------------~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+..+.. .....+..+.+++.+||+.||++|||+.|++++.+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 000000000 00112357899999999999999999999999877654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=391.54 Aligned_cols=262 Identities=21% Similarity=0.353 Sum_probs=217.1
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
..+++..++|.+.+.||+|+||.||+|.+.. +..||||.+..... ..+.|.+|+.++++++|||||++++++......
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3455667889999999999999999999875 78899999976533 467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.++++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999753 335689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..............++..|+|||++.... ++.++|||||||++|||++ |..||.+......... .. ..
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-----~~-----~~ 435 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LE-----KD 435 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HH-----TT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HH-----cC
Confidence 76544333333445677899999986444 8999999999999999999 9999987665432211 11 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... .+..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 436 ~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 436 YRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111 2233447899999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=367.95 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=211.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+..++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|||||++++++.+.+..|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34577999999999999999999965 47789999986432 223467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+.||+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeee
Confidence 9999999999999996 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..... ......||+.|+|||++.. ...|+.++|||||||++|||++|+.||........ .........
T Consensus 165 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~------- 234 (384)
T 4fr4_A 165 LPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFET------- 234 (384)
T ss_dssp CCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHHH-------
T ss_pred ccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhh-------
Confidence 65432 2334578999999999853 23489999999999999999999999976543321 111111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHhccccchh
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-MGDVLRMLEPRDLL 431 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~eil~~L~~~~~~ 431 (483)
.....+. ..+..+.+++.+||+.||.+||+ +++++++.+..+..
T Consensus 235 ~~~~~p~----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 235 TVVTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp CCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred cccCCCC----cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 1122222 23368899999999999999998 88888877665543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=360.69 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=202.7
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhc--CCCCcccccccEEEeC----CeE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQ--VKHKNLVKLFGYCVEG----QNR 224 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~----~~~ 224 (483)
..++|++.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999988 6889999998543 44556667776665 7999999999987653 457
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH--------EDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
++||||+++|+|.++++ ...+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 99999999999999994 346999999999999999999999 87 999999999999999999999
Q ss_pred EeecccccccCCCccc---cccccccCcccccccccCCCC-----CCCcchhhHHHHHHHHHHHcC----------CCCC
Q 046972 297 ISDVGLAKLHGPEWSI---STSCELRNSGYLAEELSGRTS-----IFNEKSDVYSFGILIMEIVSG----------RLPV 358 (483)
Q Consensus 297 l~DFGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~el~tg----------~~Pf 358 (483)
|+|||+++........ ......||+.|+|||++.+.. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999999765433221 123347899999999986542 244799999999999999999 8888
Q ss_pred CCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 359 DYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.................. .....+..+. .....++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVC----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHh----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 654332211111111111 1111222221 1223567889999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.26 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=209.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
+..++|++.+.||+|+||.||+|++. ++..||||++... .......+.+|+.++++++|||||++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 44578999999999999999999953 4568999999654 3334467999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC---CcE
Q 046972 223 NRILVYEYIDNGNLQQWLHGSL---GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW---NPK 296 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~---~~k 296 (483)
..++||||+++|+|.+++.... .....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999996532 2235689999999999999999999999 999999999999999555 599
Q ss_pred EeecccccccCCC-ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHH
Q 046972 297 ISDVGLAKLHGPE-WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 297 l~DFGla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|+|||+++..... .........+|+.|+|||++.+.. ++.++|||||||++|||++ |..||........... .
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~----i 299 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----V 299 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----H
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H
Confidence 9999999754221 112233456788999999985544 8999999999999999998 9999987664332211 1
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
... .... .+..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 300 -~~~-----~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 -TSG-----GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -HTT-----CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HcC-----CCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 100 1111 1223346789999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=372.81 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=215.2
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCccccc
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKL 214 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~ 214 (483)
+....+++..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++.++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445677888999999999999999999999843 357899999976533 3346799999999999 79999999
Q ss_pred ccEEEeCCe-EEEEEEecCCCCHHHHHhcccCC-----------------------------------------------
Q 046972 215 FGYCVEGQN-RILVYEYIDNGNLQQWLHGSLGE----------------------------------------------- 246 (483)
Q Consensus 215 ~~~~~~~~~-~~lv~E~~~~g~L~~~l~~~~~~----------------------------------------------- 246 (483)
++++.+.+. .++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999754221
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 247 ---------------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 247 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 999999999999999999999999999986543222
Q ss_pred -ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 312 -ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 312 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.......+|..|+|||++.+. .++.++|||||||++|||++ |..||.+............. ......+
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~ 318 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---------GTRMRAP 318 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------TCCCCCC
T ss_pred chhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------CCCCCCC
Confidence 233445678899999998644 48999999999999999998 99999876654333221111 1112222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ..+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 319 ~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 319 D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 2 233678999999999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=369.63 Aligned_cols=261 Identities=19% Similarity=0.243 Sum_probs=208.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN-----SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
..+.|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999965 5889999998532 122457799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEeecc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKISDVG 301 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DFG 301 (483)
++|||||+||+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999998865433455689999999999999999999999 9999999999999987654 9999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+... .. ...... ..
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~----~~~i~~-~~-- 248 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKE-RL----FEGIIK-GK-- 248 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HH----HHHHHH-TC--
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcHH-HH----HHHHHc-CC--
Confidence 9987654322 233457899999999996554 89999999999999999999999976432 11 111111 10
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+.......+..+.+++.+||+.||++|||+.+++++.+..
T Consensus 249 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 249 ----YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ----CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 0011000012236889999999999999999999999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=374.75 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=197.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..++|.+.+.||+|+||.||+|+.. ++..||||.+.... ....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4467999999999999999999865 56779999997653 334468999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.++++. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999974 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... ......++..|+|||++.+. .++.++|||||||++|||++ |+.||........... . ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~----i-~~~---- 266 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----V-DEG---- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH----H-HTT----
T ss_pred cccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcC----
Confidence 6543221 12223456789999998644 48999999999999999998 9999976654322111 1 110
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... .+..++..+.+++.+||+.||.+||++.++++.|+..
T Consensus 267 -~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 -YRLP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -EECC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0111 1223447899999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=370.65 Aligned_cols=273 Identities=17% Similarity=0.182 Sum_probs=209.6
Q ss_pred hcCCcccceeccC--CceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASG--DNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+| +||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568999999999 99999999976 688999999976532 233678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999653 235699999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCc------cccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-
Q 046972 307 GPEW------SISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ- 378 (483)
Q Consensus 307 ~~~~------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~- 378 (483)
.... ........||..|+|||++.+. ..++.++|||||||++|||++|+.||.+..................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2111 1112234688899999998653 4589999999999999999999999987665543332221110000
Q ss_pred --------h-------------hhhhcC--------CCC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 379 --------K-------------IAYVLD--------PKL-PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 379 --------~-------------~~~~~~--------~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
. ...... ... ........+..+.+|+.+||+.||++|||+.|++++.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 0 000000 000 0001223346789999999999999999999999987665
Q ss_pred c
Q 046972 429 D 429 (483)
Q Consensus 429 ~ 429 (483)
.
T Consensus 339 ~ 339 (389)
T 3gni_B 339 Q 339 (389)
T ss_dssp G
T ss_pred H
Confidence 4
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=359.79 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=200.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--------------------------hHHHHHHHHHHHh
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--------------------------EEEDFIEKVEAIG 204 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 204 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999965 5788999998654321 1246889999999
Q ss_pred cCCCCcccccccEEEe--CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecC
Q 046972 205 QVKHKNLVKLFGYCVE--GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNM 282 (483)
Q Consensus 205 ~l~hpnIv~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDl 282 (483)
+++||||+++++++.+ ....++||||+++|+|.+++ ....+++..++.++.||+.||.|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 56889999999999998865 345799999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCC--CCcchhhHHHHHHHHHHHcCCCCCCC
Q 046972 283 KSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI--FNEKSDVYSFGILIMEIVSGRLPVDY 360 (483)
Q Consensus 283 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlGv~l~el~tg~~Pf~~ 360 (483)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+... ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 2234578999999999865432 37889999999999999999999976
Q ss_pred CCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 361 SQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
........ . ..... ...+. ....+..+.+++.+||+.||++|||+.|++++.+
T Consensus 243 ~~~~~~~~----~-~~~~~------~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 243 ERIMCLHS----K-IKSQA------LEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SSHHHHHH----H-HHHCC------CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred ccHHHHHH----H-Hhccc------CCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 54322111 1 11110 11111 1123367899999999999999999999988654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=386.72 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=208.4
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+++..++|++.+.||+|+||.||+|.+.++..||||.+..... ..+.|.+|++++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 345567788999999999999999999998888999999976543 45789999999999999999999999866 6789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999999642 224589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
.............++..|+|||.+... .++.++|||||||++|||++ |+.||.+......... . .. ..
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~-----~~ 398 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ER-----GY 398 (452)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HT-----TC
T ss_pred cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-Hc-----CC
Confidence 654332233334567889999998644 48999999999999999999 9999987654332211 1 11 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... +..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 399 ~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 399 RMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 223457899999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=367.76 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=209.5
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 222 (483)
..+..++|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456688999999999999999999975 57889999996532 22345678899998876 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 99999999999999999964 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
++..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+ ..
T Consensus 165 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----~~------ 232 (345)
T 1xjd_A 165 CKENMLG-DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----RM------ 232 (345)
T ss_dssp CBCCCCT-TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HH------
T ss_pred hhhcccC-CCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----Hh------
Confidence 9854322 12234457899999999996554 899999999999999999999999876543322211 11
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHhccccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMG-DVLRMLEPRD 429 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-eil~~L~~~~ 429 (483)
..+..+.. .+..+.+++.+||..||++||++. +++++.+...
T Consensus 233 -~~~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 233 -DNPFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp -CCCCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -CCCCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 12233332 336788999999999999999998 8887776544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=374.26 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=213.2
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc--------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGY 217 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 217 (483)
+++..++|.+.+.||+|+||.||+|... .+..||+|++..... .....+.+|+++++.+ +|||||+++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3456678999999999999999999863 235799999976533 3347799999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
+...+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999975421 124699999999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCc
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQP 363 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~ 363 (483)
|||++.++.+||+|||+++....... .......+|..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986654322 223344677889999998654 48999999999999999999 9999987654
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... . . ........+ ..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 300 ~~~~~----~-~-----~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 300 EELFK----L-L-----KEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHH----H-H-----HTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----H-H-----HcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 32211 1 1 111112222 23346889999999999999999999999999654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=372.50 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=208.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc---hHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS---EEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+..++|++.+.||+|+||.||+|+... ++.||+|++...... ..+.+..|..++.++ +|||||++++++.+.+..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 345679999999999999999999764 678999999754222 224578899999887 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||++||+|..++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 129 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999964 35699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh----HHHHHHHHHHhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF----LIDWLKSMVAQQKI 380 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~----~~~~~~~~~~~~~~ 380 (483)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ....+......
T Consensus 202 ~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--- 276 (396)
T 4dc2_A 202 EGLRP-GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--- 276 (396)
T ss_dssp CCCCT-TCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH---
T ss_pred ecccC-CCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc---
Confidence 53222 12234457899999999996554 89999999999999999999999964332111 01111111111
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHhccccch
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM------GDVLRMLEPRDL 430 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~eil~~L~~~~~ 430 (483)
....+|.. .+..+.+|+.+||+.||.+||++ .+++++.+..+.
T Consensus 277 ---~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 277 ---KQIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ---CCCCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---cccCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 12233332 33678899999999999999995 799998877654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=360.90 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=198.4
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
.++..++|++.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.++++++||||+++++++ ..+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence 34556789999999999999999999753 45689999876433 3346799999999999999999999997 456
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 789999999999999999642 34689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
++..............+++.|+|||++... .++.++|||||||++|||++ |..||...........+ . ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~-~~--- 233 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----E-NG--- 233 (281)
T ss_dssp ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----H-TT---
T ss_pred ccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----H-cC---
Confidence 987654433333444667889999998544 48999999999999999997 99999876654332111 0 00
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.....+ ..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 --~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 234 --ERLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122 23347889999999999999999999999998653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=366.73 Aligned_cols=272 Identities=24% Similarity=0.346 Sum_probs=207.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC----eEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ----NRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~ 225 (483)
+..++|++.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++|||||++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34577999999999999999999875 7899999986542 23345677999999999999999999998754 469
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-------CCCeeeecCCCCcEEEcCCCCcEEe
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI-------EPKIVHHNMKSSNILLDHHWNPKIS 298 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~iiHrDlkp~NiLl~~~~~~kl~ 298 (483)
+||||+++|+|.++++. ..+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999953 35999999999999999999999751 2389999999999999999999999
Q ss_pred ecccccccCCCccc-cccccccCcccccccccCCC----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh--HHHHH
Q 046972 299 DVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRT----SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF--LIDWL 371 (483)
Q Consensus 299 DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~--~~~~~ 371 (483)
|||+++........ ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+...... .....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999866543222 23335789999999998653 2356788999999999999999999976543211 00000
Q ss_pred H-----HHHHhhhhhhhcCCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 372 K-----SMVAQQKIAYVLDPKLPEM-PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 372 ~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
. .............+.++.. ....++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0000001111112222211 1234567799999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.35 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=203.7
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC---CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN---SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++...+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999965 5889999998653 2233356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ + +|+||||||+|||++.++.+||+|||+|+
T Consensus 225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 99999999999999963 3568999999999999999999998 8 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.. .
T Consensus 298 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-----------~ 364 (446)
T 4ejn_A 298 EGIKD-GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------E 364 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------C
T ss_pred eccCC-CcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh-----------C
Confidence 64332 22233457899999999986554 89999999999999999999999987654432221110 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccchhh
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDLLL 432 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~~~ 432 (483)
...+|.. .+..+.+++.+||+.||.+|| ++.+++++.+..+..-
T Consensus 365 ~~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 365 EIRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 1222322 236788999999999999999 9999999888766433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=380.21 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=207.4
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC-eEEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ-NRILV 227 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv 227 (483)
.+..++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.|.+|++++++++|||||++++++.... ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 456688999999999999999999985 6799999997654 4567999999999999999999999987765 78999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
||||++|+|.++++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999754 234479999999999999999999999 99999999999999999999999999998543
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
.. .....++..|+|||.+.... ++.++|||||||++|||++ |+.||............ .. ....
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~-----~~~~ 405 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EK-----GYKM 405 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-----HT-----TCCC
T ss_pred cc----ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----Hc-----CCCC
Confidence 22 12235678899999986544 8999999999999999998 99999876554322111 11 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. .+..++..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 406 ~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 406 D----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 223445789999999999999999999999998864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=363.81 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=213.0
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
.+++..++|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 34456678999999999999999999862 347899999976533 34478999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLG--------------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 279 (483)
+.+..++||||+++|+|.+++..... ....+++.+++.++.||+.||.|||++ +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 99999999999999999999975422 124589999999999999999999999 9999
Q ss_pred ecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCC
Q 046972 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357 (483)
Q Consensus 280 rDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~P 357 (483)
|||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..|
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986644322 2233446678899999985543 8999999999999999999 9999
Q ss_pred CCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 358 VDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 358 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
|.+......... ... ...+..+ ..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 ~~~~~~~~~~~~-----~~~-----~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 253 YPGIPPERLFNL-----LKT-----GHRMERP----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp STTCCGGGHHHH-----HHT-----TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHH-----hhc-----CCcCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 987665432211 111 1111222 2334689999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=354.73 Aligned_cols=270 Identities=20% Similarity=0.253 Sum_probs=208.6
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||+||+|.... ++.||+|++....... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 679999999999999999999754 8899999986654332 3678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999985 345689999999999999999999999 9999999999999999999999999999876533
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--------hhhh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--------QKIA 381 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~ 381 (483)
.. ......+|..|+|||++.+...++.++|||||||++|+|++|+.||.+................. ....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 22344788999999998665568999999999999999999999998776654433322211000 0000
Q ss_pred hhcCCCCCC---CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 382 YVLDPKLPE---MPS-----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 382 ~~~~~~~~~---~~~-----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.......+. ... ...+..+.+++.+||+.||.+|||+.+++++.+..+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 000011110 000 1234678899999999999999999999998876553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=365.07 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=205.9
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999996 5688999999864321 12357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+ +|+|.+++.. ...+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 7899999863 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....||+.|+|||++.+....+.++|||||||++|+|++|+.||......... ..+. ......
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------~~i~-~~~~~~ 227 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------KKVN-SCVYVM 227 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------CCCC-SSCCCC
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------HHHH-cCCCCC
Confidence 322 233468999999999976654478999999999999999999999765432110 0000 001112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
|. ..+..+.+++.+||+.||.+|||+.|++++.+..
T Consensus 228 p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 228 PD----FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp CT----TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred cc----cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 22 2346788999999999999999999999887653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.29 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=204.7
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 158 QNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999964 5889999999877666678899999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE--cCCCCcEEeecccccccCCCccccc
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL--DHHWNPKISDVGLAKLHGPEWSIST 314 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl--~~~~~~kl~DFGla~~~~~~~~~~~ 314 (483)
.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 999863 234689999999999999999999999 99999999999999 5677899999999987654322 2
Q ss_pred cccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCH
Q 046972 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSR 394 (483)
Q Consensus 315 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (483)
....||+.|+|||++... .++.++|||||||++|||++|+.||.+......+..+... ....+.....
T Consensus 246 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-----------~~~~~~~~~~ 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-----------RWDLEDEEFQ 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------CCCSCSGGGT
T ss_pred ccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------cCCCChhhhc
Confidence 334689999999998654 4899999999999999999999999877654433222211 0111111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhh
Q 046972 395 KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLL 432 (483)
Q Consensus 395 ~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~ 432 (483)
..+..+.+++.+||+.||.+|||+.+++++.+..+...
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 23468899999999999999999999999877665433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.64 Aligned_cols=256 Identities=18% Similarity=0.308 Sum_probs=201.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCC-------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------- 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------- 222 (483)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356899999999999999999976 78899999997543 334578999999999999999999999986654
Q ss_pred --------------------------------------------------eEEEEEEecCCCCHHHHHhcccCCCCCCCH
Q 046972 223 --------------------------------------------------NRILVYEYIDNGNLQQWLHGSLGEAKPLTW 252 (483)
Q Consensus 223 --------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~ 252 (483)
..++|||||++|+|.+++.... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 2799999999999999997542 3344677
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc-----------ccccccccCc
Q 046972 253 DTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-----------ISTSCELRNS 321 (483)
Q Consensus 253 ~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~~~~ 321 (483)
..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999987654321 1223346899
Q ss_pred ccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHH
Q 046972 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRII 401 (483)
Q Consensus 322 ~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 401 (483)
.|+|||++.+.. ++.++|||||||++|||++|..|+.. ..... ........+. ........+.
T Consensus 241 ~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~------~~~~~---------~~~~~~~~~~-~~~~~~~~~~ 303 (332)
T 3qd2_B 241 LYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME------RVRII---------TDVRNLKFPL-LFTQKYPQEH 303 (332)
T ss_dssp GGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHH---------HHHHTTCCCH-HHHHHCHHHH
T ss_pred CccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH------HHHHH---------HHhhccCCCc-ccccCChhHH
Confidence 999999986554 89999999999999999998766421 00101 1111111111 1223446778
Q ss_pred HHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 402 LIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 402 ~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+++.+||+.||++|||+.+++++.+..
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhh
Confidence 999999999999999999999987644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.17 Aligned_cols=269 Identities=20% Similarity=0.309 Sum_probs=205.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-----CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC--C
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--Q 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 222 (483)
+..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 44577999999999999999999852 5789999999876666667899999999999999999999998653 5
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 689999999999999999643 34589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH-----HHH
Q 046972 303 AKLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK-----SMV 375 (483)
Q Consensus 303 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~-----~~~ 375 (483)
++....... .......++..|+|||.+.+.. ++.++|||||||++|||++|..||...... ...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMI 237 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccchh
Confidence 987644322 1223345677899999986554 899999999999999999999998643211 000000 000
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
........... .....+..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 238 VFHLIELLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00000011111 11112234457899999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=367.86 Aligned_cols=258 Identities=19% Similarity=0.295 Sum_probs=202.3
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCC--CcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKH--KNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~ 225 (483)
+..++|++.+.||+|+||.||+|...+++.||+|++...... ..+.+.+|+.++..++| |||+++++++.+.+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345679999999999999999999888999999998765332 33678999999999976 99999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|||| .+|+|.+++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.
T Consensus 86 lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99994 57899999963 35689999999999999999999999 999999999999997 56899999999987
Q ss_pred cCCCccc-cccccccCcccccccccCC----------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 306 HGPEWSI-STSCELRNSGYLAEELSGR----------TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 306 ~~~~~~~-~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
....... ......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.........
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------- 229 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------- 229 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-------
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-------
Confidence 6543222 2334578999999999743 244899999999999999999999999765442211
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+....++......+......+.+++.+||+.||.+|||+.+++++.+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 230 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp -----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 1111122111112222236788999999999999999999999887653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=354.75 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=212.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+..++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 34567999999999999999999998889999999976543 34679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999642 35689999999999999999999999 9999999999999999999999999999876544
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.........++..|+|||++.+.. ++.++|||||||++|||++ |+.||........... . ........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i------~~~~~~~~ 226 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----I------STGFRLYK 226 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----H------HTTCCCCC
T ss_pred cccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----H------hcCCcCCC
Confidence 333334446678899999985444 8999999999999999999 8999987654332211 1 11111112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+. ..+..+.+++.+||+.||.+|||+.++++.|..
T Consensus 227 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 227 PR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22 233678899999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=367.86 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=213.4
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYC 218 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 218 (483)
..+++..++|++.+.||+|+||.||+|...+ ++.||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455677899999999999999999999753 47899999976533 3346899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLGE--------------------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 278 (483)
.+.+..++||||+++|+|.+++...... ...+++.+++.++.||+.||.|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999753211 26789999999999999999999999 999
Q ss_pred eecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCC
Q 046972 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRL 356 (483)
Q Consensus 279 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~ 356 (483)
||||||+|||++.++.+||+|||+++....... .......+|..|+|||++.+.. ++.++|||||||++|||++ |..
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999986543221 2223446788999999986444 8999999999999999999 999
Q ss_pred CCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 357 PVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 357 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
||........... .... ..+..+ ..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 276 p~~~~~~~~~~~~-----~~~~-----~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 276 PYYGMAHEEVIYY-----VRDG-----NILACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTTTSCHHHHHHH-----HHTT-----CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCCCChHHHHHH-----HhCC-----CcCCCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9986654322111 1111 011122 23346899999999999999999999999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=368.18 Aligned_cols=257 Identities=19% Similarity=0.232 Sum_probs=198.3
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999976 688999999976433 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC--cEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN--PKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~--~kl~DFGla~~~~~ 308 (483)
+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999963 34699999999999999999999999 9999999999999987765 99999999974332
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. .......||+.|+|||++.+....+.++|||||||++|||++|+.||................... ....
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~ 241 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-------KYSI 241 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-------CCCC
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-------CCCC
Confidence 2 122334789999999998766533455999999999999999999998765544333332222111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+. ....+..+.+|+.+||+.||.+|||+.+++++.+.
T Consensus 242 ~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 242 PD--DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 11 11223678899999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=362.55 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=209.4
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCe
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 223 (483)
.+..++|++.+.||+|+||.||+|+... ++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 3456789999999999999999999765 6789999986532 22346788999999988 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999964 24699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
+..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+. .
T Consensus 169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~------- 235 (353)
T 2i0e_A 169 KENIWD-GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----E------- 235 (353)
T ss_dssp BCCCCT-TCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----H-------
T ss_pred cccccC-CcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH----h-------
Confidence 854322 12234457899999999996554 8999999999999999999999998765443222211 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRD 429 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~ 429 (483)
....+|. ..+..+.+++.+||..||.+||+ +.+++++.+...
T Consensus 236 ~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 236 HNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 1122332 23368889999999999999995 689998877654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=375.44 Aligned_cols=269 Identities=17% Similarity=0.177 Sum_probs=216.6
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEE
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
.+++..+..++|++.+.||+|+||.||+|+.+ +++.||+|++..... ...+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566677899999999999999999999975 688999999864321 12235889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
+.+..|+||||++||+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999643 24689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCC------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGR------TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
||+++..............||+.|+|||++.. ...|+.++|||||||++|||++|+.||...+.......+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99998765544433445589999999999852 234899999999999999999999999876654433322211
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHR---PKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---pt~~eil~~L~~~~ 429 (483)
. . ...-+..+ ...+.++.+++.+||. +|.+| |++++++++.+...
T Consensus 286 ~---~---~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 286 K---E---HLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp H---H---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred c---c---CcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 0 0 00011111 1233688999999999 99998 69999999877654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=363.46 Aligned_cols=257 Identities=20% Similarity=0.243 Sum_probs=195.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
...++|++.+.||+|+||.||+|.... ++.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 456789999999999999999999764 7789999987543 3457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeecccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVGLAKL 305 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFGla~~ 305 (483)
||+++|+|.+++. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999995 345689999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||........... .... . .
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~i~~-~------~ 267 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR---RILN-C------E 267 (349)
T ss_dssp --------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH---HHHT-T------C
T ss_pred cCccc--ccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH---HHHh-C------C
Confidence 54321 223346899999999986544 89999999999999999999999977665432211 1111 0 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+.......+..+.+++.+||+.||++|||+.+++++.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 1111111223446889999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=358.41 Aligned_cols=263 Identities=21% Similarity=0.344 Sum_probs=218.1
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
+++++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3455667889999999999999999999765 7789999986543 3557899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999753 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||............ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----------~~~ 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----------EKD 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----------HTT
T ss_pred eccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------hcc
Confidence 77655444444456788899999985444 8999999999999999999 99999876654322111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+ ..++..+.+++.+||..||.+|||+.++++.|+...
T Consensus 229 ~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC----CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 112222 233468899999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=354.15 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=196.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc----hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS----EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|++.+.||+|+||.||+|.+. ++.+|+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4578999999999999999999975 788999998654322 23678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC---eeeecCCCCcEEEcC--------CCCc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK---IVHHNMKSSNILLDH--------HWNP 295 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---iiHrDlkp~NiLl~~--------~~~~ 295 (483)
||||+++++|.+++. ...+++..++.++.|++.||.|||++ + |+||||||+|||++. ++.+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999994 35689999999999999999999998 7 999999999999986 6789
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
||+|||+++...... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||............
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----- 226 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV----- 226 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-----
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-----
Confidence 999999998654332 2234688999999998544 4899999999999999999999999876543221110
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.........+..++..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 227 --------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 01111111223344789999999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=363.68 Aligned_cols=265 Identities=21% Similarity=0.352 Sum_probs=196.3
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEcCCc----EEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEE
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNM----RAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 218 (483)
++++.+..++|++.+.||+|+||.||+|....+. .||+|++... .....+.+.+|++++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3455566788999999999999999999965432 7999999765 333457899999999999999999999999
Q ss_pred EeCCeE------EEEEEecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 219 VEGQNR------ILVYEYIDNGNLQQWLHGSL--GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 219 ~~~~~~------~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
...... ++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc
Confidence 877655 99999999999999995432 2233689999999999999999999999 999999999999999
Q ss_pred CCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHH
Q 046972 291 HHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~ 368 (483)
.++.+||+|||+++....... .......+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+........
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 999999999999986543322 222234567789999998554 48999999999999999999 999998766543322
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
... .. ..... +...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 251 ~~~----~~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 251 YLI----GG------NRLKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp HHH----TT------CCCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh----cC------CCCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 00 01111 22334688999999999999999999999998865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=360.76 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=207.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357899999999999999999976 478899999975422 2335688999999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||++||+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999963 34699999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh----hHHHHHHHHHHhhhhhh
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV----FLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~ 382 (483)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .............
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---- 234 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---- 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----
T ss_pred cCCC-CcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----
Confidence 3221 2234457899999999996554 8999999999999999999999996532111 0001111111111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHhccccch
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM------GDVLRMLEPRDL 430 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~eil~~L~~~~~ 430 (483)
...+|.. .+..+.+++.+||+.||.+||++ .+++++.+..+.
T Consensus 235 --~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 235 --QIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp --CCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred --CCCCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 1223332 33678899999999999999996 788888776543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.14 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=200.5
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-Cc----EEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NM----RAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|++.+.||+|+||+||+|++.. ++ .||+|.+... .....+.|.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 4668899999999999999999643 33 3588887544 2344578999999999999999999999998755 78
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999999742 45699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
....... ......+|..|+|||++.+. .++.++|||||||++|||++ |+.||........... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~----- 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEKG----- 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTT-----
T ss_pred ccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-----HHcC-----
Confidence 6543222 22334567889999998654 48999999999999999999 9999987665432111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... .+..++..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 236 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 ERLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CCCC----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CCCC----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111 1223446889999999999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=354.02 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=203.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56889999999999999999965 57889999987653 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeecccccccC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla~~~~ 307 (483)
+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999965433456799999999999999999999999 99999999999999 556789999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
... ......+|+.|+|||.+.+ .++.++|||||||++|||++|+.||.+......... ... ..+.
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~-----~~~------~~~~ 243 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-----ATY------KEPN 243 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHH------CCCC
T ss_pred Ccc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh-----hcc------CCcc
Confidence 432 2234468999999999853 389999999999999999999999987654322111 000 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+.. ....+..+.+++.+||+.||++|||+.|++++.+..
T Consensus 244 ~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 244 YAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred cccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 1100 001236788999999999999999999999876643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=365.83 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=201.1
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcE----EEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMR----AAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|++.+.||+|+||.||+|.+.. +.. ||+|.+.... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4678899999999999999999654 333 7888875443 223356889999999999999999999886 56689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999642 35688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
...... .......++..|+|||++.+.. ++.++|||||||++|||++ |+.||........... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----~~~~----- 233 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-----LEKG----- 233 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-----HHTT-----
T ss_pred cCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-----HHcC-----
Confidence 654322 2233446777999999986444 8999999999999999999 9999987654332111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.....+ ..++..+.+++.+||+.||.+|||+.+++++|...
T Consensus 234 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 234 ERLAQP----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp CBCCCC----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CCCCCC----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 12335678899999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.48 Aligned_cols=273 Identities=19% Similarity=0.233 Sum_probs=212.1
Q ss_pred eeehHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-----CCcccccc
Q 046972 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-----HKNLVKLF 215 (483)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~ 215 (483)
.+++++..+..++|.+.+.||+|+||.||+|+.. +++.||+|++... ......+..|+.+++.+. |||||+++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3556667777899999999999999999999974 6788999998643 234466788999999886 99999999
Q ss_pred cEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC----
Q 046972 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---- 291 (483)
Q Consensus 216 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---- 291 (483)
+++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 9999999999999999 89999999753 334689999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHH
Q 046972 292 ---------------------HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIME 350 (483)
Q Consensus 292 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~e 350 (483)
++.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHH
Confidence 788999999999865432 23457899999999996554 8999999999999999
Q ss_pred HHcCCCCCCCCCchhhHHHHHHHH-------HHh----hhhhhhcCC----CCCCCCCH-H---------------HHHH
Q 046972 351 IVSGRLPVDYSQPQVFLIDWLKSM-------VAQ----QKIAYVLDP----KLPEMPSR-K---------------ELKR 399 (483)
Q Consensus 351 l~tg~~Pf~~~~~~~~~~~~~~~~-------~~~----~~~~~~~~~----~~~~~~~~-~---------------~~~~ 399 (483)
|++|+.||...........+.... ... ......... ..+..... . ....
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999998766543332221100 000 000000000 01110000 0 1156
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 400 IILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 400 l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+.+|+.+||+.||++|||+.|++++.+
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 779999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=364.87 Aligned_cols=266 Identities=19% Similarity=0.240 Sum_probs=204.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCcchH-----------HHHHHHHHHHhcCCCCccc
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSVSEE-----------EDFIEKVEAIGQVKHKNLV 212 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv 212 (483)
+..++|++.+.||+|+||.||+|.+.. ++.||+|++........ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 445689999999999999999999765 37899999876542211 2345566778888999999
Q ss_pred ccccEEEeC----CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEE
Q 046972 213 KLFGYCVEG----QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNIL 288 (483)
Q Consensus 213 ~~~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiL 288 (483)
++++++... ...++||||+ +|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence 999998765 4579999999 9999999964 335799999999999999999999999 9999999999999
Q ss_pred Ec--CCCCcEEeecccccccCCCccc------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046972 289 LD--HHWNPKISDVGLAKLHGPEWSI------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDY 360 (483)
Q Consensus 289 l~--~~~~~kl~DFGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~ 360 (483)
++ .++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99 8899999999999865433211 112335899999999996554 89999999999999999999999986
Q ss_pred CCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 361 SQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
............... ...+....++.++. ..++..+.+++.+||+.||.+||++.++++.|+.
T Consensus 264 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 264 NLKDPKYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp GTTCHHHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 444333222222111 11222222222211 1223688999999999999999999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=365.10 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=211.4
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++++..++|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34566788999999999999999999962 356799999975432 2346899999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLGE-------------------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 279 (483)
...+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999753211 13489999999999999999999999 9999
Q ss_pred ecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCC
Q 046972 280 HNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLP 357 (483)
Q Consensus 280 rDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~P 357 (483)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+. .++.++|||||||++|||++ |..|
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986543322 223344677889999998554 48999999999999999998 9999
Q ss_pred CCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 358 VDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 358 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
|.............. ....+..+ ..++..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 275 ~~~~~~~~~~~~~~~---------~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ---------NGFKMDQP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp STTCCCSHHHHHHHH---------TTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cccCCcHHHHHHHHh---------cCCCCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 987665433322211 11112222 223468899999999999999999999999997544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=359.14 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=214.1
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEE------cCCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVL------LDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++++..++|.+.+.||+|+||.||+|.+ .+++.||+|.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3456668899999999999999999985 2467899999976543 3457899999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCC
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG--------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp 284 (483)
...+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 999999999999999999999975421 123589999999999999999999999 999999999
Q ss_pred CcEEEcCCCCcEEeecccccccCCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 046972 285 SNILLDHHWNPKISDVGLAKLHGPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQ 362 (483)
Q Consensus 285 ~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~ 362 (483)
+|||++.++.+||+|||+++........ ......+|..|+|||.+.+. .++.++|||||||++|||++ |+.||....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999876543222 22334567889999988554 48999999999999999999 999998766
Q ss_pred chhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
........... ......+ ...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 ~~~~~~~~~~~---------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 253 VDSKFYKMIKE---------GFRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp SSHHHHHHHHH---------TCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHHhcc---------CCCCCCc----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 54333222111 1111112 2234688999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.26 Aligned_cols=269 Identities=18% Similarity=0.237 Sum_probs=203.6
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchH-HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|.+.+.||+|+||+||+|... +++.||+|++........ ..+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999976 688999999865432221 2466899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
++ |+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 599999864 245689999999999999999999999 99999999999999999999999999998654332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh-----------h
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ-----------K 379 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-----------~ 379 (483)
.......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+........ .
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2223346799999999987656689999999999999999999999988765544333322110000 0
Q ss_pred hhhhcCCCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 IAYVLDPKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+...... .......+.+|+.+||+.||.+|||+.|++++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0000000000000 0112367889999999999999999999999887654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=373.74 Aligned_cols=252 Identities=19% Similarity=0.306 Sum_probs=209.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999975 688999999865321 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999995 346799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.... .....||+.|+|||++.+...++.++|||||||++|||++|+.||...........+ . .. ...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i----~-~~------~~~ 234 (476)
T 2y94_A 168 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI----C-DG------IFY 234 (476)
T ss_dssp TTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH----H-TT------CCC
T ss_pred cccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH----h-cC------CcC
Confidence 4322 233478999999999976654578999999999999999999999876554322111 1 11 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.|.. .+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 235 ~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 235 TPQY----LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp CCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred CCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 2222 23678899999999999999999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=366.98 Aligned_cols=262 Identities=19% Similarity=0.220 Sum_probs=211.8
Q ss_pred HhcCCcccceeccCCceEEEEEEE----cCCcEEEEEEecCCC----cchHHHHHHHHHHHhcC-CCCcccccccEEEeC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL----LDNMRAAVKLLMSNS----VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEG 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 221 (483)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++..+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346799999999999999999997 368899999986532 12335677899999999 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 9999999999999999999643 4689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
+++..............||+.|+|||++.+. ..++.++|||||||++|||++|+.||...........+......
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---- 280 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 280 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc----
Confidence 9987654433344455789999999998642 34789999999999999999999999765443333222222111
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
..+..+. ..+..+.+++.+||..||.+|| ++.+++++++....
T Consensus 281 ---~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 281 ---SEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ---CCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---cCCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 1222222 2336788999999999999999 99999999877653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=353.75 Aligned_cols=255 Identities=18% Similarity=0.254 Sum_probs=209.7
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999999765 668999999776555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeecccccccC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla~~~~ 307 (483)
+++++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999963 35689999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
... ......+|+.|+|||.+.+. ++.++|||||||++|||++|+.||...........+.. . ...
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~------~~~ 225 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE-----G------TFT 225 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----C------CCC
T ss_pred Ccc--chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----C------CCC
Confidence 432 22334689999999998543 89999999999999999999999987654432221111 0 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+.......+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 11100002346889999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.15 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=212.4
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
++++..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+++++.++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 45566788999999999999999999998888999999876543 4578999999999999999999999886 456899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999999999532 123689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
............++..|+|||.+.+.. ++.++|||||||++|||++ |+.||........... . .....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~------~~~~~ 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----L------ERGYR 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H------HTTCC
T ss_pred cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----H------hcccC
Confidence 554333334445678899999985443 8999999999999999999 9999987654332111 1 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+ ..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 229 ~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1122 23346889999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=357.59 Aligned_cols=252 Identities=23% Similarity=0.234 Sum_probs=198.7
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 225 (483)
+..++|++.++||+|+||+||+|+.. +++.||||++...... ....+..|+..+..+ +||||+++++++.+.+..+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34567999999999999999999976 6889999998664332 334556666665555 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+ +|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 67999998643 35699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....... . . ..
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~-~--------~~ 266 (311)
T 3p1a_A 207 LGTAG--AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-------Q-L--------RQ 266 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-------H-H--------TT
T ss_pred cccCC--CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------H-H--------hc
Confidence 65432 2233468999999999864 38999999999999999999977664322110 0 0 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+.......+..+.+++.+||+.||++|||+.+++++.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 1111111112336899999999999999999999999987643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=350.89 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=203.5
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchH-------HHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEE-------EDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
..++|++.+.||+|+||.||+|+.. +++.||+|++........ +.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3467999999999999999999974 688999999865432211 57899999999999999999999986554
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEcCCCC-----c
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLDHHWN-----P 295 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~~~~~-----~ 295 (483)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 799999999999999863 345799999999999999999999998 8 999999999999988776 9
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR-TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
||+|||+++..... .....+|+.|+|||++.. ...++.++|||||||++|||++|+.||.......... ....
T Consensus 169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMI 242 (287)
T ss_dssp EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHH
T ss_pred EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHH
Confidence 99999999754332 233568999999999832 3337899999999999999999999998655432210 0010
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. .....+..+ ..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 243 -~----~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 -R----EEGLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -H----HSCCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -h----ccCCCCCCC----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0 111122222 2344789999999999999999999999998863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=390.39 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=214.1
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+++..++|++.+.||+|+||.||+|.+.++..||||++..... ..+.|.+|+++|++++|||||++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345567788999999999999999999998888999999976543 45789999999999999999999999866 6789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.++|+.. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999999642 224589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
.............++..|+|||++... .++.++|||||||+||||++ |+.||.+......... . .. ..
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i-~~-----~~ 481 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ER-----GY 481 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----H-HT-----TC
T ss_pred cCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-Hc-----CC
Confidence 654332233334567889999998644 48999999999999999999 9999987654332211 1 11 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... +..++..+.+||.+||+.||++|||+.+|++.|+..
T Consensus 482 ~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 482 RMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 223447899999999999999999999999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=364.15 Aligned_cols=267 Identities=18% Similarity=0.199 Sum_probs=206.8
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN-----SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
+....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455678999999999999999999964 5778999998643 234457899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGE------------------------------------AKPLTWDTRMKIIQGTAKG 265 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~ 265 (483)
+..++||||+++|+|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999521111 2234677888999999999
Q ss_pred HHHhhhCCCCCeeeecCCCCcEEEcCCC--CcEEeecccccccCCC---ccccccccccCcccccccccCC-CCCCCcch
Q 046972 266 LAYLHEDIEPKIVHHNMKSSNILLDHHW--NPKISDVGLAKLHGPE---WSISTSCELRNSGYLAEELSGR-TSIFNEKS 339 (483)
Q Consensus 266 l~~LH~~~~~~iiHrDlkp~NiLl~~~~--~~kl~DFGla~~~~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~ 339 (483)
|.|||++ +|+||||||+|||++.++ .+||+|||+++..... .........||+.|+|||++.+ ...++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 8999999999865321 1122344578999999999854 24589999
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046972 340 DVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMG 419 (483)
Q Consensus 340 DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 419 (483)
|||||||++|||++|+.||.............. . ....+.......+..+.+++.+||+.||.+|||+.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~-------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN----K-------KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C-------CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh----c-------ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 999999999999999999987665433322111 0 01111111112346889999999999999999999
Q ss_pred HHHHhcccc
Q 046972 420 DVLRMLEPR 428 (483)
Q Consensus 420 eil~~L~~~ 428 (483)
+++++.+..
T Consensus 327 ~~l~hp~~~ 335 (345)
T 3hko_A 327 RALQHPWIS 335 (345)
T ss_dssp HHHHSHHHH
T ss_pred HHhcChhhc
Confidence 999976543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.68 Aligned_cols=257 Identities=19% Similarity=0.261 Sum_probs=210.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 466999999999999999999975 5889999999764322 357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC----CcEEeec
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW----NPKISDV 300 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DF 300 (483)
++||||+++++|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999996 345689999999999999999999999 999999999999999888 7999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+ .. .
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i----~~-~-- 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----TS-V-- 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HT-T--
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----Hh-c--
Confidence 9998765432 223346899999999986544 899999999999999999999999876543322111 00 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+.......+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 234 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 234 ----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp ----CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ----ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 011110000122367889999999999999999999999887654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=348.06 Aligned_cols=253 Identities=19% Similarity=0.312 Sum_probs=205.8
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 225 (483)
+..++|.+.+.||+|+||.||+|++. ++.+|+|++..... ...+.|.+|+.++++++||||+++++++.+. ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 34567999999999999999999985 78899999976543 3346799999999999999999999999877 7889
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.++|+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp EEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred eeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence 999999999999999753 234689999999999999999999998 8 999999999999999999999999887
Q ss_pred cccCCCccccccccccCcccccccccCCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTS--IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
.... .....+|+.|+|||.+.+.. .++.++|||||||++|||++|+.||............ ..
T Consensus 161 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------~~ 225 (271)
T 3kmu_A 161 FSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV---------AL 225 (271)
T ss_dssp CTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH---------HH
T ss_pred eeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH---------Hh
Confidence 5422 22346789999999986543 2344899999999999999999999876543322111 11
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+..+. ..+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 226 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 226 EGLRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp SCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111222222 334688999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=372.80 Aligned_cols=270 Identities=18% Similarity=0.244 Sum_probs=200.7
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCC-CCcccccccEEEeCC--e
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQ--N 223 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~--~ 223 (483)
...++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999964 5889999998654 2334467889999999997 999999999998554 6
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+|||||+ |+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 599999953 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCc--------------------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 304 KLHGPEW--------------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 304 ~~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
+...... ........||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8653210 11123347899999999987656689999999999999999999999988776
Q ss_pred hhhHHHHHHHHHHhhhhhhh---c------------------CCCCCCC------------CCHHHHHHHHHHHHHccCC
Q 046972 364 QVFLIDWLKSMVAQQKIAYV---L------------------DPKLPEM------------PSRKELKRIILIALRCVDP 410 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~---~------------------~~~~~~~------------~~~~~~~~l~~l~~~cl~~ 410 (483)
...+..+.... ........ . ....... +...++..+.+|+.+||+.
T Consensus 237 ~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 55444333211 00000000 0 0000000 0002235788999999999
Q ss_pred CCCCCCCHHHHHHhccccc
Q 046972 411 DIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 411 dP~~Rpt~~eil~~L~~~~ 429 (483)
||++|||+.|++++.+...
T Consensus 316 dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 316 NPNKRISANDALKHPFVSI 334 (388)
T ss_dssp SGGGSCCHHHHTTSTTTTT
T ss_pred CcccCCCHHHHhCCHHHHH
Confidence 9999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=355.14 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=204.4
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-C-------cEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-N-------MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
..++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 35679999999999999999998553 2 469999997766666788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC--------
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-------- 294 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~-------- 294 (483)
..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999742 34489999999999999999999999 9999999999999998887
Q ss_pred cEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCchhhHHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR-LPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~-~Pf~~~~~~~~~~~~~~~ 373 (483)
+||+|||++...... ....++..|+|||++.+...++.++|||||||++|||++|. .||....... ......
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~- 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYE- 232 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHH-
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhh-
Confidence 999999999754332 22356888999999876455899999999999999999955 4554433221 111100
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+... +..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 233 ----------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 233 ----------DRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp ----------TTCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ----------ccCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 011222211 246888999999999999999999999997644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=361.33 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=205.0
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+.|...+.||+|+||.||+|+. .+++.||||++....... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999996 568889999997653322 357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+. |+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6888888532 35689999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. ....||+.|+|||++.. ...++.++|||||||++|||++|+.||............ .. ...+
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~------~~~~ 271 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQ------NESP 271 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HH------SCCC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----Hh------cCCC
Confidence 2 23478999999998742 344899999999999999999999999766543322111 11 0111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.......+..+.+++.+||+.||++|||+.+++++.+.
T Consensus 272 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 272 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 11122334678899999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=367.27 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=202.0
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCC--CCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVK--HKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv 227 (483)
.+.|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++..++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356999999999999999999988899999999976533 33468999999999996 59999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|| +.+++|.+++.. ...+++.+++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 568899999964 34789999999999999999999999 999999999999995 5789999999998765
Q ss_pred CCcc-ccccccccCcccccccccCC----------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 308 PEWS-ISTSCELRNSGYLAEELSGR----------TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 308 ~~~~-~~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
.... .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||......... +...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~~~-- 280 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAI-- 280 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHH--
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH---HHHH--
Confidence 4322 12334579999999999854 134899999999999999999999999765443211 1111
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+........+... +..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 281 ---~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 281 ---IDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp ---HCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---hCccccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 1111112222222 36788999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=352.21 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=199.5
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++..++|++.+.||+|+||.||+|...+ .+|+|++..... ...+.|.+|++++++++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 35667889999999999999999998543 599999876533 3346799999999999999999999965 556689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence 99999999999999963 345689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCc-cccccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEW-SISTSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~-~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
..... ........||+.|+|||.+. ....++.++|||||||++|||++|+.||............... ..
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~--- 242 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GS--- 242 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH----TS---
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc----cc---
Confidence 54321 22223446899999999985 2344788999999999999999999999876654433322211 11
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+... .....++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 243 -~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 243 -LSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp -CCCCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCcchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 111111 1122345789999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.12 Aligned_cols=255 Identities=20% Similarity=0.339 Sum_probs=197.2
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCCCcccccccEEEeCCe----
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN---- 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 223 (483)
.++|++.+.||+|+||.||+|+. .+++.||+|++....... ...+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 568899999997653322 3578999999999999999999999876543
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+||||++||+|.++++. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999963 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 304 KLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............. ..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----~~--- 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR----ED--- 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CC---
T ss_pred ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CC---
Confidence 86543322 222334689999999998655 489999999999999999999999987665433222111 00
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
+..+.......+..+.+++.+||+.||.+||++.+++...
T Consensus 236 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 275 (311)
T 3ork_A 236 ----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275 (311)
T ss_dssp ----CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ----CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence 0000000112336789999999999999999888877654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=362.23 Aligned_cols=271 Identities=19% Similarity=0.242 Sum_probs=207.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch-----HHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE-----EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
..++|++.+.||+|+||.||+|... +++.||+|++....... .+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999965 58899999997543221 14688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 89999863 335688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh--h
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA--Y 382 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~ 382 (483)
....... ......+|+.|+|||++.+...++.++|||||||++|||++|..||.+......+..+........... .
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 7643322 223457899999999986655689999999999999999999999987766544443332211100000 0
Q ss_pred h-------cCCCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 383 V-------LDPKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 383 ~-------~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .....+..+ ....+..+.+++.+||+.||.+|||+.|++++.+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 0 000011111 0123468999999999999999999999999887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.73 Aligned_cols=270 Identities=21% Similarity=0.297 Sum_probs=209.7
Q ss_pred cCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.+.||+|+||.||+|+... ++.||+|++....... .+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 578999999999999999999764 8899999986654332 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++++|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999999875 345699999999999999999999999 9999999999999999999999999999865433
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH-----------HHhh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM-----------VAQQ 378 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~-----------~~~~ 378 (483)
.. ......++..|+|||++.+...++.++|||||||++|||++|+.||...........+.... ....
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 22 22334689999999998765568999999999999999999999998877654443332211 0001
Q ss_pred hhhhhcCCCCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 379 KIAYVLDPKLPEMPS-----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.......+....... ...+..+.+++.+||+.||++|||+.|++++.+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 111111111111111 1234689999999999999999999999998765443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.44 Aligned_cols=272 Identities=19% Similarity=0.248 Sum_probs=204.1
Q ss_pred HHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc-----chHHHHHHHHHHHhcC---CCCcccccccEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV-----SEEEDFIEKVEAIGQV---KHKNLVKLFGYCV 219 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~ 219 (483)
++..++|++.+.||+|+||+||+|+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34568899999999999999999995 4688999999864321 1124567777777766 4999999999998
Q ss_pred eCC-----eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 220 EGQ-----NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 220 ~~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
... ..++||||+. |+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 765 5799999997 5999999753 234499999999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+....
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999998664332 223457899999999986554 8999999999999999999999998776655443332221
Q ss_pred HHhhhhhh---------hcCCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 375 VAQQKIAY---------VLDPKLPEM---PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 375 ~~~~~~~~---------~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
........ ...+..+.. ........+.+++.+||+.||++|||+.|++++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 10000000 000000000 00123367889999999999999999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=360.65 Aligned_cols=271 Identities=17% Similarity=0.224 Sum_probs=202.8
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch--HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
...++|++.+.||+|+||+||+|+.. +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34567999999999999999999965 68889999997553322 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-----CCCCcEEeecc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-----HHWNPKISDVG 301 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~-----~~~~~kl~DFG 301 (483)
||||+++ +|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999974 99999963 34689999999999999999999999 999999999999994 44559999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh-
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI- 380 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~- 380 (483)
+++...... .......+|..|+|||++.+...++.++|||||||++|||++|+.||...........+..........
T Consensus 183 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 183 LARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 998665332 122334679999999998765668999999999999999999999998776654443332221100000
Q ss_pred ----hhh--cCCCCCC---CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 ----AYV--LDPKLPE---MPS-----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ----~~~--~~~~~~~---~~~-----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... .....+. ... ......+.+|+.+||+.||.+|||+.|++++.+..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 000 0000000 000 012367889999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=373.85 Aligned_cols=264 Identities=19% Similarity=0.219 Sum_probs=214.7
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999975 588999999965321 234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||++||+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999976544456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
..... ......||+.|+|||++.+.. |+.++|||||||++|||++|+.||...........+....... ..
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-------~~ 410 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-------AV 410 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-------CC
T ss_pred cCCCc-ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-------cc
Confidence 54322 223347899999999996554 8999999999999999999999998764332222222221111 12
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhccccch
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPRDL 430 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~~~ 430 (483)
..|. ..+..+.+++.+||+.||.+||++ .+++++.+..+.
T Consensus 411 ~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 411 TYPD----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred CCCc----ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 2222 233688899999999999999964 788887776553
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.79 Aligned_cols=255 Identities=18% Similarity=0.254 Sum_probs=207.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999965 478999999865432 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEeecccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKISDVGLAKL 305 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DFGla~~ 305 (483)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999863 35689999999999999999999999 9999999999999976655 99999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||............ ... .
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-----~~~------~ 223 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-----KAG------A 223 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHT------C
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-----Hhc------c
Confidence 654322 23346899999999986554 899999999999999999999999876543322111 111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.......+..+.+++.+||+.||++|||+.+++++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 224 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 111111112334678999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=361.51 Aligned_cols=264 Identities=22% Similarity=0.351 Sum_probs=211.5
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEc--------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGY 217 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 217 (483)
+++..++|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3455688999999999999999999863 467899999976533 3346799999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
+...+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 9999999999999999999999975422 123589999999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCc
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQP 363 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~ 363 (483)
|||++.++.+||+|||+++....... .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999986654322 2233345678899999885444 8999999999999999999 9999987654
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...... . ... .....+ ..++..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 266 ~~~~~~----~-~~~-----~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 EELFKL----L-KEG-----HRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHH----H-HHT-----CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH----H-hcC-----CCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 322111 1 111 111122 233468899999999999999999999999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.76 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=210.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367899999999999999999976 6889999998654 33345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999985 345799999999999999999999999 9999999999999999999999999999765322
Q ss_pred cc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 310 WS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 310 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......++..|+|||.+.+...++.++|||||||++|||++|+.||........... ...... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~-------~~~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKK-------TYL 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTC-------TTS
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---Hhhhcc-------ccc
Confidence 11 1233456889999999987665457899999999999999999999987654322111 111000 001
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+..+.+++.+||+.||.+|||+.+++++.+..+
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 111233467889999999999999999999999876544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.54 Aligned_cols=261 Identities=21% Similarity=0.357 Sum_probs=199.1
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5689999999999999999996 468899999997532 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.........+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999965433456789999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......++..|+|||++.+. .++.++|||||||++|||++|..||.+...... ...... .....
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---------~~~~~ 255 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKI---------EQCDY 255 (310)
T ss_dssp -----------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HHHHHH---------HTTCS
T ss_pred CC-ccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HHHHHh---------hcccC
Confidence 32 122334688999999998654 489999999999999999999999975443211 111111 11112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+.......+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 22222334468899999999999999999999999996544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=356.38 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=207.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe----CCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~ 224 (483)
+..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4457899999999999999999996 5688999999877666666789999999999999999999999873 3477
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999976444567799999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCccc--------cccccccCcccccccccCCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCch-hhHHHHHHH
Q 046972 305 LHGPEWSI--------STSCELRNSGYLAEELSGRTS--IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ-VFLIDWLKS 373 (483)
Q Consensus 305 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~-~~~~~~~~~ 373 (483)
........ ......||+.|+|||++.+.. .++.++|||||||++|||++|+.||...... .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---- 258 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---- 258 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----
Confidence 64321110 112235688999999985432 2688999999999999999999999531110 00000
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... . ....+ .....+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 259 ~~~-~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQ-N------QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHH-C------C--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred Hhh-c------cCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 0 01111 11223468999999999999999999999999997543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=354.45 Aligned_cols=257 Identities=15% Similarity=0.172 Sum_probs=205.1
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 5688999999865532 24588999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC-----cEEeeccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-----PKISDVGLAK 304 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~-----~kl~DFGla~ 304 (483)
|+ +|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999643 45799999999999999999999999 9999999999999998887 9999999998
Q ss_pred ccCCCccc------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 305 LHGPEWSI------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 305 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~~~~ 236 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-ERYQKIGDTK 236 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-HHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHH-HHHHHHHhhh
Confidence 65432211 123457899999999996654 899999999999999999999999876543221 1111111111
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
. . .. ........+ .+.+++.+||+.||.+||++.++++.|.
T Consensus 237 ~-~--~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 237 R-A--TP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp H-H--SC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred c-c--CC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 0 0 00 000001123 7889999999999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=351.36 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=207.3
Q ss_pred HhcCCcccc-eeccCCceEEEEEEEc---CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQN-VIASGDNGVVYRAVLL---DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345666666 8999999999999854 57789999997653 33457899999999999999999999999 556789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999999963 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... ......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||........... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----i~~----- 228 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQ----- 228 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-----HHT-----
T ss_pred eccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----Hhc-----
Confidence 6543221 223345678899999985444 8999999999999999998 9999987665432211 111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+..+ ..++..+.+++.+||+.||.+||++.+++++|+..
T Consensus 229 ~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 229 GKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCCC----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112222 23447899999999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=356.88 Aligned_cols=268 Identities=19% Similarity=0.330 Sum_probs=215.1
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCccccccc
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFG 216 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~ 216 (483)
...++++..++|++.+.||+|+||.||+|... .++.||+|.+..... .....+.+|+++++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34456677889999999999999999999864 367899999976533 34467999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 217 YCVEGQNRILVYEYIDNGNLQQWLHGSL------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 217 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
++.+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 9999999999999999999999996421 1225678999999999999999999999 999999999999999
Q ss_pred CCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHH
Q 046972 291 HHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~ 368 (483)
.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..........
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 999999999999986543221 2223346688899999985444 8999999999999999999 899998665432211
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. . . ....+. ....++..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 252 ~----~-~--------~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 252 F----V-M--------EGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp H----H-H--------TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H----H-H--------cCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 1 1 111111 12233467899999999999999999999999997643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=358.26 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=204.3
Q ss_pred CcccceeccCCceEEEEEEEc-----CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC--CeEEE
Q 046972 155 FAEQNVIASGDNGVVYRAVLL-----DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QNRIL 226 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 226 (483)
|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 678899999976533 3346799999999999999999999999874 67899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999953 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhH-HHHHHHHHHhhhhhhh
Q 046972 307 GPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL-IDWLKSMVAQQKIAYV 383 (483)
Q Consensus 307 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 383 (483)
..... .......+|..|+|||++.+.. ++.++|||||||++|||++|..||......... ..+.........+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 54322 2233346778899999986544 789999999999999999999998643221000 0000000000011111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+........+..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111112234447899999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=361.11 Aligned_cols=254 Identities=22% Similarity=0.243 Sum_probs=197.7
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCc---chHHHHHHHHHH-HhcCCCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSV---SEEEDFIEKVEA-IGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+|+||.||+|+.+. ++.||+|++..... .....+..|..+ ++.++|||||++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999764 77899999976432 223456777776 577899999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||++||+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999964 35689999999999999999999999 9999999999999999999999999999853
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+. . . ..
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~-~------~~ 256 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL----N-K------PL 256 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH----H-S------CC
T ss_pred ccC-CCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----h-c------cc
Confidence 322 12234457899999999996554 8999999999999999999999998765433222211 1 1 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHhccccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMG----DVLRMLEPRD 429 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~----eil~~L~~~~ 429 (483)
.++.. .+..+.+++.+||+.||.+||++. +++++.....
T Consensus 257 ~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 257 QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 22222 236788999999999999999974 6666555443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.55 Aligned_cols=256 Identities=17% Similarity=0.252 Sum_probs=194.3
Q ss_pred cCCccc-ceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHh-cCCCCcccccccEEEe----CCeEE
Q 046972 153 DGFAEQ-NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIG-QVKHKNLVKLFGYCVE----GQNRI 225 (483)
Q Consensus 153 ~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~----~~~~~ 225 (483)
++|.+. +.||+|+||+||+|... +++.||+|++... ..+.+|+.++. ..+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 78999999999999975 5788999998532 45778888874 4589999999999876 56789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeeccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVGL 302 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFGl 302 (483)
+|||||+||+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999753 234699999999999999999999999 9999999999999998 78899999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||................ ...
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i-~~~---- 282 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-RMG---- 282 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH-HHT----
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH-HcC----
Confidence 98654322 22345789999999998554 48999999999999999999999997654322100000111 111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...++.......+..+.+|+.+||+.||++|||+.+++++.+..
T Consensus 283 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 283 --QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp --CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred --cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 11122111223447889999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=346.79 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=205.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999976 68899999997642 33456789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---------------
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH--------------- 292 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~--------------- 292 (483)
|||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975433346789999999999999999999999 99999999999999844
Q ss_pred ----CCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHH
Q 046972 293 ----WNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI 368 (483)
Q Consensus 293 ----~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~ 368 (483)
..+||+|||++...... ....+|+.|+|||.+.+...++.++|||||||++|||++|..|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----
Confidence 47999999999876543 22358899999999976655778999999999999999998876433210
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. +.....+..+.. .+..+.+++.+||+.||++|||+.+++++.+..+
T Consensus 238 ---~~------~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 238 ---HE------IRQGRLPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp ---HH------HHTTCCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred ---HH------HHcCCCCCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 01 111111223322 3368899999999999999999999999877544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=361.73 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=212.4
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYCV 219 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 219 (483)
+++..++|.+.+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+++++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45566889999999999999999999653 24799999976543 3446799999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccC----------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLG----------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL 289 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl 289 (483)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999964311 134689999999999999999999999 99999999999999
Q ss_pred cCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhH
Q 046972 290 DHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFL 367 (483)
Q Consensus 290 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~ 367 (483)
+.++.+||+|||+++....... .......+|..|+|||.+.+. .++.++|||||||++|||++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999999986533221 222334567889999988644 48999999999999999999 99999876654333
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 368 IDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...... ......+. .++..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 277 ~~~~~~---------~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 YKLVKD---------GYQMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHH---------TCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhc---------CCCCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 222111 11111222 22367889999999999999999999999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=357.11 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=199.0
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcE----EEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMR----AAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
.++|++.+.||+|+||.||+|.+.. ++. |++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4679999999999999999999653 333 577777544 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999742 45689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 306 HGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 306 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
...... .......+|..|+|||.+.+. .++.++|||||||++|||++ |..||........... ... .
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----~~~-----~ 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK-----G 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHT-----T
T ss_pred ccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHc-----C
Confidence 643322 222334567789999998654 48999999999999999999 9999987665432211 111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... +..++..+.+++.+||+.||.+|||+.++++.|...
T Consensus 236 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 236 ERLPQ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 223446789999999999999999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.20 Aligned_cols=259 Identities=21% Similarity=0.321 Sum_probs=208.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 226 (483)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367899999999999999999975 688899999976533 334679999999999999999999998865 568899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC-----eeeecCCCCcEEEcCCCCcEEeecc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK-----IVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
||||+++|+|.+++.........+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999975444456699999999999999999999998 8 9999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||........... ....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----i~~~--- 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----IREG--- 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHT---
T ss_pred hheeeccccc-cccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-----Hhhc---
Confidence 9986644321 122346889999999986554 89999999999999999999999987654322111 1111
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+.++. ..+..+.+++.+||+.||.+|||+.+++++++...
T Consensus 232 --~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 --KFRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp --CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred --ccccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1112222 23468899999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=350.50 Aligned_cols=255 Identities=18% Similarity=0.234 Sum_probs=206.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
..++|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999975 688999999986654455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeeccccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLH 306 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla~~~ 306 (483)
|+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999963 34689999999999999999999999 99999999999999 78899999999999764
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .... .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-----~~~~------~ 224 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-----KEGY------Y 224 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHCC------C
T ss_pred CCC---ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HcCC------C
Confidence 432 12234689999999998654 4899999999999999999999999876543322111 1110 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.......+..+.+++.+||..||.+|||+.+++++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 11111122334688999999999999999999999986643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=358.93 Aligned_cols=266 Identities=18% Similarity=0.232 Sum_probs=199.8
Q ss_pred HhcCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCcch-----------HHHHHHHHHHHhcCCCCcccccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSE-----------EEDFIEKVEAIGQVKHKNLVKLF 215 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~~~ 215 (483)
..++|.+.+.||+|+||.||+|... .+..+|+|++....... ...+.+|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3467999999999999999999976 56789999987654321 12467888999999999999999
Q ss_pred cEEEe----CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC
Q 046972 216 GYCVE----GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291 (483)
Q Consensus 216 ~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~ 291 (483)
+++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence 99988 77889999999 99999999643 3799999999999999999999999 9999999999999998
Q ss_pred CC--CcEEeecccccccCCCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 292 HW--NPKISDVGLAKLHGPEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 292 ~~--~~kl~DFGla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
++ .+||+|||+++....... .......||..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 87 999999999986643211 111344789999999998655 489999999999999999999999965332
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
............... +........+ ....+..+.+++.+||..||++|||+.++++.|+...
T Consensus 266 ~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 266 DPVAVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CHHHHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccHHHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 222111111111111 1100000000 0122368999999999999999999999999997644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.51 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=214.4
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEE------cCCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCccccc
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVL------LDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKL 214 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~ 214 (483)
+...++++..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34456677789999999999999999999985 2467899999976543 3346799999999999 79999999
Q ss_pred ccEEEeCC-eEEEEEEecCCCCHHHHHhcccCC------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeec
Q 046972 215 FGYCVEGQ-NRILVYEYIDNGNLQQWLHGSLGE------------AKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHN 281 (483)
Q Consensus 215 ~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 281 (483)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987754 589999999999999999754221 22388999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCC
Q 046972 282 MKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVD 359 (483)
Q Consensus 282 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~ 359 (483)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999986543322 2233446788999999985544 8999999999999999998 999998
Q ss_pred CCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 360 YSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...........+.. ......+. ..+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 253 ~~~~~~~~~~~~~~---------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDEEFCRRLKE---------GTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSHHHHHHHHH---------TCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhHHHHHHhcc---------CccCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 76644332221111 11122222 2336788999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=360.10 Aligned_cols=249 Identities=17% Similarity=0.213 Sum_probs=206.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--------hHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
..++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467999999999999999999954 5788999999765321 223578899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 222 QNRILVYEYIDNG-NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 222 ~~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999996 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|+++....... .....||+.|+|||++.+...++.++|||||||++|||++|+.||...... .
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------~ 237 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------V 237 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------T
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------H
Confidence 99987654322 233468999999999876664588999999999999999999999642211 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... ...+. ..+..+.+++.+||+.||++|||+.+++++.+..+
T Consensus 238 ~~~--~~~~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 238 EAA--IHPPY----LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TTC--CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred hhc--cCCCc----ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 101 11111 12367889999999999999999999999887644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=374.56 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=214.0
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+..++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|||||++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999975 68899999986532 223467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||++||+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999753 234599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+...... ..
T Consensus 336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-------~~ 405 (576)
T 2acx_A 336 VPEGQT--IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-------VP 405 (576)
T ss_dssp CCTTCC--EECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------CC
T ss_pred cccCcc--ccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------cc
Confidence 654322 22347899999999996554 899999999999999999999999876543222221111111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
..++. ..+..+.+|+.+||+.||.+|| ++.|++++.+....
T Consensus 406 ~~~p~----~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 EEYSE----RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ccCCc----cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 22222 2336889999999999999999 78999998876653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.65 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=204.7
Q ss_pred HhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45779999999999999999999664 66899999865322 224578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999643 5689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||............ .. ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~-------~~~ 224 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SR-------VEF 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HH-------TCC
T ss_pred Ccc---cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH----Hh-------CCC
Confidence 332 22334688999999998654 4799999999999999999999999866543322111 00 112
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..+.. .+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 225 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 225 TFPDF----VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp CCCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred CCCCc----CCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 22322 236788999999999999999999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=359.02 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=183.9
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEecCCCC
Q 046972 158 QNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
.+.||+|+||.||+|... +++.||+|++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 5789999998643 4567889999999997 9999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC---CcEEeecccccccCCCccc
Q 046972 236 LQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW---NPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 236 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DFGla~~~~~~~~~ 312 (483)
|.+++.. ...+++.+++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 9999963 35799999999999999999999999 999999999999997765 799999999986544322
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh---hHHHHHHHHHHhhhhhhhcCCCC-
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV---FLIDWLKSMVAQQKIAYVLDPKL- 388 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~- 388 (483)
......+|+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ...+... .+.....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------~i~~~~~~ 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK---------KIKKGDFS 234 (325)
T ss_dssp -------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH---------HHTTTCCC
T ss_pred cccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH---------HHHcCCCC
Confidence 223446799999999986554 8999999999999999999999997654321 1111111 1111111
Q ss_pred -CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 -PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 -~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+.......+..+.+++.+||+.||.+|||+.+++++.+..+
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 11111223578999999999999999999999998776543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.27 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=203.5
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--------chHHHHHHHHHHHhcCCCCcccccccEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--------SEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 219 (483)
....++|.+.+.||+|+||+||+|... +++.||+|++..... .....+.+|++++++++|||||++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345689999999999999999999965 478999999865321 11135889999999999999999999975
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcE
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPK 296 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~k 296 (483)
.+..++||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 556899999999999999985 446799999999999999999999999 99999999999999654 4599
Q ss_pred EeecccccccCCCccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 297 l~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|+|||+++...... ......||+.|+|||++.. ...++.++|||||||++|||++|+.||............+..
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~- 359 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 359 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-
Confidence 99999998765432 2234578999999999753 344789999999999999999999999866544332221111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhhHH
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~~~ 435 (483)
.. ...........+..+.+++.+||+.||++|||+.+++++.+..+...+..
T Consensus 360 ---~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 360 ---GK------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp ---TC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHH
T ss_pred ---CC------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHH
Confidence 10 00000000122468899999999999999999999999998876554443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.70 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=204.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
+..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 345779999999999999999998643 2358999987653 3345789999999999999999999999765 456
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 8999999999999999642 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..............++..|+|||.+.+. .++.++|||||||++|||++ |+.||............ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-----~~~----- 230 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKG----- 230 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-----HHT-----
T ss_pred ccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-----hcC-----
Confidence 7654433333445677889999998544 48999999999999999998 99999866554322111 101
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.....+ ..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 231 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 231 DRLPKP----DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111112 12336789999999999999999999999999654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=345.51 Aligned_cols=259 Identities=14% Similarity=0.185 Sum_probs=207.0
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 227 (483)
+..++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.++..+ +|+|++++++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3457799999999999999999996 568899999986543 234588899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC-----cEEeeccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-----PKISDVGL 302 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~-----~kl~DFGl 302 (483)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 99999999743 34699999999999999999999999 9999999999999987776 99999999
Q ss_pred ccccCCCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHH--HHHHHH
Q 046972 303 AKLHGPEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI--DWLKSM 374 (483)
Q Consensus 303 a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~ 374 (483)
++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 986644322 1223457899999999986554 8999999999999999999999998754322111 111111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
........ ..+ .++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 237 ~~~~~~~~-~~~--------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 237 KQSTPLRE-LCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHSCHHH-HTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccCccHHH-HHh--------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 11111111 111 123688999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=362.56 Aligned_cols=273 Identities=16% Similarity=0.208 Sum_probs=208.5
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC-----
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG----- 221 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 221 (483)
++...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+|+++++.++|||||++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678899999999999999999996 4688999999865432 234799999999999999999998543
Q ss_pred ---------------------------------CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH
Q 046972 222 ---------------------------------QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268 (483)
Q Consensus 222 ---------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 268 (483)
...++||||++ |+|.+.+.........+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34789999998 58888876543456789999999999999999999
Q ss_pred hhhCCCCCeeeecCCCCcEEEc-CCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHH
Q 046972 269 LHEDIEPKIVHHNMKSSNILLD-HHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGIL 347 (483)
Q Consensus 269 LH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~ 347 (483)
||++ +|+||||||+|||++ .++.+||+|||+|+....... .....+|+.|+|||++.+...++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 688999999999986644322 2334678999999998766668999999999999
Q ss_pred HHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--hhhh----hcCCCCCC---C-----CCHHHHHHHHHHHHHccCCCCC
Q 046972 348 IMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ--KIAY----VLDPKLPE---M-----PSRKELKRIILIALRCVDPDIK 413 (483)
Q Consensus 348 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~---~-----~~~~~~~~l~~l~~~cl~~dP~ 413 (483)
+|||++|+.||.+......+..++....... .+.. .....++. . .+...+..+.+|+.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999998776655544433211000 0000 00001111 0 1112346789999999999999
Q ss_pred CCCCHHHHHHhccccch
Q 046972 414 HRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 414 ~Rpt~~eil~~L~~~~~ 430 (483)
+|||+.|++++.+....
T Consensus 312 ~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GSCCHHHHHTSGGGHHH
T ss_pred hCCCHHHHhcCHHHHHH
Confidence 99999999998876553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=352.34 Aligned_cols=261 Identities=17% Similarity=0.259 Sum_probs=206.3
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEe--CCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVE--GQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|+++++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 46889999998643 3567899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccccC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKLHG 307 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~~~ 307 (483)
||+++++|.+++. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999984 388999999999999999999999 999999999999999776 79999999998665
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh-hHHHHHHHHHHhhhhhhh---
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV-FLIDWLKSMVAQQKIAYV--- 383 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~--- 383 (483)
.... .....++..|+|||++.+...++.++|||||||++|||++|+.||....... .+..+.. ..........
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK-VLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH-HHCHHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH-hcCCchhhhHHHH
Confidence 4322 2334688899999998765668999999999999999999999996554432 2222111 1111111000
Q ss_pred ----cCC----------------CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 ----LDP----------------KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 ----~~~----------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.++ ..+.......+..+.+|+.+||+.||++|||++|++++.+..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 000 0011111123478999999999999999999999999877654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=374.82 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=211.0
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567999999999999999999976 68899999986542 2345789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeecccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLA 303 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla 303 (483)
|||||.+|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999996 345699999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+. ..
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~----- 242 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-----KG----- 242 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HC-----
T ss_pred EEcccccc--cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----cC-----
Confidence 87654322 233468999999999854 38999999999999999999999998766543322211 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
....+.......+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 243 -~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 243 -KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp -CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred -CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 01111111223457889999999999999999999999876643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.60 Aligned_cols=271 Identities=20% Similarity=0.245 Sum_probs=209.8
Q ss_pred hcCCcccceeccCCceEEEEEEE-----cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEE--eCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-----LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV--EGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~ 224 (483)
.++|++.+.||+|+||.||+|++ .++..||+|++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46789999999999999999985 357889999998776666678999999999999999999999987 45668
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999642 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHH-HHHHHhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL-KSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~ 381 (483)
....... .......+|..|+|||++.+.. ++.++|||||||++|+|++|..||............. ........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654322 2233446788899999985544 7999999999999999999999986432211000000 0000000000
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...........+..++..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111122334478999999999999999999999999997543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.98 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=204.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.++|++.+.||+|+||+||+|+.. ++..+|+|++.... ......+.+|+.+++.++|||||++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999975 57889999997653 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcEEeecccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPKISDVGLAKL 305 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DFGla~~ 305 (483)
|||++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999863 35689999999999999999999999 99999999999999764 5599999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.........+. ...
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~~------ 253 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE-----KGK------ 253 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTC------
T ss_pred CCCCc--cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCC------
Confidence 65432 2334578999999999853 38999999999999999999999998766543322211 110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+.......+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus 254 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 11111111223467889999999999999999999998876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.37 Aligned_cols=254 Identities=21% Similarity=0.265 Sum_probs=207.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|++++++++|||||++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999975 6889999998643 2234578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc---CCCCcEEeecccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD---HHWNPKISDVGLAKL 305 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DFGla~~ 305 (483)
|||.+|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999863 35689999999999999999999999 999999999999994 556799999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
..... ......||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.........+. ...
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~~------ 238 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-----TGK------ 238 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTC------
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCC------
Confidence 65432 22344789999999998543 8999999999999999999999998766543322211 110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.......+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 111111122344688999999999999999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=358.05 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=203.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCC------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------ 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 222 (483)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367999999999999999999974 688999999965432 23467899999999999999999999997653
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|+||||+ +++|.++++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999963 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-----
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ----- 377 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 377 (483)
++..... .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9875432 2344789999999998764568999999999999999999999998776554443332211000
Q ss_pred ---------hhhhhhcCCCCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 ---------QKIAYVLDPKLPE----MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 ---------~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+.. + +..+. ......+..+.+|+.+||..||.+|||+.+++++.+...
T Consensus 251 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 251 QRLQSDEAKNYMKG-L-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HTCSCHHHHHHHHH-S-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHhhhHHHHHHHHh-C-CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 00000 0 00000 011123467899999999999999999999999877654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=354.81 Aligned_cols=270 Identities=18% Similarity=0.204 Sum_probs=207.2
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEe--------C
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVE--------G 221 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~ 221 (483)
++|++.+.||+|+||.||+|+. .+++.||+|++...... ....+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999997 46889999998655332 23578899999999999999999999987 4
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+..++||||+++ +|.+.+.. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 88888753 335699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc---cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 302 LAKLHGPEW---SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 302 la~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
+++...... ........||+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998654221 12223457899999999986655689999999999999999999999987765543332221110000
Q ss_pred h--hhhh--------cCCCCCCCCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 379 K--IAYV--------LDPKLPEMPS-RK------ELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 379 ~--~~~~--------~~~~~~~~~~-~~------~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .... .......... .. ....+.+|+.+||+.||++|||+.|++++.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 0 0000 0000000000 00 1246889999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=351.33 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=196.3
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.|.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 467888999999999999999975 678999998644 34578999999999999999999999876 4579999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC-cEEeecccccccCCCc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN-PKISDVGLAKLHGPEW 310 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~-~kl~DFGla~~~~~~~ 310 (483)
++|+|.+++.... ....+++..++.++.||+.||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999997431 2234788999999999999999999921129999999999999998887 799999999755332
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .. .....+..+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~------~~~~~~~~~- 226 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AV------HNGTRPPLI- 226 (307)
T ss_dssp --------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--HH------HTTCCCCCB-
T ss_pred ---cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--HH------hcCCCCCcc-
Confidence 2234689999999998654 4899999999999999999999999765433211111 10 001111122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 227 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 227 ---KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22346788999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=368.80 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=202.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeC------C
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------Q 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 222 (483)
.++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999965 5788999999764 223346789999999999999999999999654 4
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 5777773 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-----
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ----- 377 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 377 (483)
|+...... ......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+....+..++......
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98665432 233457899999999997654 8999999999999999999999998877554444333211000
Q ss_pred ----hhhhhhcC--CCCCCCC----------------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 ----QKIAYVLD--PKLPEMP----------------SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 ----~~~~~~~~--~~~~~~~----------------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
........ +...... .......+.+|+.+||+.||++|||++|++++.+...
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00000000 0000000 0112567899999999999999999999999887653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=352.98 Aligned_cols=267 Identities=22% Similarity=0.351 Sum_probs=202.8
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccE
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGY 217 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~ 217 (483)
.+.++.+..++|.+.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 345566677889999999999999999998543 45799999876533 234679999999999999999999999
Q ss_pred EEeCCe-----EEEEEEecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc
Q 046972 218 CVEGQN-----RILVYEYIDNGNLQQWLHGSL--GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 218 ~~~~~~-----~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~ 290 (483)
+..... .++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc
Confidence 987553 499999999999999994321 2346799999999999999999999999 999999999999999
Q ss_pred CCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHH
Q 046972 291 HHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLI 368 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~ 368 (483)
.++.+||+|||+++....... .......+++.|+|||.+.+. .++.++|||||||++|||++ |..||..........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 999999999999986543321 222334567889999998654 48999999999999999999 999998766543321
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
... . ...+..+ ..++..+.+++.+||..||.+|||+.+++++|+..
T Consensus 261 ~~~----~------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 261 YLL----H------GHRLKQP----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHH----T------TCCCCCB----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----c------CCCCCCC----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110 0 0111122 23346889999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=369.37 Aligned_cols=269 Identities=16% Similarity=0.206 Sum_probs=191.6
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC-----CeE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QNR 224 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 224 (483)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|+.++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67999999999999999999965 688999999966432 3346799999999999999999999998543 568
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|+||||+ +|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+
T Consensus 133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 579999996 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcc--------------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-----
Q 046972 305 LHGPEWS--------------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS----- 353 (483)
Q Consensus 305 ~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t----- 353 (483)
....... .......||+.|+|||++.....|+.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7542211 122334789999999987555569999999999999999999
Q ss_pred ------CCCCCCCCCch--------------------hhHHHHHHHHHHhh--------------hhhhhcCCCCCC---
Q 046972 354 ------GRLPVDYSQPQ--------------------VFLIDWLKSMVAQQ--------------KIAYVLDPKLPE--- 390 (483)
Q Consensus 354 ------g~~Pf~~~~~~--------------------~~~~~~~~~~~~~~--------------~~~~~~~~~~~~--- 390 (483)
|+++|.+.... ..+..+. ...... ............
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF-NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHH-HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHH-HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 67777654311 0000000 000000 000000000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
.........+.+|+.+||..||++|||++|++++.+..+.
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 0011224678899999999999999999999999877654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=355.70 Aligned_cols=266 Identities=17% Similarity=0.236 Sum_probs=212.1
Q ss_pred hHHHHHHhcCCccc-ceeccCCceEEEEEEEc-CCcEEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCcccccccEEE
Q 046972 145 LKEIDIVTDGFAEQ-NVIASGDNGVVYRAVLL-DNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCV 219 (483)
Q Consensus 145 ~~~~~~~~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 219 (483)
++..+...+.|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34556667778887 89999999999999976 5889999998754 233457899999999999 5699999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcE
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPK 296 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~k 296 (483)
+.+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999998542 346799999999999999999999999 9999999999999998 78999
Q ss_pred EeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 297 l~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
|+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+..
T Consensus 175 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---- 247 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---- 247 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred EeeCccccccCCccc--cccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh----
Confidence 999999987654322 23347899999999986554 89999999999999999999999987665433221110
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+.......+..+.+++.+||+.||.+|||+.+++++.+..+
T Consensus 248 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 248 -------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp -------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred -------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 0111222222234468899999999999999999999999877544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=354.75 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=201.6
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
+..++|.+.+.||+|+||.||+|.... +..||+|.+..... .....+.+|+++++.++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 345678889999999999999998653 23599999976533 334679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999964 235689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 304 KLHGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 304 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
+........ ......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.......... ... ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~-~~-- 266 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AIN-DG-- 266 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHH-TT--
T ss_pred hhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHH-CC--
Confidence 876443221 122234577899999986444 8999999999999999999 999997665432211 111 00
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... .+..++..+.+++.+||+.||.+||++.++++.|+.
T Consensus 267 ---~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 267 ---FRLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp ---CCCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 122344688999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=364.43 Aligned_cols=270 Identities=19% Similarity=0.242 Sum_probs=211.9
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCC--eEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ--NRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 227 (483)
.++|.+.+.||+|+||+||+|+... ++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4678899999999999999999764 8899999997543 234567889999999999999999999998765 77999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE----cCCCCcEEeecccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKISDVGLA 303 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DFGla 303 (483)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999996542 233499999999999999999999999 99999999999999 77788999999999
Q ss_pred cccCCCccccccccccCcccccccccCCC-------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRT-------SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
+....... .....||..|+|||++.+. ..++.++|||||||++|||++|+.||..........+.+.....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 87654322 2334689999999987531 23788999999999999999999999754433222222222222
Q ss_pred hhhhh--------------hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 377 QQKIA--------------YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 377 ~~~~~--------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... ...+.......+......+.+++.+||+.||++||++.++++.+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11100 0001111223446778889999999999999999999999887744
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=349.88 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=202.2
Q ss_pred cCCccc-ceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQ-NVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+.|.+. +.||+|+||.||+|.. .+++.||+|++..........+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 7899999999999995 46889999999776656678899999999985 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEeeccccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKISDVGLAKLH 306 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DFGla~~~ 306 (483)
|+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+++..
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999643 5689999999999999999999999 9999999999999998776 999999999765
Q ss_pred CCCcc------ccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh----------
Q 046972 307 GPEWS------ISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF---------- 366 (483)
Q Consensus 307 ~~~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~---------- 366 (483)
..... .......||+.|+|||++.. ...++.++|||||||++|||++|+.||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223458999999999853 12378999999999999999999999976543210
Q ss_pred HHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 367 LIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+....... ....+.......+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus 245 ~~~~~~~~i~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 245 CQNMLFESIQEG------KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHHC------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHHHhcc------CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 000011111111 111111000113367899999999999999999999999887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=382.12 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=202.2
Q ss_pred HhcCCcccc-eeccCCceEEEEEEEc---CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQN-VIASGDNGVVYRAVLL---DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..+++.+.+ .||+|+||.||+|.++ ++..||||++.... ....+.|.+|++++++++|||||++++++.. +..+
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 334455555 7999999999999864 45679999997653 3356789999999999999999999999976 5689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|||||++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 412 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 99999999999999963 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... ......++..|+|||++... .++.++|||||||++|||++ |+.||........... ...+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-----i~~~---- 555 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQG---- 555 (613)
T ss_dssp CC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-----HHTT----
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcC----
Confidence 6543221 12233456789999998544 48999999999999999998 9999987765432211 1111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... +..++..+.++|.+||+.||++||++.++++.|+.
T Consensus 556 -~~~~~----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 556 -KRMEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -CCCCC----CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11112 22345789999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=348.95 Aligned_cols=257 Identities=17% Similarity=0.205 Sum_probs=198.3
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 6888999998765332 236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999964 35689999999999999999999999 99999999999999999999999999998665
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
...........++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ........ . .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-----~--~ 252 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSV-----MGAHINQA-----I--P 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-----HHHHHHSC-----C--C
T ss_pred ccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-----HHHHhccC-----C--C
Confidence 4433333445789999999998654 48999999999999999999999997654321 11111110 0 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHhcccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRP-KMGDVLRMLEPR 428 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~eil~~L~~~ 428 (483)
.+.......+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 00011122235788999999999999999 999999988654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.35 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=188.8
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc---chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV---SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5689999999999999999997 4688999999864321 12367899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999973 335789999999999999999999999 999999999999999999999999999986643
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||........... . ...+...
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~---~~~~~~~ 231 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--------V---VLADYEM 231 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------C---CSSCCCC
T ss_pred CCC-cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--------H---hhcccCC
Confidence 321 122346889999999986544 79999999999999999999999986554321110 0 0011222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
+. ..+..+.+++.+||+.||++|||+.+++++.+..+
T Consensus 232 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 232 PS----FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred cc----ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 22 23367889999999999999999999999776543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=361.94 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=193.4
Q ss_pred CCcccceeccCCceEEEEEEEcC--C--cEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEe-CCeEEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLD--N--MRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQNRILV 227 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv 227 (483)
.|.+.+.||+|+||.||+|.+.+ + ..||+|.+.... ....+.|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46778899999999999998642 2 357999886543 3445789999999999999999999998754 4678999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++|+|.++++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999973 345688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 308 PEWSI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 308 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..... ......+|..|+|||.+.+. .++.++|||||||++|||++ |..||............ ...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-----~~~----- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQG----- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-----HTT-----
T ss_pred ccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-----HcC-----
Confidence 32211 12234567789999998544 48999999999999999999 78888765544322111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... +..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 313 ~~~~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 313 RRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 223346889999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=360.11 Aligned_cols=269 Identities=20% Similarity=0.326 Sum_probs=210.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+..++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34578999999999999999999976 57889999987653 33346899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 110 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp ECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999643 468999999999999999999998 5 8999999999999999999999999999754
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH-----------
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV----------- 375 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------- 375 (483)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.................
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 183 IDS---MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHH---C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccc---cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 221 223347899999999986554 89999999999999999999999986554322111000000
Q ss_pred ------------------HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 ------------------AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+........+..+....+..+.+|+.+||+.||.+|||+.+++++.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 000001111111222222334568899999999999999999999998876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=345.59 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=202.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEe----CCeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 225 (483)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999965 56788999987543 3344679999999999999999999999875 35689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEc-CCCCcEEeeccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLD-HHWNPKISDVGL 302 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~-~~~~~kl~DFGl 302 (483)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999963 35689999999999999999999998 8 99999999999997 789999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
+....... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||..............
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------- 243 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---------- 243 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT----------
T ss_pred cccccccc---cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh----------
Confidence 97654332 223468999999998853 389999999999999999999999987555433221110
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+.......+..+.+++.+||+.||.+|||+.+++++.+..+
T Consensus 244 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 244 --SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 111111111222357899999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.25 Aligned_cols=262 Identities=20% Similarity=0.286 Sum_probs=195.5
Q ss_pred HHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc-hH-HHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS-EE-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
+..++|++.+.||+|+||+||+|.. .+++.||+|++...... .. +.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 4567899999999999999999997 46888999999765332 22 334555556888999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||++ |+|.+++.........+++..++.++.||+.||.|||++ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 599888865434567899999999999999999999984 28999999999999999999999999999866
Q ss_pred CCCccccccccccCccccccccc---CCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 307 GPEWSISTSCELRNSGYLAEELS---GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
..... .....+|+.|+|||++ .....++.++|||||||++|||++|+.||.......... .....
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~------- 228 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVE------- 228 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHH-------
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhc-------
Confidence 44322 2233688999999996 234458999999999999999999999997644322111 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
...+..+....+..+.+++.+||+.||++|||+.+++++.+..
T Consensus 229 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 229 --EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp --SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred --cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 1111222233446889999999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=345.55 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=205.4
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999976 5889999998654321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC----CcEEeec
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW----NPKISDV 300 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DF 300 (483)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999963 35689999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|++........ .....+++.|+|||++.... ++.++|||||||++|+|++|..||...........+ ..
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~---- 225 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----SA---- 225 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HT----
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh----Hh----
Confidence 99986644322 23346889999999986544 899999999999999999999999876543322111 00
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.....+.......+..+.+++.+||..||.+|||+.+++++.+..
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 226 ---VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp ---TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred ---cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 011111000011236788999999999999999999999976543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=351.98 Aligned_cols=268 Identities=23% Similarity=0.369 Sum_probs=204.0
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC--CCCcccccccEEEeC--
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV--KHKNLVKLFGYCVEG-- 221 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~-- 221 (483)
.......++|++.+.||+|+||.||+|... ++.||+|++... ....+..|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 344556688999999999999999999985 889999998543 334555666666554 899999999999887
Q ss_pred --CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeecCCCCcEEEcCCCC
Q 046972 222 --QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI-----EPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 222 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDlkp~NiLl~~~~~ 294 (483)
...++||||+++|+|.++++. ..+++..++.++.|++.||.|||++. ..+|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 788999999999999999953 35899999999999999999999751 338999999999999999999
Q ss_pred cEEeecccccccCCCccc---cccccccCcccccccccCCCCCCCc------chhhHHHHHHHHHHHcC----------C
Q 046972 295 PKISDVGLAKLHGPEWSI---STSCELRNSGYLAEELSGRTSIFNE------KSDVYSFGILIMEIVSG----------R 355 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~------~~DvwSlGv~l~el~tg----------~ 355 (483)
+||+|||+++........ ......||+.|+|||++.+.. ++. ++|||||||++|||++| .
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 999999999765433221 122447899999999986544 344 39999999999999999 6
Q ss_pred CCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 356 LPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM-PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 356 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.||.................. .....+..+.. ....++..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 777554332211111111111 11122222221 123678889999999999999999999999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=355.00 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=203.1
Q ss_pred hcCCcccceeccCCceEEEEEEE-----cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeC--Ce
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-----LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG--QN 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 223 (483)
.+.|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35588899999999999999984 368899999997543 33457899999999999999999999999876 66
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 89999999999999999643 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc-----------hhhHHHH
Q 046972 304 KLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP-----------QVFLIDW 370 (483)
Q Consensus 304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~-----------~~~~~~~ 370 (483)
........ .......+|..|+|||.+.+.. ++.++|||||||++|||++|..|+..... .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 87654322 2233446788899999985544 78999999999999999999998642210 0011110
Q ss_pred HHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. .+....... .+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 ~~------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 253 VN------TLKEGKRLP----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HH------HHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HH------HHhccCCCC----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 00 011111111 222344789999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=353.44 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=202.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcE--EEEEEecCC-CcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMR--AAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.+.||+|+||.||+|+.. ++.. +|+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367899999999999999999964 4554 489988654 223446789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 227 VYEYIDNGNLQQWLHGSL------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997532 2235799999999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~ 373 (483)
+||+|||+++.... ........++..|+|||++.+. .++.++|||||||++|||++ |+.||..........
T Consensus 181 ~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----- 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 252 (327)
T ss_dssp EEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----
T ss_pred EEEcccCcCccccc--cccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH-----
Confidence 99999999974322 1122334567889999998544 37999999999999999998 999998765432211
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+........+ ..++..+.+++.+||+.||.+|||+.++++.|..
T Consensus 253 -----~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 -----KLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp -----HGGGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----HhhcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111111222 2334688999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=351.21 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=206.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--------chHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--------SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999975 478899999865422 1224588999999999999999999998765
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEe
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKIS 298 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~ 298 (483)
. .++||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 899999999999999995 446799999999999999999999999 9999999999999987654 9999
Q ss_pred ecccccccCCCccccccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 299 DVGLAKLHGPEWSISTSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 299 DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
|||+++....... .....||+.|+|||++. +...++.++|||||||++|||++|..||........+...+..
T Consensus 160 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 234 (322)
T 2ycf_A 160 DFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS--- 234 (322)
T ss_dssp CCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---
T ss_pred cCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---
Confidence 9999987654321 22346899999999863 2344899999999999999999999999866544332222111
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhhH
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLRE 434 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~~ 434 (483)
... ..........+..+.+++.+||+.||++|||+.+++++.+..+.....
T Consensus 235 -~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 235 -GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285 (322)
T ss_dssp -TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHH
T ss_pred -Ccc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHH
Confidence 100 000000011236889999999999999999999999988776655443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=356.56 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=202.7
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
..++|++.+.||+|+||.||+|... +++.||+|++...... +.+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 5788999999765432 45688888877 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC----CCcEEeeccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH----WNPKISDVGLAK 304 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~----~~~kl~DFGla~ 304 (483)
|||+||+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999996 345699999999999999999999999 99999999999998543 349999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
....... ......+|+.|+|||++.+.. ++.++|||||||++|||++|..||...... ...++..... .+.
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~-~~~----- 239 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARIG-SGK----- 239 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHHH-HCC-----
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHHc-cCC-----
Confidence 6543322 223457899999999986544 789999999999999999999999764322 1111111111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..++.......+..+.+++.+||..||++|||+.+++++.+.
T Consensus 240 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 240 -FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp -CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred -cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 112221223344788999999999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=349.79 Aligned_cols=262 Identities=19% Similarity=0.287 Sum_probs=206.7
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999976 478899999977666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+++|+|.+++... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998642 35689999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 310 WSISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
........++..|+|||++. ....++.++|||||||++|||++|..||............. .. ..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~------~~ 239 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KS------DP 239 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HS------CC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh----cc------CC
Confidence 11122346889999999873 23448899999999999999999999998765433221111 10 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchh
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~ 431 (483)
+.. ..+...+..+.+++.+||+.||.+|||+.+++++.+.....
T Consensus 240 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 240 PTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 111 12233446889999999999999999999999987665433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=348.09 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=208.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888999999999999999964 58899999997653 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+++++|.+++. ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999994 35689999999999999999999999 99999999999999999999999999998654432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......++..|+|||++.+.. ++.++|||||||++|||++|+.||........... +.....+.++.
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~ 241 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFL----------IPKNNPPTLEG 241 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------HHHSCCCCCCS
T ss_pred -cccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----------hhcCCCCCCcc
Confidence 2223457889999999986544 89999999999999999999999976554322111 01111122222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 242 ----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 242 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp ----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred ----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 233678999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=358.23 Aligned_cols=279 Identities=19% Similarity=0.204 Sum_probs=210.4
Q ss_pred eehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc-----------hHHHHHHHHHHHhcCCCCcc
Q 046972 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS-----------EEEDFIEKVEAIGQVKHKNL 211 (483)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI 211 (483)
..+.++....++|++.+.||+|+||.||+|...++..||+|++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456788889999999999999999999999888999999998653221 12679999999999999999
Q ss_pred cccccEEEeC-----CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 212 VKLFGYCVEG-----QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 212 v~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
+++++++... ...++||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 9999998643 36799999997 689988863 345799999999999999999999999 99999999999
Q ss_pred EEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhh
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVF 366 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~ 366 (483)
||++.++.+||+|||+++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997543322 223346888999999987655689999999999999999999999987765444
Q ss_pred HHHHHHHHHHh----------hhhhhhcCC---CCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 367 LIDWLKSMVAQ----------QKIAYVLDP---KLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 367 ~~~~~~~~~~~----------~~~~~~~~~---~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+....... ......... ..+... .......+.+++.+||+.||.+|||+.+++++.+...
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 33332211000 000000101 111111 0122367889999999999999999999999887655
Q ss_pred h
Q 046972 430 L 430 (483)
Q Consensus 430 ~ 430 (483)
.
T Consensus 323 ~ 323 (362)
T 3pg1_A 323 L 323 (362)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.00 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=200.2
Q ss_pred CCcccceeccCCceEEEEEEEcC-C---cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeE-EEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLD-N---MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR-ILV 227 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-~lv 227 (483)
.|...+.||+|+||+||+|.+.+ + ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35567899999999999998543 2 2689999876433 3447899999999999999999999999876655 999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999974 346689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCcc---ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCchhhHHHHHHHHHHhhhhhhh
Q 046972 308 PEWS---ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVAQQKIAYV 383 (483)
Q Consensus 308 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (483)
.... .......++..|+|||.+.+.. ++.++|||||||++|||++|..| |....... ...... . .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~----~-----~ 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLA----Q-----G 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHH----T-----T
T ss_pred CCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhh----c-----C
Confidence 3321 1223346788999999996544 89999999999999999995555 44433322 211111 0 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 384 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... +...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 245 ~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 245 RRLPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 222346889999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=373.43 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=205.5
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-------------chHHHHHHHHHHHhcCCCCccccccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-------------SEEEDFIEKVEAIGQVKHKNLVKLFG 216 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~~ 216 (483)
..++|.+.+.||+|+||+||+|... ++..+|+|++..... ...+.+.+|+.++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999975 478899999875432 23467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC---
Q 046972 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW--- 293 (483)
Q Consensus 217 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~--- 293 (483)
++.+....++|||||++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999963 35699999999999999999999999 999999999999998776
Q ss_pred CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-- 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-- 260 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 69999999998765432 2234478999999999853 38999999999999999999999998766543322211
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
... ...+.......+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 261 ---~~~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 261 ---KGK------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp ---HCC------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ---cCC------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 110 011100001223688999999999999999999999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=359.53 Aligned_cols=268 Identities=20% Similarity=0.228 Sum_probs=205.4
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCe------EE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN------RI 225 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~~ 225 (483)
..+|++.+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3568899999999999999999988888999988654322 2369999999999999999999965443 78
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-CCCCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-HHWNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DFGla~ 304 (483)
+||||++++ |...+.........+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999874 4444432222456799999999999999999999999 999999999999999 78999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh------h
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ------Q 378 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------~ 378 (483)
....... .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.+......+..+....... .
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7643322 2334678999999998666568999999999999999999999999877665555444321000 0
Q ss_pred hhhhhcCCCCCCC---C-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 379 KIAYVLDPKLPEM---P-----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 379 ~~~~~~~~~~~~~---~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.........++.. + ....+..+.+|+.+||+.||.+|||+.+++++.+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 0000111111111 0 1123468999999999999999999999999876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=346.27 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=200.0
Q ss_pred cCCcccceeccCCceEEEEEEEcCC----cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEE-eCCeEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDN----MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCV-EGQNRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~l 226 (483)
..|.+.+.||+|+||.||+|...++ ..+|+|.+..... ...+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4588889999999999999986432 3578998876433 34478999999999999999999999865 4567899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999963 345689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCcc---ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 307 GPEWS---ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 307 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
..... .......+|+.|+|||.+.+. .++.++|||||||++|||++ |.+||............. .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-----~----- 247 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-----Q----- 247 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-----T-----
T ss_pred cccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-----c-----
Confidence 44322 122334567889999998544 48999999999999999999 666776555433221110 0
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
......+ ..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 248 ~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 248 GRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0111112 2233678999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.05 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=205.3
Q ss_pred HHHHhcCCcccc-eeccCCceEEEEEEEc---CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 148 IDIVTDGFAEQN-VIASGDNGVVYRAVLL---DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 148 ~~~~~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
+.+..++|.+.+ .||+|+||.||+|.+. .++.||+|++..... ...+.+.+|+++++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 344556788888 9999999999999643 367899999976532 2346899999999999999999999999 66
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 778999999999999999964 35689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 302 LAKLHGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 302 la~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
++......... ......++..|+|||.+.+.. ++.++|||||||++|||++ |+.||.......... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~- 235 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEK- 235 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHT-
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHHc-
Confidence 99876543222 222334678899999985444 7899999999999999999 999998765432211 1111
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+..+ ..++..+.+++.+||+.||.+|||+.++++.|+..-
T Consensus 236 ----~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 236 ----GERMGCP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----TCCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112222 233478999999999999999999999999997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.56 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=210.7
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhc--CCCCcccccccEEEeCC
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQ--VKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~ 222 (483)
+.......++|.+.+.||+|+||.||+|.. +++.||+|++... ....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 344456678899999999999999999998 5889999998543 45678888888877 78999999999998876
Q ss_pred ----eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeeeecCCCCcEEEc
Q 046972 223 ----NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH--------EDIEPKIVHHNMKSSNILLD 290 (483)
Q Consensus 223 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiHrDlkp~NiLl~ 290 (483)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999953 35899999999999999999999 77 999999999999999
Q ss_pred CCCCcEEeecccccccCCCccc---cccccccCcccccccccCCCCC-----CCcchhhHHHHHHHHHHHcC--------
Q 046972 291 HHWNPKISDVGLAKLHGPEWSI---STSCELRNSGYLAEELSGRTSI-----FNEKSDVYSFGILIMEIVSG-------- 354 (483)
Q Consensus 291 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DvwSlGv~l~el~tg-------- 354 (483)
.++.+||+|||++......... ......||+.|+|||++.+... ++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999865433221 2334578999999999865422 23689999999999999999
Q ss_pred --CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 355 --RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM-PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 355 --~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..||............+.... ......+.++.. ....++..+.+++.+||+.||++|||+.+++++|+..
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 788865543211111111111 111222333321 1346678899999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.51 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=205.6
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
++|.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44666679999999999999964 57889999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeecccccccCCCc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~~ 310 (483)
++++|.+++... .....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999753 2234577899999999999999999999 9999999999999987 8999999999998654322
Q ss_pred cccccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 311 SISTSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
.......|+..|+|||++.+. ..++.++|||||||++|||++|+.||........... .. . .....+.++
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~----~--~~~~~~~~~ 248 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KV----G--MFKVHPEIP 248 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HH----H--HHCCCCCCC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hh----c--ccccccccc
Confidence 122344688999999998543 2378999999999999999999999975443221110 00 0 011223333
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. ..+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 249 ~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 249 E----SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp T----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred c----cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 2 23368889999999999999999999998776543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=341.72 Aligned_cols=255 Identities=18% Similarity=0.302 Sum_probs=201.8
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.+..++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 344578999999999999999999976 68899999986532 12345789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence 9999999999999999643 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
....... .....+++.|+|||.+.+....+.++||||||+++|+|++|+.||........... . ...
T Consensus 160 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~-~~~------ 226 (276)
T 2h6d_A 160 MMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----I-RGG------ 226 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----H-HHC------
T ss_pred ccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----h-hcC------
Confidence 6654321 22346788999999987655447899999999999999999999976554322111 1 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+.. ....+.+++.+||+.||.+|||+.+++++.+.
T Consensus 227 ~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 227 VFYIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred cccCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 1112222 23678899999999999999999999997654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.89 Aligned_cols=269 Identities=18% Similarity=0.237 Sum_probs=200.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeC-----Ce
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QN 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 223 (483)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 367999999999999999999965 47789999997642 23346899999999999999999999999766 57
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+||||+. |+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 59999996 345699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcc---------------------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCC-----
Q 046972 304 KLHGPEWS---------------------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP----- 357 (483)
Q Consensus 304 ~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~P----- 357 (483)
+....... .......||+.|+|||++.....++.++|||||||++|||++|..|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 87643321 1124557899999999875566699999999999999999985444
Q ss_pred ------CCCCCc-----------------hhhHHHHHHHHHHhh-----------hh-h--hhcCCCCCCCC---CHHHH
Q 046972 358 ------VDYSQP-----------------QVFLIDWLKSMVAQQ-----------KI-A--YVLDPKLPEMP---SRKEL 397 (483)
Q Consensus 358 ------f~~~~~-----------------~~~~~~~~~~~~~~~-----------~~-~--~~~~~~~~~~~---~~~~~ 397 (483)
|.+... ...+..++. ..... .. . .......+... ....+
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN-IIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHH-HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 333221 000100000 00000 00 0 00001110000 01234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 398 KRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 398 ~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+.+|+.+||+.||++|||+.|++++.+..+
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 68899999999999999999999999877654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=355.06 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=209.3
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--------hHHHHHHHHHHHhcC-CCCccccccc
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--------EEEDFIEKVEAIGQV-KHKNLVKLFG 216 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hpnIv~~~~ 216 (483)
......++|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999985 6899999998765321 135678999999999 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcE
Q 046972 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 217 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
++......++||||++||+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999963 35689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCccccccccccCcccccccccCC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHH
Q 046972 297 ISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR-----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371 (483)
Q Consensus 297 l~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~ 371 (483)
|+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||...........+
T Consensus 241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i- 317 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI- 317 (365)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence 999999987654322 234578999999998742 224789999999999999999999999765543222111
Q ss_pred HHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... ...+.......+..+.+++.+||+.||++|||+.+++++.+.
T Consensus 318 ----~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 318 ----MEGQ------YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp ----HHTC------CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred ----HhCC------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 1110 000000001123578899999999999999999999997653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.21 Aligned_cols=252 Identities=17% Similarity=0.248 Sum_probs=207.1
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|.+.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 366888999999999999999976 47789999986542 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999863 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.... ......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||............ . . ....
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~-~------~~~~ 233 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----K-K------NEYS 233 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-T------TCCC
T ss_pred cCcc-ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----h-h------ccCC
Confidence 3221 223346889999999986544 799999999999999999999999866543221111 0 0 0112
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+. .....+.+++.+||+.||++|||+.+++++.+.
T Consensus 234 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 234 IPK----HINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred Ccc----ccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 222 223678899999999999999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=353.23 Aligned_cols=264 Identities=21% Similarity=0.343 Sum_probs=204.9
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEe----
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVE---- 220 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~---- 220 (483)
++....++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445688999999999999999999974 68899999986543 2446789999999998 79999999999987
Q ss_pred --CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEe
Q 046972 221 --GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKIS 298 (483)
Q Consensus 221 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~ 298 (483)
.+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999999753 235689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCccccccccccCcccccccccCC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 299 DVGLAKLHGPEWSISTSCELRNSGYLAEELSGR----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 299 DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|||++........ ......+++.|+|||++.. ...++.++|||||||++|+|++|..||............
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---- 246 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 246 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----
Confidence 9999986543211 2233468999999999852 334889999999999999999999999766543222111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
. ....+ .......+..+.+++.+||..||.+|||+.+++++.+..+.
T Consensus 247 ~------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 247 P------RNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp H------HSCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred h------cCccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0 00111 11122234688999999999999999999999997665443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.87 Aligned_cols=274 Identities=22% Similarity=0.312 Sum_probs=193.4
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+.+..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 456678999999999999999999984 468899999986543 233467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcc----cCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 226 LVYEYIDNGNLQQWLHGS----LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+||||+++|+|.+++... ......+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998531 11345689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcc----ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh
Q 046972 302 LAKLHGPEWS----ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377 (483)
Q Consensus 302 la~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 377 (483)
++........ .......+|+.|+|||++.+...++.++|||||||++|||++|+.||..............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----- 241 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ----- 241 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-----
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-----
Confidence 9976543211 1123346889999999986534489999999999999999999999987665433221110
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...................+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 0000000000000111123367889999999999999999999999876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=350.27 Aligned_cols=252 Identities=17% Similarity=0.254 Sum_probs=207.5
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|.+.+.||+|+||.||+|...+ ++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4678899999999999999999764 6789999986542 23446789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||+++++|.+++.. ...+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999863 35689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+ .. . ...
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~-~------~~~ 259 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KK-N------EYS 259 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HH-T------CCC
T ss_pred cCcc-cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----hc-C------CCC
Confidence 3221 223346889999999986544 799999999999999999999999866543222111 10 0 122
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
++.. ....+.+++.+||+.||++|||+.+++++.+.
T Consensus 260 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 260 IPKH----INPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred CCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 2222 23578889999999999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.58 Aligned_cols=251 Identities=16% Similarity=0.191 Sum_probs=193.9
Q ss_pred HhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCC---CcchHHHHHHHH---HHHhcCCCCcccccc-------c
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSN---SVSEEEDFIEKV---EAIGQVKHKNLVKLF-------G 216 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~~~-------~ 216 (483)
..++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ ++++.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788999999999999999995 56899999999743 333457899999 556666899999999 6
Q ss_pred EEEeCC-----------------eEEEEEEecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 046972 217 YCVEGQ-----------------NRILVYEYIDNGNLQQWLHGSLG---EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276 (483)
Q Consensus 217 ~~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 276 (483)
++.+.+ ..|+||||+ +|+|.+++..... ....+++..++.++.||+.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 278999999 6899999964211 123345688889999999999999999 9
Q ss_pred eeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCC----------CCCCcchhhHHHHH
Q 046972 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT----------SIFNEKSDVYSFGI 346 (483)
Q Consensus 277 iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGv 346 (483)
|+||||||+|||++.++.+||+|||+|+..+. ......| +.|+|||++.+. ..++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986443 2233456 899999998655 14899999999999
Q ss_pred HHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 347 LIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 347 ~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
++|||++|+.||........ ...+.. ..+ ..+..+.+++.+||+.||++|||+.+++++.+
T Consensus 302 il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-------------SEWIFR-SCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHHSSCCC------CC-------------SGGGGS-SCC-----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHHCCCCCcccccccc-------------hhhhhh-hcc-----CCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 99999999999975443211 111111 111 12267889999999999999999999998766
Q ss_pred ccc
Q 046972 427 PRD 429 (483)
Q Consensus 427 ~~~ 429 (483)
...
T Consensus 363 f~~ 365 (377)
T 3byv_A 363 YEQ 365 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.64 Aligned_cols=267 Identities=20% Similarity=0.215 Sum_probs=204.3
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC------CeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------QNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~ 225 (483)
.+|++.+.||+|+||.||+|++. +++.||||++..... .+.+|+++++.++|||||++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888999999999999999975 588999999865422 234799999999999999999998642 2367
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-CCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DFGla~ 304 (483)
+||||+++ +|.+.+.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 77777654323456799999999999999999999999 99999999999999965 568999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh--hhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ--QKIAY 382 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~ 382 (483)
....... .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.+......+..++...... ..+..
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543321 2334789999999998665568999999999999999999999999877655555444321100 00000
Q ss_pred h----cCCCCCC---CC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 383 V----LDPKLPE---MP-----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 383 ~----~~~~~~~---~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .+..++. .+ ....+.++.+|+.+||..||.+|||+.|++++.+...
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 0 0111111 00 1122468899999999999999999999998876644
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.11 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=209.8
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---------chHHHHHHHHHHHhcCC-CCcccccccEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---------SEEEDFIEKVEAIGQVK-HKNLVKLFGYCV 219 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 219 (483)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999975 578899999975431 12356889999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
..+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999964 35689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccC-----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHH
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSG-----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 374 (483)
||++....... ......+++.|+|||++. ....++.++|||||||++|||++|+.||............
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 241 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---- 241 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH----
Confidence 99998765432 223346889999999874 2334789999999999999999999999765543221111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... ....+.......+..+.+++.+||+.||.+|||+.+++++.+..+
T Consensus 242 -~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 242 -MSG------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp -HHT------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -hcC------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 111 111111112334578999999999999999999999998776544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.52 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=206.8
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
..++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999976 46789999986432 1224678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999999643 4689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||...........+ . . .+.
T Consensus 165 ~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~-~------~~~ 229 (284)
T 2vgo_A 165 PSL---RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI----V-N------VDL 229 (284)
T ss_dssp SSS---CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-T------TCC
T ss_pred ccc---ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH----h-c------ccc
Confidence 432 123346889999999986544 899999999999999999999999866543221111 0 0 122
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.++.. .+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 230 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 230 KFPPF----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred CCCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 23322 23678899999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=355.26 Aligned_cols=259 Identities=18% Similarity=0.219 Sum_probs=202.3
Q ss_pred hcCCcccceeccCCceEEEEEEEcC---------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccc---------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD---------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK--------- 213 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 213 (483)
.++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4679999999999999999999764 788999998654 35889999999999999998
Q ss_pred ------cccEEEe-CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 214 ------LFGYCVE-GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 214 ------~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
+++++.. ....++||||+ +|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5677776 67889999999 99999999743 236799999999999999999999999 99999999999
Q ss_pred EEEcCCC--CcEEeecccccccCCCccc------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 046972 287 ILLDHHW--NPKISDVGLAKLHGPEWSI------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358 (483)
Q Consensus 287 iLl~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf 358 (483)
||++.++ .+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999998 8999999999865432211 113347899999999986544 899999999999999999999999
Q ss_pred CCCCc-hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 359 DYSQP-QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 359 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... ............ ........... .....+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFV--DKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTTCHHHHHHHHHHHH--HSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCcCHHHHHHHHHhcc--CChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 86642 222222111111 11111111110 001123688999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=352.36 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=204.7
Q ss_pred HHhcCCcccceeccCCceEEEEEEE------cCCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL------LDNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 222 (483)
+..++|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 4557899999999999999999983 246789999997543 334568999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcE
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLG---EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPK 296 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~k 296 (483)
..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999975421 224589999999999999999999999 9999999999999984 45699
Q ss_pred EeecccccccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSM 374 (483)
Q Consensus 297 l~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~ 374 (483)
|+|||+++...... ........+++.|+|||++.+. .++.++|||||||++|||++ |..||...........
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----- 257 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----- 257 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-----
Confidence 99999997543221 1223345678899999998544 48999999999999999998 9999986654322111
Q ss_pred HHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... ..+.. ...++..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 258 ~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 VTSG-----GRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHTT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcC-----CCCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1110 11111 223346889999999999999999999999998743
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=351.78 Aligned_cols=269 Identities=18% Similarity=0.281 Sum_probs=210.2
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC-----CeEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QNRI 225 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 225 (483)
++|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++.+++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 57999999999999999999965 577899999975433 3347799999999999999999999999765 3689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 9999997 599999953 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCcccc--ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--hh-
Q 046972 306 HGPEWSIS--TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ--KI- 380 (483)
Q Consensus 306 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~- 380 (483)
........ .....||+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+........ .+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 65432211 23447899999999876655589999999999999999999999988776655444332110000 00
Q ss_pred --------hhhcC-CCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 381 --------AYVLD-PKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 381 --------~~~~~-~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
..... +...... .......+.+|+.+||+.||.+|||+.+++++.+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 0000000 01223678999999999999999999999998876553
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=358.40 Aligned_cols=268 Identities=18% Similarity=0.220 Sum_probs=208.1
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcC------CCCcccccccEEEeCCe
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV------KHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~ 223 (483)
...+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567999999999999999999865 4788999998654 22345677888877776 57899999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC--cEEeecc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN--PKISDVG 301 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~--~kl~DFG 301 (483)
.++||||+. ++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 6999999753 334589999999999999999999999 9999999999999999987 9999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh----
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ---- 377 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---- 377 (483)
+++..... .....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+.......
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99765432 23447899999999986655 8999999999999999999999998877655544433211000
Q ss_pred ----hhhhhhcCCC-C-----------------------------CCCC------CHHHHHHHHHHHHHccCCCCCCCCC
Q 046972 378 ----QKIAYVLDPK-L-----------------------------PEMP------SRKELKRIILIALRCVDPDIKHRPK 417 (483)
Q Consensus 378 ----~~~~~~~~~~-~-----------------------------~~~~------~~~~~~~l~~l~~~cl~~dP~~Rpt 417 (483)
......++.. . +... .......+.+|+.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0000000000 0 0000 0011357889999999999999999
Q ss_pred HHHHHHhccccch
Q 046972 418 MGDVLRMLEPRDL 430 (483)
Q Consensus 418 ~~eil~~L~~~~~ 430 (483)
+.|++++.+....
T Consensus 403 a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 PGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHTSTTTC--
T ss_pred HHHHhCChhhccC
Confidence 9999999887653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=344.20 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=198.0
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC-CeEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-QNRILVY 228 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~ 228 (483)
+..++|++.+.||+|+||.||+|.. .++.||+|.+.... ..+.+.+|++++++++||||+++++++... +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3457799999999999999999987 47899999986543 456799999999999999999999997654 4789999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999643 123478999999999999999999999 999999999999999999999999999975543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
. .....++..|+|||.+.+. .++.++|||||||++|||++ |+.||........... +.....+.
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----------~~~~~~~~ 234 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----------VEKGYKMD 234 (278)
T ss_dssp ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----------HTTTCCCC
T ss_pred c----ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------HhcCCCCC
Confidence 2 1233567889999998544 48999999999999999998 9999987654332211 11111112
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. +..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 235 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 235 A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 2 22344788999999999999999999999998864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=360.73 Aligned_cols=272 Identities=17% Similarity=0.208 Sum_probs=189.9
Q ss_pred cCCcc-cceeccCCceEEEEEEEc---CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEEE
Q 046972 153 DGFAE-QNVIASGDNGVVYRAVLL---DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRIL 226 (483)
Q Consensus 153 ~~~~~-~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 226 (483)
+.|.+ .++||+|+||+||+|+.. +++.||+|++..... ...+.+|+.+++.++|||||++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44665 458999999999999976 478899999975532 2468899999999999999999999965 678899
Q ss_pred EEEecCCCCHHHHHhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE----cCCCCcEE
Q 046972 227 VYEYIDNGNLQQWLHGSL-----GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL----DHHWNPKI 297 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl----~~~~~~kl 297 (483)
||||+. |+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 58988885321 1233589999999999999999999999 99999999999999 67789999
Q ss_pred eecccccccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch---------hh
Q 046972 298 SDVGLAKLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ---------VF 366 (483)
Q Consensus 298 ~DFGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~---------~~ 366 (483)
+|||+|+....... .......||+.|+|||++.+...++.++|||||||++|||++|+.||...... ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653221 22334578999999999876566899999999999999999999999765432 11
Q ss_pred HHHHHHHHHHhhh--hh-------------hhcCCCCCCCC--------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046972 367 LIDWLKSMVAQQK--IA-------------YVLDPKLPEMP--------SRKELKRIILIALRCVDPDIKHRPKMGDVLR 423 (483)
Q Consensus 367 ~~~~~~~~~~~~~--~~-------------~~~~~~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~ 423 (483)
+..++........ .. ........... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111000000 00 00000000000 0001246889999999999999999999999
Q ss_pred hccccch
Q 046972 424 MLEPRDL 430 (483)
Q Consensus 424 ~L~~~~~ 430 (483)
+.+....
T Consensus 334 hp~f~~~ 340 (405)
T 3rgf_A 334 DPYFLED 340 (405)
T ss_dssp SGGGTSS
T ss_pred ChhhccC
Confidence 8887553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.40 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=202.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe---------
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--------- 220 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------- 220 (483)
..++|++.+.||+|+||.||+|... +++.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999976 68899999997553 357789999999999999999998864
Q ss_pred -------CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC
Q 046972 221 -------GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW 293 (483)
Q Consensus 221 -------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~ 293 (483)
....++||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 45579999999999999999643 235689999999999999999999999 999999999999999999
Q ss_pred CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
.+||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++|..||... .....
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~- 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET------SKFFT- 229 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHH-
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH------HHHHH-
Confidence 99999999998765432 223346899999999986544 899999999999999999999887311 01111
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.......+... +..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 230 --------~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 --------DLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------HHHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------HhhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11112222222 257889999999999999999999999987544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.37 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=202.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe----------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE---------- 220 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---------- 220 (483)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457899999999999999999964 6889999998543 2334678999999999999999999998865
Q ss_pred ---CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEE
Q 046972 221 ---GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297 (483)
Q Consensus 221 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl 297 (483)
....++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999974 235678899999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCc-------------cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch
Q 046972 298 SDVGLAKLHGPEW-------------SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ 364 (483)
Q Consensus 298 ~DFGla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~ 364 (483)
+|||+++...... ........++..|+|||++.+...++.++|||||||++|||++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998654321 1122334688999999998765568999999999999999998 55422111
Q ss_pred hhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhh
Q 046972 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLR 433 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~ 433 (483)
. ...... . ......+.......+..+.+++.+||+.||.+|||+.+++++.+.......
T Consensus 235 ~---~~~~~~------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 235 V---NILKKL------R-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp H---HHHHHH------H-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred H---HHHHhc------c-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 1 111111 0 112233333344455678999999999999999999999999887654333
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=344.03 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=203.9
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999976 48899999987643 3467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999963 235689999999999999999999999 999999999999999999999999999976543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||........... . .....+..
T Consensus 178 ~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~------~~~~~~~~ 245 (314)
T 3com_A 178 TM-AKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM----I------PTNPPPTF 245 (314)
T ss_dssp TB-SCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----H------HHSCCCCC
T ss_pred hc-cccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH----H------hcCCCccc
Confidence 32 1223446889999999986554 89999999999999999999999986554322111 0 00111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
. .+...+..+.+++.+||..||.+|||+.+++++.+..
T Consensus 246 ~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 246 R--KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp S--SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred C--CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 1 1222346889999999999999999999999866543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.80 Aligned_cols=269 Identities=19% Similarity=0.257 Sum_probs=211.8
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcch-----------------HHHHHHHHHHHhcCCCCccc
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE-----------------EEDFIEKVEAIGQVKHKNLV 212 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpnIv 212 (483)
...++|++.+.||+|+||.||+|.. +++.||+|.+....... .+.+.+|+.++++++||||+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3457899999999999999999999 89999999986532111 17899999999999999999
Q ss_pred ccccEEEeCCeEEEEEEecCCCCHHHH------HhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCC
Q 046972 213 KLFGYCVEGQNRILVYEYIDNGNLQQW------LHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSS 285 (483)
Q Consensus 213 ~~~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~ 285 (483)
++++++.+.+..++||||+++|+|.++ +... ....+++..++.++.||+.||.|||+ + +|+||||||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 999999999999999999999999998 5321 25779999999999999999999999 8 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCc-chhhHHHHHHHHHHHcCCCCCCCCCch
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNE-KSDVYSFGILIMEIVSGRLPVDYSQPQ 364 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwSlGv~l~el~tg~~Pf~~~~~~ 364 (483)
|||++.++.+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|||++|+.||......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999999865433 2344578999999999976634666 999999999999999999999876653
Q ss_pred hhHHHHHHHHHHhhhhhhhcC------CCCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchh
Q 046972 365 VFLIDWLKSMVAQQKIAYVLD------PKLP---EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLL 431 (483)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~ 431 (483)
...... ..........+ +..+ .......+..+.+++.+||+.||.+|||+.+++++.+..+..
T Consensus 259 ~~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 259 VELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 222111 11111000000 0000 000023346889999999999999999999999987765543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=378.66 Aligned_cols=256 Identities=19% Similarity=0.239 Sum_probs=210.0
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 224 (483)
+..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45678999999999999999999976 47789999986431 22335788899999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|+||||++||+|.++++.. ..+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+
T Consensus 418 ~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999999643 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
...... .......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.......+. . .
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~-------~ 557 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----E-------H 557 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----S-------S
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH----h-------C
Confidence 643221 2234457999999999996554 8999999999999999999999998766543322211 1 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHhccccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKM-----GDVLRMLEPRD 429 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~eil~~L~~~~ 429 (483)
...+|. ..+.++.+|+.+||+.||.+||++ ++|+++.+...
T Consensus 558 ~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 558 NVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp CCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 122332 234688999999999999999998 88988776654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=357.00 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=192.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC------C
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------Q 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 222 (483)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367999999999999999999954 588999999866432 3346789999999999999999999998754 5
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+ +++|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 789999984 25699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh--hh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ--KI 380 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 380 (483)
++..... .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+........ .+
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 23457899999999987655689999999999999999999999988766544433332110000 00
Q ss_pred --------hhhc--CCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 --------AYVL--DPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 --------~~~~--~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+ -+..+.... ......+.+|+.+||..||.+|||+.+++++.+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 0000 011111110 112357889999999999999999999999877554
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=354.78 Aligned_cols=258 Identities=20% Similarity=0.274 Sum_probs=189.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEE-------
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCV------- 219 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~------- 219 (483)
++...+|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 445567999999999999999999965 68899999997766666678999999999996 999999999995
Q ss_pred -eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEcCCCCcE
Q 046972 220 -EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 220 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~~~~~~k 296 (483)
.....++||||+. |+|.+++.... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 3345799999996 79999986432 345699999999999999999999998 8 99999999999999999999
Q ss_pred EeecccccccCCCccc-----------cccccccCcccccccccC--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 297 ISDVGLAKLHGPEWSI-----------STSCELRNSGYLAEELSG--RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 297 l~DFGla~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
|+|||+++........ ......+|+.|+|||++. ....++.++|||||||++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999876432211 111345889999999873 233478999999999999999999999975433
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... ....... ........+.+++.+||+.||.+|||+.+++++|+..
T Consensus 259 ~~~~-------------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 259 LRIV-------------NGKYSIP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CCCC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhh-------------cCcccCC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2110 0001111 1112224678899999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=345.38 Aligned_cols=269 Identities=20% Similarity=0.298 Sum_probs=201.8
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEE-----------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV----------- 219 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----------- 219 (483)
.++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999765 8899999998766556678999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-CCCCc
Q 046972 220 ---EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-HHWNP 295 (483)
Q Consensus 220 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~-~~~~~ 295 (483)
+....++||||++ |+|.+++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 69999994 35689999999999999999999999 999999999999997 56789
Q ss_pred EEeecccccccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 296 kl~DFGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
||+|||+++....... .......++..|+|||.+.+...++.++|||||||++|||++|+.||...............
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999987643221 12233467889999998866556899999999999999999999999877654433332221
Q ss_pred HH-----Hhhhh--------hh-hcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MV-----AQQKI--------AY-VLDPKLPE-MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~-----~~~~~--------~~-~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. ....+ .. ...+..+. ......+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 00 00000 00 00010000 000123468899999999999999999999998766443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=351.59 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=207.1
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
.++++++..++|++.+.||+|+||.||+|...+ .+|+|++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 446667778999999999999999999998754 489999865422 2235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 999999999999999999963 234689999999999999999999999 999999999999998 6799999999
Q ss_pred cccccCCCc----cccccccccCcccccccccCC--------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHH
Q 046972 302 LAKLHGPEW----SISTSCELRNSGYLAEELSGR--------TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLID 369 (483)
Q Consensus 302 la~~~~~~~----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~ 369 (483)
+++...... ........|+..|+|||++.. ...++.++|||||||++|||++|+.||...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 987543211 112233468889999999864 23478999999999999999999999987654332211
Q ss_pred HHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 370 WLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .....+... ....+..+.+++.+||..||.+|||+.++++.|+...
T Consensus 255 ----~------~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 255 ----M------GTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp ----H------HTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred ----h------ccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1 111111111 1123357889999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=339.13 Aligned_cols=256 Identities=16% Similarity=0.196 Sum_probs=198.9
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEE-EeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC-VEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+++++.++|++++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 47899999999999999999996 5688999998755432 23588899999999988877776655 67788899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeeccccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLH 306 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla~~~ 306 (483)
|+ +|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 9999999963 235699999999999999999999999 99999999999999 78899999999999866
Q ss_pred CCCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch---hhHHHHHHHHHHh
Q 046972 307 GPEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ---VFLIDWLKSMVAQ 377 (483)
Q Consensus 307 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~ 377 (483)
..... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...... ........... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~ 236 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-S 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-c
Confidence 44322 1223457899999999986554 899999999999999999999999865432 11111111111 0
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... ..... .+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 237 ~~~~-~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 237 TPIE-VLCKG--------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp SCHH-HHTTT--------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred chhh-hhhcc--------CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0000 01111 12689999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=379.09 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=196.9
Q ss_pred ceeccCCceEEEEEEEc---CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLL---DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
+.||+|+||.||+|.+. .++.||||++..... ...++|.+|++++++++|||||++++++.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 457899999976432 335789999999999999999999999964 558899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc--
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-- 311 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-- 311 (483)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999963 35689999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......+|..|+|||++.... ++.++|||||||++|||++ |+.||.+......... ... ......+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-----i~~-----~~~~~~p- 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-----LEK-----GERMGCP- 594 (635)
T ss_dssp --------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHT-----TCCCCCC-
T ss_pred ccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHc-----CCCCCCC-
Confidence 2223345678899999995444 8999999999999999998 9999987665432111 111 1112222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 595 ---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 595 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2344789999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.36 Aligned_cols=277 Identities=17% Similarity=0.173 Sum_probs=202.4
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCe--
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN-- 223 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-- 223 (483)
......++|++.+.||+|+||.||+|... +++.||||++..... ....+.++++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45566789999999999999999999975 588999998865432 23456788888899999999999999976443
Q ss_pred -----EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--hCCCCCeeeecCCCCcEEEcC-CCCc
Q 046972 224 -----RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH--EDIEPKIVHHNMKSSNILLDH-HWNP 295 (483)
Q Consensus 224 -----~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiHrDlkp~NiLl~~-~~~~ 295 (483)
.++||||+++ +|...+.........+++..+..++.||+.||.||| ++ +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999986 666555433345677899999999999999999999 87 9999999999999997 8999
Q ss_pred EEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 296 KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
||+|||+++....... .....||+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+.....
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 9999999987654322 23346799999999986666689999999999999999999999988776555444333211
Q ss_pred Hhh-hhhhhcCCC--------CCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 376 AQQ-KIAYVLDPK--------LPE--------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 376 ~~~-~~~~~~~~~--------~~~--------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
... ......++. ... ......+..+.+|+.+||+.||.+|||+.|++++.+..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000 000000000 000 0111245789999999999999999999999998876553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.93 Aligned_cols=256 Identities=16% Similarity=0.197 Sum_probs=202.3
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEE-EeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC-VEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~E 229 (483)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... .+.+.+|+.+++.++|++++..++++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999996 5788999999866543 24688999999999988877666655 66778899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeeccccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLH 306 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla~~~ 306 (483)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999963 235699999999999999999999999 99999999999999 48889999999999865
Q ss_pred CCCccc------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCch---hhHHHHHHHHHHh
Q 046972 307 GPEWSI------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ---VFLIDWLKSMVAQ 377 (483)
Q Consensus 307 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~ 377 (483)
...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 236 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-
Confidence 443221 123457899999999986554 899999999999999999999999864322 222221111111
Q ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.... ..... ++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 237 ~~~~-~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 237 TPIE-VLCKG--------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp SCHH-HHTTT--------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CchH-HHHhh--------CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 0000 01111 22678999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=358.59 Aligned_cols=260 Identities=14% Similarity=0.076 Sum_probs=185.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHHHHH---HHHhcCCCCcccccc-------cEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFIEKV---EAIGQVKHKNLVKLF-------GYC 218 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnIv~~~-------~~~ 218 (483)
..|.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+ ++|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 34888999999999999999965 688999999987643 2235677784 55555 799987755 455
Q ss_pred EeC-----------------CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHH------HHHHHHHHHHHHHhhhCCCC
Q 046972 219 VEG-----------------QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTR------MKIIQGTAKGLAYLHEDIEP 275 (483)
Q Consensus 219 ~~~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 275 (483)
... ...|+|||||+ |+|.+++... ...+.+..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 433 33799999998 8999999743 123344455 67889999999999999
Q ss_pred CeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCC-CCCCCcchhhHHHHHHHHHHHcC
Q 046972 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGR-TSIFNEKSDVYSFGILIMEIVSG 354 (483)
Q Consensus 276 ~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~el~tg 354 (483)
+|+||||||+|||++.++.+||+|||+|+..+... ....+|+.|+|||++.+ ...++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998764321 13456699999999964 13489999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 355 RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 355 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
+.||....+.... .......................+..+.+++.+||+.||++|||+.+++++.+..+.
T Consensus 290 ~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 290 FLPFGLVTPGIKG------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCSTTBCCTTCTT------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCCcCccccc------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9999866432100 000000000001111111112344789999999999999999999999988765543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=349.44 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=197.9
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCC------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------ 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 222 (483)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999965 578899999976432 33467899999999999999999999997664
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 8988885 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH-------
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV------- 375 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------- 375 (483)
++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ------------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 223357899999999996654 89999999999999999999999987665433322221100
Q ss_pred Hh--hhhhhh--cCCCC--------------CCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 AQ--QKIAYV--LDPKL--------------PEMP--SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ~~--~~~~~~--~~~~~--------------~~~~--~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. ..+... ..+.. +... .......+.+|+.+||..||.+|||+.|++++.+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 000000 00110 0000 1123568899999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=352.94 Aligned_cols=268 Identities=21% Similarity=0.311 Sum_probs=207.1
Q ss_pred HhcCCcccceeccCCceEEEEEEE-----cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCC--e
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVL-----LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ--N 223 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~ 223 (483)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 446788999999999999999984 358899999998766666678999999999999999999999986543 6
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 79999999999999999743 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHH-----HHHH
Q 046972 304 KLHGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLK-----SMVA 376 (483)
Q Consensus 304 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~-----~~~~ 376 (483)
+........ ......++..|+|||.+.+.. ++.++|||||||++|||++|..||...... ...... ....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIV 269 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHHHHCTTCCTHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHHhhccccchhhhH
Confidence 876543221 123345677899999986544 789999999999999999999998532110 000000 0000
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..+...+........+..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 270 -FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000001111111111233457899999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.57 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=202.7
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC----cchHHHHHHHHHHHhcCCCCcccccccEEE--eCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS----VSEEEDFIEKVEAIGQVKHKNLVKLFGYCV--EGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~ 224 (483)
.++|.+.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 57899999986532 234578999999999999999999999984 44678
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++| |.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 87877643 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCc-cccccccccCcccccccccCCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 305 LHGPEW-SISTSCELRNSGYLAEELSGRTS-IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 305 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
...... ........++..|+|||++.+.. .++.++|||||||++|||++|+.||........... . ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----i-~~~---- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----I-GKG---- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----H-HHC----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----H-hcC----
Confidence 654321 22223456899999999986432 247899999999999999999999986554322111 1 111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
....+. .++..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 229 --~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 268 (305)
T 2wtk_C 229 --SYAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268 (305)
T ss_dssp --CCCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred --CCCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 112222 2336788999999999999999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=343.66 Aligned_cols=269 Identities=20% Similarity=0.244 Sum_probs=204.9
Q ss_pred hcCCcccceeccCCceEEEEEEE--cCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcC---CCCcccccccEEE-----
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL--LDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQV---KHKNLVKLFGYCV----- 219 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~----- 219 (483)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 47799999999999999999997 35788999998643221 123566777766655 8999999999987
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
.....++||||++ |+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6999999753 234589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.........
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998654322 233457889999999986554 899999999999999999999999877655443333222110000
Q ss_pred hhh---------hcCC---CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 IAY---------VLDP---KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~---------~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... .... ..........+..+.+++.+||+.||.+|||+.+++++.+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 000 0000 0000011223467889999999999999999999998765543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=346.20 Aligned_cols=271 Identities=21% Similarity=0.333 Sum_probs=197.3
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHH--HhcCCCCcccccccEEEe-----CC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEA--IGQVKHKNLVKLFGYCVE-----GQ 222 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~-----~~ 222 (483)
+..++|++.+.||+|+||.||+|+. +++.||+|++... ....+..|.++ +..++||||+++++++.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3457899999999999999999987 6789999998643 33445555554 455899999999986643 23
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------CCCeeeecCCCCcEEEcCCCCcE
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI------EPKIVHHNMKSSNILLDHHWNPK 296 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiHrDlkp~NiLl~~~~~~k 296 (483)
..++||||+++|+|.+++.. ...++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 56899999999999999953 34588999999999999999999862 23899999999999999999999
Q ss_pred EeecccccccCCCc-------cccccccccCcccccccccCCC------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 046972 297 ISDVGLAKLHGPEW-------SISTSCELRNSGYLAEELSGRT------SIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363 (483)
Q Consensus 297 l~DFGla~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~ 363 (483)
|+|||+++...... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654321 1122234689999999998652 2366789999999999999999776643221
Q ss_pred h-hhHHHHHHH--------HHHhhhhhhhcCCCCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 364 Q-VFLIDWLKS--------MVAQQKIAYVLDPKLPEM--PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 364 ~-~~~~~~~~~--------~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .....+... ............+.++.. ....++..+.+++.+||+.||++|||+.++++.|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1 000000000 000000011112233322 12346678999999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=349.47 Aligned_cols=254 Identities=13% Similarity=0.145 Sum_probs=202.1
Q ss_pred HHHHhcCCcccceeccCCceEEEEEE------EcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC---CCcccccccEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAV------LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK---HKNLVKLFGYC 218 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~ 218 (483)
+++..++|.+.+.||+|+||+||+|. ..+++.||+|++... ...++..|++++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34556789999999999999999994 456889999999755 3456788888888886 99999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC------
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLG-EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH------ 291 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~------ 291 (483)
...+..++|||||++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999964322 356799999999999999999999999 9999999999999998
Q ss_pred -----CCCcEEeecccccccCC-CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh
Q 046972 292 -----HWNPKISDVGLAKLHGP-EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV 365 (483)
Q Consensus 292 -----~~~~kl~DFGla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~ 365 (483)
++.+||+|||+|+.... ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999975431 1122334457899999999996655 8999999999999999999999996433211
Q ss_pred hHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHhccc
Q 046972 366 FLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHR-PKMGDVLRMLEP 427 (483)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-pt~~eil~~L~~ 427 (483)
......++..+. ...+.+++.+||+.+|.+| |++.++.+.|+.
T Consensus 293 ----------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ----------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ----------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ----------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 011122222222 3466778889999999999 567777766654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=339.23 Aligned_cols=268 Identities=16% Similarity=0.227 Sum_probs=208.4
Q ss_pred HHhcCCcccceeccCCceEEEEEEE--cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCC------cccccccEEEeC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVL--LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK------NLVKLFGYCVEG 221 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~ 221 (483)
+..++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+++++.++|+ +|+++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4457899999999999999999986 35788999998643 23346788999999888665 499999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC----------
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---------- 291 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---------- 291 (483)
+..++||||+ +++|.+++... ...++++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 88999999653 234689999999999999999999999 9999999999999987
Q ss_pred ---------CCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 046972 292 ---------HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362 (483)
Q Consensus 292 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~ 362 (483)
++.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999865432 23347899999999986554 8999999999999999999999998766
Q ss_pred chhhHHHHHHHHHH-------hhh---------------------hhhhcCCC-CCCCCCHHHHHHHHHHHHHccCCCCC
Q 046972 363 PQVFLIDWLKSMVA-------QQK---------------------IAYVLDPK-LPEMPSRKELKRIILIALRCVDPDIK 413 (483)
Q Consensus 363 ~~~~~~~~~~~~~~-------~~~---------------------~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~ 413 (483)
.......+...... ... ......+. ........+...+.+++.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 54433222111000 000 00000000 00112335567899999999999999
Q ss_pred CCCCHHHHHHhccccc
Q 046972 414 HRPKMGDVLRMLEPRD 429 (483)
Q Consensus 414 ~Rpt~~eil~~L~~~~ 429 (483)
+|||+.|++++.+...
T Consensus 319 ~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 319 KRITLREALKHPFFDL 334 (339)
T ss_dssp TSCCHHHHTTSGGGGG
T ss_pred cccCHHHHhcCHHHHH
Confidence 9999999998876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.99 Aligned_cols=269 Identities=18% Similarity=0.220 Sum_probs=206.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC-----CeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 224 (483)
.++|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999975 588899999965432 3346788999999999999999999988754 678
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599999853 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccc---------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 305 LHGPEWSI---------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 305 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
........ ......||+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 66432211 112346799999999876555689999999999999999999999987765433322221100
Q ss_pred Hhh-----------hhhh-hc-CCCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 376 AQQ-----------KIAY-VL-DPKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 376 ~~~-----------~~~~-~~-~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... .... .. .+..+... ....+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 0000 00 00001000 0123467889999999999999999999999876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=349.38 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=204.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeE----
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR---- 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~---- 224 (483)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 367999999999999999999965 5889999999765333 246789999999999999999999999877655
Q ss_pred --EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 225 --ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 225 --~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
++||||+. |+|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 69998873 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-----
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ----- 377 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 377 (483)
++..... .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 9865432 2334679999999998765568999999999999999999999998776554443332211000
Q ss_pred ---------hhhhhhcCCCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 ---------QKIAYVLDPKLPEMP----SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 ---------~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...... +..+... ....+..+.+|+.+||+.||++|||+.|++++.+...
T Consensus 267 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 267 QKLNDKAAKSYIQSL--PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp TTCSCHHHHHHHHHS--CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHhhhhhhhhhhhcc--CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 000000 0000000 0122468899999999999999999999999887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.01 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=195.9
Q ss_pred hcCCcccceeccCCceEEEEEEEcC--Cc--EEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD--NM--RAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~--~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||+|+||+||+|.+.. +. .||+|++.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4678999999999999999998532 22 58999987542 234468999999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999643 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccc--cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 305 LHGPEWSI--STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
........ ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||............ ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~---- 240 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----DKE---- 240 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTS----
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH----Hcc----
Confidence 76543221 223345677899999985444 7899999999999999999 99999876543322111 100
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
..... ....++..+.+++.+||+.||.+|||+.++++.|...
T Consensus 241 -~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 241 -GERLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -CCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 00111 1223447899999999999999999999999988643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.24 Aligned_cols=264 Identities=19% Similarity=0.320 Sum_probs=204.5
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--chHHHHHHHHHHHhcCC--CCcccccccEEE
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVK--HKNLVKLFGYCV 219 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~ 219 (483)
..+.+.+..++|++.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|++++.+++ ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 34455566788999999999999999999988899999999975432 34478899999999997 599999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
..+..++||| +.+++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||+++ +.+||+|
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 9999999999 568899999964 35789999999999999999999999 9999999999999965 7899999
Q ss_pred cccccccCCCccc-cccccccCcccccccccCC----------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHH
Q 046972 300 VGLAKLHGPEWSI-STSCELRNSGYLAEELSGR----------TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI 368 (483)
Q Consensus 300 FGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~ 368 (483)
||+++........ ......|++.|+|||.+.. ...++.++|||||||++|||++|+.||.........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~- 248 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 248 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-
Confidence 9999866443221 2234468999999999854 134889999999999999999999999765443211
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 369 DWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... .........+... +..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 249 --~~~~-----~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 249 --LHAI-----IDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp --HHHH-----HCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --HHHH-----HhcccccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 1111 1111112222222 36788999999999999999999999877543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=373.86 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=206.6
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeC
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG 221 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 221 (483)
+.++..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ...+.|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344556789999999999999999999753 45689999876433 33478999999999999999999999984 5
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+..++||||+++|+|.++++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 668999999999999999964 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
+++..............+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+ ..
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i----~~---- 607 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN---- 607 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HH----
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----Hc----
Confidence 9987655433334445677899999998544 48999999999999999997 99999876554322111 11
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
......+ ..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 608 --~~~~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 608 --GERLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111122 23346889999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=347.15 Aligned_cols=274 Identities=19% Similarity=0.199 Sum_probs=208.6
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CC-----cccccccEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HK-----NLVKLFGYC 218 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~~~~ 218 (483)
...+...++|++.+.||+|+||+||+|... +++.||||++... ......+..|++++..++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 334455688999999999999999999965 5778999998643 223456778888888774 44 599999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc--CCCCcE
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD--HHWNPK 296 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~--~~~~~k 296 (483)
...+..++||||++ |+|.+++... ....+++..++.++.||+.||.|||++ ..+|+||||||+|||++ .++.+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999996 5999999753 235689999999999999999999952 12999999999999995 477899
Q ss_pred EeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH
Q 046972 297 ISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376 (483)
Q Consensus 297 l~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 376 (483)
|+|||+++..+.. .....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+......
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876432 23457899999999996654 899999999999999999999999887765544443322110
Q ss_pred hhh------------hhhhcCC------------CC--C-----------------------CCCCHHHHHHHHHHHHHc
Q 046972 377 QQK------------IAYVLDP------------KL--P-----------------------EMPSRKELKRIILIALRC 407 (483)
Q Consensus 377 ~~~------------~~~~~~~------------~~--~-----------------------~~~~~~~~~~l~~l~~~c 407 (483)
... +..+.+. .. + ......+...+.+|+.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 000 0000000 00 0 001122345789999999
Q ss_pred cCCCCCCCCCHHHHHHhccccc
Q 046972 408 VDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 408 l~~dP~~Rpt~~eil~~L~~~~ 429 (483)
|+.||++|||+.|++++.+...
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC
T ss_pred cCCChhhCCCHHHHhcCccccc
Confidence 9999999999999999876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=336.51 Aligned_cols=257 Identities=22% Similarity=0.290 Sum_probs=207.0
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999999975 68899999986542 234578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC---CCcEEeeccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH---WNPKISDVGL 302 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DFGl 302 (483)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999998632 4689999999999999999999999 99999999999999754 4699999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
+........ .....+++.|+|||.+.+. ++.++|||||||++|+|++|..||........... .. ...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~--- 238 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VE-TGK--- 238 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCC---
T ss_pred ceeecCCCc--cccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-cCC---
Confidence 986544321 2233578899999998543 89999999999999999999999987654332211 11 111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.....+ .....+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 239 -~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 239 -YAFDLP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp -CCCCSG--GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred -CCCCch--hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 000111 111234688999999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.73 Aligned_cols=268 Identities=21% Similarity=0.285 Sum_probs=204.7
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC--------CCcccccccEEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK--------HKNLVKLFGYCV 219 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~ 219 (483)
++..++|++.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 344678999999999999999999964 5788999998644 234467899999999885 888999999987
Q ss_pred ----eCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC--
Q 046972 220 ----EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-- 293 (483)
Q Consensus 220 ----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-- 293 (483)
.....++||||+ +|+|.+++... ....+++..++.++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 556789999999 56777777532 3356999999999999999999999852 899999999999999775
Q ss_pred -----------------------------------------------CcEEeecccccccCCCccccccccccCcccccc
Q 046972 294 -----------------------------------------------NPKISDVGLAKLHGPEWSISTSCELRNSGYLAE 326 (483)
Q Consensus 294 -----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aP 326 (483)
.+||+|||+++..... .....||+.|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aP 262 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCC
Confidence 7999999999865432 2334789999999
Q ss_pred cccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhH--HHHHHHHHH---h--------hhhh-hhcCC------
Q 046972 327 ELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL--IDWLKSMVA---Q--------QKIA-YVLDP------ 386 (483)
Q Consensus 327 E~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~---~--------~~~~-~~~~~------ 386 (483)
|++.+.. ++.++|||||||++|||++|+.||......... ...+..... . .... .....
T Consensus 263 E~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 263 EVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred hhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 9986655 899999999999999999999999865532211 011111000 0 0000 00000
Q ss_pred --CC-----------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 --KL-----------PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 --~~-----------~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.. ...........+.+|+.+||+.||++|||+.|++++.+.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 00 001245667889999999999999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=341.78 Aligned_cols=263 Identities=18% Similarity=0.233 Sum_probs=203.8
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCe-----
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN----- 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 223 (483)
.++|.+.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367899999999999999999975 5889999999765332 24678999999999999999999999987654
Q ss_pred -EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 224 -RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 224 -~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
.++||||+. |+|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58888773 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-----
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ----- 377 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 377 (483)
++..... .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 2334678999999998764568999999999999999999999998776544333322211000
Q ss_pred ---------hhhhhh---cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 ---------QKIAYV---LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 ---------~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
..+... ..+.+.. .....+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000000 0011111 11233478899999999999999999999999877543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=342.11 Aligned_cols=257 Identities=17% Similarity=0.241 Sum_probs=176.3
Q ss_pred hcCCcccc-eeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEe----CCeEE
Q 046972 152 TDGFAEQN-VIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNRI 225 (483)
Q Consensus 152 ~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 225 (483)
.++|.+.+ .||+|+||.||+|... +++.||+|++... .....+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788854 6999999999999976 5889999998653 1222223334566799999999999976 45589
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeeccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVGL 302 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFGl 302 (483)
+||||+++|+|.+++... ....+++.+++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999753 235799999999999999999999999 9999999999999976 45599999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
++..... ......+|+.|+|||++.... ++.++|||||||++|+|++|+.||................ .
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~------ 246 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-R------ 246 (336)
T ss_dssp CEEC-------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh-h------
Confidence 9865432 223346789999999985444 8899999999999999999999997655432211111100 0
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
......+.......+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 0011112112223447889999999999999999999999977653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=344.24 Aligned_cols=260 Identities=18% Similarity=0.270 Sum_probs=208.6
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCC--CCcccccc
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVK--HKNLVKLF 215 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~ 215 (483)
..+.+...++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++++++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3455667789999999999999999999964 6788999998654221 2245778999999996 59999999
Q ss_pred cEEEeCCeEEEEEEecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-CCC
Q 046972 216 GYCVEGQNRILVYEYIDN-GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-HHW 293 (483)
Q Consensus 216 ~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~-~~~ 293 (483)
+++...+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++ .++
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCC
Confidence 999999999999999976 899999964 35689999999999999999999999 999999999999999 788
Q ss_pred CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
.+||+|||+++...... .....||+.|+|||++.+...++.++|||||||++|||++|+.||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 99999999998765432 23346899999999986555457899999999999999999999964211
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhhHH
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~~~ 435 (483)
... . ....+.. .+..+.+++.+||+.||++|||+.+++++.+..+......
T Consensus 255 ~~~-~------~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~ 305 (320)
T 3a99_A 255 IIR-G------QVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305 (320)
T ss_dssp HHH-C------CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred hhc-c------ccccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccc
Confidence 000 0 0111222 2367889999999999999999999999887766655544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.01 Aligned_cols=258 Identities=16% Similarity=0.204 Sum_probs=203.2
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC-CcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH-KNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~E 229 (483)
.++|++.++||+|+||.||+|.. .+++.||||++..... ...+..|+++++.++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999996 4688999998765433 2358899999999976 566666677788889999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE---cCCCCcEEeeccccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL---DHHWNPKISDVGLAKLH 306 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DFGla~~~ 306 (483)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999963 245699999999999999999999999 99999999999999 68899999999999866
Q ss_pred CCCccc------cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHH--HHHHHHHHhh
Q 046972 307 GPEWSI------STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI--DWLKSMVAQQ 378 (483)
Q Consensus 307 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~~ 378 (483)
...... ......||..|+|||++.+.. ++.++|||||||+||||++|+.||.+........ ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 443221 122457899999999986554 8999999999999999999999998755432211 1111111111
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+..+. . .++.++.+++.+||+.||++||++.+|++.|+..
T Consensus 236 ~~~~l~-~--------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 SIEALC-R--------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CHHHHH-T--------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHh-c--------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111 1 1226899999999999999999999999988653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.47 Aligned_cols=269 Identities=16% Similarity=0.219 Sum_probs=207.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-C-cEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc------ccccccEEEeC
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-N-MRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN------LVKLFGYCVEG 221 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~ 221 (483)
+..++|++.+.||+|+||.||+|.... + ..||+|++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 345789999999999999999999753 3 68999998643 234567888999999987665 89999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEE------------
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILL------------ 289 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl------------ 289 (483)
+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 66888887543 335689999999999999999999999 99999999999999
Q ss_pred -------cCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 046972 290 -------DHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQ 362 (483)
Q Consensus 290 -------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~ 362 (483)
+.++.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999864432 23347899999999996554 8999999999999999999999998766
Q ss_pred chhhHHHHHHHHHH-------hhh-hhh--------------------hcCCC-CCCCCCHHHHHHHHHHHHHccCCCCC
Q 046972 363 PQVFLIDWLKSMVA-------QQK-IAY--------------------VLDPK-LPEMPSRKELKRIILIALRCVDPDIK 413 (483)
Q Consensus 363 ~~~~~~~~~~~~~~-------~~~-~~~--------------------~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~ 413 (483)
.......+...... ... ... ...+. ............+.+|+.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 54333222111000 000 000 00000 00012234456899999999999999
Q ss_pred CCCCHHHHHHhccccch
Q 046972 414 HRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 414 ~Rpt~~eil~~L~~~~~ 430 (483)
+|||+.+++++.+....
T Consensus 324 ~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 324 QRITLAEALLHPFFAGL 340 (355)
T ss_dssp TSCCHHHHTTSGGGGGC
T ss_pred hCcCHHHHhcChhhcCC
Confidence 99999999988776553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=349.65 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=195.1
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998877778999999998653 345678999999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCC---CCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC-------------CCc
Q 046972 232 DNGNLQQWLHGSLGEAKP---LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH-------------WNP 295 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~-------------~~~ 295 (483)
. |+|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999753221111 13335678999999999999999 99999999999999754 479
Q ss_pred EEeecccccccCCCccc---cccccccCcccccccccCC------CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchh
Q 046972 296 KISDVGLAKLHGPEWSI---STSCELRNSGYLAEELSGR------TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQV 365 (483)
Q Consensus 296 kl~DFGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~ 365 (483)
||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 2234578999999999854 2448999999999999999999 999997554322
Q ss_pred hHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 366 FLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
. .+. . .. ...+..+.......+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus 248 ~--~i~----~-~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 S--NII----R-GI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHH----H-TC---CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHh----c-CC---CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1 110 0 00 01122233334567788999999999999999999999999876644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=338.49 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=186.9
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHH-HHhcCCCCcccccccEEEeCCeEE
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVE-AIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
++..++|.+.+.||+|+||.||+|... +++.||+|++..... .....+..|+. +++.++||||+++++++...+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 345578999999999999999999975 688999999976533 23345666666 778889999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 226 LVYEYIDNGNLQQWLHGS-LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
+||||+++ +|.+++... ......+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999985 888887521 11356789999999999999999999985 389999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccC---CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSG---RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
...... ......||..|+|||++. ....++.++|||||||++|||++|+.||......... ...+.
T Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~~~~~ 243 (327)
T 3aln_A 175 QLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------LTQVV 243 (327)
T ss_dssp C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCC
T ss_pred eccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------HHHHh
Confidence 654332 122336889999999983 2334899999999999999999999999764321100 00111
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+.++.......+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 1111222221222344789999999999999999999999986654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.34 Aligned_cols=257 Identities=22% Similarity=0.255 Sum_probs=194.2
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
..+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++.+ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568888999999999977666678899999999765432 356899999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-----CCCcEEeecccccc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-----HWNPKISDVGLAKL 305 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-----~~~~kl~DFGla~~ 305 (483)
|. |+|.+++... ...+.+..++.++.||+.||.|||++ +|+||||||+|||++. ...+||+|||+|+.
T Consensus 100 ~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 5999999743 23344456778999999999999999 9999999999999953 33578999999987
Q ss_pred cCCCcc--ccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 306 HGPEWS--ISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 306 ~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
...... .......||+.|+|||++.+ ...++.++|||||||++|||++ |..||......... . .
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-----~------~ 241 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-----I------L 241 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-----H------H
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-----H------H
Confidence 653321 22334578999999999863 3347889999999999999999 99999654432110 0 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccch
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~ 430 (483)
....... ...+.......+.+++.+||+.||.+|||+.+++++.+....
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 242 LGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TTCCCCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred hccCCcc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 0000111 111223445668899999999999999999999998876543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.06 Aligned_cols=267 Identities=18% Similarity=0.254 Sum_probs=201.9
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-----------CCcccccccEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-----------HKNLVKLFGYCV 219 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~ 219 (483)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999996 46889999998643 234467889999988876 899999999998
Q ss_pred eCC----eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-----
Q 046972 220 EGQ----NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD----- 290 (483)
Q Consensus 220 ~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~----- 290 (483)
..+ ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 88999999753 2355899999999999999999999942 899999999999994
Q ss_pred -CCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh----
Q 046972 291 -HHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV---- 365 (483)
Q Consensus 291 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~---- 365 (483)
..+.+||+|||+++..... .....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999865432 23347899999999986554 8999999999999999999999998654321
Q ss_pred --hHHHHHHHHH-------Hhhhh-hhhcCC--------C-----------CCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 046972 366 --FLIDWLKSMV-------AQQKI-AYVLDP--------K-----------LPEMPSRKELKRIILIALRCVDPDIKHRP 416 (483)
Q Consensus 366 --~~~~~~~~~~-------~~~~~-~~~~~~--------~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 416 (483)
.+..+..... ..... ....+. . .....+...+..+.+|+.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111111000 00000 000000 0 00113456778999999999999999999
Q ss_pred CHHHHHHhccccc
Q 046972 417 KMGDVLRMLEPRD 429 (483)
Q Consensus 417 t~~eil~~L~~~~ 429 (483)
|+.|++++.+..+
T Consensus 327 t~~ell~hp~f~~ 339 (373)
T 1q8y_A 327 DAGGLVNHPWLKD 339 (373)
T ss_dssp CHHHHHTCGGGTT
T ss_pred CHHHHhhChhhhc
Confidence 9999999887654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=336.90 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=195.6
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc------hHHHHHHHHHHHhcC----CCCcccccc
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQV----KHKNLVKLF 215 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~~~ 215 (483)
+.+...++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4456678899999999999999999985 46789999999765332 223466788888888 899999999
Q ss_pred cEEEeCCeEEEEEEe-cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc-CCC
Q 046972 216 GYCVEGQNRILVYEY-IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD-HHW 293 (483)
Q Consensus 216 ~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~-~~~ 293 (483)
+++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999964 34689999999999999999999999 999999999999999 889
Q ss_pred CcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH
Q 046972 294 NPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 294 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 373 (483)
.+||+|||+++...... .....++..|+|||++.+....+.++|||||||++|||++|+.||.....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence 99999999998765432 23346889999999986555345699999999999999999999964211
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... . ...++. .....+.+++.+||+.||++|||+.+++++.+...
T Consensus 245 ~~~-~------~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 245 ILE-A------ELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp HHH-T------CCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred Hhh-h------ccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 000 0 111222 23367889999999999999999999999877554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.82 Aligned_cols=257 Identities=19% Similarity=0.295 Sum_probs=185.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch-H-HHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE-E-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
..++|++.+.||+|+||.||+|... +++.||+|++....... . +.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467899999999999999999975 68899999997654322 2 3344555678888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||+ ++.+..+... ....+++..++.++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 5566665542 23568999999999999999999998 6 8999999999999999999999999999765
Q ss_pred CCCccccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 307 GPEWSISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
.... ......+++.|+|||++. ....++.++|||||||++|||++|+.||.......... ......
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~----- 245 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL---TKVLQE----- 245 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---HHHHHS-----
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH---HHHhcc-----
Confidence 4322 122346889999999984 23347899999999999999999999998654432211 111111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.++. ....+..+.+++.+||+.||.+|||+.+++++...
T Consensus 246 -~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 246 -EPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp -CCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred -CCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 1122221 11233678899999999999999999999987654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=322.78 Aligned_cols=231 Identities=12% Similarity=0.107 Sum_probs=184.7
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcC-CcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+..++|++.+.||+|+||.||+|.... ++.||+|++...... ..+.|.+|+.++.+++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 345679999999999999999999764 889999999765432 2367999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+||||++|++|.++++. . ....++..++.||+.||.|||++ +|+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 99999999999999942 2 35567889999999999999999 99999999999999999999998554
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
|++ .++.++|||||||++|||++|+.||.+........ .......
T Consensus 175 -----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------~~~~~~~ 219 (286)
T 3uqc_A 175 -----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------PAERDTA 219 (286)
T ss_dssp -----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE----------ECCBCTT
T ss_pred -----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH----------HHHHHhc
Confidence 222 16889999999999999999999998765421100 0000000
Q ss_pred CCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 386 PKLP--EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 386 ~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
...+ .......+..+.+++.+||+.||.+| |+.++++.|....
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0000 00111234678999999999999999 9999999997543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.13 Aligned_cols=267 Identities=19% Similarity=0.194 Sum_probs=200.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEe------CCe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE------GQN 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~ 223 (483)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999964 5889999998765 33345679999999999999999999998755 677
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC---cEEeec
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN---PKISDV 300 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DF 300 (483)
.++||||++||+|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997542 334688999999999999999999999 9999999999999997765 899999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHH-HHHhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS-MVAQQK 379 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~ 379 (483)
|++....... ......||..|+|||++.+. .++.++|||||||++|||++|..||............... ......
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccc--ccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9998765432 22335789999999998654 4899999999999999999999999764322110000000 000000
Q ss_pred hhhh--------cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhc
Q 046972 380 IAYV--------LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425 (483)
Q Consensus 380 ~~~~--------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L 425 (483)
.... .....+.......+..+.+++.+||..||++|||+.+++++.
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp 299 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence 0000 011122234455778999999999999999999998866444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=317.51 Aligned_cols=231 Identities=17% Similarity=0.270 Sum_probs=180.8
Q ss_pred cCCccc-ceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHH-hcCCCCcccccccEEEe----CCeEE
Q 046972 153 DGFAEQ-NVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAI-GQVKHKNLVKLFGYCVE----GQNRI 225 (483)
Q Consensus 153 ~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~~~~~ 225 (483)
++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 7899999999999996 4678999999853 24577888887 56699999999999987 67789
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeeccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVGL 302 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFGl 302 (483)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999753 335699999999999999999999999 9999999999999998 78899999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
+.... ...++.++|||||||++|||++|+.||......... ......
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------~~~~~~ 213 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------PGMKTR 213 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCS
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------HHHHHH
Confidence 86432 122678999999999999999999999755432110 000001
Q ss_pred hcCCCCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPS---RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
......+ .+. ...+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 214 IRMGQYE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp SCTTCCS-SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred Hhhcccc-CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 1111111 010 1234789999999999999999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=355.29 Aligned_cols=238 Identities=20% Similarity=0.292 Sum_probs=192.8
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc--CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCe---
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL--DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN--- 223 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--- 223 (483)
+..++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++|||||++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 44588999999999999999999975 588999999865432 344678999999999999999999999987665
Q ss_pred --EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 224 --RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 224 --~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
.|+||||++|++|.+++. ..+++.+++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred ceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 799999999999999874 2689999999999999999999999 99999999999999986 89999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|..||.+....
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------- 282 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------- 282 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------
Confidence 99876443 344689999999998544 589999999999999999999888642110
Q ss_pred hhcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHH-HHHhcc
Q 046972 382 YVLDPKLP-EMPSRKELKRIILIALRCVDPDIKHRPKMGD-VLRMLE 426 (483)
Q Consensus 382 ~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e-il~~L~ 426 (483)
.++ ..+.......+.+++.+||+.||.+||+..+ +.+.|.
T Consensus 283 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 283 -----GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -----SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 011 1111223367889999999999999996554 444443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=327.04 Aligned_cols=247 Identities=15% Similarity=0.172 Sum_probs=186.9
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc--------chHHHHHHHHHHHhcCC---------C----
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV--------SEEEDFIEKVEAIGQVK---------H---- 208 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h---- 208 (483)
+..++|++.+.||+|+||+||+|+. +++.||+|++..... ...+.+.+|+.+++.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456788999999999999999998 678999999976532 22367889999888875 4
Q ss_pred -------------CcccccccEEEe-------------CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 046972 209 -------------KNLVKLFGYCVE-------------GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262 (483)
Q Consensus 209 -------------pnIv~~~~~~~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i 262 (483)
|||+++++++.+ .+..|+|||||++|++.+.+. ...+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence 555555555443 688999999999998777763 2568999999999999
Q ss_pred HHHHHHhh-hCCCCCeeeecCCCCcEEEcCCC--------------------CcEEeecccccccCCCccccccccccCc
Q 046972 263 AKGLAYLH-EDIEPKIVHHNMKSSNILLDHHW--------------------NPKISDVGLAKLHGPEWSISTSCELRNS 321 (483)
Q Consensus 263 ~~~l~~LH-~~~~~~iiHrDlkp~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~ 321 (483)
+.||.||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 88 999999999999999887 8999999999865432 347899
Q ss_pred ccccccccCCCCCCCcchhhHHHHHH-HHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh-hcCCCCCCCCCHHHHHH
Q 046972 322 GYLAEELSGRTSIFNEKSDVYSFGIL-IMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY-VLDPKLPEMPSRKELKR 399 (483)
Q Consensus 322 ~y~aPE~~~~~~~~~~~~DvwSlGv~-l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 399 (483)
.|+|||++.+.. +.++||||||++ .+++++|..||... .|..... ...... ......+.......+.+
T Consensus 242 ~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 242 VSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLT-DKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp CTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHH-HHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcch-------hhhhHHH-HhhhhhhccCcccchhhhhhcCHH
Confidence 999999996553 889999998777 77788899998421 0111110 011111 11111111123456789
Q ss_pred HHHHHHHccCCCCCCCCCHHHHH-Hhcc
Q 046972 400 IILIALRCVDPDIKHRPKMGDVL-RMLE 426 (483)
Q Consensus 400 l~~l~~~cl~~dP~~Rpt~~eil-~~L~ 426 (483)
+.+|+.+||+.| |+.|++ ++.+
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred HHHHHHHHhccC-----CHHHHHhcCCC
Confidence 999999999987 999999 7754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.85 Aligned_cols=250 Identities=14% Similarity=0.139 Sum_probs=186.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCC-Cccccccc----------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKH-KNLVKLFG---------- 216 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h-pnIv~~~~---------- 216 (483)
...|...+.||+|+||.||+|.+. +++.||||++....... .+.|.+|+.+++.++| +|...+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777899999999999999954 58899999987443222 4679999999999976 32221111
Q ss_pred -----------EEEe-----CCeEEEEEEecCCCCHHHHHhc---ccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 046972 217 -----------YCVE-----GQNRILVYEYIDNGNLQQWLHG---SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277 (483)
Q Consensus 217 -----------~~~~-----~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 277 (483)
++.. ....+++|+++ +++|.++++. .......+++..++.++.||+.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111 12356777776 6799999841 112345688889999999999999999999 99
Q ss_pred eeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccC---------CCCCCCcchhhHHHHHHH
Q 046972 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG---------RTSIFNEKSDVYSFGILI 348 (483)
Q Consensus 278 iHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwSlGv~l 348 (483)
+||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||++. ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865433 333456 8999999983 233378899999999999
Q ss_pred HHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 349 MEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 349 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
|||++|+.||........ ....+.. .+ ..+..+.+++.+||+.||++|||+.+++++.+..
T Consensus 308 ~elltg~~Pf~~~~~~~~-------------~~~~~~~-~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-------------SEWIFRS-CK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-------------SGGGGSS-CC-----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHCCCCCCCcchhhh-------------HHHHHhh-cc-----cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 999999999976543221 1111111 11 1126789999999999999999999998865543
Q ss_pred c
Q 046972 429 D 429 (483)
Q Consensus 429 ~ 429 (483)
.
T Consensus 369 ~ 369 (413)
T 3dzo_A 369 Q 369 (413)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-33 Score=292.60 Aligned_cols=185 Identities=13% Similarity=0.090 Sum_probs=130.3
Q ss_pred eeccCCceEEEEEE-EcCCcEEEEEEecCCCc----------chHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEEE
Q 046972 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV----------SEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 160 ~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 227 (483)
..+.|++|.+..++ ...|+.+++|.+..... ...++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777766655 44578899999965421 1225799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++||+|.++|.. ..+++.. .|+.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999963 3556654 5789999999999999 99999999999999999999999999998765
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP 357 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~P 357 (483)
.... .....+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 4322 23345799999999998654 67889999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=259.41 Aligned_cols=186 Identities=16% Similarity=0.232 Sum_probs=145.9
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEecCCCcch--------HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE--------EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
...+.||+|+||.||+|.. .+..+++|......... .+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3356899999999999954 56778888765432211 24589999999999999999777777788888999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
|||++||+|.+++.. +..++.||+.||.|||++ +|+||||||+|||++. .+||+|||+|+...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999952 468999999999999999 9999999999999999 99999999999876
Q ss_pred CCcccc------ccccccCcccccccccCCC-CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046972 308 PEWSIS------TSCELRNSGYLAEELSGRT-SIFNEKSDVYSFGILIMEIVSGRLPVD 359 (483)
Q Consensus 308 ~~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~el~tg~~Pf~ 359 (483)
...... .....||+.|+|||++... ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532211 2345789999999998541 237888999999999999888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=213.31 Aligned_cols=147 Identities=13% Similarity=0.085 Sum_probs=119.9
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCc------------------chHHHHHHHHHHHhcCCCCccc
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSV------------------SEEEDFIEKVEAIGQVKHKNLV 212 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv 212 (483)
....|.+.+.||+|+||.||+|...+++.||+|.+..... .....+.+|+.+++.++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 3456777899999999999999997799999999964321 13457899999999999 5 7
Q ss_pred ccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC
Q 046972 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH 292 (483)
Q Consensus 213 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~ 292 (483)
++.+++.. +..++||||++||+|.+ +. . .....++.||+.||.|||++ +|+||||||+|||++ +
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 77776544 55699999999999988 52 1 12457999999999999999 999999999999999 9
Q ss_pred CCcEEeecccccccCCCccccccccccCcccccccccC
Q 046972 293 WNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330 (483)
Q Consensus 293 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~ 330 (483)
+.+||+|||+|+. +..+.|||++.
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999999999863 33478888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=184.46 Aligned_cols=136 Identities=20% Similarity=0.208 Sum_probs=106.8
Q ss_pred CcccceeccCCceEEEEEEE-cCCcE--EEEEEecCCCcc------------------------hHHHHHHHHHHHhcCC
Q 046972 155 FAEQNVIASGDNGVVYRAVL-LDNMR--AAVKLLMSNSVS------------------------EEEDFIEKVEAIGQVK 207 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 207 (483)
|.+.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+.++..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999997 67888 999987543211 1136889999999998
Q ss_pred CCcc--cccccEEEeCCeEEEEEEecCC-C----CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeee
Q 046972 208 HKNL--VKLFGYCVEGQNRILVYEYIDN-G----NLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH-EDIEPKIVH 279 (483)
Q Consensus 208 hpnI--v~~~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH 279 (483)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8764 333332 356899999942 4 77776532 224467789999999999999 88 9999
Q ss_pred ecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 280 HNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 280 rDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-19 Score=173.81 Aligned_cols=137 Identities=11% Similarity=0.113 Sum_probs=97.8
Q ss_pred CCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--------------hHHHH--------HHHHHHHhcCCCCcc
Q 046972 154 GFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--------------EEEDF--------IEKVEAIGQVKHKNL 211 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~E~~~l~~l~hpnI 211 (483)
-|.+.+.||.|+||.||+|...+|+.||||++...... ..... ..|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38999999999999999999889999999987542110 01122 234455555533332
Q ss_pred cccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC
Q 046972 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH 291 (483)
Q Consensus 212 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~ 291 (483)
.-..-+.. ...+|||||++|++|..+.. . .....++.||+.+|.|||+. |||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 21111111 12379999999998866432 1 13456889999999999998 9999999999999988
Q ss_pred CCC----------cEEeecccccc
Q 046972 292 HWN----------PKISDVGLAKL 305 (483)
Q Consensus 292 ~~~----------~kl~DFGla~~ 305 (483)
++. +.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 763 78999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4.2e-13 Score=126.84 Aligned_cols=143 Identities=15% Similarity=0.083 Sum_probs=112.2
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++...++.|+++.||++.. +++.+++|............+.+|+++++.+. +..+.++++++...+..|+||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 45788888899999999999975 46789999986532122345888999998884 67888999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-------------------------------------
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI------------------------------------- 273 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 273 (483)
++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 92 ADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred cCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999988641 11123467889999999999810
Q ss_pred -------------------CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 274 -------------------EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 274 -------------------~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=8.7e-12 Score=117.26 Aligned_cols=135 Identities=13% Similarity=0.120 Sum_probs=98.5
Q ss_pred CcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc--ccccccEEEeCCeEEEEEEecC
Q 046972 155 FAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN--LVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 155 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~E~~~ 232 (483)
+.+....+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 3333333456669999998767788999997654 2245778888888885434 5668888888888999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------------
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI--------------------------------------- 273 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 273 (483)
|.+|. .. . .. ...++.+++..|..||+..
T Consensus 99 G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98884 21 1 11 2256777888888888741
Q ss_pred ----------------CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 274 ----------------EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 274 ----------------~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
...++|+|++|.|||+++++.+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=7.3e-11 Score=116.77 Aligned_cols=143 Identities=12% Similarity=0.184 Sum_probs=106.7
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEec--CCC-cchHHHHHHHHHHHhcCC--CCcccccccEEEeC---CeEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLM--SNS-VSEEEDFIEKVEAIGQVK--HKNLVKLFGYCVEG---QNRILV 227 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~---~~~~lv 227 (483)
...+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 345678999999999988654 578888775 322 123356888999999886 45688889888766 447999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI---------------------------------- 273 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 273 (483)
|||++|..+.+.. ...++..+...++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999998774421 234678888899999999999999721
Q ss_pred ---------------------CCCeeeecCCCCcEEEcCCCC--cEEeecccccc
Q 046972 274 ---------------------EPKIVHHNMKSSNILLDHHWN--PKISDVGLAKL 305 (483)
Q Consensus 274 ---------------------~~~iiHrDlkp~NiLl~~~~~--~kl~DFGla~~ 305 (483)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 58999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=8.5e-11 Score=113.51 Aligned_cols=186 Identities=16% Similarity=0.194 Sum_probs=120.7
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-CCCc--ccccccEEEeCC---eEEEEEEec
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKN--LVKLFGYCVEGQ---NRILVYEYI 231 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~---~~~lv~E~~ 231 (483)
.+.++.|.+..||+.. ..+++|+.... .....+.+|+++++.+ .+.. +.+++....... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 46888885432 3346788999999887 3333 344444433332 348899999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhC---------------------------------------
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED--------------------------------------- 272 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 272 (483)
+|.+|.+... ..++..+...++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988875432 2366777778888888888888861
Q ss_pred ----------------CCCCeeeecCCCCcEEEcC--CCCcEEeecccccccCCCcccccccc----cc---------Cc
Q 046972 273 ----------------IEPKIVHHNMKSSNILLDH--HWNPKISDVGLAKLHGPEWSISTSCE----LR---------NS 321 (483)
Q Consensus 273 ----------------~~~~iiHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~~~~~~~~~----~~---------~~ 321 (483)
..+.++|+|++|.||+++. +..+.|.||+.+....+......... .+ ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1135899999999999998 45678999999875433211110000 00 00
Q ss_pred cccc-ccccCCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 046972 322 GYLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPV 358 (483)
Q Consensus 322 ~y~a-PE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf 358 (483)
+... |+...+ ...-.+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 222211 122368999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=5.6e-07 Score=86.66 Aligned_cols=136 Identities=13% Similarity=0.110 Sum_probs=92.9
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCC---cccccccEEE-eCCeEEEEEEecCC
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK---NLVKLFGYCV-EGQNRILVYEYIDN 233 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~E~~~~ 233 (483)
.+.++.|....||+. +..+++|+.. .......+..|.++|+.+.+. .|.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 5678888742 223346789999999998642 3566666664 34557899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED----------------------------------------- 272 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 272 (483)
..|.+..- ..++..+...++.+++..|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88876321 1134444445555555555555532
Q ss_pred ----------------CCCCeeeecCCCCcEEEcC---CCCc-EEeecccccc
Q 046972 273 ----------------IEPKIVHHNMKSSNILLDH---HWNP-KISDVGLAKL 305 (483)
Q Consensus 273 ----------------~~~~iiHrDlkp~NiLl~~---~~~~-kl~DFGla~~ 305 (483)
..+.++|+|++|.|||++. ++.+ .|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 4554 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.5e-06 Score=81.84 Aligned_cols=134 Identities=17% Similarity=0.131 Sum_probs=94.7
Q ss_pred eeccCCce-EEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 160 VIASGDNG-VVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 160 ~lg~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--|.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68987754 4567888875432 3456888999888774 33477888999999999999999999888
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-------------------------------------------
Q 046972 237 QQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI------------------------------------------- 273 (483)
Q Consensus 237 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 273 (483)
.+..... ......+..+++..|.-||+..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765311 1122345556666666666421
Q ss_pred ------------CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 274 ------------EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 274 ------------~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
.+.++|+|+.+.|||++.++.+-|.||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987767799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=6.7e-07 Score=87.94 Aligned_cols=80 Identities=9% Similarity=0.052 Sum_probs=54.1
Q ss_pred ccee-ccCCceEEEEEEEc-------CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCC-C--CcccccccEEEeC--
Q 046972 158 QNVI-ASGDNGVVYRAVLL-------DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVK-H--KNLVKLFGYCVEG-- 221 (483)
Q Consensus 158 ~~~l-g~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~-- 221 (483)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998754 25678888764322 101245677888887774 2 3567778777654
Q ss_pred -CeEEEEEEecCCCCHH
Q 046972 222 -QNRILVYEYIDNGNLQ 237 (483)
Q Consensus 222 -~~~~lv~E~~~~g~L~ 237 (483)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.3e-05 Score=78.05 Aligned_cols=141 Identities=16% Similarity=0.230 Sum_probs=79.3
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcC-----CCCcccccc-c--EEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-----KHKNLVKLF-G--YCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~-~--~~~~~~~~~lv~E~ 230 (483)
+.|+.|..+.||+....++ .+++|+.... ...+..|..++..| ..|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987555 5889988652 22333444444443 234444321 1 22356778999999
Q ss_pred cCCCCHH--------------HHHhcccCC---C-------CCCCHHHH-------------------------------
Q 046972 231 IDNGNLQ--------------QWLHGSLGE---A-------KPLTWDTR------------------------------- 255 (483)
Q Consensus 231 ~~~g~L~--------------~~l~~~~~~---~-------~~l~~~~~------------------------------- 255 (483)
++|..+. ..++..... . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111211000 0 01122211
Q ss_pred HHHHHHHHHHHHHhhh----------CCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 256 MKIIQGTAKGLAYLHE----------DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 256 ~~i~~~i~~~l~~LH~----------~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
..+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224446666653 023489999999999999888889999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-05 Score=80.00 Aligned_cols=75 Identities=11% Similarity=0.060 Sum_probs=48.8
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-------chHHHHHHHHHHHhcCCC--Cc-ccccccEEEeCCeEEE
Q 046972 158 QNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-------SEEEDFIEKVEAIGQVKH--KN-LVKLFGYCVEGQNRIL 226 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-Iv~~~~~~~~~~~~~l 226 (483)
.+.||.|.++.||++... +++.+++|....... .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999743 467899998653211 122456778888877632 33 4455543 4555689
Q ss_pred EEEecCCC
Q 046972 227 VYEYIDNG 234 (483)
Q Consensus 227 v~E~~~~g 234 (483)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.3e-05 Score=72.54 Aligned_cols=81 Identities=17% Similarity=0.210 Sum_probs=58.5
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-C--CcccccccEEEeCCeEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-H--KNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~~lv~ 228 (483)
...+.-.+.+|.|..+.||+....+|+.+++|+...........|..|...|+.|. . --+.+++++ + .-++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEE
Confidence 34455567899999999999999999999999876554444456888998888774 2 134445543 2 247899
Q ss_pred EecCCCCH
Q 046972 229 EYIDNGNL 236 (483)
Q Consensus 229 E~~~~g~L 236 (483)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.7e-05 Score=79.85 Aligned_cols=79 Identities=6% Similarity=0.055 Sum_probs=47.8
Q ss_pred CCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCC--CCCcchhhHHHHHHHHHHH
Q 046972 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTS--IFNEKSDVYSFGILIMEIV 352 (483)
Q Consensus 275 ~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~el~ 352 (483)
..++|+|++|.|||++.++ +++.||+.+..-.+..........-...|++|+...... .-....++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 999999988753322111111001112356666542111 0112345567888888877
Q ss_pred cC
Q 046972 353 SG 354 (483)
Q Consensus 353 tg 354 (483)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=8.4e-05 Score=71.36 Aligned_cols=140 Identities=14% Similarity=0.183 Sum_probs=92.1
Q ss_pred ccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC---CCcccccccEEEeCCeEEEEEEecCC
Q 046972 157 EQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK---HKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.++++++...+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999875 5668888886532 3567888988888873 36788899988888889999999998
Q ss_pred CCHH--------H---HHhcccC-CC-----------------CCCCHHHHH---HHH----------------HHHHHH
Q 046972 234 GNLQ--------Q---WLHGSLG-EA-----------------KPLTWDTRM---KII----------------QGTAKG 265 (483)
Q Consensus 234 g~L~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~~i~~~ 265 (483)
..+. . .|+.... .. ..-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1222111 00 011343221 111 112222
Q ss_pred H-HHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 266 L-AYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 266 l-~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+ ..|.. ...+.++|+|+.+.|++++.++ +-|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23421 2356899999999999999887 8888974
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00031 Score=62.71 Aligned_cols=101 Identities=13% Similarity=0.064 Sum_probs=65.6
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcccc
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 313 (483)
-+|.+.|+. .+.+++++++|.++.|.+.+|.-+-... .-..+=+-|..|++..+|.+-..+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 379999974 4578999999999999999988762210 111223456889999999887653 2111
Q ss_pred ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC
Q 046972 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR 355 (483)
Q Consensus 314 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~ 355 (483)
.....+.|||... . ..+.+.=|||||+++|.-+--.
T Consensus 98 ----~~~~~~~~pe~~~-~-~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-S-QCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -------------CCSS-S-SSCHHHHHHHHHHHHHHHHTTT
T ss_pred ----ccccCCCChhhcc-c-cchHHHHHHHHHHHHHHHhhcC
Confidence 1122356888763 2 2578899999999999988633
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00062 Score=65.87 Aligned_cols=32 Identities=25% Similarity=0.219 Sum_probs=27.4
Q ss_pred CCeeeecCCCCcEEEcCC----CCcEEeeccccccc
Q 046972 275 PKIVHHNMKSSNILLDHH----WNPKISDVGLAKLH 306 (483)
Q Consensus 275 ~~iiHrDlkp~NiLl~~~----~~~kl~DFGla~~~ 306 (483)
..++|+|+.+.|||++.+ +.+.|.||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 489999999999999874 67899999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0033 Score=60.27 Aligned_cols=143 Identities=12% Similarity=0.121 Sum_probs=77.4
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-----CCcccccc-c--EEEeCCeEEEEEEe
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-----HKNLVKLF-G--YCVEGQNRILVYEY 230 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~-~--~~~~~~~~~lv~E~ 230 (483)
+.|+.|....+|+....++ .+++|...... ....+..|+.++..|. -|.++... | +....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788889999987655 68888876531 1123455666665552 33333221 1 12334667899999
Q ss_pred cCCCCHH-----H---------HHhccc---CCC--CCC---CHHHHHH------------HHHHHHHHHHHhhhC----
Q 046972 231 IDNGNLQ-----Q---------WLHGSL---GEA--KPL---TWDTRMK------------IIQGTAKGLAYLHED---- 272 (483)
Q Consensus 231 ~~~g~L~-----~---------~l~~~~---~~~--~~l---~~~~~~~------------i~~~i~~~l~~LH~~---- 272 (483)
++|..+. . .++... ... ... .|..... +...+...+++++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9986431 0 112110 000 001 1221100 011234455555532
Q ss_pred CCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 273 ~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
...+++|+|+.+.|||++.+..+.|.||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13479999999999999987656799998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00055 Score=65.23 Aligned_cols=71 Identities=11% Similarity=0.144 Sum_probs=42.2
Q ss_pred cceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcc-cccccEEEeCCeEEEEEEec-CCCC
Q 046972 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL-VKLFGYCVEGQNRILVYEYI-DNGN 235 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~-~~g~ 235 (483)
.+.|+.|....+|+. ..+++|+....... ......|+.+++.+....+ .+++++ +.+.-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 56888887543111 1123457766666532222 344443 344457899999 6544
Q ss_pred H
Q 046972 236 L 236 (483)
Q Consensus 236 L 236 (483)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0021 Score=61.77 Aligned_cols=143 Identities=14% Similarity=0.161 Sum_probs=80.1
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC--CcccccccE-----EEeCCeEEEEEEec
Q 046972 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH--KNLVKLFGY-----CVEGQNRILVYEYI 231 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~-----~~~~~~~~lv~E~~ 231 (483)
..++ |....||+....+|+.+++|....... ....+..|..++..+.. -.+++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 777899988776677899999864322 34456667777766631 123444432 23355678899999
Q ss_pred CCCCHH-----H------H---HhcccC-----CCCCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 046972 232 DNGNLQ-----Q------W---LHGSLG-----EAKPLTWDTR----------------------MKIIQGTAKGLAYLH 270 (483)
Q Consensus 232 ~~g~L~-----~------~---l~~~~~-----~~~~l~~~~~----------------------~~i~~~i~~~l~~LH 270 (483)
+|..+. . . ++.... ......+... ...+..++..+.-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 111000 0111222110 011112222222211
Q ss_pred h-CCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 271 E-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 271 ~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
. .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234689999999999999 4 889999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00083 Score=67.52 Aligned_cols=72 Identities=14% Similarity=0.226 Sum_probs=48.3
Q ss_pred cceeccCCceEEEEEEEcC--------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc-ccccccEEEeCCeEEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN-LVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~ 228 (483)
.+.|+.|-...||++...+ +..+++|+..... ....+..|..+++.|...+ ..++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4568888889999998753 4688888874321 2245667888888774333 355666543 2 3899
Q ss_pred EecCCCC
Q 046972 229 EYIDNGN 235 (483)
Q Consensus 229 E~~~~g~ 235 (483)
||++|-+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0024 Score=62.87 Aligned_cols=142 Identities=15% Similarity=0.204 Sum_probs=81.1
Q ss_pred cceeccCCceEEEEEEEc--------CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEE
Q 046972 158 QNVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.+.|..|-...+|++... ++..+++|+.-. .......+.+|.++++.|. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345777888899998864 246788888533 2223456778999888774 3223556665533 2899
Q ss_pred EecCCCCHHH--------------HH---hcc-cCCCCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 046972 229 EYIDNGNLQQ--------------WL---HGS-LGEAKPLT--WDTRMKIIQGTAK-------------------GLAYL 269 (483)
Q Consensus 229 E~~~~g~L~~--------------~l---~~~-~~~~~~l~--~~~~~~i~~~i~~-------------------~l~~L 269 (483)
||++|.+|.. .| +.. ..-.+... +.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999855421 11 111 00112222 3444444443321 22333
Q ss_pred h----hC-CCCCeeeecCCCCcEEEcCC----CCcEEeeccccc
Q 046972 270 H----ED-IEPKIVHHNMKSSNILLDHH----WNPKISDVGLAK 304 (483)
Q Consensus 270 H----~~-~~~~iiHrDlkp~NiLl~~~----~~~kl~DFGla~ 304 (483)
. .. ....++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 11 13378999999999999876 689999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.015 Score=56.19 Aligned_cols=31 Identities=19% Similarity=0.232 Sum_probs=27.6
Q ss_pred CCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 275 ~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
..++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0036 Score=40.04 Aligned_cols=7 Identities=0% Similarity=0.534 Sum_probs=2.6
Q ss_pred HHhhhcc
Q 046972 43 IFIFHRR 49 (483)
Q Consensus 43 ~~~~~rr 49 (483)
+|++|||
T Consensus 32 ~~~RRRr 38 (44)
T 2l2t_A 32 VYVRRKS 38 (44)
T ss_dssp HHHHTTC
T ss_pred HHhhhhh
Confidence 3333333
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0093 Score=60.26 Aligned_cols=74 Identities=14% Similarity=0.175 Sum_probs=45.9
Q ss_pred cceeccCCceEEEEEEEcC-CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcc-cccccEEEeCCeEEEEEEecCCCC
Q 046972 158 QNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNL-VKLFGYCVEGQNRILVYEYIDNGN 235 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~E~~~~g~ 235 (483)
.+.|+.|-...+|++...+ +..+++|+...... ..-+...|..+++.|...++ .++++++ .+ .+||||++|-+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 4568888889999998765 46788887643221 11112478888887754344 5667665 22 25999998744
Q ss_pred H
Q 046972 236 L 236 (483)
Q Consensus 236 L 236 (483)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0051 Score=41.04 Aligned_cols=35 Identities=29% Similarity=0.635 Sum_probs=24.9
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccc
Q 046972 17 GIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKK 51 (483)
Q Consensus 17 ~~~~~i~i~~~~~~~~~i~l~~~~~~~~~~~rrk~ 51 (483)
+.|+|++++++++.++++.++++++|-+-+.+|++
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~LwK~GFFKR~~ 40 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALWKIGFFKRPL 40 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHHHcCcccCCC
Confidence 56899988888877777777777776665555444
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0053 Score=39.20 Aligned_cols=19 Identities=26% Similarity=0.399 Sum_probs=8.1
Q ss_pred HHHHHHHHHHHHhhhcccc
Q 046972 33 LIFIAILFLYIFIFHRRKK 51 (483)
Q Consensus 33 ~i~l~~~~~~~~~~~rrk~ 51 (483)
+++++.+++.+|++|||.+
T Consensus 23 l~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 23 LVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHhheehhhhh
Confidence 3333333344454554443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0028 Score=62.21 Aligned_cols=73 Identities=14% Similarity=0.118 Sum_probs=41.7
Q ss_pred cceeccCCceEEEEEEEcC---------CcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCc-ccccccEEEeCCeEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLD---------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKN-LVKLFGYCVEGQNRILV 227 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv 227 (483)
.+.|+.|..-.+|+....+ +..+++|+...... ...+...|..+++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3457778888999988654 25788887644321 1112356777777664223 34566543 2 2689
Q ss_pred EEecCCCC
Q 046972 228 YEYIDNGN 235 (483)
Q Consensus 228 ~E~~~~g~ 235 (483)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0074 Score=40.47 Aligned_cols=36 Identities=28% Similarity=0.548 Sum_probs=25.8
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccc
Q 046972 16 FGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRKK 51 (483)
Q Consensus 16 ~~~~~~i~i~~~~~~~~~i~l~~~~~~~~~~~rrk~ 51 (483)
.+.|+|++++++++.++++.++++++|.+-+.+|++
T Consensus 8 ~~vp~wiIi~svl~GLllL~li~~~LwK~GFFkR~~ 43 (54)
T 2knc_A 8 RAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNR 43 (54)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTC
T ss_pred CCcchHHHHHHHHHHHHHHHHHHHHHHHcCcccCCC
Confidence 357999998888877777777777777665555444
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.012 Score=37.31 Aligned_cols=35 Identities=29% Similarity=0.538 Sum_probs=24.4
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHHHHHhhhccc
Q 046972 16 FGIPLWILIVTLTLLFLLIFIAILFLYIFIFHRRK 50 (483)
Q Consensus 16 ~~~~~~i~i~~~~~~~~~i~l~~~~~~~~~~~rrk 50 (483)
...|+|++++.+++.++++.+++++++-+-+.+|+
T Consensus 6 ~~vp~wiIi~s~l~GLllL~li~~~LwK~GFFkR~ 40 (42)
T 2k1a_A 6 RAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRN 40 (42)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTTTCCC
T ss_pred CCcchHHHHHHHHHHHHHHHHHHHHHHHcCcccCC
Confidence 35799998888887777776666666655444444
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.75 E-value=0.016 Score=36.01 Aligned_cols=31 Identities=19% Similarity=0.198 Sum_probs=14.3
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHHHHhhhc
Q 046972 17 GIPLWILIVTLTLLFLLIFIAILFLYIFIFHR 48 (483)
Q Consensus 17 ~~~~~i~i~~~~~~~~~i~l~~~~~~~~~~~r 48 (483)
+++.+.+.+++++.++.+++++.++ +|++||
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~-~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGIL-VFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHH-HHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHH-HHHeec
Confidence 4445555555555554444333333 333444
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.009 Score=38.33 Aligned_cols=7 Identities=29% Similarity=0.714 Sum_probs=2.6
Q ss_pred HHhhhcc
Q 046972 43 IFIFHRR 49 (483)
Q Consensus 43 ~~~~~rr 49 (483)
+|++||+
T Consensus 33 ~~~RRr~ 39 (44)
T 2ks1_B 33 LFMRRRH 39 (44)
T ss_dssp HHHHTTT
T ss_pred HHhhhhH
Confidence 3333333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.03 Score=55.87 Aligned_cols=74 Identities=12% Similarity=0.095 Sum_probs=45.9
Q ss_pred cceeccCCceEEEEEEEcC--------CcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEE
Q 046972 158 QNVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 228 (483)
.+.+..|-...+|+....+ +..+++|+...... ..-+..+|..+++.+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888999998753 57788888644321 1112356777777663 22234555433 2 27899
Q ss_pred EecCCCCH
Q 046972 229 EYIDNGNL 236 (483)
Q Consensus 229 E~~~~g~L 236 (483)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=91.97 E-value=0.077 Score=31.95 Aligned_cols=9 Identities=33% Similarity=0.368 Sum_probs=4.0
Q ss_pred HHHHHhhhc
Q 046972 40 FLYIFIFHR 48 (483)
Q Consensus 40 ~~~~~~~~r 48 (483)
.+.+|++||
T Consensus 26 ~~~~~iRRr 34 (35)
T 1iij_A 26 VVGILIKRR 34 (35)
T ss_dssp TTTHHHHHC
T ss_pred HhheEEeec
Confidence 334444444
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.28 E-value=0.18 Score=31.89 Aligned_cols=6 Identities=50% Similarity=0.955 Sum_probs=2.5
Q ss_pred HHhhhc
Q 046972 43 IFIFHR 48 (483)
Q Consensus 43 ~~~~~r 48 (483)
++++||
T Consensus 34 ~~~~rR 39 (41)
T 2k9y_A 34 FFIHRR 39 (41)
T ss_dssp HSSSSS
T ss_pred eeEeee
Confidence 344443
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.07 E-value=0.43 Score=32.91 Aligned_cols=20 Identities=15% Similarity=0.104 Sum_probs=9.5
Q ss_pred HHHHHHHHHHHHHHHHHHHh
Q 046972 26 TLTLLFLLIFIAILFLYIFI 45 (483)
Q Consensus 26 ~~~~~~~~i~l~~~~~~~~~ 45 (483)
++++++.+++++.+.+++++
T Consensus 13 vlGg~~~lll~~glcI~ccv 32 (70)
T 2klu_A 13 VLGGVAGLLLFIGLGIFFSV 32 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHH
T ss_pred HHhHHHHHHHHHHHHHHHhh
Confidence 44444444444455555444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.42 E-value=0.069 Score=53.93 Aligned_cols=62 Identities=8% Similarity=0.062 Sum_probs=19.0
Q ss_pred cccceeccCCceEEEEEEEcC-CcEEEE------EEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe
Q 046972 156 AEQNVIASGDNGVVYRAVLLD-NMRAAV------KLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE 220 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 220 (483)
.+.+.|| ||.||+|.+.. ..+||+ |....... .....|.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 99999999764 357888 66654322 222568899999999999999999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.55 E-value=0.18 Score=49.76 Aligned_cols=29 Identities=21% Similarity=0.321 Sum_probs=24.2
Q ss_pred CeeeecCCCCcEEE------cCCCCcEEeeccccc
Q 046972 276 KIVHHNMKSSNILL------DHHWNPKISDVGLAK 304 (483)
Q Consensus 276 ~iiHrDlkp~NiLl------~~~~~~kl~DFGla~ 304 (483)
.++|+|+.+.|||+ +.+..+.++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 445679999998775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.63 E-value=1.3 Score=39.31 Aligned_cols=116 Identities=9% Similarity=0.103 Sum_probs=77.8
Q ss_pred CCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCc
Q 046972 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSN 286 (483)
Q Consensus 207 ~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~N 286 (483)
.||+.+.. .+-.+.+.+.+.++.-+ +...|- .-...+....++++..|+....+++.. +|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888866 45556665555555433 333332 124477889999999999988777654 788899999
Q ss_pred EEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046972 287 ILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359 (483)
Q Consensus 287 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~ 359 (483)
++++.++.+++.-.|+-..+ +|.- ++...=.-.+=|++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~~------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPLP------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCCC------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCCC------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877754221 2221 1222223467788888999988874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.29 E-value=2.7 Score=37.36 Aligned_cols=115 Identities=10% Similarity=0.069 Sum_probs=74.3
Q ss_pred CCCcccccccEEEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCCeeeecCCCC
Q 046972 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA-YLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 207 ~hpnIv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiHrDlkp~ 285 (483)
.||+. -...-.+++.+.+.++.-+++.=+..+ ..++...+++++..|+.-.. +++. -+|-=|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 233335666666666665343333334 23677889999998888777 6654 478889999
Q ss_pred cEEEcCCCCcEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~ 359 (483)
|++++.++.+++.-.|+-.. ++|.-+ ++.-=.-.+=|++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987775322 222211 111123356677888888877763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 483 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-54
Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 29/287 (10%)
Query: 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIG 204
EI I SG G VY+ ++ AVK+L + + + + F +V +
Sbjct: 4 EIP--DGQITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
+ +H N++ GY Q +V ++ + +L LH + I + TA+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQ 115
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-GY 323
G+ YLH I+H ++KS+NI L KI D GLA + +L S +
Sbjct: 116 GMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 324 LAEE--LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
+A E + ++ +SDVY+FGI++ E+++G+LP + +I +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG------- 225
Query: 382 YVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
L P L ++ S K +KR++ C+ RP +L +E
Sbjct: 226 -YLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-51
Identities = 63/268 (23%), Positives = 122/268 (45%), Gaps = 21/268 (7%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
I SG G+V+ L+ + A+K + EEDFIE+ E + ++ H LV+L+G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+E LV+E++++G L +L + +T + + +G+AYL E ++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EACVI 123
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEK 338
H ++ + N L+ + K+SD G+ + + S++ + + E S ++ K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE-VFSFSRYSSK 182
Query: 339 SDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELK 398
SDV+SFG+L+ E+ S ++ +++ + + P + S +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---------FRLYKPRLAS-THVY 232
Query: 399 RIILIALRCVDPDIKHRPKMGDVLRMLE 426
+I+ C + RP +LR L
Sbjct: 233 QIM---NHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-50
Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 21/279 (7%)
Query: 149 DIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH 208
++ + + +G G V+ + + AVK L S+S + F+ + + Q++H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 67
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
+ LV+L+ + ++ EY++NG+L +L LT + + + A+G+A+
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAF 124
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL 328
+ E +H +++++NIL+ + KI+D GLA+L + + A E
Sbjct: 125 IEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
F KSDV+SFGIL+ EIV+ +I Q +
Sbjct: 182 I-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------QNLERGYRMVR 231
Query: 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427
P+ +EL +++ C + RP + +LE
Sbjct: 232 PDNCP-EELYQLM---RLCWKERPEDRPTFDYLRSVLED 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-49
Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 23/269 (8%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
+ +G GVV A+K++ S+SE+E FIE+ + + + H+ LV+L+G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVC 68
Query: 219 VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIV 278
+ + ++ EY+ NG L +L +++ + + + YL + +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 279 HHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEK 338
H ++ + N L++ K+SD GL++ + S+ + E+ S F+ K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL-MYSKFSSK 181
Query: 339 SDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKEL 397
SD+++FG+L+ EI S G++P + + IA L P + S
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETA----------EHIAQGLRLYRPHLAS---- 227
Query: 398 KRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+++ I C RP +L +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-48
Identities = 63/306 (20%), Positives = 114/306 (37%), Gaps = 35/306 (11%)
Query: 158 QNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGY 217
Q I G G V+R AVK+ S E + ++H+N++
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAE-IYQTVMLRHENILGFIAA 65
Query: 218 CVEGQNRI----LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ LV +Y ++G+L +L+ +T + +K+ TA GLA+LH +I
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 274 -----EPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG------ 322
+P I H ++KS NIL+ + I+D+GLA H G
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 323 --YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP------QVFLIDWLKSM 374
L + ++ + +++D+Y+ G++ EI + + D
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 375 VAQQKIAYVLDPKLPEMPSRKE-LKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLR 433
+ + L P +P E L+ + I C + R + + L L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ----LS 296
Query: 434 EEYRIK 439
++ IK
Sbjct: 297 QQEGIK 302
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (409), Expect = 1e-46
Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 144 SLKEIDIVTDGFAE---------QNVIASGDNGVVYRAVLLDNMR----AAVKLLMSNSV 190
+ ++ + FA+ + VI +G+ G V L + A+K L S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 191 SEE-EDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKP 249
++ DF+ + +GQ H N++ L G + +++ E+++NG+L +L + G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---Q 124
Query: 250 LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309
T + +++G A G+ YL + VH ++ + NIL++ + K+SD GL++ +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 310 WSISTSCELRNS----GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV 365
S T + A E + F SDV+S+GI++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 366 FLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRML 425
+I+ ++ D +LP P + + L C D HRPK G ++ L
Sbjct: 241 DVINAIEQ-----------DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 426 EP 427
+
Sbjct: 288 DK 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-46
Identities = 65/291 (22%), Positives = 123/291 (42%), Gaps = 23/291 (7%)
Query: 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV 206
EI + + + G G V+ R A+K L ++S E F+++ + + ++
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKL 69
Query: 207 KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
+H+ LV+L+ + +V EY+ G+L +L G G K L + + A G+
Sbjct: 70 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGM 126
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAE 326
AY+ VH +++++NIL+ + K++D GLA+L + + A
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386
E + F KSDV+SFGIL+ E+ + ++D ++ + P
Sbjct: 184 EAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----RGYRMPCPP 237
Query: 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYR 437
+ PE L ++ +C + + RP + LE +Y+
Sbjct: 238 ECPE-----SLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 63/280 (22%), Positives = 119/280 (42%), Gaps = 27/280 (9%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHK 209
+ + I +G G + D K L S++E + + +V + ++KH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 210 NLVKLFGYCVEGQNRIL--VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
N+V+ + ++ N L V EY + G+L + E + L + ++++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 268 YLHE--DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
H D ++H ++K +N+ LD N K+ D GLA++ + S + + Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMS 182
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
E R S +NEKSD++S G L+ E+ + P ++ + +
Sbjct: 183 PEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------KELAGKIRE 228
Query: 386 PKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLR 423
K +P R EL II R ++ HRP + ++L
Sbjct: 229 GKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 2e-46
Identities = 66/310 (21%), Positives = 115/310 (37%), Gaps = 43/310 (13%)
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLL-MSNSVSEEEDF 196
L ++ + I G G V++A AVK+L S + DF
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 197 IEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHG-------------- 242
+ + + + N+VKL G C G+ L++EY+ G+L ++L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 243 ------SLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPK 296
S PL+ ++ I + A G+AYL E K VH ++ + N L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 297 ISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRL 356
I+D GL++ S + + +SDV+++G+++ EI S L
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 357 PVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
M ++ I YV D + P + + C RP
Sbjct: 241 Q------------PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRP 287
Query: 417 KMGDVLRMLE 426
+ R+L+
Sbjct: 288 SFCSIHRILQ 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-46
Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 34/285 (11%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEA 202
+++KE+ ++ I G+ G V + AVK + + + + F+ +
Sbjct: 4 LNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASV 53
Query: 203 IGQVKHKNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG 261
+ Q++H NLV+L G VE + + +V EY+ G+L +L L D +K
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLD 111
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS 321
+ + YL VH ++ + N+L+ K+SD GL K E S +
Sbjct: 112 VCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPV 164
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
+ A E R F+ KSDV+SFGIL+ EI S P ++ ++
Sbjct: 165 KWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------- 216
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
P+ + ++ C D RP + LE
Sbjct: 217 --YKMDAPDGCP-PAVYEVM---KNCWHLDAAMRPSFLQLREQLE 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 9e-46
Identities = 55/307 (17%), Positives = 124/307 (40%), Gaps = 41/307 (13%)
Query: 148 IDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLL-MSNSVSEEEDFIEKVEAIGQ 205
+++ D F + + + +G+ GVV++ + A KL+ + + I +++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 VKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
+V +G + E++D G+L Q L +A + K+ KG
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L YL E + KI+H ++K SNIL++ K+ D G++ + + Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 171
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV-------------------- 365
E + + ++ +SD++S G+ ++E+ GR P+ +
Sbjct: 172 PERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 366 ---------FLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
+ +D M + + Y+++ P++PS +C+ + R
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 417 KMGDVLR 423
+ ++
Sbjct: 291 DLKQLMV 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-45
Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 31/278 (11%)
Query: 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEE---DFIEKVEAIGQVK 207
F++ I G G VY A + ++ A+K + + E D I++V + +++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H N ++ G + LV EY KPL + G +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLA 129
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
YLH ++H ++K+ NILL K+ D G A + P S + ++A E
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP-----YWMAPE 181
Query: 328 --LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
L+ ++ K DV+S GI +E+ + P + + +M A IA
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP----------LFNMNAMSALYHIAQNES 231
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
P L + + + C+ + RP +L+
Sbjct: 232 PALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-45
Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 31/299 (10%)
Query: 158 QNVIASGDNGVVYRAVLLDN----MRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLV 212
VI G G VY LLDN + AVK L + E F+ + + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 213 KLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
L G C+ + +V Y+ +G+L+ ++ E T + AKG+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YLAEEL 328
K VH ++ + N +LD + K++D GLA+ + S + ++A E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE- 204
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
S +T F KSDV+SFG+L+ E+++ P + +L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---------RRLLQ 255
Query: 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP-RDLLLREEYRIKRAASYHN 446
PE L ++ L+C P + RP +++ + + E Y + A+Y N
Sbjct: 256 PEYCP-DPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY-VHVNATYVN 309
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 8e-45
Identities = 52/287 (18%), Positives = 116/287 (40%), Gaps = 21/287 (7%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKV 200
+ + ++ ++ + G G VY V ++ AVK L E E+F+++
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEA 64
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+ ++KH NLV+L G C ++ E++ GNL +L + ++ + +
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMAT 122
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRN 320
+ + YL + +H ++ + N L+ + K++D GL++L + + +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 321 SGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380
+ A E + F+ KSDV++FG+L+ EI + + ++
Sbjct: 180 IKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------------LSQV 225
Query: 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427
+L+ +++ + C + RP ++ + E
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-44
Identities = 68/306 (22%), Positives = 134/306 (43%), Gaps = 33/306 (10%)
Query: 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDN-----MRAAVKLL-MSNSVSEEEDFIEKV 200
EI Q VI +G+ G VY+ +L + + A+K L + + DF+ +
Sbjct: 3 EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+GQ H N+++L G + + +++ EY++NG L ++L + + + +++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLR 117
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL--HGPEWSISTSCEL 318
G A G+ YL VH ++ + NIL++ + K+SD GL+++ PE + +TS
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378
+ A E F SDV+SFGI++ E+++ +
Sbjct: 175 IPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NH 220
Query: 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEYRI 438
++ ++ I + ++C + RPK D++ +L+ L+R +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK---LIRAPDSL 277
Query: 439 KRAASY 444
K A +
Sbjct: 278 KTLADF 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-43
Identities = 61/303 (20%), Positives = 110/303 (36%), Gaps = 37/303 (12%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLL-MSNSVSEEEDFIE 198
+ + + + + +G G V A M AVK+L S ++E E +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 199 KVEAIGQVK-HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLG------------ 245
+++ + + H N+V L G C G +++ EY G+L +L
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 246 --EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303
+ L + + AKG+A+L +H ++ + NILL H KI D GLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP 363
+ + + R S ++ +SDV+S+GI + E+ S P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
K ++ + + I C D D RP +++
Sbjct: 253 V------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 424 MLE 426
++E
Sbjct: 301 LIE 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-43
Identities = 62/285 (21%), Positives = 124/285 (43%), Gaps = 29/285 (10%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIG 204
++++ D + + G G VY+A + ++ AA K++ + S E ED++ +++ +
Sbjct: 6 RDLNP-EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 205 QVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAK 264
H N+VKL N ++ E+ G + + +PLT + + T
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLD 121
Query: 265 GLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYL 324
L YLH + KI+H ++K+ NIL + K++D G++ + S + ++
Sbjct: 122 ALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWM 177
Query: 325 AEEL----SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380
A E+ + + ++ K+DV+S GI ++E+ P P L+ KS
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------- 230
Query: 381 AYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLR 423
+P PSR K + +C++ ++ R +L+
Sbjct: 231 ----EPPTLAQPSRWSSNFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-43
Identities = 63/291 (21%), Positives = 125/291 (42%), Gaps = 34/291 (11%)
Query: 146 KEIDIVTDGFAEQNV-IASGDNGVVYRAVLL---DNMRAAVKLL-MSNSVSEEEDFIEKV 200
K++ + D ++ + G+ G V + V + A+K+L ++ E+ + +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 201 EAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQ 260
+ + Q+ + +V+L G C + + +LV E G L ++L G + + + +++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 261 GTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS--ISTSCEL 318
+ G+ YL E VH ++ + N+LL + KISD GL+K G + S + S
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQ 377
+ A E F+ +SDV+S+G+ + E +S G+ P +
Sbjct: 174 WPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------------P 219
Query: 378 QKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ +A++ K E P EL ++ C + RP V + +
Sbjct: 220 EVMAFIEQGKRMECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-42
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 32/286 (11%)
Query: 148 IDIVTDG--FAEQNVIASGDNGVVYRAVLLDNMRA-AVKLLMSNSVSEE--EDFIEKVEA 202
+ + DG I G VY+ + + A L +++ + F E+ E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM 61
Query: 203 IGQVKHKNLVKLFGYCVE----GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKI 258
+ ++H N+V+ + + +LV E + +G L+ +L K +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSW 117
Query: 259 IQGTAKGLAYLHEDIEPKIVHHNMKSSNILL-DHHWNPKISDVGLAKLHGPEWSISTSCE 317
+ KGL +LH P I+H ++K NI + + KI D+GLA L
Sbjct: 118 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAV 173
Query: 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377
+ ++A E+ ++E DVY+FG+ ++E+ + P Q + + S V
Sbjct: 174 IGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-- 229
Query: 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
P + + E+K II C+ + R + D+L
Sbjct: 230 -------KPASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-42
Identities = 67/303 (22%), Positives = 119/303 (39%), Gaps = 43/303 (14%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDN---MRAAVKLL-MSNSVSEEEDFI 197
+ +I Q+VI G+ G V +A + + M AA+K + S + DF
Sbjct: 6 VLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 198 EKVEAIGQV-KHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGS------------L 244
++E + ++ H N++ L G C L EY +GNL +L S
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 245 GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304
A L+ + A+G+ YL + + +H ++ + NIL+ ++ KI+D GL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ 364
+ ++A E S S++ SDV+S+G+L+ EIVS
Sbjct: 176 GQEVYVKKTMGR--LPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
L +K+ + P E+ ++ +C RP +L
Sbjct: 233 AELY---------EKLPQGYRLEKPLNCD-DEVYDLM---RQCWREKPYERPSFAQILVS 279
Query: 425 LEP 427
L
Sbjct: 280 LNR 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-41
Identities = 61/281 (21%), Positives = 117/281 (41%), Gaps = 35/281 (12%)
Query: 157 EQNVIASGDNGVVYRAVLLD---NMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNL 211
E + SG+ G V + AVK+L + + ++ + + + Q+ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE 271
V++ G C E ++ +LV E + G L ++L + + + ++++ + G+ YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 272 DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR--NSGYLAEELS 329
VH ++ + N+LL KISD GL+K + + + + A E
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 330 GRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
F+ KSDV+SFG+L+ E S G+ P M + A + +
Sbjct: 183 -NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR-------------GMKGSEVTAMLEKGER 228
Query: 389 PEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427
P+ +E+ ++ C D+++RP V L
Sbjct: 229 MGCPAGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRN 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-41
Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 22/274 (8%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKHKN 210
+ + + G G V AV AVK++ M +V E+ +++ + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+VK +G+ EG + L EY G L + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 271 EDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS-GYLAEELS 329
I H ++K N+LLD N KISD GLA + ++ + Y+A EL
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389
R E DV+S GI++ +++G LP D + K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------SDWKEKKTYLNPWK 230
Query: 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
++ S ++ + + + R + D+ +
Sbjct: 231 KIDS--APLALL---HKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 9e-41
Identities = 55/281 (19%), Positives = 113/281 (40%), Gaps = 23/281 (8%)
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEA 202
S+ + + I G +G VY A+ + A++ + ++E I ++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 203 IGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGT 262
+ + K+ N+V + G +V EY+ G+L + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCREC 125
Query: 263 AKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG 322
+ L +LH + +++H ++KS NILL + K++D G PE S ++ +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 181
Query: 323 YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382
++A E + K D++S GI+ +E++ G P P + L +
Sbjct: 182 WMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGTPEL 236
Query: 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
KL + + RC+D D++ R ++L+
Sbjct: 237 QNPEKLSA-----IFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-41
Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 160 VIASGDNGVVYRAVLLDNMRA------AVKLLMSNS-VSEEEDFIEKVEAIGQV-KHKNL 211
V+ SG G V A + AVK+L + SE E + +++ + Q+ H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLG-------------------EAKPLTW 252
V L G C L++EY G+L +L + LT+
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 253 DTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312
+ + AKG+ +L VH ++ + N+L+ H KI D GLA+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 313 STSCELRNS-GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371
R ++A E I+ KSDV+S+GIL+ EI S + P
Sbjct: 221 VVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--- 276
Query: 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ I P + +E+ I+ C D + RP ++ L
Sbjct: 277 -----YKLIQNGFKMDQPFYAT-EEIYIIM---QSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-40
Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 30/275 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKH 208
+ F + G G VY A A+K+L + + E +VE ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
N+++L+GY + L+ EY G + + L + I A L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL 328
H +++H ++K N+LL KI+D G + + YL E+
Sbjct: 122 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEM 175
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
+ +EK D++S G+L E + G+ P + + Q ++I+ V +
Sbjct: 176 I-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----------KRISRV-EFTF 223
Query: 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
P+ + + + +I R + + RP + +VL
Sbjct: 224 PDFVT-EGARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-40
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 31/282 (10%)
Query: 160 VIASGDNGVVYRAVLLDNMRA----AVKLL-MSNSVSEEEDFIEKVEAIGQVKHKNLVKL 214
I G G V++ + + A+K S S E F+++ + Q H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 215 FGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIE 274
G E ++ E G L+ +L L + + + LAYL
Sbjct: 74 IGVITENP-VWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES--- 126
Query: 275 PKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSI 334
+ VH ++ + N+L+ + K+ D GL++ S ++A E
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRR 185
Query: 335 FNEKSDVYSFGILIMEI-VSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPS 393
F SDV+ FG+ + EI + G P + + +I +P
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----------GRIENGERLPMPPNCP 235
Query: 394 RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435
L ++ +C D RP+ ++ L +L EE
Sbjct: 236 -PTLYSLM---TKCWAYDPSRRPRFTELKAQLST---ILEEE 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-40
Identities = 57/292 (19%), Positives = 110/292 (37%), Gaps = 34/292 (11%)
Query: 143 ISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEEE---D 195
I K++ ++ + G GVV R + AVK L + +S+ E D
Sbjct: 5 IGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 57
Query: 196 FIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTR 255
FI +V A+ + H+NL++L+G + ++ V E G+L L G T
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTL 113
Query: 256 MKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK-LHGPEWSIST 314
+ A+G+ YL + +H ++ + N+LL KI D GL + L +
Sbjct: 114 SRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 315 SCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM 374
+ S +T F+ SD + FG+ + E+ + ++
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----K 226
Query: 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ ++ P+ ++ ++ ++C + RP + L
Sbjct: 227 IDKEGERLPRPEDCPQ-----DIYNVM---VQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (361), Expect = 3e-39
Identities = 55/278 (19%), Positives = 115/278 (41%), Gaps = 23/278 (8%)
Query: 149 DIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK 207
D V D + + +G GVV+R A K +M+ S++E ++++ + ++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H LV L + +++YE++ G L + + E ++ D ++ ++ KGL
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLC 138
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSGYLA 325
++H E VH ++K NI+ + K+ D GL P+ S+ + + + A
Sbjct: 139 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAA 193
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
E++ +D++S G+L ++SG P +++ + + +D
Sbjct: 194 PEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNMD 245
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
S ++ K I + + D R + L
Sbjct: 246 DSAFSGIS-EDGKDFI---RKLLLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 65/338 (19%), Positives = 138/338 (40%), Gaps = 42/338 (12%)
Query: 141 IRISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLDN-----MRAAVK-LLMSNSVSEEE 194
+RI LKE + F + V+ SG G VY+ + + + A+K L + S +
Sbjct: 3 LRI-LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 56
Query: 195 DFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDT 254
+ +++ + V + ++ +L G C+ L+ + + G L ++ +
Sbjct: 57 EILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQY 112
Query: 255 RMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIST 314
+ AKG+ YL + ++VH ++ + N+L+ + KI+D GLAKL G E
Sbjct: 113 LLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 315 SCELRNS-GYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLK 372
+ + ++A E S I+ +SDV+S+G+ + E+++ G P D
Sbjct: 170 AEGGKVPIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------- 215
Query: 373 SMVAQQKIAYVLDPKLPEMPSR--KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDL 430
+ A + + + + P ++ I+ ++C D RPK +++ +
Sbjct: 216 GIPASEISSILEKGERLPQPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSK--M 270
Query: 431 LLREEYRIKRAASYHNYPQKNKTAVLCDADISTHDEEN 468
+ + + + A + D ++
Sbjct: 271 ARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 308
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 53/293 (18%), Positives = 114/293 (38%), Gaps = 31/293 (10%)
Query: 147 EIDIVTDGFAEQNVIASGDNGVVYRAVL------LDNMRAAVKLL-MSNSVSEEEDFIEK 199
E+ + + G G+VY V R A+K + + S+ E +F+ +
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLH------GSLGEAKPLTWD 253
+ + ++V+L G +GQ +++ E + G+L+ +L + P +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 254 TRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSIS 313
+++ A G+AYL+ K VH ++ + N ++ + KI D G+ +
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 314 TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKS 373
+ S + +F SDV+SFG+++ EI +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------- 241
Query: 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+Q + +V++ L + P + + C + K RP +++ ++
Sbjct: 242 ---EQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-38
Identities = 62/290 (21%), Positives = 111/290 (38%), Gaps = 38/290 (13%)
Query: 159 NVIASGDNGVVYRAVLL--------DNMRAAVKLLMSNSVSEE-EDFIEKVEAIGQV-KH 208
+ G G V A + + AVK+L S++ ++ D I ++E + + KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLH------------GSLGEAKPLTWDTRM 256
KN++ L G C + ++ EY GNL+++L S + L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 257 KIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC 316
A+G+ YL K +H ++ + N+L+ KI+D GLA+ +
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 317 ELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA 376
R + I+ +SDV+SFG+L+ EI + P L LK
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK---- 251
Query: 377 QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
+ + PS + ++ C RP ++ L+
Sbjct: 252 --------EGHRMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (338), Expect = 6e-36
Identities = 54/276 (19%), Positives = 107/276 (38%), Gaps = 23/276 (8%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHK 209
V D + + SG GVV+R V K + + ++ ++ + Q+ H
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
L+ L + +L+ E++ G L + E ++ + ++ +GL ++
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHM 143
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
H E IVH ++K NI+ + KI D GLA P+ + + + + A E
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPE 198
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387
+ +D+++ G+L ++SG P D L+++ ++ + D
Sbjct: 199 IV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-------DDLETLQNVKRCDWEFDED 250
Query: 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
S E K I + + + R + D L
Sbjct: 251 AFSSVS-PEAKDFI---KNLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 53/279 (18%), Positives = 104/279 (37%), Gaps = 28/279 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEED---FIEKVEAIGQVKH 208
+ F ++ G V A L + A+K+L + +E + + + ++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
VKL+ + + Y NG L +++ + L Y
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEY 123
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR-NSGYLAEE 327
LH I+H ++K NILL+ + +I+D G AK+ PE + + + Y++ E
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387
L + SD+++ G +I ++V+G P + QKI L+
Sbjct: 181 LL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----------QKIIK-LEYD 228
Query: 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426
PE + + ++ + + D R ++
Sbjct: 229 FPEKFF-PKARDLV---EKLLVLDATKRLGCEEMEGYGP 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 131 bits (330), Expect = 8e-35
Identities = 49/271 (18%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEED------FIEKVEAIGQ 205
+ F+ +I G G VY D A+K L + ++ + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 206 VKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKG 265
+V + + + ++ G+L L + + G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 266 LAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
L ++H +V+ ++K +NILLD H + +ISD+GLA + + GY+A
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMA 173
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385
E+ + ++ +D +S G ++ +++ G P F K ++ +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--------FRQHKTKDKHEIDRMTLTMA 225
Query: 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
+LP+ S EL+ ++ + D+ R
Sbjct: 226 VELPDSFS-PELRSLL---EGLLQRDVNRRL 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-34
Identities = 53/280 (18%), Positives = 103/280 (36%), Gaps = 20/280 (7%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSV-SEEEDFIEKVEAI 203
K+ + + D + ++V+ +G V A A+K + ++ +E ++ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA 263
++KH N+V L G + L+ + + G L + E T ++I
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVL 117
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGY 323
+ YLH+ LD ISD GL+K+ P +ST+C GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP--GY 175
Query: 324 LAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYV 383
+A E+ + +++ D +S G++ ++ G P LK+
Sbjct: 176 VAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---- 230
Query: 384 LDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
P ++ K I ++ D + R L+
Sbjct: 231 --PYWDDIS--DSAKDFI---RHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 41/266 (15%), Positives = 104/266 (39%), Gaps = 22/266 (8%)
Query: 160 VIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCV 219
+ G+ G+V+R V + + + + +++ +++ + +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 220 EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVH 279
+ ++++E+I ++ + ++ S A L + + + L +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNIGH 125
Query: 280 HNMKSSNILLDHHWNP--KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNE 337
+++ NI+ + KI + G A+ P + + + + +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 338 KSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKEL 397
+D++S G L+ ++SG P Q + + + + Y D + + S E
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-------YTFDEEAFKEIS-IEA 234
Query: 398 KRIILIALRCVDPDIKHRPKMGDVLR 423
+ R + + K R + L+
Sbjct: 235 MDFV---DRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (319), Expect = 4e-34
Identities = 51/285 (17%), Positives = 112/285 (39%), Gaps = 32/285 (11%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSE---------EEDFIEKVEA 202
+ + + ++ G + VV R + AVK++ E +++V+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 203 IGQVK-HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG 261
+ +V H N+++L LV++ + G L +L E L+ KI++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRA 118
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSC---EL 318
+ + LH + IVH ++K NILLD N K++D G + P + C
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 319 RNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378
+ ++ + ++ D++S G+++ +++G P + + + L M+
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----RMIMSG 230
Query: 379 KIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ P+ + +K ++ R + + R + L
Sbjct: 231 NYQF-GSPEWDDYS--DTVKDLV---SRFLVVQPQKRYTAEEALA 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-34
Identities = 60/302 (19%), Positives = 109/302 (36%), Gaps = 36/302 (11%)
Query: 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIE 198
+ + D + G G V A AVK+L + SE +
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 199 KVEAIGQVKH-KNLVKLFGYCVEGQNRI-LVYEYIDNGNLQQWLHGSLGEAKP------- 249
+++ + + H N+V L G C + + ++ E+ GNL +L E P
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 250 -----LTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304
LT + + AKG+ +L K +H ++ + NILL KI D GLA+
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQ 364
+ + R + ++ +SDV+SFG+L+ EI S
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 365 VFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRM 424
+++ + P+ + E+ + + L C + RP +++
Sbjct: 243 DEEF--------CRRLKEGTRMRAPDYTT-PEMYQTM---LDCWHGEPSQRPTFSELVEH 290
Query: 425 LE 426
L
Sbjct: 291 LG 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 29/276 (10%)
Query: 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEED----FIEKVEAIGQVK 207
+ F ++ G G V+ A N A+K L + V ++D +EK +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H L +F +N V EY++ G+L + GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
+LH IV+ ++K NILLD + KI+D G+ K + + + + E
Sbjct: 118 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387
L G+ +N D +SFG+L+ E++ G+ P + +P
Sbjct: 175 LLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------NPF 221
Query: 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
P KE K ++ ++ + + R + +R
Sbjct: 222 YPRWLE-KEAKDLL---VKLFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (307), Expect = 2e-32
Identities = 55/286 (19%), Positives = 116/286 (40%), Gaps = 30/286 (10%)
Query: 152 TDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL---MSNSVSEEEDFIEKVEAIGQVK 207
+D + ++ G V+ A L + AVK+L ++ S F + + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 208 HKNLVKLFGYCVE----GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA 263
H +V ++ G +V EY+D L+ +H P+T +++I
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR--NS 321
+ L + H+ I+H ++K +NI++ K+ D G+A+ + T +
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
YL+ E + R + +SDVYS G ++ E+++G P P + V + I
Sbjct: 179 QYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIP 233
Query: 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-MGDVLRMLE 426
+ + +L ++ L+ + + ++R + ++ L
Sbjct: 234 --PSARHEGLS--ADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-32
Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 27/285 (9%)
Query: 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEK-----VEAIGQVKHKNLV 212
+ + G VY+A N A+K + SE +D I + ++ + ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 213 KLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHED 272
L N LV+++++ S LT + T +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 273 IEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRT 332
+ I+H ++K +N+LLD + K++D GLAK G T ++ Y A EL
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT-HQVVTRWYRAPELLFGA 175
Query: 333 SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMP 392
++ D+++ G ++ E++ + L +++ + + LP+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 393 SRKELKRIILIAL-------------RCVDPDIKHRPKMGDVLRM 424
+ K I L + + R L+M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (299), Expect = 3e-31
Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 24/281 (8%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLFG 216
I G GVVY+A A+K + E I ++ + ++KH N+VKL+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 217 YCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK 276
+ +LV+E++D + L T + G+AY H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 277 IVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFN 336
++H ++K N+L++ KI+D GLA+ G + E+ Y A ++ + ++
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 337 EKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLIDWLKSMVAQQKIAYVLD--------P 386
D++S G + E+V+G Q+ I + + V +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 387 KLPEMPSRKELKRIILIAL----RCVDPDIKHRPKMGDVLR 423
+P LK + + + + D R L
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-30
Identities = 55/288 (19%), Positives = 110/288 (38%), Gaps = 24/288 (8%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHK 209
+ F + I G GVVY+A L A+K + ++ +E I ++ + ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
N+VKL LV+E++ + +L + + +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFC 118
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELS 329
H +++H ++K N+L++ K++D GLA+ G T E+ Y A E+
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEIL 174
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389
++ D++S G + E+V+ R L +++ ++ + +P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 390 EM-PSRKELKRIILIAL-------------RCVDPDIKHRPKMGDVLR 423
+ PS + R + + + D R L
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-29
Identities = 50/293 (17%), Positives = 114/293 (38%), Gaps = 24/293 (8%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL-MSNSVSEEEDFIEKVEAIGQVKH 208
V + + I G G+V A ++ +R A+K + + + + +++ + + +H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
+N++ + + Y+ + L+ L + + L+ D + +GL Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR--NSGYLAE 326
+H ++H ++K SN+LL+ + KI D GLA++ P+ + Y A
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLI------------DWLKSM 374
E+ + + + D++S G ++ E++S R L D +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 375 VAQQKIAYVLDPKLPEMPSRKELKRIILIAL----RCVDPDIKHRPKMGDVLR 423
+ + + P ++P + AL + + + R ++ L
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 32/291 (10%)
Query: 155 FAEQNVIASGDNGVVYRAVLLD-NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK 213
+ + VI +G GVVY+A L D A+K ++ ++ +++ + ++ H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVR 77
Query: 214 LFGYCVEGQNR------ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
L + + LV +Y+ + H S + + L + + LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLA 136
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHGPEWSISTSCELRNSGYLAE 326
Y+H I H ++K N+LLD K+ D G AK + R Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRAP 191
Query: 327 ELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSM------VAQQKI 380
EL + + DV+S G ++ E++ G+ L++ +K + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 381 AYVLDPKLPEMPSRKELKRII------LIAL--RCVDPDIKHRPKMGDVLR 423
+ K P++ + K IAL R ++ R +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 49/273 (17%), Positives = 105/273 (38%), Gaps = 29/273 (10%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQV-KHKNLVKLFGY 217
V+ G NG V + + A+K+L + +VE + + ++V++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 218 C----VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI 273
+ ++V E +D G L + + T +I++ + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 274 EPKIVHHNMKSSNILLDHHWNP---KISDVGLAKLHGPEWSISTSCELRNSGYLAEELSG 330
I H ++K N+L K++D G AK S++T C Y+A E+ G
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP--YYVAPEVLG 186
Query: 331 RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390
+++ D++S G+++ ++ G P + + M + ++ P
Sbjct: 187 PEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIRMGQYEFPNPEW 241
Query: 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+E+K +I + + R + + +
Sbjct: 242 SEVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-28
Identities = 46/286 (16%), Positives = 99/286 (34%), Gaps = 40/286 (13%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK--------HKN 210
++ SG G VY + + DN+ A+K + + +S+ + +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 211 LVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLH 270
+++L + + +L+ E + + E L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVRHCH 127
Query: 271 EDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELS 329
++H ++K NIL+D + K+ D G L Y E
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG---TRVYSPPEWI 181
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389
+ V+S GIL+ ++V G +P ++ + + + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQVFFRQRVS 228
Query: 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435
E + +I C+ RP ++ +D+LL +E
Sbjct: 229 S-----ECQHLI---RWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (279), Expect = 5e-28
Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLL---MSNSVSEEEDFIEK 199
SL++ I+ + +G G V+ + A+K+L + + + E ++
Sbjct: 2 SLQDFQIL-------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 200 VEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKII 259
+ V H +++++G + Q ++ +YI+ G L L S +
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYA 110
Query: 260 QGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELR 319
L YLH I++ ++K NILLD + + KI+D G AK
Sbjct: 111 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGT--- 164
Query: 320 NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379
Y+A E+ T +N+ D +SFGILI E+++G P S L +
Sbjct: 165 -PDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------ 216
Query: 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP 416
+ + P + +++K ++ R + D+ R
Sbjct: 217 -----ELRFPPFFN-EDVKDLL---SRLITRDLSQRL 244
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (277), Expect = 5e-28
Identities = 44/288 (15%), Positives = 93/288 (32%), Gaps = 30/288 (10%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
I SG G +Y + A+KL + + + + ++ + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 219 -VEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277
EG ++V E + + S + + T + + + Y+H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 278 VHHNMKSSNIL---LDHHWNPKISDVGLAKLHGPEWSISTSCELRNS------GYLAEEL 328
+H ++K N L I D GLAK + + N Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
+ + D+ S G ++M G LP + + + ++K++ ++
Sbjct: 185 H-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS--EKKMSTPIEVLC 241
Query: 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREEY 436
P E + C +P + ++ R+L R+ +
Sbjct: 242 KGYP--SEFATYL---NFCRSLRFDDKPDYSYLRQLF--RNLFHRQGF 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 32/284 (11%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEE------EDFIEKVEAI 203
V D + + SG VV + ++ A K + ED +V +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 204 GQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTA 263
+++H N++ L + IL+ E + G L +L E + LT + + ++
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQIL 123
Query: 264 KGLAYLHEDIEPKIVHHNMKSSNILLDHHWNP----KISDVGLAKLHGPEWSISTSCELR 319
G+ YLH +I H ++K NI+L P KI D GLA
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--G 178
Query: 320 NSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379
++A E+ ++D++S G++ ++SG P Q +++
Sbjct: 179 TPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSA 230
Query: 380 IAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+ Y + + S K I R + D K R + D L+
Sbjct: 231 VNYEFEDEYFSNTS-ALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 50/286 (17%), Positives = 106/286 (37%), Gaps = 27/286 (9%)
Query: 159 NVIASGDNGVVYRAVLL--DNMRAAVKLLMSNSVSEEED-----FIEKVEAIGQVKHKNL 211
I G G V++A L A+K + + E + + + +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 212 VKLFGYCVEGQNRILVYEYIDNGNLQQW--LHGSLGEAKPLTWDTRMKIIQGTAKGLAYL 269
V+LF C + + ++ Q + + +T ++ +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 270 HEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELS 329
H ++VH ++K NIL+ K++D GLA+++ + ++++ Y A E+
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL--WYRAPEVL 187
Query: 330 GRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLI----------DWLKSMVAQ 377
S + D++S G + E+ + S Q+ I DW + +
Sbjct: 188 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
++ + + E + + L+C+ + R L
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (269), Expect = 5e-27
Identities = 39/301 (12%), Positives = 94/301 (31%), Gaps = 32/301 (10%)
Query: 149 DIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK 207
++V + I G GV++ LL+N + A+K S+ ++ +
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLA 58
Query: 208 H-KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
+ ++ + EG + +LV + + + + T + +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARV 114
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHHWNP-----KISDVGLAKLHGPEWSISTSCELRNS 321
+HE +V+ ++K N L+ + + D G+ K + +
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 322 G------YLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375
Y++ + + D+ + G + M + G LP + +
Sbjct: 172 NLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYERI 228
Query: 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435
++K + L P +E + + + P + + +L R
Sbjct: 229 GEKKQSTPLRELCAGFP--EEFYKYM---HYARNLAFDATPDYDYLQGLF--SKVLERLN 281
Query: 436 Y 436
Sbjct: 282 T 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 26/292 (8%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVK 207
V + + + SG G V AV + A+K L SE + ++ + ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H+N++ L + ++ G L + + L D ++ KGL
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
Y+H I+H ++K N+ ++ KI D GLA+ E + + Y A E
Sbjct: 136 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPE 188
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV---------AQQ 378
+ + + D++S G ++ E+++G+ S L + +K Q
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 379 KIAYVLDPKLPEMPSRKELKRI-------ILIALRCVDPDIKHRPKMGDVLR 423
A LPE+ + + + + + + D + R G+ L
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 5e-25
Identities = 49/284 (17%), Positives = 109/284 (38%), Gaps = 28/284 (9%)
Query: 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVKHKNLVKLF 215
I G G V++A + A+K + + E + ++ + ++KHKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 216 GYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEP 275
+ LV+E+ D + + + L + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 276 KIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIF 335
++H ++K N+L++ + K+++ GLA+ G S E+ Y ++ ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLY 179
Query: 336 NEKSDVYSFGILIMEIVSGRLPVDYSQP---QVFLIDWLKSMVAQQKIAYVLD----PKL 388
+ D++S G + E+ + P+ Q+ I L +++ +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 389 PEMPSRKELKRII---------LIALRCVDPDIKHRPKMGDVLR 423
P P+ L ++ L+ + + R + L+
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQ-NLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 53/282 (18%), Positives = 98/282 (34%), Gaps = 35/282 (12%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEED---FI 197
++++ + D + ++ G G V A+K+L + +++ +
Sbjct: 1 KVTMNDFDYL-------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 198 EKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMK 257
+ + +H L L V EY + G L L + T +
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARF 109
Query: 258 IIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCE 317
L YLH +V+ ++K N++LD + KI+D GL K G +
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTF 165
Query: 318 LRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ 377
YLA E+ + + D + G+++ E++ GRLP + L
Sbjct: 166 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---- 220
Query: 378 QKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMG 419
+ + P S E K ++ + D K R G
Sbjct: 221 -------EIRFPRTLS-PEAKSLL---AGLLKKDPKQRLGGG 251
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 53/288 (18%), Positives = 113/288 (39%), Gaps = 35/288 (12%)
Query: 142 RISLKEIDIVTDGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSVSEEEDFI 197
++ ++ +++ V+ +G G V+ + A+K+L ++ ++
Sbjct: 20 KVGIENFELL-------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 198 EK----VEAIGQVKHK-NLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTW 252
E + + ++ LV L L+ +YI+ G L L + + T
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTE 128
Query: 253 DTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312
+ L +LH+ I++ ++K NILLD + + ++D GL+K + +
Sbjct: 129 HEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 313 STSCELRNSGYLA-EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWL 371
Y+A + + G S ++ D +S G+L+ E+++G P + +
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245
Query: 372 KSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMG 419
+ ++ +P P+ S K +I R + D K R G
Sbjct: 246 RRILKS-------EPPYPQEMS-ALAKDLI---QRLLMKDPKKRLGCG 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-24
Identities = 47/296 (15%), Positives = 103/296 (34%), Gaps = 38/296 (12%)
Query: 159 NVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE--EEDFIEKVEAIGQVKHKNLVKLF 215
I G G V++A + A+K ++ + E + +++ + +KH+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 216 GYCVEGQNRI--------LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
C + LV+++ ++ + T +++Q GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSG---YL 324
Y+H KI+H +MK++N+L+ K++D GLA+ + + Y
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 325 AEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFL----------------- 367
EL + D++ G ++ E+ + + + Q L
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 368 IDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423
+D + + + + + + + + + D R D L
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 95.7 bits (237), Expect = 2e-22
Identities = 51/299 (17%), Positives = 112/299 (37%), Gaps = 43/299 (14%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKN 210
D + + G V+ A+ + +N + VK+L +++ +++ + ++ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91
Query: 211 LVKLFGYCVEGQNR--ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
++ L + +R LV+E+++N + +Q + LT + K L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDY 144
Query: 269 LHEDIEPKIVHHNMKSSNILLDH-HWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
H I+H ++K N+++DH H ++ D GLA+ + P + R + E
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR--YFKGPE 199
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLP-------VDYSQPQVFLIDWLKSMVAQQKI 380
L +++ D++S G ++ ++ + P D ++ K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 381 AYVLDPKLPEMPSRKELKRIILIAL----------------RCVDPDIKHRPKMGDVLR 423
LDP+ ++ R KR + + D + R + +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 3e-22
Identities = 57/292 (19%), Positives = 111/292 (38%), Gaps = 26/292 (8%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLL--MSNSVSEEEDFIEKVEAIGQVK 207
V + + + + SG G V A +R AVK L S+ + ++ + +K
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 208 HKNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLA 267
H+N++ L ++ + +L ++ + + LT D +I +GL
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 268 YLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEE 327
Y+H I+H ++K SN+ ++ KI D GLA+ E + + Y A E
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 188
Query: 328 LSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQP--QVFLI----------DWLKSMV 375
+ +N+ D++S G ++ E+++GR + Q+ LI K
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 376 AQQKIAYVLDPKLPEMPSRKELKRIILIAL----RCVDPDIKHRPKMGDVLR 423
+ ++P+M +A+ + + D R L
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 8e-22
Identities = 50/269 (18%), Positives = 91/269 (33%), Gaps = 31/269 (11%)
Query: 153 DGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEED---FIEKVEAIGQVKH 208
D F + +G G V A+K+L V + + + + + V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
LVKL + N +V EY+ G + L + Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL 328
LH +++ ++K N+L+D +++D G AK LA E+
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT----PEALAPEI 209
Query: 329 SGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388
+ +N+ D ++ G+LI E+ +G P QP + + +
Sbjct: 210 I-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKIVSGKVRF 257
Query: 389 PEMPSRKELKRIILIALRCVDPDIKHRPK 417
P S +LK ++ + D+ R
Sbjct: 258 PSHFS-SDLKDLL---RNLLQVDLTKRFG 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.7 bits (190), Expect = 3e-16
Identities = 52/253 (20%), Positives = 92/253 (36%), Gaps = 32/253 (12%)
Query: 151 VTDGFAEQNVIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEE--EDFIEKVEAIGQVK 207
V + I SG G+V A + + A+K L ++ + ++ + V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 208 HKNLVKLFGYCV------EGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQG 261
HKN++ L E Q+ LV E +D Q L + ++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQ 127
Query: 262 TAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNS 321
G+ +LH I+H ++K SNI++ KI D GLA+ G + ++ R
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 322 GYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381
E + G + E D++S G ++ E+V ++ K+
Sbjct: 185 -RAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW----------NKVI 231
Query: 382 YVLDPKLPEMPSR 394
L PE +
Sbjct: 232 EQLGTPCPEFMKK 244
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 71.2 bits (173), Expect = 4e-14
Identities = 32/214 (14%), Positives = 75/214 (35%), Gaps = 17/214 (7%)
Query: 160 VIASGDNGVVYRAV-LLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYC 218
+ G V+ A +++N A+K++ + V E ++++ + +V + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 219 VEGQNRILVYEYIDNGNL------------QQWLHGSLGEAKPLTWDTRMKIIQGTAKGL 266
++L + N E + + +I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 267 AYLHEDIEPKIVHHNMKSSNILLDHH-WNPKISDVGLAKLHGPEWSISTSCELRNSGYLA 325
Y+H I+H ++K N+L++ + + +A L W +
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 326 EELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVD 359
+ + +D++S LI E+++G +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.1 bits (163), Expect = 1e-13
Identities = 31/206 (15%), Positives = 61/206 (29%), Gaps = 34/206 (16%)
Query: 159 NVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS----------EEEDFIEKVEAIGQVKH 208
++ G V+ VK S + F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 209 KNLVKLFGYCVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAY 268
+ L KL G V VY + N L + + E + + +++ + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDA--KELYRVRVENPDEVLDMILEEVAK 118
Query: 269 LHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSISTSCELRNSGYLAEEL 328
+ IVH ++ N+L+ I D + G E L ++
Sbjct: 119 FY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE---------ILERDV 165
Query: 329 SGRTSIFNEK----SDVYSFGILIME 350
+ F+ D+ S I++
Sbjct: 166 RNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 483 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.16 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=428.13 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=213.8
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
++|++.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|++++++++|||||++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999995 468899999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
+||+|.+++.. ..+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998853 4599999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
.......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+....+..... .. .+.+ .
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----~~------~~~~--~ 237 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----NG------TPEL--Q 237 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----HC------SCCC--S
T ss_pred ccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh----CC------CCCC--C
Confidence 2234457999999999996654 89999999999999999999999987665433222111 11 1111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+...+..+.+|+.+||+.||++|||+.|++++.+.+
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 2233457889999999999999999999999876653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=430.08 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=208.1
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCC--CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSN--SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+++..++|++.+.||+|+||+||+|++++ .||||++... .....+.|.+|++++++++|||||+++|++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 35667889999999999999999998643 5999998654 33445789999999999999999999998754 5689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|||||++|+|.+++.. ....+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 80 lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999963 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCcc-ccccccccCcccccccccCCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEWS-ISTSCELRNSGYLAEELSGRT--SIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
...... .......||+.|+|||++... ..|+.++|||||||++|||+||+.||.+..+.......... .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~----~---- 225 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----G---- 225 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH----T----
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc----C----
Confidence 654322 233445789999999998532 34899999999999999999999999877655433222211 1
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+.++ .....+++.+.+++.+||+.||++|||+.+++++|+.
T Consensus 226 ~~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 226 YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp SCCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111111 1223345789999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=426.32 Aligned_cols=256 Identities=24% Similarity=0.272 Sum_probs=209.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 588999999976532 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
|+||+|.+++. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999995 446799999999999999999999999 99999999999999999999999999998764332
Q ss_pred c-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCC
Q 046972 311 S-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLP 389 (483)
Q Consensus 311 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (483)
. .......||+.|+|||++.+...++.++|||||||++|||++|+.||.............. .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~------------~~~~~ 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------EKKTY 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH------------TTCTT
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh------------cCCCC
Confidence 2 2234457999999999987666457889999999999999999999976654332221110 11111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 390 EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 390 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+....+.++.+|+.+||+.||++|||++|++++.+.
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 11223344678899999999999999999999987764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=422.16 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=200.2
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecC
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYID 232 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 232 (483)
++|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|+|...+..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999889999999987644 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCccc
Q 046972 233 NGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWSI 312 (483)
Q Consensus 233 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 312 (483)
+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999863 346689999999999999999999999 9999999999999999999999999999877654444
Q ss_pred cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCC
Q 046972 313 STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG-RLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEM 391 (483)
Q Consensus 313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (483)
......||..|+|||++.+.. |+.++|||||||++|||+|+ .+||......... ..+ .....+..|
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i---------~~~~~~~~p-- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDI---------STGFRLYKP-- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHH---------HHTCCCCCC--
T ss_pred eecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HHH---------HhcCCCCCc--
Confidence 444557899999999996554 89999999999999999994 6666544432221 111 111112222
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 392 PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 392 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..++.++.+++.+||+.||++|||+++++++|+.
T Consensus 225 --~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 2334688999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-56 Score=428.27 Aligned_cols=262 Identities=20% Similarity=0.346 Sum_probs=217.0
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
+++++..++|++.+.||+|+||+||+|++. +++.||||++.... ...++|.+|+++|++++|||||+++|+|.+++..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 345566788999999999999999999976 47889999986543 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++|||||++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 9999999999999999653 346799999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..............|+..|+|||++.+.. |+.++|||||||++|||++|..||....+.....+.+ ....
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i---------~~~~ 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDY 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---------HTTC
T ss_pred ecCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---------hcCC
Confidence 87655444445556888999999986544 8999999999999999999777665444433222211 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+..+ ..++..+.+|+.+||+.||++|||++++++.|+.
T Consensus 234 ~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 234 RMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22222 2344789999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=424.73 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=212.3
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
++++..++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4566778899999999999999999999888999999996543 345789999999999999999999998754 56799
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 99999999999988543 224589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLP-VDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
............||+.|+|||++... .++.++|||||||++|||+||..| |....... ... . +.....
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~---~------i~~~~~ 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQ---N------LERGYR 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHH---H------HHTTCC
T ss_pred cCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHH---H------HHhcCC
Confidence 65544455556789999999998644 489999999999999999996555 44433322 111 1 111122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+..| ..++.++.+|+.+||+.||++|||+.++++.|+.
T Consensus 229 ~~~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 MVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2222 2344688999999999999999999999998863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=425.43 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=214.0
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
+.|++.+.||+|+||+||+|+.. ++..||||++........+.|.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 57889999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++... ..++++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 999999998632 35699999999999999999999999 9999999999999999999999999999754332 1
Q ss_pred ccccccccCcccccccccC----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 312 ISTSCELRNSGYLAEELSG----RTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.......||+.|+|||++. ....|+.++|||||||++|||++|+.||.+.+....+..+... ..+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------~~~~ 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------EPPT 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS----------CCCC
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----------CCCC
Confidence 2233457999999999974 2334899999999999999999999999877765543322211 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+ ..+...+.++.+|+.+||+.||++|||+.|++++.+..
T Consensus 235 ~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 1 11234457899999999999999999999999976543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=418.29 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=208.9
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 57889999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999963 35699999999999999999999999 999999999999999999999999999986544
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.. .....||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.......+ . . ..+.+
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~-~------~~~~~ 223 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----S-R------VEFTF 223 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-T------TCCCC
T ss_pred Cc---ccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH----H-c------CCCCC
Confidence 32 23457899999999996654 899999999999999999999999876644322211 1 1 12223
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
|.. .+.++.+|+.+||+.||++|||++|++++.+
T Consensus 224 p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 224 PDF----VTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 332 3367889999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-56 Score=421.14 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=199.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEe--CCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVE--GQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 226 (483)
.++|++.+.||+|+||+||+|+.+ +|+.||+|.+...... ..+.+.+|++++++++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999975 5789999999765432 34678999999999999999999999865 456899
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI--EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|||||++|+|.+++.........+++..++.++.||+.||.|||++. ..+||||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999999754445577999999999999999999999861 0139999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
....... ......||+.|+|||++.+.. |+.++|||||||++|||+||+.||.+.+.......+ ... .
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-----~~~-----~ 230 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-----REG-----K 230 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----HHT-----C
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH-----HcC-----C
Confidence 7654322 223457899999999996554 899999999999999999999999876543322111 111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+.++. ..+.++.+|+.+||+.||++|||+.|++++.+
T Consensus 231 ~~~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 231 FRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CCCCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 112222 33468899999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=413.53 Aligned_cols=253 Identities=22% Similarity=0.377 Sum_probs=214.6
Q ss_pred hcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEec
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYI 231 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 231 (483)
.++|++.++||+|+||+||+|++++++.||||++..... ..++|.+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 367999999999999999999999898999999976544 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++.. ....+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999863 345689999999999999999999999 999999999999999999999999999987665544
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......+|..|+|||.+.... ++.++|||||||++|||+| |+.||........... +.....+..|
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~----------i~~~~~~~~p- 223 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----------IAQGLRLYRP- 223 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----------HHTTCCCCCC-
T ss_pred eeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH----------HHhCCCCCCc-
Confidence 4444567899999999986554 8999999999999999998 8999987765432211 1111112222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..++..+.+|+.+||+.||++|||+++++++|.
T Consensus 224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 234478999999999999999999999999884
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-55 Score=423.84 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=198.8
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-C---cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-N---MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.++||+|+||+||+|+++. + ..||||.+..... ...+.|.+|+++|++++|||||+++|++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4678889999999999999999753 2 2588998866533 344689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
|||||++|+|.+++.. ....+++.++..++.||++||.|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999863 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcccc----ccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 307 GPEWSIS----TSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 307 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
....... .....+|+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+......... . ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~----i-~~---- 248 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA----I-EQ---- 248 (299)
T ss_dssp -----------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----H-HT----
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH----H-Hc----
Confidence 5432221 2223578899999998654 48999999999999999998 8999987665432211 1 11
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.+ .+..++..+.+|+.+||+.||++|||+.|+++.|+.
T Consensus 249 ---~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 249 ---DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ---TCCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCC--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 223455789999999999999999999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=430.78 Aligned_cols=267 Identities=20% Similarity=0.329 Sum_probs=210.1
Q ss_pred HHhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC-cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS-VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
+..++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++|++++|||||+++++|.+.++.|+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45678999999999999999999975 57889999997653 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
||||+||+|.+++.+ ...+++..++.++.||+.||.|||+ + +|+||||||+|||++.++.+||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999964 3469999999999999999999996 6 8999999999999999999999999999865
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH----------
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA---------- 376 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------- 376 (483)
... ......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..............
T Consensus 156 ~~~---~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 156 IDS---MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHH---TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CCC---ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 322 223458999999999997654 999999999999999999999999765543211100000000
Q ss_pred -------------------hhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 377 -------------------QQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 377 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
............+..+....+.++.+|+.+||+.||++|||++|++++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 000001111111222222234678899999999999999999999997553
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=411.68 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=200.4
Q ss_pred cccceeccCCceEEEEEEEc-CCcEEEEEEecCCC--cchHHHHHHHHHHHhcCCCCcccccccEEEe----CCeEEEEE
Q 046972 156 AEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS--VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE----GQNRILVY 228 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~ 228 (483)
++.++||+|+||+||+|+.. ++..||+|.+.... ....+.|.+|+++|++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999975 57789999987643 2344679999999999999999999999875 35679999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eeeecCCCCcEEEc-CCCCcEEeecccccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPK--IVHHNMKSSNILLD-HHWNPKISDVGLAKL 305 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDlkp~NiLl~-~~~~~kl~DFGla~~ 305 (483)
|||++|+|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+|||++ .++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999963 35689999999999999999999998 7 99999999999996 578999999999986
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.... ......||+.|+|||++.+ . |+.++|||||||++|||++|+.||....+...+...+ ..
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i------------~~ 227 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------TS 227 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH------------TT
T ss_pred ccCC---ccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH------------Hc
Confidence 5433 2234579999999999854 3 8999999999999999999999998665543322111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
...+...+...+.++.+++.+||+.||++|||++|++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 11111112223357889999999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-54 Score=419.77 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=195.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
.+.|++.+.||+|+||+||+|+.+ +++.||||++..... .....+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 567999999999999999999975 578899999976533 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc---CCCCcEEeeccccccc
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD---HHWNPKISDVGLAKLH 306 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DFGla~~~ 306 (483)
||+||+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+. .++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999996 346799999999999999999999999 999999999999994 5789999999999866
Q ss_pred CCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 307 GPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
..... .....||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.........+. .. ..
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-----~~------~~ 226 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL-----KA------EY 226 (307)
T ss_dssp --------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----TT------CC
T ss_pred cCCCe--eeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh-----cc------CC
Confidence 44322 23457999999999996554 8999999999999999999999998765443222111 11 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.......+.++.+|+.+||+.||++|||+.|++++.+.
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 12222223344788999999999999999999999997654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=425.68 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=210.4
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcCC------cEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEEE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLDN------MRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYCV 219 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 219 (483)
+++..++|++.++||+|+||+||+|++... ..||+|.+..... .....|.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 456678899999999999999999996542 3589999866532 3346799999999998 8999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeee
Q 046972 220 EGQNRILVYEYIDNGNLQQWLHGSLG-------------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHH 280 (483)
Q Consensus 220 ~~~~~~lv~E~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHr 280 (483)
+.+..++|||||++|+|.++|+.... ....+++..++.++.||+.||+|||++ +||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 99999999999999999999975321 124589999999999999999999999 99999
Q ss_pred cCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCC
Q 046972 281 NMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPV 358 (483)
Q Consensus 281 Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf 358 (483)
||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+. .|+.++|||||||++|||+| |+.||
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543322 223345689999999998644 48999999999999999998 89999
Q ss_pred CCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 359 DYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.+......+...+.. ...+..| ..++.++.+|+.+||+.||++|||++||+++|.
T Consensus 268 ~~~~~~~~~~~~~~~---------~~~~~~p----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN---------GFKMDQP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHHHHT---------TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhc---------CCCCCCC----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 876655443332211 1122222 234478999999999999999999999999984
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-54 Score=424.95 Aligned_cols=257 Identities=20% Similarity=0.278 Sum_probs=214.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 5889999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC--CCCcEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH--HWNPKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~ 308 (483)
|+||+|.+++.. ....+++..++.++.||+.||.|||++ +||||||||+|||++. ++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999953 345699999999999999999999999 9999999999999954 67899999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+.. .....
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-----------~~~~~ 244 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-----------CDWNM 244 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------TCCCS
T ss_pred ccc--cceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------CCCCC
Confidence 322 23357899999999986554 89999999999999999999999987665433322111 11122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
+.......+..+.+|+.+||+.||++|||++|++++.+..
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 2222233447889999999999999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-54 Score=423.05 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=214.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||.||+|+.. +++.||||++..........+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999974 6889999999877656667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEc--CCCCcEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLD--HHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~--~~~~~kl~DFGla~~~~~ 308 (483)
|+||+|.+++.. ...++++.+++.++.||+.||.|||++ +||||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998853 345699999999999999999999999 999999999999998 678999999999987765
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+.. .+...
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-----------~~~~~ 247 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-----------CDWEF 247 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-----------CCCCC
T ss_pred CCc--eeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------CCCCC
Confidence 422 23347899999999996554 89999999999999999999999987665433222111 11222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.......+.++.+|+.+||+.||.+|||+.|++++.+.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 322233445788999999999999999999999997543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-54 Score=419.93 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=206.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch---HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE---EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
+.|+..+.||+|+||+||+|+.. +++.||||++....... .+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34899999999999999999965 57889999997654332 257899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||++|+|..++. ...++++.+++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987774 346799999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccccccccCcccccccccCC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGR--TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDP 386 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (483)
. ....||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.+......+.... . .
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~----~---------~ 229 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----Q---------N 229 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----H---------S
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----h---------C
Confidence 2 34579999999999853 2348999999999999999999999998765443222111 1 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 387 KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 387 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
..+...+...+..+.+|+.+||+.||.+|||++|++++.+
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 1111222334478899999999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=415.02 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=207.0
Q ss_pred HhcCCcccce-eccCCceEEEEEEEc---CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 151 VTDGFAEQNV-IASGDNGVVYRAVLL---DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 151 ~~~~~~~~~~-lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
..++|.+.+. ||+|+||+||+|.++ ++..||||++..... ...+.|.+|+++|++++|||||+++|++.+ +..|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3456777774 999999999999864 345799999976533 345789999999999999999999999865 5689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|||||++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 85 lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999999853 345799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 306 HGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 306 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
...... .......||+.|+|||++... .++.++|||||||++|||+| |+.||.+......... .. .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-----i~-----~ 227 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-----IE-----Q 227 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-----HH-----T
T ss_pred ccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-----HH-----c
Confidence 754432 223344688999999998544 48999999999999999998 9999987665432211 11 1
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+..| ..++.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 228 ~~~~~~p----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 228 GKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp TCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112222 3345789999999999999999999999998853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=415.41 Aligned_cols=248 Identities=20% Similarity=0.305 Sum_probs=204.6
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999975 58899999986432 223467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||+||+|.+++.. .+.+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999863 35799999999999999999999999 999999999999999999999999999987654
Q ss_pred Cc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
.. ........||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.......+. . ..+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-----~------~~~~ 228 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-----K------LEYD 228 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----T------TCCC
T ss_pred CCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-----c------CCCC
Confidence 32 22334457999999999996554 8999999999999999999999998766543322211 1 1222
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLR 423 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~ 423 (483)
+|.. .+.++.+|+.+||+.||++|||++|++.
T Consensus 229 ~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 3332 3367889999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=415.39 Aligned_cols=261 Identities=22% Similarity=0.313 Sum_probs=205.5
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 225 (483)
+++++..++|++.+.||+|+||+||+|+++++..||||++.... ...+.|.+|+.++++++|||||+++|++. .+..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeE
Confidence 34455678899999999999999999999999899999986543 34578999999999999999999999985 45689
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccc
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKL 305 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~ 305 (483)
+|||||++|+|.+++... ....+++.+++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 88 lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 999999999999998643 234699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcC
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLD 385 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (483)
.............+|+.|+|||++... .++.++|||||||++|||++|..||............+. ....
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---------~~~~ 232 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------RGYR 232 (285)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---------TTCC
T ss_pred ccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---------hcCC
Confidence 755444444456789999999998644 489999999999999999996655544443322222111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 386 PKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 386 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.. +..+++++.+++.+||+.||++|||+++|+++|+.
T Consensus 233 ~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 233 MPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 222 23344789999999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=410.88 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=200.3
Q ss_pred HhcCCcccceeccCCceEEEEEEEcCC-----cEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLLDN-----MRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
..++|++.++||+|+||+||+|.++++ ..||||++..... ....+|.+|++++++++|||||+++|++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 346788999999999999999997643 3689999876533 3346799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++|||||.+|+|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+
T Consensus 85 ~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999998863 346799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
....... .......||..|+|||++.+. .++.++|||||||++|||++|..|+............+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i---------~~ 228 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------ND 228 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---------HT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH---------hc
Confidence 7644322 222334678999999998554 48999999999999999999666554443332221111 11
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+. .+..++..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 229 ~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 229 GFRLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp TCCCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCCC----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 11111 223455789999999999999999999999998853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=409.26 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=197.4
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEecCC
Q 046972 159 NVIASGDNGVVYRAVLLD---NMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEYIDN 233 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 233 (483)
++||+|+||+||+|.+++ ++.||||++..... ...+.|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 46799999865432 234689999999999999999999999865 457899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc--
Q 046972 234 GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-- 311 (483)
Q Consensus 234 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-- 311 (483)
|+|.++++. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999963 45699999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCC
Q 046972 312 ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPE 390 (483)
Q Consensus 312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
.......||+.|+|||.+.... ++.++|||||||++|||+| |+.||.+........ ....+ ..+..|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-----~i~~~-----~~~~~p- 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKG-----ERMGCP- 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTT-----CCCCCC-
T ss_pred ccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-----HHHcC-----CCCCCC-
Confidence 2233457889999999986544 8999999999999999998 899998765432211 11111 112222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 391 MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 391 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..++.++.+|+.+||+.||++|||+++|++.|+.
T Consensus 233 ---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 3345789999999999999999999999988753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=410.91 Aligned_cols=257 Identities=21% Similarity=0.251 Sum_probs=211.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc------chHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV------SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 688999999864322 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC----CcEEeec
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW----NPKISDV 300 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DF 300 (483)
|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999964 35699999999999999999999999 999999999999998876 4999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|+|+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.. .
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-----~-- 231 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-----V-- 231 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-----T--
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh-----c--
Confidence 99987654322 2345789999999999654 489999999999999999999999987665433222110 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....+.......+..+.+|+.+||+.||++|||++|++++.+...
T Consensus 232 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 232 ----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp ----CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred ----CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 111111111123467889999999999999999999999876544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=409.14 Aligned_cols=257 Identities=20% Similarity=0.285 Sum_probs=199.3
Q ss_pred HHHhcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCCe
Q 046972 149 DIVTDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQN 223 (483)
Q Consensus 149 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 223 (483)
++..++|++.+.||+|+||.||+|++.. +..||||.+..... ...+.|.+|++++++++|||||+++|++. .+.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 4567889999999999999999998653 34688998865433 33467999999999999999999999985 567
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++|||||++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 82 ~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence 8999999999999998863 345789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
+..............||+.|+|||++.+.. |+.++|||||||++|||++ |..||...........+ . .+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~-~~---- 225 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----E-NG---- 225 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----H-TT----
T ss_pred eeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----H-cC----
Confidence 876654444455567899999999986544 8999999999999999998 89999877665432211 1 11
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..+.. +..++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 226 -~~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 226 -ERLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122 22345789999999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=409.84 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=213.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+++|+.++|||||++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999964 68899999996532 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
||||+||+|.+++.. ...+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999963 45689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
... .......||+.|+|||++.+.+ |+.++|||||||++|||++|+.||.+.+.......+. . ....
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~-----~------~~~~ 223 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----M------EEIR 223 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----H------CCCC
T ss_pred cCC-cccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh-----c------CCCC
Confidence 332 2233457999999999996655 8999999999999999999999998776543322111 1 1223
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccch
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRDL 430 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~~ 430 (483)
+|.. .+.++.+|+.+||+.||.+||+ +++++++.+..+.
T Consensus 224 ~p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 224 FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCcc----CCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 3333 3367889999999999999994 8999998776553
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-52 Score=403.96 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=210.9
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999974 58899999986432 223467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
|||+||+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999996 446688999999999999999999999 999999999999999999999999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. .....||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.......+.. . ....
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-----~------~~~~ 220 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----A------ELRF 220 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----C------CCCC
T ss_pred c----cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-----C------CCCC
Confidence 3 23457999999999996554 89999999999999999999999987665433222111 1 1223
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
|.. .+.++.+++.+||..||.+|+ |+++++++.+..+.
T Consensus 221 p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 221 PPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCC----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 322 236788999999999999996 99999998776654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-52 Score=397.78 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=211.7
Q ss_pred hcCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCcc---------hHHHHHHHHHHHhcCC-CCcccccccEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVS---------EEEDFIEKVEAIGQVK-HKNLVKLFGYCVE 220 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 220 (483)
.++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999996 46889999999764321 1246889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeec
Q 046972 221 GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDV 300 (483)
Q Consensus 221 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DF 300 (483)
.+..|||||||+||+|.++|+. ..++++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999963 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccccccccccCcccccccccCC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHH
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGR-----TSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMV 375 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 375 (483)
|+++....... .....||+.|+|||.+.+ ...++.++||||+||++|||++|+.||.+.+.......+..
T Consensus 155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~--- 229 (277)
T d1phka_ 155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--- 229 (277)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh---
Confidence 99987765332 234578999999998752 23478899999999999999999999987665432222111
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
. ....+.......++++.+|+.+||+.||++|||+.|++++.+.
T Consensus 230 --~------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 230 --G------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp --T------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred --C------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 1 1122222233455789999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-53 Score=408.18 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=213.4
Q ss_pred hHHHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCcccccccE
Q 046972 145 LKEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSVS-EEEDFIEKVEAIGQVKHKNLVKLFGY 217 (483)
Q Consensus 145 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~ 217 (483)
+.++++++++|++.+.||+|+||+||+|+++ +++.||||++...... ..++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4566778899999999999999999999964 3568999998765433 34679999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhccc--------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSL--------------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKI 277 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 277 (483)
+...+..++||||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999996421 1234588999999999999999999999 99
Q ss_pred eeecCCCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC-
Q 046972 278 VHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR- 355 (483)
Q Consensus 278 iHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~- 355 (483)
|||||||+|||++.++.+||+|||+|+....... .......+++.|+|||.+.+.. |+.++|||||||++|||++|.
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999986544322 2233456888999999986544 899999999999999999985
Q ss_pred CCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 356 LPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 356 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.||.+......... .. +...+. .+..++.++.+|+.+||+.||++|||+.||+++|+.
T Consensus 241 ~p~~~~~~~e~~~~-----v~--------~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 241 QPYYGMAHEEVIYY-----VR--------DGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp CTTTTSCHHHHHHH-----HH--------TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHH-----HH--------cCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 67776654432211 11 111111 122344688999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-51 Score=404.84 Aligned_cols=251 Identities=20% Similarity=0.228 Sum_probs=210.7
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 228 (483)
++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 68899999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+.+|+|..++.. ...+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999963 35699999999999999999999999 999999999999999999999999999987653
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
. .....||+.|+|||++.+.. |+.++|||||||++|||+||+.||.+.+.......+. . . .+..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----~-~------~~~~ 257 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV----S-G------KVRF 257 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----H-C------CCCC
T ss_pred c----cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh----c-C------CCCC
Confidence 2 23457899999999996554 8999999999999999999999998765443222211 1 1 1222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccch
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRDL 430 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~~ 430 (483)
+. ..+.++.+++.+||+.||.+|+ |+++++++.+..+.
T Consensus 258 p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 258 PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred Cc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 22 2336788999999999999994 99999998776553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-52 Score=411.22 Aligned_cols=257 Identities=18% Similarity=0.247 Sum_probs=208.3
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc---chHHHHH---HHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV---SEEEDFI---EKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
-++|++.++||+|+||.||+|+.. +|+.||+|++..... .....+. .++++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999975 588999999854321 1122333 447788888999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
|+|||||+||+|.++|.. ...+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999963 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 305 LHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
..... ......||+.|+|||++.+...|+.++|||||||+||||+||+.||......... .... .....
T Consensus 156 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~-------~~~~~ 224 (364)
T d1omwa3 156 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------MTLTM 224 (364)
T ss_dssp ECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHH-------HSSSC
T ss_pred ecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH-------hcccC
Confidence 76543 2334579999999999866556899999999999999999999999875543221 1100 00111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHhccccch
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPK-----MGDVLRMLEPRDL 430 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~eil~~L~~~~~ 430 (483)
.+..+. ..+.++.+|+.+||+.||++||| +++++++.+..+.
T Consensus 225 ~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 225 AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp CCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 122222 23467899999999999999999 7999998877654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=405.58 Aligned_cols=254 Identities=16% Similarity=0.244 Sum_probs=208.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
.++|++.+.||+|+||+||+|... +++.||+|++..... +...+.+|+++|+.++|||||++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 578999999999999999999975 578899999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC--CCcEEeecccccccCC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH--WNPKISDVGLAKLHGP 308 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~--~~~kl~DFGla~~~~~ 308 (483)
|+||+|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999963 234699999999999999999999999 99999999999999854 4799999999987654
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
... .....+|+.|+|||...+.. |+.++|||||||++|||++|+.||...+.......+.. . ...+
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~-----~------~~~~ 222 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-----A------EYTF 222 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----T------CCCC
T ss_pred CCc--ccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----C------CCCC
Confidence 322 23347889999999986554 89999999999999999999999987765443322211 0 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
+.......+.++.+|+.+||..||++|||+.|++++.+
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 11111123367889999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=403.17 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=204.3
Q ss_pred ehHHHHHHhcCCcccceeccCCceEEEEEEEcC------CcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccc
Q 046972 144 SLKEIDIVTDGFAEQNVIASGDNGVVYRAVLLD------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLF 215 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~ 215 (483)
...++++..++|++.++||+|+||.||+|.+.. ++.||||++..... ...+.+.+|...+.++ +|+|||.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 345677888999999999999999999999643 46799999876533 3446788888888777 689999999
Q ss_pred cEEEeC-CeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecC
Q 046972 216 GYCVEG-QNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNM 282 (483)
Q Consensus 216 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDl 282 (483)
+++... ...++|||||++|+|.++++.... ....+++.+++.++.||+.||.|||++ +||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 468999999999999999964321 234589999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcC-CCCCCC
Q 046972 283 KSSNILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG-RLPVDY 360 (483)
Q Consensus 283 kp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg-~~Pf~~ 360 (483)
||+||||+.++.+||+|||+|+....... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||.+
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986544322 233445789999999998654 489999999999999999996 567876
Q ss_pred CCchhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 361 SQPQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
......+...+.. ...+..|. .++.++.+++.+||+.||++|||+.|++++|+.
T Consensus 240 ~~~~~~~~~~~~~---------~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 240 VKIDEEFCRRLKE---------GTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCCSHHHHHHHHH---------TCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHhc---------CCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 6554333222111 11222332 234688999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=397.85 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=199.2
Q ss_pred HHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC-CeEEEEE
Q 046972 150 IVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-QNRILVY 228 (483)
Q Consensus 150 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~ 228 (483)
+..++|++.+.||+|+||.||+|+++ +..||||++.... ..+.|.+|++++++++|||||+++|+|.+. +..++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 34567888999999999999999984 6789999996543 446799999999999999999999998654 5689999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGP 308 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 308 (483)
||+++|+|.++|... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999643 223589999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 309 EWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
. .....++..|+|||++.+. .++.++|||||||++|||+| |+.||...........+ .....+.
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----------~~~~~~~ 220 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----------EKGYKMD 220 (262)
T ss_dssp ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----------TTTCCCC
T ss_pred C----CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----------HcCCCCC
Confidence 2 2234578899999998655 48999999999999999998 78888766554322111 1112233
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+. .++..+.+|+.+||+.||++|||+.+++++|+.
T Consensus 221 ~~~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 221 APD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCc----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 333 334688999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=400.45 Aligned_cols=265 Identities=19% Similarity=0.222 Sum_probs=205.4
Q ss_pred ccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcch-----HHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 157 EQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSE-----EEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 157 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
..++||+|+||+||+|+.+ +++.||||++....... .+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 58899999986543221 14688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
|.++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99887777663 456789999999999999999999999 99999999999999999999999999998765442
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh--hhh------
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK--IAY------ 382 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~------ 382 (483)
. ......||+.|+|||++.....|+.++|||||||++|||++|..||.+..+...+..+......... ...
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2 2233478999999999876666899999999999999999999999887765544443322110000 000
Q ss_pred -hcCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 383 -VLDPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 383 -~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......+..+. .....++.+|+.+||+.||++|||++|++++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00001111110 112367899999999999999999999999876544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-52 Score=396.49 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=201.2
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCcccccccEEEeCC----e
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS---EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ----N 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~ 223 (483)
.++|++.+.||+|+||+||+|+.. +++.||||++...... ....|.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999964 6889999999765332 2357999999999999999999999997654 3
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.|+|||||+||+|.+++.. .+.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7899999999999999863 35799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 304 KLHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.++.......+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~----~~---- 229 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----RE---- 229 (277)
T ss_dssp EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HC----
T ss_pred hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH----hc----
Confidence 75543222 233445789999999998654 48999999999999999999999998766543322211 11
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHhcc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP-KMGDVLRMLE 426 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~eil~~L~ 426 (483)
++..+.......+..+.+++.+||+.||.+|| |++++++.|.
T Consensus 230 ---~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 230 ---DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 11111111223346889999999999999999 8899888774
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=404.89 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=202.1
Q ss_pred cCCcccceeccCCceEEEEEEEcC-Cc----EEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLD-NM----RAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 226 (483)
++|++.++||+|+||+||+|.+.. |+ .||+|.+... .....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999653 33 5889988654 334567899999999999999999999999865 5678
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
++||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998864 356799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccc-cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhhhhc
Q 046972 307 GPEWSI-STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIAYVL 384 (483)
Q Consensus 307 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (483)
...... ......||+.|+|||++.+. .|+.++|||||||++|||+| |..||.+....... ..+ ..+ .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i----~~~-----~ 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL----EKG-----E 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHH----HHT-----C
T ss_pred ccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHH----HcC-----C
Confidence 543322 23344689999999998655 48999999999999999999 89999876654322 111 111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 385 DPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
.+.. +..++..+.+|+.+||+.||.+|||+.+++++|..
T Consensus 231 ~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 RLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1112 23345789999999999999999999999998854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=397.60 Aligned_cols=270 Identities=19% Similarity=0.291 Sum_probs=209.9
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.++||+|+||+||+|... +++.||+|++...... ..+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 5889999999654322 24679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
|+.+ ++.+++.. .....+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976 55555532 2456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh-----hhh-
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI-----AYV- 383 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~- 383 (483)
.. ......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+....+............. ...
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 22 23345789999999998777767899999999999999999999998776655444333221110000 000
Q ss_pred -cCCCCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 -LDPKLPEMPS-------RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 -~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+.... ...+.++.+|+.+||..||++|||++|++++.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 0011111000 122367889999999999999999999999866544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=401.46 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=208.2
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCC---cchHHHHHHHHHHHh-cCCCCcccccccEEEeCCeEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNS---VSEEEDFIEKVEAIG-QVKHKNLVKLFGYCVEGQNRILV 227 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv 227 (483)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 58889999996432 223356677777665 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccC
Q 046972 228 YEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHG 307 (483)
Q Consensus 228 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 307 (483)
||||++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999963 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCC
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPK 387 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (483)
... .......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+........ . . ..+.
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----~-~------~~~~ 221 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----R-M------DNPF 221 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-H------CCCC
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH----H-c------CCCC
Confidence 432 2334457899999999996655 899999999999999999999999876654332211 1 1 1233
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHhccccc
Q 046972 388 LPEMPSRKELKRIILIALRCVDPDIKHRPKMG-DVLRMLEPRD 429 (483)
Q Consensus 388 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-eil~~L~~~~ 429 (483)
.|.. .+..+.+|+.+||+.||++|||+. +++++.+..+
T Consensus 222 ~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 222 YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 3332 336788999999999999999996 7888766544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-51 Score=395.39 Aligned_cols=267 Identities=20% Similarity=0.254 Sum_probs=210.3
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 230 (483)
++|++.++||+|+||+||+|+.++++.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999765332 246899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCc
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEW 310 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 310 (483)
+.++++..+.+ ....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877777764 457799999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-----hhhh--
Q 046972 311 SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK-----IAYV-- 383 (483)
Q Consensus 311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 383 (483)
. ......+++.|+|||.+.+...++.++|||||||++|||++|+.||.+.+....+............ ....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 2333468889999999877766899999999999999999999999877655544433221110000 0000
Q ss_pred cCCCCC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 384 LDPKLP-------EMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 384 ~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...... .......+..+.+|+.+||+.||++|||++|++++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000000 00111233678899999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=396.19 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=196.7
Q ss_pred hcCCcccceeccCCceEEEEEEEcC----CcEEEEEEecCCC---cchHHHHHHHHHHHhcCCCCcccccccEEEeCCeE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD----NMRAAVKLLMSNS---VSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNR 224 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 224 (483)
.++|++.+.||+|+||+||+|++.. ...||||++.... ....++|.+|++++++++|||||+++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3668999999999999999998643 2368999986542 2234689999999999999999999999965 467
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
++|||||++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999988642 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 305 LHGPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
....... .......++..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+.......+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i----~~~---- 230 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----DKE---- 230 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTS----
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH----HhC----
Confidence 7654322 222334678899999999654 48999999999999999998 89999876654432211 111
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
...+. .+..++..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 231 -~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 -GERLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -CCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111 122344688999999999999999999999998853
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=400.03 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=214.3
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGYC 218 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 218 (483)
++++..++|++.++||+|+||.||+|++. +++.||||++..... .....|.+|+.+++.+ +|||||+++|++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 45567789999999999999999999863 456899999976543 3446799999999999 699999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCC
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSL--------------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKS 284 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp 284 (483)
.+.+..++|||||++|+|.++++... .....+++..+..++.||+.||+|||++ ++|||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 99999999999999999999996532 1234689999999999999999999999 999999999
Q ss_pred CcEEEcCCCCcEEeecccccccCCCc-cccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 046972 285 SNILLDHHWNPKISDVGLAKLHGPEW-SISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQ 362 (483)
Q Consensus 285 ~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~ 362 (483)
+|||++.++.+||+|||+++...... ........||+.|+|||++... .++.++|||||||++|||+| |.+||....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998765432 2334445789999999998544 48999999999999999999 566666655
Q ss_pred chhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 363 PQVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
....+...+.. + ..+..+ ...+..+.+|+.+||+.||++|||+.+|+++|+.
T Consensus 253 ~~~~~~~~i~~----~-----~~~~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 253 VDSKFYKMIKE----G-----FRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SSHHHHHHHHH----T-----CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhc----C-----CCCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 54433332221 1 122222 2334789999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=399.29 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=203.0
Q ss_pred hcCCcccceeccCCceEEEEEEEcC-Cc--EEEEEEecCC-CcchHHHHHHHHHHHhcC-CCCcccccccEEEeCCeEEE
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLLD-NM--RAAVKLLMSN-SVSEEEDFIEKVEAIGQV-KHKNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 226 (483)
.++|++.++||+|+||+||+|.+++ +. .||||.+... .....+.|.+|+++|.++ +|||||+++|++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3778999999999999999999754 33 4678887544 333446899999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhcc------------cCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCC
Q 046972 227 VYEYIDNGNLQQWLHGS------------LGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWN 294 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~ 294 (483)
||||+++|+|.++|+.. ......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999643 12346799999999999999999999999 9999999999999999999
Q ss_pred cEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCchhhHHHHHHH
Q 046972 295 PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGR-LPVDYSQPQVFLIDWLKS 373 (483)
Q Consensus 295 ~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~-~Pf~~~~~~~~~~~~~~~ 373 (483)
+||+|||+|+...... ......||..|+|||.+.... |+.++|||||||++|||++|. .||.+.+..... . .
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-~---~ 238 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-E---K 238 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-H---H
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH-H---H
Confidence 9999999998654322 223346889999999986554 899999999999999999965 567655433221 1 1
Q ss_pred HHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 374 MVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
+.....+.. +..++.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 239 ------i~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 239 ------LPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp ------GGGTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HHhcCCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111112222 23345789999999999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=398.79 Aligned_cols=263 Identities=23% Similarity=0.360 Sum_probs=208.3
Q ss_pred HHHHhcCCcccceeccCCceEEEEEEEcC--------CcEEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCcccccccE
Q 046972 148 IDIVTDGFAEQNVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNSV-SEEEDFIEKVEAIGQV-KHKNLVKLFGY 217 (483)
Q Consensus 148 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 217 (483)
+++..++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 45677899999999999999999998543 24689999976644 3347889999999888 79999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCC
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSLG------------EAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSS 285 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~ 285 (483)
|.+++..++|||||++|+|.++|..... ....+++.+++.++.||+.||+|||++ +||||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 9999999999999999999999965421 235689999999999999999999999 9999999999
Q ss_pred cEEEcCCCCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCc
Q 046972 286 NILLDHHWNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVS-GRLPVDYSQP 363 (483)
Q Consensus 286 NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~t-g~~Pf~~~~~ 363 (483)
|||++.++.+||+|||+++....... .......+++.|+|||.+.+. .|+.++|||||||++|||++ |+.||.+...
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999986643322 223445788899999998554 49999999999999999998 7889876654
Q ss_pred hhhHHHHHHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 364 QVFLIDWLKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.... . . +.....+..|. .++..+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 244 ~~~~-~----~-----i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 EELF-K----L-----LKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHH-H----H-----HHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-H----H-----HHcCCCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 3221 1 1 11111222222 3446889999999999999999999999999643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=401.20 Aligned_cols=255 Identities=17% Similarity=0.258 Sum_probs=200.7
Q ss_pred hcCCcccc-eeccCCceEEEEEEE-cCCcEEEEEEecCCCcchHHHHHHHHHHHhc-CCCCcccccccEEEe----CCeE
Q 046972 152 TDGFAEQN-VIASGDNGVVYRAVL-LDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQ-VKHKNLVKLFGYCVE----GQNR 224 (483)
Q Consensus 152 ~~~~~~~~-~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~----~~~~ 224 (483)
.++|.+.+ .||+|+||+||+|+. .+++.||||++.. ...+.+|++++.+ .+|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788764 699999999999996 4688999999853 2457789998655 589999999999876 4668
Q ss_pred EEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeecc
Q 046972 225 ILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVG 301 (483)
Q Consensus 225 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFG 301 (483)
|+|||||+||+|.++|... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 9999999999999999743 235799999999999999999999999 9999999999999985 5679999999
Q ss_pred cccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhh
Q 046972 302 LAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIA 381 (483)
Q Consensus 302 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (483)
+|+....... .....||+.|+|||++.+.. |+.++|||||||++|||+||+.||.+.........+.. . .
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~------~-i 229 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------R-I 229 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C-C
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH------H-H
Confidence 9987654322 33457999999999986554 89999999999999999999999976554332211100 0 0
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 382 YVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
......+|.......+.++.+|+.+||+.||++|||+.|++++.+
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 001112222222345678999999999999999999999998643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=391.44 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=197.8
Q ss_pred cceeccCCceEEEEEEEcCC----cEEEEEEecCC-CcchHHHHHHHHHHHhcCCCCcccccccEEEe-CCeEEEEEEec
Q 046972 158 QNVIASGDNGVVYRAVLLDN----MRAAVKLLMSN-SVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVE-GQNRILVYEYI 231 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~ 231 (483)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|++++++++|||||+++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999997543 25899998654 33444789999999999999999999999876 46889999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCCcc
Q 046972 232 DNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPEWS 311 (483)
Q Consensus 232 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 311 (483)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999973 445678889999999999999999999 999999999999999999999999999987644322
Q ss_pred ---ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhhhcCCCC
Q 046972 312 ---ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAYVLDPKL 388 (483)
Q Consensus 312 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (483)
.......||..|+|||.+... .++.++|||||||++|||+||..||........... .... + ..+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~-g-----~~~~~ 255 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQ-G-----RRLLQ 255 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH---HHHT-T-----CCCCC
T ss_pred ccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHc-C-----CCCCC
Confidence 122334688999999998544 489999999999999999998888765433221111 1111 1 11222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 389 PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 389 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
| ..++..+.+|+.+||+.||++|||+.||+++|+.
T Consensus 256 p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 256 P----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2 2344688999999999999999999999999854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=396.25 Aligned_cols=265 Identities=20% Similarity=0.335 Sum_probs=214.5
Q ss_pred HHHHHHhcCCcccceeccCCceEEEEEEEc------CCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEE
Q 046972 146 KEIDIVTDGFAEQNVIASGDNGVVYRAVLL------DNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYC 218 (483)
Q Consensus 146 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 218 (483)
+++++..++|++.+.||+|+||+||+|.+. ++..||||++..... .....|.+|++++++++|||||+++|++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 346677789999999999999999999864 257899999975533 3345799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCC
Q 046972 219 VEGQNRILVYEYIDNGNLQQWLHGSL------GEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHH 292 (483)
Q Consensus 219 ~~~~~~~lv~E~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~ 292 (483)
......++|||||++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence 99999999999999999999985321 2234578999999999999999999999 99999999999999999
Q ss_pred CCcEEeecccccccCCCcc-ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCchhhHHHH
Q 046972 293 WNPKISDVGLAKLHGPEWS-ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSG-RLPVDYSQPQVFLIDW 370 (483)
Q Consensus 293 ~~~kl~DFGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg-~~Pf~~~~~~~~~~~~ 370 (483)
+.+||+|||+|+....... .......+|+.|+|||.+.+.. ++.++|||||||++|||+|| ..||.+.+....+...
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986644322 2334446899999999986554 89999999999999999997 5777765543322111
Q ss_pred HHHHHHhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcccc
Q 046972 371 LKSMVAQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPR 428 (483)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~ 428 (483)
.+...+. .+..++..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 249 -------------~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 -------------MEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -------------HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -------------HhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 1223447899999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=392.47 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=198.4
Q ss_pred cCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHH--HHHHHhcCCCCcccccccEEEeCC----eEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIE--KVEAIGQVKHKNLVKLFGYCVEGQ----NRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 226 (483)
++|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+.. |+..+..++|||||+++|++.+.+ .+|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5678889999999999999997 6789999998543 2334444 555566789999999999998654 6799
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI-----EPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
|||||++|+|.++|++ ..+++.+++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999963 35899999999999999999999621 2399999999999999999999999999
Q ss_pred cccccCCCcc---ccccccccCcccccccccCCCC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCchh--------
Q 046972 302 LAKLHGPEWS---ISTSCELRNSGYLAEELSGRTS-----IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV-------- 365 (483)
Q Consensus 302 la~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~-------- 365 (483)
+++....... .......||+.|+|||++.... .++.++|||||||+||||+||..||.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987643322 2234457999999999985432 15678999999999999999998875432111
Q ss_pred --hHHHHHHHHHHhhhhhhhcCCCCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 366 --FLIDWLKSMVAQQKIAYVLDPKLPEMP-SRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 366 --~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
........ .......+|.++... .......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 234 ~~~~~~~~~~----~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 234 SDPSVEEMRK----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SSCCHHHHHH----HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred ccchHHHHHH----HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 00111111 111222233333322 23456779999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=389.40 Aligned_cols=253 Identities=18% Similarity=0.276 Sum_probs=205.6
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc------hHHHHHHHHHHHhcCC--CCcccccccEEEeCC
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS------EEEDFIEKVEAIGQVK--HKNLVKLFGYCVEGQ 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~ 222 (483)
.++|++.+.||+|+||+||+|+.. +++.||||++...... ....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999965 6889999998653211 1234678999999986 899999999999999
Q ss_pred eEEEEEEecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-CCCcEEeec
Q 046972 223 NRILVYEYIDN-GNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-HWNPKISDV 300 (483)
Q Consensus 223 ~~~lv~E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DF 300 (483)
..++||||+.+ +++.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 688888853 35799999999999999999999999 9999999999999985 478999999
Q ss_pred ccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh
Q 046972 301 GLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI 380 (483)
Q Consensus 301 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (483)
|+|+..... ......||+.|+|||++.+...++.++|||||||++|||++|+.||...+. .. ..
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------i~-~~-- 219 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------II-RG-- 219 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HH-HC--
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------Hh-hc--
Confidence 999865433 223457999999999986655467889999999999999999999974211 00 01
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccchhhhHH
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRDLLLREE 435 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~~~~~~~ 435 (483)
...++.. .+.++.+|+.+||+.||++|||++|++++.+..+...+++
T Consensus 220 ----~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p~e 266 (273)
T d1xwsa_ 220 ----QVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266 (273)
T ss_dssp ----CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred ----ccCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCCCC
Confidence 1122222 2367889999999999999999999999887766555443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=386.46 Aligned_cols=269 Identities=20% Similarity=0.229 Sum_probs=204.0
Q ss_pred hcCCcccceeccCCceEEEEEEEc-C-CcEEEEEEecCCCc--chHHHHHHHHHHHhcC---CCCcccccccEEEe----
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-D-NMRAAVKLLMSNSV--SEEEDFIEKVEAIGQV---KHKNLVKLFGYCVE---- 220 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~---- 220 (483)
.++|++.+.||+|+||+||+|+.. + ++.||||++..... .....+.+|+.+++.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999974 3 56789999865322 1223466777776655 89999999999863
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEee
Q 046972 221 -GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISD 299 (483)
Q Consensus 221 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D 299 (483)
....+++|||+.+|++..... .....+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 246799999999877765554 2456789999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh
Q 046972 300 VGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK 379 (483)
Q Consensus 300 FGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (483)
||+++..... .......||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.++...+..+.........
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 9999865432 2334568999999999986554 899999999999999999999999887765554443332111100
Q ss_pred hhh---------hcCCCC---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 IAY---------VLDPKL---PEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~---------~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
... ...... ...........+.+|+.+||+.||++|||+.|++++.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 000 000000 00011123367889999999999999999999999876544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=383.90 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=202.8
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEeCC------
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ------ 222 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 222 (483)
.++|++.++||+|+||+||+|... +++.||||++...... ..+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999975 5889999999764332 3467899999999999999999999997654
Q ss_pred eEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccc
Q 046972 223 NRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGL 302 (483)
Q Consensus 223 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGl 302 (483)
..|+||||| +++|..+++ ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 668888774 24699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh-----
Q 046972 303 AKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ----- 377 (483)
Q Consensus 303 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 377 (483)
|+..... .....+|+.|+|||++.+...++.++||||+||++|||++|+.||.+.+....+..........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 9876543 3445789999999998766668999999999999999999999998776544433322211000
Q ss_pred --------hhhhhhcCCCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 --------QKIAYVLDPKLPEM----PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 --------~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
....... +..... ........+.+|+.+||..||++|||+.|++++.+...
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000000 111100 11122357889999999999999999999999876554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=379.29 Aligned_cols=270 Identities=17% Similarity=0.176 Sum_probs=203.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEe--------C
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVE--------G 221 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~ 221 (483)
++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999974 688999999865422 234678999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecc
Q 046972 222 QNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVG 301 (483)
Q Consensus 222 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFG 301 (483)
+..++|||||.++++..+. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4679999999887766555 2456789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccc---cccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh
Q 046972 302 LAKLHGPEWSI---STSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ 378 (483)
Q Consensus 302 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (483)
+++........ ......||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.++......+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99866543221 223346899999999987665689999999999999999999999987665444333222110000
Q ss_pred -hh-hhhc---------CCCCCCCCCH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 379 -KI-AYVL---------DPKLPEMPSR------KELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 379 -~~-~~~~---------~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. .... .......... .....+.+|+.+||+.||++|||++|++++.+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 00 0000 0000000000 11246778999999999999999999999987654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=385.83 Aligned_cols=266 Identities=20% Similarity=0.197 Sum_probs=202.6
Q ss_pred CCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccccccEEEeC------CeEEE
Q 046972 154 GFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG------QNRIL 226 (483)
Q Consensus 154 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~l 226 (483)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++|||||+++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4777899999999999999975 588999999976532 234799999999999999999998643 34789
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKL 305 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~ 305 (483)
|||||++| +.+.+.........+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999865 4444432223456799999999999999999999999 999999999999999775 899999999987
Q ss_pred cCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH------hhh
Q 046972 306 HGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA------QQK 379 (483)
Q Consensus 306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------~~~ 379 (483)
...... .....|+..|+|||.+.+...|+.++|||||||++|||++|+.||........+..+...... ...
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654322 233478999999998876666999999999999999999999999877765554443321100 000
Q ss_pred hhhhcCCCCCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 380 IAYVLDPKLPE--------MPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 380 ~~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.....+..++. ......+.++.+|+.+||..||++|||+.|++++.+..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00011111111 011223467899999999999999999999999876544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=372.08 Aligned_cols=269 Identities=17% Similarity=0.199 Sum_probs=211.5
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeCCeEEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 229 (483)
++|++.++||+|+||+||+|+.. +++.||||++..... .....+.+|+.+++.++|||||++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 678899999865432 335789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccccccCCC
Q 046972 230 YIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLHGPE 309 (483)
Q Consensus 230 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 309 (483)
++.+++|..++. ..+.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988885 446789999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhh------hhh
Q 046972 310 WSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKI------AYV 383 (483)
Q Consensus 310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~------~~~ 383 (483)
.. ......++..|+|||.+.....++.++|||||||++|||++|+.||....+.......+......... ...
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 22 22334567889999998776667999999999999999999999976555443322222221111000 000
Q ss_pred cC----C-----CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 384 LD----P-----KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 384 ~~----~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.+ + .............+.+|+.+||+.||++|||++|++++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00 0 0000111223467889999999999999999999999876543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=381.97 Aligned_cols=267 Identities=18% Similarity=0.246 Sum_probs=201.7
Q ss_pred cCCcccceeccCCceEEEEEEE-cCCcEEEEEEecCCCc-chHHHHHHHHHHHhcCCCCcccccccEEEeCC----eEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVL-LDNMRAAVKLLMSNSV-SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEGQ----NRIL 226 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 226 (483)
++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|||||++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5699999999999999999996 4788999999975433 33468899999999999999999999997653 2345
Q ss_pred EEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeeccccccc
Q 046972 227 VYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLAKLH 306 (483)
Q Consensus 227 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~~~ 306 (483)
+++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5566779999999953 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCcc--ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhh------
Q 046972 307 GPEWS--ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQ------ 378 (483)
Q Consensus 307 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------ 378 (483)
..... .......||+.|+|||++.....++.++||||+||++|||++|+.||....................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 43322 2234457899999999986666689999999999999999999999987665433222211100000
Q ss_pred -----hhhhh-cCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccc
Q 046972 379 -----KIAYV-LDPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEP 427 (483)
Q Consensus 379 -----~~~~~-~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~ 427 (483)
..... ..+.....+. .....++.+|+.+||+.||++|||+.|++++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 00000 0011110000 0122578899999999999999999999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=377.93 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=211.5
Q ss_pred cCCcccceeccCCceEEEEEEEc----CCcEEEEEEecCCCc----chHHHHHHHHHHHhcCCC-CcccccccEEEeCCe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL----DNMRAAVKLLMSNSV----SEEEDFIEKVEAIGQVKH-KNLVKLFGYCVEGQN 223 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 223 (483)
++|++.+.||+|+||+||+|... +|+.||||.+..... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999852 478899999865321 233568899999999966 899999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999963 34578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhhhhh
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTS-IFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQKIAY 382 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (483)
+.+............|++.|+|||.+.+.. .++.++|||||||+||||++|+.||.+................
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~------ 250 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK------ 250 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH------
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc------
Confidence 877655444455568899999999986443 4788999999999999999999999877655444333322211
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHhccccc
Q 046972 383 VLDPKLPEMPSRKELKRIILIALRCVDPDIKHRP-----KMGDVLRMLEPRD 429 (483)
Q Consensus 383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~eil~~L~~~~ 429 (483)
..+..+. ..+.++.+++.+||+.||++|| |++|++++.+...
T Consensus 251 -~~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 251 -SEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp -CCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -CCCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 1222222 3347899999999999999999 5899998877654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=376.16 Aligned_cols=262 Identities=16% Similarity=0.240 Sum_probs=204.8
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeC--CeEEEEE
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEG--QNRILVY 228 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~ 228 (483)
++|++.++||+|+||+||+|+.. +++.||||++... ..+.+.+|+++|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999974 6888999998654 3467899999999995 99999999999854 5689999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCC-CcEEeecccccccC
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHW-NPKISDVGLAKLHG 307 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DFGla~~~~ 307 (483)
|||.+|+|..+. +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997754 4589999999999999999999999 999999999999998765 58999999998765
Q ss_pred CCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHH---------hh
Q 046972 308 PEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVA---------QQ 378 (483)
Q Consensus 308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------~~ 378 (483)
... ......+|+.|+|||.+.+...++.++||||+||++|||++|+.||............+..... ..
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 432 2334478899999999877666899999999999999999999999876654322111111110 00
Q ss_pred hh------hhhcCC--------CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 379 KI------AYVLDP--------KLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 379 ~~------~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. ...... ..+.......+.++.+|+.+||..||++|||++|++++.+..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 000000 0111111223467899999999999999999999999876544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-46 Score=359.75 Aligned_cols=256 Identities=15% Similarity=0.163 Sum_probs=194.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCCCcccc-cccEEEeCCeEEEEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKHKNLVK-LFGYCVEGQNRILVYEY 230 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~E~ 230 (483)
++|++.+.||+|+||.||+|++. +++.||||++..... ..++..|+++++.++|+|+|. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 56999999999999999999964 588999998876532 245788999999998766554 55566788888999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC---CCCcEEeecccccccC
Q 046972 231 IDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH---HWNPKISDVGLAKLHG 307 (483)
Q Consensus 231 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DFGla~~~~ 307 (483)
+ +|+|.+.+.. ....+++..+..++.|++.||+|||++ +||||||||+|||++. +..+||+|||+|+...
T Consensus 85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 5577776643 346799999999999999999999999 9999999999999854 5579999999998764
Q ss_pred CCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-h
Q 046972 308 PEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK-I 380 (483)
Q Consensus 308 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~ 380 (483)
.... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..................... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 3221 1233457999999999996655 899999999999999999999999876544332222111111000 0
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 381 AYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
.....+ .++.++.+++.+||+.||++||++.++.+.|+
T Consensus 237 ~~~~~~--------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 237 IEVLCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp HHHHTT--------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred hhHhcc--------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 001111 22367899999999999999999999888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=370.31 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=196.4
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCcccccccEEEe------CCe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVS--EEEDFIEKVEAIGQVKHKNLVKLFGYCVE------GQN 223 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~ 223 (483)
++|++.++||+|+||+||+|++. +|+.||||++...... ....+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 5899999999765332 33578999999999999999999999964 368
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
+|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999764 555552 3489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHh------
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQ------ 377 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------ 377 (483)
+...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+.......
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc--ccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8654432 23344789999999999665 48999999999999999999999998776544333322211000
Q ss_pred ---hhhhhhcCC----------------CCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 378 ---QKIAYVLDP----------------KLPEM--PSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 378 ---~~~~~~~~~----------------~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
......... ..+.. ........+.+|+.+||..||++|||++|++++.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000000000 00000 11234578899999999999999999999999987654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=370.55 Aligned_cols=266 Identities=20% Similarity=0.236 Sum_probs=204.5
Q ss_pred hcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCc--chHHHHHHHHHHHhcCCCCcccccccEEEeC-----Ce
Q 046972 152 TDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSV--SEEEDFIEKVEAIGQVKHKNLVKLFGYCVEG-----QN 223 (483)
Q Consensus 152 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 223 (483)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999964 689999999976533 2336789999999999999999999998643 33
Q ss_pred EEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEEeecccc
Q 046972 224 RILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKISDVGLA 303 (483)
Q Consensus 224 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla 303 (483)
.+++|+|+.+|+|.+++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 466778888999999994 34699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHHHHHHHHhhh-hh-
Q 046972 304 KLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDWLKSMVAQQK-IA- 381 (483)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~- 381 (483)
..... ......|++.|+|||...+...++.++|||||||++|+|++|+.||.+.+.......+......... ..
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 75432 2344578889999998777666799999999999999999999999877655444333322111000 00
Q ss_pred --------hh--cCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHhccccc
Q 046972 382 --------YV--LDPKLPEMPS----RKELKRIILIALRCVDPDIKHRPKMGDVLRMLEPRD 429 (483)
Q Consensus 382 --------~~--~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~~~~ 429 (483)
.. ..+..+.... ......+.+|+.+||+.||.+|||+.|++++.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 00 0011111110 112367889999999999999999999999876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7e-46 Score=356.98 Aligned_cols=257 Identities=14% Similarity=0.181 Sum_probs=202.6
Q ss_pred HhcCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCCC-CcccccccEEEeCCeEEEEE
Q 046972 151 VTDGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVKH-KNLVKLFGYCVEGQNRILVY 228 (483)
Q Consensus 151 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 228 (483)
..++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+|++.++.++| +|++.+++++......++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3578999999999999999999965 57899999885543 22357788999999965 89999999999999999999
Q ss_pred EecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcC-----CCCcEEeecccc
Q 046972 229 EYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDH-----HWNPKISDVGLA 303 (483)
Q Consensus 229 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~-----~~~~kl~DFGla 303 (483)
||+ +|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7899999864 335689999999999999999999999 9999999999999974 577999999999
Q ss_pred cccCCCcc------ccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchhhHHHH--HHHHH
Q 046972 304 KLHGPEWS------ISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQVFLIDW--LKSMV 375 (483)
Q Consensus 304 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~ 375 (483)
+....... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.......... +....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 87543211 1223457999999999996654 899999999999999999999999865543322211 11111
Q ss_pred HhhhhhhhcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHhcc
Q 046972 376 AQQKIAYVLDPKLPEMPSRKELKRIILIALRCVDPDIKHRPKMGDVLRMLE 426 (483)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~eil~~L~ 426 (483)
....... +.+. +++++.+++..|+..+|++||+++.+.+.|.
T Consensus 233 ~~~~~~~-l~~~--------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 233 QSTPLRE-LCAG--------FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHSCHHH-HTTT--------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CCCChHH-hcCC--------CCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1111111 1111 2257889999999999999999998887764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-41 Score=333.69 Aligned_cols=267 Identities=18% Similarity=0.217 Sum_probs=194.1
Q ss_pred cCCcccceeccCCceEEEEEEEc-CCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-----------CCcccccccEEEe
Q 046972 153 DGFAEQNVIASGDNGVVYRAVLL-DNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-----------HKNLVKLFGYCVE 220 (483)
Q Consensus 153 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~ 220 (483)
++|++.++||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++++.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999974 689999999975432 3457788998888774 5789999998864
Q ss_pred --CCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCC---
Q 046972 221 --GQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWN--- 294 (483)
Q Consensus 221 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~--- 294 (483)
....+++|+++..+......... .....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 35667777776655433333221 355678999999999999999999998 6 9999999999999987654
Q ss_pred ---cEEeecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCchh------
Q 046972 295 ---PKISDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILIMEIVSGRLPVDYSQPQV------ 365 (483)
Q Consensus 295 ---~kl~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el~tg~~Pf~~~~~~~------ 365 (483)
+|++|||.|..... ......||+.|+|||++.... ++.++||||+||+++||++|+.||.......
T Consensus 168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc----ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 89999999975532 234457899999999987554 8999999999999999999999997543321
Q ss_pred hHHHHHHH-------HHHhhh-hhhhcC--------CC-----------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 046972 366 FLIDWLKS-------MVAQQK-IAYVLD--------PK-----------LPEMPSRKELKRIILIALRCVDPDIKHRPKM 418 (483)
Q Consensus 366 ~~~~~~~~-------~~~~~~-~~~~~~--------~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 418 (483)
.+...+.. ...... .....+ .. .........+..+.+|+.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111100 000000 000000 00 0112345667889999999999999999999
Q ss_pred HHHHHhccccc
Q 046972 419 GDVLRMLEPRD 429 (483)
Q Consensus 419 ~eil~~L~~~~ 429 (483)
+|+|++.+..+
T Consensus 323 ~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 323 GGLVNHPWLKD 333 (362)
T ss_dssp HHHHTCGGGTT
T ss_pred HHHhcCcccCC
Confidence 99999877654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1e-25 Score=201.58 Aligned_cols=169 Identities=15% Similarity=0.133 Sum_probs=120.1
Q ss_pred cccceeccCCceEEEEEEEcCCcEEEEEEecCCCcc------------------hHHHHHHHHHHHhcCCCCcccccccE
Q 046972 156 AEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVS------------------EEEDFIEKVEAIGQVKHKNLVKLFGY 217 (483)
Q Consensus 156 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpnIv~~~~~ 217 (483)
.+.++||+|+||+||+|...+|+.||||++...... ....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999989999999987532111 01234568889999999999988765
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeecCCCCcEEEcCCCCcEE
Q 046972 218 CVEGQNRILVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDIEPKIVHHNMKSSNILLDHHWNPKI 297 (483)
Q Consensus 218 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDlkp~NiLl~~~~~~kl 297 (483)
. ..+++|||++++.+.+ ++...+..++.|++.||.|||++ +|+||||||+|||+++++ ++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEE
Confidence 3 2379999998865433 33344567899999999999999 999999999999999764 899
Q ss_pred eecccccccCCCccccccccccCcccccccccCCCCCCCcchhhHHHHHHH
Q 046972 298 SDVGLAKLHGPEWSISTSCELRNSGYLAEELSGRTSIFNEKSDVYSFGILI 348 (483)
Q Consensus 298 ~DFGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv~l 348 (483)
+|||+|.............. ... ...+.+.+ .|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~r--d~~-~~~~~f~r--~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER--DVR-NIITYFSR--TYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH--HHH-HHHHHHHH--HHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH--HHH-HHHHHHcC--CCCCcccHHHHHHHH
Confidence 99999976543211110000 000 00122322 278899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=7.9e-08 Score=87.95 Aligned_cols=148 Identities=16% Similarity=0.099 Sum_probs=99.4
Q ss_pred HHHHHhcCCcccceeccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEE
Q 046972 147 EIDIVTDGFAEQNVIASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRI 225 (483)
Q Consensus 147 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 225 (483)
++.-..+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444446677666655555678998864 55667888876543333345677888777663 434677788888889999
Q ss_pred EEEEecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------------------------
Q 046972 226 LVYEYIDNGNLQQWLHGSLGEAKPLTWDTRMKIIQGTAKGLAYLHEDI-------------------------------- 273 (483)
Q Consensus 226 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 273 (483)
+||++++|.++.+.... . . ....++.+++..++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~----~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED----E--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTT----C--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEecccccccccccc----c--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999888665421 0 1 12234455556666666431
Q ss_pred ------------------------CCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 274 ------------------------EPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 274 ------------------------~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137999999999999987666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=8.7e-06 Score=73.46 Aligned_cols=73 Identities=12% Similarity=0.138 Sum_probs=51.9
Q ss_pred eccCCc-eEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC--CCcccccccEEEeCCeEEEEEEecCCCCH
Q 046972 161 IASGDN-GVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK--HKNLVKLFGYCVEGQNRILVYEYIDNGNL 236 (483)
Q Consensus 161 lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~E~~~~g~L 236 (483)
+..|.. +.||+....++..+++|........ .+..|...++.+. .-.+.+++++..+++..++||++++|-++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444543 6899998878888888986554332 3556666666553 33467778888888889999999988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00015 Score=69.67 Aligned_cols=76 Identities=13% Similarity=0.079 Sum_probs=47.0
Q ss_pred cceeccCCceEEEEEEEc-CCcEEEEEEecCC------C-cchHHHHHHHHHHHhcCC-C--CcccccccEEEeCCeEEE
Q 046972 158 QNVIASGDNGVVYRAVLL-DNMRAAVKLLMSN------S-VSEEEDFIEKVEAIGQVK-H--KNLVKLFGYCVEGQNRIL 226 (483)
Q Consensus 158 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~~l 226 (483)
.+.||.|....||++... +++.+++|.-.+. . .....+...|.+.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999854 4677888865321 1 112234456777776552 2 345555554 4556689
Q ss_pred EEEecCCCC
Q 046972 227 VYEYIDNGN 235 (483)
Q Consensus 227 v~E~~~~g~ 235 (483)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.06 E-value=0.0016 Score=60.49 Aligned_cols=135 Identities=17% Similarity=0.157 Sum_probs=77.2
Q ss_pred eEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-----CCcccccc--cEEEeCCeEEEEEEecCCCCH---
Q 046972 167 GVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-----HKNLVKLF--GYCVEGQNRILVYEYIDNGNL--- 236 (483)
Q Consensus 167 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~--~~~~~~~~~~lv~E~~~~g~L--- 236 (483)
-.||++...+|..+++|+..+... ..+++..|...+..|. .+..+..- ..+......+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 489999998999999999865532 3456777888777663 22222221 233456778899999986432
Q ss_pred --HHH------H---hc----c-cCCCCCCCHH----------------------HHHHHHHHHHHHHHHh-hhCCCCCe
Q 046972 237 --QQW------L---HG----S-LGEAKPLTWD----------------------TRMKIIQGTAKGLAYL-HEDIEPKI 277 (483)
Q Consensus 237 --~~~------l---~~----~-~~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~i 277 (483)
..+ + +. . .......+.. .....+..+...+.-+ ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 1 10 0 0011111111 1122223333332222 12224578
Q ss_pred eeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 278 VHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 278 iHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
||+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4589999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.30 E-value=0.005 Score=58.67 Aligned_cols=72 Identities=17% Similarity=0.245 Sum_probs=46.9
Q ss_pred ceeccCCceEEEEEEEcC--------CcEEEEEEecCCCcchHHHHHHHHHHHhcCC-CCcccccccEEEeCCeEEEEEE
Q 046972 159 NVIASGDNGVVYRAVLLD--------NMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-HKNLVKLFGYCVEGQNRILVYE 229 (483)
Q Consensus 159 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E 229 (483)
+.|+.|-.=.+|++...+ ...+++++.- .. .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 567778888999998654 3456666654 22 22345667888888774 4334567776632 67999
Q ss_pred ecCCCCH
Q 046972 230 YIDNGNL 236 (483)
Q Consensus 230 ~~~~g~L 236 (483)
|++|-.|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.16 E-value=0.085 Score=47.78 Aligned_cols=158 Identities=10% Similarity=0.044 Sum_probs=80.0
Q ss_pred ehHHHHHHhcCCccccee-----ccCCceEEEEEEEcCCcEEEEEEecCCCcchHHHHHHHHHHHhcCC-----CCcccc
Q 046972 144 SLKEIDIVTDGFAEQNVI-----ASGDNGVVYRAVLLDNMRAAVKLLMSNSVSEEEDFIEKVEAIGQVK-----HKNLVK 213 (483)
Q Consensus 144 ~~~~~~~~~~~~~~~~~l-----g~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~ 213 (483)
+.++++-...+|.+++.. ..|---+.|+....+| .+++|+...... .++...|++++..|. -|..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 445666666778775544 3454567899887665 588998755322 123334555555442 233332
Q ss_pred ccc---EEEeCCeEEEEEEecCCCCHHH--------------HHhc---ccCCC--CCCCH------------------H
Q 046972 214 LFG---YCVEGQNRILVYEYIDNGNLQQ--------------WLHG---SLGEA--KPLTW------------------D 253 (483)
Q Consensus 214 ~~~---~~~~~~~~~lv~E~~~~g~L~~--------------~l~~---~~~~~--~~l~~------------------~ 253 (483)
..+ +..-......++.+..+..... .++. ..... ..... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 211 2233455667777776643210 0000 00000 00000 0
Q ss_pred HHHHHHHHHHHHHHHhhh-CCCCCeeeecCCCCcEEEcCCCCcEEeeccccc
Q 046972 254 TRMKIIQGTAKGLAYLHE-DIEPKIVHHNMKSSNILLDHHWNPKISDVGLAK 304 (483)
Q Consensus 254 ~~~~i~~~i~~~l~~LH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DFGla~ 304 (483)
.....+..+...+.-.+. ..+.++||+|+.+.||+++.+...-+.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 123489999999999999988777899999774
|